Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.6383794066126046,1.8210608961392387,0.0,1.0,0.51,24/60,20.91%,LCMT2;THUMPD1;RPP40;ADAT2;RTRAF;FTSJ1;TSEN2;NSUN6;ADAT1;TSEN15;TRIT1;TRMT61A;DTWD1;DTWD2;THG1L;KARS1;ZBTB8OS;TRMT1;ANKRD16;POP1;CLP1;NSUN2;TRPT1;CDKAL1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.8281763676698357,1.7413682260547563,0.0,1.0,0.88,3/15,4.00%,ITGA1;BMP2;PPP1R15B
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.7985797234452883,-1.7397011605658483,0.0,0.1388457824677564,0.12,18/43,11.40%,GBP2;TRIM22;SP100;GBP1;B2M;CIITA;ICAM1;HLA-A;TRIM5;IRF1;HLA-C;HLA-DRA;CD44;IFNGR2;STAT1;IRF7;HLA-B;HLA-E
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.7375405741521015,-1.723130204983324,0.0,0.14810216796560682,0.21,35/81,14.14%,GBP2;IFI44L;MX1;B2M;IFITM3;WARS1;GMPR;TRIM5;IRF1;IFI35;IL15;HLA-C;PARP14;BST2;CMPK2;IFIT3;PSMB9;PLSCR1;PARP9;TMEM140;HERC6;IL4R;HELZ2;IRF7;ISG15;EPSTI1;DDX60;LPAR6;IFIH1;PROCR;SP110;IFIT2;IL7;C1S;IFI44
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.8200022581806767,-1.7229428996408147,0.0,0.09873477864373788,0.21,4/25,6.53%,LEF1;SP100;MSX2;GATA1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.7874119255746533,1.7185116467596278,0.0,1.0,0.94,2/29,2.36%,ACP3;ABCA1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.7500224551011834,-1.7119000811889944,0.0,0.11801891509759295,0.32,5/45,2.23%,ANXA1;PIF1;RECQL4;BLM;RPS27A
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.741206236367199,-1.7115655204995663,0.0,0.09441513207807435,0.32,47/85,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.7033333977484187,-1.7060616705776637,0.0,0.08485020039696224,0.35,24/117,12.07%,GGT5;LEF1;ANXA1;IL1R1;SP100;POU4F1;MX1;CIITA;TIMP2;IFITM3;NLRP12;APP;BST2;TIMP1;PLSCR1;CHI3L1;SRF;IL1RAPL1;OSMR;STAT1;PTPN7;ISG15;SELP;SIGIRR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),0.907543167344081,1.7056017045591736,0.0,1.0,0.95,4/12,4.61%,TFB2M;FASTKD1;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.7478081660594565,-1.7028289660117324,0.0,0.08330746948065385,0.38,23/62,11.40%,GBP2;TRIM22;SP100;GBP1;TLR2;B2M;CIITA;ICAM1;HLA-A;TRIM5;IRF1;CCL2;HLA-C;HLA-DRA;GBP7;CD44;IFNGR2;RPL13A;STAT1;WNT5A;IRF7;HLA-B;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.9209133059165139,1.7021725020605654,0.0,1.0,0.97,1/9,0.60%,RGCC
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),0.7702911916119848,1.6923650894676936,0.0,1.0,0.98,1/16,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.768736221421265,1.6874296906374968,0.0,1.0,0.98,2/31,2.36%,ACP3;ABCA1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8179257211809253,-1.6866953842344377,0.0136986301369863,0.09256385497850425,0.51,19/38,13.26%,GBP2;IFI6;SP100;MX1;IFIT1;IFITM3;HLA-A;IRF1;IFI35;HLA-C;BST2;IFIT3;STAT1;IRF7;ISG15;HLA-B;HLA-E;HLA-F;IFIT2
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8179257211809253,-1.6866953842344377,0.0136986301369863,0.09256385497850425,0.51,19/38,13.26%,GBP2;IFI6;SP100;MX1;IFIT1;IFITM3;HLA-A;IRF1;IFI35;HLA-C;BST2;IFIT3;STAT1;IRF7;ISG15;HLA-B;HLA-E;HLA-F;IFIT2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7188407510925298,-1.6853037807753877,0.0,0.08793566222957905,0.51,47/87,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.8329234044625317,-1.680075143501925,0.0,0.0908808757970769,0.57,3/28,2.72%,GGT5;AWAT1;ALOX12
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.624705937653039,1.6787261562075617,0.0,1.0,0.99,22/63,17.39%,ABCD2;CEL;PEX13;ABCD1;ACADM;MCAT;PHYH;ABHD1;CPT2;LPIN3;ABCD3;EHHADH;PLA2G15;SCP2;ECHDC1;AIG1;ACOX1;PEX2;ACADS;SLC25A17;ACAD10;BDH2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7108511630766036,1.676936169895914,0.0,1.0,0.99,11/31,19.78%,NR1D1;CCDC88C;FBXL3;BTRC;PLK1;DERL1;MUL1;PEX2;EP300;MDM2;PYHIN1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.9414556796222753,-1.6731680973496479,0.0,0.10182024047635468,0.66,2/7,2.79%,P2RY12;SHTN1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.7017753494545304,1.6693840253522203,0.0,1.0,0.99,13/37,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.8162447745821977,-1.6679719269830635,0.015384615384615385,0.1082285073594819,0.72,2/16,7.04%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.8241065756071323,-1.6624330613681346,0.0,0.11702715950853754,0.79,2/16,0.47%,LEF1;HPN
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6942909434078869,-1.6608455294963211,0.0,0.11416208780682191,0.79,48/105,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;HELZ2;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6689669708178269,-1.6607298119616172,0.0,0.10702695731889555,0.79,66/147,19.30%,IFI44L;SOCS3;C1R;MX1;B2M;CIITA;ICAM1;IFIT1;IFITM3;P2RY14;WARS1;HLA-A;IRF1;STAT4;IFI35;IL15;NOD1;NLRC5;GPR18;CCL2;PARP14;BST2;CMPK2;IFIT3;PSMB9;PLSCR1;HERC6;BTG1;STAT1;IL4R;HELZ2;IRF7;ISG15;EPSTI1;HLA-B;APOL6;SELP;DDX60;NAMPT;CFH;IFIH1;MVP;PIM1;MTHFD2;SP110;IFIT2;IL7;RNF213;C1S;IFI44;TNFAIP2;ZNFX1;CD74;SERPING1;MARCHF1;HLA-DRB1;PML;USP18;PSME1;RIPK2;NMI;CDKN1A;IL15RA;SAMD9L;PARP12;ARID5B
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5823377752710267,1.6605699621543604,0.0,1.0,1.0,23/52,24.10%,LCMT2;THUMPD1;ADAT2;TFB1M;FTSJ1;PUS7L;APOBEC3F;NSUN6;TRIT1;TRMT61A;DTWD1;DTWD2;THG1L;TRMT1;ANKRD16;NSUN3;NSUN2;CDKAL1;RBM15;MEPCE;URM1;JMJD6;ADARB1
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.7780379769203655,1.6597042354547948,0.0,0.9683004844630357,1.0,7/15,16.19%,PRDX6;GDE1;LYPLA2;PLA2G4C;MGLL;GPCPD1;ABHD6
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.8400170285416988,1.6578102126285692,0.0,0.9139507624013343,1.0,5/13,12.91%,TOP3B;MTERF1;HMGB1;TOP1MT;ERCC3
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.7264234377740273,1.6524369658806826,0.0,0.9080103325690871,1.0,3/21,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.6588441399659046,-1.6522287463122483,0.0,0.11924402494289665,0.83,37/118,14.02%,COL4A1;SOCS3;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;ITGA2;PHEX;COL6A2;SULF1;ITGA5;NOD1;THY1;LMOD1;BGN;MMP14;PODN;CD44;COL11A2;OLFML1;SRPX2;OSMR;EMP1;WNT5A;THBS2;IGFBP7;ALPL;FN1;SFRP4;RUNX2;IGFBP5;PRRX1;C1QTNF1;PTH1R;C1S
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.6345017214002981,1.651259606472649,0.0,0.8580982158101417,1.0,16/48,17.39%,ABCD2;ABCD1;ACADM;MCAT;CPT2;ABCD3;EHHADH;ETFDH;SCP2;ECHDC1;ACOX1;PEX2;ACADS;SLC25A17;ACAD10;BDH2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.6849306351109555,-1.6505152658920617,0.0,0.11673330600066925,0.83,30/89,15.16%,COL4A1;ANGPTL2;SPARC;C1R;TLR2;COL4A2;ICAM1;COL5A1;COL6A2;SULF1;B4GALNT1;THY1;LMOD1;BGN;MMP14;PODN;TLR3;LDB2;ELN;SRPX2;THBS2;IGFBP7;AEBP1;CFH;PRRX1;SNED1;MMRN2;C1S;ROBO4;SERPING1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7136080391880786,-1.6504579461556976,0.0,0.11058944779010772,0.83,47/88,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7074771642164177,1.6491455041986003,0.0,0.8272283032055658,1.0,6/25,7.53%,LIMD1;MEN1;GREM1;SOX9;RORB;RANBP3L
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.6031088800437827,1.6467988829335631,0.0,0.8026679363054766,1.0,20/79,14.94%,RANBP17;NXT2;GDAP1;ABCD2;NUP62CL;SAMM50;PPP1R10;PEX13;ABCD1;AKT1;IPO5;RAB8B;IPO8;TOMM22;ABCD3;NUP214;NXT1;RANBP6;PEX2;NUP188
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7767044743886881,-1.6424564155272574,0.0,0.12866375842012093,0.91,11/30,14.41%,IL1R1;RASGRP1;HLA-A;IL12A;TLR3;ZFPM1;ISG15;IL18;FADD;SLC11A1;BTN3A1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.9153290434600305,-1.641909753924115,0.0,0.12694471539909155,0.92,3/9,7.04%,ENPP2;CYP1B1;PDXDC1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.6711513065748318,-1.6417398928886728,0.0,0.12159524585812605,0.92,29/80,19.03%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;PODN;LDB2;GFAP;ELN;THBS2;FN1;SLIT3;IGFBP5;PRRX1;RASL12;C1S;TNS2;COL12A1;TEK;AQP1;PCDH18;PDGFRA;SVEP1
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.6929202920390618,-1.6414715247656855,0.0,0.11791830221174673,0.93,24/80,12.74%,ECM2;COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;ABCA8;ASPN;SULF1;THY1;LMOD1;BGN;PODN;MYH11;ELN;ITGA8;ITGA11;THBS2;SLIT3;SFRP4;IGFBP5;PRRX1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6964965665369122,-1.6397250106122083,0.0,0.11531913599405323,0.93,48/97,20.53%,RPL19;RPL3;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;MAN1A1;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.7567042477733337,1.6352410318811281,0.0,0.8611330459279495,1.0,6/20,12.34%,BMP2;GPATCH2;PPP6R1;PPP1R36;PPP1R26;ZCCHC9
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.9213932641909569,-1.6311495081472052,0.0,0.13773501620801434,0.95,1/10,0.04%,GGT5
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.7316908171628177,1.6296944212791216,0.0,0.8601347465470918,1.0,9/21,17.57%,GDAP1;PLD6;MFF;CHCHD3;OPA1;THG1L;MIEF2;VPS11;MIGA1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.7950763244314227,-1.6289428318888017,0.0,0.1399138269482776,0.95,4/43,3.17%,GGT5;CD24;CXCL2;IL12A
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.844512082231917,1.6282403276493547,0.05,0.8307847447498719,1.0,1/10,0.16%,DGKB
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.7643056814826928,-1.6260491647409319,0.013513513513513514,0.14501670613299003,0.96,11/33,10.15%,CD24;P2RY13;IL13RA1;IGHG1;GFI1B;POU2F3;IRAG2;IL4R;IRF7;KLF3;CTSS
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.8180438035294657,-1.6243299461790164,0.0,0.142812804823978,0.96,6/19,9.67%,SOCS3;NLRC5;PARP14;PARP9;IFNGR2;STAT1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.6463910561632565,-1.623375096768121,0.0,0.14076089670869096,0.97,39/100,19.03%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;COL6A2;SULF1;THY1;LMOD1;BGN;CCL2;PODN;LDB2;TIMP1;GFAP;SYP;SRPX2;THBS2;IGFBP7;MEG3;FN1;SLIT3;IGFBP5;PRRX1;C1QTNF1;RASL12;C1S;PNPLA3;TNS2;RELN;COL12A1;TEK;VCL;PCDH18;PTPN21;PDGFRA;SVEP1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.8482261533483922,1.623181862556256,0.05128205128205128,0.844333093490085,1.0,2/7,6.63%,SLC35G1;LETM1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.7584685674674374,-1.6228965900619334,0.0,0.13730305155144798,0.97,10/29,19.00%,CLIC1;P2RY12;GATA1;FN1;MYH9;PIK3CB;TLN1;VCL;FERMT3;PDGFRA
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.6774669871098893,-1.6224988171319075,0.0,0.13496407242027073,0.97,34/118,13.92%,IL1R1;RASGRP1;SLC28A2;HPN;SCN1B;MET;APLNR;GPR183;TLR2;ICAM1;PDPN;IRF1;KCNJ2;IL15;ITGA5;CCL2;BEST1;MMP14;TLR3;BST2;TIMP1;LDLR;IFNGR2;OSMR;IL4R;IRF7;CD55;SLC7A2;NAMPT;IL18;HRH1;GPC3;CLEC5A;VIP
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.8393265835521153,-1.6212791748131086,0.015151515151515152,0.134506851765639,0.97,4/18,5.98%,CXCL2;DUSP1;DOCK8;CCL2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.8591939335519035,-1.6183000227726623,0.016129032258064516,0.13828478940728062,0.99,3/17,1.91%,SLC28A2;RPE65;B2M
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.5810400038090298,1.6178794366564528,0.0,0.8228677966164604,1.0,16/50,20.89%,NUP42;NUP37;NUP54;IPO8;NDC1;NUP214;RAE1;AAAS;NUP188;POLR2C;NUP205;PUM2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.5810400038090298,1.6178794366564528,0.0,0.8228677966164604,1.0,16/50,20.89%,NUP42;NUP37;NUP54;IPO8;NDC1;NUP214;RAE1;AAAS;NUP188;POLR2C;NUP205;PUM2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.6106090692625209,1.617223815948391,0.0,0.7952203293068124,1.0,12/68,10.04%,G0S2;LEPR;KSR2;PPARGC1A;ADIPOR1;ELOVL6;PDGFC;ESRRG;PRKAB1;SIRT6;HSF1;CPT2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.6679989364192844,-1.6149104780269974,0.0,0.14129600215836385,0.99,21/71,15.49%,CD24;CD5;TAGAP;TMC8;IGHG1;ARHGAP9;HLA-DRA;ACAP1;IFIT3;RCSD1;WAS;IRAG2;CRELD2;CTSS;BIRC3;CD55;P2RY10;SP140;BLNK;CD74;CD37
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.8247677753638863,1.614515393943531,0.044444444444444446,0.7829861703943999,1.0,5/12,10.74%,ELOVL6;ELOVL4;ABCD1;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5739125524419544,1.6141396918708744,0.0,0.756810760628308,1.0,39/93,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MTIF2;FASTKD2;MRPS9;MRPL58;GATC;MRPS2;MRPL50;QRSL1;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;LARS2;MRPL47;NOA1;MRPL4;MRPS11;MRPL1;MTRF1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7502424821693865,1.612031341798503,0.0,0.743954883045928,1.0,5/19,3.42%,CPA1;ACE2;CEL;ANXA4;AMY2B
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.6729573778431502,-1.6109063085639885,0.0,0.14704429533728106,0.99,23/83,12.75%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;CSPG4;COL5A1;SPON2;COL6A2;SULF1;THY1;LMOD1;BGN;MMP14;PODN;TIMP1;SRPX2;THBS2;FN1;IGFBP5;PRRX1;C1QTNF1
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.676093103389364,-1.6099597445147167,0.0,0.1463023152299137,0.99,27/69,19.03%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;MATN2;ASPN;SULF1;LMOD1;BGN;PODN;MYH11;ELN;SRPX2;THBS2;SLIT3;IGFBP5;SLCO2A1;RASL12;C1S;SERPING1;TNS2;COL12A1;TEK;AQP1;PDGFRA;SVEP1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.6511179809531865,-1.604191895238685,0.0,0.16086096959777904,0.99,56/142,20.87%,GGT5;RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;CARNS1;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;EEF1A2;RPL23;RPL4;RHD;RPL18A;RPL41;RPL7;RPS12;RPS20;COPS5;MRPL23;RPL15;MRPL51;RPL11;RPS25;RPL29;RPL36;GGTA1
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.9270654323231173,-1.6032237660777149,0.0,0.1593072661998468,0.99,3/8,4.70%,CDKN2A;B2M;ARG2
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6857452916417183,-1.600907568173712,0.0,0.16163073138554207,0.99,21/77,13.26%,IFI44L;IFI6;TLR2;MX1;IFIT1;IFITM3;TRIM5;IRF1;NLRC5;TLR3;BST2;IFIT3;PLSCR1;STAT1;IRF7;ISG15;MAP3K14;IFIH1;FADD;RNASE1;IFIT2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6358468913269845,-1.6005690414269444,0.0,0.15944124020047357,0.99,43/165,11.69%,KLF2;IL1R1;COL8A1;COL4A1;ANGPTL2;FOSB;SPARC;C1R;COL4A2;FOSL2;LAMB1;ADAMTS10;COL5A1;COL4A4;CTHRC1;SPON2;FBLN7;ASPN;COX7A1;COL6A2;SULF1;PI16;KLF4;THY1;LMOD1;BGN;MMP14;PODN;GSTM5;CYP1B1;CD44;ELN;LRRK1;SRPX2;IGF1;THBS2;IGFBP7;HHIP;P4HTM;FN1;SLIT3;CD55;COPZ2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.8077110635108187,1.5985562382421943,0.020833333333333332,0.8519201687846045,1.0,4/11,10.74%,ELOVL6;ELOVL4;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.7174417011363574,1.5959561234770003,0.0,0.8201628393375449,1.0,13/33,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.7174417011363574,1.5959561234770003,0.0,0.8201628393375449,1.0,13/33,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.8617173024454634,-1.5957516379491306,0.0,0.1670664699612028,0.99,3/12,10.60%,TJP3;LSR;ARHGEF18
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.6662397598836987,-1.5951456706607539,0.0,0.1648518179140981,0.99,17/74,17.53%,ENPP2;THBS1;SPARC;PROX1;RAB11A;EGF;VIL1;WNT5A;FGF1;MAPRE2;FGF7;HYAL1;GPI;PIK3CB;PIK3CD;TEK;ETS1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6290470099681215,-1.5944762027488848,0.0,0.1625249081599319,0.99,24/99,14.62%,GGT5;CXCL2;ANXA1;THBS1;TLR2;CIITA;ADGRE5;SIGLEC1;TPST1;PRDX5;NOD1;CCL2;CD44;CHI3L1;MMP25;IL18;HRH1;TNFRSF1A;TAC4;SLC11A1;APOL3;FOS;HYAL1;BLNK
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.6577346450619967,-1.59430140288761,0.0,0.15946227744024144,0.99,48/111,19.04%,ECM2;COL4A1;ANGPTL2;APLNR;SPARC;C1R;COL4A2;ICAM1;CSPG4;P2RY14;ABCA8;ASPN;COX7A1;COL6A2;THY1;LMOD1;BGN;PODN;LDB2;ZIC1;ELN;THBS2;ALPL;SLIT3;GLI1;IGFBP5;SLC38A11;PRRX1;C1QTNF1;RASL12;PTH1R;C1S;ROBO4;PDZD2;SERPING1;TNS2;MCAM;PDE5A;TEK;NOTCH3;ADGRF5;AQP1;ANGPT2;PCDH18;HIGD1B;PDGFRA;SVEP1;ADM
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.5541447146281466,1.589795082537387,0.0,0.8619896512031372,1.0,25/91,21.51%,NUP62CL;NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;DDX25;NUP205;THOC1;AGFG1;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.6467076733774226,-1.589428112996036,0.0,0.17175737534900234,1.0,33/103,17.30%,ENPP2;NPY;RIMBP2;TAGLN3;CDH22;PCSK2;CHGB;STMN2;CCK;SH3GL2;LRRTM1;SYT4;ELAVL4;GAP43;SYP;PLPPR1;SCG5;CPLX2;CA10;HPCA;SST;CALY;KCNB2;GAD2;GLP1R;KCNC1;GDAP1L1;RAB3C;PTPRN;TCEAL5;SYT13;VWA5B2;SULT4A1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8715379967399479,1.5884178154581896,0.023809523809523808,0.8496338849346935,1.0,3/9,7.32%,ABCD2;ABCD1;MID1IP1
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.8892457949810157,1.5877339320665496,0.023809523809523808,0.8300950106321884,1.0,2/6,8.97%,SNX18;SPIRE2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7468610537499549,-1.5870045922144917,0.0,0.1772799048610049,1.0,9/34,12.29%,GGT5;ANXA1;WNT8B;CCL2;TLR3;CYP1B1;ALPL;IL18;IGFBP5
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.9116052868613825,-1.5868661529514738,0.0,0.1737049363639165,1.0,3/9,4.70%,CDKN2A;B2M;ARG2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.6786091390183768,1.5846111743654463,0.06451612903225806,0.8337972599403429,1.0,11/27,20.01%,GDAP1;ABCD2;PEX13;ABCD1;RAB8B;ABCD3;PEX2;SLC25A17;PEX6;ZFAND6;PEX12
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.9182309196527723,-1.5843384451312803,0.0,0.1781854208336207,1.0,2/11,0.10%,PRAME;KLF2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.7957055446108465,-1.5814154023117868,0.0,0.18493880413052177,1.0,7/24,5.98%,CD24;IL13RA1;GPR87;ICAM1;FLG;DUOXA1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.5803605845728758,1.5812519046702775,0.0,0.8408647162125905,1.0,13/78,10.04%,G0S2;LEPR;KSR2;PPARGC1A;ADIPOR1;ELOVL6;ACACB;PDGFC;ESRRG;PRKAB1;SIRT6;HSF1;CPT2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.6963130687160051,-1.5808488649807193,0.013333333333333334,0.18346156056739543,1.0,26/65,15.87%,TYMP;ZFP36;ADGRE5;IRF1;IFI35;TMC6;PIM3;HLA-C;ANO9;RPS6KA1;RHBDF2;IL4R;HELZ2;IRF7;MMP25;CD55;HLA-E;SBNO2;SIGIRR;TC2N;IFIH1;ARRDC2;HLA-F;ST6GALNAC2;PRKCD;JUNB
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.864333753634613,-1.5801574911115297,0.0,0.18258674138897113,1.0,4/11,6.84%,CIITA;IFITM3;TRIM5;BST2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.7415951941459868,-1.5798355631792196,0.0,0.18014350238124288,1.0,10/29,13.63%,P2RY13;MYO1F;TLR2;SIGLEC1;IGSF6;CLEC12A;CTSS;PILRA;SLC11A1;CLEC5A
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.8502444529453865,1.5795940306937328,0.02631578947368421,0.8329976417107735,1.0,1/12,1.07%,LIMD1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.8509252144822798,-1.5789626941265726,0.018867924528301886,0.17849105620383274,1.0,2/11,5.06%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.8751601129750748,-1.5786906555696416,0.0,0.17621415355167108,1.0,4/10,9.10%,CACNA1H;KCNB1;SYT4;SYT1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.8955596595041734,-1.5777715623892536,0.016666666666666666,0.17587132445915812,1.0,3/9,3.31%,CIITA;IFITM3;TRIM5
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.7972565551071881,-1.5777587290089345,0.018518518518518517,0.17273076509381602,1.0,4/20,6.47%,CDKN2A;SUV39H1;CENPV;POLE3
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.786219611338662,-1.5775711427007064,0.0136986301369863,0.1700251862499894,1.0,4/24,0.81%,ANXA1;PIF1;RECQL4;BLM
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.9568698317559345,1.576769008000475,0.022727272727272728,0.8344757543526111,1.0,2/6,2.60%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.8252808475126631,-1.5763038001378755,0.0,0.1722006888307002,1.0,5/18,6.92%,CCBE1;C3;SULF1;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7713350554376595,-1.5759767246869534,0.0,0.16975269675718915,1.0,6/28,6.56%,KLF2;EPN1;THBS1;ITGA5;KLF4;CEACAM1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.803198385320048,-1.5752865075498308,0.0,0.17000894697718616,1.0,9/21,13.03%,CACNA1H;SCN1B;KCNJ2;SCN9A;YWHAH;SCN2A;CACNA1C;SCN1A;SCN3B
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.6906973404083526,-1.571902372079097,0.0,0.17754050872926228,1.0,12/41,7.63%,CD24;CXCL2;P2RY13;MYO1F;DOCK8;NR1I3;TLR2;TAGAP;ARG2;CEACAM1;IGSF6;CLEC12A
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.7567849978425523,-1.5691257125175413,0.016129032258064516,0.18572489611816018,1.0,4/29,8.26%,ENPP2;FSCN1;CLRN1;VIL1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7510768878154187,-1.5664705572378221,0.0,0.1945310222087931,1.0,9/25,11.40%,GBP2;TLR2;HLA-A;IL12A;GBP7;TNFRSF14;LYG1;ROMO1;HLA-E
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.7307593458504168,-1.5664429395617845,0.0,0.19163610601018463,1.0,11/44,10.01%,ANXA1;DHCR24;MET;COL5A1;ALOX12;LSR;FLG;ABCA12;FA2H;CLIC4;WNT5A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.9374472843042496,-1.5646389852872662,0.0,0.1942416895241228,1.0,3/9,3.17%,THBS1;APLNR;IL12A
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.8769659624754635,-1.5598132386833317,0.015625,0.21065289420865668,1.0,4/14,6.56%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.8991098393957304,-1.5591048243539092,0.05263157894736842,0.20930483625736412,1.0,2/8,0.78%,ANXA1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8254079094883368,-1.5573434570644902,0.015873015873015872,0.2145303462442981,1.0,5/17,6.92%,CCBE1;C3;SULF1;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.6534929549005077,-1.5571134975961738,0.012658227848101266,0.2128968664505598,1.0,22/74,16.48%,OPTC;COL8A1;COL4A1;COL4A2;COL5A1;COL4A4;COL27A1;COL6A2;SCX;COL24A1;CYP1B1;COL11A2;P4HA2;P3H2;COL10A1;P4HA3;PPIB;TLL1;LAMA3;ITGB4;COL12A1;COL9A2
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.7131385790708132,1.555477088071459,0.0,1.0,1.0,13/35,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;NUP205;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7173615970161846,1.5539820666163733,0.0,1.0,1.0,2/21,2.98%,RGCC;DACH1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.9275537731661132,1.5519957203906705,0.02,1.0,1.0,3/6,6.76%,ERCC8;LIG4;ERCC6
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.8851294863770232,-1.5513566140373447,0.015873015873015872,0.2363022983522673,1.0,2/11,1.34%,DUSP1;DOCK8
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.7985222799450894,-1.5494272296285516,0.0,0.2394926783035385,1.0,6/20,6.23%,COL8A1;DUSP1;COL4A2;LAMB1;ITGA5;MMP14
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6572113841626949,-1.5489862438289252,0.0,0.23848048747934086,1.0,21/84,13.26%,IFI44L;IFI6;TLR2;MX1;IFIT1;IFITM3;TRIM5;IRF1;NLRC5;TLR3;BST2;IFIT3;PLSCR1;STAT1;IRF7;ISG15;MAP3K14;IFIH1;FADD;RNASE1;IFIT2
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7673280885524607,-1.5484877496405112,0.016666666666666666,0.23736922810926026,1.0,8/23,15.97%,COL8A1;COL4A2;LAMB1;ITGA5;MMP14;FN1;LAMA3;COL12A1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.7052782471337112,-1.5474274666715735,0.0,0.24029076407257663,1.0,9/44,9.54%,ARHGAP4;EPS8L2;SHTN1;PDPN;ARHGEF3;ARHGDIG;WAS;CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.898377517091831,-1.546919689894691,0.0,0.23869132737123636,1.0,1/9,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.8475582629358358,-1.5463185577821563,0.0,0.2377429538395268,1.0,4/11,6.56%,CD24;APOLD1;MAFF;CEACAM1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6909305429386579,-1.5462150999749973,0.02564102564102564,0.2352564470038089,1.0,8/52,10.92%,ENPP2;AGPAT4;PLAAT4;PLB1;ANGPTL3;PLPPR1;PLPPR5;LPCAT4
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.8976530255560509,-1.54620599510841,0.01818181818181818,0.23247768192678187,1.0,1/8,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.8095505441247068,1.546127492695379,0.023809523809523808,1.0,1.0,1/12,0.54%,PTCD2
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.9057348625120893,-1.5460968440663503,0.0,0.2301207736427625,1.0,1/12,0.18%,ANXA1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.6575123802560678,1.5452765907879682,0.030303030303030304,1.0,1.0,5/21,18.25%,MYO10;CCDC88C;KIF1B;MAP6;CCDC88A
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.923334752671718,-1.5450303436338753,0.0,0.23106252299009125,1.0,1/10,0.04%,GGT5
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.853911899692855,1.5444550078666752,0.046511627906976744,1.0,1.0,1/8,0.25%,LEPR
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),0.8476418921887695,1.5441893343691049,0.0,0.98649222181694,1.0,1/12,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.7812493975542689,-1.5431946464359412,0.015873015873015872,0.2352950338280744,1.0,4/20,7.79%,ANXA1;THBS1;RHOBTB2;XKR4
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.8842414136713779,1.5425630641726618,0.043478260869565216,0.9810088355813558,1.0,2/5,5.84%,BCL10;FAM3A
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.9057435341130777,-1.5423513122845716,0.03773584905660377,0.23626359569513347,1.0,1/5,0.33%,THBS1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7106078531744807,1.542053266541885,0.09090909090909091,0.9631462213553459,1.0,3/11,4.15%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.9372165761434734,1.54182969859312,0.02127659574468085,0.9433801706632181,1.0,2/5,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.9693589710623629,-1.5417439521366436,0.0,0.23676272785465607,1.0,1/6,0.11%,LEF1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.6379423905933389,-1.5417278843367725,0.0,0.23405431901707507,1.0,7/101,4.35%,CACNA1H;CD24;CP;KCNQ1;ANK3;MAOB;PODXL
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.880806171773012,-1.5375678921309388,0.0,0.24796223268947554,1.0,1/8,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6917821440718321,1.5372924879913923,0.05405405405405406,0.9611876013744238,1.0,8/20,16.37%,GDAP1;ABCD2;PEX13;ABCD1;RAB8B;ABCD3;PEX2;SLC25A17
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.7171062663280512,-1.5367676779391175,0.0,0.2490613493258824,1.0,14/39,15.88%,CD24;TAGAP;IGHG1;KLF4;PDK1;CD9;PRDM1;P2RY10;CCR10;PPIB;SSR4;CD74;CD37;MAN1A1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.7276814237582855,-1.5362057276436167,0.0,0.24896485132149423,1.0,6/32,7.39%,CDKN2A;GPNMB;KLF4;CCL2;GFI1B;PLK3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.6281363257423053,-1.5359257693612574,0.0,0.24687200867562442,1.0,14/87,9.24%,ENPP2;EFNA1;SOCS3;CSPG4;IL12A;IL15;ITGA5;GATA1;PARP14;PTK6;CD44;TNFRSF14;PARP9;IGF1
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.6718759916960728,1.5359225612323872,0.029411764705882353,0.9550424574815415,1.0,10/25,20.01%,GDAP1;ABCD2;PEX13;ABCD1;RAB8B;ABCD3;PEX2;SLC25A17;PEX6;PEX12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7408856483268582,-1.5355169890074833,0.0,0.24586623951593717,1.0,9/23,13.21%,RASGRP1;HLA-A;IL12A;CD160;HLA-DRA;HLA-B;HLA-E;FADD;HLA-F
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),0.9057482949205142,1.535297478372316,0.0,0.940038628990951,1.0,3/9,4.61%,TFB2M;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.8520092049999107,-1.5352896177186666,0.017543859649122806,0.2437514847767279,1.0,2/12,0.99%,THBS1;MET
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.9264738326306403,-1.5343499894270713,0.0,0.2443278897344695,1.0,2/7,2.09%,TLCD2;ANK3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.5796170350706037,1.5340201035338599,0.0,0.9318713655856743,1.0,13/70,15.10%,RANBP17;NUP62CL;NUP42;U2AF1;RITA1;RANBP3L;XPO1;EIF4E;NUP214;RAE1;XPO7;NUP188;THOC3
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.8854203340370269,1.533278032644747,0.0,0.9189844950486598,1.0,1/8,1.59%,AMER2
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.8795511137952061,-1.532000949226267,0.017857142857142856,0.2502242470995001,1.0,2/12,1.14%,MET;NR4A3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.6492108353876705,-1.5312974742749812,0.0,0.2512163117911234,1.0,32/92,19.03%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;ABCA8;MATN2;ASPN;COX7A1;LMOD1;BGN;PODN;CYP1B1;MYH11;ELN;THBS2;TPM4;IGFBP5;PRRX1;C1QTNF1;RNASE1;RASL12;RASD1;C1S;TNS2;COL12A1;TEK;ADGRF5;AQP1;PTPN21;PDGFRA;SVEP1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.6943895181652588,-1.5303240218709138,0.0,0.2529750462125292,1.0,10/36,19.00%,CLIC1;P2RY12;GATA1;FN1;MYH9;PIK3CB;TLN1;VCL;FERMT3;PDGFRA
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8942171305964532,-1.5296926218120381,0.0,0.2530403488201848,1.0,3/9,0.33%,KLF2;EPN1;THBS1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8917921827118446,1.528812579822208,0.0,0.927519954754994,1.0,1/8,0.30%,ACE2
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8917921827118446,1.528812579822208,0.0,0.927519954754994,1.0,1/8,0.30%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.7265828363505779,-1.528611892065542,0.0,0.25628617347173366,1.0,7/37,5.98%,ANXA1;DOCK8;HLA-A;IL15;THY1;PDCD1LG2;CCL2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.8322065577285178,-1.5284645353450914,0.0,0.25421660789972716,1.0,4/12,9.67%,SOCS3;PARP9;IFNGR2;STAT1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.6100890505993852,-1.5276940336707183,0.0,0.25407833662466983,1.0,39/124,19.30%,LEF1;COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;COL5A1;SULF1;THY1;LMOD1;BGN;FILIP1L;PODN;LDB2;ITGA8;SRPX2;THBS2;FGF1;FN1;IGFBP5;PRRX1;AMOTL2;RASD1;C1S;ROBO4;SFRP2;DLC1;TNS2;SNCG;COL12A1;PML;TEK;MRC1;ANGPT2;PCDH18;PDGFRA;SVEP1;ARID5B
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6158194010530336,1.5273854949780876,0.03571428571428571,0.9226573292253247,1.0,8/33,23.19%,PTCD2;RBM23;PAPOLA;IWS1;QKI;SLTM;RBM39;JMJD6
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.7216168994450339,-1.5265945899466122,0.0,0.25553233904671935,1.0,5/29,6.31%,CDKN2A;GPNMB;KLF4;CCL2;GFI1B
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6050548706670501,-1.5264744626783147,0.0,0.25306957951123066,1.0,53/147,19.53%,CXCL2;KLF2;EFNA1;SOCS3;FOSB;DUSP1;NR4A3;GPR183;TLR2;ICAM1;FOSL2;ZFP36;IRF1;BTG3;PLK2;ATF3;MAFF;KLF4;CCL2;TRIP10;CD44;CCND1;LDLR;IFNGR2;GADD45A;BTG1;SPSB1;BIRC3;IER3;NAMPT;IL18;TNIP2;IFIH1;IFIT2;FOS;NR4A1;TNFAIP2;JUNB;F3;CEBPD;BCL6;IRS2;PFKFB3;RIPK2;GADD45B;IER2;CDKN1A;IER5;IL15RA;GFPT2;BHLHE40;PLAUR;KLF6
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.524463631769093,1.526460432558728,0.0,0.9153264408888022,1.0,27/93,22.51%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;IWS1;DDX25;NUP205;THOC1;AGFG1;PCID2;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1;ENY2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.69056772236725,-1.5260043082694792,0.014285714285714285,0.2525801824957997,1.0,12/46,14.41%,IL1R1;RASGRP1;HLA-A;IL12A;PDCD1LG2;TLR3;ZFPM1;ISG15;IL18;FADD;SLC11A1;BTN3A1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.9280881757424948,-1.523407096918549,0.017241379310344827,0.2607215248561203,1.0,1/8,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.7547321019906074,-1.522459717676175,0.014285714285714285,0.26115588598789646,1.0,3/25,5.61%,ABCA5;ABCA8;ABCA12
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8923535773345648,-1.5213637973964487,0.01694915254237288,0.26345097186189675,1.0,4/10,8.26%,ENPP2;PDPN;CD44;VIL1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5585640520106552,-1.5186810381123832,0.0,0.2731956062651283,1.0,91/376,17.04%,CXCL2;ANXA1;GBP2;IL1R1;IFI6;SOCS3;TRIM22;SP100;IL13RA1;GBP1;MX1;B2M;CIITA;ICAM1;RPS27A;IFIT1;IFITM3;HLA-A;IL12A;TRIM5;IRF1;INPP5D;STAT4;IFI35;SLA;ST18;DUOX1;IL15;FSCN1;NOD1;CCL2;HLA-C;HLA-DRA;CEACAM1;BST2;CD44;TIMP1;CCND1;TNFRSF14;IFIT3;PSMB9;F13A1;IFNGR2;CA1;LMNB1;OSMR;STAT1;IL4R;TCP1;IRF7;ISG15;PSMB6;BIRC3;HLA-B;SYK;FN1;HLA-E;IL17RE;IL18;NUMBL;PSMC3;TNIP2;MAP3K14;GREM2;PIM1;UBC;TNFRSF1A;HLA-F;IFIT2;IL7;FOS;IL3RA;PIK3CB;PSMA8;LTBR;VAV1;IL1RAP;PRKCD;PIK3CD;JUNB;IL27RA;PSMA7;HLA-DRB1;F3;ANXA2;CEBPD;STAT6;PML;BCL6;NDN;IRS2
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.8145447946635286,-1.5180138106319756,0.0,0.27332534536105507,1.0,6/18,8.45%,GRIN2D;PLK2;GRIN2A;SLC24A2;SLC24A1;SLC8A3
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.8923537911592642,-1.518006100106654,0.05555555555555555,0.27077090288104516,1.0,3/8,4.38%,MET;PROX1;CCDC39
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.735267869495196,1.517667808113256,0.02702702702702703,0.9867191080398623,1.0,5/13,16.37%,SLC19A1;SLC25A24;SLC25A41;SLC25A5;SLC25A17
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.6520075020642826,-1.5173215625796679,0.013333333333333334,0.27143493399715096,1.0,16/65,15.80%,ENPP2;EFNA1;CSPG4;IL15;ITGA5;APP;GATA1;CD44;TNFRSF14;IGF1;DMTN;FGF7;CD74;SFRP2;PRKCD;RELN
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.8928521448741229,-1.5164988849329173,0.0,0.2731058326705227,1.0,1/9,0.47%,HPN
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5296780498901025,1.516458137981939,0.0,0.9804986701736208,1.0,24/88,21.51%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;DDX25;NUP205;THOC1;AGFG1;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1
prerank,MSigDB_Hallmark_2020__Coagulation,-0.6408867441253777,-1.5156485058218099,0.0,0.27474635136801495,1.0,22/85,16.45%,ANXA1;THBS1;HPN;C3;SPARC;C1R;ITGA2;MAFF;F8;MMP14;TIMP1;CD9;FN1;PRSS23;CFH;F10;C1S;WDR1;SERPING1;PLAT;SH2B2;F3
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.7188752206768075,1.515172820110132,0.0,0.9764180120556888,1.0,8/18,17.57%,GDAP1;PLD6;MFF;CHCHD3;OPA1;THG1L;MIEF2;MIGA1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.5627768105225449,1.5149246816350375,0.0625,0.9639379161686871,1.0,33/78,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MTRF1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.8823948177892507,1.514849891316169,0.02040816326530612,0.9486953575237141,1.0,2/6,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8528664276909992,1.514725205028066,0.023255813953488372,0.9346787274119196,1.0,2/6,9.15%,CHPT1;PLA2G4C
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.8676995472189893,1.5145699210925052,0.0,0.9218296482841044,1.0,1/8,0.08%,MEOX2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.6134178535338026,-1.5145469084777403,0.0,0.2781085192372178,1.0,22/101,12.60%,KCNT2;DEPP1;RIMBP2;PGR;PCSK2;CHGB;STMN2;RCAN2;PROX1;GC;SH3GL2;SYT4;GRIA3;LDB2;EDIL3;PLPPR1;SCG5;SST;SHC2;KCNB2;IGFBP5;F10
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),0.9485167588809211,1.5145035929413335,0.027777777777777776,0.9076038821068806,1.0,2/5,3.04%,ACP3;NT5C1A
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.6806222540313174,1.514058799100368,0.06451612903225806,0.8988933360475959,1.0,8/23,20.01%,ABCD2;PEX11A;MFF;ABCD1;ABCD3;PEX2;PEX6;PEX12
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.9814224333217203,-1.513370726366199,0.0,0.28165858729173443,1.0,1/5,1.64%,COL4A2
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.9318704619651167,-1.513179093815438,0.0,0.27998518258099786,1.0,1/5,2.20%,ZFP36
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.6027504938183296,-1.513071898620789,0.0,0.2781787431196102,1.0,34/155,11.51%,ECM2;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;ADAMTS10;COL5A1;THSD4;ITGA2;COL4A4;ADAMTSL2;MMP19;COL27A1;COL6A2;MMP21;ITGA5;APP;BGN;COL24A1;MMP14;MARCOL;CD44;COL11A2;ELN;ITGA8;COL10A1;ADAM19;MMP25;ITGA11;FN1;MMP24
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5566788853591429,1.5129641687716582,0.05555555555555555,0.8921710812237105,1.0,35/84,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRRF;MRPS9;MRPL58;MRPS2;MRPL50;APEH;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MTRF1;MRPS10;MRPL17;MRPS21;ABCE1;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.7849835486244908,-1.5120871740713622,0.0,0.2803477451218525,1.0,5/25,3.62%,GGT5;ANXA1;POU4F1;WNT8B;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7700875658513686,-1.5118447388698444,0.0,0.27920769704291937,1.0,9/20,13.21%,B2M;HLA-A;CD160;TNFRSF14;WNT5A;SCIMP;CD55;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),-0.9006210535909096,-1.5117247141535635,0.029850746268656716,0.2775333361235837,1.0,2/7,0.96%,CACNA1H;SERPINA10
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.5400732339931178,1.5115499684784606,0.037037037037037035,0.8926137464037165,1.0,14/66,18.45%,ATP6V0D2;ATP6V1A;EIF2S1;ATP6V1G1;MIOS;SESN2;EIF2AK4;MAPK8;WDR24;DAP;PRKD1;SESN3;EIF2AK3;SLC38A9
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6031721613619746,-1.5113634916866108,0.0,0.27706401337633646,1.0,34/155,11.51%,ECM2;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;ADAMTS10;COL5A1;THSD4;ITGA2;COL4A4;ADAMTSL2;MMP19;COL27A1;COL6A2;MMP21;ITGA5;APP;BGN;COL24A1;MMP14;MARCOL;CD44;COL11A2;ELN;ITGA8;COL10A1;ADAM19;MMP25;ITGA11;FN1;MMP24
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.6372992978312165,-1.5107713380257473,0.01282051282051282,0.27761378018343,1.0,18/70,14.82%,MET;STMN2;PSRC1;PROX1;APP;LMOD1;CAV3;SYNPO2L;BAIAP2;BAIAP2L1;VIL1;CDC42EP1;PFN2;CDC42EP3;DCTN1;FES;MYLK3;WDR1
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5920192302014331,-1.5087037077623522,0.011111111111111112,0.2849424002421623,1.0,29/140,13.63%,IFI6;C3;TRIM22;SP100;TLR2;MX1;B2M;CIITA;TRIM61;IFIT1;IFITM3;SFTPD;TRIM5;SLA;COLEC12;APP;NLRC5;TLR3;BST2;PTK6;TRIM17;IRF7;ISG15;SYK;HLA-E;IFIH1;SLC11A1;FES;CLEC5A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),-0.919134915793029,-1.5085214613298024,0.018867924528301886,0.283122997748301,1.0,2/7,3.17%,CDKN2A;IL12A
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7446344685205978,-1.5070609590521284,0.0,0.2869479504333632,1.0,12/37,10.01%,GBP2;SP100;GBP1;TLR2;CIITA;IFITM3;CCL2;BST2;GBP7;RPL13A;STAT1;WNT5A
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.9130724676550993,1.5068987661403161,0.0,0.9208254765539475,1.0,1/6,2.79%,LIG4
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.9800321695907794,-1.50654780614837,0.0,0.28754999176655677,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.8356922928684251,1.505899532856139,0.05128205128205128,0.9172114285396143,1.0,1/11,0.67%,POLD3
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.7515873299703149,1.5050019944649724,0.025,0.9125625777457986,1.0,3/12,8.19%,SLC19A1;SLC25A24;SLC25A41
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.7101613496866646,1.5038927951593748,0.05555555555555555,0.9122122288966856,1.0,6/17,11.00%,ABCD2;ACACB;ABCD1;MID1IP1;CPT2;ABCD3
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.6273016109643212,-1.5037735122921105,0.0,0.29754800479380483,1.0,35/107,17.72%,THBS1;COL4A1;ANGPTL2;C3;APLNR;CALD1;C1R;COL4A2;CDH6;CLDN16;MAOB;LMOD1;BGN;LDB2;NRGN;IGF1;SPSB1;IGFBP7;IGFBP5;C1QTNF1;SLCO2A1;RNASE1;RASL12;MMRN2;C1S;ROBO4;SLC14A2;SERPING1;TNS2;PXDC1;FMO2;TEK;SHROOM4;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.7341360755160139,-1.5028511167450274,0.0,0.2999068901303538,1.0,4/27,7.61%,LEF1;HPN;LRRC19;POU2F3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9237928624334109,-1.502339475481142,0.0,0.30017135828743524,1.0,1/7,0.02%,ENPP2
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.8999467939690822,-1.502308993284959,0.0,0.29788068921035193,1.0,2/7,3.62%,RPE65;RBP2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6509212272691742,1.5012637122445605,0.08108108108108109,0.9208812638722896,1.0,3/17,4.15%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.8037089649920588,-1.5010302064443324,0.05263157894736842,0.3006878976567349,1.0,1/14,0.05%,CD24
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.9641641068122456,-1.500654292094836,0.0,0.2996485723955301,1.0,1/6,0.33%,THBS1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.540246459128221,1.50000678665622,0.038461538461538464,0.9188675709430935,1.0,14/65,18.45%,ATP6V0D2;ATP6V1A;EIF2S1;ATP6V1G1;MIOS;SESN2;EIF2AK4;MAPK8;WDR24;DAP;PRKD1;SESN3;EIF2AK3;SLC38A9
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.8780743196028714,1.4988280810191175,0.0196078431372549,0.9162931338799957,1.0,1/5,1.83%,MACIR
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.5774972673804166,1.4977208880733897,0.09090909090909091,0.9131803824483525,1.0,21/49,17.39%,ABCD2;PPARGC1A;ADIPOR1;PEX13;ABCD1;ACADM;CYP4V2;MCAT;PHYH;CPT2;ABCD3;EHHADH;ADH5;SCP2;ECHDC1;ACOX1;PEX2;ACADS;SLC25A17;ACAD10;BDH2
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),0.8659633343139778,1.4952257134568103,0.10526315789473684,0.9189844950486599,1.0,1/5,0.48%,DAO
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.7403215872016725,1.494608564076211,0.0625,0.9116314366869257,1.0,1/8,12.29%,MAPK12
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.7649730523674761,-1.4941309769658506,0.0,0.33002574448105176,1.0,7/23,19.45%,IFI6;IL12A;IFIH1;VWCE;LGALS8;GSDME;EIF5A
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.5578638702307481,1.4929877418549313,0.0,0.9159934365190895,1.0,13/42,13.59%,ERCC8;PRIMPOL;MEN1;MAPK10;ERCC6;ERCC2;TYR;DCT;MAPK8;DRD2;ERCC3;FECH;GTF2H2
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.8990447362903278,-1.4915913021005263,0.015384615384615385,0.34022516161946414,1.0,2/9,1.11%,TMEM204;APLNR
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.7316382915652775,-1.491281328674438,0.04225352112676056,0.3391203050576111,1.0,4/30,12.36%,LEF1;PDE6B;WNT5A;GNG2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.7217367643412501,1.4906384744516497,0.06896551724137931,0.9234142905924535,1.0,5/15,15.97%,NXT2;XPO1;NXT1;AAAS;NUP205
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.9535921797575726,-1.4903669623083529,0.0,0.34060714756751875,1.0,1/6,0.54%,EFNA1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.7602890934103488,-1.4900372270471467,0.057971014492753624,0.3389633107309854,1.0,3/19,6.31%,CD24;SCX;GFI1B
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.6230468814713507,-1.4899820666769863,0.012345679012345678,0.3367953004847503,1.0,25/87,15.16%,IL1R1;P2RY6;IL13RA1;TLR2;ITGA2;SLC39A14;SERPINF1;SIGLEC1;MMP19;CCL2;DYSF;MMP14;ITPR3;F13A1;CHI3L1;FAM20C;SNX10;CTSZ;RNASE1;CLEC5A;PTH1R;EGFL7;TNFAIP2;RASSF4;SERPING1
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),-0.9235056648643349,-1.489685345494352,0.01639344262295082,0.3358842825874401,1.0,1/5,0.11%,LEF1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.6382776798356204,1.4895114609168867,0.03225806451612903,0.9216873906223322,1.0,3/28,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.8243139891290453,-1.4887130116458978,0.0,0.33883776110744446,1.0,3/11,7.22%,CD24;PODXL;BASP1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.6446747775719363,-1.4874557571327496,0.0,0.34201673661985016,1.0,10/61,5.06%,KLF2;EPN1;THBS1;ISM1;SPARC;COL4A2;SERPINF1;CD160;SULF1;KLF4
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5989539534842638,-1.4872084218518116,0.0,0.3409546312877279,1.0,30/109,14.18%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL4A2;CSPG4;COL5A1;CHAD;COL6A2;SULF1;THY1;LMOD1;BGN;MMP14;PODN;ELN;COL10A1;STAT1;EMP1;THBS2;IGFBP7;FN1;SLIT3;AEBP1;RUNX2;IGFBP5;PRRX1;C1S;CRTAC1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),-0.9215909354771471,-1.4871571254933895,0.0,0.3387837092213256,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.7212071244966116,-1.487143900300839,0.0,0.3365779322516251,1.0,4/33,4.18%,SCN1B;PKP2;ANK3;CHRM1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.8479764895142949,1.486836161807932,0.024390243902439025,0.9301192305503385,1.0,4/8,13.24%,ZC3H8;SNAPC5;SNAPC1;SNAPC3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.882560887665085,-1.486520134294935,0.0,0.33785807067154056,1.0,1/6,0.11%,LEF1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6647899754255198,-1.4854500677889357,0.014084507042253521,0.3413858539556864,1.0,12/50,12.36%,MX1;ZFP36;IFIT1;IFITM3;PROX1;TRIM5;BST2;HEXIM1;PLSCR1;STAT1;ISG15;IFIH1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.6092910959410247,-1.484222006233428,0.0,0.3457645666176211,1.0,25/118,13.93%,IL1R1;COL4A1;ANGPTL2;CALD1;COL4A2;THY1;GFRA2;LMOD1;BGN;MAP1B;EFNB3;SCARA3;GAP43;ARHGEF17;EDIL3;SHC2;NUAK1;DAB2IP;ADCY5;IGFBP5;NOS1;AMOTL2;CRMP1;TNFRSF1A;PTH1R
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6689944119644106,-1.4838119403860295,0.015384615384615385,0.3455504462059611,1.0,11/44,6.48%,LEF1;SP100;CD5;TAGAP;SKAP1;TMC8;GPR171;SLA;ARHGAP9;ARHGAP15;ACAP1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.7841533703200316,-1.483046813499658,0.019230769230769232,0.3467340567653697,1.0,5/15,7.85%,KLF2;HPN;APP;KLF4;EGF
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.5805797998007014,-1.4824903162512713,0.023529411764705882,0.3463903171678585,1.0,44/156,18.15%,ECM2;THBS1;COL4A1;SPARC;CALD1;COL4A2;COL5A1;ITGA2;CDH6;CTHRC1;MATN2;IL15;COL6A2;ITGA5;THY1;BGN;MMP14;CD44;TIMP1;BASP1;EDIL3;ELN;GADD45A;PFN2;WNT5A;THBS2;FN1;SLIT3;SFRP4;TPM4;PRRX1;PDLIM4;BDNF;PPIB;SNTB1;LAMA3;COL12A1;EMP3;OXTR;GPC1;SPP1;GADD45B;TGFB1;ENO2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.6434100747349872,1.4823122452056425,0.05555555555555555,0.9590248222889435,1.0,5/28,13.24%,ZC3H8;SNAPC5;RO60;SNAPC1;SNAPC3
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.6258119270033725,-1.4822311646815696,0.0,0.3449254460854399,1.0,19/73,11.47%,COL4A1;ANGPTL2;SPARC;CALD1;C1R;COL5A1;ABCA8;COL6A2;THY1;LMOD1;BGN;PODN;LDB2;ELN;GALNT15;ITGA11;THBS2;IGFBP7;AEBP1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6255009967521001,-1.482187121314218,0.014492753623188406,0.3428590037760839,1.0,22/62,11.27%,P2RY13;MYO1F;GBP1;TYMP;TLR2;MX1;ICAM1;TAGAP;IFIT1;IFITM3;DYSF;HLA-DRA;IGSF6;CD44;TNFRSF14;IFIT3;CLEC12A;PLSCR1;IRF7;CTSS;PILRA;FN1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7440424452178287,-1.4819784960325755,0.04838709677419355,0.3416223341073331,1.0,3/24,4.28%,ANXA1;THBS1;DUOX1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.705053196342353,-1.481852884822688,0.013888888888888888,0.3403407436030832,1.0,7/27,13.21%,B2M;HLA-A;MFSD6;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.6940865340401987,-1.4813306244710795,0.014925373134328358,0.34102472886817364,1.0,3/29,1.53%,THBS1;MET;P2RY12
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.8442594172549397,1.480812246093546,0.044444444444444446,0.9629643938568,1.0,3/8,7.14%,SOX8;SOX9;RORB
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.7462286163103851,-1.4807332598171006,0.014705882352941176,0.34151827539454677,1.0,3/25,4.35%,COL4A1;MET;PODXL
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5772866710399845,-1.4805844257345304,0.011363636363636364,0.3399016882489881,1.0,25/168,11.98%,CACNA1H;IL13RA1;MET;PKP2;ALDOB;GPR87;COL5A1;KDELR3;LDHA;GMPPB;SLC16A3;CHST4;HK2;TPST1;VLDLR;CD44;GLRX;P4HA2;GAPDHS;TGFA;PDK3;PGK1;PYGL;IER3;GALK1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.5937133022530179,1.480067662473457,0.058823529411764705,0.9575972889582671,1.0,10/49,11.03%,ASCL1;NCSTN;BMP2;POFUT1;MAML3;KAT2B;PBX1;NOTCH2;HEYL;DTX4
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.7972468088403674,1.4798383348380268,0.0,0.9494108984724161,1.0,3/11,9.29%,WNT7A;CXXC4;STIL
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.8044292824087746,-1.4798277433822888,0.03076923076923077,0.341471046946508,1.0,3/15,5.65%,CACNA1H;KCNB1;SYT4
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6316292195861885,1.4790684461238266,0.045454545454545456,0.9449878722935388,1.0,15/39,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;JMJD8;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.7412442953304759,-1.4790238897730212,0.046153846153846156,0.3437323153144071,1.0,3/18,4.28%,THBS1;P2RY12;DUOX1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.7029397526321981,1.4782722050048198,0.0,0.9405357132343851,1.0,5/23,10.09%,CHAMP1;ZNF207;SGO2;NSL1;PLK1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.9115092390585704,-1.4782563937992466,0.01639344262295082,0.3450804096746404,1.0,1/7,2.19%,KDELR3
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),-0.9410223812691155,-1.4781888134806462,0.0,0.34301352588553324,1.0,1/8,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.572124563550003,-1.476883177064687,0.0,0.3466778342119452,1.0,45/217,11.51%,ECM2;OPTC;THBS1;COL8A1;COL4A1;SPARC;COL4A2;ICAM1;LAMB1;ADAMTS10;COL5A1;TIMP2;THSD4;ITGA2;SCUBE3;COL4A4;ADAMTSL2;MMP19;COL27A1;COL6A2;MMP21;ITGA5;APP;SCX;BGN;COL24A1;MMP14;MARCOL;CYP1B1;CD44;TIMP1;COL11A2;ELN;ITGA8;P4HA2;P3H2;KIF9;COL10A1;ADAM19;CTSS;MMP25;ITGA11;P4HA3;FN1;MMP24
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8158796287233299,-1.4767674347427242,0.0,0.3452631790698209,1.0,5/17,9.67%,IFITM3;IRF1;BST2;PLSCR1;STAT1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.9152387120702827,-1.4767245679081231,0.03225806451612903,0.3434061526624882,1.0,1/7,0.18%,ANXA1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.6133136779147967,1.476349905617857,0.03125,0.9461427759324507,1.0,2/24,0.45%,SLC6A13;SLC26A7
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.6046518663782781,-1.4761095657063832,0.0,0.3442004088830307,1.0,32/108,11.79%,GBP2;CDKN2A;TLR2;FYB1;B2M;ICAM1;WARS1;HLA-A;IL12A;STAT4;GCNT1;IL15;THY1;CCL2;BRCA1;HLA-DRA;TLR3;IGSF6;TIMP1;RPL9;IFNGR2;PRKCG;WAS;TPD52;STAT1;IL4R;IRF7;CTSS;HLA-E;ACHE;RPS3A;IL18
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.874930426967225,-1.4760131620321377,0.017241379310344827,0.3424862634204658,1.0,1/10,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8586702298316238,1.4749756609944373,0.046511627906976744,0.947404059389226,1.0,1/5,0.65%,ASCL1
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.5972904096776349,-1.4745533634753398,0.012658227848101266,0.3472837802943517,1.0,16/92,12.60%,CACNA1H;LEF1;POU4F1;TGFBR2;RAMP3;NLRP12;KLF4;CCL2;CYP1B1;IL1RAPL1;PTPN7;SLIT3;IL18;SIGIRR;IGFBP5;NOS1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.7686420655661221,-1.4743220948327116,0.0,0.3464132148437963,1.0,5/17,12.36%,CD24;KLF4;PARP9;WNT5A;IFIH1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.7943364869388209,-1.473766458956445,0.031746031746031744,0.3473932629614949,1.0,1/15,0.33%,THBS1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.795929949898502,-1.4734818385965958,0.06349206349206349,0.34703131498228457,1.0,4/14,7.01%,FLRT3;P2RY12;GAP43;APOD
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.8397767787613489,-1.473347001839795,0.0,0.34584721291670906,1.0,2/14,0.81%,RECQL4;BLM
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.6381544585656974,1.473106311963261,0.0,0.9550863283250812,1.0,12/30,23.95%,MTHFS;SLC39A8;OAT;GLUD1;GLS;RIMKLB;GLUL;PRODH;DDAH1;ALDH4A1;GCLC;GOT2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.7374191870361664,-1.4729799018577936,0.0,0.345334382035189,1.0,2/23,3.94%,KLF2;ATF3
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.8087014168470442,1.4728227915095429,0.025,0.9462166760164881,1.0,6/10,14.25%,WNT7A;SOX8;PEF1;KLHL12;CDH2;TAPT1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.626912172099391,1.4722423077877658,0.047619047619047616,0.9405086977863722,1.0,17/44,20.89%,NUP42;NUP37;NUP54;RUBCNL;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;JMJD8;NOA1;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.557974378206318,-1.4721304813209162,0.0,0.34716890549584895,1.0,80/290,18.92%,CXCL2;LEF1;ANXA1;GBP2;IL1R1;SOCS3;DUSP1;IL13RA1;POU4F1;GBP1;DOCK8;TLR2;ICAM1;ZFP36;RPS27A;IFIT1;IL12A;IRF1;INPP5D;STAT4;SLA;DUOX1;NLRP12;FSCN1;YBX3;CCL2;BRCA1;GBP7;TIMP1;CCND1;F13A1;CHI3L1;IFNGR2;RPL13A;ST3GAL6;IL1RAPL1;OSMR;STAT1;IL4R;WNT5A;PTPN7;DAB2IP;SYK;FN1;IL18;NUMBL;SBNO2;SIGIRR;GREM2;PIM1;UBC;TNFRSF1A;IL7;FOS;MYLK3;HYAL1;IL3RA;PIK3CB;VAV1;IL1RAP;PIK3CD;JUNB;IL27RA;F3;CEBPD;STAT6;ERBIN;BCL6;NDN;GPER1;DAPK3;TGFB1;PLP2;GSDME;CDKN1A;AKAP6;CD4;LAMA5;GBP3;SHMT1
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.5163291972277324,1.471945486890872,0.0,0.9324760281328655,1.0,27/83,25.97%,DERL2;USP13;TMUB2;VCP;RNF103-CHMP3;ECPAS;AUP1;UGGT1;STT3B;DERL1;FBXO27;TMEM129;UBE4A;POMT2;RCN3;ERLIN1;RHBDD1;DNAJB14;RHBDD2;DNAJC18;UGGT2;TMUB1;SEL1L;UBQLN1;DNAJB12;DNAJB2;UBE2J2
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.810194054031156,1.4715839511682958,0.07142857142857142,0.9163190357017693,1.0,1/7,0.30%,ACE2
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.810194054031156,1.4715839511682958,0.07142857142857142,0.9163190357017693,1.0,1/7,0.30%,ACE2
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),-0.9623798045772848,-1.4714898047913596,0.0,0.3485489252670111,1.0,3/6,2.77%,CCBE1;APLNR;PROX1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6635458408953111,-1.4709966340105143,0.011904761904761904,0.3492132877648338,1.0,7/47,8.03%,ANXA1;GBP2;IL1R1;GBP1;APP;CCL2;CHI3L1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.749815137513934,-1.4709425630248512,0.05128205128205128,0.3476227547949955,1.0,5/23,4.46%,ANXA1;MET;PROX1;CCDC39;LSR
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7173530366882594,1.4707821256254248,0.0,0.9121087080630016,1.0,8/18,20.43%,FAM47E;MSH2;PLK1;NIPBL;PPHLN1;TASOR;MCM9;WAPL
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.8150689916520826,-1.4700624436049199,0.01639344262295082,0.34966794182397043,1.0,8/15,16.59%,S100A10;RFTN1;CAV3;FA2H;FLOT1;EMP2;ANXA2;CLN3
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),-0.9230734380002235,-1.4699016661217348,0.05454545454545454,0.3486748182961715,1.0,2/6,2.77%,CCBE1;PROX1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.6985791631254887,-1.4697485851086907,0.046153846153846156,0.3472722354676498,1.0,9/31,12.78%,CD24;ANXA1;IL15;PDCD1LG2;IGF1;HHLA2;SYK;IL18;FADD
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.9533357905503992,-1.469337572457227,0.0,0.3467222364449058,1.0,1/6,0.02%,ENPP2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.8477667893643877,1.4693161501878353,0.022222222222222223,0.9125609016614185,1.0,1/8,0.65%,ASCL1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.6631843928328632,-1.4688724153984563,0.02702702702702703,0.34768647999229185,1.0,7/34,14.80%,ECM2;PDPN;THY1;MINK1;DMTN;EMP2;PIK3CB
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),0.5478341591954308,1.4688479240234058,0.0,0.9068490455342118,1.0,31/78,25.88%,MRPL10;MRPS30;MRPL15;PTCD3;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.7163200755352873,-1.468755135679482,0.0136986301369863,0.3464680605340662,1.0,11/34,21.32%,S100A10;SKAP1;THY1;EMP2;TEK;CCL28;CD36;CX3CL1;RRAS;SFRP1;RIN2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7956017949474439,1.4686945618095264,0.02857142857142857,0.8984936439691433,1.0,2/12,4.00%,ITGA1;PPP1R15B
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.6784439979767649,-1.4684864735028582,0.0,0.3460345445279751,1.0,15/38,14.75%,GBP2;SP100;TYMP;GPR183;TLR2;CIITA;IRF1;IGSF6;CTSS;BIRC3;APOL6;HLA-E;IFIH1;CLEC5A;SRGN
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.8312912553237858,-1.468397171776433,0.07575757575757576,0.34448073322387,1.0,1/9,0.10%,KLF2
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.8151749317601891,1.467708200172743,0.05263157894736842,0.8963370752945193,1.0,3/6,10.09%,INTS13;NUP54;PLK1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.8630893611052213,1.4673215113164912,0.02702702702702703,0.8902794341880834,1.0,1/5,10.69%,NIPBL
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.794153297140221,1.4672678376102188,0.08108108108108109,0.8818859283511937,1.0,3/8,6.83%,PLIN5;LMO3;PTGIS
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.6870724931564772,-1.46560188005162,0.02857142857142857,0.35733716762580825,1.0,5/33,5.90%,ANXA1;SFTPD;GPNMB;IL15;PDCD1LG2
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7717238271818495,-1.4654867811724452,0.05357142857142857,0.35578915623978086,1.0,2/11,2.75%,NR4A3;WNT8B
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),-0.984595117904945,-1.4645687888274108,0.0,0.35848371227001163,1.0,1/5,0.69%,NPY
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.7977488781484179,1.4640056079015733,0.1,0.8947592582769601,1.0,3/10,8.28%,CEBPA;ZC3H8;AR
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.5779180787328229,1.4639631338950851,0.0,0.8862652328410449,1.0,18/55,21.74%,METTL8;LCMT2;TFB2M;TYW3;TFB1M;FTSJ1;NSUN6;ZCCHC4;TRMT61A;CBLL1;MTO1;NSUN3;FBL;TRMT5;VIRMA;NSUN2;RBM15;MEPCE
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.923565093864398,1.4637352865778674,0.027777777777777776,0.8791252530549526,1.0,1/7,0.12%,SPSB4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7702725561963029,-1.4633854509836708,0.028169014084507043,0.3621498282888724,1.0,5/18,5.91%,APLNR;RAMP3;CEMIP;THY1;TRPC3
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.6712018579891362,-1.463235776274229,0.02666666666666667,0.36065067582216154,1.0,10/37,13.64%,SLC6A15;SLC25A45;PDPN;SLC38A4;SLC7A14;SLC3A1;SLC7A2;SLC43A2;SLC38A11;SLC38A1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6403431754171147,-1.462887597121832,0.04054054054054054,0.36040504176389815,1.0,10/43,12.78%,THBS1;RASGRP1;TLR2;APP;TLR3;WNT5A;SYK;HLA-E;IFIH1;FADD
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.894112934945906,1.4628390789537473,0.045454545454545456,0.8772734749743091,1.0,3/5,9.12%,MOXD1;TYR;DCT
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.8228208048381129,-1.4625688728552633,0.05172413793103448,0.36094979832309293,1.0,1/8,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),0.79290404788331,1.461756711802984,0.02631578947368421,0.8806679921301932,1.0,3/8,6.17%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.7154499415725571,-1.4616066320593921,0.0,0.36403552066413875,1.0,7/29,13.03%,SCN1B;ANK3;CAV3;YWHAH;GLRX;HECW2;SCN3B
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6998860951133385,1.460298912830365,0.13513513513513514,0.8838942718115076,1.0,5/14,18.19%,PRKRA;DROSHA;AGO3;TSN;CLP1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7228819099665892,-1.4601384539310258,0.04918032786885246,0.3691836279090028,1.0,10/25,17.69%,C3;C1R;HLA-DRA;CD55;CFH;C1S;SUSD4;SERPING1;HLA-DRB1;CR1L
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8790642812759457,-1.4598990808259655,0.05263157894736842,0.36860768636989705,1.0,3/9,5.98%,ANXA1;MSMP;CCL2
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.9112829244300596,1.4595989876729871,0.02564102564102564,0.8722722519285392,1.0,1/5,3.41%,PASK
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.9112829244300596,1.4595989876729871,0.02564102564102564,0.8722722519285392,1.0,1/5,3.41%,PASK
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8627082211807936,1.4594112513494362,0.0,0.8653366957532913,1.0,2/9,3.70%,DGKB;DGKE
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7707811671993765,-1.4588091058940356,0.06060606060606061,0.3722320439005372,1.0,4/13,10.15%,HPN;LMO2;GATA1;CTSS
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.631607785311224,1.4565084460692888,0.047619047619047616,0.8787458992902266,1.0,15/40,20.89%,NUP42;NUP37;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;JMJD8;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.7546365936979087,1.4563560563618645,0.0625,0.8721779475735109,1.0,2/10,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.8998233099285501,1.4559303480197214,0.0392156862745098,0.8673225020892679,1.0,1/5,1.63%,BMP2
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.8111539419581433,-1.455855606612498,0.0,0.38598647920570067,1.0,4/13,11.30%,HPN;PIEZO2;LHFPL5;SCN1A
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5512352877959832,1.4556521649871241,0.0,0.861363956915174,1.0,19/61,20.91%,LCMT2;THUMPD1;ADAT2;TYW3;FTSJ1;PUS10;TPRKB;NSUN6;TRIT1;TRMT61A;DTWD1;DTWD2;THG1L;TRMT1;MTO1;ANKRD16;TRMT5;NSUN2;CDKAL1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.7291896782268545,-1.455194263923477,0.014492753623188406,0.3867165178354521,1.0,5/25,10.73%,CENPV;KIF14;HTR2B;SVIL;FGF1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7062032098311931,-1.4545879345046138,0.029411764705882353,0.387913755325301,1.0,12/27,18.00%,ANXA1;NPY;CHRM1;HTR2B;CCL2;CHRM3;HRH1;CNR1;HTR1E;HTR2C;CHRM5;HTR2A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.7600072646498122,-1.4545587012169712,0.04918032786885246,0.3860762828822818,1.0,6/18,18.26%,TMEM204;ITGA5;DAB2IP;MMRN2;PRKCB;NIBAN2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5897551128575216,1.454277891148046,0.06060606060606061,0.8626700827333047,1.0,16/39,27.75%,SMARCAD1;ERCC6;HNRNPC;RBBP4;HDAC2;SMARCA2;MBD3;CHD4;ACTR6;PBRM1;MTA2;SMARCC1;ARID1B;INO80;VPS72;CHD8
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.8708098129559585,1.454244014011336,0.0625,0.8556859149472688,1.0,1/7,0.65%,ASCL1
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.6483253440710199,-1.4540916138739992,0.0,0.38670077485943655,1.0,8/63,8.03%,GGT5;GBP2;GBP1;ZFP36;YBX3;CCL2;BRCA1;CHI3L1
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.8952088895901109,-1.4540650156899528,0.018867924528301886,0.38484123948638743,1.0,3/7,10.39%,COL4A2;ITGA2;ITGA11
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5365692376592589,1.4535670203675801,0.0,0.8531601871438782,1.0,15/75,15.95%,DIRAS3;KDM1B;KAT2B;EED;ERCC6;DNMT3B;SMYD5;RBBP4;POLR1F;PPHLN1;KAT2A;DDX21;TASOR;AEBP2;EP300
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.989592356741407,-1.453449460801596,0.0,0.3859773209103661,1.0,1/5,0.05%,CD24
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.7730318605754752,-1.4531466427505968,0.015384615384615385,0.38529704634802403,1.0,2/22,1.94%,MET;ICAM1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.7842689663078452,-1.4527292732327777,0.06666666666666667,0.38549852240052696,1.0,2/15,6.99%,NEFL;HAP1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.8086613901816876,-1.4524560579199564,0.08064516129032258,0.385056471972461,1.0,1/13,0.69%,NPY
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.765119531917081,-1.452322846159089,0.05714285714285714,0.38420839509796895,1.0,1/18,0.02%,ENPP2
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.806144452897067,1.4522429497073879,0.023255813953488372,0.8548848662736394,1.0,2/6,9.17%,NLGN3;ATP1A2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),-0.7176401006226059,-1.4521568089723356,0.029850746268656716,0.3830510116316338,1.0,2/31,6.51%,GGT5;GSTM5
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7048385441385245,1.4520558487918118,0.05128205128205128,0.8499421098685335,1.0,7/12,28.35%,ZNF304;TRIM28;PPHLN1;TASOR;RESF1;SETDB1;ATF7IP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.8050276395210783,-1.4512265111642098,0.0625,0.38533655531051486,1.0,3/15,5.06%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.6093141450668583,1.4507260261196375,0.0,0.85354597063343,1.0,10/31,16.99%,SAMM50;MAIP1;CHCHD3;TMEM11;OPA1;SLC25A5;DNAJC11;APOOL;BAD;MTX2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8675210341914944,1.4505383455142893,0.041666666666666664,0.8481355153004532,1.0,1/5,0.30%,ACE2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.7319925788655234,-1.4500185304316404,0.015384615384615385,0.3897118030235764,1.0,3/23,5.61%,ABCA5;ABCA8;ABCA12
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.702497261766846,-1.4493486078872302,0.04,0.39140648436079606,1.0,7/29,13.03%,SCN1B;PKP2;ANK3;ATP1A1;YWHAH;NOS1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7951662669517496,-1.4490719954619249,0.057971014492753624,0.3909042798707603,1.0,5/15,11.79%,IL1R1;B2M;HLA-A;CD55;IL18
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.8074215922691576,-1.448470307713551,0.031746031746031744,0.3921784381983997,1.0,1/11,0.99%,MET
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.9138452535759976,-1.4474666002661807,0.017543859649122806,0.39555620694147486,1.0,2/8,0.81%,RECQL4;BLM
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8624353398546234,1.447245763818798,0.022727272727272728,0.8649265835752092,1.0,4/8,12.91%,TOP3B;HMGB1;TOP1MT;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.7442575656210078,-1.4472398912892976,0.02666666666666667,0.39447117723540776,1.0,5/23,6.99%,P2RY6;APLNR;CEMIP;THY1;HAP1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8251446994185024,-1.4468630837880359,0.04918032786885246,0.3941823031820455,1.0,5/10,12.77%,TLR2;B2M;RPS27A;PGK1;UBC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.8528316033264854,1.4463722657424884,0.05,0.8656608166682273,1.0,3/9,4.85%,BMP2;EFNB2;GREM1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.7628672961904892,-1.4463015813851505,0.013513513513513514,0.39480874294822127,1.0,2/20,1.14%,KCNQ1;NR4A3
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.7084044435865363,1.4458964518231232,0.08108108108108109,0.8619221017585794,1.0,1/13,1.17%,FAM47E
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.9087533833623477,-1.4456904443446048,0.037037037037037035,0.39672695227235566,1.0,2/6,0.78%,ANXA1;CDKN2A
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.8485173277056672,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.8485173277056672,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.8485173277056672,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",0.8823931519057593,1.444144960808465,0.020833333333333332,0.8485173277056672,1.0,3/6,6.63%,ELOVL6;ELOVL4;ELOVL2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5463996819605701,-1.4441117548779911,0.0,0.40220071312055206,1.0,86/326,18.85%,CP;C3;SERPINA10;CHGB;RPL19;RPL3;LAMB1;RPS27A;WARS1;RPS27;SFTPD;RPS14;RPS4X;PHEX;RPL27A;RPL35;APP;ATP23;RPL7A;DENND3;RPL37A;RPL27;TIMP1;RPL9;SERPIND1;RPL21;NOTUM;RPL13A;ST3GAL6;FAM20C;IGF1;CHRM3;RPS11;RPS16;RPL24;RPLP1;IGFBP7;RPS13;USP6;RPL38;DAB2IP;FN1;RPS3A;SHISA5;BAP1;RPS8;RPL10A;RPL10;PRSS23;RPLP2;RPS23;IGFBP5;SEC11C;RPS21;RPS7;RPS18;GPC3;RPL8;F5;RPS6;RPS15;B4GALT7;RPS9;UBE2S;TMEM208;RPL12;APH1A;RPL5;PLAT;EEF1A2;ITIH2;RPL23;RPL4;PIGH;FBXL2;SPP1;RPL18A;RPL41;LTBP1;RPL7;RPS12;RPS20;COPS5;PAPPA;TF;MRPL23
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.7876328138369711,1.4439162420220168,0.06060606060606061,0.8443539371035316,1.0,3/9,6.17%,ACP3;TMEM100;SCN11A
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.6654785165798089,1.4435910775325922,0.08108108108108109,0.8402541097166958,1.0,10/25,16.31%,SAMM50;DMAC2L;LETM1;CHCHD3;ATP5PB;ATP5MC2;DNAJC11;ATP5MC1;APOOL;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7721672301404241,-1.4434266984705215,0.02857142857142857,0.40376696370716075,1.0,5/14,11.40%,LEF1;ZFPM1;PRKCQ;SYK;HLA-E
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7035351911464363,-1.443390745364028,0.013157894736842105,0.40211956722689385,1.0,4/28,3.30%,CP;B2M;SLC39A14;TMC8
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.7526171973099727,1.4431861424187766,0.045454545454545456,0.8366474847501824,1.0,3/10,16.63%,BMP2;NFKB1;ERLIN1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7249779299918795,-1.4421362859090725,0.045454545454545456,0.40702619900180825,1.0,8/15,16.36%,HLA-A;IL12A;HLA-DRA;HLA-B;HLA-E;FADD;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.9101887450958123,-1.4420802312077794,0.0,0.40525216508397205,1.0,3/7,8.80%,THBS1;ANK3;FBP1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.8620734352526868,-1.4409385265824122,0.0,0.4101420265138453,1.0,1/7,0.02%,ENPP2
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.8315472903689625,1.44083374832264,0.09523809523809523,0.8452458243525838,1.0,1/8,0.48%,DAO
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.813416105133415,-1.4393792609264628,0.029411764705882353,0.41632792691689247,1.0,2/16,5.68%,S100A10;THY1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.7917557652406809,-1.439222578809475,0.014925373134328358,0.41532817992832477,1.0,5/15,13.21%,RASGRP1;IL12A;CD160;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.7501869650573124,1.4385511944475393,0.07692307692307693,0.8539706203700637,1.0,5/13,20.52%,EIF3E;EIF2AK4;EIF4EBP2;C8ORF88;EIF4EBP1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),-0.9150912734193664,-1.4384996093861258,0.038461538461538464,0.41765807569224656,1.0,2/5,3.94%,THBS1;ATF3
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.7356877364004963,-1.438332070883449,0.04411764705882353,0.4164960242537252,1.0,3/21,6.70%,CENPV;KIF14;SVIL
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.6209825583623104,-1.4375842801664207,0.02531645569620253,0.4183474850117377,1.0,11/68,3.86%,HPN;ALDOB;GRAMD2A;THSD4;PROX1;GC;ABCA8;S100A6;MATN2;MAOB;BHMT
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.7210183415310552,-1.4375687843014844,0.043478260869565216,0.41653734740326925,1.0,3/24,5.06%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.7091913990858915,-1.4373674433436383,0.014705882352941176,0.4157218068307713,1.0,3/23,1.53%,THBS1;GPR183;P2RY12
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.6347912205081168,1.4372856950313673,0.06060606060606061,0.8557377923851801,1.0,12/23,29.27%,VCP;AUP1;UGGT1;DERL1;POMT2;FBXL17;ZYG11B;UGGT2;KLHL15;NGLY1;RNF5;YME1L1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.655061717569994,-1.4368293506912988,0.014285714285714285,0.4164155528572449,1.0,5/36,8.73%,KLF2;APP;KLF4;LDLR;LTBP4
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.6881003307364827,1.4367441997367099,0.10526315789473684,0.8525417989032732,1.0,6/17,16.65%,HSPA1A;PLK1;CEP97;CHMP2B;HNRNPU;VPS4B
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),0.6135082086888154,1.4366366923333647,0.0,0.8472326379066037,1.0,13/33,21.77%,TFB2M;PTCD3;FASTKD2;GATC;MRPS2;QRSL1;GFM2;MRPS7;MRPS14;LARS2;MRPL47;NOA1;MRPS11
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),-0.9268418186635626,-1.4361520353823143,0.0,0.4145338007587128,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),-0.9268418186635626,-1.4361520353823143,0.0,0.4145338007587128,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),-0.9268418186635626,-1.4361520353823143,0.0,0.4145338007587128,1.0,1/5,0.41%,SLC28A2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.696513714897653,1.4354311723456528,0.11764705882352941,0.8495050283570013,1.0,2/11,4.15%,WNT7A;NLGN3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.8777441150683696,-1.4351696500003197,0.04918032786885246,0.4173752098836781,1.0,1/8,2.05%,ABCA5
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.5688664606541062,1.43484456649769,0.06896551724137931,0.8483059761854168,1.0,9/36,19.94%,NXT2;RITA1;SNRPF;XPO1;NXT1;AAAS;NUP205;GEMIN4;MALT1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8538117555625058,-1.4347955303170254,0.03508771929824561,0.4175305218129098,1.0,2/7,9.67%,IFIT1;STAT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.8644288821407026,1.4347689724158175,0.14,0.8426530982462987,1.0,5/7,12.57%,NUDT16L1;ERCC6;HSF1;CYREN;TFIP11
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.6201163141729071,-1.4341949956285631,0.0,0.4194645804239569,1.0,11/82,11.78%,CD24;IFI6;POU4F1;HIC1;BRCA1;CYP1B1;PDK1;MLLT11;SCN2A;DAB2IP;BCL2L2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.6691634686133202,-1.433965427053826,0.03225806451612903,0.41897945761972333,1.0,8/29,15.81%,CDKN2A;B2M;IL15;ARG2;WNT5A;IFIH1;PRKCD;ECHDC3
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.8735555229408553,1.4333751735153728,0.0784313725490196,0.8468467445755032,1.0,1/6,0.65%,ASCL1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.8157018447725491,-1.432918986278751,0.08333333333333333,0.42300897285727473,1.0,1/10,1.91%,B2M
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.5525779541600502,-1.43273350178718,0.0,0.4220052544484129,1.0,53/268,16.48%,OPTC;COL8A1;COL4A1;MYO1F;COL4A2;B2M;STMN2;COL5A1;RPS27A;NEFL;RHOBTB2;COL4A4;KIF14;POF1B;MYO15A;COL27A1;COL6A2;CLRN1;APP;SCX;LMOD1;COL24A1;RND2;CYP1B1;GFAP;PLK3;MYH11;COL11A2;P4HA2;NLRP5;P3H2;COL10A1;P4HA3;STMN4;RHOF;DCTN1;KIF2C;TPM4;MYO1E;CORO7;ELMO1;UBC;EMP2;PPIB;B4GALT7;TLL1;APH1A;LAMA3;STMN1;ITGB4;COL12A1;RHOD;COL9A2
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.7208209468206457,1.4324372554258777,0.05405405405405406,0.8461726157697422,1.0,5/13,14.93%,ZNF304;TRIM28;SIRT6;PPHLN1;TASOR
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.7658450452359286,-1.431915623654824,0.08333333333333333,0.42451028449175376,1.0,3/15,5.93%,C3;APP;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.7401342185745343,-1.4318541616557183,0.03333333333333333,0.42304392800426865,1.0,4/16,12.29%,P2RY6;NR4A3;IGF1;IGFBP5
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.8919474928864237,-1.4313123560847083,0.01639344262295082,0.4219913172816707,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.8919474928864237,-1.4313123560847083,0.01639344262295082,0.4219913172816707,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6688900533928126,1.4311139461129525,0.13157894736842105,0.8489300576920091,1.0,8/12,29.64%,KAT2B;NAA30;NAA11;EP300;NAA50;NAA25;NAA15;NAA35
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7348487495971214,-1.4304938538421312,0.03225806451612903,0.4241872527733935,1.0,3/20,5.98%,CXCL2;ANXA1;CCL2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.9155472122728082,-1.4304696361857143,0.02,0.42259399470433184,1.0,1/6,0.05%,CD24
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5823066098385317,-1.4295335020950364,0.012195121951219513,0.42522469280903863,1.0,40/129,17.72%,ECM2;IL1R1;ANGPTL2;C3;C1R;TLR2;SERPINF1;ABCA8;MAOB;ASPN;COX7A1;COL6A2;LMOD1;BGN;TRIP10;RSPO3;PODN;CYP1B1;TIMP1;OLFML1;SRPX2;THBS2;IGFBP7;EPSTI1;APOL6;COPZ2;CFH;F10;C1QTNF1;FGF7;C1S;ROBO4;SERPING1;PLAC9;TNS2;STAT6;PXDC1;FMO2;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6048874728679978,-1.4289550699469649,0.05194805194805195,0.4264360127111746,1.0,16/62,11.40%,GBP2;TLR2;SFTPD;HLA-A;IL12A;COLEC12;NOD1;TLR3;GBP7;TNFRSF14;ISG15;LYG1;ROMO1;SYK;SELP;HLA-E
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.9371724266912052,-1.4289135445811976,0.017543859649122806,0.4248530433180047,1.0,2/5,5.16%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.6655680039653874,1.4285096948751297,0.07142857142857142,0.8595524052415914,1.0,4/21,9.61%,LIG4;MEN1;HSF1;ATR
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.731969307188599,-1.4273099827076141,0.029850746268656716,0.43295150468285826,1.0,8/20,17.19%,RFTN1;LAT2;SYK;BMX;BLNK;PIK3CD;SH2B2;PRKCB
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.749886671002659,1.427283395985212,0.10344827586206896,0.8620225651004104,1.0,4/9,15.99%,SLC2A5;DRD2;SPX;GPR37L1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.7074149596494167,-1.4271735636676723,0.045454545454545456,0.431802918647708,1.0,10/25,13.03%,SCN1B;KCNQ1;PKP2;KCNJ2;GJC1;ATP1A1;CAV3;CACNA1C;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.8098995452889296,1.4271270815238257,0.06818181818181818,0.8575213902226816,1.0,3/7,16.65%,VCP;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),-0.8680127279415957,-1.4269386813656242,0.0,0.4312955202653038,1.0,4/6,8.45%,KCNJ2;CAV3;C12ORF57;SLC8A3
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.8052909312072047,1.426841285006864,0.075,0.8535459706334301,1.0,3/8,13.51%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.6703478159693513,1.4266994849679686,0.0975609756097561,0.8487784165632253,1.0,4/15,10.95%,MGAM;PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.8392846979356198,-1.4265903612648203,0.0851063829787234,0.4318288962457181,1.0,3/6,15.76%,CCL2;PRKCH;PRKCD
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.92099214021424,-1.4259041663808332,0.017241379310344827,0.43394377750281266,1.0,2/7,0.81%,RECQL4;BLM
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.8404804477379226,-1.4256210875607487,0.03125,0.43343392410569453,1.0,2/11,1.34%,RASGRP1;DOCK8
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.749119225192789,1.4242137453969592,0.05555555555555555,0.8612603458489984,1.0,3/10,11.98%,SOX9;NUDT21;SOX5
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.6890200627407286,1.4241121571626265,0.12195121951219512,0.8561255762335667,1.0,7/16,20.58%,RTRAF;TSEN2;TSEN15;ZBTB8OS;CLP1;ERN1;TRPT1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.8416351645579373,1.4238153399064954,0.05405405405405406,0.8518878680856211,1.0,1/5,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7901975144079205,-1.4237570561652284,0.016666666666666666,0.44156251610101493,1.0,3/13,7.62%,ZFP36;IFITM3;HEXIM1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.6093258354073178,-1.4232475102889666,0.07462686567164178,0.44306746016876175,1.0,14/56,20.03%,THBS1;CDKN2A;SKAP1;THY1;PLET1;MINK1;EMP2;SEMA3E;PIK3CB;VCL;CCL28;DAPK3;CD36;CX3CL1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7050390906465512,1.4229007428301328,0.04878048780487805,0.8525726287370938,1.0,7/11,28.35%,ZNF304;TRIM28;PPHLN1;TASOR;RESF1;SETDB1;ATF7IP
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8204263806348304,-1.4228064279906392,0.06666666666666667,0.44170314547555,1.0,6/12,7.70%,MET;ALOX12;LSR;FLG;ABCA12;FA2H
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8204263806348304,-1.4228064279906392,0.06666666666666667,0.44170314547555,1.0,6/12,7.70%,MET;ALOX12;LSR;FLG;ABCA12;FA2H
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.8249382384280145,1.4222313096810901,0.09523809523809523,0.8515376271731161,1.0,1/6,2.91%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.8220350779798207,-1.421930128779088,0.03389830508474576,0.4448827769239239,1.0,1/14,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7649277520943745,-1.4217705293041922,0.045454545454545456,0.4436965870229311,1.0,3/15,9.68%,CXCL2;CCL2;THPO
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6599357771079017,-1.4205892270802973,0.0,0.447487269569827,1.0,9/36,14.78%,MX1;IFIT1;IFITM3;PROX1;BST2;PLSCR1;ISG15;IFIH1;APOBEC3H
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.6989235485428805,1.4197157394046276,0.029411764705882353,0.8650743837432842,1.0,4/15,5.69%,SLC39A10;RUNX1;LPXN;FOXP1
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7206836364663047,1.419523034359512,0.1,0.8606680316357047,1.0,5/13,6.69%,ABCD2;AKT2;PLIN5;ABCD1;AKT1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.7933651593851773,-1.4194327922830756,0.02,0.451818416743153,1.0,3/11,7.79%,THBS1;RHOBTB2;XKR4
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.7006271523068262,-1.4192658773229125,0.07692307692307693,0.45100940374009146,1.0,11/29,18.41%,NEFL;GRIN2A;APP;CCL2;GRIA3;GRIA1;GRIN2B;NLGN1;RELN;CAPN1;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6284394727412211,-1.419155826432793,0.023529411764705882,0.44999458811496523,1.0,5/41,7.85%,TLR2;DYSF;BST2;PLSCR1;EGF
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.9409881483885189,1.4186583323310367,0.021739130434782608,0.8617166671044509,1.0,3/5,5.13%,DSCAM;SOX8;SOX9
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.7344266225565945,1.4186489543472989,0.1,0.8563005138932236,1.0,6/13,18.82%,RAD54B;TPRKB;SMC6;RAD52;MSH3;DMC1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.9337843500342891,1.4184619311871258,0.0,0.8519613283250811,1.0,1/5,0.97%,DSCAM
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.5829744836700886,-1.418223609859998,0.011494252873563218,0.4533869124840654,1.0,32/95,20.01%,KCNT2;HPN;KCNQ1;KCNV1;LRRC55;KCNB1;KCNK1;KCNJ13;KCNJ2;SLC24A2;ATP1A1;KCNH8;SLC24A1;SLC9A2;ATP1B1;KCNG1;KCNB2;KCNK12;SLC12A7;KCNC1;KCND3;SLC9A5;KCNH7;KCNK10;KCNAB3;KCNV2;KCNE4;KCNF1;HCN1;ABCC9;KCNQ5;KCNC2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.8877653111705036,-1.4176713988262666,0.017543859649122806,0.45542117890749695,1.0,1/6,0.18%,ANXA1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6868133841487616,1.4175588940743868,0.125,0.8534028182693826,1.0,5/15,19.67%,PRKRA;DROSHA;AGO3;TSN;PUM2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.8083810175848054,-1.4174588000583437,0.07017543859649122,0.45478543087551904,1.0,7/11,12.78%,RFTN1;COLEC12;TLR3;SCARA3;SCIMP;TNIP2;FADD
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.7943171428401279,-1.417023809130366,0.06578947368421052,0.4558595865482729,1.0,3/13,6.69%,KCNB1;PIM3;BMP8A
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.7472593775388365,-1.4168016333931455,0.07692307692307693,0.455053618145261,1.0,4/24,11.00%,CDKN2A;B2M;ARG2;NUAK1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.6766394300579542,-1.416726687305089,0.03076923076923077,0.45383919940953216,1.0,2/39,0.33%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.8817118619011186,1.4164596963761107,0.07894736842105263,0.8543283877731773,1.0,4/7,10.39%,DNA2;PRIMPOL;POLG2;MGME1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6802486489139664,1.416299388299103,0.03333333333333333,0.8502236798988735,1.0,10/19,25.08%,VCP;AUP1;UGGT1;DERL1;POMT2;DNAJB14;DNAJC18;UGGT2;DNAJB12;KLHL15
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.8716914872488815,-1.4160395361837435,0.022727272727272728,0.4556275106953067,1.0,2/7,5.06%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),-0.8553132590917063,-1.4158600024042742,0.08928571428571429,0.4550027715832254,1.0,3/5,12.78%,NLRC5;WNT5A;FADD
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6481649345289524,1.4156985676008067,0.03125,0.8496821822889989,1.0,7/27,17.23%,RNF6;FOXP1;RNF14;AR;HEYL;EP300;NCOA2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),0.7981208125205506,1.4156389036333774,0.1111111111111111,0.8450977855662198,1.0,5/9,12.01%,PPP1R3D;PPP1R3G;AKT1;RUBCNL;PPP1R3F
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.8520570573643812,1.415531045405314,0.023809523809523808,0.8404305081578433,1.0,3/5,8.21%,TMEM167B;TRAPPC11;TMEM167A
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),-0.939306405107504,-1.4155083769344585,0.017543859649122806,0.45516824038507303,1.0,1/5,1.30%,ALDOB
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.8277780136000202,-1.4152678669509478,0.07936507936507936,0.4533255461767773,1.0,1/9,2.20%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.8277780136000202,-1.4152678669509478,0.07936507936507936,0.4533255461767773,1.0,1/9,2.20%,ZFP36
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.731710818323583,-1.4149959212199406,0.06451612903225806,0.45336019482172524,1.0,1/17,0.33%,THBS1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.82850253570511,1.4143392354097981,0.044444444444444446,0.8427861183975662,1.0,1/6,1.54%,METAP1D
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5727886118777137,-1.413868789054021,0.024691358024691357,0.4580732736008962,1.0,22/123,13.19%,S100A10;PKP2;MRAP2;FYB1;ANK3;KCNB1;RAMP3;TESC;RAB11A;ZDHHC22;ABCA12;CAV3;ATP1B1;KCNB2;PDZK1;FLOT1;PLEKHF1;TSPAN32;EMP2;FYB2;SCN3B;TNFRSF1A
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.54404105649752,1.4137089479334144,0.05555555555555555,0.8426452630566659,1.0,14/44,16.99%,SAMM50;DMAC2L;MAIP1;LETM1;CHCHD3;TMEM11;ATP5PB;OPA1;ATP5MC2;DNAJC11;ATP5MC1;APOOL;ATP5F1A;MTX2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.7143355980096959,-1.4136187910216087,0.05333333333333334,0.4576544800857497,1.0,11/33,18.15%,ALDOB;LDHA;HK2;ENOSF1;GAPDHS;PGK1;ENO4;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.7308177336957538,-1.4133815070122342,0.043478260869565216,0.4576731255543663,1.0,1/16,0.33%,THBS1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),0.822390518451378,1.4131005306718272,0.046511627906976744,0.8418246207772265,1.0,2/7,6.48%,DAO;MOXD1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6094420259955466,-1.4130918670513508,0.0136986301369863,0.45749185877865056,1.0,19/57,15.49%,MYO1F;DOCK8;RASGRP2;TAGAP;P2RY14;STAG3;TMC8;ARHGAP9;GPR18;ACAP1;RCSD1;WAS;IL4R;CTSS;BIRC3;P2RY10;SP140;CD74;CD37
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.8272266878954466,1.4127296596357144,0.05,0.839049237481402,1.0,2/6,8.57%,MSRB1;MSRB3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.8317626193217607,-1.4126795153746654,0.07017543859649122,0.45777636953168527,1.0,3/8,2.09%,SCN1B;PKP2;ANK3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7368878242951258,-1.4125636554262728,0.04054054054054054,0.45700097543672963,1.0,10/23,18.15%,ALDOB;LDHA;HK2;GAPDHS;PGK1;ENO4;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8061332917500266,1.41230835806684,0.047619047619047616,0.8371147898180804,1.0,2/6,13.33%,CSGALNACT1;DSE
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.7371242278619643,-1.4122184011607908,0.05,0.4576146168545841,1.0,3/13,10.44%,ANXA1;RAB11FIP5;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8071730637991001,-1.4119848525738103,0.05660377358490566,0.4570750640339262,1.0,2/10,11.74%,NR4A3;PINK1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.8080581839675827,1.4117888388880757,0.08,0.8366089407847823,1.0,2/8,6.41%,ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.7793753655765184,-1.411016398379365,0.06349206349206349,0.4610203307144939,1.0,7/14,18.89%,ITGA2;SCX;ITGA8;ITGA3;ITGB4;CRB2;TBX20
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5867346807313716,-1.4096587079622689,0.0,0.46620893718750883,1.0,20/123,11.79%,LEF1;ANXA1;TIMP2;IFITM3;IRF1;BTG3;ATF3;APP;BGN;BRCA1;CD44;TIMP1;CCND1;NEFH;GADD45A;EMP1;BIRC3;IER3;BCL2L2;IL18
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),-0.8760392647990246,-1.4092235914915845,0.07692307692307693,0.466489350546055,1.0,2/5,12.06%,ITGA5;TNIP2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6620495134075177,-1.4090302887365123,0.06666666666666667,0.4661528682711178,1.0,7/35,4.12%,GBP2;IL1R1;GPR183;CD5;TAGAP;GPR171;SLA
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.7712654018836527,-1.409022642037755,0.0847457627118644,0.4645608944635455,1.0,4/12,10.01%,DOCK8;APP;TNFRSF14;WNT5A
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7301247323074822,1.408417268245234,0.10256410256410256,0.8551432496428025,1.0,5/15,13.75%,DERL2;VCP;AUP1;DERL1;TMEM129
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.8497603380684584,-1.4081725801407017,0.03076923076923077,0.46767244923340817,1.0,3/6,13.87%,ALOX12;DUOX1;NOXA1
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.7942222293930091,-1.4080705068670762,0.07017543859649122,0.46647058266675984,1.0,2/15,1.53%,THBS1;P2RY12
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.7114103380405152,1.408033384999644,0.10638297872340426,0.8520903108385514,1.0,4/15,13.16%,ADAMTS9;STT3B;ADAMTS12;FBXO27
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.6154225900614898,-1.407772910889677,0.0,0.46633031766756805,1.0,14/62,17.37%,CD24;SOCS3;VRK2;IFNGR2;STAT1;BIRC3;SYK;SIGIRR;FADD;TNFRSF1A;IL7;CD74;USP18;CDC37
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.8216552952299613,-1.407501801182694,0.057692307692307696,0.46622282557386147,1.0,3/7,15.76%,CCL2;PRKCH;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.8671934055309971,-1.4074183992060239,0.09090909090909091,0.4651333712669839,1.0,4/6,11.74%,TOMM7;HK2;ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8695080275177067,-1.4071877227420124,0.018518518518518517,0.46499910628962604,1.0,3/7,7.25%,PKP2;NEFL;GFAP
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.6988788960351947,1.40718470442454,0.08823529411764706,0.8521645089468557,1.0,4/13,10.13%,AGMO;GK;MOGAT1;LPIN3
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7881795060922498,1.4069795848094309,0.11904761904761904,0.8435960633186175,1.0,5/8,18.07%,ABHD17A;LYPLA2;ABHD17B;ABHD17C;LYPLAL1
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7881795060922498,1.4069795848094309,0.11904761904761904,0.8435960633186175,1.0,5/8,18.07%,ABHD17A;LYPLA2;ABHD17B;ABHD17C;LYPLAL1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.7994773000933306,-1.4069203066630263,0.047619047619047616,0.46344682645169766,1.0,5/12,13.21%,RASGRP1;IL12A;CD160;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.7994773000933306,-1.4069203066630263,0.047619047619047616,0.46344682645169766,1.0,5/12,13.21%,RASGRP1;IL12A;CD160;HLA-E;HLA-F
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.6883232848373798,1.406487849908085,0.125,0.841777382250454,1.0,6/17,17.26%,DERL2;VCP;AUP1;DERL1;TMEM129;RHBDD1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.6058434186113324,1.4059181977110549,0.0,0.840750818229961,1.0,3/28,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.7496591414157631,-1.4053097123477891,0.11940298507462686,0.47073098276737324,1.0,4/14,6.33%,SCN1B;KCNQ1;NOS1AP;CAV3
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8419540711472414,1.405097394541332,0.15789473684210525,0.8420374856361253,1.0,4/7,13.27%,RUNX1;TWSG1;HMGB1;TARM1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.8276194598359888,1.4050543181685355,0.09523809523809523,0.8376512598208894,1.0,1/5,6.09%,ZNF304
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.6619473426702297,1.4050421703950717,0.10810810810810811,0.8331240929656822,1.0,3/17,13.16%,ADAMTS9;STT3B;FBXO27
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.674880599176722,-1.4049764433158953,0.05555555555555555,0.4709536742694202,1.0,7/32,8.45%,GRIN2D;GRIN2A;HTR2B;SLC24A2;SLC24A1;ITPR3;SLC8A3
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.8480765861739761,-1.404946540761668,0.01694915254237288,0.4694664779010448,1.0,2/10,1.45%,COL4A1;TGFBR2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.7134813158910752,1.4041593100036809,0.1,0.8341800657380269,1.0,2/13,4.39%,YAE1;LTO1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.7859663569718486,1.4031387601404788,0.1,0.8367877054224587,1.0,2/8,9.80%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.8121601517038612,1.4029844385722743,0.13157894736842105,0.8329613647114145,1.0,1/8,0.43%,NGF
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.6815224232039031,1.402567695204969,0.08888888888888889,0.8306610424352873,1.0,4/14,10.95%,MGAM;PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7706124384542938,-1.4012770379101225,0.07692307692307693,0.48755456590517177,1.0,1/12,0.33%,THBS1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.6892592397197522,-1.401242349298389,0.03278688524590164,0.48620707558375675,1.0,4/22,10.01%,ANXA1;FLG;CLIC4;WNT5A
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.8574554134085276,-1.4012073200422226,0.03389830508474576,0.4847455302412501,1.0,1/7,0.18%,ANXA1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6320033087645076,1.401207122337585,0.09090909090909091,0.8341066533923371,1.0,6/22,17.37%,SNF8;VPS37A;PTPN23;VPS37B;VPS4B;UBAP1L
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.7859559318584076,-1.401176529889766,0.0847457627118644,0.4833549645731829,1.0,4/11,15.27%,FABP3;LIPI;LIPH;PNPLA3
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.8188625342309338,-1.401098822292684,0.043478260869565216,0.48230961795400173,1.0,5/11,12.77%,GRIN3A;GRIN2A;ADCY7;GLRA2;GRIN2B
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7084701855214142,1.4010699243461655,0.09375,0.8304788142944478,1.0,3/9,10.13%,CEL;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.8040747059420725,1.4009978278869781,0.11904761904761904,0.8265854811510337,1.0,3/6,14.67%,PLIN5;ABHD5;GPLD1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7109842449537787,1.3999850586817533,0.10810810810810811,0.8287870839675384,1.0,5/9,27.14%,CHPT1;PLA2G4C;GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),0.8839792609078357,1.399920624864213,0.02040816326530612,0.8246428266543087,1.0,1/6,0.41%,SLC6A13
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.7840852723139915,1.3991528761184648,0.1,0.8252741321675368,1.0,4/7,13.37%,MRRF;MTIF2;DENR;GFM2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.9130551391810777,-1.3990577363327217,0.04,0.4911669554796883,1.0,1/5,0.81%,C3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6291296503172902,1.3989778027611022,0.08108108108108109,0.8222641811337756,1.0,7/27,14.99%,EED;DNMT3B;SMYD5;RBBP4;PPHLN1;TASOR;AEBP2
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.7620343918696063,-1.3983470590215754,0.043478260869565216,0.49392679992628097,1.0,5/16,16.81%,PLK2;PLK3;ZWILCH;WEE2;WEE1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.7657099950467555,-1.3983036741097532,0.10714285714285714,0.49252440743791054,1.0,5/9,19.78%,SP100;FOXM1;TFAP4;RPS6KA6;KAT5
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),0.9001578454275565,1.3982695994003373,0.018867924528301886,0.822427107120753,1.0,1/5,0.41%,SLC6A13
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.6317038426561356,-1.3981306655354304,0.05172413793103448,0.49188492837762826,1.0,3/35,1.22%,THBS1;CDKN2A;GBP1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7812745984214267,-1.3980244918007838,0.06153846153846154,0.490888963382756,1.0,5/14,11.79%,RFTN1;IL12A;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.8349544462248417,-1.3971264655459945,0.046875,0.4947223511229767,1.0,2/8,6.62%,SOCS3;PARP14
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7570879732459729,-1.3970120914935071,0.04477611940298507,0.49375351804017625,1.0,6/20,12.58%,TLR2;IRF1;TLR3;IRF7;BIRC3;FLOT1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.8302911635574016,-1.3962053553428506,0.12121212121212122,0.4970768302237941,1.0,1/5,5.72%,PLN
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.6873942899299448,-1.3960453425499508,0.08955223880597014,0.49625500071328227,1.0,3/22,8.06%,ENPP2;CYP1B1;ANGPTL3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.7666338862820664,1.3960236427341832,0.023809523809523808,0.8311385461884764,1.0,5/9,22.00%,ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A;ATP5F1C
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.6593534751205788,-1.3960176667652346,0.029850746268656716,0.4947286677109897,1.0,7/31,12.15%,ANXA1;OVOL3;OVOL2;FLG;CLIC4;WNT5A;GLI1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.5661276229726024,-1.3959593604415912,0.04597701149425287,0.49353632485672555,1.0,33/97,17.39%,KCNQ1;CDH22;PCSK2;CCK;PROX1;KCNB1;ST18;MYO15A;SLC24A2;SRRM4;TCEAL6;SLC7A14;SYP;XKR4;MOG;MOBP;UNC13C;CPLX2;SCN1A;STMN4;SYNPR;SCN3B;GAD2;TAS1R1;CNDP1;SGSM1;SLC4A10;CNTN2;GABRA1;CNTNAP5;SV2B;PRKCB;RPH3A
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.7384766085739364,1.3958288585369025,0.06818181818181818,0.8280275859443895,1.0,3/12,9.28%,WNT7A;INTU;SALL1
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.8779076877536587,-1.3954718995823943,0.10714285714285714,0.4945554537422942,1.0,3/7,6.63%,PLK2;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5617421735886061,-1.395451259067148,0.024691358024691357,0.49316615899306887,1.0,22/120,13.19%,S100A10;PKP2;MRAP2;FYB1;ANK3;KCNB1;RAMP3;TESC;RAB11A;ZDHHC22;ABCA12;CAV3;ATP1B1;KCNB2;PDZK1;FLOT1;PLEKHF1;TSPAN32;EMP2;FYB2;SCN3B;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.5215012969438961,1.3954474148728375,0.02631578947368421,0.8259990511025598,1.0,14/56,20.97%,CDKL1;TESK1;TBC1D19;ODAD3;CEP97;KCTD17;TBC1D5;TAPT1;CCDC88A;CEP120;EVI5L;TBC1D22B;SAXO1;TBC1D7
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7282898805669743,1.3953381903502613,0.08333333333333333,0.8227137998574879,1.0,1/14,0.44%,WNT7A
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7082676731867703,-1.395327283676334,0.06451612903225806,0.4922528287784306,1.0,8/23,17.69%,C3;C1R;CD55;CFH;C1S;SUSD4;SERPING1;CR1L
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.8464527759146787,1.3951717825126788,0.10638297872340426,0.8191730533727268,1.0,1/5,0.94%,SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.7909881645615051,1.3951165730699853,0.075,0.8154381606314123,1.0,2/9,1.65%,VEGFD;VEGFC
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.7735734103406039,-1.39485887514983,0.015384615384615385,0.4932081631307473,1.0,4/17,6.56%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.672824274074367,-1.394754198635849,0.015625,0.4925035456270072,1.0,8/30,13.03%,SCN1B;KCNQ1;PVALEF;ATP1B1;RCSD1;TNNT1;NOS1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7826912958506255,-1.394584886563088,0.05084745762711865,0.4920347416201117,1.0,2/13,8.72%,ANXA1;SRPX2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),-0.7935350135936117,-1.3939896066113486,0.10638297872340426,0.4932413518402852,1.0,3/5,20.40%,CHRM1;PRKCH;HES1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.8185372997087051,-1.3933943201801617,0.08333333333333333,0.4939805229660302,1.0,1/7,5.65%,SYT4
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5847354687884261,1.393133221076329,0.10714285714285714,0.8228926614033115,1.0,4/28,6.64%,PRDX6;HSPA1A;ZPR1;SF3B4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.7278247539812855,-1.3927543113482281,0.10294117647058823,0.49568947354897475,1.0,6/19,11.18%,NR4A3;SKAP1;THY1;CCL2;CD44;PRKCQ
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.8366097111407591,1.3926841678047435,0.075,0.8221354789141198,1.0,3/6,13.51%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.6978213418357596,-1.3925598055916486,0.08955223880597014,0.4953023314081261,1.0,2/18,1.47%,MET;MRAP2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.6827946718493314,1.391849026915086,0.0975609756097561,0.823367529350006,1.0,6/15,20.58%,RTRAF;TSEN2;TSEN15;ZBTB8OS;CLP1;TRPT1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.8189448236545682,1.3911204782019269,0.15789473684210525,0.8237422862462959,1.0,1/6,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.9038191957761843,-1.390315248978994,0.03773584905660377,0.5060537154640196,1.0,1/6,0.94%,DUSP1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7318657406530854,1.3897448147278337,0.1,0.8282058866448383,1.0,5/12,14.42%,ADRA1A;LMBRD2;ADRB2;DRD2;ZDHHC21
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5986975800935775,1.3894105312877811,0.02702702702702703,0.8264333339191917,1.0,11/23,22.16%,EAF2;ERCC6;HTATSF1;KAT7;HMGN1;THOC1;CCNT1;ZMYND11;CCAR2;CCNT2;WDR43
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),-0.8922992563522537,-1.3892158480639274,0.0,0.5086199835638424,1.0,2/5,7.22%,CD24;BASP1
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),-0.8922992563522537,-1.3892158480639274,0.0,0.5086199835638424,1.0,2/5,7.22%,CD24;BASP1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.7647948708806502,-1.3882512306439574,0.10344827586206896,0.5120361538810919,1.0,5/10,19.78%,SP100;FOXM1;TFAP4;RPS6KA6;KAT5
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6204351004751186,1.3882453975205113,0.14285714285714285,0.830396138454299,1.0,1/24,0.44%,WNT7A
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.575080854400722,-1.3881361226746927,0.0,0.5109862413737368,1.0,45/127,19.03%,COL4A1;ANGPTL2;OGN;CALD1;C1R;COL4A2;COL5A1;NEXN;ABCA8;SPON2;GJC1;COX7A1;SULF1;THY1;PLN;LMOD1;BGN;PODN;LDB2;HEXIM1;MYH11;ELN;ITGA8;THBS2;HHIP;SLIT3;IGFBP5;OBSCN;SLC38A11;PRRX1;ITGA9;RASL12;C1S;PRXL2C;TNS2;SNCG;COL12A1;VASN;TEK;NOTCH3;AQP1;PCDH18;SMTN;PDGFRA;SVEP1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.6125290957771017,-1.3879043974532745,0.08333333333333333,0.5106719829511057,1.0,10/50,19.14%,THBS1;S100A10;THY1;APOD;DMTN;DLC1;TEK;VCL;DAPK3;PHLDB2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.6010632808474996,-1.387310684688606,0.02631578947368421,0.5120934478448248,1.0,14/60,8.69%,THBS1;FOSB;MYO1F;NR1I3;GAB3;TUBB1;GFI1B;GATA1;CEACAM1;CD44;TMCC2;CLEC12A;UROD;CA1
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.9066169504662815,-1.3872299035562687,0.05555555555555555,0.5111086112849218,1.0,2/5,7.17%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),0.8471367826034816,1.3867422198847061,0.0851063829787234,0.834983417485674,1.0,3/5,14.24%,MTHFS;QDPR;DHFR
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.6769109473363668,-1.386586971098738,0.04225352112676056,0.5128537910971183,1.0,4/32,2.99%,ANXA1;GBP1;ZFP36;SFTPD
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8412086633571105,-1.3862198194439428,0.01639344262295082,0.5133414029242019,1.0,6/9,11.79%,TGFBR2;HLA-A;SYK;CD55;HLA-E;IL18
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.8697057381558323,-1.3858430376839332,0.08928571428571429,0.5136879486284694,1.0,2/7,1.95%,EFNA1;GRIN3A
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.8937618589088734,-1.3857855336347125,0.01694915254237288,0.5124346031116541,1.0,2/7,6.62%,POLQ;PMS2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.76475793529944,-1.3856946987951422,0.07936507936507936,0.5114908330592601,1.0,3/16,5.06%,KLF2;NOS1AP;KLF4
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.6732591974423797,-1.3856061106407975,0.04838709677419355,0.5105526474450459,1.0,1/23,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.6722600999924,1.3851801179303285,0.17647058823529413,0.8394164173675499,1.0,3/12,4.85%,SOX8;BMP2;GREM1
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.9181656945562088,1.38493558386749,0.044444444444444446,0.8369127671031377,1.0,1/5,1.63%,BMP2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.7681119548953855,-1.3844416473319354,0.06349206349206349,0.5157090055985281,1.0,2/12,4.67%,SULT1C3;TPST1
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.8734367986845282,-1.3842828369878133,0.05,0.5152267516082921,1.0,1/6,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.9015606119851519,-1.3840718332224782,0.05660377358490566,0.5131339551279129,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.9015606119851519,-1.3840718332224782,0.05660377358490566,0.5131339551279129,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.8274370174597127,-1.3839560055289488,0.03636363636363636,0.5120697225122794,1.0,2/7,4.77%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.8471903928037975,1.3837876484694251,0.11904761904761904,0.8401506080321015,1.0,3/7,10.39%,DNA2;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.8330253989719614,-1.3834308219646168,0.125,0.513406497962169,1.0,2/6,8.69%,SHTN1;WAS
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.728010671497906,-1.3832347154365712,0.045454545454545456,0.5129915673011599,1.0,1/16,2.20%,ZFP36
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.6346757294006937,-1.3831902929149131,0.10666666666666667,0.5118299634244924,1.0,6/41,6.80%,ANXA1;MET;SIX3;PROX1;LSR;GCM2
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.7535030903744488,-1.38294244710295,0.04918032786885246,0.5115019940094581,1.0,1/14,1.22%,GBP1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),0.7989048386649308,1.3828502578123512,0.11627906976744186,0.8420569709017294,1.0,3/6,15.55%,ASCL1;FOXJ1;RCN3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.6247543385744715,-1.3823929763642855,0.08064516129032258,0.5129846284814463,1.0,11/38,20.03%,LEF1;ACKR4;PRKCQ;CCR10;NR4A1;PRKCD;DEFB109B;CCL28;ABCC1;PDGFRA;CX3CL1
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.8727122410174523,-1.382048010540969,0.034482758620689655,0.5133713401042775,1.0,1/8,0.81%,BLM
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.711834887396767,1.3816122876031494,0.19047619047619047,0.8461566627044077,1.0,5/12,19.50%,VCP;CBFA2T3;IFNLR1;IDE;NOA1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.739257331473262,1.3815807724917324,0.10526315789473684,0.8422727219646866,1.0,5/11,15.31%,VCP;AUP1;UGGT1;DERL1;POMT2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.623968657941343,-1.3814153133860645,0.08333333333333333,0.5150781827318139,1.0,7/52,12.59%,ENPP2;PLAAT4;PLB1;DBI;LPCAT4;ACHE;SLC44A3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6775098984931832,1.3812551726873499,0.0967741935483871,0.840829604998954,1.0,2/16,2.88%,RGCC;SERPINF2
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.6567096916016356,-1.381251507733064,0.045454545454545456,0.5143227531754326,1.0,16/31,26.70%,UNC13C;CPLX1;SYT1;CPLX2;STX19;RIMS2;SYT5;SYT2;CDK5;DOC2B;STX1B;RIMS1;STX3;STX4;RIMS3;RAB3A
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.6744064953393718,-1.381017366905809,0.09722222222222222,0.5142553261248947,1.0,5/20,14.79%,PLK2;SLC24A2;SLC24A1;ACHE;PNKD
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.9141046699187118,1.3808543378875626,0.019230769230769232,0.8392404338047452,1.0,1/5,3.02%,SDC4
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5545598644674545,-1.3807347078466412,0.011363636363636364,0.5143718354839489,1.0,46/147,14.75%,GGT5;S100A10;COL4A1;ANGPTL2;APOLD1;APLNR;SPARC;C1R;TGFBR2;ICAM1;PROX1;PDPN;ABCA8;RAMP3;USHBP1;PODXL;F8;COX7A1;CASZ1;LMOD1;BGN;PODN;CYP1B1;LDB2;HEXIM1;CLIC4;EMP1;CD9;IGFBP7;CD55;ADIRF;BMX;CFH;PRKCH;PROCR;C1QTNF1;SLCO2A1;RNASE1;PCDH12;RASL12;MMRN2;C1S;EGFL7;ROBO4;MFSD2A;SRGN
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),-0.9081797889846484,-1.3801282618434618,0.031746031746031744,0.5163964892571979,1.0,1/5,0.03%,CACNA1H
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.7369732393032384,1.379996674157432,0.09523809523809523,0.8406302982715971,1.0,1/7,0.30%,ACE2
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.7381410580785158,1.3794417522912221,0.09302325581395349,0.8404793409595357,1.0,6/11,20.09%,ARV1;ABCA1;RELCH;STARD4;NPC2;SERAC1
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6189847269196033,1.3790766942433408,0.13333333333333333,0.8392808705405088,1.0,7/24,14.50%,RANBP17;NUP42;STYX;RANBP3L;XPO1;NUP214;XPO7
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5971161412229963,-1.3788830310409121,0.024691358024691357,0.5212779123183824,1.0,14/63,15.97%,COL4A1;CALD1;COL4A2;COL5A1;COL6A2;LMOD1;BGN;RSPO3;ITGA8;IGFBP7;IGFBP5;PTH1R;PLAT;COL12A1
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.7522480127284024,-1.3784640135701411,0.04477611940298507,0.5222577503084934,1.0,6/16,13.20%,IFI6;CEACAM1;EGF;RHBDF2;WDR54;RHBDF1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6716431770971159,1.378182002517299,0.10256410256410256,0.8410690601146907,1.0,2/14,6.66%,ABCA1;ABHD5
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8664661229662847,-1.3780342480563892,0.07017543859649122,0.5221583942153334,1.0,3/7,2.23%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8664661229662847,-1.3780342480563892,0.07017543859649122,0.5221583942153334,1.0,3/7,2.23%,TLR2;B2M;RPS27A
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),0.8239494100250361,1.3770552943045242,0.07894736842105263,0.8432566493436024,1.0,4/7,12.01%,PPP1R3D;PPP1R3G;AKT1;PPP1R3F
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.8707256264235183,-1.3768559295781273,0.05454545454545454,0.5270209458943251,1.0,1/7,2.14%,KMO
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.8071621314556404,-1.3766180757659785,0.08771929824561403,0.5268168957373817,1.0,3/6,18.14%,APP;DCTN1;MAPT
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.808546949705057,-1.3763884734632075,0.030303030303030304,0.5268447446657416,1.0,3/13,2.16%,HPN;COL4A1;LAMB1
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6581914550755741,-1.376064528308805,0.07547169811320754,0.5272559916178889,1.0,7/28,15.30%,THBS1;CDKN2A;APOD;PLET1;DMTN;SEMA3E;DLC1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.6937456844962533,1.3759674999402938,0.12121212121212122,0.8460968421624474,1.0,3/18,5.86%,DGKB;DGKE;MOGAT1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.6602930802054303,-1.3758124721901195,0.031746031746031744,0.527537474323773,1.0,19/35,21.57%,MYO1F;TLR2;CIITA;TAGAP;GPNMB;SIGLEC1;HLA-DRA;IGSF6;CTSS;ACHE;HLA-F;CD74;HLA-DRB1;PRKCB;WDFY4;NAPSB;SPI1;PTPRC;PTAFR
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.7254383169565202,1.3758108819183448,0.17073170731707318,0.8432467734010509,1.0,2/9,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.8089536194836875,1.3756167656129843,0.17073170731707318,0.8408324931128841,1.0,2/7,2.60%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7101799046552826,1.3755223909457956,0.08571428571428572,0.8377253876201946,1.0,1/16,1.07%,LIMD1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8608136568437287,-1.375226863477901,0.06779661016949153,0.5277154132185465,1.0,5/6,13.21%,HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8608136568437287,-1.375226863477901,0.06779661016949153,0.5277154132185465,1.0,5/6,13.21%,HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7076578716860031,-1.3752170650582243,0.078125,0.5262988584979983,1.0,2/12,5.06%,ANXA1;KLF4
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.9046462114507953,-1.3747515195293654,0.08163265306122448,0.527361755788977,1.0,3/5,5.62%,CIITA;NLRP12;NLRC5
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.6847294538764142,-1.3745082869436982,0.046875,0.5270857557267817,1.0,6/20,8.36%,IHO1;STAG3;MEIOB;RNF212B;SYCE2;SYCE1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),-0.9001932932070094,-1.3744895032119793,0.09615384615384616,0.5257075091556949,1.0,1/5,1.11%,APLNR
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6077755903277426,-1.374481447943298,0.09859154929577464,0.5243367125660733,1.0,5/30,14.80%,C3;B2M;LRPAP1;FLOT1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.8250848965722758,-1.3743975413611278,0.11764705882352941,0.5232976534552961,1.0,3/7,8.24%,RAMP3;CCL2;GRM6
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.6065896737472793,-1.3743972459124392,0.0410958904109589,0.5218909393331045,1.0,15/82,14.33%,COL4A1;ANGPTL2;FABP3;LAMB1;COX7A1;SULF1;LMOD1;PLD1;CAV3;TNNT1;IL4R;PRKCQ;PRRX1;RASL12;ITGA3
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6973386757863959,-1.374386589909876,0.05084745762711865,0.520541400007803,1.0,5/22,11.20%,EFNA1;P2RY12;TESC;CYP1B1;SYK
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7754581722363991,-1.3743364768204134,0.06779661016949153,0.5193970750210938,1.0,4/13,7.93%,ANK3;TESC;GLRX;ATP1B1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.7891905162172042,-1.373839247886961,0.08196721311475409,0.5208506410403783,1.0,1/10,1.11%,APLNR
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.6814186176487737,1.3734140804057098,0.125,0.8460774433903876,1.0,4/16,12.58%,COX18;COX10;SMIM20;COX19
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.7883043230912141,1.3725318048471453,0.06818181818181818,0.8475268908997781,1.0,3/9,9.95%,OTUD3;TNFAIP3;OTUB2
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.7370288183899245,-1.3720851232028948,0.058823529411764705,0.5271965766839373,1.0,8/20,18.15%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.7370288183899245,-1.3720851232028948,0.058823529411764705,0.5271965766839373,1.0,8/20,18.15%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.4944054414480053,1.3712555303178608,0.0,0.8512295626895282,1.0,21/70,25.97%,DERL2;TMUB2;VCP;RNF103-CHMP3;ECPAS;AUP1;STT3B;DERL1;FBXO27;TMEM129;UBE4A;ERLIN1;DNAJB14;RHBDD2;DNAJC18;TMUB1;SEL1L;UBQLN1;DNAJB12;DNAJB2;UBE2J2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.6793665745841528,-1.3711071757650457,0.09090909090909091,0.5307239230024134,1.0,9/26,13.03%,SCN1B;KCNQ1;PKP2;KCNJ2;ATP1A1;ATP1B1;CACNA1C;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.6079059857443316,-1.3709141437934556,0.0547945205479452,0.5304959087039818,1.0,9/54,7.78%,TLCD2;A4GALT;MYOF;ANK3;COL5A1;DYSF;CAV3;FA2H;PLSCR1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.690778109905141,-1.3708583476138851,0.06451612903225806,0.5293921737494297,1.0,4/24,9.10%,CACNA1H;KCNB1;SYT4;SYT1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.7149240982466648,1.3707444133177722,0.08333333333333333,0.8502370699543225,1.0,3/13,10.09%,ZNF207;FBXO5;PLK1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7345438326274518,-1.3706410694774795,0.125,0.5292417367064927,1.0,4/16,5.68%,APLNR;RAMP3;CEMIP;THY1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5970783115343351,-1.3705707290820857,0.0945945945945946,0.5283893773982365,1.0,10/45,12.78%,THBS1;RASGRP1;TLR2;APP;TLR3;WNT5A;SYK;HLA-E;IFIH1;FADD
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.8851752104427009,-1.3701685233483476,0.07407407407407407,0.5294990858287337,1.0,2/6,2.83%,NOS1AP;LRRC55
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.6686808830810504,1.3695441457073456,0.10344827586206896,0.853595885602473,1.0,4/19,9.29%,SOX8;BMP2;LIG4;STIL
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.7346438929628578,-1.3694768442923742,0.01639344262295082,0.531446695497678,1.0,5/17,11.30%,CACNA1H;ANK3;SCN9A;SCN2A;SCN1A
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.804510641283836,1.369344671112157,0.10204081632653061,0.8509120296469049,1.0,3/9,8.68%,DSCAM;RORB;CEP290
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.6668731529090051,-1.3693313366964084,0.05714285714285714,0.5308116338221863,1.0,10/31,17.36%,SLC28A2;ABO;ALDOB;SLC18A2;VIL1;SLC3A1;CYP3A4;ADH4;CDH17;CYP3A5
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.6823613822492518,-1.3692532464711669,0.04838709677419355,0.5299160796152816,1.0,4/24,3.31%,TRIM22;CIITA;IFITM3;TRIM5
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.6057545201447346,-1.3692468865647793,0.024390243902439025,0.5285946240374533,1.0,17/74,8.11%,CD24;ST6GAL1;IL1R1;CDKN2A;PGR;ICAM1;PSCA;ITGA2;POF1B;OVOL2;PLEKHG6;ITGA5;BRCA1;ANLN;CEACAM1;CRYBA1;BAIAP2L1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.6589786935709557,-1.3687049452363726,0.07894736842105263,0.5304767730159847,1.0,4/36,2.09%,TLCD2;S100A10;RFTN1;ANK3
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.7204223156824556,1.3685252560020114,0.16666666666666666,0.8515667336000772,1.0,4/12,18.09%,RPP40;RPP14;RPP25L;POP1
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.7598580810706494,1.3683935282404027,0.14893617021276595,0.8485207649188782,1.0,6/8,23.79%,NOTCH2;HEYL;HEY1;HEY2;JAG1;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.8286824429065456,1.368204315446425,0.09523809523809523,0.845991598249663,1.0,2/5,12.81%,HSPA1A;SLC25A5
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6731492934132765,-1.3676264342909865,0.07352941176470588,0.5351332993860108,1.0,9/24,13.21%,B2M;HLA-A;IL12A;HLA-DRA;HLA-B;CD55;HLA-E;FADD;HLA-F
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8543305201923003,-1.3669599506167651,0.017857142857142856,0.5378672003904779,1.0,3/9,2.47%,SP100;MX1;IFIT1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.7126967665366613,-1.3668053776364737,0.109375,0.5372017895581122,1.0,5/26,5.16%,SCN1B;KCNQ1;PKP2;KCNJ2;CTNNA3
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.823224648101488,-1.3667913252956223,0.15254237288135594,0.5359022165145801,1.0,3/9,12.77%,RPS27A;ISG15;UBC
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5677924700187409,-1.3667513386163648,0.0410958904109589,0.5347976822244066,1.0,27/74,19.24%,CD24;ACKR4;GPR18;TRPC3;CAV3;JPH3;ITPR3;S1PR3;CACNA1C;ADCY5;CD55;LPAR6;LPAR4;C1QTNF1;P2RY10;CCR10;TAC4;GLP1R;CIB2;JPH4;HTR2C;ADCY8;RYR2;GPER1;PLCE1;PDGFRA;CD36
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.7138179947218887,-1.3663401955925103,0.06557377049180328,0.5355312371154834,1.0,3/17,7.37%,SULT1C3;TPST1;PAPSS2
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.8183241755900198,-1.3662841877610992,0.03333333333333333,0.533200529271379,1.0,1/8,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.8183241755900198,-1.3662841877610992,0.03333333333333333,0.533200529271379,1.0,1/8,0.67%,KCNQ1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.5360898489915974,-1.366215858443643,0.0,0.5323937190375734,1.0,70/259,15.75%,NPY;TAGLN3;CDH22;PCSK2;NRN1;STMN2;PPP1R14C;CCK;NEFM;PROX1;TCEAL3;SNCB;KCNK1;TESC;MATN2;SH3GL2;ZDHHC22;SLITRK1;LRRTM1;BEX1;SYT4;SLC32A1;SRRM4;ELAVL4;GRIA3;SPOCK3;GAP43;HAP1;NRGN;IFIT3;TCEAL6;ZIC1;SYP;RIT2;NEFH;NCALD;VSNL1;ARHGDIG;CPLX1;IGF1;CPLX2;CA10;HPCA;TCEAL2;SCN2A;OGFOD1;MEG3;SCN1A;CALY;STMN4;GAD1;C11ORF87;GNG2;SYNPR;SCN3B;SLC11A1;GAD2;RGS7BP;MAP7D2;GABRG2;NMT1;TMEM130;CNTN2;KCNC1;GDAP1L1;PCP4;SYT5;RGS17;RAB3C;GABRA1
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.508423290545103,-1.3658896357170314,0.0,0.5329166263762429,1.0,71/265,17.42%,ZIC4;GRIN2D;NPY;TAGLN3;CDH22;PCSK2;NRN1;STMN2;L1CAM;PDE4A;CCK;NEFM;TCEAL3;SNCB;RAMP3;SH3GL2;ZDHHC22;SLITRK1;LRRTM1;SYT4;VLDLR;ELAVL4;CALN1;SPOCK3;GAP43;HAP1;NRGN;TCEAL6;SYP;RIT2;NCALD;TMEM163;IGSF21;PRKCG;CPLX1;SYT1;CPLX2;CA10;PLPPR5;HPCA;SST;TCEAL2;SHISA9;STMN4;GAD1;C11ORF87;EID2;SYNPR;NOS1;ELMO1;SHISA8;GAD2;RGS7BP;VIP;GABRG2;SEMA3E;CNTN2;KCNC1;GDAP1L1;RGS17;RAB3C;PRKCD;RELN;CACNB1;TCEAL5;SYT13;SV2B;ADCY8;PRKCB;SULT4A1;FGF12
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6331228522468717,-1.365836882519079,0.04054054054054054,0.5318593832674658,1.0,14/43,18.48%,NR4A3;ALDOB;LDHA;SLC16A3;HK2;PDHX;GAPDHS;PGK1;ENO4;GPI;PFKL;PGAM1;ENO2;PCK2
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7897124754938252,-1.3654325564048277,0.06779661016949153,0.5323578709451227,1.0,1/8,2.77%,PROX1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.6162056275430643,1.3648093339962708,0.11904761904761904,0.8648288959104729,1.0,7/23,20.00%,GPATCH2;PPP1R36;PPP1R26;ZCCHC9;PPP1R1B;STYXL1;PPP4R4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5848175515718377,-1.3647354308096076,0.05,0.5348390323820308,1.0,24/83,16.60%,IL1R1;IL13RA1;TYMP;ICAM1;FOSL2;ZFP36;KLF4;HLA-C;SYNGR2;FBP1;RHBDF2;IL4R;HELZ2;IER3;TMBIM1;SBNO2;CTSZ;IFIH1;MVP;TNFRSF1A;TNFAIP2;LTBR;JUNB;CEBPD
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.8809100228573736,1.363950207791798,0.030303030303030304,0.8659479206340867,1.0,2/5,10.96%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6405982011547623,-1.3639087301369333,0.07246376811594203,0.5378144180927672,1.0,9/37,13.61%,SLC32A1;SYN3;SYN2;CPLX1;SYT1;CPLX2;RIMS2;GAD1;GAD2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.7464314014685833,-1.36365848502041,0.0625,0.537789106815558,1.0,3/13,7.04%,C3;NR4A3;ACSL5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.8031300253657349,-1.3634942235418146,0.11764705882352941,0.5373056839358671,1.0,4/9,11.79%,RFTN1;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5943859610875627,-1.363357078274711,0.0759493670886076,0.5368246483296563,1.0,12/53,11.12%,THBS1;ISM1;SPARC;COL4A2;SERPINF1;CD160;SULF1;KLF4;STAT1;THBS2;PGK1;DAB2IP
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.7023160882750835,1.3632060894308684,0.11363636363636363,0.8668637091823205,1.0,2/12,1.38%,ASCL1;SOX8
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7517857529545355,-1.3628304662308814,0.058823529411764705,0.5385118853675543,1.0,5/12,21.26%,NLRP12;PTK6;HHIP;GLRA1;OPTN
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),-0.874642727983864,-1.3624632843385407,0.06666666666666667,0.5388717395235086,1.0,4/7,11.12%,TLR2;PRDX4;TLR3;DAB2IP
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.6575323909267238,-1.3624089710025813,0.03225806451612903,0.5379139709657685,1.0,10/34,10.34%,CP;FMO6P;C1ORF87;POF1B;DUOX1;ZNF750;DUOXA1;FUT2;TMC4;CLCA4
prerank,MSigDB_Hallmark_2020__Complement,-0.5556073913548348,-1.3614861756442413,0.0125,0.5413061817544902,1.0,32/145,16.93%,CP;RASGRP1;C3;C1R;COL4A2;TIMP2;IRF1;PHEX;MAFF;F8;CTSC;MMP14;TIMP1;PSMB9;PLSCR1;WAS;IRF7;CTSS;FN1;CD55;CFH;GNG2;PIM1;F10;F5;C1S;SERPING1;PLAT;PRKCD;ATOX1;F3;DOCK10
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7433884746137321,-1.3609042493576815,0.08823529411764706,0.5429208742739197,1.0,2/16,3.27%,RPS27;RPS14
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.7983240639999111,-1.3608907079242016,0.09836065573770492,0.5416674637683714,1.0,2/13,2.20%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.6857983251916304,-1.3605516931664214,0.0625,0.5425769654686597,1.0,4/26,10.14%,KCNQ1;KCNJ13;KCNJ2;CHRM3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.6420451276260066,1.360018753507099,0.12195121951219512,0.8808401525192222,1.0,7/17,19.61%,MTHFS;SLC19A1;MTHFD2L;DHFR;DHFR2;SLC46A1;PM20D2
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.5647657654099087,-1.3599029585333455,0.024390243902439025,0.5450733542559864,1.0,36/117,15.75%,NPY;TAGLN3;CDH22;STMN2;CCK;SNCB;SH3GL2;PLP1;SLITRK1;LRRTM1;SYT4;ELAVL4;GAP43;GFAP;NRGN;TCEAL6;RIT2;ZNF536;ARHGDIG;CPLX2;CA10;HPCA;SST;TCEAL2;SCN2A;STMN4;C11ORF87;SYNPR;SCN3B;GAD2;RGS7BP;GABRG2;CNTN2;KCNC1;RAB3C;GABRA1
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.7273351003552654,1.3598916960653977,0.10256410256410256,0.8780358972170054,1.0,4/8,24.16%,TMX3;PRDX3;CHCHD4;LOXL2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.4981779450573775,1.3597027866380855,0.04,0.8757333840997557,1.0,11/67,12.64%,RANBP17;NXT2;NUP62CL;PPP1R10;SNRPF;AKT1;IPO5;IPO8;NUP214;NXT1;RANBP6
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.6770885779143239,1.3595608231978837,0.09090909090909091,0.8725930215820142,1.0,10/17,24.80%,GREM1;SOX9;ADAMTS12;TRPS1;SOX5;MDK;EFEMP1;BMPR1B;LOXL2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5821752366685987,-1.3595102854343668,0.041666666666666664,0.5456795759916365,1.0,6/43,11.17%,NLRP12;KLF4;THY1;PIM3;PTK6;HHIP
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.8680875735093865,1.3594694653599106,0.02564102564102564,0.8692891518695578,1.0,1/5,3.54%,ADIPOR1
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5887091189872254,1.3593342095394056,0.05714285714285714,0.8666265921474251,1.0,7/31,17.28%,RNF6;RUNX1;RNF14;AR;EP300;NCOA2;UFM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7296399700640562,-1.35897558853376,0.06060606060606061,0.5472196669982226,1.0,3/21,11.45%,S100A10;THY1;MAPRE2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5803286371396743,-1.3588393009982316,0.0547945205479452,0.5466607666134357,1.0,7/56,6.53%,CACNA1H;NR4A3;LMO2;RAMP3;AKR1C1;ATP1A1;GATA1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.5964835922209302,-1.3588244478711382,0.05063291139240506,0.5453942246575179,1.0,13/68,12.78%,THBS1;RASGRP1;TLR2;ZFP36;ARG2;APP;TLR3;IGF1;WNT5A;SYK;HLA-E;IFIH1;FADD
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.7250859985637663,-1.3584852399241927,0.07142857142857142,0.5456395661890778,1.0,8/21,18.15%,ALDOB;HK2;GAPDHS;PGK1;GPI;PFKL;PGAM1;ENO2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5268071025876951,-1.3581455734513976,0.0,0.5458616450271746,1.0,36/210,13.72%,ANXA1;CCBE1;IL1R1;RASGRP1;C3;RFTN1;TLR2;HLA-A;IL12A;IRF1;IL15;SULF1;APP;HTR2B;NOD1;BRCA1;TLR3;CYP1B1;TNFRSF14;ZFPM1;CHI3L1;WNT5A;IRF7;SCIMP;ISG15;HHLA2;PRKCQ;SYK;HLA-E;IL18;IFIH1;FLOT1;FADD;CXCL17;SLC11A1;IL7
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.6541255124818584,-1.358025981391244,0.06060606060606061,0.5452451838495703,1.0,2/26,2.09%,AMN;ANK3
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),0.8730743435975566,1.3572955288972062,0.0625,0.8757428686025198,1.0,1/5,0.41%,SLC6A13
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.9318756779928374,-1.3571728507014975,0.020833333333333332,0.5487431573761306,1.0,1/5,0.99%,MET
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.844190861558634,-1.3571323595465086,0.11764705882352941,0.5476402292057622,1.0,4/7,14.25%,GRIN2D;GRIN2A;GRIN2B;PDLIM4
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.6155117400172652,1.3566242565161484,0.07407407407407407,0.8769628696905887,1.0,7/20,12.31%,PPP1R3D;PASK;PPP1R3G;AKT2;AKT1;PPP1R3F;EPM2AIP1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.515287239791126,-1.35631664195861,0.0,0.5508971747243131,1.0,37/202,19.17%,ENPP2;LEF1;THBS1;LAMB1;SHTN1;PDPN;GPNMB;RAB11A;PODXL;SEMA3B;CEMIP;MMP14;EGF;ANGPTL3;VIL1;PLET1;IGF1;FGF1;DAB2IP;FN1;DMTN;F10;HYAL1;SEMA3E;DDRGK1;PIK3CD;MGAT5;RHOD;F3;SEMA4G;GPER1;TGFB1;FERMT3;HSPA5;NUMB;PDGFRA;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.6607834615130811,-1.3562220875289661,0.12857142857142856,0.5501436663816763,1.0,7/27,12.58%,TLR2;IRF1;TLR3;IRF7;ISG15;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8036388806169644,-1.3561957557697657,0.11666666666666667,0.5490234485407378,1.0,3/9,10.82%,PKP2;CTNNA3;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.8093859793498049,1.3559969968839998,0.058823529411764705,0.8780329452007826,1.0,4/8,5.99%,ABCD2;AKT2;PLIN5;ABCD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.741258075862868,-1.3557636108090747,0.05,0.5505811082864601,1.0,5/19,10.82%,PKP2;NOS1AP;CTNNA3;CAV3;CACNA1C
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.7939694077939148,-1.355706586002476,0.04918032786885246,0.5495951792201448,1.0,2/12,2.20%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.8389794698775825,1.3555566889298434,0.038461538461538464,0.8770968717007034,1.0,2/5,1.63%,RGCC;BMP2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8210622537667713,1.3554855311941387,0.06382978723404255,0.873809013188305,1.0,1/6,0.60%,RGCC
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6976000265532725,1.3547820383231566,0.25806451612903225,0.87497101119184,1.0,3/8,6.69%,SOX9;PLIN5;AKT1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.8657748186353348,1.3546698594588376,0.09090909090909091,0.872177135368762,1.0,2/6,5.86%,RGCC;ATF5
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.4948431441101113,1.354405226854007,0.0,0.8702741004996596,1.0,27/69,28.78%,INTS13;ZC3H8;SNAPC5;GTF2F2;GTF2A2;INTS7;SNAPC1;SNAPC3;INTS8;TAF8;POLR2C;POU2F1;INTS14;RPRD1B;CCNT1;CCNT2;TAF13;GTF2B;RPAP2;INTS4;POLR2A;INTS6;RPRD2;INTS9;INTS11;POLR2K;POLR2D
prerank,PanglaoDB_Augmented_2021__Basophils,-0.592713568018777,-1.3540650050227339,0.05063291139240506,0.5565077374548766,1.0,15/69,10.60%,P2RY13;MYO1F;GPR183;TLR2;L1CAM;SIGLEC1;CD44;SLC26A8;CLEC12A;F13A1;GRM6;IL4R;CTSS;PDK3;IGFBP7
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.49529227764164035,1.3540505031152898,0.0,0.8686594246201126,1.0,27/68,28.78%,INTS13;ZC3H8;SNAPC5;GTF2F2;GTF2A2;INTS7;SNAPC1;SNAPC3;INTS8;TAF8;POLR2C;POU2F1;INTS14;RPRD1B;CCNT1;CCNT2;TAF13;GTF2B;RPAP2;INTS4;POLR2A;INTS6;RPRD2;INTS9;INTS11;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.7646079382840054,1.3539013247979301,0.16326530612244897,0.8657880642361407,1.0,1/6,1.63%,BMP2
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.835098734871194,-1.3537659019171826,0.11320754716981132,0.5571955689894859,1.0,2/6,12.58%,HTR2B;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.8389028921691312,-1.3535023944017854,0.1206896551724138,0.5571267745810858,1.0,2/5,10.67%,SRF;LRPAP1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.6433185447367186,-1.353492026328154,0.041666666666666664,0.5559415197154434,1.0,5/33,6.29%,THBS1;SP100;ICAM1;TMC8;BRCA1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5362982138873165,-1.3534106504065349,0.024390243902439025,0.5551902885064871,1.0,53/161,20.53%,RPL19;RPL3;ZFP36;RPS27A;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;RPL13A;PATL2;HELZ2;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;SAMD4A;RPL5;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.6261569000467792,1.3523441475888822,0.1111111111111111,0.8707072123710334,1.0,7/27,18.02%,NCSTN;MID1IP1;MSH2;MAPK8;MSH3;POT1;ABL2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.5926853683357755,-1.3520899504028667,0.029850746268656716,0.5611550099736113,1.0,26/59,21.37%,MYO1F;GPR183;DOCK8;TAGAP;SERPINF1;SLA;ARHGAP9;HLA-DRA;BST2;WAS;IRF7;CTSS;P2RY10;IL3RA;BLNK;CD37;BCL11A;SLC15A4;ETV6;CD4;WDFY4;PSTPIP1;NAPSB;SPI1;PACSIN1;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.8421534507419801,1.3520585122500164,0.09302325581395349,0.8687051270025191,1.0,3/5,13.51%,SPRED1;SPRY1;SPRED2
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.5553401917328735,-1.3514593863685735,0.012987012987012988,0.5632531903519168,1.0,19/123,10.54%,RASGRP1;CDKN2A;ARHGAP4;RASGRP2;EPS8L2;SHTN1;PDPN;ARHGEF3;PLK2;RALGDS;PLD1;USP50;RIT2;ARHGDIG;WAS;IGF1;CDC42EP1;CDC42EP3;SHC2
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.8747151268899556,-1.351074575735014,0.1016949152542373,0.5639160277667452,1.0,1/5,1.41%,SLC6A15
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.8340350270276982,-1.3507653120160386,0.061224489795918366,0.5630932541758712,1.0,1/6,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.8340350270276982,-1.3507653120160386,0.061224489795918366,0.5630932541758712,1.0,1/6,0.33%,THBS1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.6136982961931331,1.3506870647206177,0.02857142857142857,0.8716474179896456,1.0,7/20,20.22%,HMGB1;DNASE1L2;CASP3;EXOG;DFFB;DNASE1L1;FBH1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.5616903855334382,-1.3506259141712458,0.07142857142857142,0.56280091824944,1.0,34/101,19.43%,COL4A1;ANGPTL2;CALD1;C1R;COL4A2;ABCA8;MATN2;MAOB;LMOD1;BGN;ADAM21;IGF1;THBS2;IGFBP5;NOS1;F10;C1QTNF1;SLCO2A1;AMOTL2;RASL12;C1S;ASS1;SERPING1;TNS2;COL12A1;FMO2;TEK;MLANA;ADGRF5;AQP1;PTPN21;PDGFRA;SVEP1;PLAUR
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.7855641241398472,-1.3505056616142814,0.09259259259259259,0.5622147219013297,1.0,1/6,3.77%,STAT4
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.7186590612809931,-1.3504429172103791,0.07936507936507936,0.561315631485557,1.0,1/12,0.99%,MET
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.8498865096235424,1.3503440659299908,0.05084745762711865,0.8699697571533309,1.0,2/5,6.41%,ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.5768053704290304,1.3499373678787931,0.05405405405405406,0.8685719361581227,1.0,6/33,17.36%,MAML3;KAT2B;ENHO;ROBO1;EP300;POGLUT1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.7941448860259566,1.3498938616648526,0.12121212121212122,0.8652365613596156,1.0,1/7,0.43%,NGF
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.7660795556571156,-1.3498909942801995,0.0784313725490196,0.5630233210756006,1.0,2/13,0.47%,CCBE1;HPN
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.6589549247230246,-1.3498331334093308,0.1095890410958904,0.5618961069973412,1.0,1/23,0.44%,TMEM204
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.8932619467231884,-1.3495798652443838,0.0392156862745098,0.5616933520388605,1.0,2/5,7.17%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5659479047432231,-1.3494855228618132,0.038461538461538464,0.5608660789384461,1.0,34/86,22.18%,HPN;KCNQ1;KCNV1;LRRC55;KCNB1;KCNK1;KCNJ13;KCNJ2;SLC24A2;KCNH8;SLC24A1;SLC9A2;KCNG1;KCNB2;KCNK12;KCNC1;KCND3;SLC9A5;KCNMB4;KCNH7;KCNK10;AQP1;KCNAB3;KCNV2;KCNF1;HCN1;ABCC9;KCNQ5;KCNC2;ATP1B3;KCNK13;KCNJ6;KCNQ4;SLC9A7
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.7202768296412887,-1.3493884645601595,0.06451612903225806,0.5601049265182437,1.0,2/18,5.61%,ABCA8;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5062304464497975,-1.349052875844533,0.0,0.5604056529438503,1.0,24/275,7.44%,PRAME;LEF1;ANXA1;THBS1;HPN;APIP;IFI6;DHCR24;MET;POU4F1;RPS27A;NAA38;PDPN;KIF14;PLK2;PRDX5;HTR2B;SCX;PIM3;GATA1;CD44;NUAK2;PLK3;IFIT3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.581120561907868,-1.3489454846232054,0.06666666666666667,0.5594625659852908,1.0,13/67,17.95%,THBS1;MET;SPARC;PROX1;EGF;WNT5A;FGF1;GPI;PIK3CB;PIK3CD;TEK;ETS1;TGFB1
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),-0.8839840898132993,-1.3486715282311559,0.05660377358490566,0.5598253684470029,1.0,1/5,0.71%,FLRT3
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.7277384112581158,1.3485952949200524,0.16279069767441862,0.8685436776109683,1.0,2/8,8.16%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.7621464363848687,-1.3484929061515039,0.05,0.5596505503566717,1.0,4/13,11.51%,ANXA1;GCM2;CD9;MMP24
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.7030923766102134,-1.348354058581657,0.12280701754385964,0.5590651143246149,1.0,2/17,5.68%,ICAM1;THY1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.6724883594681648,-1.3483316693362737,0.08108108108108109,0.5579486469158843,1.0,5/24,13.20%,EFNA1;CTSC;ATP5IF1;PINK1;RHBDF1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.6225471044713159,1.3480156456032546,0.15151515151515152,0.8686615337684571,1.0,6/21,8.28%,CEBPA;ZC3H8;TENM1;POLR3F;BRF2;AR
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6359472006338421,-1.3480136598712062,0.0136986301369863,0.5584139817597024,1.0,12/34,16.59%,GRIN3A;KCNB1;GRIN2A;APP;GRIA3;GRM6;GRIK1;GRIN2B;GRID2;GRM7;GRIK2;CLN3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.7104531907090631,-1.3476149277942377,0.07575757575757576,0.5594902678071579,1.0,3/24,2.77%,PKP2;TGFBR2;PROX1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.7203919225788116,-1.3474957855637095,0.11594202898550725,0.5588491773041413,1.0,6/17,10.10%,PLN;CCL2;CAV3;EGF;GRM6;PLPP4
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.6197234129797798,-1.347426009848355,0.1206896551724138,0.5579667803286673,1.0,14/35,19.27%,OVOL3;RBP2;OVOL2;ZNF750;POU2F3;WAS;EMP1;GLI1;FGF7;LAMA3;ALDH3A2;HLA-DRB1;SVEP1;FLG2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.727226711555822,-1.347364676699374,0.11290322580645161,0.5570070571513502,1.0,2/12,4.77%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.759573735370302,-1.347207913917826,0.11475409836065574,0.5562338261312219,1.0,4/10,12.60%,CACNA1H;ERVW-1;CD9;NOS1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),0.8617608153478028,1.3468442913004863,0.020833333333333332,0.8716674081638014,1.0,2/6,4.85%,LEPR;GREM1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.6781312434620922,-1.3468423787518726,0.10294117647058823,0.5569797553171614,1.0,5/27,8.66%,APLNR;TGFBR2;CCDC39;MMP21;SRF
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.6023020735523618,1.3462637058086286,0.12903225806451613,0.8717723928926777,1.0,3/21,7.29%,IBA57;CIAO3;LYRM4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.6470608539791753,-1.3459450776308646,0.10666666666666667,0.5602835692522405,1.0,6/30,13.03%,SCN1B;CAV3;YWHAH;CHRM3;PDZK1;SCN3B
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.8320221817041499,-1.3456342543155386,0.08064516129032258,0.5603332838546586,1.0,3/7,11.73%,TLR2;CCL2;NAMPT
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.8705498583210645,-1.3453562685949727,0.05357142857142857,0.5606036509761039,1.0,1/5,1.14%,NR4A3
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7511680097816715,-1.3448238467388727,0.11290322580645161,0.5620349047309527,1.0,4/11,14.82%,CNTNAP1;PLP1;TENM4;MYRF
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.6209396664201139,-1.3446941622877628,0.06944444444444445,0.5614407644408932,1.0,5/36,9.91%,IL12A;STAT4;CA1;LMNB1;TCP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6293344257649335,-1.3446498800861137,0.05555555555555555,0.5604901011801845,1.0,20/41,19.43%,IL1R1;S100A10;GPR87;FOSL2;MAFF;PLEKHG6;KLF4;ADAM19;IER3;CD55;TMEM40;IL18;SMAGP;LTBR;SH2D3A;ANXA2;MLANA;CD4;BHLHE40;PLAUR
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8891393423844711,-1.3446006456060202,0.03389830508474576,0.5595037143829719,1.0,2/5,5.16%,PKP2;CTNNA3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.8035875960304868,1.3444609128496094,0.1956521739130435,0.8780446946760385,1.0,3/6,10.47%,LIG4;MSH2;EXOSC6
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.7539972241561363,-1.3443258058538199,0.12698412698412698,0.559772960761637,1.0,4/12,6.33%,SCN1B;KCNQ1;NOS1AP;CAV3
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.7851025491619753,-1.3441198976251387,0.16666666666666666,0.5584092558991689,1.0,1/6,5.06%,KLF4
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.7851025491619753,-1.3441198976251387,0.16666666666666666,0.5584092558991689,1.0,1/6,5.06%,KLF4
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.7325232424671482,1.3440629485162068,0.0975609756097561,0.8766966471499769,1.0,6/12,14.25%,SOX8;PEF1;KLHL12;HEYL;CDH2;TAPT1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.807103821661167,-1.3438711294445114,0.06779661016949153,0.5587777957678919,1.0,3/8,11.79%,LEF1;HLA-E;IL18
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.6399899947989129,1.3438415407369417,0.15789473684210525,0.8742811025462927,1.0,3/13,17.40%,PRKRA;DROSHA;AGO3
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.5729413672736662,-1.3437376155530474,0.1038961038961039,0.5585342398277406,1.0,4/74,3.17%,GGT5;ANXA1;WNT8B;IL12A
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.7603638337521642,1.3431936035409928,0.1111111111111111,0.8750617709497748,1.0,4/7,14.92%,MSH2;GTF2H2;MSH3;POT1
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7831112764736673,-1.3427942121445207,0.07352941176470588,0.5618095376370492,1.0,3/10,11.17%,NLRP12;PTK6;HHIP
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5756104211902122,-1.3426592059858862,0.0684931506849315,0.5612860367245276,1.0,18/75,16.59%,PCSK2;C1R;MMEL1;C1RL;PHEX;ATP23;MMP14;KLK6;ADAM19;CTSS;AEBP1;SEC11C;SRGN;MYRF;TMEM208;APH1A;F3;CLN3
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.8549085226292885,-1.3423776856816831,0.06896551724137931,0.5613714046328485,1.0,2/5,7.96%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.7471207478037155,-1.3421059365787555,0.11475409836065574,0.5614173558601306,1.0,4/14,12.60%,CACNA1H;ERVW-1;IGF1;NOS1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.8192491242404181,-1.3420671343057884,0.16071428571428573,0.5604887572403663,1.0,1/7,5.65%,SYT4
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.5332384168485625,1.3418590822221736,0.07407407407407407,0.8797299372513578,1.0,6/43,8.50%,POLD3;APEX2;DNA2;RFC3;ERCC6;PRMT6
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5777145451536894,-1.341378768728645,0.02702702702702703,0.5633755131475309,1.0,22/80,11.20%,CXCL2;P2RY6;NR4A3;MYO1F;TLR2;TAGAP;ADGRE5;GPNMB;GPR34;GPR171;SLA;SIGLEC1;CCL2;HLA-DRA;IGSF6;PARP14;CLEC12A;F13A1;IL4R;SCIMP;CTSS;SYK
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.6171938257829238,-1.3407135620976303,0.07246376811594203,0.5658426514293933,1.0,6/37,10.10%,MTMR7;MTMR11;SGPP2;PLPPR1;PLPPR5;PLPP4
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.7226557456195065,1.3406483324283214,0.09090909090909091,0.8827007992932685,1.0,3/12,14.11%,DNA2;HUS1;RAD9B
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.5451940822810847,-1.3406197991314752,0.012345679012345678,0.5650461766564385,1.0,21/141,12.60%,CACNA1H;APLNR;SPARC;FABP3;COL4A2;PTP4A3;COX7A1;COL6A2;APP;CAV3;SVIL;APOD;SYNGR2;MYH11;TNNT1;IGF1;IGFBP7;AEBP1;ACHE;MYH9;NOS1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.8445000046883229,1.34045262534417,0.06666666666666667,0.8801290441466902,1.0,4/6,14.18%,ABCD2;ABCD1;ABCD3;ACOX1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),0.8191821786168423,1.340169760207004,0.1276595744680851,0.878549473416298,1.0,2/5,3.86%,MYORG;SELENON
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.6212090837602601,1.3401589503557054,0.14285714285714285,0.8753377368960218,1.0,6/22,20.44%,METTL8;TRMT61A;CBLL1;VIRMA;DKC1;NSUN2
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.8306461147158708,1.3401027719643566,0.1111111111111111,0.8727376315721498,1.0,2/6,2.59%,RNF6;UBE2T
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.6269588298101976,-1.3400839472216581,0.07352941176470588,0.566166142622175,1.0,10/36,18.48%,THBS1;KCNB1;SLC39A14;EIF2B2;PDK3;IRS2;PFKL;ADCY8;GPER1;PCK2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.6985794844788193,-1.339609105633299,0.078125,0.5674742834275927,1.0,2/15,2.75%,SIX3;WNT8B
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.7642997411009117,-1.339545756555248,0.06349206349206349,0.5665446757935895,1.0,2/16,2.20%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.7051212238894143,-1.3395407920388194,0.10606060606060606,0.5653692719019016,1.0,5/14,19.40%,APP;IGF1;MFSD2A;PPIB;GHR
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.8054385324910538,1.3395100973722198,0.08888888888888889,0.8732110003490042,1.0,3/7,6.76%,ERCC8;LIG4;ERCC6
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.5859279580219169,1.3394587019456994,0.12903225806451613,0.8703042358444014,1.0,3/22,7.29%,IBA57;CIAO3;LYRM4
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.7747108594255862,1.3392949564693768,0.12244897959183673,0.8684155306084552,1.0,3/7,17.81%,PRKRA;DROSHA;TSN
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.6874754825539111,1.3391634274300102,0.13513513513513514,0.8657542645164296,1.0,6/13,26.39%,SNF8;VTA1;LEPROTL1;CHMP6;TMEM50B;VPS25
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.6649578586826161,-1.3387278580420605,0.07575757575757576,0.568376565414592,1.0,3/19,10.67%,APP;WDR54;LRPAP1
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.686840164342557,1.3385454439103317,0.08823529411764706,0.86603990440647,1.0,6/12,15.62%,AKT2;AKT1;ERBB4;ZNF703;CSF1R;ID2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6109671422991646,-1.3385328600164743,0.05333333333333334,0.5679480994414547,1.0,7/37,11.20%,MX1;RAMP3;CAV3;CEACAM1;ARR3;CD9;SYK
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.5544534084074165,-1.3385154086724744,0.038461538461538464,0.5668343284250673,1.0,33/114,17.42%,NPY;RIMBP2;CDH22;SIX3;PCSK2;CHGB;STMN2;PROX1;SH3GL2;LRRTM1;SYT4;ELAVL4;JPH3;NKX6-2;SYP;PLPPR1;IGSF21;CPLX2;CA10;SST;TCEAL2;MEG3;KCNB2;SCN3B;NPTX2;GAD2;KCNC1;PCP4;RAB3C;TCEAL5;SYT13;SULT4A1;FGF12
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.7941257494624265,-1.3384378378056128,0.125,0.5659727396175376,1.0,1/8,0.99%,MET
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),-0.789732671671461,-1.338315156467334,0.10344827586206896,0.5654378073419966,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.8276414103813552,1.3381456226052806,0.17391304347826086,0.8650087540657635,1.0,3/5,7.69%,ACP3;TPK1;SLC25A19
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5649277507968327,-1.3381063642255147,0.038461538461538464,0.5655310115131361,1.0,28/90,20.09%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;LMOD1;BGN;CCL2;SRPX2;FN1;ACHE;IGFBP5;PRRX1;C1QTNF1;AMOTL2;RHBDF1;TNS2;COL12A1;CAPN1;AFAP1L1;GPC1;ANGPT2;PTPN21;SYNC;NNMT;ANTXR1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.7466478841709855,-1.3374548837400413,0.057971014492753624,0.5679331985521602,1.0,2/18,6.59%,POU4F1;TLR3
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.729536900711681,-1.3370084617190852,0.08620689655172414,0.5689654587954225,1.0,5/14,9.67%,TYMS;DUOX1;AKR1C1;TRPC3;STAT1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.7489008612513022,-1.3367008871413575,0.16129032258064516,0.5693336904991504,1.0,5/13,16.15%,ANXA1;LTBP4;RIMS2;VIP;PTPRN
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.763210339191139,1.3364023947768084,0.14583333333333334,0.8708215773292243,1.0,1/10,1.13%,SLIT1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.8522808491760823,-1.3362018118221077,0.06349206349206349,0.570452976992526,1.0,3/6,11.77%,RPS6KA1;SELP;SOX15
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8453868702304767,-1.3360796341130436,0.05084745762711865,0.5699530186059788,1.0,6/7,13.21%,B2M;HLA-A;HLA-C;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.762205159216191,-1.3359467605896236,0.09375,0.5694738219649194,1.0,6/10,22.98%,IL12A;STAT4;STAT1;IL27RA;IL12RB2;STAT3
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.6468475694411079,1.3355546349735534,0.20833333333333334,0.8720649608684397,1.0,4/14,19.21%,COX18;SMIM20;COX19;FASTKD3
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),-0.8665426547598686,-1.3355069570281983,0.05555555555555555,0.570361644585729,1.0,1/6,0.18%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.645473937445145,-1.3353249347420537,0.06896551724137931,0.5700515149543127,1.0,7/22,12.60%,IFIT1;PLN;TIMP1;PARP9;ATP5IF1;TMBIM1;NOS1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.7621754294689845,-1.335005539068963,0.11864406779661017,0.5706552347165736,1.0,2/11,10.55%,DUSP1;CCNB1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6008025858575912,-1.3349803888921201,0.02702702702702703,0.5696394505072732,1.0,13/60,16.79%,SLC28A2;SLC6A15;SLC32A1;SYN3;SLC18A2;SYN2;CPLX1;SYT1;GAD1;GAD2;SLC38A1;PPFIA1;SLC29A4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.7168797395561585,-1.3349175674002234,0.1724137931034483,0.568868885896952,1.0,3/10,20.65%,KLK6;MYRF;HJV
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.8334036926797921,-1.3349033261511682,0.125,0.5678237119801366,1.0,2/6,6.56%,HPN;CEACAM1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.6451661850980076,-1.3348639802671918,0.12121212121212122,0.5668935653304285,1.0,4/23,10.68%,NPY;GLRA2;HCRTR2;MCHR2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.7060602976278274,-1.3348055235760763,0.07017543859649122,0.565930246414393,1.0,1/16,0.33%,THBS1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.8410093651354579,-1.3338787539691153,0.12280701754385964,0.5700866129978297,1.0,3/8,9.61%,CENPH;CENPE;NUF2
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9076122156450281,-1.3338657332432309,0.034482758620689655,0.5690656838311418,1.0,2/6,3.86%,APIP;BHMT
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.7963198386653529,-1.3338505186893856,0.1,0.5679754800433489,1.0,5/9,11.26%,P4HA2;P3H2;OGFOD1;P4HTM;P4HA3
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),0.7093855922365757,1.333835506567672,0.17073170731707318,0.878461383966682,1.0,2/9,4.85%,EFNB2;GREM1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),-0.818935421209972,-1.3338339734673992,0.11363636363636363,0.5669261718653805,1.0,1/8,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.521049191135419,1.3336557323164566,0.0,0.8763476969189163,1.0,10/52,8.94%,RGCC;ERCC8;PPP1R10;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;SIRT6;HMGB1
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6111489328893678,-1.3334915703686754,0.07246376811594203,0.5676884628602784,1.0,8/45,14.31%,ENPP2;RAB11A;CEACAM1;VIL1;PFN2;DAB2IP;EMP2;HYAL1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.5926757285488282,-1.3329939445514065,0.0958904109589041,0.5695774690498159,1.0,17/61,20.36%,EFNA1;LAMB1;PROX1;KIF14;POF1B;ATRNL1;ITGA8;FN1;RADIL;TMEFF2;RELN;MICALL2;TEK;FERMT3;LAMA5;ANTXR1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.8253290978397012,1.3329253300082575,0.125,0.87663005078484,1.0,2/6,5.64%,BMP2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5469751821719012,-1.332724257621427,0.05263157894736842,0.5698041783971463,1.0,19/78,17.99%,THBS1;P2RY12;TLR2;IFI35;IL15;NLRP12;APP;TLR3;PLSCR1;WNT5A;SCIMP;DDX60;IL18;TNFRSF1A;ETS1;ABCC1;NMI;TGFB1;SLC15A4
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.711121782094516,1.3325457764999962,0.1111111111111111,0.8722999384388971,1.0,3/11,18.98%,AP3S1;AP3B1;BLOC1S4
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.711121782094516,1.3325457764999962,0.1111111111111111,0.8722999384388971,1.0,3/11,18.98%,AP3S1;AP3B1;BLOC1S4
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.6974363665037158,-1.332544823008313,0.11290322580645161,0.5694129063216891,1.0,7/17,13.03%,SCN1B;PKP2;KCNJ2;ATP1A1;CACNA1C;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),0.7498548695043984,1.3319687658947317,0.21052631578947367,0.8724737268944943,1.0,4/10,18.09%,RPP40;RPP14;RPP25L;POP1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4728393579181243,1.3317471878330147,0.13043478260869565,0.8710148135755315,1.0,31/89,27.75%,CHRAC1;SMARCAD1;SOX9;KAT2B;ERCC6;HNRNPC;KDM5A;RBBP4;BAZ1A;KAT2A;HDAC2;SMARCA2;DR1;MBD3;CHD4;DAXX;TADA2B;PBRM1;RUVBL1;ZBTB1;BAHD1;MTA2;SMARCC1;ARID1B;PADI4;BAZ1B;BAZ2B;INO80;HCFC2;MYSM1;CHD8
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.8105136679396627,-1.3310773506269908,0.07017543859649122,0.5753269271961398,1.0,2/8,0.67%,KCNT2;KCNQ1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.6645146809388979,-1.331031115477836,0.12698412698412698,0.5743117150590127,1.0,5/24,11.28%,APLNR;TGFBR2;PROX1;ZFPM1;SLIT3
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6231522687049242,-1.3309116449203129,0.12857142857142856,0.573715464502246,1.0,8/36,13.61%,SLC32A1;SYN3;SYN2;CPLX1;SYT1;CPLX2;GAD1;GAD2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),0.49411749639340363,1.3308384995305333,0.0,0.8730159391157072,1.0,34/92,25.88%,MRPL10;MRPS30;EEF1D;EEFSEC;MRPL15;PTCD3;MRPS9;MRPL58;MRPS2;MRPL50;MRPL37;GFM2;MRPL18;MRPL42;MRPL52;MRPL41;MRPS31;MRPS27;MRPL9;MRPS7;MRPS35;MRPS14;MRPL47;MRPL4;MRPS11;MRPL1;MRPS10;MRPL17;MRPS21;MRPL24;MRPL13;EEF2;MRPL3;MRPS16
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7803832934046497,1.330801632237846,0.13636363636363635,0.8701031818230324,1.0,4/6,17.67%,NBDY;CNOT2;CNOT6L;CNOT1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.7677225211349601,-1.3307746913645513,0.12121212121212122,0.573175559582847,1.0,1/9,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5751301370007627,1.330765728576809,0.14705882352941177,0.8674468577214854,1.0,3/22,4.12%,MSH4;POLD3;PMS1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.8622072222549224,1.3303117074853765,0.1,0.867084975684857,1.0,1/5,1.63%,BMP2
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.8182722443528045,-1.3296748489485242,0.14814814814814814,0.5764252620202088,1.0,2/6,9.54%,CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.8182722443528045,-1.3296748489485242,0.14814814814814814,0.5764252620202088,1.0,2/6,9.54%,CDC42EP1;CDC42EP3
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.8620064481116934,-1.3293918146744688,0.09090909090909091,0.576671026112697,1.0,1/5,7.19%,IFFO1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.6580207008679371,1.3293755519183863,0.16666666666666666,0.8697369457464766,1.0,6/18,17.33%,MTHFS;SLC19A1;MTHFD2L;DHFR;DHFR2;SLC46A1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.7064398885168245,1.3293470876005458,0.21052631578947367,0.8667973692642688,1.0,5/7,15.62%,AKT2;AKT1;ERBB4;ZNF703;ID2
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.5226307249523388,1.3292992536906196,0.08333333333333333,0.8643051166568868,1.0,9/51,10.63%,RGCC;NAF1;CCT7;POLG2;GREM1;RFC3;MAP3K4;ATR;CCT3
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.7520732533624137,-1.3290705128322535,0.1,0.5772732307105367,1.0,3/13,12.35%,PLN;CAV3;HECW2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),0.6351512860000265,1.3285760857301894,0.1388888888888889,0.8653523888213303,1.0,5/18,13.37%,SLC6A13;SLC47A1;SFXN2;SLC22A2;SLC6A1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.75494290009601,-1.3281724333039828,0.08823529411764706,0.5801916698084243,1.0,4/9,18.56%,FES;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.8431864118043539,-1.3280723260476666,0.08928571428571429,0.579734544026909,1.0,3/5,13.56%,COL5A1;RPS23;SLC11A1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.6519328460935518,-1.328006590912187,0.046875,0.5789238415498199,1.0,9/26,14.79%,ANXA1;IL12A;SYT4;IL1RAPL1;RHBDF2;TNFRSF1A;RHBDF1;GRM7;PNKD
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.73256729746528,-1.3277485151032826,0.09230769230769231,0.5790028721758852,1.0,4/19,9.24%,POU4F1;MSX2;GATA1;IGF1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.8289579476759409,1.3277144874266327,0.09090909090909091,0.8672027061635649,1.0,3/5,10.68%,MTERF3;FASTKD2;MRPS2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.7612471623636735,-1.3276438288666346,0.10714285714285714,0.5783028606926629,1.0,1/12,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.6345502604361907,1.3276323954778382,0.10526315789473684,0.8650034796085995,1.0,6/22,16.65%,HSPA1A;PLK1;CEP97;CHMP2B;HNRNPU;VPS4B
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.7166819553219108,-1.3275525873928502,0.10144927536231885,0.5778528290184793,1.0,2/17,8.80%,KCNQ1;FBP1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),-0.7387739030047951,-1.3273500822071522,0.10606060606060606,0.5776866111182271,1.0,4/11,13.52%,P2RY12;EPS8L2;PLEKHM1;NLGN1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.6606861045484814,-1.326792803374875,0.14285714285714285,0.5792104035670131,1.0,8/25,17.65%,C1R;C1RL;GRIN2A;MMP14;PGK1;FADD;PLAT;RIPK2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),-0.7850479831019649,-1.325659043730688,0.19047619047619047,0.5841885799971636,1.0,2/5,4.27%,KCNQ1;GJC1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.6920982249822353,1.3256480468471021,0.16216216216216217,0.8733566672357863,1.0,5/9,24.19%,NAF1;NUFIP1;ZNHIT3;RUVBL1;ZNHIT6
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.6096139349842038,-1.3254741452352938,0.11594202898550725,0.583818465623892,1.0,2/32,4.40%,MET;SEMA3B
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.8803540277376513,-1.3252771461609572,0.06451612903225806,0.5836247294807242,1.0,2/5,2.46%,THBS1;NOS1AP
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5887628985080586,1.3251887353995757,0.125,0.8723736289565746,1.0,11/18,29.47%,ZNF706;NCOA3;CNOT2;KAT2A;CNOT1;WDR43;LOXL2;ESRRB;TAF5L;ZC3H13;REST
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.5354202392734487,-1.3251676498369072,0.037037037037037035,0.5830998917296834,1.0,14/118,11.39%,GRIN2D;COL4A1;SIX3;TGFBR2;PROX1;CIC;GRIN2A;NNAT;HAP1;APOD;ZIC1;CA10;B3GNT5;ZFHX2
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.6468370963969076,1.324648575404367,0.15789473684210525,0.8720822866957926,1.0,5/15,20.44%,METTL8;TRMT61A;CBLL1;VIRMA;NSUN2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.5604861328068358,-1.3244319289205406,0.038461538461538464,0.5854358767604684,1.0,28/98,17.71%,GBP2;COL4A1;C1R;COL4A2;MATN2;COBLL1;SULF1;BGN;SCARA3;SRPX2;OSMR;FGF1;FN1;IL17RE;IGFBP5;C1QTNF1;SLCO2A1;AMOTL2;FRAS1;C1S;TNS2;LAMA3;COL12A1;RHOD;F3;PXDC1;FMO2;ADGRF5
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.651196826458589,-1.3242722596545355,0.0945945945945946,0.5849270068923602,1.0,2/28,6.34%,KLF2;GLRA2
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.645359899735354,1.3240197516656302,0.12121212121212122,0.8730826895168174,1.0,7/23,22.27%,DERL2;VCP;AUP1;DERL1;TMEM129;PREB;SEL1L
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),0.7760266439412447,1.3230609144332814,0.10256410256410256,0.8763828152076312,1.0,3/6,13.44%,TNFAIP3;GREM1;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.8272862203525533,1.3228970915479,0.1568627450980392,0.874498357373924,1.0,2/5,6.83%,LMO3;PTGIS
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.8454333102692835,-1.3227668485490915,0.10344827586206896,0.5914882432857179,1.0,2/5,7.10%,TYMS;CMPK2
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.8282558365387374,-1.3225682685396474,0.10526315789473684,0.591489966934738,1.0,1/6,0.47%,HPN
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.775577637644554,-1.3223352644847035,0.06060606060606061,0.5913013659337125,1.0,3/10,6.90%,CHRM1;HTR2B;GAP43
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.6870288460731537,-1.322153371880746,0.14285714285714285,0.590854428028833,1.0,5/19,13.03%,SCN1B;CAV3;YWHAH;NOS1;SCN3B
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7494643201877408,-1.3216141733988007,0.10606060606060606,0.5924948579471372,1.0,2/11,10.67%,SRF;LRPAP1
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.8355993747111092,-1.321602426192143,0.11764705882352941,0.5903822275419331,1.0,1/5,5.53%,KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.8355993747111092,-1.321602426192143,0.11764705882352941,0.5903822275419331,1.0,1/5,5.53%,KIF17
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.5138994561523523,-1.3211643980539074,0.011363636363636364,0.5914487504033908,1.0,57/191,20.53%,RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;RPL27A;RPL35;RPL7A;RPL37A;RPL27;RPL9;RPL21;GTPBP2;RPL13A;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;RPL8;RPS6;RPS15;RPL26L1;RPS9;RPL12;RPL5;EEF1A2;GARS1;RPL23;RPL4;RPL18A;RPL41;RPL7;RPS12;RPS20;COPS5;MRPL23;PPA1;RPL15;MRPL51;RPL11;DARS2;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6734035753360774,-1.3210642132688502,0.07936507936507936,0.5908859023442966,1.0,3/26,1.45%,COL4A1;MET;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.5922112474194569,-1.3207797229609022,0.08,0.5911448849125364,1.0,12/53,13.58%,MET;PSRC1;LMOD1;CAV3;BAIAP2;BAIAP2L1;CDC42EP1;PFN2;CDC42EP3;DCTN1;PINK1;FES
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.8125546928795324,-1.3206014905557342,0.11666666666666667,0.5911301655781938,1.0,4/7,15.95%,ITGA2;ITGA8;ITGA3;ITGB4
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.7642247879740205,-1.3200832536078329,0.11290322580645161,0.5927319647382713,1.0,2/9,7.85%,KCNQ1;EGF
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.8085960294377972,-1.3200757004918973,0.06896551724137931,0.5916953357323177,1.0,1/9,0.81%,BLM
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.531335283029458,-1.3198410621284102,0.07317073170731707,0.5917475014697237,1.0,40/134,17.72%,COL4A1;TAMALIN;ANGPTL2;CALD1;C1R;COL4A2;COL5A1;COL4A4;COX7A1;SULF1;ITGA5;PI16;LMOD1;BGN;SCARA3;CYP1B1;SRPX2;SQOR;IGFBP7;FN1;BMX;IGFBP5;TRIM47;PROCR;C1QTNF1;SLCO2A1;AMOTL2;ITGA9;MMRN2;C1S;ROBO4;TNS2;ITGB4;COL12A1;PXDC1;AFAP1L1;TEK;ENPP4;ADGRF5;AQP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.6905943170878038,-1.3197614883387616,0.10294117647058823,0.5909026054834352,1.0,1/18,0.18%,ANXA1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7293673900125173,-1.3197320252915938,0.16071428571428573,0.5899425545582554,1.0,5/9,21.77%,GATA1;ZFPM1;THPO;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5824167166550784,-1.3196102845119084,0.07894736842105263,0.5895929771845747,1.0,13/54,15.79%,MET;EPS8L2;ARHGEF3;GPR18;SYNPO2L;RIT2;ARHGEF18;LPAR6;LPAR4;P2RY10;ITGA3;DLC1;STMN1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7378302688214667,-1.3195556728754019,0.12727272727272726,0.5888070964141727,1.0,5/12,10.82%,PKP2;GJC1;ATP1A1;ATP1B1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6334918611298259,-1.319358674238268,0.1388888888888889,0.5888976290873805,1.0,11/34,13.92%,THBS1;OGN;NR4A3;IL12A;APOD;ELN;IGF1;STAT1;IL18;IGFBP5;VIP
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8494409050101726,-1.319139747671374,0.10294117647058823,0.588903989672118,1.0,2/7,3.16%,B2M;HLA-A
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.8089546688227469,1.3190786668190766,0.15555555555555556,0.8919320644502559,1.0,1/5,2.74%,CARD18
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.7554102049906398,-1.319051237219035,0.11428571428571428,0.5884081725242967,1.0,6/12,16.36%,B2M;HLA-A;HLA-DRA;HLA-E;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.4346140744738155,1.3188573186675006,0.0,0.8898591106121332,1.0,14/107,10.13%,TBC1D4;ATP6V0D2;PDK4;PDE3B;ATP6V1A;TRIB3;KAT2B;AKT2;ATP6V1G1;AKT1;AP3S1;RAB8B;INSIG2;LPIN3
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5241688280429215,-1.3184196229321006,0.04597701149425287,0.5903702620596516,1.0,20/202,10.89%,TLCD2;EPN1;A4GALT;MX1;MYOF;ANK3;RPS27A;SH3GL2;SUN3;DYSF;TRIP10;CAV3;SYNGR2;SYP;LDLR;EGF;SYT1;WNT5A;TGFA;M6PR
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.782856536105707,-1.3183136982675134,0.0784313725490196,0.5898902678801293,1.0,4/9,13.03%,KCNQ1;GJC1;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.6370426025751202,-1.318198949329359,0.06060606060606061,0.5893620557723074,1.0,8/36,6.59%,TLR2;PTP4A3;IFI35;NLRP12;APP;NOD1;LRRC19;TLR3
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.6645715007275569,-1.3180236780206318,0.12307692307692308,0.5888523585831813,1.0,9/21,19.14%,MET;WAS;ARHGEF18;TMEFF2;PPFIA1;DLC1;STMN1;RHPN2;PHLDB2
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.4634760567282167,1.3179652409504798,0.08695652173913043,0.8916057253895436,1.0,24/74,20.08%,GDAP1;ABCD2;ZDHHC14;ZDHHC11;TRAM1;PEX13;ABCD1;VPS37A;RAB8B;ZDHHC18;ABCD3;TAOK2;SSR1;ZDHHC20;VPS37B;ZDHHC21;PEX2;SLC25A17;GOLGA7;ZDHHC11B;RAB3IP;ICMT;PEX12;PIKFYVE
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.835153960384678,-1.317765739932113,0.06896551724137931,0.5889914399402818,1.0,2/7,6.91%,GBP2;GBP7
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7194448539443025,-1.3176985348231676,0.06349206349206349,0.5882192880861192,1.0,3/14,10.73%,ITGA5;KLF4;FGF1
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8465295256667241,-1.317301771400958,0.12698412698412698,0.5880527257457918,1.0,1/5,1.14%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8465295256667241,-1.317301771400958,0.12698412698412698,0.5880527257457918,1.0,1/5,1.14%,NR4A3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7682549470628953,-1.3171704056467164,0.11940298507462686,0.5876981269293575,1.0,6/13,19.00%,CELA2A;PRKCQ;SYK;SELP;C1QTNF1;PDGFRA
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.8389788474252832,-1.316835027030747,0.078125,0.5880353174353788,1.0,2/6,0.90%,S100A10;RFTN1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7209353702555733,-1.3167754988315645,0.12903225806451613,0.5872060580276425,1.0,2/15,7.17%,TIMP2;TIMP1
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.8781403990547652,-1.3165189916596,0.07547169811320754,0.5875429258573626,1.0,2/5,10.08%,CDKN2A;IRF7
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.508909591328462,-1.3165099029847016,0.011904761904761904,0.586553926264847,1.0,30/186,13.56%,CACNA1H;HPN;SCN1B;KCNQ1;KCNV1;SLC6A15;LRRC55;KCNB1;SLC39A14;KCNK1;KCNJ2;SCN9A;SLC24A2;SLC4A11;ATP1A1;TRPC3;KCNH8;SLC24A1;SLC9A2;ATP1B1;SLC8A3;SCN2A;CACNA1C;SCN1A;KCNG1;SLC24A5;KCNB2;SCN3B;KCNK12;SLC11A1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5474336293794709,-1.3161971591810024,0.060240963855421686,0.5867438292385223,1.0,18/91,11.40%,THBS1;P2RY13;MYO1F;SPARC;RASGRP2;P2RY12;ALOX12;ITGA2;HLA-A;ADGRE5;TUBB1;NRGN;CLEC12A;F13A1;CTSS;CD9;SELP;HLA-E
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.771921671162117,1.315921300048038,0.2619047619047619,0.8995891040384056,1.0,2/6,12.03%,THEM4;NAIF1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.7397923398696296,1.3157784330138511,0.1388888888888889,0.8973631839793027,1.0,5/8,25.23%,ABCD1;PEX6;ZFAND6;PEX12;PEX16
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.7477163939217759,-1.3153717832379013,0.12698412698412698,0.5893449386342655,1.0,1/15,0.54%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.5541532782476121,1.3153338486931254,0.14285714285714285,0.896777519795383,1.0,8/21,30.56%,NOL11;UBTF;EIF2AK3;DHX33;WDR43;WDR75;PWP1;MTOR
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.5531514390123529,-1.3140718212415745,0.07692307692307693,0.5942469347117367,1.0,4/79,2.75%,CD24;LEF1;RPS27A;WNT8B
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6926651154183678,-1.3140143083498415,0.109375,0.5935129424130481,1.0,6/14,20.03%,TRIM5;SCIMP;CD55;SIGIRR;CD36;CX3CL1
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.7958393441014868,-1.313492173321993,0.09375,0.5950348267672464,1.0,4/9,16.81%,PLK2;ZWILCH;WEE2;WEE1
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.6772200005426564,-1.3134677767628407,0.08450704225352113,0.5940592860595965,1.0,5/29,6.95%,GGT5;OGN;CSPG4;BGN;OMD
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.702080740768347,1.313199891387887,0.12121212121212122,0.9044456699393805,1.0,7/11,26.84%,PEX13;PEX2;PEX6;PEX12;PEX16;PEX5L;PEX5
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.4491076022482916,1.3130491250317868,0.05,0.9019319314633166,1.0,11/51,18.40%,KAT2B;ERCC6;SERTAD2;POLR1F;H1-2;KAT2A;DDX21;ASF1A;EP300;SPHK2;ATAD2B
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),-0.8910273145218648,-1.3129885845735212,0.05263157894736842,0.5953325911907186,1.0,2/5,6.91%,IL15;PTK6
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8572881464630797,-1.31297091956205,0.09259259259259259,0.5944728135762337,1.0,2/6,8.48%,DUOX1;DIO1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.7715426454215341,-1.312711799498354,0.1694915254237288,0.5946624005053821,1.0,2/8,5.04%,C3;APP
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.7022377866316499,-1.3120168554810223,0.09230769230769231,0.5969565140427947,1.0,3/17,8.39%,GBP1;RIT2;NEUROD2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.6346109930844311,-1.3116999580567188,0.12698412698412698,0.5973978155189811,1.0,7/38,8.06%,CCBE1;COL4A1;APLNR;TGFBR2;PROX1;CYP1B1;ANGPTL3
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.6633236373290344,1.3114880373123632,0.20588235294117646,0.9073019848182322,1.0,6/11,21.32%,SEPHS1;PSPH;SRR;CTH;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.741288558749074,-1.3112524892516504,0.14285714285714285,0.598462155803928,1.0,6/12,11.40%,HLA-A;IL12A;HLA-DRA;SYK;CD55;HLA-E
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6986002398216444,-1.3110841219707576,0.1076923076923077,0.598243871701314,1.0,4/14,4.94%,MAOB;PRDX4;DUOX1;PRDX5
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.466771939108431,1.3109420605663837,0.0,0.9075309294598181,1.0,13/66,13.59%,MTERF1;NUDT21;SNRPF;UBTF;ERCC2;WDR33;CSTF3;PAPOLA;POLR1F;CPSF7;ERCC3;GTF2H5;GTF2H2
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5843374936516751,-1.3109287849392197,0.08823529411764706,0.5978827067344319,1.0,10/55,7.44%,LEF1;CD5;TAGAP;SKAP1;GPR171;MAFF;CD160;ARHGAP9;THY1;IFIT3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.573919769429152,-1.3109150288166604,0.1111111111111111,0.5969651714362401,1.0,6/54,12.02%,LEF1;CDKN2A;CCND1;SRF;CCNB1;RUNX2
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.8535743134406057,-1.3108481113146524,0.08333333333333333,0.5962098336046716,1.0,3/5,11.73%,TLR2;CCL2;NAMPT
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5727542837638059,1.3104206227316273,0.10810810810810811,0.9072493741957549,1.0,16/28,29.15%,EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;LSM5;LSM7;CNOT8;EXOSC8;PATL1;DCP1A;EXOSC5;DDX6;LSM1;LSM6;CNOT7
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5798530753878155,-1.310414333882631,0.09722222222222222,0.5974893637308872,1.0,16/64,17.53%,THBS1;SP100;SPARC;PROX1;CEACAM1;SVBP;EGF;WNT5A;FGF1;DAB2IP;EMP2;GPI;PIK3CB;PIK3CD;TEK;ETS1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.8037176534505611,1.3103703361402201,0.14634146341463414,0.9046137529103941,1.0,2/5,14.67%,JAM2;GPLD1
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.7192445952927032,-1.3099682087751614,0.06944444444444445,0.5987011120039455,1.0,1/17,0.02%,ENPP2
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.5148262963773061,-1.3099250241933602,0.06976744186046512,0.5978359201115944,1.0,26/168,13.52%,S100A10;RFTN1;PKP2;MRAP2;FYB1;ANK3;KCNB1;RAMP3;TESC;RAB11A;ZDHHC22;LRRC4;ABCA12;THY1;CAV3;ATP1B1;KCNB2;PDZK1;FLOT1;PLEKHF1;TSPAN32;EMP2;FYB2;SCN3B;TNFRSF1A;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.6514319090257465,-1.3097298285972105,0.15942028985507245,0.5977002915582974,1.0,9/24,19.14%,MET;WAS;ARHGEF18;TMEFF2;PPFIA1;DLC1;STMN1;RHPN2;PHLDB2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.8295683429395246,1.3095904180871143,0.06666666666666667,0.9060774348154833,1.0,1/5,6.09%,ZNF304
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),0.7500023242476387,1.308985489318746,0.18604651162790697,0.9063793857777019,1.0,3/6,15.27%,PRUNE1;BNIPL;MINPP1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6720113976201016,-1.3089845030667362,0.10294117647058823,0.6002773879841093,1.0,9/24,15.76%,SOCS3;THY1;PARP14;PTK6;SH3BP5;MVP;DMTN;SFRP2;PRKCD
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),-0.859013169999386,-1.3087553159267313,0.109375,0.5992605972903777,1.0,2/5,8.03%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),-0.859013169999386,-1.3087553159267313,0.109375,0.5992605972903777,1.0,2/5,8.03%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.7975316420333134,-1.3084077161227723,0.2033898305084746,0.5997980914717282,1.0,2/5,19.24%,MFSD2A;CD36
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.8093269107781774,-1.308354389721172,0.10714285714285714,0.5990338005690106,1.0,3/8,11.79%,ANXA1;NFKBID;IL18
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.7498297676168671,-1.3082700293426213,0.14285714285714285,0.5983815422343511,1.0,4/15,12.55%,PDPN;CEACAM1;CD44;TMEFF2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5684722225716767,1.3081016721198286,0.15151515151515152,0.908366778084839,1.0,16/30,29.15%,EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;LSM5;LSM7;CNOT8;EXOSC8;PATL1;DCP1A;EXOSC5;DDX6;LSM1;LSM6;CNOT7
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.8163286347462246,-1.307964175588634,0.125,0.5988709713499654,1.0,3/6,15.76%,IL15;SYK;PRKCD
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.7201035299369183,-1.3077045016197226,0.13636363636363635,0.5992029211504118,1.0,4/13,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8290329793517385,-1.3074389751347932,0.11666666666666667,0.5984346409449206,1.0,2/5,9.67%,STAT4;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8290329793517385,-1.3074389751347932,0.11666666666666667,0.5984346409449206,1.0,2/5,9.67%,STAT4;STAT1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.5204189554464042,1.3073760164960304,0.05263157894736842,0.9094827568850046,1.0,12/67,12.64%,RANBP17;NXT2;NUP62CL;KPNA2;PPP1R10;NUP54;AKT1;IPO5;IPO8;NUP214;NXT1;RANBP6
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.6952580834871589,-1.3070374746365465,0.11475409836065574,0.5992773130274988,1.0,4/12,14.80%,IFIT1;PLN;ATP5IF1;PAM16
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.6548989738243197,-1.3057899399699344,0.09523809523809523,0.6045905705025749,1.0,8/25,17.69%,C3;C1R;CD55;CFH;C1S;SUSD4;SERPING1;CR1L
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.5586091347035591,1.305565128543645,0.17142857142857143,0.9165139387909225,1.0,8/35,10.28%,CPAMD8;ASCL1;ADAMTS18;FREM2;ZDHHC16;SMG9;PBX1;ATF6
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.5961696939916552,-1.3053645890370287,0.0375,0.605451058106477,1.0,8/53,16.14%,ECM2;P2RY12;IL12A;SYK;RNASE10;HYAL1;SFRP2;RHOD
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.7187808210195994,-1.3053291150907602,0.125,0.6046116734104269,1.0,3/9,12.60%,AKAP5;CACNA1C;NOS1
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.8015893117919398,-1.3045923823556276,0.1111111111111111,0.6072250493148933,1.0,4/8,18.03%,GFAP;PLK3;EEF1A2;CTSA
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.5514396138552057,1.3042298251132518,0.09090909090909091,0.9205137649127112,1.0,3/30,6.41%,ATP6V0D2;ATP6V1A;ATP6V1G1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5434650210224167,1.3042172737929225,0.06896551724137931,0.9176461207852573,1.0,4/29,3.54%,ACE2;GOLT1A;EFNA2;ARHGEF16
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.6878531890936923,-1.303971909220455,0.0967741935483871,0.6090763161808158,1.0,5/18,12.77%,TGFBR2;GRIN3A;GRIN2A;SLIT3;GRIN2B
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.7202911917937035,-1.3037434485040957,0.1791044776119403,0.6090486749796244,1.0,1/10,2.07%,IHO1
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.7123995990174329,1.303572975401088,0.15,0.9187194186602643,1.0,4/9,16.37%,SLC25A24;SLC25A41;SLC25A5;SLC25A17
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.7416208261987945,-1.3035306266940192,0.1206896551724138,0.609327628136644,1.0,6/14,21.67%,MET;GPNMB;FGF7;TSC2;CX3CL1;SCG2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7118244448440398,1.303445220268024,0.125,0.9166854702980372,1.0,1/8,2.36%,ABCA1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.6176310875842518,1.3034393076828132,0.11428571428571428,0.9138913195037276,1.0,4/18,12.34%,GPATCH2;PPP1R36;PPP1R26;ZCCHC9
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.7545198485403181,-1.3033225795852554,0.1875,0.6092690632981813,1.0,2/11,9.67%,IRF1;STAT1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.6494688653642811,-1.3031316766757441,0.14285714285714285,0.6093634373782919,1.0,4/25,8.66%,APLNR;TGFBR2;CCDC39;SRF
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.8051918929833538,-1.3028793805529233,0.17543859649122806,0.6095184981039234,1.0,1/6,6.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.6625476837617239,-1.3025457811953733,0.07575757575757576,0.610160226945476,1.0,3/22,3.68%,LEF1;POU4F1;TESC
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5742707128472962,1.302316435573337,0.11764705882352941,0.9169622476720821,1.0,2/15,6.64%,PRDX6;SF3B4
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5748625053892413,-1.3021306909766628,0.07894736842105263,0.6108910442193831,1.0,8/60,7.35%,ANXA1;CDKN2A;KIF14;GPNMB;KLF4;CCL2;GFI1B;CCND1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.4341408303657017,1.3017384342755092,0.047619047619047616,0.9174310064722514,1.0,12/93,10.97%,FGF6;NGF;TRIB3;THEM4;EGFR;MAPK10;UBE2N;AKT1;RALB;EIF4E;NCK1;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.560655777844326,1.301573018008832,0.11538461538461539,0.9153562721153861,1.0,8/28,15.28%,RGCC;SERPINF2;RUNX1;AKT1;RAB27A;ADGRB1;HDAC2;ZBTB20
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.5917799628791429,-1.3013470091313537,0.12162162162162163,0.6138197537271273,1.0,16/57,14.73%,C1ORF87;TEKT2;RSPH4A;CFAP126;ECT2L;TMEM212;CCDC39;DCDC2B;ANKUB1;DNAH3;FAM81B;CCDC181;DRC3;CXCL17;DRC1;AKAP14
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6400331783953889,-1.3012399823080645,0.14516129032258066,0.6131787283559673,1.0,2/27,4.40%,THBS1;SEMA3B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6227673653210475,-1.3008682102502458,0.17142857142857143,0.6137800324971702,1.0,7/30,18.28%,P2RY6;NR4A3;IGF1;IGFBP5;APLN;GPER1;CDKN1A
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.635871629321265,-1.3008126853472306,0.1,0.6129599616871817,1.0,5/25,10.03%,ANXA1;RAMP3;STAT4;STAT1;EIF2B2
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),-0.8204505391524385,-1.3006486074315695,0.16666666666666666,0.6127305084277406,1.0,1/7,0.24%,CCBE1
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.8714697331652872,-1.3005230314153908,0.14035087719298245,0.6123512910244627,1.0,2/5,9.95%,ANK3;MLLT11
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6884465622930236,1.3004549483695491,0.2,0.9186375251418982,1.0,2/13,5.94%,CSPG5;MFF
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.8288972934736626,-1.300371041421111,0.1724137931034483,0.6120334112458569,1.0,4/8,13.52%,P2RY12;SFTPD;CCL2;CXCL17
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.609736490814629,-1.3003303840650327,0.14864864864864866,0.6113265034876937,1.0,7/31,9.02%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;SERPIND1;SERPINE3
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6208532428017685,-1.2999302209377905,0.1527777777777778,0.6120148346725992,1.0,8/24,18.14%,MET;STMN2;PSRC1;CAV3;DCTN1;FES;ANKRD53;MAPT
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.6487542589441166,1.2998879639918417,0.1,0.9183359038855645,1.0,3/12,12.49%,PIK3R4;TRAPPC8;PIK3C3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.90194742589114,-1.299360735048142,0.1206896551724138,0.6142561342410372,1.0,2/5,5.91%,MLIP;TRPC3
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6802396836090892,-1.2992402231714246,0.18055555555555555,0.6138177957397136,1.0,3/10,7.93%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.6504289325987723,1.2989056813218316,0.08571428571428572,0.9202432598134321,1.0,6/17,14.18%,CEL;CYP4F3;CYP4F12;LPIN3;PLA2G15;ACOX1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7260240203789323,1.2987103860444003,0.1891891891891892,0.9186664567715859,1.0,2/6,21.02%,SLC25A19;ABCC5
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.8512962552268726,1.2984223229832446,0.1276595744680851,0.9174419420896838,1.0,3/5,10.39%,DNA2;PRIMPOL;MGME1
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.7998783031475403,-1.2983698019017604,0.17647058823529413,0.6169284047834642,1.0,3/6,6.33%,MYOF;DYSF;CAV3
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.4829136922800119,1.298169955281361,0.0,0.9159171977167537,1.0,6/61,4.85%,SPSB4;MEX3A;CSPG5;EFNA2;POU3F2;MID1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.7087456771918617,-1.297863482131253,0.11290322580645161,0.6182729773210511,1.0,4/14,13.03%,SCN1B;KCNJ2;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7117721506738416,-1.2976127352056914,0.11475409836065574,0.6183948969599239,1.0,4/15,9.67%,P2RY6;DUOX1;TRPC3;STAT1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.7583955951407495,-1.29749625463469,0.14035087719298245,0.6179675696393444,1.0,2/11,3.79%,MET;POF1B
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5946746039332294,-1.2972577058817771,0.0958904109589041,0.6182969308228153,1.0,7/46,8.06%,CD24;FABP3;ABCA5;AKR1C1;CAV3;LDLR;ANGPTL3
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.5620938276527259,-1.2972401628364572,0.06493506493506493,0.6174127419532661,1.0,19/77,17.51%,CP;IL1R1;C1ORF87;C3;KCNJ2;PLD1;HLA-DRA;ST3GAL6;FAM20A;ANKUB1;CTSS;APOL6;CLMN;RASSF4;CD74;MSR1;ERICH3;FMO2;MRC1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.5587401807568307,-1.297091106134209,0.1095890410958904,0.6171366554491888,1.0,14/53,18.19%,TLR2;IFI35;IL15;NLRP12;APP;TLR3;OSMR;WNT5A;IL18;TNFRSF1A;ETS1;ABCC1;NMI;NUPR1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6498767565225421,-1.297083585246531,0.12,0.6152038088038745,1.0,9/23,18.90%,ACOT1;ACSM5;ACOT4;GLYAT;DBI;ACOT2;OXSM;ACOT8;ACOT6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6498767565225421,-1.297083585246531,0.12,0.6152038088038745,1.0,9/23,18.90%,ACOT1;ACSM5;ACOT4;GLYAT;DBI;ACOT2;OXSM;ACOT8;ACOT6
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7196868558979271,-1.296253953082508,0.14814814814814814,0.6178416929684258,1.0,2/12,4.75%,THBS1;SULF1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7286814119554869,-1.2959658321738667,0.1694915254237288,0.6180360973216106,1.0,8/11,25.61%,UNC13C;SYT1;RIMS2;SYT5;SYT2;DOC2B;RIMS1;RIMS3
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),-0.8154639375821465,-1.2955903773593953,0.13114754098360656,0.6186253333199467,1.0,1/7,0.89%,TEKT2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.7792947411827225,-1.2954414642775118,0.1935483870967742,0.618335325081525,1.0,1/8,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.6230273893596454,1.2954272525035082,0.1388888888888889,0.9273155126063394,1.0,6/18,17.22%,ACVR1C;HMGB1;CASP3;EXOG;BLCAP;DFFB
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5224245152997655,-1.2951008324688522,0.060240963855421686,0.6189952302087769,1.0,16/85,13.21%,CCNB2;TEKT2;RPL39L;ART3;CLGN;MEP1B;GSG1;SEPTIN4;ZC2HC1C;NEFH;SCG5;GAPDHS;GAD1;KIF2C;NOS1;PCSK1N
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.8524461458358903,-1.2950110227045775,0.05263157894736842,0.6185014750768403,1.0,2/6,3.16%,ANXA1;HLA-A
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.8747805811781936,-1.2946330317125665,0.08771929824561403,0.6192318141148461,1.0,1/6,7.39%,PLK3
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.776205830696525,1.2943116280598244,0.1,0.9299489512485379,1.0,3/7,19.78%,PDE12;RO60;PYHIN1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.6175627185216853,1.293896304923654,0.18181818181818182,0.9294844653223248,1.0,4/16,8.36%,MTHFS;OAT;GLUD1;GLS
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.70003466137824,-1.2936574012242508,0.1694915254237288,0.6230259469707018,1.0,1/16,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.838483077195149,-1.293619541711511,0.1568627450980392,0.6221219594793516,1.0,1/7,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),-0.7437639048413157,-1.2932739881546753,0.13114754098360656,0.6230460041440449,1.0,2/11,3.20%,P2RY12;SKAP1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7663435199569688,1.2930505041966067,0.12727272727272726,0.9308801060538279,1.0,2/8,6.41%,ATP6V1A;ATP6V1G1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.6696232155369506,-1.292621803491241,0.11594202898550725,0.6249506521283077,1.0,5/17,13.52%,P2RY12;EPS8L2;PFN2;PLEKHM1;NLGN1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.7715471240446045,-1.2924895566798786,0.16129032258064516,0.6244811089774441,1.0,3/6,22.35%,PLSCR1;SIGIRR;APOL2
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.6599938293060615,1.292179425124114,0.125,0.9325705226285648,1.0,5/18,17.67%,LIMD1;CNOT8;HELZ;AGO3;CNOT1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.6497686711037349,-1.2920127983580045,0.12307692307692308,0.6248276145391911,1.0,1/19,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.6497686711037349,-1.2920127983580045,0.12307692307692308,0.6248276145391911,1.0,1/19,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.7212248881188625,-1.2918288223745695,0.109375,0.6248778874519367,1.0,5/14,17.65%,TLR3;STAT1;IRF7;IFIH1;RIPK2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.714568238242933,1.2912670687354901,0.20930232558139536,0.9317374760216534,1.0,1/11,2.75%,INPP1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.714568238242933,1.2912670687354901,0.20930232558139536,0.9317374760216534,1.0,1/11,2.75%,INPP1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.7932308588850896,-1.2912071300529036,0.08064516129032258,0.6266931756676438,1.0,2/11,4.37%,ANXA1;IL15
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),-0.7484000177639847,-1.2911666235414971,0.21666666666666667,0.6259236651743038,1.0,3/8,7.70%,B3GALT2;UGT8;FA2H
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.5624311449838378,-1.2911095510168518,0.14473684210526316,0.6252423731260544,1.0,16/54,15.43%,IL1R1;SOCS3;IL13RA1;TLR2;IRF1;CD44;IFNGR2;OSMR;STAT1;IL4R;CD9;PIM1;TNFRSF1A;IL7;IL3RA;LTBR
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.6173590030029383,-1.2910353822467482,0.125,0.6245774683765617,1.0,9/31,23.12%,EFNA1;HAP1;IGF1;RTN1;RTN2;TMED10;RTN4;GSAP;SP1
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7964031690705384,-1.2906978918494163,0.1774193548387097,0.6251554532230814,1.0,4/8,19.31%,SIX3;DAB2IP;RYR2;COL4A3
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.5372744387261427,-1.2904034502107866,0.08641975308641975,0.6255465319447319,1.0,27/115,17.57%,COL4A1;ANGPTL2;CALD1;COL4A2;CSPG4;LAMB1;GPNMB;FLG;FILIP1L;MMP14;CCND1;SRPX2;OSMR;EMP1;THBS2;FN1;PRRX1;AMOTL2;RHBDF1;TNS2;PLAT;COL12A1;PXDC1;AFAP1L1;GPC1;CTNS;MLANA
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.6508987694137924,-1.2903073878296425,0.14084507042253522,0.6250264112358049,1.0,3/20,3.78%,SP100;WARS1;GPNMB
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.7570667629205056,-1.29024189277917,0.1724137931034483,0.6243091292453565,1.0,4/8,15.75%,WNT5A;GABRB2;GABRG2;GABRA1
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),0.789429503824308,1.290228512756212,0.14583333333333334,0.9313800456943109,1.0,1/5,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),0.789429503824308,1.290228512756212,0.14583333333333334,0.9313800456943109,1.0,1/5,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),-0.8136559123631366,-1.2899804753512165,0.11320754716981132,0.6246855321665704,1.0,1/5,0.99%,MET
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),0.7460546323705288,1.2895447927566137,0.1590909090909091,0.9316508186361937,1.0,4/7,16.63%,BRPF1;PHF14;KAT7;BRPF3
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.5928027802612763,1.2894670540998487,0.19444444444444445,0.9292733631442798,1.0,6/29,17.29%,ITGA1;PPP1R15B;PPP6R1;PPP1R1B;STYXL1;MAGI2
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.828151011339801,-1.2891314037198447,0.14516129032258066,0.6273961106249445,1.0,1/6,0.11%,LEF1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.6621045883341364,1.288599385258982,0.16129032258064516,0.9308021895019708,1.0,5/17,18.80%,SDC4;SNF8;SMPD3;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),0.7930639341951837,1.288178751678478,0.2,0.9308749331366746,1.0,2/6,5.58%,CYP4F3;CYP4F12
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.5602864821834939,1.2880357364130632,0.14705882352941177,0.9288810367062442,1.0,5/20,23.01%,UQCRHL;UQCRC2;MTFR1;SDHB;SLC25A14
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.5830721259575079,1.2879584836379427,0.17647058823529413,0.9264734616109225,1.0,2/17,1.38%,NGF;SOX8
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.6213238008717595,1.2878131231584824,0.16666666666666666,0.9246666492180149,1.0,4/15,15.48%,GIT1;CASK;MDK;AJAP1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.7691755910728648,-1.2874581946189143,0.13559322033898305,0.6345075610198264,1.0,1/6,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.7661791088531695,-1.2874480514613837,0.16129032258064516,0.6335544342278722,1.0,5/9,17.63%,PLSCR1;CD74;CD200;MYO18A;GPER1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6186812002352663,1.2874018901567665,0.10526315789473684,0.9242683510573428,1.0,1/11,1.06%,UQCRHL
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.7471831205817154,1.287357091684494,0.1320754716981132,0.9219269184801883,1.0,3/7,16.82%,RAB22A;ALS2;PICALM
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),0.8013946552106741,1.287014495216733,0.1590909090909091,0.920633390673747,1.0,3/8,4.85%,CHAMP1;CRIPT;MID1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5559237135800821,-1.28688347235877,0.09722222222222222,0.6353656267831974,1.0,10/66,9.10%,OTOS;HPN;KCNQ1;EPS8L2;CDH23;CLRN1;CEMIP;NDUFB9;COL11A2;MYO3A
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.7524371004363453,-1.2868434985724944,0.15384615384615385,0.6345266326231631,1.0,1/9,3.07%,CNTNAP1
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),-0.778177367490664,-1.2859492675592998,0.19642857142857142,0.6362643043651216,1.0,3/6,7.70%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),-0.778177367490664,-1.2859492675592998,0.19642857142857142,0.6362643043651216,1.0,3/6,7.70%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.706079426972593,1.2858456323677478,0.27906976744186046,0.9231192361528613,1.0,2/6,12.46%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.8017159083469825,1.2857263138244,0.13513513513513514,0.9209294868084835,1.0,3/7,12.98%,JAM2;AKT1;WASL
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.6793308025447963,-1.2856535722158964,0.12307692307692308,0.6364780291419059,1.0,3/13,2.79%,P2RY12;ITGA2;SHTN1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.593107192159326,1.2853552520091387,0.15384615384615385,0.920098512794369,1.0,5/26,10.69%,WNT7A;ZNF358;INTU;SALL1;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.683649018885234,-1.2852582919783646,0.10144927536231885,0.637250406441893,1.0,6/19,12.84%,ARHGEF3;GPR18;SYNPO2L;LPAR6;LPAR4;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.637507655345683,1.285093526379058,0.16666666666666666,0.9189525270347783,1.0,5/13,6.66%,ABCD2;AKT2;PLIN5;ABCD1;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.6926036223386256,-1.2848357423451304,0.14754098360655737,0.6381042219898246,1.0,6/17,18.61%,GBP1;MRAP2;TMBIM1;PPFIA1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6217164565271548,-1.2843153883601492,0.14705882352941177,0.6395270197279913,1.0,7/32,12.29%,THBS1;P2RY6;NR4A3;IGF1;STAT1;IL18;IGFBP5
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7966633721056864,-1.2843103846592767,0.18181818181818182,0.6385792443381715,1.0,3/6,9.24%,CDKN2A;IL12A;IGF1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.640278109551265,1.2842384170638173,0.125,0.9205863880467674,1.0,7/13,24.80%,BMP2;SPRY1;HEYL;HEY1;HEY2;RBPJ;TGFBR1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.7581069686816202,1.2841971655550584,0.1702127659574468,0.9183328119053455,1.0,4/8,16.16%,DPH5;DPH3;DPH1;CPEB3
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.5131251713841529,-1.2840903404355712,0.047619047619047616,0.6386905993516795,1.0,50/162,19.53%,CP;EFNA1;DUSP1;ALDOB;FOSL2;COL5A1;KDELR3;ZFP36;LDHA;ATF3;MAFF;HK2;PRDX5;BGN;VLDLR;GLRX;PDK1;LXN;FBP1;P4HA2;TPD52;BTG1;GAPDHS;PDK3;NDRG1;PGK1;IER3;GALK1;MYH9;PIM1;GPC3;FOS;GPI;F3;ANXA2;IRS2;PFKL;ANKZF1;PFKFB3;GPC1;ETS1;ENO2;CDKN1A;HSPA5;ADM;GYS1;BHLHE40;PLAUR;KLF6;PAM
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.450577872165744,1.2840796517264286,0.0,0.9160917905056588,1.0,23/92,20.77%,ABCB10;RFWD3;RCC2;UCP3;XPO1;UGGT1;BRPF1;NDC1;STT3B;GANAB;DDX21;ZDHHC5;NUP188;URB2;NUP205;DCAF1;CNOT1;DHX15;CHD4;UBAP2L;NUP85;NSUN2;NUP153
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.7322697854685348,1.2836002453493884,0.125,0.9161709546269422,1.0,4/7,25.23%,PEX6;ZFAND6;PEX12;PEX16
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5930582377314155,-1.2835828843203902,0.08108108108108109,0.6398979539818338,1.0,15/53,16.18%,PSCA;NEFL;GRIN2A;APP;GRIA3;GRIA1;MINK1;SHISA9;DLGAP3;GRIN2B;SHISA8;NLGN1;NPTX2;RELN;CAPN1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.7836279176809442,-1.2833123233389505,0.1694915254237288,0.6404504211454324,1.0,1/5,6.29%,BRCA1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.6564123503548863,1.2832794300275712,0.14285714285714285,0.9151778218832308,1.0,2/11,6.66%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.6459741263707488,-1.283235529710782,0.10294117647058823,0.6398389999440883,1.0,4/21,7.93%,KCNT2;KCNQ1;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.7172722298165947,-1.2830927671496475,0.13793103448275862,0.6394366363918046,1.0,4/15,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.5768023508609788,1.2829287464186403,0.125,0.9143159286899464,1.0,5/17,22.80%,ARV1;GNB3;PANK2;TTC39B;ABCB11
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.6792905970375366,-1.282881729555272,0.11864406779661017,0.6394355245631309,1.0,2/16,4.75%,THBS1;SULF1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.6614185999088988,1.2825884697679077,0.2558139534883721,0.9136468935243129,1.0,1/8,1.63%,BMP2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.597513083865137,-1.2825279460361598,0.0759493670886076,0.6399578426043613,1.0,6/40,12.29%,ANXA1;STAT4;STAT1;CELA2A;EIF2B2;IGFBP5
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6940340649676024,1.2824587349229846,0.17142857142857143,0.9116996521491143,1.0,5/10,25.19%,PLD6;VAT1;MUL1;ZDHHC6;PID1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.6350175921450324,-1.2823432421005956,0.19047619047619047,0.6399146978796268,1.0,4/26,5.98%,C3;SFTPD;IL15;CCL2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.5700805150947859,-1.2822161023194796,0.11688311688311688,0.6394871429108415,1.0,7/61,7.39%,CENPV;KIF14;PLK2;RAB11A;DCDC1;SVIL;PLK3
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.6983413647748091,-1.2821741912750386,0.16666666666666666,0.638759165170182,1.0,1/12,0.08%,CXCL2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7136377803936717,1.2816525659593048,0.21951219512195122,0.9127251579306812,1.0,1/12,2.75%,INPP1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.5817645668586836,-1.2814986458961621,0.17567567567567569,0.6406349880213462,1.0,11/33,16.90%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;SERPIND1;SERPINE3;SPINK6;SERPING1;UBXN1;CRB2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.6524398939043159,-1.2814554687210258,0.12857142857142856,0.6399211380441558,1.0,1/17,2.75%,WNT8B
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7577435089557313,-1.2812535133714251,0.19402985074626866,0.6397964507164668,1.0,4/10,20.15%,YBX3;BIRC3;NUPR1;CASP8
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.7327543516073056,1.280822104668771,0.19444444444444445,0.9147089915527727,1.0,5/8,23.80%,BLMH;ADO;TST;CTH;TXN2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.73298511251805,-1.2807792657238717,0.09090909090909091,0.6411989571301838,1.0,4/12,16.32%,APP;LDLR;PFDN6;PFDN1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7703807026254341,1.280210414819036,0.09090909090909091,0.9151005120215266,1.0,3/5,16.19%,LYPLA2;MGLL;ABHD6
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.5065148743520435,-1.2800327885849674,0.047619047619047616,0.6435774264012799,1.0,25/143,11.12%,THBS1;ISM1;SP100;APLNR;SPARC;COL4A2;WARS1;SERPINF1;GPNMB;HK2;CD160;SULF1;KLF4;BRCA1;CEACAM1;CYP1B1;CHI3L1;ANGPTL3;BTG1;STAT1;WNT5A;THBS2;PGK1;FGF1;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),-0.7587376655189928,-1.279279135044089,0.15254237288135594,0.6464246424475338,1.0,3/10,13.92%,CAV3;NOS1;VIP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7594410690258212,-1.279226767679521,0.19696969696969696,0.6456803919197043,1.0,3/6,7.39%,DOCK8;APP;TNFRSF14
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.7216189123267968,-1.279019324375418,0.13559322033898305,0.6457921308317287,1.0,4/14,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.8181250638218207,-1.278944429563392,0.12962962962962962,0.6450915793816256,1.0,2/6,5.37%,TMSB10;PFN4
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.734991357071475,1.2787056016252858,0.20588235294117646,0.9199431879866901,1.0,4/9,19.77%,RFWD3;FEM1B;THOC1;CCAR2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.7562401346747665,-1.278509290560157,0.15789473684210525,0.6461632726076083,1.0,5/11,15.13%,P2RY12;SKAP1;PODXL;SYK;SFRP2
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.7049026530889186,-1.2785054473508362,0.1388888888888889,0.645234836912113,1.0,4/15,13.13%,GRIN2D;GRIN2A;GRIN2B;GRID2
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6619642052240884,1.2783044623742768,0.14285714285714285,0.9193623067249113,1.0,4/13,17.22%,HMGB1;CASP3;EXOG;DFFB
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5856216809945974,-1.2782341783226059,0.08641975308641975,0.6456968882292373,1.0,4/40,10.39%,CACNA1H;CAV3;IGF1;ITGA11
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.796298726956197,-1.2780772787453765,0.15151515151515152,0.6453638075012925,1.0,1/8,0.18%,ANXA1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.547884901524956,-1.2779498438288412,0.14864864864864866,0.644870479364758,1.0,12/53,16.18%,PSCA;TJP3;PTK6;ANO9;SYNGR2;RHBDF2;TMC4;IL4R;TMCO4;PRKCD;SH2D3A;CAPN1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.6574538014374558,-1.277655387819502,0.2033898305084746,0.6454383702290979,1.0,5/19,15.85%,CXCL2;CCL2;SYK;PPIB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.56297052619935,-1.2774234362324264,0.11267605633802817,0.6453616268161215,1.0,8/59,8.45%,CACNA1H;KCNQ1;PLN;ATP1A1;CAV3;ITPR3;ATP1B1;SLC8A3
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6582154521443819,-1.277414895068251,0.1016949152542373,0.6444959047072677,1.0,6/18,12.78%,CD24;PDCD1LG2;IGF1;HHLA2;IL18;FADD
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.7707038689713741,1.277285332825943,0.17142857142857143,0.9222295076577347,1.0,4/6,21.32%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.7047994046302062,-1.277195363905041,0.1746031746031746,0.644581026486675,1.0,1/14,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.661268748180011,-1.2770740541090342,0.15873015873015872,0.6444258237955925,1.0,3/19,7.93%,SCN1B;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.5261086767765569,1.2770316884631179,0.11428571428571428,0.921062760619564,1.0,10/29,19.94%,ASCL1;HES6;AKT1;NOTCH2;HEYL;PRUNE1;HEY1;YTHDF2;HEY2;HES5
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7618423631936606,-1.2767991752844192,0.22641509433962265,0.644683942479784,1.0,5/9,18.20%,CD55;SUSD4;SERPING1;CR1L;A2M
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6132744443349507,1.2765771883087214,0.17857142857142858,0.9206977055990351,1.0,4/17,19.52%,RAB33B;PDE4DIP;MAP2K2;MYO5A
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.7987146563527022,1.2762008981626132,0.16279069767441862,0.920121030791505,1.0,3/5,19.35%,RUNX1;HMGB1;GLI3
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),-0.8242731620559465,-1.2759022944982097,0.14754098360655737,0.6476543979516093,1.0,1/5,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.7957969962317394,-1.2756677747983889,0.13333333333333333,0.6476946587025296,1.0,1/5,1.31%,TYMP
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.8133578267806048,-1.2756299629583778,0.23529411764705882,0.646899342364816,1.0,1/6,4.43%,ITM2A
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.8025820073762375,-1.2756028924200578,0.21052631578947367,0.6460665746339437,1.0,1/7,5.68%,THY1
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6547218220084735,-1.2755419461437059,0.19402985074626866,0.6453948671336939,1.0,3/20,13.52%,TJP3;ARHGEF18;NLGN1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.5392461368514734,-1.2754885501610294,0.07792207792207792,0.6447646896926369,1.0,9/62,12.78%,THBS1;IFI6;ICAM1;BRCA1;GATA1;IGF1;UNC5B;TMBIM1;FADD
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.8312476730081264,-1.2752322260300246,0.13043478260869565,0.6450988662348066,1.0,1/5,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.6697019622066736,1.2751409879596394,0.25,0.9228946789069983,1.0,4/9,15.95%,KAT2B;KAT2A;KAT7;EP300
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.6321952074233863,-1.2748458028881662,0.13043478260869565,0.6459192702454488,1.0,1/27,0.11%,LEF1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.8635891155475468,-1.2744290965847296,0.11764705882352941,0.6469871607851221,1.0,2/5,9.67%,COL4A1;STAT1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.6567262827096372,1.2744001340780067,0.20512820512820512,0.9236808946559671,1.0,3/10,18.53%,NOVA1;PCBP4;PCBP3
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.7739335095160361,1.2743657693958146,0.23404255319148937,0.9212545641194934,1.0,2/5,16.09%,MRPL18;TST
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.5765232438531654,-1.274037053942352,0.07246376811594203,0.647828818226153,1.0,21/74,19.03%,COL4A1;CALD1;COL4A2;CSPG4;LAMB1;COL5A1;LMOD1;TEAD2;SCARA3;DAB2IP;GLI1;IGFBP5;PRRX1;AMOTL2;RHBDF1;PDGFRL;COL12A1;NOTCH3;PCDH18;PTPN21;SVEP1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.7893418971497494,-1.273854430909414,0.30612244897959184,0.6476323201867135,1.0,1/5,1.13%,POU4F1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7158952698164516,-1.2737230830678836,0.13114754098360656,0.6472661757322904,1.0,3/15,9.24%,NR4A3;TRPC3;IGF1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),0.8565041529963675,1.2736456030493866,0.11904761904761904,0.9224032070265282,1.0,3/7,4.85%,CHAMP1;CRIPT;MID1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),-0.7855383373447408,-1.2736118134932048,0.140625,0.6468749176026036,1.0,2/6,16.90%,SCX;CRB2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6619024462098673,1.2722846155580367,0.2,0.9274898473133492,1.0,2/12,9.46%,FAM47E;SERTAD2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6019856227976708,1.2722175041014596,0.2647058823529412,0.925463036584778,1.0,4/15,18.23%,ASAH2B;QDPR;DHFR;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6542289137803693,-1.2714045056256429,0.18032786885245902,0.6547358712513384,1.0,6/23,12.11%,ANK3;ABCB1;GLRX;ATP1B1;CTSS;PDZK1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7455811699771123,-1.2712497854454314,0.09230769230769231,0.654804532415543,1.0,2/13,0.81%,ANXA1;BLM
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8768688045509558,-1.271180787537308,0.14814814814814814,0.6542090402988491,1.0,1/5,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.7622261805121942,-1.2710425245119794,0.18867924528301888,0.6539662355314185,1.0,2/7,17.19%,ITGA5;PRKCB
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.5788951702222211,-1.270989081354619,0.1282051282051282,0.6533346426077458,1.0,8/49,12.36%,MX1;IFIT1;IFITM3;PROX1;BST2;PLSCR1;ISG15;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7207153278956321,-1.270839390916248,0.16666666666666666,0.6530029937349104,1.0,3/12,12.29%,NR4A3;IGF1;IGFBP5
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.4725512065129205,1.270687428941178,0.1,0.9307544447489733,1.0,8/54,12.50%,RNF6;UBE2T;KBTBD7;TNFAIP3;RNF146;UBE2G1;UBE2D1;FBXO38
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.557390782151693,-1.270619240873302,0.08823529411764706,0.6529441384189988,1.0,12/54,8.80%,CXCL2;IL1R1;C3;TYMP;NRN1;PPP1R14C;SFTPD;SIGLEC1;KLF4;DUOXA1;CLDN18;FBP1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7467197400229664,-1.2701298569359094,0.2222222222222222,0.6544367970281902,1.0,2/9,7.83%,PARP14;PARP9
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),0.7550208465178854,1.2700455812643152,0.16666666666666666,0.9293670699444975,1.0,3/6,15.65%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),0.7550208465178854,1.2700455812643152,0.16666666666666666,0.9293670699444975,1.0,3/6,15.65%,DPH5;DPH3;DPH1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.6702874890104311,-1.269896337575613,0.1864406779661017,0.6545697543898329,1.0,5/17,15.85%,CXCL2;CCL2;SYK;PPIB;PIK3CD
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.8335840439319466,-1.2698484165304234,0.16981132075471697,0.6539159353864445,1.0,1/6,1.11%,APLNR
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.6872908905953246,1.2698199490706124,0.2631578947368421,0.9279210990753961,1.0,1/5,12.61%,ADRB2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.6126898600002523,-1.26981126379501,0.12280701754385964,0.6531995652154867,1.0,6/24,15.33%,THBS1;RHOBTB2;XKR4;MYH9;ELMO1;MSR1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.766641174746512,-1.2697772685534232,0.18867924528301888,0.652523753234578,1.0,3/7,6.56%,LEF1;TESC;CEACAM1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.7057862185834235,1.269560663709662,0.1836734693877551,0.9266308443689175,1.0,5/9,22.71%,ACACB;MID1IP1;CPT2;CPT1A;SLC25A20
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.7014967832437727,-1.2693581858436895,0.22580645161290322,0.6536086575326812,1.0,5/13,18.26%,POU4F1;IGF1;DDRGK1;TGFB1;NIBAN2
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.5594699259376833,-1.2692874843056594,0.09333333333333334,0.6530110738684369,1.0,13/87,13.56%,GGT5;CXCL2;ZFP36;IL12A;PDCD1LG2;CCL2;WNT5A;DAB2IP;SELP;SBNO2;TNIP2;NOS1;SLC11A1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.45349453379444504,1.2692569768107735,0.10344827586206896,0.9259680529902059,1.0,8/66,7.53%,LIMD1;BMP2;MEN1;GREM1;SOX9;RORB;FBXO5;RANBP3L
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.8159769042739025,-1.2692178824427056,0.16393442622950818,0.6525687762253584,1.0,2/5,12.99%,HLA-A;EMP2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.8009681006988969,-1.2689337209565772,0.14754098360655737,0.6531632904892025,1.0,2/7,12.29%,NR4A3;IGFBP5
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.8733883820082358,-1.268304750509498,0.09803921568627451,0.6550201401127149,1.0,3/5,10.25%,P2RY12;CCL2;CD9
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.7149694147122045,-1.2679018612410005,0.15151515151515152,0.6560303848572945,1.0,1/12,1.31%,TYMP
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),0.6832292327916926,1.267249186637884,0.15555555555555556,0.934949784965689,1.0,4/9,17.94%,GREM1;SOX9;ADAMTS12;EFEMP1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.5290711520239061,-1.2672136268711187,0.06896551724137931,0.6583238131586744,1.0,31/124,15.95%,NPY;APLNR;NRN1;RCAN2;BCAS1;CTHRC1;MATN2;ART3;SEMA3B;PLP1;THY1;LMOD1;GAP43;APOD;GFAP;TCEAL6;MAG;HAPLN2;SHC2;NDRG1;FGF1;DAB2IP;ADCY5;IGFBP5;RASL12;TMEM132C;CNTN2;TNS2;STMN1;PHYHIP;ITGB4
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.7144620866409198,-1.267059803898321,0.1875,0.6580552629687484,1.0,5/13,12.44%,PDPN;CD44;VIL1;WAS;DMTN
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.7740201560541395,-1.2669731283573735,0.24444444444444444,0.6575842915612836,1.0,3/5,17.69%,CD55;CFH;CR1L
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.5239578844153225,-1.2668994220446816,0.10465116279069768,0.6570385306056377,1.0,7/99,7.89%,ENPP2;B4GALNT1;ABCA12;UGT8;PDXDC1;FA2H;SGPP2
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.810120019962308,-1.2668813882048773,0.1896551724137931,0.6561650343544614,1.0,3/6,5.75%,CLDN16;LETM2;SLC4A11
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.6451440432563448,-1.2668687405242625,0.08823529411764706,0.6552939247050642,1.0,4/29,8.26%,SPARC;PDPN;CD44;VIL1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.7609680920199245,1.266546657723814,0.1875,0.9355922499811397,1.0,2/7,5.94%,PEX11A;MFF
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8202611002887594,-1.266545029506676,0.20689655172413793,0.6561047270481811,1.0,3/6,7.96%,LEF1;GPR183;ZFPM1
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6310811123223342,-1.2664981239406112,0.14705882352941177,0.6554756798661738,1.0,5/27,10.60%,ANXA1;TYMP;TSPYL2;SCG5;IGFBP7
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8110835135757248,-1.2663784585967646,0.14035087719298245,0.6551002188124945,1.0,1/6,0.18%,ANXA1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.7349094987288076,-1.2663297368504296,0.11666666666666667,0.6544239393758791,1.0,2/10,2.47%,MX1;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.5616564662484993,1.2662888209531087,0.10714285714285714,0.934618172105279,1.0,2/27,4.00%,ITGA1;PPP1R15B
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.8666128625485546,1.2662593666545892,0.13725490196078433,0.9323033229194694,1.0,1/5,3.26%,MITF
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.7910005009252503,1.2661963743757632,0.13333333333333333,0.9304964227551515,1.0,3/6,9.92%,ZSWIM6;SALL1;ERBB4
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6413228673273763,-1.2661949375364132,0.17105263157894737,0.6532901016816224,1.0,6/26,12.78%,RPS27A;TLR3;IRF7;BIRC3;UBC;FADD
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6413228673273763,-1.2661949375364132,0.17105263157894737,0.6532901016816224,1.0,6/26,12.78%,RPS27A;TLR3;IRF7;BIRC3;UBC;FADD
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.6696579615657926,1.2656935687325839,0.24324324324324326,0.9307071085072314,1.0,4/8,17.10%,TGFBRAP1;VPS39;VPS11;VPS8
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.7707388812229696,-1.2656044532497992,0.15517241379310345,0.6547859381402286,1.0,2/10,3.82%,KCNQ1;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.7866514275172043,1.2654155368169724,0.175,0.9295231748901542,1.0,1/6,2.98%,DACH1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6348560825518933,1.265300386941643,0.15,0.9278240169328278,1.0,1/16,0.98%,ATP6V0D2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.715852525046998,-1.265197430022839,0.171875,0.6555522313126285,1.0,2/13,9.24%,NR4A3;IGF1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.5490821324942722,-1.264476211964582,0.14516129032258066,0.6577405155247183,1.0,5/52,12.02%,LEF1;CDKN2A;CCND1;CCNB1;RUNX2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.6655381507467159,1.2644550654543543,0.2,0.9293974670423434,1.0,4/10,17.70%,COPS2;COPS8;COPS7A;COPS7B
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.6979287531757935,1.264274068224713,0.18421052631578946,0.9280817824824996,1.0,3/9,13.02%,PGAP1;GAS1;SCFD1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5504169231580169,-1.2642538870333828,0.09333333333333334,0.6578770156531537,1.0,9/46,10.44%,ANXA1;SEPTIN5;HAP1;SEPTIN4;CPLX1;IL1RAPL1;SYT1;CPLX2;RIMS2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5820223803485771,-1.2642124146302989,0.136986301369863,0.6572656609631128,1.0,5/38,9.91%,IL12A;STAT4;CA1;LMNB1;TCP1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6936515490728419,1.264209724537421,0.1,0.9260542697549164,1.0,4/13,16.65%,SDC4;SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.47810480498120467,1.2639612512862977,0.1,0.9248683006060908,1.0,10/63,15.53%,DNA2;KPNA2;PDE12;GTF2F2;HNRNPC;DNASE1L2;LSM8;EXD2;HNRNPU;POLR2C
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.6301937809860484,-1.2639421523206524,0.09836065573770492,0.6577383496167453,1.0,6/25,16.85%,LEF1;HLA-DRA;TESPA1;IL7;HLA-DRB1;BCL6
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7339844921739188,1.2638236464898747,0.1956521739130435,0.9232593735280467,1.0,2/6,15.51%,HSPA1A;CPNE1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6494134737879914,-1.2637108688260668,0.13333333333333333,0.6578121795948898,1.0,3/19,3.62%,RPE65;GC;RBP2
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.8243032099707084,-1.2633691291317934,0.10344827586206896,0.6585186208336701,1.0,3/5,12.44%,ANK3;PDPN;DMTN
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.7231815647794007,-1.2632166303419432,0.18181818181818182,0.657574615755048,1.0,4/10,13.45%,STAG3;SYCE2;SYCE1;TEX11
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.7231815647794007,-1.2632166303419432,0.18181818181818182,0.657574615755048,1.0,4/10,13.45%,STAG3;SYCE2;SYCE1;TEX11
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.5018057704159087,-1.2628300920210198,0.07058823529411765,0.6584762778323984,1.0,25/155,14.33%,CD24;TMEM204;SP100;TRIM5;OVOL2;NLRP12;SULF1;APP;CAV3;RSPO3;PTK6;TIMP1;LFNG;ZIC1;PLSCR1;SLC8A3;TSPYL2;IGFBP7;HHIP;CD55;GLI1;IGFBP5;CD63;VEPH1;ITGA3
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),-0.8274045444183262,-1.2627717972872232,0.17857142857142858,0.6579068556452169,1.0,1/5,1.91%,B2M
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.6182313209844159,1.2624139380921542,0.29411764705882354,0.9275056933352676,1.0,4/18,12.02%,SLC6A13;SLC47A1;SLC3A2;SLC22A2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.42435436141194904,1.2620779218473386,0.15,0.9268655695108416,1.0,27/89,21.91%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;BAG2;COMMD1;VCP;RNF14;CSNK1E;CBFA2T3;XPO1;PLK1;RCHY1;TRIB2;EIF3H;FHIT;COP1;UBQLN4;ZYG11B;MDM2;CCAR2;SMAD7;RNF217;SUMO2;NUB1;DDA1
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),-0.8211658058883511,-1.261752793461361,0.2037037037037037,0.6615665667072193,1.0,4/5,17.63%,P2RY6;HRH1;PTH1R;GPER1
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",-0.819177381241189,-1.2617339051788092,0.21818181818181817,0.6607360600254163,1.0,2/5,8.80%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.6145899797218194,-1.2616636754857367,0.11864406779661017,0.6602765395033731,1.0,2/24,4.82%,MTMR7;MTMR11
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5097794826123602,-1.2609682424739006,0.1511627906976744,0.6624085526432538,1.0,45/135,20.74%,THBS1;SPARC;F8;APP;ABCA12;RAB11FIP5;SYT4;TIMP1;SYNGR2;EGF;F13A1;GTPBP2;CPLX1;SYT1;IGF1;CPLX2;TAGLN2;RAB11FIP1;CD9;RIMS2;FN1;SELP;MYH9;CD63;F5;SRGN;WDR1;SERPING1;SYT5;TLN1;SYT2;SYT13;VCL;CDK5;TGFB1;FERMT3;A2M;SYNGR3;TF;SELENOP;CD36;RAB27B;TMED10;STEAP2;SYT12
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.46960459328410503,-1.260785176914578,0.010869565217391304,0.6623280976826141,1.0,69/345,18.59%,PRAME;LEF1;ANXA1;THBS1;HPN;APIP;IFI6;DHCR24;POU4F1;RPS27A;NAA38;ALOX12;PDPN;KIF14;PLK2;PRDX5;ITGA5;KLF4;HTR2B;SCX;CCL2;PIM3;GATA1;CD44;NUAK2;PLK3;IFIT3;PRKCG;RPS6KA1;IGF1;MAG;WNT5A;UNC5B;BIRC3;RPS3A;PINK1;BCL2L2;PTRH2;RPL10;PRKCH;PIM1;UBC;CLEC5A;IL7;RNF213;VIP;BDNF;CD74;THOC6;DDRGK1;PRKCD;CCND2;NRBP2;CLN3;TEK;AHI1;MYO18A;SNX6;RIPK2;AQP1;LRP2;HIPK3;CDKN2D;NUPR1;NIBAN2;HSPA5;COPS5;VSTM2L;FOXB1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5677604747909992,-1.2607633082998764,0.19736842105263158,0.6615621973807595,1.0,6/42,8.87%,THBS1;IFI6;DHCR24;KLF4;CD44;RPS6KA1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.631512149520802,1.2607235571074995,0.24390243902439024,0.9314506652099478,1.0,4/12,18.78%,RAB23;EFL1;OPA1;AK4
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.5166494807569554,-1.2604288248110491,0.0875,0.6622656472246723,1.0,25/82,19.24%,CD24;ACKR4;CDH23;PLN;TRPC3;CAV3;ITPR3;S1PR3;WNT5A;HCRTR2;CACNA1C;ADCY5;CD55;C1QTNF1;CCR10;TAC4;GLP1R;CIB2;CLN3;ADCY8;RYR2;GPER1;PLCE1;PDGFRA;CD36
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5677696894510644,-1.2603688523569885,0.16176470588235295,0.6615506965178747,1.0,14/54,15.49%,RASGRP2;TAGAP;TMC8;ARHGAP9;GPR18;ACAP1;RCSD1;WAS;CTSS;ZBTB32;P2RY10;IL7;SP140;CD37
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.7037050165098762,-1.2603003242041628,0.208955223880597,0.6610571487628226,1.0,1/18,0.04%,GGT5
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.6189036474376515,-1.260071190889631,0.13333333333333333,0.6612469492753885,1.0,5/29,11.28%,APLNR;TGFBR2;PROX1;ZFPM1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6251252545531233,-1.2600084999798784,0.1506849315068493,0.6607064439654892,1.0,6/30,10.15%,P2RY6;ANK3;LRRC55;CCL2;HAP1;CTSS
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.7232179656853891,-1.2598360702740885,0.14754098360655737,0.6605682243931867,1.0,3/9,18.65%,DCTN1;CLMN;SYNE3
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6884298881952635,1.2598020223312805,0.2619047619047619,0.9330120913487879,1.0,2/10,10.40%,PUS10;DROSHA
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.6542926194993746,-1.2595775914052911,0.15873015873015872,0.6610126823347001,1.0,3/17,9.67%,SOCS3;ST18;STAT1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.5201523914466678,-1.2595758557341186,0.14285714285714285,0.6601595981765367,1.0,35/104,20.36%,RIMBP2;CDH22;STMN2;MYT1;SNCB;ZDHHC22;SLITRK1;LRRTM1;ATRNL1;SYT4;JPH3;GAP43;SLC18A2;SYP;PRKCG;CPLX2;HPCA;SCN2A;CALY;STMN4;KCNB2;GAD2;GABRG2;CNTN2;KCNC1;GDAP1L1;SYT13;SULT4A1;MAPT;CELF4;ST8SIA3;PRR36;PTPN5;CHRNA6;PAK5
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6583948538004132,1.2595511866193847,0.15789473684210525,0.9317700347741943,1.0,4/14,15.19%,SMARCAD1;SIRT6;ELK4;HDAC2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5261604759515675,1.2595463305636296,0.14285714285714285,0.929463673301981,1.0,1/28,0.54%,RNF6
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6090317440969923,-1.259527920480597,0.1388888888888889,0.6595144417592619,1.0,6/21,15.76%,TMSB10;PFN4;VIL1;PFN2;KANK3;PRKCD
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.5397921162012649,-1.2595220645893699,0.08641975308641975,0.6586776249566985,1.0,21/90,16.77%,C1ORF87;ANGPTL2;TEKT2;RSPH4A;SIX3;CFAP126;TMEM212;EFNB3;GFAP;SPAG17;NME9;FAM81B;CFAP61;DRC3;CXCL17;DRC1;AKAP14;DNAH2;ZBBX;ERICH3;USP18
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6282050841626498,-1.259501112100844,0.13157894736842105,0.657927468300276,1.0,7/29,13.20%,KCNB1;IL12A;RAB11FIP5;BMP8A;RHBDF2;RAB11FIP1;RHBDF1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6578235006908693,-1.2593867895647735,0.19047619047619047,0.6576252108323084,1.0,1/17,0.51%,IFI6
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.8435959003417766,-1.25938445688921,0.18867924528301888,0.6567700415074289,1.0,1/6,6.23%,MMP14
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5767371561892464,-1.2593597191201282,0.10526315789473684,0.6559651785210445,1.0,11/43,13.93%,P2RY6;P2RY12;CHRM1;HTR2B;GPR18;LPAR6;LPAR4;HRH1;P2RY10;VIP;PTH1R
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.6398026265033208,-1.2591031371997574,0.19696969696969696,0.6563869835589836,1.0,4/18,11.67%,ZFP36;MAFF;ABCA12;SFRP4
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6682022768333267,1.259068220320505,0.20512820512820512,0.9295853252518353,1.0,4/7,15.95%,KAT2B;KAT2A;KAT7;EP300
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.5625062956000284,1.2588131200843449,0.16666666666666666,0.928473011011202,1.0,3/18,10.13%,WNT7A;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.6104962651241256,1.258753737120282,0.10810810810810811,0.9263874858996082,1.0,1/9,4.54%,DUSP6
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.7904599928226019,-1.2583791724584168,0.19047619047619047,0.6588340289324939,1.0,2/6,9.24%,KLF4;DLEC1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.7144931851937573,1.2583442548969346,0.2,0.926376314728982,1.0,1/9,0.60%,RGCC
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.5010708207304138,-1.2583412557677922,0.011494252873563218,0.658137391135003,1.0,73/271,20.53%,PIF1;TYMS;RECQL4;BLM;RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;RPL27A;GCNT1;HELB;RPL35;SCX;RPL7A;RPL37A;RPL27;BRCA1;POLE3;RPL9;RPL21;DONSON;GTPBP2;RPL13A;POLR2I;RPA3;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;PAX8;RPA1;RPL8;RPS6;RPS15;RPS9;RPL12;RPL5;EEF1A2;CDK2;CDC7;RPL23;RPL4;POLD1;RPL18A;RPL41;RPL7;RPS12;RPS20;COPS5;RBMS1;MRPL23;RPL15;MRPL51;KAT5;RPL11;SET;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.617157550766325,-1.258253194585525,0.1323529411764706,0.6578372055300497,1.0,2/23,5.86%,THBS1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.5024840447352946,-1.2581399045477306,0.10588235294117647,0.6575258508744021,1.0,16/120,7.96%,LEF1;ANXA1;THBS1;GBP1;ZFP36;SFTPD;IL12A;GPNMB;NLRP12;ADCY7;KLF4;NLRC5;PDCD1LG2;CEACAM1;APOD;ZFPM1
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.711723462092759,-1.2576481826039727,0.22580645161290322,0.6592073300943375,1.0,5/14,15.79%,STMN2;KIF14;STMN4;KIF2C;STMN1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.7937860874491391,1.2574435216007263,0.16279069767441862,0.9256601960547521,1.0,2/7,11.56%,CEL;CYP46A1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.7937860874491391,1.2574435216007263,0.16279069767441862,0.9256601960547521,1.0,2/7,11.56%,CEL;CYP46A1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.5056874250946826,-1.2567272311617876,0.07407407407407407,0.6622782998481322,1.0,11/137,7.68%,CD24;LEF1;COL4A1;COL4A2;LAMB1;GJC1;PODXL;KLF4;THY1;TEAD2;ZIC1
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.822342365031042,-1.2564482040747966,0.23728813559322035,0.6625692184958771,1.0,3/5,9.82%,PCSK2;CEACAM1;CELA2A
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6932137732559103,-1.2563979884097782,0.19696969696969696,0.6619919754252156,1.0,6/16,12.58%,RFTN1;IFIT1;COLEC12;TLR3;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.5355203131011093,1.256355907484938,0.11627906976744186,0.9286414020156804,1.0,3/30,5.12%,WNT7A;SOX21;PSMD11
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),0.69212667891405,1.2563317973329071,0.15217391304347827,0.9265255322649357,1.0,4/8,17.94%,GREM1;SOX9;ADAMTS12;EFEMP1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.4254929712595508,1.255831570659549,0.08333333333333333,0.9272030611742907,1.0,58/176,24.38%,SPSB4;RNF6;FBXO45;KLHL8;SPSB2;FEM1C;ELOC;WDR91;RNF150;PSMD11;KEAP1;FBXL14;ANAPC1;RNF146;RNF14;UBE2G1;BTRC;PLK1;FBXO8;RNF114;UBE2D1;RCHY1;PSMD14;FBXO10;UBE4A;CDC26;UBE3B;FBXO21;RNF11;RC3H1;KCTD21;NDFIP1;CNOT4;UBQLN4;RNF166;UBL7;RC3H2;MDM2;RNF217;NEDD4L;FEM1A;PSMF1;RNF34;NUB1;BUB3;MIB1;TRIP12;CDC34;RNF130;RNF20;FBXL7;RLIM;UBE2A;UBE3C;ITCH;RNF168;UBQLN1;RNF13
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7500166791678642,1.255749547878302,0.20930232558139536,0.9254032707054362,1.0,2/6,10.55%,TNFAIP3;TIRAP
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.665222888215466,1.2556879096160407,0.18181818181818182,0.9190186095958474,1.0,2/12,10.09%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.665222888215466,1.2556879096160407,0.18181818181818182,0.9190186095958474,1.0,2/12,10.09%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.665222888215466,1.2556879096160407,0.18181818181818182,0.9190186095958474,1.0,2/12,10.09%,ZNF207;PLK1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.7378798678265304,1.2555920528917082,0.22727272727272727,0.9172556220299922,1.0,3/7,10.47%,LIG4;MSH2;EXOSC6
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6844979872192878,-1.2555480368281293,0.140625,0.6648220876417649,1.0,2/13,1.14%,C3;NR4A3
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.8603304254024039,-1.255347938662829,0.14814814814814814,0.6648004805959361,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.6331510545651696,1.2552672695571554,0.25,0.9166418271101671,1.0,4/11,25.30%,KEAP1;NFKBIE;PKD2;LATS1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.619355658554086,-1.2550268221480414,0.18518518518518517,0.6652168907847776,1.0,3/35,3.82%,APIP;B2M;KCNJ2
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.5238778427242943,-1.254899211380817,0.08974358974358974,0.6649229357753449,1.0,23/103,17.72%,CACNA1H;RASGRP2;B2M;ANK3;ADCY7;SYT4;GLRA2;NEUROD2;FBP1;SYT1;CLIC4;MT1H;WNT5A;HPCA;CPNE9;DMTN;NLGN1;FOS;SYT5;SYT2;SYT13;ADCY8;AQP1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5164765341021131,-1.2547378421916926,0.1111111111111111,0.6647832166351608,1.0,11/106,5.04%,NPY;FLRT3;POU4F1;CFAP126;STMN2;L1CAM;LAMB1;RAB11A;SH3GL2;PLP1;APP
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.7353756881954275,-1.2545877339426843,0.15217391304347827,0.6646202703195433,1.0,2/10,5.06%,KLF2;KLF4
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.7392933395525976,-1.2545595220345238,0.14925373134328357,0.6639042397472237,1.0,3/12,11.72%,CCNB2;CCNB1;DCTN1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),-0.8437583564389507,-1.2541884869536462,0.1774193548387097,0.6645073289168404,1.0,3/7,6.27%,PODXL;FSCN1;PLD1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.6641631025302083,-1.2535698257967458,0.18840579710144928,0.6661308487463222,1.0,10/16,15.76%,ALOX12;PDPN;CEACAM1;CELA2A;CD9;PRKCQ;SYK;DMTN;C1QTNF1;PRKCD
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.7654171853047188,-1.2535312572519413,0.21428571428571427,0.665450821557759,1.0,2/9,9.95%,IFI6;MLLT11
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),-0.7934249136727254,-1.2530884288381186,0.22,0.6663777372395535,1.0,2/5,11.20%,MMP14;SYK
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),-0.8266256150721133,-1.2526814527052998,0.26785714285714285,0.6674193305744642,1.0,3/5,8.48%,YBX3;TLR3;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.5763772442629371,-1.2524619886113755,0.08571428571428572,0.6673479948576507,1.0,8/38,18.62%,C3;B2M;CALY;FLOT1;GPC3;NLGN1;CLN3;TF
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6137627267345092,1.2523173168911887,0.1935483870967742,0.9283057589819265,1.0,3/14,12.63%,NT5C1A;VCP;NUDT15
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.7264312853810793,-1.2522824218082291,0.20408163265306123,0.6672768390543726,1.0,2/10,10.90%,CDKN2A;ROMO1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5202186498893525,1.252250384481786,0.08571428571428572,0.9265873392051331,1.0,7/31,17.47%,NAF1;CCT7;MAP3K4;ATR;CCT3;POT1;PKIB
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.5769718232832581,-1.2521921698448664,0.15625,0.6666812562538694,1.0,6/36,4.36%,CACNA1H;KCNQ1;ANK3;KCNB1;KCNJ2;SCN9A
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.7541994250772143,-1.251860520533034,0.1746031746031746,0.6673329997601223,1.0,3/8,13.94%,HAP1;NEFH;DRC1
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.7478155216651388,-1.251800395248035,0.1864406779661017,0.6667155855951713,1.0,1/8,1.39%,DGAT2L6
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),-0.7354686113082685,-1.251335128018462,0.23076923076923078,0.6681089487444714,1.0,2/6,15.12%,WNT5A;CD74
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.5105816799117138,-1.2509363762861265,0.11392405063291139,0.6690000420908814,1.0,44/121,17.15%,GRIN2D;SPINK8;TAGLN3;CDH22;STMN2;CCK;KCNB1;SNCB;GRIN2A;SLITRK1;LRRTM1;SYT4;SLC32A1;SRRM4;ELAVL4;GRIA3;GAP43;GRIA1;GFAP;NRGN;TCEAL6;RIT2;IGSF21;CPLX2;CA10;HPCA;TCEAL2;CALY;STMN4;KCNB2;C11ORF87;SYNPR;GRIN2B;GAD2;GABRG2;CNTN2;KCNC1;PCP4;RAB3C;GABRA1;KCND3;TCEAL5;OXTR;ADCY8
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6625400011095274,-1.2508495184787276,0.18461538461538463,0.66860297401432,1.0,2/13,7.01%,SP100;APOD
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.772361869973262,-1.249973483879858,0.23728813559322035,0.6715623383509207,1.0,3/7,14.80%,IL12A;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.7090265368959949,-1.2497828886199864,0.21428571428571427,0.6713132913122684,1.0,2/13,6.53%,MSX2;GATA1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.6854767253458631,-1.2496158710515366,0.16129032258064516,0.671318781150212,1.0,6/16,18.61%,GBP1;MRAP2;TMBIM1;PPFIA1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.6130252017687272,1.2494102351939453,0.20588235294117646,0.9378218366122442,1.0,4/13,20.77%,NUP54;NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7246005047376087,-1.249235705915994,0.19642857142857142,0.6721426923962148,1.0,2/10,0.47%,THBS1;HPN
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.5856236943254276,-1.249211259579472,0.11940298507462686,0.6713642586090172,1.0,12/41,18.74%,EFNA1;LAMB1;KIF14;ATRNL1;ITGA8;FN1;RADIL;TMEFF2;MICALL2;TEK;FERMT3;LAMA5
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5784443752368129,-1.2491247151690965,0.1111111111111111,0.6709327172845647,1.0,7/47,8.06%,CD24;FABP3;ABCA5;AKR1C1;CAV3;LDLR;ANGPTL3
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),-0.7746721708764075,-1.2490713466292258,0.1323529411764706,0.6704103719882338,1.0,2/8,16.52%,ACOT4;OXSM
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.47942861803390363,1.2489809172951696,0.125,0.9374611757526001,1.0,13/67,12.18%,SPSB4;PSMD10;BCL10;PEF1;TRIB3;DCUN1D2;UBE2N;COMMD1;DCUN1D1;PLK1;UBE2D1;RCHY1;DERL1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.7464531286186995,-1.2489063113202177,0.23333333333333334,0.6703251857247544,1.0,3/7,11.40%,HLA-A;IRF1;HLA-E
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.6332150988156295,-1.2488236068600105,0.2112676056338028,0.6697934293351743,1.0,6/26,18.13%,PIF1;RPA1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),0.6439646043275322,1.2485381038167327,0.2,0.9374779910790507,1.0,5/12,15.94%,TNFAIP3;FOXJ1;SAMSN1;ID2;RC3H1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.7315567830888863,1.248361984101302,0.22857142857142856,0.9364771665879942,1.0,5/10,21.41%,PSMD10;PSMD11;POMP;PSMG2;PSMG1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7523515212249399,-1.2480417297336135,0.15625,0.6724323556349437,1.0,3/9,20.15%,YBX3;BIRC3;CASP8
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),0.7081188416261636,1.247481702456035,0.2641509433962264,0.9385265569428178,1.0,2/7,18.29%,ME2;FH
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.8071113417689917,-1.2470553992049755,0.15517241379310345,0.6756018649789101,1.0,1/5,14.98%,BOK
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.5747728893880995,-1.2470464222610955,0.13043478260869565,0.6748144712390981,1.0,4/33,11.91%,CACNA1H;ATP1B1;SLC7A2;SFXN3
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.8129751825096527,-1.2470002489377938,0.21052631578947367,0.6742456071937921,1.0,1/5,1.53%,P2RY12
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6766980594004569,1.2465429354063655,0.16216216216216217,0.9412593130020364,1.0,8/10,31.84%,SESN2;EIF2AK4;SESN3;SESN1;GCN1;IMPACT;MTOR;LARS1
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.7990077213898427,1.2464130138038352,0.16363636363636364,0.9354863838142394,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.7990077213898427,1.2464130138038352,0.16363636363636364,0.9354863838142394,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.7990077213898427,1.2464130138038352,0.16363636363636364,0.9354863838142394,1.0,1/5,5.53%,DCXR
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.6323091547585455,-1.2464113088882696,0.19117647058823528,0.6760349344475582,1.0,6/17,17.01%,TYMP;APP;SLC8A3;DLGAP3;NPTX2;HTR2C
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.776651229265271,1.2464040431323735,0.18604651162790697,0.933342286898062,1.0,2/5,12.75%,PTPRK;CASK
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.7703315649192385,-1.2461814004416338,0.15254237288135594,0.6762392294670384,1.0,3/9,11.12%,EFNA1;NELL1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.7775561288961372,1.2460652033720458,0.14634146341463414,0.9332102612258836,1.0,2/6,8.94%,AGER;HMGB1
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.687991676731742,-1.245861597795725,0.20634920634920634,0.6767610339391574,1.0,4/10,22.92%,STEAP3;ATOX1;STEAP2;STEAP4
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7095349242820568,1.245343311722927,0.3018867924528302,0.9325546959642603,1.0,2/7,5.13%,SOX8;SOX9
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7095349242820568,1.245343311722927,0.3018867924528302,0.9325546959642603,1.0,2/7,5.13%,SOX8;SOX9
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5591618899822575,-1.2452844377351955,0.16216216216216217,0.6785180129337294,1.0,8/46,4.84%,MYO1F;CD5;TAGAP;ITGA2;SPON2;GPR171;SLA;ARHGAP9
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.8020664119525186,-1.245155145917287,0.15384615384615385,0.6775153654190692,1.0,1/6,3.07%,CNTNAP1
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.8020664119525186,-1.245155145917287,0.15384615384615385,0.6775153654190692,1.0,1/6,3.07%,CNTNAP1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.57477213900868,-1.2451327130171004,0.17142857142857143,0.6768350450845796,1.0,13/37,16.18%,HPN;TIMP2;SCUBE3;MMP19;MMP14;CD44;TIMP1;KIF9;CTSS;FLOT1;ADAMTS4;TLL1;CAPN1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.7745192887073289,1.245016730659839,0.16666666666666666,0.9320852810960066,1.0,2/5,10.96%,EIF2AK4;NCK1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),-0.7644675553988222,-1.2449600114506594,0.21052631578947367,0.6768223922928243,1.0,3/8,8.06%,TLCD2;FABP3;ANGPTL3
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.6648203452997883,-1.2448743205112833,0.23880597014925373,0.6764602600310935,1.0,3/12,10.15%,LMO2;GATA1;CTSS
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),-0.8015050387034242,-1.2448693642244726,0.19642857142857142,0.6748163711853313,1.0,4/6,19.50%,CD74;HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),-0.8015050387034242,-1.2448693642244726,0.19642857142857142,0.6748163711853313,1.0,4/6,19.50%,CD74;HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.6734297101580656,1.2445983334808772,0.25,0.9320095543558794,1.0,2/9,14.98%,PLA2G4C;PLBD1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.6032408919932446,-1.2444035720714455,0.27941176470588236,0.675738608298173,1.0,8/23,15.79%,STMN2;KIF14;VIL1;STMN4;KIF2C;DSTN;WDR1;STMN1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4878985029760725,-1.2443007964788555,0.022727272727272728,0.6753571057843766,1.0,32/157,19.17%,LEF1;THBS1;LAMB1;PDPN;GPNMB;DUOX1;PODXL;SEMA3B;CEMIP;MMP14;EGF;ANGPTL3;VIL1;PLET1;IGF1;FGF1;F10;SEMA3E;CCDC25;DDRGK1;PIK3CD;MGAT5;RHOD;F3;SEMA4G;GPER1;TGFB1;FERMT3;HSPA5;NUMB;PDGFRA;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.6967028615268909,-1.2439678095121975,0.24074074074074073,0.6760075045669844,1.0,2/17,4.28%,ANXA1;DUOX1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),0.7088754810363918,1.2438517557193907,0.22,0.9331581760407953,1.0,2/6,4.85%,BMP2;GREM1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.6440690831261981,-1.2438173257215233,0.23076923076923078,0.6758504540709822,1.0,4/17,15.41%,ANK3;TMC8;FAM20A;CIB2
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.6529672033275509,-1.2434996576590578,0.15873015873015872,0.6762415641913891,1.0,5/20,15.71%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.7541369337966143,-1.2434805147872319,0.26666666666666666,0.6755151583045271,1.0,4/10,17.31%,CNTNAP1;TENM4;CD9;GPC1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5611071610014492,-1.2434297006631514,0.15942028985507245,0.675002395955295,1.0,14/44,16.60%,ANXA1;PGR;EPS8L2;OVOL2;BTG1;TMC4;WNT5A;CD9;SLC44A3;PTH1R;CD74;ITGB4;RHOD;CEBPD
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.48797555553204086,-1.243329097261457,0.07407407407407407,0.6748138943811968,1.0,43/149,20.53%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7;MAPT;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.7430473316104207,-1.2429093901888497,0.23076923076923078,0.6758273959764687,1.0,2/10,10.55%,CCNB2;CCNB1
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5678922262709364,-1.2421706220020623,0.13043478260869565,0.6781719170874088,1.0,11/35,10.58%,CXCL2;MYO1F;TYMP;TLR2;GPNMB;SIGLEC1;IGSF6;CLEC12A;PLET1;CTSS;PILRA
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4686150295376768,-1.2419723425780098,0.031914893617021274,0.6782688615643109,1.0,59/304,18.34%,ENPP2;LEF1;ANXA1;THBS1;ARHGAP4;TMSB10;LAMB1;NEXN;PDPN;KIF14;GPNMB;PODXL;SEMA3B;SULF1;CEMIP;THY1;MMP14;PODN;CEACAM1;BST2;CYP1B1;LDB2;EGF;ANGPTL3;VIL1;PLET1;IGSF10;CLIC4;IGF1;MINK1;SST;FGF1;IGFBP5;LDLRAD4;TMEFF2;F10;AMOTL2;FGF7;SEMA3E;ROBO4;CD74;SFRP2;DLC1;DDRGK1;PIK3CD;MGAT3;MGAT5;RHOD;F3;FGF22;CLN3;DOCK10;VCL;SEMA4G;GPER1;TGFB1;FERMT3;MCTP1;HSPA5
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.718150141634197,1.241761738261132,0.2619047619047619,0.9401997244252867,1.0,1/7,2.53%,SRI
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5936903671165717,1.241668944364947,0.1388888888888889,0.9384728225634261,1.0,7/15,24.95%,ADAT1;YARS2;THG1L;KARS1;POP1;TRPT1;FARS2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.6316847425992177,-1.2415750461236972,0.19117647058823528,0.6792967551344652,1.0,10/26,22.18%,CALD1;FSCN1;BAIAP2;BAIAP2L1;DMTN;ADD2;RHOD;DPYSL3;NEDD9;MYO1B
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),-0.8213885097639362,-1.2415176941988815,0.18181818181818182,0.6787610049936899,1.0,1/6,0.18%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.6479620390276191,-1.2413965669581328,0.26785714285714285,0.6785472461070594,1.0,4/16,15.79%,MET;ITGA3;DLC1;STMN1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.7068079084797814,-1.2413766062085885,0.2318840579710145,0.6778148444989183,1.0,4/13,13.21%,B2M;HLA-A;CD55;HLA-F
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.6864903568903208,1.2412117654988668,0.2564102564102564,0.9387971075791205,1.0,3/10,19.47%,BLMH;TST;CTH
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5770446953328525,-1.241119049170346,0.1506849315068493,0.6780881590809092,1.0,9/31,13.19%,SOCS3;IL12A;IL15;PARP14;PTK6;PARP9;IGF1;IL18;TNFRSF1A
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.410161233892917,1.239871754533068,0.0,0.9428876531831787,1.0,49/276,15.49%,TBC1D4;RANBP17;NXT2;NUP62CL;NUP42;TMED5;ARFIP1;TRAK2;RAB23;COX18;SCFD2;TBC1D12;PPP1R10;MAIP1;AKT2;ARL5A;RABL3;AKT1;RANBP3L;IPO5;STX7;SNF8;DNAJC27;ARFIP2;IPO8;XPO1;AP1S3;C17ORF75;RAB22A;RAB1B;AP3B1;NUP214;RAB28;COPB2;NXT1;SNX31;RANBP6;SCFD1;SEC23IP;NAPB;TBC1D5;SEC31B;XPO7;TMED3;RAB21;NUP188;SNX27;TBC1D8B;ARCN1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.8176845108497582,-1.2397818417768587,0.18518518518518517,0.6823199835532003,1.0,2/6,10.55%,DUSP1;CCNB1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.8176845108497582,-1.2397818417768587,0.18518518518518517,0.6823199835532003,1.0,2/6,10.55%,DUSP1;CCNB1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.38888630598889273,1.2397649297911268,0.0,0.9412693830602203,1.0,85/352,20.49%,TTC29;PTCD2;ATAD3C;LIMD1;ABCD2;CSPG5;REEP6;PPARGC1A;PEX11A;TFB2M;CATIP;LIG4;AFG1L;TMED5;TFB1M;ALAS1;TNFAIP3;PI4K2A;POLG2;MTERF1;GORASP2;PLIN5;ABCD1;BLZF1;TRAPPC11;ZFYVE16;STX7;SYNE1;FMNL3;TTC17;AUP1;GABPB1;TRAPPC12;DIAPH3;DNAJC28;ATL2;ABCD3;ESRRA;BRWD1;TMEM11;TRAPPC8;OPA1;BRWD3;MICAL2;SIRT5;VAPA;WASL;GOLGA5;CHMP2B;MICAL1;SEC23IP;MDK;SEC31B;PRKD1;VAPB;TMED3;PEX2;MIEF2;NRF1;MTFR1;HPS3;PRDX3;VPS11;PDZD8;EIF2AK3;VPS4B;MSTO1;MTX2;ABI2;TNIK;FGD4;TOR1B;YTHDF2;EPS15;PEX6;KLHL20;CHMP6;GOLGA8N;DYRK3;ZMYM3;TMED2;PEX12;PIKFYVE;RAB3GAP1;PYROXD2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.5477699189694938,-1.2396138791230646,0.10126582278481013,0.6821362471990724,1.0,13/66,12.78%,RFTN1;TLR2;RPS27A;SFTPD;COLEC12;TLR3;SCARA3;SCIMP;CTSS;BIRC3;TNIP2;UBC;FADD
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.5517329354445109,-1.2391053886397287,0.12857142857142856,0.6831168576248738,1.0,7/58,5.35%,LEF1;HPN;EFNA1;TGFBR2;PDPN;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5878109817313718,-1.2390309991789228,0.14925373134328357,0.6826474631850734,1.0,7/25,15.12%,NLRC5;PARP14;PARP9;WNT5A;FADD;IL7;CD74
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5243097973297627,1.2387672446856444,0.2413793103448276,0.9435118995772457,1.0,7/60,3.54%,LEPR;NR1D1;PPARGC1A;CEBPA;PDK4;MCU;ADIPOR1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.6217370708790448,-1.2387453217084718,0.19047619047619047,0.6830774325319042,1.0,8/19,17.30%,GRIN2D;GRIN2A;JPH3;ITPR3;CACNA1C;GRIN2B;JPH4;RYR2
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.6282555884038532,-1.2385981420788217,0.14285714285714285,0.6829483763479027,1.0,6/27,18.13%,PIF1;RPA1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),0.7516942028153577,1.238563157696904,0.23255813953488372,0.9402943731020023,1.0,4/5,24.77%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),0.7516942028153577,1.238563157696904,0.23255813953488372,0.9402943731020023,1.0,4/5,24.77%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.6754575184906964,-1.238189100823479,0.21052631578947367,0.6841638225589469,1.0,6/13,17.69%,ICAM1;WNT5A;CD55;CFH;NOXA1;CR1L
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7078287040835571,1.2381603197835866,0.2,0.9403550406512157,1.0,3/9,12.79%,ADRA1A;ADRB2;DRD2
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.7493296453899517,-1.2381182424589625,0.2033898305084746,0.6836189987728497,1.0,5/8,22.89%,HK2;FBP1;PFKL;GFPT2;HK1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.47862585858548357,1.2379644803955538,0.11538461538461539,0.9391169775625564,1.0,12/51,16.99%,GDAP1;SLC25A24;ABCB10;COX18;MAIP1;MFF;TOMM22;SLC25A5;TIMM23;FLVCR1;BAD;MTX2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6517632843724047,-1.2378240571206418,0.15789473684210525,0.6841439222498401,1.0,7/25,10.99%,THBS1;SPARC;IL12A;SULF1;CCL2;STAT1;ATP5IF1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6743355989708376,-1.2377289946750487,0.14492753623188406,0.6837201923323989,1.0,5/17,20.67%,HAP1;IGF1;RTN1;RTN2;RTN4
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.6111949923399665,-1.2377195897628546,0.25,0.6829167608490471,1.0,2/24,6.11%,STMN2;MAP1B
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.7609577691217391,-1.2375488853764658,0.16363636363636364,0.682843123604337,1.0,4/6,22.93%,CRMP1;DPYSL2;DPYSL3;DPYD
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.6157140559369363,-1.2374421441039636,0.15625,0.6823681510853815,1.0,8/26,13.03%,CACNA1H;SCN1B;SCN9A;YWHAH;SCN2A;ATP5IF1;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.5227369748096938,-1.2373729670826588,0.21052631578947367,0.6818942909142459,1.0,20/63,18.75%,HPN;NR4A3;B2M;LAMB1;ZFP36;FUT2;SGPP2;IGF1;TGFA;FGF1;DAB2IP;FGF7;NR4A1;HYAL1;SFRP2;DEAF1;TGFB1;TINF2;NUPR1;NLRC3
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.8120227686442543,-1.236944950970595,0.2909090909090909,0.6830562926501484,1.0,1/5,5.75%,SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.7559578954111912,-1.236744533036644,0.25,0.6830909718448731,1.0,1/5,12.07%,SIGIRR
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.6444720095801447,1.2366909283471808,0.16216216216216217,0.9433207164732677,1.0,3/13,10.44%,BMP2;SOX9;HEYL
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6165580051633187,1.2362295006285227,0.19444444444444445,0.9431461192953209,1.0,1/12,0.45%,SLC26A7
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.6230336672349467,-1.2361694318023768,0.21739130434782608,0.6847457075930263,1.0,1/22,0.03%,CACNA1H
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.5324662642363881,-1.235837546295918,0.1038961038961039,0.685166716746481,1.0,25/92,15.83%,ENPP2;APLNR;P2RY12;RAMP3;MAOB;GRIN2A;PLP1;GRIA3;OPALIN;GFAP;TCEAL6;CHI3L1;IGSF21;GALNT15;CA10;TGFA;BAALC;SYNPR;RNASE1;RGS7BP;TMEM132C;RASSF4;SERPING1;RTN1;KCND3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.7968616504128301,-1.235640249878161,0.22033898305084745,0.6853173514462065,1.0,2/5,17.53%,PML;ETS1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6135914329252941,-1.235617101432633,0.18309859154929578,0.6846281031945,1.0,4/26,11.81%,TOMM7;ARIH2;PINK1;BAP1
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5676575649742758,1.2355929535787855,0.13793103448275862,0.9436551348813386,1.0,8/32,16.65%,SDC4;CADPS2;RAB27A;SNF8;SMPD3;STXBP5;RAB9A;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.6540291323057278,-1.235229810150594,0.22641509433962265,0.6853703041503629,1.0,4/18,7.39%,SFTPD;GPNMB;PDCD1LG2;TNFRSF14
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.7289794888406593,1.2349349749681713,0.15,0.9446918108678114,1.0,3/8,16.33%,METAP1D;NAA30;METAP1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.7384373040763894,-1.2347027238817532,0.22033898305084745,0.6868624616989614,1.0,1/6,8.66%,SRF
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.7244230291800118,1.2345553581922453,0.23529411764705882,0.9443390906954994,1.0,2/7,4.85%,TNFAIP3;GREM1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5680182341545391,-1.23454799726897,0.1794871794871795,0.6866457552739149,1.0,7/38,12.77%,TLR2;RPS27A;SFTPD;NOD1;TLR3;CTSS;UBC
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.787347263102933,-1.2343054871005887,0.1111111111111111,0.6866866723034964,1.0,5/8,16.36%,TGFBR2;HLA-DRA;PRKCQ;CD55;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.7384161809835135,1.234261590989104,0.23255813953488372,0.9435105952349992,1.0,3/7,15.62%,BMP2;SERPINE2;ID2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.7167016935174002,-1.234221245343996,0.25862068965517243,0.6863636599215334,1.0,3/8,20.01%,MAPRE2;FGF7;EPB41L4B
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.7131432844274831,1.2340555654649705,0.32,0.9426356146754626,1.0,2/6,19.01%,PLEKHA3;TTPA
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.7925995886117383,-1.2339302208494316,0.18181818181818182,0.6860615133700905,1.0,1/5,1.62%,TLR2
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.7925995886117383,-1.2339302208494316,0.18181818181818182,0.6860615133700905,1.0,1/5,1.62%,TLR2
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4925334643975329,-1.2338848942789111,0.12048192771084337,0.6854204164617952,1.0,22/137,15.90%,CXCL2;RASGRP1;FOSB;ICAM1;CCK;IRF1;BTG3;ATF3;ABCB1;MMP14;POLE3;UROD;BTG1;CHRNA5;PSMC3;HLA-F;NPTX2;FOS;NR4A1;PRKCD;JUNB;CDK2
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.6392607289361995,1.2338822721692804,0.2702702702702703,0.9414143074784189,1.0,1/8,2.84%,PDK4
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.824542419824803,-1.2337733185448723,0.23333333333333334,0.6850044821418447,1.0,2/5,3.07%,ANK3;CNTNAP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.7766683198453466,-1.2336778309793948,0.23214285714285715,0.6846746201812306,1.0,5/7,21.92%,CEACAM1;HLA-E;HLA-F;PTPRC;KLRD1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.512409292719982,1.2336058131796974,0.21052631578947367,0.9406226341287528,1.0,19/50,21.32%,NUP42;NUP37;NUP54;TRIM28;NDC1;NUP214;ZNF451;RAE1;AAAS;NUP188;KIAA1586;NUP205;EYA1;PIAS4;NUP210;NUP85;NUP153;NUP50;SUMO2
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.6626700616908253,1.233268070883493,0.21052631578947367,0.9401581627811492,1.0,1/12,3.16%,DERL2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.7635809974869174,1.2332155544303192,0.2916666666666667,0.9383787491994426,1.0,1/5,3.00%,PDE12
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.541899147346348,-1.2331053717855176,0.1388888888888889,0.6862265492160708,1.0,15/57,15.95%,CD24;EFNA1;KCNQ1;TJP3;OVOL2;FA2H;TMC4;CHRM3;LGR5;C1ORF115;SLC44A3;SLCO2A1;AATK;ALS2CL;ITGB4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6337228237640221,-1.2329705062242264,0.18518518518518517,0.6861083447861953,1.0,8/29,17.43%,CENPV;CENPH;MIS18A;CENPE;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.5602177196296951,-1.2320868646748235,0.16417910447761194,0.6888426078337327,1.0,2/32,2.09%,AMN;ANK3
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.5970457163008349,-1.2320477989674996,0.136986301369863,0.6882239116782772,1.0,5/32,11.81%,TOMM7;ARIH2;ATP5IF1;PINK1;BAP1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.7802450916286492,-1.231409510509467,0.1875,0.69032536234026,1.0,2/7,5.75%,PDPN;SLC4A11
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6728883931750325,-1.231350142643129,0.21212121212121213,0.6897486526914205,1.0,2/19,2.77%,PKP2;PROX1
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7712109016737805,1.231254228859472,0.08,0.945037172714399,1.0,2/6,21.51%,ADRB2;FYCO1
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),0.7694551622191868,1.2309987915478806,0.1956521739130435,0.9418259530191176,1.0,2/5,2.79%,WNT7A;ZNF358
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),0.7694551622191868,1.2309987915478806,0.1956521739130435,0.9418259530191176,1.0,2/5,2.79%,WNT7A;ZNF358
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.8330774404220604,-1.2309826035166784,0.18867924528301888,0.6904609196104665,1.0,2/5,6.56%,IL12A;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.7557218791140469,-1.2308976917177572,0.26666666666666666,0.690085678283366,1.0,1/6,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5663016187882695,1.2308034463645967,0.16666666666666666,0.9407480697977112,1.0,8/32,11.15%,NGF;ASCL1;BRINP3;BMP2;BEND6;KCTD11;HEYL;ZC4H2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.48888432177839447,-1.2307009423677355,0.13095238095238096,0.6901219836195992,1.0,43/160,16.71%,ENPP2;CDH22;BCAS1;SNCB;ST18;ZDHHC9;PLP1;VLDLR;NINJ2;OPALIN;ANLN;EFNB3;NKX6-2;GFAP;TCEAL6;FA2H;KLK6;MOG;MOBP;TMEM163;IGSF21;MAG;CPLX2;CA10;FAM163B;HAPLN2;HPCA;CREB5;ADCY5;STMN4;SYNPR;ARRDC2;RGS7BP;TMEM151A;PLLP;MYRF;CNTN2;ADAMTS4;PHYHIP;ITGB4;MCAM;FASN;TCEAL5
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.6755154155449612,-1.2305289033698408,0.21428571428571427,0.6899373154261422,1.0,3/15,2.99%,GBP1;ZFP36;SFTPD
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.7090812381958806,1.2303053176649372,0.21951219512195122,0.9409284306939583,1.0,2/7,14.77%,VAT1;MUL1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5789032094714773,-1.230258604400861,0.20270270270270271,0.6903414405632944,1.0,9/38,18.14%,MET;STMN2;PSRC1;CAV3;DCTN1;FES;STMN1;ANKRD53;MAPT
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.7639095938779089,-1.2300505532500292,0.21666666666666667,0.6903878272002182,1.0,3/7,11.40%,HLA-A;IRF1;HLA-E
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.49458452123212104,-1.2300245915860382,0.13793103448275862,0.6897317556246507,1.0,37/122,18.74%,C3;C1R;MATN2;MAOB;SLC16A3;SEMA3B;SCX;LMOD1;BGN;GATA1;ARHGEF17;FAM20C;CDC42EP1;SHC2;DAB2IP;CD55;IGFBP5;F10;C1QTNF1;SLCO2A1;AMOTL2;RHBDF1;RASL12;PTH1R;C1S;GPRC5C;BOK;SERPING1;TNS2;VASN;PXDC1;PFKFB3;AQP1;CTSA;PTPN21;TF;LAMA5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.7451420921652409,-1.2290526608276715,0.18333333333333332,0.6929723894205218,1.0,2/9,6.84%,IL12A;BST2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.7091365483213553,-1.2289360512188388,0.16417910447761194,0.6926704926334941,1.0,1/12,0.74%,RIMBP2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7603482070029077,1.2281723651050875,0.1956521739130435,0.94780393514907,1.0,2/6,8.49%,MAP3K4;YY1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.42545326259500776,1.2281693802982745,0.13333333333333333,0.9457901215529253,1.0,24/92,21.51%,NUP42;U2AF1;NUP37;NUP54;WDR33;EIF4E;NDC1;NUP214;NXT1;SMG7;RAE1;AAAS;NUP188;THOC3;DDX25;NUP205;THOC1;AGFG1;NUP210;NUP85;CPSF2;NUP153;NUP50;SMG1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.644798631643612,1.2281656328710857,0.25,0.9438093728497722,1.0,3/13,11.68%,PPARGC1A;ENOX2;ETFDH
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6155300710555518,1.2281151471285985,0.21212121212121213,0.9420320639773269,1.0,4/14,14.18%,ABCD1;EHHADH;SCP2;ACOX1
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.8017414248819218,-1.2275150317768093,0.203125,0.6972691021580534,1.0,1/5,6.32%,OPALIN
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.7292756085755231,1.227119049804511,0.2826086956521739,0.9445665566186416,1.0,2/6,7.79%,ZC3H8;IDO1
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),-0.7064126359346901,-1.2269619177756557,0.22580645161290322,0.6979398056239563,1.0,1/7,11.20%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),-0.7064126359346901,-1.2269619177756557,0.22580645161290322,0.6979398056239563,1.0,1/7,11.20%,SYK
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.6495214785550714,1.226925596219286,0.2222222222222222,0.9433533235066162,1.0,2/9,1.24%,CD200R1;NR1D1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6967782175988583,1.2268513188087151,0.16666666666666666,0.9415641154065512,1.0,5/12,21.18%,PSMD10;KEAP1;NFKBIB;NFKBIE;PKD2
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.4914048140935293,-1.2265858773075726,0.12195121951219512,0.6985499471887346,1.0,19/127,8.00%,COL4A1;ANGPTL2;APLNR;SPARC;TLR2;COL4A2;RCAN2;COL5A1;KCNJ2;PLP1;THY1;LMOD1;BGN;GSTM5;SCARA3;LDB2;CD44;EDIL3;DBI
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.6423478963876665,-1.2265380606061562,0.18055555555555555,0.697910665671635,1.0,7/21,14.33%,PROX1;PDPN;CCDC39;CHI3L1;FGF1;FGF7;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5616616796233052,1.2264604314190994,0.12903225806451613,0.9414255656849173,1.0,4/20,10.07%,BMP2;CARF;SMAD5;SESN2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),-0.7583382690858551,-1.2260451699410482,0.21666666666666667,0.6993401824453391,1.0,1/7,6.33%,CAV3
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6696802611334043,-1.225608326080448,0.15789473684210525,0.700372163700584,1.0,2/11,1.45%,LEF1;TGFBR2
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6656674100098103,-1.2255567171917523,0.23636363636363636,0.6998884716689346,1.0,5/15,18.93%,CNTNAP1;PLP1;EIF2B2;MYRF;PRDM8
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.6514926652361182,-1.224984088977006,0.14285714285714285,0.7017147811474462,1.0,4/21,9.24%,NR4A3;MLIP;CAV3;IGF1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.5487355309012216,-1.2247382224872034,0.1927710843373494,0.7020683986040006,1.0,15/50,22.42%,EFNA1;STMN2;THY1;EFNB3;MAG;PAQR3;CRMP1;NLGN1;PTPRO;BCL11A;DPYSL3;STX1B;RTN4;ITM2C;OMG
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.5096760553995304,-1.224603965800024,0.1590909090909091,0.7019253489413474,1.0,15/108,8.65%,IFI44L;SERPINA10;MX1;PLAG1;MYOT;STAG3;SNCB;CLDN16;MYO15A;MFSD6;LFNG;ZC2HC1C;PDE6B;EGF;ARHGDIG
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.503457970938843,-1.2245828972097845,0.07894736842105263,0.7012563354425013,1.0,16/116,9.44%,NPY;RIMBP2;TAGLN3;CDH22;CHGB;STMN2;TTLL7;LRRTM1;SYT4;MAP1B;ELAVL4;PLD1;GAP43;SLC18A2;PLD2;CPLX2
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.4864929689237038,-1.2245351388061863,0.08860759493670886,0.7006609664041036,1.0,23/151,12.11%,RASGRP1;PGR;MYOF;THSD4;TJP3;OVOL2;PODXL;SEMA3B;KLF4;SVIL;ANXA9;CD44;CCND1;PAPSS2;BLVRB;RAPGEFL1;HR;KAZN;SLC7A2;TMPRSS3;SH3BP5;PRSS23;PDZK1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.6950349801193959,1.2244472646786484,0.2222222222222222,0.9477976994245622,1.0,1/8,3.16%,DERL2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.642852609826007,1.224381172690365,0.35135135135135137,0.9461066851937348,1.0,3/11,8.69%,RPP40;RCL1;TBL3
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),-0.7804035353062558,-1.2242266967340372,0.23333333333333334,0.7009729974345461,1.0,2/8,8.03%,CHI3L2;CHI3L1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.7346128774770561,1.2240993779863811,0.24444444444444444,0.9452151271982244,1.0,2/5,13.56%,PRIMPOL;DDX21
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),-0.8125921835363488,-1.2239809390092296,0.22950819672131148,0.7011197770982928,1.0,3/6,13.52%,SFTPD;CCL2;CXCL17
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.697506838561832,1.2239323571417893,0.2222222222222222,0.9439439761688667,1.0,3/6,23.98%,ADRB2;GPR37L1;ADRB1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.5825942274418549,-1.223722823633455,0.17105263157894737,0.7013895124408926,1.0,7/29,17.04%,ALDOB;APOD;FBP1;GALK1;CHST15;PMM1;IRS2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6887674481546133,-1.2236176303629467,0.21666666666666667,0.7010737118144651,1.0,5/13,13.35%,SP100;SPOCK3;WAS;CD9;SPINT2
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.7157618269501811,1.223164822219095,0.25,0.9452842308384852,1.0,2/5,20.07%,AKR1C3;PDCD7
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5099763429200801,-1.2230649053888123,0.12,0.7023269683114308,1.0,10/81,11.73%,CACNA1H;GRIN3A;CDH23;RAMP3;SLC24A2;TRPC3;SLC24A1;SLC8A3;CACNA1C;SLC24A5
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7482330162840256,1.223054633148228,0.23529411764705882,0.9438273948927425,1.0,2/6,12.23%,DCXR;FGGY
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.7196165523631418,-1.2228872006489453,0.2878787878787879,0.702154180453092,1.0,4/10,11.20%,ANK3;CELA2A;PRKCQ;SYK
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.46778471359580726,1.2227155717949,0.18518518518518517,0.943233771787576,1.0,14/60,20.70%,U2AF1;NUDT21;WDR33;CSTF3;PAPOLA;CPSF7;TENT4A;MTPAP;THOC3;THOC1;TENT4B;CLP1;RPRD1B;CPSF2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.6169154830684092,1.2224663654198153,0.2558139534883721,0.9422624815407433,1.0,2/14,11.71%,ARFIP2;CSF1R
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6301238111393104,-1.2223990800050952,0.24242424242424243,0.7033011929317028,1.0,3/18,9.09%,SIX3;PROX1;SHCBP1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6446033823886816,-1.2221644857287102,0.2222222222222222,0.7034852978366324,1.0,2/18,3.06%,PIF1;CENPV
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.749649131615666,-1.2218529493613068,0.23728813559322035,0.7040466001545835,1.0,5/8,17.89%,IFI35;DYSF;SYK;SBNO2;NMI
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5465409403927003,-1.221797553956982,0.1780821917808219,0.7035158806081011,1.0,27/67,21.72%,TYMP;A4GALT;MYOF;EPS8L2;ITGA2;SLC16A3;DUOXA1;RARRES1;SRPX2;EMP1;FBXO32;CD9;ADIRF;ITGA3;LTBR;LAMA3;ITGB4;RHOD;CAPN1;ANXA2;PLP2;HEBP2;MYO1C;NNMT;RRAS;OPTN;DNPH1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.8044771604508061,-1.2217662125284607,0.23636363636363636,0.7028641322531682,1.0,1/5,0.81%,C3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.6756845953142399,1.221619862256495,0.2564102564102564,0.9433816840425987,1.0,2/8,10.29%,SESN2;ANKRD2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),-0.7883394023686008,-1.2216172786149164,0.26785714285714285,0.7026613778088018,1.0,2/5,3.68%,LEF1;TESC
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.7257259821887723,1.2213669146360657,0.21428571428571427,0.9423668042788326,1.0,2/7,8.36%,GLUD1;GLS
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),-0.8160111860538839,-1.2209492606998458,0.125,0.7046842588561125,1.0,2/5,8.80%,ALDOB;FBP1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.6331070227325878,1.2207789023106868,0.17073170731707318,0.9434811463496883,1.0,3/13,10.44%,BMP2;SOX9;HEYL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6490299142268574,-1.2206575859219961,0.16923076923076924,0.7049366828434226,1.0,5/19,10.82%,PKP2;CTNNA3;PLN;CAV3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.7025367194691722,-1.2199980400861903,0.20588235294117646,0.7067194566250381,1.0,6/13,16.59%,SYP;SHISA9;SHISA8;SLC4A10;GRIK2;CLN3
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.7286876405003189,-1.2199703164440134,0.1864406779661017,0.706067768626514,1.0,5/11,21.66%,WNT5A;IFIH1;IL7;CD74;AGPAT2
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),-0.7185503910298967,-1.219918303675125,0.203125,0.7054478538875427,1.0,3/9,10.01%,TGFBR2;STAT1;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.5261303094087667,1.2199002802411523,0.08333333333333333,0.9452034951541767,1.0,7/29,17.47%,NAF1;CCT7;MAP3K4;ATR;CCT3;POT1;PKIB
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.6240496040725209,1.2193307225508165,0.25,0.9458841256383193,1.0,2/10,0.94%,SLC6A13;SLC19A1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.7224754466317016,-1.2192395471150916,0.25396825396825395,0.7077598077335655,1.0,4/10,13.21%,IL12A;HLA-E;IL18;HLA-F
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.7180930838425885,-1.2190698388493817,0.21875,0.7076945811001042,1.0,4/7,22.93%,CRMP1;DPYSL2;DPYSL3;DPYD
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.5202648782888437,1.2190586973799165,0.11764705882352941,0.9452948296073603,1.0,7/30,15.04%,TNFAIP3;USP13;BRCC3;USP27X;OTUB2;PSMD14;SPATA2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5152811915926365,1.2190203629396275,0.16666666666666666,0.943466863012919,1.0,4/28,5.45%,DGKB;GK;DGKE;LYPLA2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),-0.8178935144764015,-1.2190084589104606,0.32142857142857145,0.7063659575236675,1.0,1/5,2.20%,ZFP36
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),-0.8178935144764015,-1.2190084589104606,0.32142857142857145,0.7063659575236675,1.0,1/5,2.20%,ZFP36
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.65175624535401,1.2189398180180304,0.27906976744186046,0.9417398787284489,1.0,7/12,23.79%,BMP2;NOTCH2;HEYL;HEY1;HEY2;JAG1;RBPJ
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.7184225881645354,1.2189049013530424,0.20588235294117646,0.9399966513202641,1.0,3/7,23.26%,SIRT5;AKR1C3;PPTC7
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.7645334399157229,-1.2187384150103258,0.2698412698412698,0.7066546037407878,1.0,2/6,11.72%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.7152205967128886,1.2185287093347346,0.2682926829268293,0.9396336746654154,1.0,2/6,4.15%,CHRNA4;NLGN3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5169662686653689,-1.218431459258352,0.175,0.7072642348042673,1.0,12/101,9.24%,GGT5;ALOX12;ACOT1;LDHA;SLC16A3;AKR1C1;ACOT4;GLYAT;PDHX;FA2H;ANGPTL3;IGF1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.5583116275193335,1.2182917339016242,0.1875,0.938714761771193,1.0,7/16,30.19%,HSF1;ATR;MDM2;WRN;TSPYL5;KDM1A;MAP3K20
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.6702743148520922,-1.2182239880855312,0.26229508196721313,0.707250096710487,1.0,1/14,2.79%,SHTN1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.5093734565273887,-1.2181261723619803,0.09523809523809523,0.7068549029582768,1.0,17/123,11.27%,CD24;RASGRP1;APIP;DUSP1;VRK2;TRIM5;CAV3;CEACAM1;EGF;RIT2;IGF1;THPO;MINK1;WDR54;DAB2IP;SYK;FN1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.8108246461320721,-1.2177934302714424,0.17307692307692307,0.7075224443254134,1.0,1/6,5.89%,LMOD1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5137824160367443,1.2173914814273745,0.15789473684210525,0.9403260416192158,1.0,3/28,4.13%,MEOX2;ACE2;SGCD
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.6761241918687024,-1.2172455228725243,0.2,0.709249274103402,1.0,3/12,12.04%,MYOF;DYSF;MYH9
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),-0.7631945302985776,-1.216888068210452,0.23636363636363636,0.7100027528523976,1.0,5/6,23.70%,FADD;TNFRSF10A;CASP8;SPI1;ZDHHC3
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.6978738092077431,1.216840524842744,0.16666666666666666,0.9409361244831076,1.0,4/8,19.94%,BMP2;SERPINE2;ID2;HES5
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.7258880914425452,-1.2158720393647502,0.23333333333333334,0.7135205377776678,1.0,4/10,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.4306244183837453,1.2157214545222639,0.14285714285714285,0.944036848385507,1.0,19/76,20.89%,NUP42;HSPA1A;NUP37;BAG2;NUP54;HSF1;ATR;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;CCAR2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.6363476791149066,-1.2156955647676706,0.203125,0.7135196984948625,1.0,10/26,22.18%,CALD1;FSCN1;BAIAP2;BAIAP2L1;DMTN;ADD2;RHOD;DPYSL3;NEDD9;MYO1B
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.8284664119332374,-1.2154602754320463,0.2909090909090909,0.7136583544494475,1.0,1/5,2.46%,NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.6730499565299156,1.2154157114735378,0.24444444444444444,0.9435081033007322,1.0,1/7,2.57%,NAF1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.7154410077846223,-1.2153654981146436,0.21568627450980393,0.7133090101875769,1.0,5/11,23.18%,ITM2A;NECAB1;SOAT1;ITM2C;NECAB2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),-0.705423786123484,-1.2152666104944727,0.18032786885245902,0.7130300132801731,1.0,1/9,0.43%,P2RY6
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.5021989558413982,-1.2152184222387474,0.08536585365853659,0.7124735262438798,1.0,13/97,14.31%,EFNA1;DUSP1;IL12A;KIF14;TESC;PODXL;FUT2;ARHGDIG;MINK1;NUAK1;IL18;FES;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.7234525889867387,-1.2151283075375705,0.1864406779661017,0.7122158650800497,1.0,3/10,11.44%,TLR2;TLR3;DDX60
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.820680556824658,-1.2150416162272617,0.22413793103448276,0.7117308146826834,1.0,3/5,11.88%,IL15;IL18;TMBIM1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.6058183273832299,-1.2149294552291778,0.19718309859154928,0.7114150997444166,1.0,8/22,19.40%,STAT4;IL15;CCL2;PTK6;STAT1;STAT6;NMI;GHR
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.49805581227837886,-1.2147982038624068,0.1625,0.7111692845159376,1.0,21/111,19.82%,AMN;SPARC;MX1;SFTPD;RAMP3;COLEC12;VLDLR;LDLR;AP1S1;CD9;M6PR;SYK;MSR1;MICALL1;CLN3;MRC1;LRP2;ADM;CD36;CLTB;DNM1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.688076964712835,-1.2147196805689198,0.1694915254237288,0.7107856915217033,1.0,6/12,23.42%,ANGPTL3;IL18;GCKR;PNPLA8;SCARB1;MTLN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7081642159374607,1.2145381074886479,0.2,0.9453725728343707,1.0,1/7,3.12%,MCU
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.5216077969110373,1.2143634426097447,0.25806451612903225,0.9441778680528401,1.0,4/26,7.96%,NAF1;PPP1R10;MAP3K4;SIRT6
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7522940899966727,-1.2141167719637622,0.3064516129032258,0.7122976136677416,1.0,3/6,17.20%,CHRM1;CHRM3;CHRM5
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7996150556145425,-1.2141076221273848,0.17857142857142858,0.7115587586702208,1.0,3/6,12.99%,DMTN;CD63;EMP2
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.6997609357703649,-1.2140597867558165,0.2631578947368421,0.7109790312024454,1.0,2/12,6.69%,KCNB1;BMP8A
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.6415552722059523,1.2139201960157728,0.23076923076923078,0.9442473949038261,1.0,1/12,1.63%,BMP2
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.7441489901279448,1.2139138007461008,0.26666666666666666,0.9423741684340229,1.0,3/5,17.33%,SLC19A1;ABCC2;SLC46A1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.772398082999906,-1.2135519708926015,0.20689655172413793,0.7122891926512723,1.0,2/6,5.22%,FABP3;HTR2B
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5564436072165656,1.2131531901016546,0.2727272727272727,0.9437470211038433,1.0,5/26,19.67%,PUS10;PRKRA;DROSHA;AGO3;PUM2
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.7446284802248044,-1.2129878352287478,0.25396825396825395,0.7138225776070556,1.0,4/7,17.21%,B2M;GREM2;BDNF;PTPRF
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.474935694597474,1.212830974753893,0.07142857142857142,0.9433390067440669,1.0,10/47,12.98%,MSRB1;ZNF207;CATIP;WASHC5;MID1IP1;TTC17;SPIRE2;DIAPH3;CASQ1;WASL
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),0.7198377001393967,1.212626144704821,0.27906976744186046,0.942160284178101,1.0,2/5,14.64%,PRUNE1;BNIPL
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.7434484434082775,-1.2125880795800137,0.2413793103448276,0.7145576232253655,1.0,3/6,11.26%,P4HA2;P4HTM;P4HA3
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7789225099042769,-1.2125233453713584,0.24193548387096775,0.714045813918396,1.0,1/7,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.4775146801001827,1.212460724102983,0.14705882352941177,0.940872904999432,1.0,11/41,18.09%,ERCC8;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;RAD52;KAT7;EYA1;CEBPG;EYA2
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.49483138051391323,-1.2124398307227324,0.1780821917808219,0.7136918096765902,1.0,18/80,13.21%,CACNA1H;RIMBP2;STMN2;LRRTM1;SYT4;TMEM74B;SLC18A2;PLPPR1;CPLX1;SYT1;CPLX2;FAM163B;SHC2;ADCY5;CALY;F10;RAP1GAP;PCSK1N
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),-0.7714839569067795,-1.21226148246369,0.23529411764705882,0.7135929576878792,1.0,3/7,7.70%,B3GALT2;UGT8;FA2H
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),-0.7625191031488647,-1.2121807958611488,0.19230769230769232,0.7130837883951214,1.0,1/5,1.39%,DGAT2L6
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.5584209645109035,1.211688949596185,0.1935483870967742,0.9403231443144955,1.0,2/16,0.62%,WNT7A;SLITRK2
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.5584209645109035,1.211688949596185,0.1935483870967742,0.9403231443144955,1.0,2/16,0.62%,WNT7A;SLITRK2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.5218270050350965,-1.2114565234809413,0.1875,0.7151241285470097,1.0,41/96,22.53%,MET;A4GALT;GRAMD2A;ICAM1;THSD4;PDPN;COL4A4;SEMA3B;SCARA3;AKAP5;CLDN18;OSMR;DAB2IP;RADIL;SLC44A3;SLCO2A1;AMOTL2;EMP2;RHBDF1;ITGA3;SEMA3E;LAMA3;ITGB4;COL12A1;RHOD;F3;PXDC1;PTPRF;GPC1;NOTCH3;PTPN21;LAMA5;COL4A3;ANTXR1;KIAA1217;WWTR1;P2RX7;SH3D19;EPB41L1;CTNND1;FBLIM1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7673438587069743,-1.2113819630127367,0.22641509433962265,0.7146631880163338,1.0,3/6,21.76%,MAPT;HEBP2;ARL6IP5
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.5661798889028902,1.2107706732986872,0.14285714285714285,0.9423598233137297,1.0,4/21,9.00%,PDE3A;ADCY1;SOX9;PDE7B
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.7634560819470763,-1.2106964335478447,0.20634920634920634,0.7168437236445829,1.0,3/9,6.56%,ANXA1;NLRP12;CEACAM1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5651540132767181,1.2106760479995264,0.3333333333333333,0.9408123307403525,1.0,5/32,9.03%,H2BC18;H2BC21;SOX9;ANP32B;RBBP4
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5047421844715659,-1.2105162590580139,0.13157894736842105,0.7169951433371755,1.0,36/105,20.36%,CDH22;STMN2;SNCB;SH3GL2;SLITRK1;SLC32A1;GAP43;GFAP;TCEAL6;ZNF536;SYN2;IGSF21;CA10;HPCA;SST;STMN4;GAD1;C11ORF87;SYNPR;GAD2;RGS7BP;VIP;GABRG2;CNTN2;KCNC1;PHYHIP;TCEAL5;SULT4A1;GADD45B;ST8SIA3;PARM1;GABBR2;PTPN5;KCNC2;PLPPR4;PAK5
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7640013921899363,1.2105035203295471,0.2619047619047619,0.9397647759773619,1.0,1/5,6.72%,LMO3
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),-0.7814190968911032,-1.2104698119494535,0.24285714285714285,0.7164072897763836,1.0,3/5,20.21%,C1R;C1S;C1QB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),-0.7503796083829292,-1.2101993045244162,0.29508196721311475,0.7167822461541111,1.0,3/6,24.26%,PLN;SLC9A1;TRDN
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6211108151302535,-1.210180354528344,0.1891891891891892,0.7161764427330563,1.0,13/27,26.85%,APP;SYP;SHISA9;SHISA8;SLC4A10;GRIK2;CLN3;MCTP1;NSMF;NETO1;SLC8A2;RAB3A;SHISA7
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.782238449223702,-1.210153933479302,0.38181818181818183,0.7155234452589677,1.0,3/7,10.12%,TNFRSF14;WNT5A;SCIMP
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.4362405569544123,1.2100550512952393,0.14285714285714285,0.9394830400126909,1.0,10/74,9.29%,MEOX2;SOX8;BMP2;ANXA4;ZNF358;EHF;SOX9;FOXJ1;SALL1;STIL
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7310324078474335,1.2098196810290942,0.3225806451612903,0.9383751366473981,1.0,1/6,3.07%,ARFIP1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.4830777431926365,-1.209714572456968,0.16470588235294117,0.7162273515135897,1.0,21/118,16.79%,ARHGAP4;TAGAP;ARHGEF3;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;TRIP10;ARHGAP39;ARHGEF17;ARHGDIG;ARHGEF18;RHOF;FOXM1;OBSCN;DLC1;VAV1;RASGRF2;RELN;RHOD;ARHGAP22
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.7582758651127877,-1.2094778006313662,0.2857142857142857,0.7165912564046443,1.0,2/6,16.28%,GMPPB;PMM1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.8120557860338402,-1.2094576271092818,0.20689655172413793,0.7159205464125546,1.0,2/6,9.49%,FSCN1;KIF9
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.4652314266190265,-1.2092630296397762,0.06593406593406594,0.7160620134817826,1.0,71/229,20.50%,GRIN2D;NPY;RIMBP2;SNCB;CHRM1;GRIN2A;PLP1;HTR2B;SLC32A1;SYN3;GRIA3;GLRA2;UTS2;HAP1;GRIA1;AKAP5;SLC18A2;NRGN;RIT2;SYN2;UNC13C;CPLX1;RPS6KA1;CBLN2;SYT1;GRIK1;MINK1;HCRTR2;CHRM3;GABRE;GABRB2;SST;CHRNA5;GABRD;PCDHB5;GAD1;HRH1;GRIN2B;GRID2;NLGN1;NPTX2;GAD2;HTR1E;GABRG2;PDLIM4;APBA2;SLC12A7;GRM7;GRIK2;SYT5;SNCG;GABRA1;CACNB1;KCNMB4;HTR2C;CHRM5;CHRNE;CDK5;TBC1D24;HTR2A;SLC1A6;PTCHD1;GLRA1;GABBR2;SLC17A7;GABRA6;CHRNA6;GABRG3;GABRA3;PCDHB4;CDH8
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.5788945903289191,-1.2092547171081178,0.2054794520547945,0.7153353996875264,1.0,11/37,17.20%,P2RY12;CHRM1;ADCY7;AKAP5;CHRM3;ADCY5;HTR1E;GRM7;ADCY3;ADCY8;CHRM5
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.7132407014783178,-1.208978924126939,0.28125,0.7155831336173818,1.0,5/12,10.00%,DUSP1;SULF1;TIMP1;IGF1;WEE2
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.6803757811692173,1.2083910673020255,0.25,0.943162718818106,1.0,5/7,28.77%,NUFIP1;ZNHIT3;RUVBL1;ZNHIT6;PIH1D2
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.6953089282161857,-1.2083642961194183,0.2222222222222222,0.7174179861951432,1.0,3/8,25.82%,BDNF;XBP1;HDAC5
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),-0.7158499206577148,-1.2079684618469606,0.18518518518518517,0.7182974370393194,1.0,1/9,0.55%,PIF1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.50996805704253,-1.2073485688754912,0.20270270270270271,0.7202600960365751,1.0,14/56,17.99%,TLR2;IFI35;IL15;NLRP12;APP;TLR3;PLSCR1;WNT5A;IL18;TNFRSF1A;ETS1;ABCC1;NMI;SLC15A4
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.42657558225728304,1.2073176722985144,0.13636363636363635,0.9463280323075036,1.0,25/79,31.14%,WASHC2C;PHETA1;VTI1A;VPS50;RAB7B;TBC1D5;RAB9A;RHOBTB3;SNX5;VAMP3;TBC1D23;RIC1;PIKFYVE;VPS29;SNX2;SNX3;RGP1;SNX1;VPS54;WASHC2A;SNX12;VTI1B;VPS26B;SURF4;VPS26A
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5021301085588634,-1.2073096480949157,0.1875,0.7197055547038501,1.0,23/78,15.12%,ANXA1;NR4A3;MYO1F;TAGAP;KMO;PDPN;HLA-A;SLA;PDCD1LG2;HLA-C;HLA-DRA;TLR3;IGSF6;CLEC12A;ADAM19;SCIMP;CTSS;HLA-B;P2RY10;SLC11A1;PPP1R14A;ASS1;CD74
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.7010904282891848,-1.2062809858997012,0.2857142857142857,0.7229850333315866,1.0,1/8,0.69%,SOCS3
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.579988421027365,-1.2057442177801487,0.20754716981132076,0.7244772868715713,1.0,10/23,24.22%,KLF4;SRF;FOS;APLN;ETS1;TGFB1;SPI1;GNL3;STAT3;PPARG
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.5062969453736327,1.2056479888489755,0.1875,0.9519927181317493,1.0,2/20,6.64%,PRDX6;SF3B4
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.6069409286737234,-1.2055479436210659,0.27941176470588236,0.7245225376044743,1.0,8/24,14.33%,PROX1;PDPN;CCDC39;BASP1;CHI3L1;FGF1;FGF7;ITGA3
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.6040457369303311,-1.2053817150933142,0.2608695652173913,0.7244339597528202,1.0,5/24,15.71%,OGN;OMD;ST3GAL6;B3GNT2;CHST6
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8307282439920887,-1.2051766676321194,0.15873015873015872,0.7245268751796842,1.0,1/5,1.32%,GPR183
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.7091895682511067,1.2051345334747512,0.2702702702702703,0.9521779494621819,1.0,1/6,12.98%,WASL
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5273231213504009,-1.204472089754103,0.1388888888888889,0.7266119623245677,1.0,10/63,9.10%,OTOS;KCNQ1;EPS8L2;CDH23;CLRN1;CEMIP;NDUFB9;COL11A2;PIEZO2;MYO3A
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.6679752806823603,-1.2044284255105768,0.25,0.7259977415783181,1.0,2/14,5.34%,A4GALT;B4GALNT1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.5962576061512935,-1.2043544515256712,0.15151515151515152,0.7256226144383775,1.0,7/45,11.18%,THBS1;NR4A3;TESC;GATA1;ZFPM1;THPO;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.7152838269813198,-1.2039400074277233,0.29310344827586204,0.7265027163949421,1.0,1/7,0.94%,DUSP1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.5748002364932422,-1.2037582668013584,0.2361111111111111,0.7264411338713014,1.0,5/23,11.12%,THBS1;SP100;SVBP;PFN2;DAB2IP
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5838445190658981,-1.2036187869730874,0.21621621621621623,0.7263417415352179,1.0,4/29,15.85%,NR4A3;PLEKHM1;MYH9;PIK3CD
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6016047513909372,-1.2036178457658844,0.2112676056338028,0.7255983006534009,1.0,2/18,8.06%,APLNR;ANGPTL3
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.7547072951790749,1.203523280325701,0.23404255319148937,0.9566578664891988,1.0,1/7,1.39%,NCSTN
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.6809932100798088,-1.203319069538168,0.19402985074626866,0.7260867789908929,1.0,3/14,13.03%,SCN1B;CAV3;SCN3B
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.5256415820954407,-1.2031721801593567,0.21621621621621623,0.7259407784876996,1.0,8/53,6.59%,TLR2;PTP4A3;IFI35;NLRP12;APP;NOD1;LRRC19;TLR3
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6961915507127672,-1.202589645393577,0.25396825396825395,0.7276841342095843,1.0,2/12,6.20%,ABCA12;ABCB1
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.613037977571696,-1.2021212305145805,0.22950819672131148,0.7285747260107246,1.0,6/24,17.53%,APP;TIMP1;LRPAP1;SLCO2A1;CCND2;SPP1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.627510645320738,1.2020986822959605,0.1956521739130435,0.9601701598452438,1.0,1/8,1.03%,GALNT3
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),-0.8031657951825689,-1.2019795184657416,0.26785714285714285,0.7283795077142525,1.0,3/5,16.51%,B2M;BDNF;ANXA2
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.7187919195656839,-1.20176747045344,0.22727272727272727,0.7283635994493697,1.0,4/8,18.39%,SLC3A1;CLN3;SLC15A4;SLC7A7
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.7525360693603433,-1.201660259640146,0.2786885245901639,0.727980854580944,1.0,2/6,13.59%,ISG15;HERC5
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5343779404872767,-1.201547747442419,0.2028985507246377,0.7277398470447054,1.0,13/43,17.44%,SERPINA10;TIMP2;SERPINF1;SPOCK3;TIMP1;PSMB9;SERPIND1;SERPINE3;BIRC3;SERPING1;APH1A;CRB2;PSME1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.6821025572690833,-1.201432585523151,0.19718309859154928,0.7274711649228472,1.0,3/12,7.78%,TLR2;DYSF;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),-0.7370460848177103,-1.2013451456932092,0.27450980392156865,0.7270623526913397,1.0,4/8,21.77%,KLF4;SIGIRR;PTPRC;SH2B3
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.6684326651257109,-1.2013382314676717,0.20967741935483872,0.7263358284330466,1.0,3/14,11.34%,SKAP1;KIF14;SELP
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6769312492749454,-1.2012946625972931,0.234375,0.7257418041196338,1.0,3/15,11.34%,ICAM1;SYK;SELP
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.7544364201282986,1.2012776490344648,0.17073170731707318,0.9620587917062072,1.0,1/7,1.39%,NCSTN
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.7762492677572634,-1.2009126045554908,0.2549019607843137,0.7264766634317983,1.0,3/8,14.82%,STMN2;VIL1;WDR1
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.6905310981622789,-1.20066857549725,0.3333333333333333,0.7268084003473614,1.0,5/8,29.96%,PARP9;DDX11;DTX3L;KDM4D;HMBOX1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.619589026835857,-1.2004572463412477,0.25,0.7268968615605303,1.0,2/16,6.53%,LEF1;GATA1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.5377362190717808,-1.2000171457407416,0.18421052631578946,0.7279639164845229,1.0,10/61,11.20%,THBS1;IFI6;DHCR24;NLRP12;KLF4;NOD1;CD44;RPS6KA1;NLRP2;SYK
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5560532650187922,-1.1999611535492425,0.24285714285714285,0.7273991790825881,1.0,9/40,15.12%,ANXA1;GPR183;IL12A;IL15;PDCD1LG2;HLA-E;IL18;IL7;CD74
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.6557816309565971,-1.1997805411026434,0.2,0.7274588711310651,1.0,1/13,5.04%,APP
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6642693076937914,-1.1997499500644386,0.2222222222222222,0.7268957748136257,1.0,3/18,13.52%,SEPTIN5;RIMS2;NLGN1
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.5916798474944333,1.1995073345209983,0.175,0.9675942407521096,1.0,2/16,6.55%,SLC6A13;SLC25A18
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.6184968156056994,1.1994020871334072,0.2857142857142857,0.9661657041074833,1.0,3/12,6.69%,PPARGC1A;AKT2;AKT1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.7389004869312686,-1.1993929483629922,0.3,0.7275871802362509,1.0,3/8,11.03%,GATA1;IGF1;NECAB1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.6387059700707536,-1.1992658474389783,0.2786885245901639,0.7273960812168512,1.0,7/15,24.64%,ANGPTL3;IL18;GCKR;PNPLA8;SCARB1;MTLN;XBP1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.6784576764414383,-1.1992644503244745,0.14814814814814814,0.7266679570114289,1.0,3/10,17.65%,NOD1;ERBIN;RIPK2
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5187922244273526,-1.1992605840509365,0.18571428571428572,0.7259875709819068,1.0,16/50,18.23%,ANXA1;SEPTIN5;HAP1;SEPTIN4;CPLX1;SYT1;RHBDF2;SCG5;CPLX2;RIMS2;RHBDF1;RAB3C;KCNMB4;SEPTIN1;MCTP1;RAB15
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),-0.7645903834206367,-1.199067041046716,0.29310344827586204,0.7262425053393397,1.0,2/6,20.75%,TCP1;TBCE
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.7969519970702295,1.198599892239545,0.2,0.9679880109863105,1.0,2/6,12.99%,BMP2;AKR1C3
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5726449785602343,1.198559972636695,0.18181818181818182,0.9662796961393992,1.0,1/17,1.28%,SRPRB
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5335524344515995,-1.198522102040738,0.10256410256410256,0.7277717623813916,1.0,11/77,8.52%,CACNA1H;CALD1;MYOF;MYOT;GJC1;LMOD1;DYSF;CAV3;UTS2;MYH11;TNNT1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5900829182871467,-1.1984408704323697,0.23529411764705882,0.7272584274901347,1.0,8/24,18.28%,OGN;IL12A;APOD;IGFBP5;VIP;APLN;GPER1;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.46424924284676106,1.198310402995151,0.20689655172413793,0.9656482846779795,1.0,15/34,33.23%,MIOS;WDR24;PIK3CA;SLC38A9;GOLPH3;LAMTOR3;RPTOR;RHEB;WDR59;SIK3;LARS1;KLHL22;PIP4P1;MLST8;RICTOR
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7040199000766598,-1.1978671456006675,0.26785714285714285,0.728543919134598,1.0,5/10,22.98%,MX1;STAT1;IL27RA;TYK2;STAT3
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.7174693349201108,-1.197828132558698,0.2727272727272727,0.7280124168224789,1.0,4/8,18.14%,SYK;PRKCD;TGFB1;MAPT
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.621064301837549,-1.1976453010021677,0.25,0.7279420300963604,1.0,7/26,17.43%,CENPV;CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.5869557667035987,1.1974730383910717,0.3191489361702128,0.9673084961702177,1.0,7/16,28.37%,UBTF;EIF2AK3;DHX33;WDR43;MAF1;WDR75;POLR2K
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.545588104666859,-1.197367214231725,0.23529411764705882,0.7283313852255993,1.0,9/52,11.12%,THBS1;HPN;SPARC;B2M;SULF1;CEACAM1;STAT1;ATP5IF1;DAB2IP
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.6276959245919888,1.1973358656639386,0.2727272727272727,0.9658071220036752,1.0,7/14,24.66%,AIFM2;COQ3;COQ2;COQ9;PDSS2;COQ6;UBIAD1
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),-0.7115126016030857,-1.1973254931591508,0.21052631578947367,0.7277833097684898,1.0,4/8,18.19%,ZFP36;BOK;TEK;NUPR1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.48332695063844344,1.1969591755652182,0.16666666666666666,0.9655928831651824,1.0,8/54,8.19%,SLC6A13;SLC19A1;SLC39A8;SFXN2;SLC25A18;SLC25A19;SLC3A2;SLC25A41
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6135782933841635,-1.1966539212067364,0.21666666666666667,0.7297958167740308,1.0,2/25,6.29%,CD24;BRCA1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8018127022989328,-1.1964312767578282,0.21153846153846154,0.7298889083507979,1.0,3/6,7.23%,TIMP2;TIMP1;SVBP
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6013978980838635,-1.196390148018758,0.2602739726027397,0.7293226073073881,1.0,3/26,7.17%,EFNA1;TIMP2;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.513630138564171,-1.1960964017568214,0.17333333333333334,0.7297544076684767,1.0,10/70,13.54%,LEF1;SP100;IFIT1;TMC8;PLN;ZFPM1;LRPAP1;CTSZ;IFIT2;TFAP4
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.6125672661082678,1.1960322913024743,0.225,0.9677206151369546,1.0,1/10,1.63%,BMP2
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.6115803730891237,-1.195638636238346,0.21875,0.7306056849616275,1.0,4/29,8.66%,APLNR;TGFBR2;CCDC39;SRF
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.6444652026805328,-1.195591367152939,0.2638888888888889,0.7300859954113228,1.0,7/17,22.37%,TLR3;STAT1;IRF7;IFIH1;RIPK2;NLRC3;HSPD1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),-0.7875109425153195,-1.195530590611922,0.23809523809523808,0.729558210288213,1.0,5/5,21.28%,ALPL;FES;SPP1;CDKN2D;SFRP1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.4740995680815836,-1.195501630876469,0.15294117647058825,0.728976800418311,1.0,8/136,5.98%,RASGRP1;S100A10;DOCK8;RASGRP2;ARHGAP9;ARHGAP15;THY1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.7422074031785334,1.1952094605716141,0.2558139534883721,0.9696671677028754,1.0,1/5,0.44%,WNT7A
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5616710165708081,1.1951762944293842,0.2,0.9680647380532676,1.0,3/17,17.32%,ARFIP1;ARFIP2;ABI2
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.7355040618952642,-1.195121234209151,0.2833333333333333,0.7296889692705669,1.0,2/8,5.04%,GRIN3A;APP
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.7121777389317226,-1.1949712708493074,0.26865671641791045,0.729663228925347,1.0,2/10,8.06%,RASGRP1;ANGPTL3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.6773852733985259,-1.1949636657671319,0.23809523809523808,0.7289562545942111,1.0,4/9,21.56%,SYT1;KCNMB4;RYR2;CALM3
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6600874671190704,-1.1948647936653702,0.2830188679245283,0.7286227368847163,1.0,1/10,0.47%,HPN
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.6868529056590046,-1.194119005701136,0.25,0.7309462103469057,1.0,1/12,1.11%,APLNR
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.4938143262136333,-1.1936095460782066,0.17073170731707318,0.7322779098695742,1.0,20/94,15.88%,TAGLN3;STMN2;SNCB;GNG3;CAMK2N2;SLITRK1;SLC32A1;EFNB3;JPH3;GAP43;ARHGAP39;PRKCG;NYAP1;HPCA;GAD1;C11ORF87;TMEM151A;CNTN2;KCNC1;PHYHIP
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.640274883964632,-1.1933889007093716,0.265625,0.7325031163035007,1.0,4/17,10.44%,YBX3;SLC4A11;RCSD1;SCN2A
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6008949811359885,1.193253154836869,0.2222222222222222,0.9745943082868983,1.0,1/14,1.63%,BMP2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.601467757540722,-1.1930636002421646,0.30158730158730157,0.7328815533434777,1.0,7/31,13.56%,TLR2;SFTPD;IL15;DYSF;PLSCR1;SYK;SLC11A1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.6082630890139272,-1.1929414486023486,0.15714285714285714,0.7326542004298587,1.0,3/19,10.92%,PLB1;DBI;LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.6411670175442474,1.1925565747049174,0.2682926829268293,0.9756778036589117,1.0,4/9,20.40%,RALB;PIP4K2B;PIP4K2C;RAB3GAP1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.47987749489358283,-1.1924441372306163,0.16470588235294117,0.7337174107053428,1.0,28/114,19.58%,KCNV1;KCNK1;KCNJ13;KCNJ2;SCN9A;SLC4A11;SLC5A4;SLC18A2;ATP1B1;SLC8A3;PIEZO2;SCN2A;SCN1A;KCNG1;KCNB2;SCN3B;SLC22A4;KCNC1;KCND3;KCNMB4;CLN3;SLC29A4;AQP1;LRP2;KCNAB3;SLC25A29;KCNF1;ABCC9
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.6776706576109884,-1.1921525607352415,0.20754716981132076,0.7335865592367432,1.0,4/15,15.30%,THBS1;APOD;DMTN;DLC1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.6776706576109884,-1.1921525607352415,0.20754716981132076,0.7335865592367432,1.0,4/15,15.30%,THBS1;APOD;DMTN;DLC1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.7823711587855349,1.1921210145393337,0.2653061224489796,0.97596271474868,1.0,1/5,1.39%,NCSTN
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.43633121065252733,1.1920056067699683,0.2,0.974724851184878,1.0,32/90,30.72%,U2AF1;PPARGC1A;SNRPF;SF3B4;HNRNPC;RP9;NOVA1;SMNDC1;SNRPN;SYNCRIP;DHX15;CCAR2;PDCD7;CDK12;MBNL1;USB1;SCAF11;SNRPB;SNRNP48;MAGOH;YJU2;SNRNP35;SCNM1;SRSF2;LSM1;KHSRP;SRPK2;LSM6;MAGOHB;SNRNP40;PTBP1;DHX16
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.529153874014154,-1.1919313941066563,0.1891891891891892,0.7335752973413066,1.0,14/71,8.20%,POU4F1;L1CAM;ANK3;CCK;SHTN1;S100A6;PLP1;APP;SLITRK1;MAP1B;GAP43;SVBP;BAIAP2;NEFH
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.41501705822339763,1.1913973692230102,0.09090909090909091,0.9752457958698607,1.0,14/67,12.60%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;BAG2;VCP;SIRT6;RNF14;CSNK1E;CBFA2T3;PLK1;RCHY1;TRIB2
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.4872444453933325,-1.191227623323168,0.19736842105263158,0.7353973608491245,1.0,30/110,19.26%,KCNT2;RIMBP2;PCSK2;CHGB;STMN2;NEFM;GNRHR;SULF1;SYT4;THY1;GRIA3;GAP43;GRIA1;ZNF385D;ZNF536;SST;CACNA1C;C11ORF87;FGF7;GAD2;TMEM130;RAB3C;PTPRN;TCEAL5;SEZ6L2;PCDH18;CELF4;ST8SIA3;PDGFRA;CNTN4
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4999651369067391,-1.1909989445932456,0.1686746987951807,0.7356716625406031,1.0,22/79,13.59%,C3;B2M;ICAM1;SFTPD;HLA-A;IRF1;IL15;ADCY7;CD160;COLEC12;HLA-C;HLA-DRA;NPDC1;PLSCR1;IRF7;PILRA;BIRC3;HLA-B;SYK;HLA-E;HLA-F;HERC5
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5445767913624575,-1.1909565375766213,0.15492957746478872,0.7351202509867473,1.0,9/48,13.97%,CD24;RASGRP1;HTR2B;EGF;FGF1;DAB2IP;DIRAS1;NEK10;DIRAS2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6361894782435836,1.18978622537835,0.3,0.9802273525913573,1.0,9/13,29.40%,PPARGC1A;SLC25A18;ETFDH;SLC25A22;SDHB;ETFRF1;SLC25A12;UQCRFS1;NDUFA5
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.7030990919029492,-1.1893450503039509,0.3050847457627119,0.7404391543643528,1.0,4/11,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.7097492962631536,-1.1893279413961495,0.25396825396825395,0.7398036304911578,1.0,3/9,17.30%,TGFBR2;SFRP2;RYR2
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7667369903711735,-1.1892558721960353,0.32142857142857145,0.739446579079972,1.0,1/6,1.41%,SLC6A15
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.7339389082528319,-1.1892056658228338,0.21818181818181817,0.7389293917265674,1.0,2/8,7.96%,TGFBR2;ZFPM1
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),-0.7290916996288483,-1.1889404791855336,0.2727272727272727,0.739109439130674,1.0,4/6,26.84%,TAS1R1;CD36;ASIC2;ASIC3
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.7057878928578509,-1.1888938809302372,0.2962962962962963,0.7385668205230905,1.0,5/12,12.78%,SKAP1;IRF1;ADCY7;IRF7;FADD
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.42266627303184057,1.1888748492975658,0.08333333333333333,0.9821852584921912,1.0,23/64,26.32%,ELOC;EAF2;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;ELP2;IWS1;POLR2C;ELP4;PCID2;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;CDK12;MLLT3;CCNH;TCEA1;POLR2A
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.4808491042688566,-1.1887721761997612,0.1590909090909091,0.7382212430302021,1.0,15/113,13.20%,COL4A1;MET;COL4A2;CSPG4;LAMB1;BARX2;LMOD1;SCARA3;ARHGEF17;SRPX2;NUAK1;DAB2IP;IGFBP5;AMOTL2;RHBDF1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.48693945817903694,-1.1885937360295271,0.20253164556962025,0.7380810386348484,1.0,29/126,13.52%,FLRT3;CDH22;TGFBR2;ICAM1;L1CAM;NEXN;MYOT;CDH6;FAT2;CDH23;CLDN16;SLITRK1;LRRC4;CEACAM1;CLDN20;CLDN18;TENM4;IGSF21;IL1RAPL1;MAG;CDH7;CDH19;CDH9;PCDHB5;SELP;MMP24;CDH12;GRID2;NLGN1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6078825892821338,-1.1884281131169798,0.25396825396825395,0.7378344017542081,1.0,4/20,6.33%,CACNA1H;KCNQ1;PLN;CAV3
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.47320613948962803,1.1882821814364337,0.2692307692307692,0.9827744260003607,1.0,9/35,16.58%,NR1D1;ID1;ALDH1A1;NOVA1;PGAM5;LAMA4;LGR4;ABHD6;PCTP
prerank,GO_Biological_Process_2021__nose development (GO:0043584),-0.7211451244391289,-1.1881551795825924,0.3181818181818182,0.738112352223025,1.0,1/6,2.77%,PROX1
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.7463125854542974,-1.1879501373065526,0.3269230769230769,0.7381590256794911,1.0,2/5,6.90%,APP;GAP43
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.692654496234469,-1.187682629419667,0.2,0.7384361327336884,1.0,5/10,12.78%,CD24;IGF1;HHLA2;IL18;FADD
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.7205161162627811,1.1875886626400378,0.2765957446808511,0.9820388128420082,1.0,2/7,10.94%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.7205161162627811,1.1875886626400378,0.2765957446808511,0.9820388128420082,1.0,2/7,10.94%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),0.8326968056675822,1.187407587172057,0.1951219512195122,0.9809749898923095,1.0,2/5,4.85%,EFNB2;GREM1
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7590198766762978,-1.1869917852024972,0.2830188679245283,0.7403513996950567,1.0,3/7,14.82%,CNTNAP1;PLP1;MYRF
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.48987568144901167,-1.1869833831849765,0.19047619047619047,0.7396701547206768,1.0,45/123,21.87%,B3GALT2;PCSK2;STMN2;NEFM;PROX1;ZDHHC22;SLITRK1;SLC24A2;SYT4;SRRM4;GRIA1;TCEAL6;SYP;ZNF536;GRM6;CA10;SCN2A;SCN1A;STMN4;C11ORF87;SYNPR;SCN3B;GAD2;GABRG2;TMEM130;CNTN2;KCNC1;GDAP1L1;RAB3C;GABRA1;CNTNAP5;LRTM1;TCEAL5;SV2B;CELF4;ST8SIA3;HCN1;CNTN4;PTPN5;CNTNAP2;PAK5;PDC;VSTM2B;OPCML;VWC2L
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4955573322394251,-1.1866228950557745,0.2125,0.7402632956122368,1.0,24/95,15.16%,P2RY13;TGFBR2;TLR2;LMO2;GPR171;MAFF;SIGLEC1;THY1;DYSF;ABCB1;GFI1B;CD44;CLEC12A;F13A1;ARID3A;SELP;HLA-E;BAALC;PROCR;RNASE1;FES;ROBO4;IL3RA;SERPING1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.737286137198304,-1.186546473605422,0.3137254901960784,0.7398395752308617,1.0,1/8,3.17%,IL12A
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.578750365921375,-1.1863822585291508,0.16393442622950818,0.7398313911308612,1.0,2/27,2.20%,PIF1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.5473985353887227,-1.1863649136720862,0.24285714285714285,0.7391884990426268,1.0,3/51,3.20%,ECM2;S100A10;SKAP1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5622871679108762,-1.1863395437563617,0.2328767123287671,0.7385732519978465,1.0,6/38,8.87%,THBS1;IFI6;DHCR24;KLF4;CD44;RPS6KA1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.4251499981534832,1.186309521086618,0.1935483870967742,0.9842435478312268,1.0,9/41,16.58%,NR1D1;ID1;ALDH1A1;NOVA1;PGAM5;LAMA4;LGR4;ABHD6;PCTP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.6383860959043584,-1.1861210012619645,0.22033898305084745,0.7388126626406908,1.0,3/15,5.90%,SFTPD;GPNMB;PDCD1LG2
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7238245673247524,1.1860238620571482,0.3191489361702128,0.9835800110978317,1.0,1/5,9.41%,PGGT1B
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.6095904059919453,-1.1857619615716173,0.2923076923076923,0.73950872401915,1.0,5/18,16.24%,SYT4;SYT1;CPNE9;RIMS2;SYT2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.43987471793220323,1.1857041223460865,0.2692307692307692,0.9828978911121723,1.0,14/71,13.66%,LEPR;SLC6A13;SLC19A1;AGER;SLC24A3;SLC15A2;ATP1A2;SLC4A4;ABCC2;SLC22A2;SLC5A6;SLCO1C1;SLC6A1;ATP8A1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3955034181563749,1.1856790303380185,0.09090909090909091,0.9811894135726827,1.0,36/115,26.52%,FAM47E;CHRAC1;HMGN4;SMARCAD1;SOX9;KAT2B;KDM5A;RBBP4;HP1BP3;BRWD1;BAZ1A;KAT2A;HMG20A;HDAC2;SMARCA2;HMGN1;CDAN1;HMGN3;DR1;EHMT1;HDAC10;DAXX;TADA2B;PBRM1;HMGN2;RUVBL1;ZBTB1;MTA2;LOXL2;SMARCC1;PADI4;BAZ1B;BAZ2B;SETDB1;INO80;HCFC2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),-0.7084558436181355,-1.1855979089245092,0.3157894736842105,0.7394745461954475,1.0,1/7,0.81%,C3
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),-0.7435505269390393,-1.1855671063935693,0.2459016393442623,0.7388525868810258,1.0,4/7,21.38%,PLEKHM1;SYK;SPP1;ADAM8
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),-0.8011541436373969,-1.185553777170342,0.24074074074074073,0.7381967434535716,1.0,1/5,3.17%,IL12A
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.38705103885547953,1.1855258585601771,0.05263157894736842,0.9798435278841863,1.0,36/155,16.99%,PTCD2;ATAD3C;GDAP1;PPARGC1A;TFB2M;AIFM2;PLD6;AFG1L;TFB1M;SAMM50;ALAS1;TRAK2;POLG2;MTERF1;RAB5IF;MFF;GABPB1;MGME1;TOMM22;ESRRA;CHCHD3;TMEM11;OPA1;SIRT5;DNM3;TMEM70;MUL1;THG1L;TIMM23;MIEF2;COX7A2L;NRF1;MTFR1;PRDX3;MSTO1;MTX2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.6153192273483351,-1.1853035724241032,0.28125,0.7384441350243515,1.0,4/18,11.28%,EFNA1;TGFBR2;ZFPM1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.7337042947443891,-1.1849418222879096,0.25,0.7391285062659733,1.0,2/6,10.82%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.610420949755082,-1.184431768244726,0.2236842105263158,0.7406594314743641,1.0,3/16,4.46%,MET;PROX1;LSR
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5403353222690378,-1.1844203233109427,0.29577464788732394,0.7399868934790992,1.0,1/46,0.02%,ENPP2
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3823370119888774,1.184193036205837,0.13333333333333333,0.9835862096887585,1.0,20/129,16.57%,ATP6V0D2;PDK4;ATP6V1A;EIF2S1;PIK3R4;ATP6V1G1;RALB;MIOS;GAS2L1;SESN2;XPR1;EIF2AK4;MAPK8;PIK3C3;WDR24;AKR1C3;DAP;PRKD1;SESN3;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.6559176294525622,-1.1839425779919632,0.26229508196721313,0.7408510839698024,1.0,2/12,6.62%,SOCS3;PARP14
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.6181190659514196,-1.1838834158479918,0.23333333333333334,0.7403975319076274,1.0,4/26,13.13%,NPY;PROX1;DRAXIN;GRID2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.4888215083204917,-1.1835716895485109,0.18421052631578946,0.7408069048392542,1.0,19/81,17.30%,THBS1;RASGRP2;SYT4;TRPC3;ITPR3;NEUROD2;SYT1;CLIC4;WNT5A;HPCA;CPNE9;DMTN;NLGN1;SYT5;SYT2;KCNMB4;SYT13;ADCY8;RYR2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.6522624224431353,1.1835621185788694,0.2564102564102564,0.9844334603931937,1.0,1/6,14.38%,CFLAR
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5403398693629256,-1.1833060128633048,0.22535211267605634,0.7411807098311681,1.0,7/39,11.88%,PSRC1;KIF14;RAB11A;CENPE;NUF2;CCNB1;KIF2C
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.6289575926249206,1.1832341941376305,0.2727272727272727,0.9840895216487456,1.0,4/8,19.77%,SPRED1;SPRED2;EP300;CCAR2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.41823363509165273,1.1829816890201446,0.09090909090909091,0.9832267027469748,1.0,17/60,20.89%,LIMD1;NUP42;NUP37;NUP54;IPO8;NDC1;NUP214;RAE1;AAAS;NUP188;POLR2C;NUP205;PUM2;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.6551811794412399,-1.1826082352690632,0.3225806451612903,0.7433529412907542,1.0,4/10,19.14%,SCX;TENM4;CRB2;PHLDB2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4761993050066465,-1.1823228431657549,0.12345679012345678,0.7436802401157596,1.0,27/142,15.42%,PGR;MYOF;ZFP36;BTG3;TJP3;OVOL2;SEMA3B;LSR;KLF4;ANXA9;CD44;CCND1;PAPSS2;GINS2;BLVRB;RAPGEFL1;HR;CD9;SNX10;TMPRSS3;PRSS23;PDZK1;EMP2;FOS;ST6GALNAC2;ASS1;PCP4
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.5963759023701388,-1.182183256302696,0.22058823529411764,0.7435644927757786,1.0,3/23,7.93%,SCN1B;KCNQ1;ATP1B1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.43467234221495443,1.181962286814955,0.3076923076923077,0.9860221201874606,1.0,14/73,13.66%,LEPR;SLC6A13;SLC19A1;AGER;SLC24A3;SLC15A2;ATP1A2;SLC4A4;ABCC2;SLC22A2;SLC5A6;SLCO1C1;SLC6A1;ATP8A1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),-0.8251681201264068,-1.181884886534312,0.25396825396825395,0.7437783092406648,1.0,2/5,14.77%,P2RY12;GPI
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.625785062880857,1.1817950494778593,0.2926829268292683,0.9848479785992381,1.0,8/14,27.02%,ERI1;INTS7;INTS8;INTS6L;TOE1;INTS14;ELAC2;INTS6
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.49439385039333344,1.181776405225352,0.1388888888888889,0.9831194219814674,1.0,5/27,13.00%,RAB33B;COG6;COPB2;VTI1A;GOLGA5
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.427669289926803,1.1817685140365042,0.16,0.9813558306764952,1.0,23/62,26.32%,ELOC;EAF2;GTF2F2;ELOA;ERCC2;ERCC3;GTF2H5;GTF2H2;ELP2;IWS1;POLR2C;ELP4;PCID2;CCNT1;GTF2H3;NELFA;CCNT2;CTDP1;CDK12;MLLT3;CCNH;TCEA1;POLR2A
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.49908249386732534,1.1817371825450913,0.21212121212121213,0.979742948562107,1.0,5/48,3.54%,LEPR;CEBPA;PDK4;MCU;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5768232454409273,-1.1817155208692387,0.20588235294117646,0.7437839115943461,1.0,4/21,8.03%,CEMIP;APP;EGF;CHI3L1
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8018681282905903,1.1816547361102656,0.28125,0.978197638966804,1.0,2/6,12.04%,RFWD3;FEM1B
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),-0.8006934055537496,-1.1811336840476716,0.38461538461538464,0.7454677640245466,1.0,2/5,11.67%,ZFP36;SFRP4
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.5173896782536569,-1.1811328570193294,0.18421052631578946,0.7447717156921241,1.0,14/70,15.76%,CD24;RASGRP1;DUSP1;HTR2B;CAV3;EGF;FGF1;DAB2IP;PAQR3;DIRAS1;NEK10;DIRAS2;PIK3CB;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6439676187243247,1.180944256517161,0.325,0.9795133326532662,1.0,4/12,17.67%,NUDT21;RC3H1;CNOT8;CNOT1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.6416501670743628,-1.1809410707135048,0.29411764705882354,0.7448454531861693,1.0,3/11,13.10%,SIX3;GCM2;PAX8
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6847703588196201,-1.1807327905140552,0.265625,0.7449190532384735,1.0,4/11,12.58%,IFIT1;COLEC12;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.6605857619335154,1.1806734242125791,0.25,0.979163330779986,1.0,1/7,10.85%,STARD4
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.580027659030571,-1.1806729492882029,0.208955223880597,0.7443719764230406,1.0,4/27,12.44%,ANXA1;DUOX1;VIL1;DMTN
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5993634518574792,-1.1806439444453996,0.25757575757575757,0.743808696242617,1.0,9/16,16.36%,HLA-A;IL12A;HLA-DRA;CEACAM1;HLA-B;HLA-E;FADD;HLA-F;HLA-DRB1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.5752520309651776,1.180285057694861,0.3157894736842105,0.9787941191779375,1.0,3/18,17.54%,PRKRA;DROSHA;TENT4B
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.6660439372776025,1.1801661291333527,0.22916666666666666,0.977568090124631,1.0,3/10,16.71%,LIG4;HMGB1;DCAF1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.6379505366696949,1.1801120939185452,0.25,0.9761017110763518,1.0,4/7,33.18%,SLC25A46;TMCC1;SPAST;DNM1L
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.4423739785461588,1.1801118031978564,0.2,0.9743555541692386,1.0,9/63,6.69%,RITA1;BEND6;POFUT1;MAML3;KAT2B;ENHO;EGFR;LLGL1;AKT1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5149178128562059,-1.179949445009163,0.21621621621621623,0.7458444448546766,1.0,7/72,6.04%,PIF1;ERCC6L;BLM;HK2;DEPDC1B;ATAD5;CENPH
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.48034001498026174,-1.179886420902936,0.16470588235294117,0.7453496003064833,1.0,16/118,16.80%,GBP2;TRAM1L1;GBP1;RAB11A;APP;FSIP2;ISG15;SNX10;IFT122;OBSCN;PAQR3;RPA1;MICALL1;DDRGK1;ALDH3A2;EMD
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.7449649117185229,1.1798730377935593,0.26666666666666666,0.9733269218456548,1.0,1/5,10.85%,STARD4
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.5717562955916191,1.1797180630246524,0.1891891891891892,0.9723628155532161,1.0,3/20,3.19%,THUMPD1;TFB2M;TFB1M
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.5712626891243918,1.1796855624051208,0.25,0.9707541338131762,1.0,8/21,25.55%,VCP;VTA1;CHMP2B;LEPROTL1;VPS4B;CHMP6;TMEM50B;SORT1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.56741983483957,1.1784323936260133,0.21212121212121213,0.9733152986619221,1.0,2/11,10.44%,FOXP1;HEYL
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.6128489425976448,-1.1784055851341908,0.24615384615384617,0.7500849305795213,1.0,5/17,16.24%,SYT4;SYT1;CPNE9;RIMS2;SYT2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5341426472421608,-1.1781901212853627,0.24324324324324326,0.7501017934764094,1.0,11/44,20.97%,TOMM7;ARIH2;YWHAH;PPP3CC;PINK1;BAP1;NMT1;MICALL2;BBC3;CASP8;UBL5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),-0.7750054787968192,-1.1778310003640953,0.36363636363636365,0.7505900151479157,1.0,1/5,6.33%,CAV3
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.42403725151194566,1.1778120186980334,0.15,0.9740916828926288,1.0,20/90,16.65%,TMX1;BET1;ABCA1;ARFIP1;EGFR;SEC22B;AP3S1;STX7;AP2B1;RAB22A;AP3B1;ERGIC3;COPB2;RPS6KA3;DOP1A;RAB9A;ARCN1;KIF1B;VAMP3;VPS4B
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.5268921469006013,-1.177792805875679,0.20512820512820512,0.7500926116801105,1.0,19/62,17.63%,GRIN2D;PLK2;GRIN2A;APP;SLC24A2;CCL2;SLC24A1;HAP1;AKAP5;SLC8A3;SYT1;RIMS2;FLOT1;GRIN2B;NLGN1;GRIK2;RELN;ADCY8;GPER1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.5044309463463733,-1.17773404250433,0.16883116883116883,0.7496560118217515,1.0,23/93,20.76%,COL4A1;COL4A2;CSPG4;LAMB1;TEAD2;SCARA3;ARHGEF17;NUAK1;DAB2IP;AMOTL2;RHBDF1;BOK;COL12A1;MCAM;SEZ6L2;PTPRF;GPC1;LARP6;PTPN21;GLIS2;NXN;ANTXR1;CD276
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.5365241261139778,-1.1773430157993952,0.21739130434782608,0.7503740613095847,1.0,14/58,17.54%,PROX1;LMOD1;SYNPO2L;BAIAP2;BAIAP2L1;VIL1;CDC42EP1;PFN2;CDC42EP3;FES;MYLK3;WDR1;TEK;CDK5
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5571807709751586,-1.1772379617096191,0.14285714285714285,0.7500490156593062,1.0,9/37,13.19%,SOCS3;IL12A;IL15;PARP14;PTK6;PARP9;IGF1;IL18;TNFRSF1A
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.6947127695874665,-1.1771876623578472,0.2786885245901639,0.7495198196305503,1.0,6/10,29.32%,DAB2IP;MMRN2;NIBAN2;EMILIN1;CADM4;CNMD
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6690363269924454,1.1771716958716092,0.3469387755102041,0.9733440128721574,1.0,1/6,5.80%,ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6690363269924454,1.1771716958716092,0.3469387755102041,0.9733440128721574,1.0,1/6,5.80%,ANAPC1
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),-0.7704784403303149,-1.1769427389373848,0.3333333333333333,0.7497587019506564,1.0,3/5,16.72%,ABCB1;GABRE;ATP8B1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.5373156906177822,-1.1767597557253044,0.2112676056338028,0.7499034738704711,1.0,3/42,5.81%,A4GALT;B4GALNT1;UGT8
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5992729200479673,-1.1766767363288908,0.26153846153846155,0.7496140865952216,1.0,4/26,6.56%,GBP1;CD160;THY1;CEACAM1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6844666725304211,1.1766467837035604,0.2558139534883721,0.9733133734969147,1.0,6/9,30.93%,SMARCAD1;HDAC2;SIRT2;HDAC9;REST;RCOR1
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.6059846682021333,1.1764560287698307,0.2571428571428571,0.9726817532950821,1.0,3/15,8.51%,POLD3;RFC3;DCLRE1B
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6701386884664191,1.1763387522655617,0.3,0.9715523262687491,1.0,2/8,15.94%,RUNX1;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7360683913112955,-1.175937026036169,0.2727272727272727,0.7521556957803345,1.0,2/7,11.74%,TOMM7;PINK1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.5662309050794233,-1.1756934168100086,0.17142857142857143,0.752255409684481,1.0,11/31,13.52%,PSCA;TJP3;POF1B;OVOL2;FUT2;CEACAM1;TMC4;CAPN8;LIPH;KPNA7;CXCL17
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4788727785275574,-1.1756615956023264,0.16666666666666666,0.7516677114409336,1.0,17/85,14.45%,FLRT3;CDH22;POU4F1;PKP2;CDH6;GJC1;FSCN1;SLITRK1;CDH7;CDH19;CDH9;PCDHB5;FN1;ACHE;CDH12;NLGN1;BDNF
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6217945938279337,-1.175336302330048,0.26785714285714285,0.7521745636788053,1.0,3/14,11.79%,C3;APP;IL18
prerank,PanglaoDB_Augmented_2021__Microglia,-0.5123302881058805,-1.1753219943249118,0.22666666666666666,0.7515117956941894,1.0,13/59,7.63%,P2RY13;P2RY6;MYO1F;GPR183;P2RY12;TAGAP;GPR34;SLA;SIGLEC1;COLEC12;HLA-DRA;IGSF6;CLEC12A
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.6996509349001809,1.1751961736026242,0.2727272727272727,0.9749990733085917,1.0,1/8,1.63%,BMP2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6399753099112511,-1.1751247323867389,0.28125,0.7516963440585261,1.0,3/16,7.96%,CEACAM1;TLR3;ZFPM1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.6388196786413138,-1.1750811996866581,0.3283582089552239,0.7511873831008973,1.0,4/13,7.93%,KCNQ1;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.6435516466968283,-1.1748924212324339,0.27941176470588236,0.7513381082662131,1.0,4/10,22.93%,CRMP1;DPYSL2;DPYSL3;DPYD
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.7043519595157917,-1.174836355114896,0.3269230769230769,0.7508388396907223,1.0,1/8,2.14%,KMO
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.6567457437505013,-1.1747806065886452,0.2459016393442623,0.7503404805297587,1.0,1/10,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.604537514197901,-1.1747229195032616,0.203125,0.7498346057480709,1.0,6/16,17.32%,THBS1;WNT5A;TNIP2;CD74;CD200;MYO18A
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.4746489959910153,-1.1746452643824365,0.125,0.7493969699059705,1.0,38/133,17.30%,DHCR24;TAGLN3;STMN2;NEFM;SH3GL2;SCN9A;CLGN;PLP1;SLITRK1;LRRTM1;SYT4;MAP1B;ELAVL4;GAP43;TCEAL6;ZNF536;NEFH;PIEZO2;CA10;TCEAL2;SCN2A;SYNM;STMN4;C11ORF87;SYNPR;CRMP1;SCN3B;RGS7BP;CNTN2;KCNC1;GDAP1L1;ADD2;RAB3C;SNCG;VWA5A;TCEAL5;ADCY8;SULT4A1
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7342954181959306,-1.1744020832209936,0.375,0.7496074875198363,1.0,4/6,22.09%,LDLR;MGAT3;LRP2;LAPTM4B
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.49412421891865616,1.17429785327366,0.19444444444444445,0.97673961090162,1.0,10/21,30.11%,ERCC6;KAT7;HMGN1;THOC1;CCNT1;CCNT2;CDK12;SCAF8;CDK13;SUPT16H
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.5002576084279243,-1.17413901210596,0.2222222222222222,0.7498260226929309,1.0,8/89,8.70%,GGT5;OGN;CSPG4;BGN;GSTM5;OMD;PAPSS2;ST3GAL6
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.6968550837433053,1.173995065022844,0.2926829268292683,0.9764446526987609,1.0,1/6,8.98%,XPO1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.49471613266212744,1.1731327950569665,0.19444444444444445,0.9778190861250734,1.0,2/24,0.60%,MEOX2;RGCC
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.6596790128706858,-1.1731248884927281,0.2727272727272727,0.7526876443224865,1.0,4/14,14.33%,TMEM204;SULF1;SFRP4;ITGA3
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.7834524506440372,-1.1725462791648111,0.2631578947368421,0.7541941923031174,1.0,1/5,5.75%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5286129569524198,-1.17250994123308,0.2222222222222222,0.7536456927335812,1.0,14/56,13.20%,EPN1;IFI6;SH3GL2;DOK1;CEACAM1;PTK6;HAP1;EGF;RHBDF2;TGFA;WDR54;DAB2IP;MVP;RHBDF1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.5014679729183977,-1.1723755896553643,0.23684210526315788,0.7534748010723111,1.0,9/72,15.76%,THBS1;EFNA1;RPS4X;PLD1;TNFRSF1A;SAMD4A;RPL5;RBM3;PRKCD
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.7429731111321203,-1.1723597124260914,0.23529411764705882,0.7528610488436847,1.0,2/8,8.19%,BLM;DONSON
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.7032548059594803,1.172186239976445,0.32653061224489793,0.9800412852127863,1.0,2/6,11.19%,SOX8;ARX
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.5700524076277421,-1.1721325766757535,0.22058823529411764,0.7531339431558789,1.0,3/32,2.85%,LEF1;TGFBR2;PDPN
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5746225618198275,1.1720049973300948,0.25,0.9790889756590032,1.0,5/18,15.62%,MCU;MFF;RALA;MUL1;MIEF2
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.7883806258576505,-1.1718062144142063,0.26666666666666666,0.7536567434881914,1.0,4/6,18.00%,HTR2B;HTR1E;HTR2C;HTR2A
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.6008014205862089,-1.1717965386813731,0.28,0.7530111297931493,1.0,7/23,14.33%,PROX1;PDPN;CCDC39;CHI3L1;FGF1;FGF7;ITGA3
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.7434045220406402,1.1716494242396749,0.2857142857142857,0.9787722290101589,1.0,3/6,20.37%,EIF2AK4;EIF2AK3;SAXO1
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6486258919658108,1.1714828017720242,0.22857142857142856,0.9777859722283458,1.0,4/6,32.86%,SENP2;SENP5;SENP6;SENP1
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.710277579782029,1.171247525818827,0.2765957446808511,0.9768228177415248,1.0,2/5,12.79%,ATP1A2;DRD2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.6247864017924346,-1.1711744214596933,0.288135593220339,0.7547828365497423,1.0,2/22,1.45%,APLNR;TGFBR2
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.779622880591837,-1.1711486711706218,0.3333333333333333,0.7541873158828616,1.0,1/7,1.83%,PLAAT4
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.6773302004622337,-1.1708294265802268,0.3333333333333333,0.7547072909015567,1.0,1/9,1.60%,GRAMD2A
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5858812607416668,-1.1704694042947044,0.2602739726027397,0.7553343512536761,1.0,8/24,23.02%,SYNPO2L;VIL1;WAS;PFN2;CX3CL1;FHOD1;RDX;SLC9A1
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.45349906721571787,-1.170344621021757,0.13793103448275862,0.7550886092757699,1.0,26/211,10.09%,ZIC4;GRIN2D;COL4A1;C3;TAGLN3;SIX3;TGFBR2;PROX1;CIC;SH3GL2;LSR;GRIN2A;NNAT;UGT8;HAP1;APOD;ZIC1;KLK6;MOG;SLC8A3;GRIK1;CA10;HAPLN2;EIF2B2;SH3GL3;B3GNT5
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.6445587018139407,-1.1701666840151412,0.24193548387096775,0.7549926042359615,1.0,3/14,6.33%,KCNQ1;PKP2;CAV3
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.775967805899876,-1.1701636969329343,0.32,0.754316693220531,1.0,3/5,12.99%,CAV3;FLOT1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6500407995057297,-1.170082469882515,0.2711864406779661,0.753940050273037,1.0,4/10,19.24%,IL18;PRKCH;MSR1;CD36
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.7141296745131588,1.1699165442654502,0.3111111111111111,0.9805017201860224,1.0,1/5,1.27%,AGMO
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6907261625804659,-1.1698212486896682,0.3076923076923077,0.7541513936135169,1.0,1/11,2.00%,STMN2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.6765484239596046,-1.1695362796546174,0.2459016393442623,0.7547012093814351,1.0,1/10,7.39%,PLK3
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5183180802998064,-1.169200560475655,0.2535211267605634,0.755439961130544,1.0,13/42,19.24%,ICAM1;GRIN2A;APP;NOD1;IGF1;CACNB1;RPL23;SNX6;CDK5;GPER1;RIPK2;ABCC1;CD36
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.7126799003957482,-1.1689188292308197,0.2727272727272727,0.7558391502157401,1.0,2/6,25.06%,GRIN2B;FYN
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.57485284969455,-1.168668539243691,0.2571428571428571,0.7560398071280788,1.0,5/23,12.35%,DUSP1;CENPE;ANAPC11;CCNB1;HECW2
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.5153267993866973,-1.1685685486085708,0.2028985507246377,0.7557624643316098,1.0,6/50,10.61%,THBS1;SNCB;TRPC3;ITPR3;PLSCR1;NDRG1
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.6674575787753549,1.1678019733890088,0.3157894736842105,0.9873662814315909,1.0,2/7,12.46%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6089112168326748,-1.1675904170748457,0.3472222222222222,0.7587767738771256,1.0,10/20,24.26%,P2RY6;HAP1;ATP1B1;RYR2;AKAP6;STAC2;CALM3;SLC9A1;GSTO1;TRDN
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6075994277627801,-1.1675686950589492,0.2982456140350877,0.7581522281747366,1.0,2/15,5.22%,NOS1AP;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5614561372411808,1.1673622738059517,0.2777777777777778,0.987371009563266,1.0,4/14,10.20%,FGL1;TNFAIP3;FOXJ1;SAMSN1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7904503774292846,-1.1672474250354195,0.24561403508771928,0.7585554529059201,1.0,1/5,0.24%,CCBE1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.7830009400454805,-1.1672257264235555,0.3090909090909091,0.7580060649002124,1.0,3/6,17.15%,NEUROD2;CPLX2;ADCY8
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5203535670671422,1.1671910010837432,0.2647058823529412,0.9864566685119048,1.0,4/24,10.29%,SOX8;SOX9;RANBP3L;ANKRD2
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6365804608572359,-1.1671390952517595,0.3125,0.7569921209091625,1.0,4/11,22.98%,IL15;CD4;IL15RA;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6365804608572359,-1.1671390952517595,0.3125,0.7569921209091625,1.0,4/11,22.98%,IL15;CD4;IL15RA;STAT3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6856529566099578,-1.167028234858799,0.3230769230769231,0.7567320211337277,1.0,2/8,7.93%,LRRC55;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.6295201355459119,-1.16682434656092,0.36231884057971014,0.756832169734138,1.0,7/16,21.16%,TLR2;IFI35;TLR3;FLOT1;SLC15A4;RTN4;RSAD2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5161630781277429,1.1664832057436103,0.21875,0.9875951457126699,1.0,2/21,5.17%,PIK3R4;TRIM24
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.5259906372214438,1.1659659900403407,0.3076923076923077,0.9878917679290207,1.0,8/31,16.46%,DNA2;ERCC6;ATR;INTS7;HUS1;RAD9B;ATRIP;HINFP
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.7460962306588507,-1.165778001901449,0.3392857142857143,0.7599304588292614,1.0,2/5,16.36%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7155722844951502,1.1657321896380881,0.38095238095238093,0.9870006796601044,1.0,1/6,1.98%,PPARGC1A
prerank,MSigDB_Hallmark_2020__DNA Repair,0.36378744183747574,1.1657077202095867,0.0,0.9854134823649656,1.0,26/134,15.53%,POLD3;ERCC8;SNAPC5;AK1;HCLS1;RFC3;SMAD5;ZNF707;NUDT21;ELOA;BRF2;ERCC2;RAD52;RALA;GTF2A2;CSTF3;RRM2B;MPC2;TAF12;DGUOK;ERCC3;GTF2H5;RAE1;VPS37B;AAAS;POLR2C
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.583503574615854,-1.165578458417722,0.2535211267605634,0.7600357729063922,1.0,3/28,6.08%,MX1;MYOF;DYSF
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.5947992733745657,-1.1655484632099455,0.3013698630136986,0.7595374013844086,1.0,6/23,18.14%,STMN2;MAP1B;STMN4;MAPRE2;STMN1;MAPT
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.7617553197670898,-1.1655419229962392,0.3333333333333333,0.7589013874236753,1.0,2/5,15.80%,VLDLR;RELN
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.6994825919335034,-1.1652504348989685,0.33962264150943394,0.7594225227757091,1.0,3/6,22.84%,AEBP1;CHADL;EMILIN1
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),-0.7228587173564437,-1.1648565918646323,0.34545454545454546,0.7601948933471888,1.0,1/5,1.92%,CIITA
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.5431584866851928,1.1647341404035,0.2631578947368421,0.9878255706926495,1.0,3/26,4.15%,WNT7A;SLITRK2;NLGN3
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.7254573083748594,-1.1646219613603441,0.32786885245901637,0.7604945553146137,1.0,3/6,22.09%,HSD17B14;CYP3A4;HSD11B1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.48393798294714696,-1.164342772789478,0.20689655172413793,0.7609560842873213,1.0,29/112,18.70%,P2RY6;KCNQ1;BLM;POU4F1;NR4A3;P2RY12;RAMP3;ATP1A1;CCL2;BRCA1;CYP1B1;GABRB2;ADCY5;IL18;IGFBP5;GNG2;DMTN;HRH1;FES;GABRG2;CIB2;ADCY3;ADCY8;SPP1;GPER1;AQP1;TGFB1;AKAP6;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5044007699782372,-1.1643337387575623,0.2073170731707317,0.7603297265688305,1.0,15/82,14.11%,CD24;RASGRP1;PSRC1;PROX1;CEMIP;HTR2B;CCND1;EGF;WNT5A;FGF1;DAB2IP;DIRAS1;NEK10;DIRAS2;MTCP1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.5246345039065803,-1.1639120355561319,0.2375,0.7611634407461801,1.0,14/63,20.29%,ANXA1;SFTPD;CHRM1;IL15;CALY;FLOT1;GPC3;SLC11A1;BOK;ANXA2;SYNGR3;IL15RA;DOC2B;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.7276249833543198,-1.1633473112131836,0.28846153846153844,0.7624977922573114,1.0,4/7,18.14%,SYK;PRKCD;TGFB1;MAPT
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.7054025871217536,-1.1632867775454594,0.3230769230769231,0.7620982843282658,1.0,3/8,20.01%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),-0.7620946301855691,-1.163254824232831,0.2857142857142857,0.7615054539222853,1.0,1/6,1.60%,GRAMD2A
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.413373355831518,1.1632019848189368,0.23529411764705882,0.991855256487092,1.0,20/104,12.99%,ETV5;PPARGC1A;PRDX6;SLC25A24;HSPA1A;SOD3;EIF2S1;KEAP1;EGFR;AKT1;BRF2;ADNP2;RAD52;ERMP1;SESN2;ANKRD2;PTPRK;MAPK8;PRDX1;AKR1C3
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.5257648657837558,-1.1629526185886176,0.23076923076923078,0.7619879157781076,1.0,11/59,15.79%,FMO6P;C1ORF87;MROH9;CYP4X1;FUT2;ATP1B1;SPAG17;DNAH3;CXCL17;AKAP14;ZBBX
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.7357084067873088,1.1628504731935625,0.3018867924528302,0.9916784017383172,1.0,4/5,26.07%,RPRD1B;CTDP1;SSU72;RPAP2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.5668589025982979,-1.162747897539204,0.2698412698412698,0.7621305928783754,1.0,2/30,6.92%,ANXA1;CYP1B1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.6565886515831459,1.1626466491904124,0.30434782608695654,0.990576266122241,1.0,3/7,27.02%,HUS1;CLSPN;TICRR
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.6039557070122749,1.1625937568502949,0.2553191489361702,0.9892275252658757,1.0,2/10,4.85%,BMP2;GREM1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.504434600299894,-1.162396442577423,0.19230769230769232,0.7626761740907438,1.0,13/60,13.03%,SCN1B;SLC6A15;KCNK1;SCN9A;SLC24A2;SLC4A11;SLC24A1;SLC5A4;ATP1B1;SLC8A3;SCN2A;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.6865234783004921,1.1622427081278714,0.3,0.9888060933671422,1.0,2/8,12.24%,IL17D;TICAM1
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.424372004553897,1.1619979946207057,0.17647058823529413,0.9883476996436428,1.0,18/82,16.24%,ETV5;PPARGC1A;PRDX6;SLC25A24;HSPA1A;SOD3;EIF2S1;KEAP1;BRF2;ADNP2;RAD52;ERMP1;SESN2;PRDX1;PIK3CA;PRKD1;CAT;PRDX3
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.4987001861218507,-1.1619669244102038,0.22077922077922077,0.7635752712295535,1.0,13/61,13.03%,SCN1B;SLC6A15;KCNK1;SCN9A;SLC24A2;ATP1A1;SLC24A1;SLC9A2;ATP1B1;SLC8A3;SCN2A;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.7003566029448476,-1.1616980185038048,0.25757575757575757,0.7637805880665433,1.0,3/12,5.98%,MSMP;GPR183;CCL2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.5820248345343065,1.1615335494043322,0.3235294117647059,0.9884464684837102,1.0,2/16,2.97%,CPA1;CYP4F3
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4103894717987476,1.1614807344008247,0.19230769230769232,0.987148628445744,1.0,26/90,21.32%,NUP42;NUP37;KAT2B;NUP54;TRIM28;VCPKMT;NDC1;NUP214;SIRT5;ZNF451;RAE1;AAAS;NUP188;KIAA1586;P3H4;EP300;NUP205;EYA1;PIAS4;HDAC10;CTH;NUP210;NUP85;NUP153;NUP50;SUMO2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5098084634120696,-1.1613662392130317,0.2777777777777778,0.7642509353881162,1.0,11/42,10.58%,P2RY13;MYO1F;TYMP;TLR2;SIGLEC1;HLA-DRA;IGSF6;CLEC12A;IRF7;CTSS;PILRA
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.6569853790424602,1.1611255497447397,0.22857142857142856,0.9870199378532886,1.0,5/10,24.86%,NT5C1A;ADSS2;AK4;AK3;NT5E
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.5208478288957569,1.1610122924859365,0.22580645161290322,0.9857478981899425,1.0,7/25,23.56%,MEN1;WDR82;KMT2A;BEND3;ASH2L;KMT2C;TET3
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4650039547803195,-1.1609936296956826,0.21428571428571427,0.7648088517598916,1.0,50/143,19.89%,CDH22;STMN2;SNCB;PLP1;ZDHHC22;SLITRK1;LRRTM1;SLC24A2;SYT4;SLC32A1;SRRM4;ELAVL4;GRIA3;GAP43;ITPR3;TCEAL6;SYP;RIT2;IGSF21;CPLX1;CPLX2;CA10;HPCA;TCEAL2;CALY;STMN4;GAD1;C11ORF87;SYNPR;GRID2;SHISA8;GAD2;GABRG2;CNTN2;KCNC1;GDAP1L1;PCP4;RAB3C;GABRA1;SYT2;TCEAL5;PDE5A;SULT4A1;CELF4;SLC1A6;ST8SIA3;HCN1;PDE1A;PTPN5;CNTNAP2
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.6558705988374358,-1.1609783699500102,0.3,0.7641936995146419,1.0,3/9,20.01%,MAPRE2;FGF7;EPB41L4B
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.7774733587648966,1.1607791837128367,0.22448979591836735,0.9851652333513966,1.0,3/7,14.52%,LIG4;MSH2;MSH3
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6585775898814644,1.1605761013176936,0.39473684210526316,0.9845085165561064,1.0,2/8,19.75%,GINS3;MCM6
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.45090179126650554,-1.1603394443726687,0.2073170731707317,0.7659618893814826,1.0,24/106,18.86%,FLRT3;APLNR;POU4F1;PKP2;TGFBR2;MMP21;HTR2B;SYNPO2L;ZFPM1;SRF;SMYD4;CACNA1C;IFT122;FN1;GPC3;PDLIM4;DLC1;APLN;TSC2;TEK;FGF12;TGFB1;CDKN1A;PLCE1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.7247333709972302,-1.1603036403320999,0.26785714285714285,0.7647247755940373,1.0,2/6,22.98%,STAT1;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.7247333709972302,-1.1603036403320999,0.26785714285714285,0.7647247755940373,1.0,2/6,22.98%,STAT1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.5752276451747349,1.16013210570925,0.3170731707317073,0.9843661163991805,1.0,5/18,15.92%,TEX15;APOBEC3F;SMYD5;PIWIL4;ZNF91
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.5797216979114781,-1.1601146093713532,0.2571428571428571,0.7647838507186807,1.0,9/29,20.30%,SEPTIN5;CPLX1;CPLX2;RIMS2;PNKD;KCNMB4;GPER1;MCTP1;STX1B
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.6618313161015834,1.1599867201545355,0.34146341463414637,0.98339100048664,1.0,2/8,5.50%,MITF;USP13
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),0.5205196302150716,1.1596532366156915,0.3783783783783784,0.9829673596690105,1.0,10/31,20.44%,LCMT2;TYW3;FTSJ1;NSUN6;TRMT1L;TRMT61A;TRMT1;MTO1;TRMT5;NSUN2
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.6295418189044244,1.1596378140351054,0.3076923076923077,0.9814127246641983,1.0,2/9,1.24%,CD200R1;NR1D1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.6500353277282899,-1.1594320561685594,0.38235294117647056,0.7665773969165404,1.0,2/12,2.77%,PKP2;PROX1
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.685880138187239,-1.1593925176580928,0.3333333333333333,0.7660517551189105,1.0,1/7,2.72%,ALOX12
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6664152791492602,-1.1592065465290968,0.26229508196721313,0.7658861035204171,1.0,4/12,12.99%,TIMP1;DMTN;CD63;EMP2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7156969436391114,-1.1589359902566565,0.3220338983050847,0.766159239609761,1.0,2/7,4.35%,SKAP1;PODXL
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.7370776916334358,-1.1585296986226894,0.25862068965517243,0.7668381669109907,1.0,1/6,5.29%,SCX
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.7626392990547609,-1.1582391715628024,0.2982456140350877,0.7672294005471089,1.0,1/5,1.91%,B2M
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.7134926638115907,1.1581372789307938,0.29545454545454547,0.9854781756306767,1.0,1/5,6.56%,SEC22B
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.5904238030544159,-1.157991323762942,0.2727272727272727,0.7675802008543939,1.0,1/26,0.17%,ST6GAL1
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",-0.7710175161778259,-1.1578762514879224,0.32075471698113206,0.7673980574458246,1.0,2/5,9.37%,RSPO3;PLEKHA4
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.557950964250134,-1.1577814545251295,0.24324324324324326,0.7670098233544704,1.0,10/36,18.48%,ALDOB;SLC39A14;FBP1;GAPDHS;PGK1;CHST15;GPI;PGAM1;ENO2;PCK2
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.7665826506628357,-1.1577731965671012,0.2807017543859649,0.7664001648194513,1.0,1/7,2.77%,PROX1
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6687501698237391,1.157357445598449,0.358974358974359,0.9864640054212165,1.0,2/8,11.79%,NT5C1A;ADSS2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.6116825540052513,1.1573388074889408,0.3,0.9848737368081183,1.0,6/11,20.12%,SMYD2;KMT5A;METTL18;SETD3;EHMT1;CSKMT
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.5650449917171928,1.1573325471378448,0.23684210526315788,0.9832699590093268,1.0,3/15,11.32%,KLRG1;RAB23;VEZF1
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6386312518469699,1.1572745692480522,0.37777777777777777,0.9818024835891378,1.0,3/9,19.77%,MFF;ERBB4;CCAR2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.5887432125713922,-1.1572513285890724,0.2727272727272727,0.7676063723769645,1.0,1/27,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5106130419122967,-1.1569681516089323,0.18181818181818182,0.7680107772395265,1.0,14/53,17.28%,CDH22;PKP2;CDH6;CNTNAP1;GJC1;FSCN1;CD9;CDH7;CDH19;CDH9;CDH12;WDR1;TLN1;VCL
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.6393396505496292,-1.1569293197394868,0.28125,0.7674572064995543,1.0,3/12,12.99%,HLA-A;CD55;EMP2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.4863329433780803,-1.1568563035513295,0.24358974358974358,0.7669836280708189,1.0,18/72,17.72%,THBS1;APLNR;HK2;BRCA1;CYP1B1;CHI3L1;ANGPTL3;BTG1;WNT5A;FGF1;HYAL1;SFRP2;PIK3CD;F3;PRKCB;TEK;ETS1;AQP1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.5971173468406709,1.1567748244403309,0.3684210526315789,0.9823954389972507,1.0,2/17,4.24%,PRNT;GCNA
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7760133513021372,1.1567581385894279,0.28888888888888886,0.9808595816411356,1.0,2/5,15.67%,NCK1;NCK2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6124124881492276,-1.1566978761371647,0.22580645161290322,0.7668741630292497,1.0,3/25,5.22%,P2RY6;P2RY12;HTR2B
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5449872350741378,1.156544826155153,0.2972972972972973,0.9798316592508803,1.0,9/19,25.53%,HSPA1A;DCUN1D2;DCUN1D1;DCUN1D5;DAXX;ITCH;UBQLN1;TGFBR1;DNAJB2
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),0.7026308573207435,1.156488589824802,0.32,0.9785281594924123,1.0,1/6,2.36%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.48538089668057377,-1.1562078900347315,0.1891891891891892,0.768193193047522,1.0,20/84,17.72%,THBS1;APLNR;HK2;ITGA5;KLF4;BRCA1;CYP1B1;CHI3L1;ANGPTL3;BTG1;WNT5A;FGF1;HYAL1;SFRP2;PIK3CD;F3;PRKCB;TEK;ETS1;AQP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7174510717170259,-1.1561156063502944,0.25806451612903225,0.7678621186117164,1.0,2/10,12.29%,NR4A3;IGFBP5
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.7086207048248757,-1.1559456416545182,0.25396825396825395,0.7672488853520119,1.0,3/10,8.45%,SLC24A2;SLC24A1;SLC8A3
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.7086207048248757,-1.1559456416545182,0.25396825396825395,0.7672488853520119,1.0,3/10,8.45%,SLC24A2;SLC24A1;SLC8A3
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),0.568570786016989,1.1557247217937978,0.3076923076923077,0.9798837700931471,1.0,4/16,5.66%,RIOK2;KAT2B;RIOK1;METTL18
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.6575697162893319,-1.155630388774798,0.37735849056603776,0.7676744383918195,1.0,3/8,12.06%,THBS1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.7087537443780629,-1.155526313005417,0.3333333333333333,0.7673292130913308,1.0,3/7,21.76%,MAPT;HEBP2;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.7011403258196718,-1.1553783641375148,0.3333333333333333,0.7672122538044457,1.0,2/7,5.68%,ICAM1;THY1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.7003411107344503,-1.1553304323228077,0.30303030303030304,0.7666797398456857,1.0,3/9,16.32%,LDLR;PFDN6;PFDN1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.5843253152252524,-1.1548089032692574,0.2153846153846154,0.7679272974668832,1.0,5/24,11.93%,SOCS3;ST18;ST3GAL6;STAT1;SBNO2
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4925128453659538,-1.1546415162844383,0.1917808219178082,0.7677866356732228,1.0,9/69,6.17%,ENPP2;ANGPTL2;ALDOB;PROX1;ABCA8;GRIN2A;THY1;BGN;GRIA3
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6501890549739577,-1.1546071503240576,0.288135593220339,0.7672080395902199,1.0,1/10,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.6529187010037301,-1.1544842498090673,0.3230769230769231,0.7670369513096276,1.0,3/10,12.60%,PLN;CAV3;NOS1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),0.64742915188941,1.1540028813261298,0.29545454545454547,0.9844044842636586,1.0,4/9,22.42%,ACSS1;PDHA1;MLYCD;DLAT
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.5502435311347872,1.1539390953980795,0.3103448275862069,0.9830258873059962,1.0,5/13,20.70%,NUDT21;CPSF6;CPSF7;ERN1;CPSF2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5402221946500851,-1.1537539734759201,0.16,0.7689986355332329,1.0,15/61,16.45%,COL4A1;COL4A2;MYOF;MMP14;MYH11;SRPX2;OSMR;EMP1;AMOTL2;RHBDF1;ITGA3;LAMA3;COL12A1;RHOD;F3
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.69728808389639,1.1537263488642122,0.3125,0.9822983920478104,1.0,1/5,2.79%,LIG4
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.7269989068649771,-1.153512482492709,0.2807017543859649,0.769294608559967,1.0,4/7,19.11%,ATP5IF1;PINK1;MAPT;SREBF1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5009283407466283,1.1533092199430195,0.3076923076923077,0.9822372777562707,1.0,5/19,17.36%,HSPA1A;BBS10;TMEM35A;PSMG2;MKKS
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.622820261256097,-1.1530638994681361,0.328125,0.770221731779854,1.0,4/18,13.92%,PLN;CAV3;NOS1;VIP
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.6415245394240565,-1.152813792283743,0.3225806451612903,0.7703993034389383,1.0,3/12,9.00%,SCX;TENM4;NLRP5
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6564636232898234,-1.1528117147505796,0.375,0.7697591495971039,1.0,4/11,19.10%,WNT5A;CD74;TGFB1;CUEDC2
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.5683514437984288,-1.152488384003808,0.2608695652173913,0.7701857227476133,1.0,6/26,11.20%,THBS1;TLR2;TLR3;SCIMP;HLA-B;SYK
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.5961472528133152,1.1524312985617284,0.39473684210526316,0.9842941128448076,1.0,3/13,11.91%,FHDC1;TMED5;VTI1A
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.48476544170479974,-1.1523306130015973,0.18840579710144928,0.7699898240373932,1.0,26/100,14.15%,KCNT2;RIMBP2;CDH22;PCSK2;CHGB;STMN2;RCAN2;PROX1;MAOB;LRRTM1;SYT4;ELAVL4;GRIA3;ATP1B1;PLPPR1;IGSF21;CPLX2;SST;SHC2;UNC5B;KCNB2;GPC5-AS1;NPTX2;GAD2;RGS7BP;GABRG2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.5370573073839261,-1.1519578448606564,0.18181818181818182,0.7707649320257063,1.0,4/36,9.24%,LEF1;SP100;EGF;IGF1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.6717027949511584,-1.1516703964731365,0.3333333333333333,0.7711507948414552,1.0,3/8,12.07%,KLF4;APOD;SIGIRR
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.5656352201130922,-1.151565792895362,0.27631578947368424,0.7709235704043048,1.0,5/27,9.24%,MYOF;DYSF;CAV3;MYH11;IGF1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.48963481374813494,1.1514412922735842,0.23333333333333334,0.9864546151505882,1.0,6/36,12.04%,SMYD2;RFWD3;KMT5A;UBE2N;FBXO5;FEM1B
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6943631283174682,-1.1514032258389104,0.38333333333333336,0.7708748826326982,1.0,2/8,12.36%,IRF7;IFIH1
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.45205218978844597,-1.1513972062102447,0.16304347826086957,0.7702767751329945,1.0,42/163,22.28%,COL4A1;ANGPTL2;MET;CALD1;COL4A2;LAMB1;THSD4;COL4A4;PODXL;SULF1;SCARA3;ARHGEF17;NUAK1;DAB2IP;TDRD5;RHPN1;MYO1E;AMOTL2;RHBDF1;PTH1R;ITGA3;SEMA3E;TNS2;LAMA3;COL12A1;CRB2;PTPRF;PTPRO;MAPT;PTPN21;PLCE1;ADM;COL4A3;ANTXR1;KIAA1217;CDKN1C;WWTR1;OPTN;SH3D19;MYO1B;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6164354645055137,-1.151371847422936,0.296875,0.7697105989256809,1.0,4/15,11.60%,KCNJ2;ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),0.78348644134368,1.1512578436046061,0.35,0.9856161482400437,1.0,2/5,4.92%,COX18;COX10
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.5434452071963752,-1.1507487719332306,0.22857142857142856,0.7711388132115726,1.0,8/29,19.25%,KCNQ1;DUOX1;STAT1;IGFBP5;DMTN;AQP1;AKAP6;HCN1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.6477323882091391,-1.1505834557365815,0.2807017543859649,0.771097828437278,1.0,2/9,7.96%,EFNA1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5462914389682285,-1.1504690590229487,0.29850746268656714,0.7709720617705436,1.0,6/24,17.37%,NLRC5;WNT5A;ISG15;FADD;USP18;CDC37
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.4359488469462466,1.1503792362643435,0.18181818181818182,0.9872177754600591,1.0,16/59,21.70%,PRDX6;GDE1;CPNE3;PIGP;PLA2G4C;CSF1R;PLA2G15;GPLD1;DGKH;CPNE1;GPCPD1;ABHD6;PON1;SERINC5;PLCB1;PIGF
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.581332140114323,1.1498490964450048,0.2894736842105263,0.9876615540148458,1.0,5/15,12.84%,DUSP19;MAP3K4;DVL2;SASH1;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.45330218891039337,-1.1497823866966148,0.11764705882352941,0.7727964342081303,1.0,32/195,17.63%,KLF2;CCBE1;P2RY6;C3;TLR2;SLC39A14;DEPDC1B;SULF1;ITGA5;RSPO3;HAP1;KLK6;IGF1;SCIMP;RIMS2;FGF1;DAB2IP;GLI1;DMTN;RSPO4;CD63;EMP2;NLGN1;IL7;BDNF;CD74;RELN;MGAT5;F3;PRKCB;TEK;GPER1
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.7335666538016566,-1.1488348759539742,0.3333333333333333,0.7756727834080549,1.0,1/6,2.85%,PDPN
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),-0.7374349281136824,-1.1487752987315856,0.31666666666666665,0.7752126674218043,1.0,2/5,17.76%,LDLR;LRP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.6494844353605127,1.1487102257394732,0.3111111111111111,0.9906796164663924,1.0,3/11,5.26%,CARD18;TNFAIP3;GIT1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),0.5605134202735029,1.148629466756273,0.2962962962962963,0.9895297047582774,1.0,1/10,6.78%,NOL11
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.646683078646887,1.148491269792847,0.3023255813953488,0.9884745176711627,1.0,3/10,16.33%,METAP1D;NAA11;METAP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6218300336260669,-1.148431037166312,0.2711864406779661,0.7758603917542104,1.0,5/17,12.06%,IL12A;THY1;CCL2;PRKCQ;TNIP2
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.7412160382022646,-1.1481937453509168,0.29411764705882354,0.7754180050388332,1.0,3/6,17.69%,CD55;SUSD4;CR1L
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",-0.7412160382022646,-1.1481937453509168,0.29411764705882354,0.7754180050388332,1.0,3/6,17.69%,CD55;SUSD4;CR1L
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.7047637220286123,-1.1481267386427583,0.3230769230769231,0.7750516519923409,1.0,1/7,0.33%,THBS1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.6810339945703681,-1.1481164508211092,0.3333333333333333,0.7744483657965603,1.0,3/10,22.98%,STAT6;GHR;STAT3
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.6536346429749963,-1.1479062421553232,0.3384615384615385,0.7744585762196543,1.0,2/14,7.29%,RAMP3;AKAP5
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.5810355215504627,-1.1478173094746822,0.23943661971830985,0.7740939244028798,1.0,2/23,2.23%,TLR2;RPS27A
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),-0.7140196622825539,-1.1477386180326434,0.38181818181818183,0.7738674594090573,1.0,2/7,4.06%,TJP3;SH3GL2
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.6893518258155101,1.147730334747183,0.35714285714285715,0.9904042042208308,1.0,3/6,23.83%,OARD1;FHIT;MACROD2
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.6647229086643265,1.147600929915612,0.2702702702702703,0.9895143463062641,1.0,2/8,2.59%,RNF6;UBE2T
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.6324456331207011,1.1472324215346317,0.30303030303030304,0.987743118787922,1.0,9/10,36.77%,SESN2;SESN3;RPTOR;SESN1;MTOR;LARS1;KLHL22;UBR2;UBR1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.6324456331207011,1.1472324215346317,0.30303030303030304,0.987743118787922,1.0,9/10,36.77%,SESN2;SESN3;RPTOR;SESN1;MTOR;LARS1;KLHL22;UBR2;UBR1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.6400416316075273,-1.147221370597681,0.24193548387096775,0.7751917363179176,1.0,3/15,9.59%,SYNGR2;SYP;STX19
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.578353423193469,-1.1466315054342426,0.27941176470588236,0.7764985677817543,1.0,3/21,5.61%,PLAAT4;ZFP36;ABCA12
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.7145412072681399,1.1465983363868026,0.35135135135135137,0.9885417174809142,1.0,1/5,3.84%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6079940654047007,-1.1465621230688234,0.2602739726027397,0.7761105629659778,1.0,5/19,20.67%,HAP1;IGF1;RTN1;RTN2;RTN4
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.7372045520863728,1.146289654131053,0.425531914893617,0.9880572405538552,1.0,5/5,26.30%,C17ORF75;TBC1D23;WDR11;TRIP11;FAM91A1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.5508556008816994,-1.1462636760394382,0.28169014084507044,0.7763859997534479,1.0,8/33,19.17%,MYO1F;MYO15A;SYT4;HAP1;MYO1E;CLN3;MYO1H;MYO1C
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.5858241666572032,1.1459693512865308,0.21951219512195122,0.9875923040805874,1.0,5/16,16.85%,THEM4;NAIF1;SLC25A5;MUL1;BAD
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5446596371544545,-1.1456694170254087,0.25333333333333335,0.7778028073888641,1.0,7/37,12.58%,TLR2;IRF1;TLR3;IRF7;ISG15;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.7085141316747757,1.1456561467322697,0.3333333333333333,0.9853923461182365,1.0,4/6,28.73%,PTGIS;SIRPA;ROCK2;KHSRP
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.7085141316747757,1.1456561467322697,0.3333333333333333,0.9853923461182365,1.0,4/6,28.73%,PTGIS;SIRPA;ROCK2;KHSRP
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5764841024406553,-1.1455252269290193,0.21739130434782608,0.7776276526706881,1.0,5/20,15.27%,FABP3;LIPI;LIPE;LIPH;PNPLA3
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.5869990890582598,-1.1453179793874058,0.2542372881355932,0.777726373311592,1.0,1/20,0.33%,THBS1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),-0.6560987691214519,-1.1452503579800006,0.3220338983050847,0.7772706119322949,1.0,1/11,2.91%,KCNB1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.4742131701514289,-1.1451428276442046,0.20987654320987653,0.7770128649347212,1.0,19/98,13.93%,COL4A1;ANGPTL2;CALD1;COL4A2;LAMB1;SULF1;NNAT;THY1;LMOD1;BGN;MAP1B;SCARA3;ZIC1;SLIT3;IGFBP5;PRRX1;AMOTL2;RASL12;PTH1R
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.6592502667983005,1.145111178691532,0.28205128205128205,0.9859016030350655,1.0,4/9,18.06%,GALNT3;MGAT5B;POGLUT1;GALNT1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.578350837427851,-1.1448910479116445,0.296875,0.7772255613399831,1.0,4/21,7.87%,TYMP;KIF14;NKX6-2;TENM4
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.6260650889920262,-1.1446858187292548,0.32142857142857145,0.7774000357155395,1.0,2/12,5.22%,NOS1AP;HTR2B
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.37780800737909054,1.144571007712862,0.125,0.9865345168335905,1.0,53/258,16.55%,CHRNA4;POLD3;APEX2;FANCF;ERCC8;DNA2;UBE2T;LIG4;KPNA2;PRIMPOL;MEN1;RFWD3;PMS1;RFC3;SMARCAL1;BRCC3;UBE2N;TRIM28;ERCC6;COMMD1;VCP;ERCC2;WDR33;CSNK1E;PRMT6;DCLRE1B;RAD52;MSH2;ATR;SLC30A9;XRCC2;MGME1;HUS1;TDP2;MAPK8;ERCC3;EXD2;GTF2H5;GTF2H2;GTF2H2C;TENT4A;RAD9B;POLK;ATRIP;MSH3;APTX;ALKBH3;RAD51B;ASF1A;BACH1;EYA1;HINFP;HERC2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5295843759267639,-1.1441838657749466,0.2361111111111111,0.7784219068425337,1.0,4/39,9.85%,ZFP36;IFITM3;HEXIM1;POLR2I
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.6191542353157569,1.1441607396985218,0.2727272727272727,0.986307877651264,1.0,3/10,16.16%,NUDT21;HSF1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),0.7577370898197178,1.1441225562732287,0.3023255813953488,0.9848868061981939,1.0,1/5,0.64%,CD200R1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),-0.7320799019133319,-1.1437947069261618,0.3333333333333333,0.779124487174459,1.0,1/5,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.7747254441521583,-1.1437598810645646,0.34375,0.7785791419816426,1.0,2/6,8.06%,ANXA1;ANGPTL3
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6014238544800494,-1.143730617599687,0.28125,0.7780648867010422,1.0,4/22,5.35%,HPN;EFNA1;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.5296467207112106,-1.143521658027938,0.2857142857142857,0.7781851586350962,1.0,2/40,6.92%,ANXA1;CYP1B1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5120806337194743,1.1431463472705903,0.22727272727272727,0.9863554083593244,1.0,5/19,17.98%,MSL2;KMT2A;KANSL2;KAT7;MCRS1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.7241255560689535,-1.1428992204615849,0.3225806451612903,0.779729873822591,1.0,3/8,15.93%,NOS1AP;NOS1;CACNB1
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.692982384440449,-1.1426779421817714,0.3728813559322034,0.7798184687241134,1.0,3/8,17.53%,ABCA12;DBI;SPP1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.7623695954427281,-1.142571562893293,0.3,0.7794930161523148,1.0,3/6,19.16%,HAP1;SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.6158272213043711,-1.1422736426964397,0.29411764705882354,0.7797922028180997,1.0,4/14,23.56%,RAMP3;ANXA2;OPTN;ECE1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.560347021185057,-1.1422438720380999,0.2876712328767123,0.7792719541002827,1.0,9/33,18.48%,ALDOB;SLC39A14;FBP1;GAPDHS;PGK1;GPI;PGAM1;ENO2;PCK2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.6036316077276614,1.1420411143258087,0.2727272727272727,0.9890997400946517,1.0,3/12,7.96%,LIG4;PPP1R10;SIRT6
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.6168374262792016,1.1420377597953306,0.35,0.9875566827778115,1.0,2/11,4.99%,CHAMP1;RCC2
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.7452087493023514,1.1419788144642542,0.2558139534883721,0.986248881041776,1.0,1/5,5.23%,CA2
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),0.711440468988032,1.1417900092355946,0.3111111111111111,0.9857239137892715,1.0,2/6,17.84%,PON2;PON1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),0.6931081755629368,1.1417546873376636,0.3333333333333333,0.9843346606677577,1.0,2/6,3.84%,NR1D1;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6854327855860987,-1.141692408806598,0.2777777777777778,0.7806068292392419,1.0,1/12,1.11%,APLNR
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.47988865751442045,-1.1416000762565992,0.3076923076923077,0.7804093118402435,1.0,13/78,16.36%,HLA-A;SH3GL2;MFSD6;HLA-DRA;CENPE;AP1S1;CTSS;HLA-E;DCTN1;KIF2C;HLA-F;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5637859785368544,1.1414183632001627,0.375,0.9842906867552641,1.0,7/14,14.25%,BMP2;SOX9;TRPS1;SOX5;KAT2A;MDK;TAPT1
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.4264082049059594,-1.1413820704029698,0.12371134020618557,0.7805643816098258,1.0,80/413,19.24%,PRAME;LEF1;THBS1;HPN;IL13RA1;TGFBR2;TLR2;ZFP36;PROX1;PDPN;SFTPD;IL12A;RPS4X;KIF14;RAMP3;COPS9;IL15;COLEC12;HTR2B;SCX;TRPC3;MMP14;PTK6;TIMP1;CCND1;EGF;TENM4;SRF;RPS6KA1;OSMR;IGF1;S1PR3;THPO;WNT5A;TGFA;FGF1;ROMO1;FN1;NAMPT;FOXM1;GLI1;FLOT1;EMP2;FGF7;SLC11A1;IL7;NOXA1;VIP;HYAL1;RPS6;MFSD2A;MYRF;RPS9;SFRP2;DDRGK1;PRKCD;ECHDC3;CDK2;CCND2;RHOD;CAPN1;CDC7;FGF22;RPL23;FASN;IRS2;RYR2;ETS1;GPER1;RIPK2;TGFB1;MAPT;NUPR1;SPDYA;AKAP6;IER5;IL15RA;PDGFRA;CAPNS1;CD36
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.5891333748795402,-1.141171298087328,0.2835820895522388,0.7807416674125426,1.0,11/20,25.61%,SYT4;SYT1;RIMS2;SYT5;SYT2;SYT13;DOC2B;SYT12;RIMS1;SYT17;RIMS3
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6848660079918479,-1.1410392330875907,0.28846153846153844,0.7806717298579156,1.0,2/8,9.68%,TESC;THPO
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.64950968130375,-1.1409359199930464,0.36764705882352944,0.7803775986927665,1.0,1/16,0.81%,BLM
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5097839294293712,-1.140811102443205,0.30864197530864196,0.7802557719091999,1.0,11/64,12.15%,ANXA1;SIX3;OVOL3;PROX1;OVOL2;AKR1C1;BASP1;VIL1;TAGLN2;PGK1;GLI1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.5192058580504074,-1.1407946314212913,0.27631578947368424,0.7796937168265962,1.0,9/58,12.06%,CXCL2;TLR2;ZFP36;PDCD1LG2;CCL2;WNT5A;DAB2IP;SBNO2;TNIP2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),-0.8330901663262328,-1.1407055853073458,0.2653061224489796,0.7795129669579777,1.0,5/5,16.72%,PODXL;FSCN1;PLD1;RAP1GAP;ATP8B1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5087192017380735,1.1404961857840843,0.2619047619047619,0.9860085537746635,1.0,8/23,19.10%,ABHD17A;LYPLA2;ABHD17B;SIRT6;SIRT5;ABHD17C;LYPLAL1;HDAC10
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.5773663784616383,-1.1403283263627282,0.3939393939393939,0.7803386370104114,1.0,1/21,2.00%,STMN2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.614498317758045,-1.1401237534974054,0.2542372881355932,0.7804182974973667,1.0,5/14,12.58%,SKAP1;KLF4;THY1;CD44;FLOT1
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.6660906686824991,-1.1396885408414823,0.288135593220339,0.7814130513084874,1.0,3/15,5.22%,P2RY6;P2RY12;HTR2B
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6938486839521378,1.1396723451553172,0.3541666666666667,0.9871582363301129,1.0,5/7,27.47%,AKT1;BAD;CLOCK;RFX3;RHEB
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6181927532608482,1.1394376420004875,0.32558139534883723,0.9865656657276194,1.0,3/9,15.48%,ACADM;ETFDH;ACADS
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.6182962575844269,1.1392981531019792,0.35714285714285715,0.9855891377391257,1.0,3/10,10.29%,SOX8;SOX9;ANKRD2
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),0.6996427144846111,1.1392368521275784,0.358974358974359,0.9841954072050538,1.0,2/5,19.39%,ENPP3;DCK
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.49926319988900103,-1.139046861107982,0.2564102564102564,0.7830902131181461,1.0,9/60,12.06%,CXCL2;ZFP36;PDCD1LG2;CCL2;WNT5A;DAB2IP;IL18;SBNO2;TNIP2
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.7292536137447037,1.139005829245456,0.3448275862068966,0.9835576733185467,1.0,1/5,3.84%,TNFAIP3
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.5273152961668253,1.1387867756030714,0.3103448275862069,0.9830440801657291,1.0,9/17,29.88%,PTPN23;RAB21;VPS11;DNAJC13;MAP2K2;EZR;SNX3;SNX12;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.5685092213710798,-1.1386761878465987,0.3472222222222222,0.7837692128248103,1.0,3/30,3.82%,KCNQ1;NOS1AP;KCNJ2
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.47055846919385985,-1.1383438206036833,0.2625,0.7844100089012397,1.0,6/100,5.98%,RASGRP1;S100A10;DOCK8;RASGRP2;THY1;CCL2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.613404708634931,1.1380017280269374,0.34146341463414637,0.9846931565245288,1.0,3/8,20.59%,COMMD1;WNK3;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.7708790518698125,-1.1375948693158788,0.3492063492063492,0.7861549074191971,1.0,3/5,19.16%,HAP1;SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.4470138027560892,-1.1374344622523598,0.18292682926829268,0.7861257739667606,1.0,26/127,18.84%,GBP2;GBP1;ZFP36;ST18;YBX3;CCL2;BRCA1;TNFRSF14;PSMB9;CHI3L1;STAT1;PSMB6;BIRC3;DAB2IP;PSMC3;MAP3K14;TNFRSF1A;HYAL1;PSMA8;LTBR;PSMA7;ERBIN;PSME1;GPER1;GSDME;GBP3
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.47386949804410294,-1.1374310379759045,0.2727272727272727,0.7855042784559854,1.0,27/91,19.56%,THBS1;SPARC;F8;APP;TIMP1;EGF;F13A1;GTPBP2;IGF1;TAGLN2;CD9;FN1;SELP;CD63;F5;SRGN;WDR1;SERPING1;TLN1;VCL;TGFB1;FERMT3;A2M;TF;SELENOP;CD36;RAB27B
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.7185219082845398,-1.1374284133372605,0.3709677419354839,0.7848837765431492,1.0,1/6,6.33%,CAV3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4347539223929679,1.1374219444325027,0.21739130434782608,0.9853279000036027,1.0,5/38,5.49%,DNA2;RIDA;HSPA1A;ZPR1;NUDT16L1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),0.5265955650672665,1.1372012034782368,0.36666666666666664,0.9847444566233138,1.0,4/20,10.43%,SAMM50;COX18;MAIP1;TOMM22
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6330361526088426,-1.1371296022061481,0.2857142857142857,0.785432403953385,1.0,5/15,14.80%,CCBE1;IL12A;DAB2IP;CD63;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.6962127321949699,-1.1370472374670144,0.32142857142857145,0.7851675440056126,1.0,4/7,18.75%,PIK3IP1;DAB2IP;TSC2;NLRC3
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.51775557747255,-1.1369204227472764,0.3235294117647059,0.7849252509449129,1.0,1/46,0.11%,LEF1
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.6707729013888992,1.136769609279289,0.2765957446808511,0.9834616434847893,1.0,6/7,32.10%,EEFSEC;SEPSECS;SECISBP2;SELENOT;SECISBP2L;DIO2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.6707729013888992,1.136769609279289,0.2765957446808511,0.9834616434847893,1.0,6/7,32.10%,EEFSEC;SEPSECS;SECISBP2;SELENOT;SECISBP2L;DIO2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.49969586914541947,-1.1367687422374428,0.28169014084507044,0.7848456073400492,1.0,18/60,18.86%,P2RY12;RCAN2;ACKR4;HTR2B;ATP1B1;LAT2;CHRM3;PPP3CC;CACNA1C;SELP;NUDT4;DMTN;CCR10;RCAN3;RYR2;MCTP1;PPP1R9A;PLCE1
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6360384457091726,-1.1366597913210195,0.2833333333333333,0.7846260656163562,1.0,3/13,4.61%,IHO1;MEIOB;RNF212B
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.6345364696869477,1.1365416168281937,0.35135135135135137,0.9829182879655083,1.0,3/8,16.49%,GLUD1;GLS;GLUL
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.7610784294125578,-1.1364971394114334,0.42105263157894735,0.7845909699713377,1.0,2/5,12.36%,TLR3;IFIH1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4049051201852902,1.1363863536656156,0.23529411764705882,0.9821693472500773,1.0,18/96,16.89%,CD247;PPARGC1A;MITF;OCLN;SOX9;LPXN;NUP54;TCAP;LLGL1;MDN1;NDC1;KMT2A;CAPZA1;WASL;NUP205;VAMP3;PICALM;PARD6B
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5156490632368405,1.1359911257293955,0.2631578947368421,0.9821986269343598,1.0,3/18,6.91%,ABCD2;ABCD1;RAB27A
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),-0.740863076622948,-1.135883800881783,0.4032258064516129,0.7863512862919516,1.0,3/5,18.05%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5809672861432581,-1.1358780479309496,0.3225806451612903,0.7857561109589091,1.0,2/20,6.03%,IHO1;HROB
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.5262262357724278,-1.135860833853699,0.3116883116883117,0.785198612037101,1.0,9/55,8.45%,SLC39A14;KCNJ13;KCNJ2;SLC24A2;ATP1A1;SLC24A1;SLC9A2;ATP1B1;SLC8A3
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.6240787958807235,-1.1352860041148525,0.30434782608695654,0.78645510377018,1.0,1/13,0.94%,DUSP1
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5017667188234904,-1.1349973003216867,0.21621621621621623,0.7866827468874386,1.0,22/73,18.41%,ANK3;NEFL;GRIN2A;APP;GRIA3;JPH3;GRIA1;MINK1;CTSS;HPCA;SHISA9;KCNG1;NOS1;GRIN2B;SHISA8;NLGN1;RELN;JPH4;CACNB1;CAPN1;FGF12;LRRC7
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),-0.7452743851859711,-1.134977428107883,0.37037037037037035,0.7861111807366844,1.0,3/5,17.72%,YBX3;RCSD1;AQP1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7078054472692448,1.1349616091287857,0.35555555555555557,0.9846210180249036,1.0,2/6,19.45%,RORB;RP1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.7177771431746678,1.134772031969919,0.3541666666666667,0.9838385166844024,1.0,2/7,14.42%,PSMD10;NFKBIB
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5602719835029908,-1.1345118332126487,0.2463768115942029,0.78705639854982,1.0,3/27,8.19%,BLM;BRCA1;DONSON
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5776015095813675,1.1344540677953088,0.2682926829268293,0.983384517076291,1.0,3/14,18.04%,GNL3L;MUL1;PIAS4
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.5421530546367366,-1.134310530484778,0.35526315789473684,0.7870488728448948,1.0,8/33,18.62%,C3;B2M;EGF;SFRP4;CD63;ANXA2;AHI1;TF
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.684515970361163,-1.1341765337536949,0.3157894736842105,0.7869536207777543,1.0,4/7,22.84%,TNFRSF1A;TGFB1;CHADL;EMILIN1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.7299676227561268,-1.1333527855825445,0.40350877192982454,0.7892694166336014,1.0,1/7,3.97%,RAB11A
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.45886641666617306,1.132738899879753,0.17142857142857143,0.9879708912695344,1.0,3/23,7.46%,SLIT1;NLGN3;ALCAM
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5208946270049765,-1.1326817996804186,0.2465753424657534,0.7911946604207594,1.0,5/45,2.16%,CXCL2;S100A10;EFNA1;C3;EPS8L2
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.5650990148094192,1.1325796053525776,0.2564102564102564,0.9870328592738463,1.0,4/9,19.38%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.6285665669077611,-1.132525141071819,0.32786885245901637,0.7911109550357477,1.0,2/11,10.67%,WDR54;LRPAP1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.4588041404665301,-1.1323697124165493,0.2804878048780488,0.7912095937831897,1.0,29/145,18.27%,NPY;FLRT3;POU4F1;STMN2;L1CAM;LAMB1;SHTN1;CNTNAP1;RAB11A;SH3GL2;PLP1;APP;SVBP;NEFH;NYAP1;MINK1;DAB2IP;STMN4;NLGN1;BDNF;GRM7;MICALL1;STMN1;MICALL2;DOCK10;CDK5;TBC1D24;MAPT;PPP1R9A
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.5455894446089052,-1.1322850447902255,0.3076923076923077,0.7909075256227822,1.0,10/27,19.24%,ICAM1;RAMP3;GRIN2A;APP;IGF1;CACNB1;SNX6;CDK5;ABCC1;CD36
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.4913414965504645,1.1313702625609843,0.2894736842105263,0.9902329419867195,1.0,7/27,14.77%,PSMD10;HSPA1A;AKT1;VAT1;OPA1;SLC25A5;MUL1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.6438614925984133,-1.1313417545294353,0.3090909090909091,0.7934876373314549,1.0,1/13,2.20%,ZFP36
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.634018426641917,-1.1310714072022052,0.35714285714285715,0.7937805021668025,1.0,1/7,2.18%,COL5A1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),0.7100358016489386,1.1309925913281238,0.3684210526315789,0.9901815754876532,1.0,2/5,14.77%,SIRPA;MUL1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.6712072374144078,1.130859338124683,0.375,0.9892274099572751,1.0,2/7,14.66%,GAS1;SERPINE2
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.719119136919243,-1.1307762155089545,0.42592592592592593,0.794065641637026,1.0,2/5,18.14%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.5644829766396013,-1.1307135994925968,0.26153846153846155,0.7937477612835143,1.0,7/19,19.40%,STAT4;CCL2;STAT1;THPO;STAT6;NMI;GHR
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6822642928116007,-1.1305860160423284,0.288135593220339,0.7935246840429957,1.0,4/11,12.60%,ANK3;GLRX;ATP1B1;NOS1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5745860462255246,-1.1305532277580024,0.3484848484848485,0.7929612748025413,1.0,7/21,18.61%,GBP1;MRAP2;TMBIM1;DMTN;PPFIA1;TGFB1;NUMB
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.7342371193321295,-1.1304427841134441,0.3333333333333333,0.7926884619927559,1.0,4/6,21.64%,KCNK1;KCNK12;KCNK10;KCNK13
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.4617093950517267,-1.1301467376532102,0.23333333333333334,0.7930818986680541,1.0,20/158,11.27%,RASGRP1;P2RY6;APIP;GBP1;GPR183;ICAM1;PSCA;RAMP3;GPNMB;APP;HTR2B;CCL2;CEACAM1;CD44;CHI3L1;THPO;SCIMP;DAB2IP;SYK;FN1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.5659655581999857,1.1299138591220619,0.2916666666666667,0.9910489518119058,1.0,8/23,20.48%,PRELID2;MTTP;SLC25A19;SCP2;PRELID3B;PCTP;NPC2;TRIAP1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.6012562867788394,1.1298277420176344,0.3333333333333333,0.9898245641138681,1.0,4/13,8.28%,SERPINB9;TRIM24;NCOA4;AR
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.48389035169024974,-1.129710898028779,0.2692307692307692,0.7940387815898222,1.0,14/70,14.47%,POU4F1;ANK3;CCK;SHTN1;S100A6;APP;SLITRK1;MAP1B;BAIAP2;NEFH;MINK1;SLITRK4;SLITRK5;MFSD2A
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.5630091417214969,-1.1296642440833777,0.3,0.7936140225163266,1.0,7/21,12.55%,COL5A1;PDPN;ITGA5;CEACAM1;CD44;PLET1;TMEFF2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.48360751676644936,1.1294377704300989,0.28,0.989926758509504,1.0,12/44,18.21%,LEPR;FLT3;RABL3;PBX1;MSH2;TOX;SLC25A5;KAT7;DCAF1;CHD7;CEBPG;GPR89B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5998702205248356,-1.1287767569139124,0.34375,0.7955369132435488,1.0,3/15,10.87%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5998702205248356,-1.1287767569139124,0.34375,0.7955369132435488,1.0,3/15,10.87%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.6832137179619805,-1.1286055702603166,0.39215686274509803,0.7954363858623974,1.0,1/7,5.90%,PDCD1LG2
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.6738375061922295,1.128600307088996,0.2619047619047619,0.9914681608088001,1.0,2/7,8.50%,PRDM4;PRMT6
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.4689107448537794,1.128063521652514,0.30303030303030304,0.9920918277389218,1.0,8/36,7.54%,LEPR;TFCP2L1;MUC20;EHF;ALDH1A1;TRIM29;CYP4F12;CAPN13
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.4730352841748512,-1.1280123495343497,0.3125,0.7964957644111418,1.0,10/54,19.00%,ANXA1;PRDX5;CYP1B1;ROMO1;FOS;PRKCD;ANKZF1;AQP1;MAPT;PDGFRA
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6838673301963286,-1.1279621208920596,0.37735849056603776,0.7960779440608531,1.0,2/8,17.65%,NOD1;RIPK2
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.6962516077665405,-1.127960242437621,0.3888888888888889,0.7954665830984887,1.0,1/6,16.59%,CLN3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),0.7232858199914405,1.1278757695570745,0.4523809523809524,0.9913459442504315,1.0,4/7,24.36%,VCP;TFIP11;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.6813962353881203,-1.1276378667843665,0.3389830508474576,0.7959269800251806,1.0,1/8,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.4547897494394221,-1.1275384191182198,0.21333333333333335,0.7956541945510701,1.0,8/104,8.72%,CD24;THBS1;CDKN2A;APP;NLRC5;LDB2;EGF;SRPX2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.5748171952931351,-1.1271003743017316,0.26785714285714285,0.7965012088510781,1.0,3/21,7.01%,THBS1;TLR2;APOD
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.42953476998409656,1.1268989418960804,0.23809523809523808,0.9935696602356154,1.0,4/47,4.15%,ACE2;WNT7A;SLITRK2;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.46365588763646526,-1.1265510531653606,0.27586206896551724,0.7976767279568967,1.0,20/170,11.12%,CD24;RASGRP1;P2RY6;GPR183;ICAM1;TRIM5;RAMP3;GPNMB;APP;HTR2B;CCL2;CD44;EGF;RIT2;CHI3L1;IGF1;THPO;SCIMP;FGF1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.5851571995331667,-1.1265460722709912,0.2903225806451613,0.7970879886488738,1.0,4/17,18.35%,PSRC1;DCTN1;ANKRD53;FSD1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.7656761772713344,-1.1258580285815787,0.36363636363636365,0.798876896258022,1.0,2/5,11.18%,NFKBID;PRKCQ
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.7397729205822026,-1.1252840894695666,0.375,0.8001837670483342,1.0,2/6,20.30%,UNC13C;STX1B
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.74725052554613,-1.1246322118999212,0.3793103448275862,0.8016029841138469,1.0,2/7,7.35%,GPR183;LFNG
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.5875678601445211,-1.1244180614985348,0.375,0.8018058246602505,1.0,2/9,7.40%,OR51M1;OR51I2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5786768667703589,1.1242773291814703,0.3333333333333333,1.0,1.0,5/20,18.57%,TEX15;DNMT3B;BEND3;METTL4;EHMT1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.7393735088081401,-1.1241703820327669,0.3898305084745763,0.8020939936144268,1.0,1/6,0.81%,BLM
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7184927433236734,-1.1239945271371126,0.4166666666666667,0.802060811501337,1.0,3/5,19.11%,ATP5IF1;PINK1;SREBF1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.6363345402550031,1.1237282664578279,0.3953488372093023,1.0,1.0,1/7,3.84%,TNFAIP3
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6412655666242046,-1.123614020161545,0.373134328358209,0.8028043902685333,1.0,2/10,10.88%,C12ORF57;IFT122
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.6266656403035682,-1.123165263670767,0.3709677419354839,0.8039028398952359,1.0,1/15,1.31%,FABP3
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.4669758445887313,1.1230906330718007,0.2692307692307692,1.0,1.0,4/30,10.46%,PEX11A;HP1BP3;EPS8;RAB22A
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6283147569996578,1.122650498267656,0.3611111111111111,1.0,1.0,3/8,10.96%,PPP1R15B;TMEM33;NCK1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.41423210580107583,1.1225372415482884,0.2903225806451613,1.0,1.0,14/61,17.33%,MTHFS;SLC19A1;CD320;FLAD1;TPK1;AOX1;SLC25A19;CUBN;SLC5A6;MTHFD2L;DHFR;PANK2;DHFR2;SLC46A1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6688098435445333,-1.1222093372127708,0.36507936507936506,0.8067569623264855,1.0,3/9,14.80%,IL12A;DAB2IP;PIK3CB
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.5675271730241969,-1.1221593148114795,0.29508196721311475,0.8062510830681437,1.0,2/16,2.93%,TYMS;GMPR
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.45927226678690714,-1.1220558342475075,0.3132530120481928,0.805987512992798,1.0,19/100,14.43%,ENPP2;TMSB10;NEXN;KIF14;DUOX1;CEACAM1;SPOCK3;LDB2;EGF;WAS;MINK1;SST;FGF1;AMOTL2;FGF7;SPINT2;FES;CCDC25;ROBO4
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),0.6520392281533052,1.1219345273598107,0.391304347826087,1.0,1.0,4/7,25.58%,DCLRE1B;TFIP11;DCLRE1C;DCLRE1A
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.6296483472187344,1.121469036921922,0.40625,1.0,1.0,3/12,3.97%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.6231423083760181,-1.12133176604427,0.38095238095238093,0.8078751790723597,1.0,3/10,12.60%,AKAP5;CACNA1C;NOS1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.7113522847868354,-1.1212821008007299,0.3037974683544304,0.807490187150794,1.0,2/9,4.80%,CDH23;CLRN1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.3980921856830384,1.1208823542322373,0.2,1.0,1.0,23/75,21.91%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;USP13;BAG2;VCP;RNF14;CSNK1E;CBFA2T3;PLK1;RCHY1;TRIB2;TMTC3;COP1;ZYG11B;MDM2;SMAD7;RNF217;SUMO2;NUB1;DDA1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.6218670749288606,1.120802340015126,0.3333333333333333,1.0,1.0,7/13,21.01%,RARB;SALL1;NIPBL;ID2;RBPMS2;GLI3;PCSK5
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5264217831707464,-1.1207206221308035,0.3076923076923077,0.8089769071398528,1.0,7/32,8.69%,MYO1F;CD5;TAGAP;TMC8;SLA;ARHGAP9;WAS
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.6623845688784021,1.1206113747304907,0.43478260869565216,1.0,1.0,2/6,3.44%,LIMD1;MEN1
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.5464566544662173,-1.1205740634932777,0.28169014084507044,0.808761633280815,1.0,5/23,11.79%,IGF1;WNT5A;FGF1;PINK1;IL18
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7154232512097292,-1.120445865896116,0.40625,0.8079148631783094,1.0,3/7,20.01%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7154232512097292,-1.120445865896116,0.40625,0.8079148631783094,1.0,3/7,20.01%,CDK2;AQP1;KCNC2
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6414416278812813,1.1201833839392001,0.3902439024390244,1.0,1.0,1/7,6.63%,LETM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6417518679492669,-1.1199465805268196,0.38181818181818183,0.8090434222277679,1.0,3/10,12.06%,THBS1;WNT5A;TNIP2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.49936671314601677,1.1198351244202749,0.27586206896551724,1.0,1.0,4/34,12.98%,WNT7A;TMEM106B;TAOK2;WASL
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4999891350137595,-1.1195013703917054,0.33766233766233766,0.8098454741445034,1.0,18/62,17.15%,GGT5;PLK2;RAMP3;ADCY7;GIPR;RHBDF2;ADCY5;SYK;MYH9;GNG2;RXFP1;VIP;PTH1R;GLP1R;PTH2R;ADCY3;HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7131241232668183,1.1194806727582047,0.325,1.0,1.0,3/6,24.19%,ZNHIT3;FBL;ZNHIT6
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.5026735152948684,-1.1192652199160018,0.2608695652173913,0.8102088827649735,1.0,9/41,14.42%,CENPV;FAT2;SEMA3B;HTR2B;PDXDC1;RADIL;AMOTL2;GPC3;SEMA3E
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5164891180531127,1.1189448732325473,0.3235294117647059,1.0,1.0,4/20,12.49%,WDR91;SNF8;PTPN23;PIK3C3
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4313894752821969,1.1188468194931953,0.1,1.0,1.0,7/57,6.91%,RGCC;BMP2;NMB;CADPS2;APBB3;MYOM1;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.47013195214155107,1.1183399063257495,0.2727272727272727,1.0,1.0,14/40,20.40%,SDC4;RALB;CNOT2;G3BP1;KCTD17;TAPT1;PIP4K2B;CNOT6L;CNOT1;CCDC88A;CEP120;PIP4K2C;SAXO1;RAB3GAP1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.3285764309387241,1.1182171206796445,0.0,1.0,1.0,82/341,21.37%,SPSB4;RNF6;RNF25;FBXO45;KLHL8;NUP42;SPSB2;UBE2T;BCL10;RFWD3;ELOC;NUP37;MSL2;MKRN3;TRIM24;KEAP1;DCUN1D2;PEX13;CUL1;NUP54;UBE2N;TRIM28;COMMD1;VCP;DCUN1D1;RNF103-CHMP3;RNF14;FBXL3;LMO7;FBXO9;UBE2G1;BTRC;PLK1;NDC1;DTX4;UBE2D1;RCHY1;NUP214;DERL1;ZNF451;CUL2;TSPAN17;RAE1;TMEM129;FBXO10;DCUN1D5;MUL1;PEX2;AAAS;NUP188;KIAA1586;RNF26;CBLL1;FBXL17;NUP205;VPS11;EYA1;KLHL24;HERC2;UFM1;VHL;MARCHF3;TRIM52;PIAS4;CNOT4;UBE2E3;MKRN1;KLHL20;SHPRH;MDM2;NUP210;PEX12;NUP85;FBH1;TRIM7;NEDD4L;NUP153;NUP50;EIPR1;RNF34;SUMO2;NUB1
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.6446338681725685,-1.1181829279890652,0.36507936507936506,0.8134057568484252,1.0,1/11,0.48%,APIP
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),0.6712585710640255,1.1181273843191601,0.37254901960784315,0.9995725366915824,1.0,1/5,2.21%,KCNE1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5054923288010668,-1.1180644014240386,0.2987012987012987,0.813202348163132,1.0,18/61,17.15%,GGT5;PLK2;RAMP3;ADCY7;GIPR;RHBDF2;ADCY5;SYK;MYH9;GNG2;RXFP1;VIP;PTH1R;GLP1R;PTH2R;ADCY3;HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.473491778580185,-1.118057827906979,0.3157894736842105,0.8126050605649041,1.0,19/73,16.14%,ECM2;L1CAM;ITGA2;SIGLEC1;THY1;THBS3;CD44;ANGPTL3;ITGA8;ZYX;ITGA11;FN1;CD63;EMP2;ITGA3;PPFIA1;DLC1;ITGB4;RHOD
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.484293157668477,-1.1180543360671829,0.23376623376623376,0.8119946132434246,1.0,19/61,18.74%,FYB1;ITGA2;ITGA5;THY1;CEACAM1;ANGPTL3;ZYX;ISG15;ITGA11;SYK;FN1;MYH9;FYB2;LAMA3;ITGB4;CDH17;ERBIN;FERMT3;LAMA5
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.772349985424089,-1.1178241493917176,0.37254901960784315,0.8120809032483916,1.0,3/5,21.92%,HLA-E;HLA-F;KLRD1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.45267166436961814,1.1176703432570827,0.2,0.9997884867930638,1.0,7/25,16.53%,DCHS1;FAT4;STK4;CASP3;DVL2;AMOTL1;MOB1B
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5837181730649543,-1.1175856356377476,0.3484848484848485,0.812265385071993,1.0,3/18,10.87%,IFI6;GATA1;UNC5B
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5610129717848704,-1.117330356093587,0.359375,0.8124074807874562,1.0,11/23,21.38%,IFI35;NLRC5;PLSCR1;WNT5A;HLA-E;FADD;NMI;SLC15A4;SPI1;TRIM62;ADAM8
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),0.760290705591506,1.1172211136661425,0.36666666666666664,1.0,1.0,2/6,21.53%,PUS10;RPUSD4
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6432460981306645,1.1171671707167805,0.4166666666666667,0.9974935799515423,1.0,2/7,7.46%,SLIT1;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6432460981306645,1.1171671707167805,0.4166666666666667,0.9974935799515423,1.0,2/7,7.46%,SLIT1;ALCAM
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.5970810141161101,-1.1171202710161243,0.38333333333333336,0.8126054605124282,1.0,4/17,25.82%,MMP14;BDNF;XBP1;HDAC5
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.6322570849276173,1.1170298929478237,0.34146341463414637,0.9966025579560225,1.0,3/8,22.09%,STXBP6;VAMP3;VAMP4
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5422427538036002,1.1167899387071774,0.34285714285714286,0.996300211368078,1.0,9/18,23.28%,NUDT21;HSF1;CPSF6;CPSF7;ZC3H14;CPEB3;CCNT1;VIRMA;RNF20
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.3934857217870939,1.1167159427879512,0.2608695652173913,0.9951207956291617,1.0,18/111,14.58%,BET1;FHDC1;TMED5;PI4K2A;GORASP2;BLZF1;SEC22B;TRAPPC11;SYNE1;TRAPPC12;DNAJC28;ATL2;TRAPPC8;VTI1A;GOLGA5;SEC23IP;PRKD1;TMED3
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.6388146759781426,-1.1163167272509043,0.3225806451612903,0.8148141795851923,1.0,5/10,11.27%,ANXA1;THBS1;FLG;F13A1;FN1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5678998679043799,1.1161220063794557,0.34375,0.9959903329032868,1.0,2/11,21.51%,ADRB2;FYCO1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.6329735419048464,-1.1160978762200078,0.38333333333333336,0.8148980104249804,1.0,4/9,16.36%,HLA-A;NOD1;HLA-B;HLA-DRB1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.44491591168382444,-1.1159532595718509,0.2911392405063291,0.814729840101048,1.0,21/86,20.40%,FLRT3;APLNR;POU4F1;PKP2;TGFBR2;ZFPM1;SRF;SMYD4;CACNA1C;FN1;PDLIM4;TSC2;CRB2;TEK;FGF12;TGFB1;CDKN1A;PLCE1;NXN;CASP8;CXADR
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5249920316713195,-1.1158948978417387,0.3333333333333333,0.8143382045238804,1.0,11/47,18.48%,ALDOB;SLC39A14;APOD;FBP1;GAPDHS;PGK1;GPI;IRS2;PGAM1;ENO2;PCK2
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),-0.6989711812141837,-1.1155649642225256,0.43103448275862066,0.8146736990319436,1.0,3/5,21.76%,SLC43A2;GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.5593617918044086,-1.1152683620098962,0.27631578947368424,0.8149319000034364,1.0,5/33,11.12%,TIMP2;NELL1;TIMP1;PRKCG;DAB2IP
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5203066956262987,-1.1151402090553246,0.28,0.8148060635941268,1.0,3/35,8.19%,BLM;BRCA1;DONSON
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.5389093234226675,-1.1150171091059082,0.25675675675675674,0.8145828343202454,1.0,8/41,15.64%,RPL3;RPS27;RPS14;RPL24;RPL10;RPS15;MRPL20;RPL5
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.535007721255196,-1.1149841380828533,0.3220338983050847,0.8141231335276438,1.0,4/25,9.19%,SOCS3;CYP1B1;EGF;CRLF3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.6016334148782158,1.1149223018511472,0.3055555555555556,0.9986244680920924,1.0,8/12,38.54%,USP13;UBQLN1;NFE2L2;UBQLN2;ATXN3;BCAP31;RNFT1;SGTA
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.5740924654542862,-1.1145334341785644,0.2878787878787879,0.81490990822805,1.0,2/23,1.14%,C3;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6235628524341541,-1.1144739614302326,0.3548387096774194,0.8145062881354185,1.0,3/11,5.98%,THBS1;CD160;CCL2
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.47722060320287246,1.1143975828312962,0.2,0.9988390021447632,1.0,10/28,14.80%,ABCD2;ELOVL6;CYP4F12;ELOVL4;ABCD1;ELOVL2;HACD2;ABCD3;ACOX1;PEX2
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.6969614560467643,1.1143304896308883,0.4146341463414634,0.9962959851641426,1.0,1/5,17.20%,GINS3
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.6969614560467643,1.1143304896308883,0.4146341463414634,0.9962959851641426,1.0,1/5,17.20%,GINS3
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.6227673895174071,-1.1139390384320822,0.3620689655172414,0.8151591099719893,1.0,1/13,2.20%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.6227673895174071,-1.1139390384320822,0.3620689655172414,0.8151591099719893,1.0,1/13,2.20%,ZFP36
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.4524618248790847,1.1138021458937553,0.27586206896551724,0.9968997820941117,1.0,2/30,1.76%,LEPR;REEP6
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.7551784194624245,-1.1137387240535757,0.3333333333333333,0.8151517234864877,1.0,1/6,7.58%,CENPE
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.4584981322889734,-1.1135662106259965,0.2857142857142857,0.815054210979637,1.0,13/119,8.66%,NPY;FLRT3;POU4F1;STMN2;L1CAM;LAMB1;RAB11A;SH3GL2;PLP1;APP;SRRM4;TENM4;SRF
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.7233552769917564,-1.1135271098155946,0.43333333333333335,0.8145965659721318,1.0,1/5,0.18%,ANXA1
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.6935856704787037,-1.1132231130176327,0.43333333333333335,0.814880393319365,1.0,1/6,7.95%,MYH11
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.6497115726239535,-1.1131125034270668,0.34615384615384615,0.8147417937831426,1.0,3/8,16.17%,SLCO3A1;SLCO2A1;SLCO1A2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6447098009133745,1.1127794854891657,0.37142857142857144,0.9990471875793155,1.0,6/12,28.80%,SAXO2;PCM1;SAXO1;DAG1;CLASP2;BICD2
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.4004429905968485,1.1123421452819269,0.1724137931034483,0.9989541975703418,1.0,16/59,27.46%,H2BC18;H2BC21;SOX9;ANP32B;H1-2;ASF1A;DAXX;ACTR6;KAT6B;H2BC5;SART3;SMARCC1;PADI4;INO80;VPS72;ARID2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.629516089574062,1.1122977684612998,0.41379310344827586,0.9976736484955376,1.0,3/13,3.97%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5539478984622599,1.1118851199756714,0.4117647058823529,0.9979034356385883,1.0,6/14,14.67%,EFNB2;GREM1;AKT1;ROBO1;EPHB4;GPLD1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.5555446326462341,-1.111749362557544,0.32432432432432434,0.8184193271773801,1.0,5/20,15.39%,TEKT2;CCDC39;DNAH3;DRC1;DNAH2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7328368506687906,-1.1117250576156057,0.37254901960784315,0.817905274990658,1.0,4/5,26.51%,MSR1;SCARB1;EHD1;SREBF2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6220011902273699,-1.1116700280470018,0.3559322033898305,0.8175162362590702,1.0,6/12,23.77%,CYP1B1;HSD17B14;CYP3A4;CYP3A5;HSD17B7;CYP2D6
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.4928456981533104,-1.1116215802393195,0.2878787878787879,0.8170312129376859,1.0,10/33,16.68%,L1CAM;THY1;VLDLR;ACHE;MYH9;GLI1;CRMP1;RTN1;DPYSL2;PML
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.6323211118977952,1.1114666643384916,0.32653061224489793,0.9978924790848557,1.0,1/6,5.85%,PLIN5
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.6258181354639333,1.111437616584306,0.3953488372093023,0.9965868487457628,1.0,3/9,18.76%,RTRAF;RBFOX1;SIDT1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.695856175627154,1.1113059303587092,0.5,0.9956839204883284,1.0,4/7,24.16%,SOX9;SOX5;BMPR1B;LOXL2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.5134529293556289,-1.1110829804482287,0.3466666666666667,0.818256207226212,1.0,10/42,21.20%,KCNB1;ITPR3;GIPR;CELA2A;CACNA1C;PAX8;GLP1R;HTR2C;KCNC2;ITPR1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4689653831176629,-1.110938116330355,0.24050632911392406,0.8181570378211633,1.0,23/123,13.35%,MYO1F;RHOBTB2;PROX1;POF1B;MYO15A;CLRN1;GAS2L3;LMOD1;RND2;SVIL;BAIAP2;BAIAP2L1;VIL1;WAS;NLRP5;RHOF;TPM4;MYO1E;DMTN;CORO7;ELMO1;EMP2;DSTN
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.7270432086956871,1.1107879091969508,0.3958333333333333,0.9962339917185928,1.0,3/5,24.36%,VCP;DYRK3;ZFAND1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7623207584353116,-1.1105418429385634,0.4444444444444444,0.8189113926841769,1.0,1/5,5.64%,YBX3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.5243366598375311,-1.1103139738992083,0.3424657534246575,0.819011315651186,1.0,6/32,9.54%,LMOD1;BAIAP2;BAIAP2L1;CDC42EP1;PFN2;CDC42EP3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.4296960285553312,-1.1102358943784276,0.19318181818181818,0.8186231887174668,1.0,61/178,20.39%,NPY;SNCB;CHRM1;GRIN2A;PLP1;HTR2B;GRIA3;GLRA2;UTS2;HAP1;GRIA1;AKAP5;SLC18A2;NRGN;RIT2;SYN2;UNC13C;CPLX1;RPS6KA1;SYT1;GRIK1;MINK1;HCRTR2;CHRM3;GABRE;GABRB2;SST;CHRNA5;GABRD;PCDHB5;GAD1;HRH1;GRIN2B;NLGN1;NPTX2;GAD2;HTR1E;GABRG2;APBA2;SLC12A7;GRM7;GRIK2;SYT5;SNCG;GABRA1;CACNB1;KCNMB4;HTR2C;CHRM5;CHRNE;CDK5;HTR2A;SLC1A6;PTCHD1;GLRA1;GABBR2;GABRA6;CHRNA6;GABRG3;GABRA3;PCDHB4
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.5609512645131421,1.1101515123791785,0.42105263157894735,0.9971963647586833,1.0,5/15,16.31%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5589388443188055,-1.1099682002840578,0.20634920634920634,0.8189085796121278,1.0,1/21,0.95%,SP100
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.6065953361375052,-1.109850800265919,0.35185185185185186,0.8186995075433829,1.0,5/13,20.23%,SULF1;WNT5A;DEAF1;PDGFRA;KIAA1217
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.5966508403555794,1.109840477014403,0.36585365853658536,0.9970911039814842,1.0,9/15,28.19%,INTS7;INTS8;INTS6L;TOE1;INTS14;INTS4;INTS6;INTS9;INTS11
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.6673742543207409,-1.1094724920792294,0.2962962962962963,0.8192861087056664,1.0,3/8,19.89%,CNTN2;AGRN;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.5816073387739955,-1.1094649298455646,0.36065573770491804,0.818713936846883,1.0,5/16,14.77%,TNFRSF14;WNT5A;SCIMP;HLA-E;GPI
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.6986547959719257,-1.1094630568466435,0.34615384615384615,0.8181152256402638,1.0,1/7,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),-0.7200194903730038,-1.1093696188770252,0.375,0.8178115787343252,1.0,3/6,20.30%,NLGN1;GPER1;STX1B
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5243156406744338,1.109345199761346,0.3333333333333333,0.9975258032622696,1.0,2/18,2.91%,ACE2;ADRA1A
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.49595327455125976,-1.109316968782599,0.2625,0.8173648174992559,1.0,19/53,13.56%,MYO1F;TAGAP;ALOX12;PROX1;SPON2;ARHGAP9;GATA1;PLK3;CLEC12A;SYP;PDE6B;F13A1;WAS;CD9;PILRA;SELP;ACHE;TSPAN32;SLC11A1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5986879757702032,-1.109249221833367,0.36065573770491804,0.816980197217656,1.0,2/15,3.28%,ABCA5;ABCA8
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.7259840707979336,1.1090894581577804,0.38636363636363635,0.9971350690172415,1.0,1/5,5.78%,SF3A1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5126693699983125,1.1080664618866263,0.3055555555555556,0.9991513370470958,1.0,5/16,15.95%,MAML3;KAT2B;PBX1;HEYL;EP300
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.45065616220161914,1.1079758141807576,0.2692307692307692,0.9980955614008878,1.0,8/43,8.97%,ERCC8;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;HMGB1;SPIRE2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5691992109354023,-1.1074917284327894,0.3442622950819672,0.8220503123736265,1.0,7/17,23.58%,COL5A1;C12ORF57;IFT122;RARG;FBN2;STAT3;NKD1
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.6433846517483364,-1.107337264620047,0.38333333333333336,0.821935654631159,1.0,4/11,13.10%,ARG2;CYP1B1;NOS1;GCHFR
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.7119493747811336,-1.107334530691694,0.3584905660377358,0.8213372162886455,1.0,3/7,7.61%,CLDN16;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.6266834106337822,-1.1071661327760594,0.4090909090909091,0.8213390419641571,1.0,1/13,0.81%,BLM
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5314931327533531,-1.107011402121386,0.37142857142857144,0.8212932217942008,1.0,1/22,0.55%,PIF1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.4295525495312956,1.1068322382811353,0.28125,1.0,1.0,6/38,11.68%,UQCRHL;SDHAF4;PPARGC1A;COX10;LYRM7;ETFDH
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.48082875943582454,-1.106616473894042,0.31645569620253167,0.8219615912771573,1.0,11/66,18.52%,TLR2;IRF1;TLR3;STAT1;IRF7;ISG15;IFIH1;FLOT1;STAT6;RIPK2;DDX41
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),0.7018971798255751,1.1066006900062204,0.3469387755102041,1.0,1.0,2/5,14.45%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.4983661517201895,-1.106556193090746,0.3561643835616438,0.8214940186770691,1.0,17/47,19.24%,P2RY12;RCAN2;ACKR4;HTR2B;LAT2;CHRM3;NUDT4;NOS1;HRH1;CCR10;GUCY1A1;RCAN3;RYR2;MCTP1;PPP1R9A;PLCE1;CD36
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.7058487178522239,1.1064892340281431,0.32608695652173914,0.9990698525791389,1.0,3/6,20.74%,SPX;MKKS;BBS2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5767381089503298,-1.1062622475021173,0.3508771929824561,0.8218896126972502,1.0,1/18,0.78%,CDKN2A
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.4923125732621143,-1.106157308139899,0.3116883116883117,0.8215720749979926,1.0,20/65,18.04%,LMO2;ADGRE5;TMC8;ADCY7;GAB3;TUBB1;GFI1B;GATA1;CD44;LMNB1;PRSS57;PTPN7;PIM1;TSPAN32;IL27RA;ETS1;CR1L;BCL11A;NMI;FERMT3
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.6110829329136882,-1.1061433837558738,0.3448275862068966,0.8209905343983557,1.0,1/14,0.81%,C3
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.40440301851428206,1.1061277106149139,0.2,0.9990574816859836,1.0,22/97,16.56%,POLD3;ERCC8;LIG4;COPS2;RFC3;COPS8;ERCC6;COMMD1;ERCC2;SLC30A9;HUS1;COPS7A;ERCC3;GTF2H5;GTF2H2;GTF2H2C;POLK;POLR2C;EP300;AQR;PPIE;HMGN1
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.6472268775138349,1.1059070914556788,0.40476190476190477,0.9982916698556987,1.0,1/5,2.59%,UBE2T
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.63153511699972,-1.105833836463714,0.3972602739726027,0.8213381943070678,1.0,1/11,1.11%,APLNR
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.6347586983860661,-1.1055844730197226,0.3387096774193548,0.8215770045539049,1.0,4/12,13.10%,ARG2;CYP1B1;NOS1;GCHFR
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.6825402859149411,-1.1055665971973094,0.38596491228070173,0.821037333841132,1.0,3/7,22.81%,LDLR;TGFB1;ACMSD
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.4738750961221204,-1.1055285322164015,0.29411764705882354,0.8205728271764978,1.0,13/103,10.12%,RASGRP1;P2RY6;GPR183;ICAM1;RAMP3;GPNMB;APP;HTR2B;CCL2;CD44;CHI3L1;THPO;SCIMP
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7094568976954572,-1.1049421513156565,0.37142857142857144,0.8219062238372341,1.0,1/7,1.32%,GPR183
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.6157681011654871,-1.1048879070395556,0.37254901960784315,0.8214957734871996,1.0,2/11,7.83%,PARP14;PARP9
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),-0.7595044567905422,-1.104776350094563,0.43636363636363634,0.8212748272877771,1.0,1/5,5.11%,ATP23
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.4886379320525657,1.10477570332101,0.2682926829268293,1.0,1.0,7/24,19.46%,NR1D1;PGM2;AGL;PYGM;UGP2;PPP1R3C;PYGB
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),-0.6974264903957503,-1.1047255710273949,0.4642857142857143,0.8208789181382126,1.0,2/6,12.78%,SKAP1;FADD
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.614035571688865,1.1046020786884647,0.43902439024390244,0.9998659007115716,1.0,2/10,5.26%,HSPA1A;GIT1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.585713987466367,1.1045939075239024,0.38461538461538464,0.9985237239604342,1.0,4/10,12.75%,ABHD17A;LYPLA2;ABHD17B;ABHD17C
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6930145821466503,1.1045617523086046,0.38461538461538464,0.9972320632481552,1.0,3/8,7.57%,CASS4;MCU;EFS
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.5508903912339345,1.1044119501894676,0.3793103448275862,0.9963492782316442,1.0,14/25,24.73%,TRIB3;DCUN1D2;UBE2N;FBXO5;DCUN1D1;PLK1;FEM1B;DCUN1D5;SMAD7;FEM1A;DCUN1D4;ARRDC4;FBXW7;AXIN1
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5221570457050688,-1.104369389419134,0.3382352941176471,0.8214334763638269,1.0,7/39,7.03%,MYO1F;CD5;TAGAP;GPR171;SLA;ARHGAP9;CD44
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.6933138071424416,-1.1043226378793052,0.3898305084745763,0.8210447596176957,1.0,1/7,1.14%,NR4A3
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.6992846374582479,-1.1039683020688926,0.3958333333333333,0.8216118453237352,1.0,2/6,7.04%,THBS1;ACSL5
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.6586648120391984,1.103955621567431,0.4166666666666667,0.9969634896753845,1.0,6/8,31.86%,TRIT1;MTO1;TRMT5;RPUSD4;TRMT61B;HSD17B10
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.6751371164976745,-1.1038943834894719,0.38181818181818183,0.8213176735750638,1.0,1/7,4.15%,ST18
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),-0.7607169280969732,-1.1037908128007807,0.40816326530612246,0.8210239287810349,1.0,1/5,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5062637140073126,-1.1037093426335878,0.28125,0.8206634861150769,1.0,6/32,15.79%,MET;FBP1;DAB2IP;ITGA3;DLC1;STMN1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.7337934258362238,-1.103548960022101,0.40350877192982454,0.8205785743844403,1.0,1/5,1.62%,TLR2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.5905277462994629,1.1034064861346253,0.3018867924528302,0.9974671919477045,1.0,3/9,23.68%,UBXN2B;PARD6A;CEP72
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.69743058148063,-1.1030676237959063,0.41818181818181815,0.8213785378957861,1.0,1/5,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.43463551458795446,1.102904033652336,0.23076923076923078,0.997922941636982,1.0,20/52,20.89%,NUP42;NUP37;ABCD1;NUP54;NDC1;NUP214;RAE1;AAAS;NUP188;COX7A2L;EP300;NUP205;BEND3;JMJD8;SPHK2;AK4;NUP210;NUP85;NUP153;NUP50
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7275595779245498,-1.1025846777699517,0.39285714285714285,0.8222979044548442,1.0,1/5,10.67%,LRPAP1
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.6969478468129096,-1.102420079671051,0.3793103448275862,0.8222856178560433,1.0,2/6,14.47%,LDLR;MFSD2A
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.42806140304804663,1.1023666559803997,0.24242424242424243,0.9985014888796053,1.0,2/44,2.78%,G0S2;BCL10
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.5495483991496223,-1.1021077187208677,0.3108108108108108,0.8226478848418354,1.0,6/29,16.44%,POLE3;POLE4;RPA3;RPA1;CDK2;CDC7
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.5638042449929899,1.1020656736537153,0.35555555555555557,0.9981184645618534,1.0,4/13,20.95%,TMEM33;ATL2;ZFYVE27;RAB18
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.45104726004539347,-1.101789911994423,0.3125,0.8231566615366394,1.0,21/111,17.67%,GBP2;IL1R1;GBP1;RPS27A;ST18;NOD1;CCL2;PSMB9;PSMB6;DAB2IP;PSMC3;TNIP2;UBC;MYLK3;HYAL1;PSMA8;IL1RAP;PSMA7;PSME1;RIPK2;RBX1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.6296229714799145,-1.1015900180673182,0.3088235294117647,0.8231371034495387,1.0,1/11,0.33%,THBS1
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.546009097035499,-1.1014967798400666,0.3548387096774194,0.8228439529404932,1.0,2/22,2.29%,PCSK2;LMO2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5577992634411274,-1.101472831749707,0.3382352941176471,0.8223644966008123,1.0,3/24,8.55%,TYMS;GLRX;NUDT13
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5784261918099686,1.101413257200499,0.3055555555555556,0.9987106367984054,1.0,1/10,1.38%,SOX8
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.6758202632809137,-1.1013031698328641,0.4,0.822318894811196,1.0,1/6,11.85%,FOXM1
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.621358664847389,-1.1010423280160535,0.36666666666666664,0.8225330701712167,1.0,4/13,11.28%,APLNR;TGFBR2;ZFPM1;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.583903899725958,-1.1002435902669192,0.3181818181818182,0.823718563775306,1.0,8/19,23.06%,APP;IGF1;GAPDHS;PRXL2C;PFKFB4;PFKFB3;P2RX7;PFKFB2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.583903899725958,-1.1002435902669192,0.3181818181818182,0.823718563775306,1.0,8/19,23.06%,APP;IGF1;GAPDHS;PRXL2C;PFKFB4;PFKFB3;P2RX7;PFKFB2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.6117290770321789,-1.0997149565835647,0.3,0.8247884688798912,1.0,1/15,0.24%,CCBE1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.617271762376438,1.0996855552102252,0.34210526315789475,1.0,1.0,1/8,0.44%,WNT7A
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),-0.6782263172578938,-1.0994489900686024,0.40384615384615385,0.8245150264966983,1.0,2/5,16.36%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),-0.6782263172578938,-1.0994489900686024,0.40384615384615385,0.8245150264966983,1.0,2/5,16.36%,HLA-DRA;HLA-DRB1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5900375965935667,-1.0994387519811673,0.373134328358209,0.8239774448759862,1.0,8/19,22.15%,HTR2B;ITPR3;HTR2C;RYR2;HTR2A;ITPR1;PTPRC;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6959560821987345,1.0993739399126796,0.4090909090909091,1.0,1.0,1/5,6.66%,ABHD5
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4585135410473834,1.0988243449389716,0.28125,1.0,1.0,5/27,12.84%,MEN1;DUSP19;MARVELD3;SIRPA;TAOK3
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5542749082878766,-1.098630785618285,0.34328358208955223,0.8260843678915547,1.0,4/22,17.54%,SLC6A15;SLC43A2;SLC38A1;CTNS
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.6574883124907979,1.0984634621301692,0.3157894736842105,1.0,1.0,2/11,15.49%,TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.502660586724152,1.0981568048024433,0.3235294117647059,1.0,1.0,8/21,19.75%,S1PR1;SOX9;FBXO5;SGMS2;ANKH;ECM1;HEY1;HEY2
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.7201650479438324,-1.0980725093529664,0.4090909090909091,0.8271951023014661,1.0,4/7,25.47%,CCDC39;DRC1;DNAAF1;CCDC40
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.5962588974533254,1.0979439404964324,0.35,1.0,1.0,4/13,15.44%,TEX15;APOBEC3F;SMYD5;PIWIL4
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5434247088632088,1.0978440340001816,0.3333333333333333,1.0,1.0,1/11,7.15%,FBXO5
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4652058914096027,1.0975638489491126,0.2903225806451613,1.0,1.0,5/22,15.78%,NR1D1;TNFAIP3;TICAM1;RAB7B;LGR4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.6869075760897626,1.0973562979891909,0.4,1.0,1.0,4/6,16.85%,AKT2;AKT1;VCP;BAD
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.5670616942169252,1.0973553768762958,0.2857142857142857,0.9988089685310445,1.0,2/13,3.97%,OCLN;RUNX1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.4472705891199025,-1.097344010281094,0.29411764705882354,0.8292768640161408,1.0,31/115,20.39%,FLRT3;POU4F1;L1CAM;ANK3;MYOT;SNCB;APP;SLITRK1;LRRC4;ARHGAP39;SLC8A3;UNC13C;CBLN2;PCDHB5;ACHE;DCTN1;NLGN1;SEMA3E;BDNF;CNTN2;PPFIA1;SNCG;CACNB1;PTPRF;CDK5;MAPT;AGRN;DOK7;CX3CL1;C1QB;PCDHB4
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.6447505486532228,-1.0972912656185876,0.3968253968253968,0.8282648099796753,1.0,1/7,1.67%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.6447505486532228,-1.0972912656185876,0.3968253968253968,0.8282648099796753,1.0,1/7,1.67%,MX1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.6623449592374834,-1.0972440505631613,0.43333333333333335,0.8278655021119564,1.0,2/8,14.60%,OGFOD1;GLE1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.6262543049541731,1.097062997891552,0.37209302325581395,0.9982640995945538,1.0,2/9,2.81%,COQ3;GK
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5699526221862719,1.096754207981439,0.3611111111111111,0.9980858408832979,1.0,3/17,7.72%,KPNA2;NUP54;IPO5
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.4233560405274501,-1.0967100947487167,0.30120481927710846,0.8291095574692554,1.0,33/155,15.80%,FLRT3;TAGLN3;STMN2;NEFL;NEFM;ELAVL2;SNCB;SH3GL2;ZDHHC22;SLITRK1;ATRNL1;SYT4;MAP1B;EFNB3;GAP43;EDIL3;ZNF536;TMEM163;SYT1;PLPPR5;STMN4;INSYN2A;ACHE;CRMP1;GRID2;NLGN1;CNR1;SLITRK5;CNTN2;KCNC1;GDAP1L1;CIB2;RELN
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.5047036315827308,-1.09659035218826,0.35064935064935066,0.828815702618781,1.0,10/56,16.14%,RHOBTB2;FSCN1;RND2;BST2;BAIAP2;RHOF;DMTN;DLC1;PRKCD;RHOD
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.707754696947886,-1.096483515854949,0.44642857142857145,0.8285222660670262,1.0,2/6,12.25%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.5467634422376455,-1.0963381733661663,0.3333333333333333,0.828446502057613,1.0,2/20,2.79%,L1CAM;SHTN1
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.6480006367420517,-1.0962758302175704,0.35384615384615387,0.8281076933489143,1.0,1/10,1.31%,TYMP
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6711359773521022,-1.0955339985202555,0.3709677419354839,0.8299585536659267,1.0,1/9,2.14%,KMO
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.5362471115609214,-1.0951833638361932,0.37333333333333335,0.8303417946169672,1.0,11/46,19.62%,KCNQ1;NOS1AP;KCNJ2;CAV3;GNG2;CD63;KCNMB4;KCNAB3;AKAP6;GABBR2;KCNIP4
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.48745416605247127,1.094729609888099,0.34375,1.0,1.0,5/40,5.64%,HSPA1A;RIOK2;ZPR1;RIOK1;EGFR
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.5364289459233125,-1.0945266352519207,0.37142857142857144,0.8317420378873444,1.0,10/30,16.14%,GPR87;EPS8L2;ABCA12;BAIAP2L1;HR;KPNA7;ITGA3;LAMA3;ITGB4;RHOD
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5696620088290718,1.0943000827859428,0.3235294117647059,1.0,1.0,3/9,14.86%,ZSWIM6;ZSWIM5;TUBB2B
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.530569616509773,-1.0940526141875708,0.3076923076923077,0.8326023632999152,1.0,4/24,8.72%,ANXA1;THBS1;KLF4;SRPX2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.43176080102956976,-1.0940053262950478,0.3058823529411765,0.8321700339009412,1.0,9/135,5.35%,PRAME;HPN;EFNA1;SIX3;PKP2;ABCA5;COL5A1;OVOL2;ZNF750
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.44129283334548924,1.0939181497246449,0.3,1.0,1.0,17/39,27.21%,PPARGC1A;MFF;PRMT6;CSNK2A2;MUL1;MIEF2;EP300;GOLPH3;MYO19;USP36;FZD5;MARCHF5;FBXW7;INF2;PID1;HAX1;STOX1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.42011321463352325,1.0935557236035471,0.2727272727272727,1.0,1.0,2/59,0.43%,G0S2;NGF
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.5207931305966641,-1.0935423538943603,0.32857142857142857,0.8331336526759515,1.0,6/54,13.58%,THBS1;NR4A3;GATA1;ZFPM1;PRKCQ;FES
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6945692032691622,-1.093422745691684,0.40625,0.8329437699763,1.0,2/7,9.67%,TGFBR2;STAT1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6815857786778602,1.0929736760055473,0.4166666666666667,1.0,1.0,1/7,7.37%,SLC4A7
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.45828395945507167,-1.092899101856877,0.29213483146067415,0.834036312239884,1.0,11/82,14.33%,THBS1;TGFBR2;RPS27A;ADAMTSL2;ASPN;LTBP4;EID2;LDLRAD4;UBC;VEPH1;ITGA3
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6823378120211733,-1.0927853715715146,0.4074074074074074,0.8337806903106116,1.0,4/7,21.59%,EMP1;EMP2;EMP3;P2RX7
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.6923430894409909,1.0925253326798356,0.425531914893617,1.0,1.0,2/5,20.40%,TMEM33;RAB3GAP1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),-0.6988314759252866,-1.0924751128087646,0.43859649122807015,0.8341917321531386,1.0,3/6,22.79%,PLSCR1;P2RX7;ANO7
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.47868250196259177,1.0924169590061164,0.3076923076923077,1.0,1.0,3/24,4.98%,ACE2;OCLN;TRIB3
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.5571359158919161,1.092386287648657,0.3695652173913043,1.0,1.0,1/13,1.08%,CHAMP1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5339410930487499,-1.0923766030977546,0.34615384615384615,0.8338580278529009,1.0,4/32,6.92%,AWAT1;ALOX12;CYP4Z1;CYP1B1
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.41765886041324907,-1.09222917895729,0.2682926829268293,0.8336683037426232,1.0,42/188,20.53%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),-0.654566676393347,-1.0920707724796712,0.41379310344827586,0.8336092184761327,1.0,5/5,34.57%,AQP1;AQP11;SLC26A6;SLC5A11;SLC2A13
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6538192002290988,1.0920375172065493,0.475,1.0,1.0,1/6,10.09%,PLK1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.5065996995355199,-1.091697587740829,0.4166666666666667,0.8341820737893917,1.0,5/40,12.78%,CCBE1;CTSC;ATP5IF1;PINK1;FADD
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.7147432622538138,1.0915735974449752,0.4146341463414634,1.0,1.0,3/5,27.14%,GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.7147432622538138,1.0915735974449752,0.4146341463414634,1.0,1.0,3/5,27.14%,GNPAT;AGPS;FAR1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.4923588857017883,-1.0915225866521372,0.379746835443038,0.8341292197366732,1.0,8/54,13.59%,ANXA1;IL1R1;IRF1;LRRC19;WNT5A;BIRC3;SBNO2;HERC5
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.3972710043064245,1.0914727421988342,0.21428571428571427,1.0,1.0,20/74,19.92%,SDHAF4;SAMM50;COX18;NDUFB1;DMAC2;NDUFAF3;SMIM20;LYRM7;NDUFAF4;NDUFAF2;COX19;NDUFV3;NDUFA8;TIMMDC1;NDUFS1;NDUFV1;CHCHD4;NDUFAF7;FASTKD3;UQCC1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.490063884922189,1.091181955756832,0.3142857142857143,1.0,1.0,4/23,9.95%,OTUD3;TNFAIP3;USP27X;OTUB2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.5644977152422627,1.0911210370726188,0.3055555555555556,0.9991640496128866,1.0,5/11,23.28%,GTF2A2;TAF12;BDP1;DR1;GTF2B
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5376698112590994,1.090810265502519,0.3103448275862069,0.9989582846169217,1.0,3/12,11.84%,NUDT21;CPSF6;CPSF7
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6350988552197099,-1.090745164760706,0.40350877192982454,0.8360734254562285,1.0,4/10,21.37%,EGF;MGAT5;HES1;PTPRC
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.6886299785055445,-1.090651569933613,0.3620689655172414,0.8358178090481766,1.0,4/7,22.78%,LAMA3;ITGB4;PLEC;DST
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.5908146789580793,-1.0905532262031685,0.34545454545454546,0.8349506382910256,1.0,1/15,1.14%,AMN
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.5908146789580793,-1.0905532262031685,0.34545454545454546,0.8349506382910256,1.0,1/15,1.14%,AMN
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.729994462651739,-1.0905166960017156,0.42857142857142855,0.834449855090732,1.0,1/6,3.97%,RAB11A
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6665853679718947,-1.0902678480312114,0.3968253968253968,0.834688728412256,1.0,2/11,7.77%,APP;SYP
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.40259255473960587,1.0902675287720716,0.25,0.9996915119577685,1.0,12/64,13.14%,RANBP17;NXT2;NUP62CL;PPP1R10;AKT1;IPO5;IPO8;RALA;NUP214;NXT1;RANBP6;TSPAN17
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.5113813705197591,-1.0900129336383386,0.3333333333333333,0.8349143123582455,1.0,13/47,18.56%,LEF1;GPR183;TGFBR2;IL15;SNX10;SBNO2;MYH9;PIK3CD;CDK2;HLA-DRB1;PML;CDKN1A;CD4
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.47151177814244477,-1.0898596849894664,0.3888888888888889,0.8347576739879656,1.0,14/76,16.59%,PCSK2;MMEL1;TESC;PHEX;NNAT;MMP14;ADAM19;CTSS;AEBP1;TSPAN32;SRGN;APH1A;F3;CLN3
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.7330462914103553,-1.0898135249875385,0.4375,0.8343295786546047,1.0,2/5,18.34%,DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.6692688816234282,-1.0896532689542169,0.40350877192982454,0.8343416302517749,1.0,1/6,6.02%,DENND3
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.5236704575439004,-1.0895587303925278,0.3333333333333333,0.8341340438795652,1.0,9/24,19.24%,ICAM1;GRIN2A;APP;IGF1;CACNB1;SNX6;CDK5;ABCC1;CD36
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.44998937604035105,-1.0891167200036729,0.345679012345679,0.83497244748183,1.0,9/71,10.43%,P2RY12;EPS8L2;FSCN1;CLRN1;ANLN;CDC42EP1;CDC42EP3;PLPPR5;PLEKHM1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.5875535067102211,1.0889991265921581,0.38235294117647056,1.0,1.0,5/10,23.21%,PTPN23;RAB21;VPS11;EIPR1;EZR
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.4757430785559849,-1.0889522960991007,0.3291139240506329,0.8349259719061085,1.0,16/70,20.76%,SH3GL2;APP;ARHGEF17;SCG5;HSD17B14;SST;ZFHX2;CRMP1;TMEM151A;PCP4;SEZ6L2;SPP1;LRP2;GLIS2;PRR36;CD276
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.399846998361565,1.0887256612544696,0.23809523809523808,1.0,1.0,7/60,7.02%,ATP6V0D2;PDK4;ATP6V1A;AKT2;ATP6V1G1;AKT1;AP3S1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.46765336104254823,-1.0878852910196732,0.3333333333333333,0.8377737930154053,1.0,8/90,9.94%,PIF1;RECQL4;BLM;HELB;BRCA1;POLE3;DONSON;RPA3
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.46419848102405803,1.0878266457432513,0.36363636363636365,1.0,1.0,7/33,17.29%,OTUD3;TRIB3;THEM4;AKT1;DRD2;MUL1;MAGI2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.5753994455634186,-1.0877970034423745,0.3770491803278688,0.837532188727563,1.0,1/14,0.81%,C3
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.6795505913213614,-1.0869065941724934,0.41818181818181815,0.839788470936064,1.0,5/6,29.91%,CX3CL1;FRRS1L;NECAB2;FYN;SHANK3
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6212531593367735,-1.0867400060194612,0.4117647058823529,0.8397966703765549,1.0,2/12,8.19%,BLM;DONSON
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.5088818147268587,-1.0865152008920185,0.36507936507936506,0.8399848437025031,1.0,13/37,21.38%,SKAP1;IFI35;IL15;HLA-DRA;PLSCR1;FADD;CD74;HLA-DRB1;NMI;SLC15A4;RSAD2;PTPRC;ADAM8
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.6677726701661596,-1.0863602817010853,0.4603174603174603,0.8398258822862336,1.0,1/6,1.14%,NR4A3
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.6282994661472943,-1.0863155757806309,0.43333333333333335,0.8393975378823932,1.0,4/12,22.57%,PPP3CC;HRH1;PLCE1;NFATC2
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.5574470816526995,1.086256717982878,0.38235294117647056,1.0,1.0,2/10,4.15%,CEL;NLGN3
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.5855867921412365,-1.0862499212445795,0.37681159420289856,0.839059592706396,1.0,4/16,11.06%,PKD2L2;CAV3;PIEZO2;LHFPL5
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.45254049417461717,-1.0861460164440646,0.3170731707317073,0.8387285258377738,1.0,15/70,19.24%,GBP1;MRAP2;RAMP3;MMP14;AKAP5;TMBIM1;PRKCH;ITGA3;PPFIA1;CLN3;CDK5;GPER1;TGFB1;NUMB;STAC2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.5234916767490994,-1.0860205028264551,0.3561643835616438,0.838532439058558,1.0,5/32,9.67%,PTP4A3;FAT2;ANLN;CYP1B1;STAT1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.6738910605906779,-1.0856335567362634,0.4423076923076923,0.8389639580555165,1.0,2/7,13.13%,PROX1;GRID2
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),-0.6108140727131296,-1.085413141908686,0.38333333333333336,0.8391006209564866,1.0,6/16,23.97%,B4GALNT1;ST8SIA3;B3GALT4;ST6GALNAC3;NEU4;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.5775355263322766,-1.085181837596178,0.36363636363636365,0.8391412071252262,1.0,7/21,17.23%,APP;EGF;IGF1;GAPDHS;PRXL2C;PFKFB4;PFKFB3
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.48408999067840724,-1.0851091599352782,0.35135135135135137,0.8387728976112883,1.0,13/58,19.68%,SULT1C3;ACOT1;ACSM5;TPST1;ACOT4;GLYAT;DBI;ACOT2;OXSM;SULT4A1;ACOT8;ACOT6;HINT1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.43472053535872346,1.0849557898169215,0.2903225806451613,1.0,1.0,10/41,24.54%,SMARCAD1;SIRT6;ELK4;MIER3;PRDM5;HDAC2;HDAC10;MIER2;MTA2;SIRT2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.45232465214729195,1.0849402589697532,0.34375,1.0,1.0,19/51,19.44%,PNLDC1;CNOT9;PDE12;EXOSC1;DCP1B;EXOSC6;DIS3;EDC3;CNOT2;LSM5;LSM7;RC3H1;CNOT8;CNOT6L;CNOT1;EXOSC8;CNOT4;PATL1;RC3H2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),0.6256483844961254,1.0848251410324605,0.35714285714285715,1.0,1.0,3/7,22.02%,ERCC2;ERCC3;USH2A
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.647923987330878,-1.0847671423396374,0.391304347826087,0.8394392578005777,1.0,1/9,8.80%,FBP1
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.6832457951200408,-1.0843858071379848,0.4032258064516129,0.8399260786967461,1.0,2/6,17.76%,NLGN1;LRP2
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.47422048010403,-1.0842556904904128,0.2916666666666667,0.8396727381882705,1.0,7/56,10.73%,BLM;PLK2;RAB11A;HTR2B;PLK3;NLRP5;FGF1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5620952660398522,1.084249643145232,0.4473684210526316,1.0,1.0,5/14,16.31%,DMAC2L;ATP5PB;ATP5MC2;ATP5MC1;ATP5F1A
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.5048256868629508,-1.0841174885729241,0.34782608695652173,0.8394579695958337,1.0,14/37,19.10%,TIMP2;SCUBE3;MMP19;MMP14;CD44;TIMP1;KIF9;CTSS;FLOT1;ADAMTS4;TLL1;CAPN1;A2M;CAPNS1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),0.45884662801508536,1.0841164171513968,0.38461538461538464,1.0,1.0,3/20,16.84%,NT5C1A;NUDT15;FHIT
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.49106150681042743,-1.083808917733,0.4,0.8397273239985973,1.0,11/41,19.32%,IPCEF1;PRDX4;GLRX;SBNO2;FES;TXNRD2;JUNB;ATOX1;ABCC1;CDKN2D;NDUFA6
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.5073446255585062,1.0836346407428061,0.375,1.0,1.0,4/15,12.67%,CD200R1;TNFAIP3;FOXJ1;SIRPA
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),-0.7208569035244337,-1.0835474753960206,0.49056603773584906,0.8392731672381347,1.0,1/5,6.29%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),-0.7208569035244337,-1.0835474753960206,0.49056603773584906,0.8392731672381347,1.0,1/5,6.29%,BRCA1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5513528894682963,-1.083098190603829,0.38461538461538464,0.8399995130581904,1.0,6/19,12.99%,THBS1;ZNF750;DUOXA1;MYH11;ADIRF;EMP2
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.40790932358027626,1.0830299539662025,0.37037037037037035,1.0,1.0,24/81,17.26%,ERCC8;CDC25A;PRIMPOL;MEN1;EIF2S1;EGFR;MAP3K4;AKT1;ERCC6;ERCC2;YY1;MSH2;ATR;PTPRK;EIF2AK4;MAPK8;ERCC3;GTF2H2;POLK;SMPD1;CAT;EP300;NOC2L;RHBDD1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.48786323094529255,1.0828966546179262,0.3333333333333333,1.0,1.0,6/31,12.43%,SLC6A13;SLC19A1;SLC47A1;ATP1A2;SLC22A2;SLC5A6
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.7568589757332256,-1.082732683787717,0.45161290322580644,0.8406740730239094,1.0,1/6,4.38%,CCDC39
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.6022890136149733,-1.0827127702666695,0.40625,0.8401359402205941,1.0,4/10,29.36%,EIF2B2;INHA;EIF2B4;EIF2B5
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.5493651511528178,-1.0824047114738486,0.421875,0.8404607832346176,1.0,6/24,20.36%,CDKN2A;SRF;PRKCD;PML;CDKN1A;SPI1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.4903291483068151,1.0822663341816294,0.34615384615384615,1.0,1.0,7/31,14.70%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2;RRN3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.5682494928461532,-1.0821970507896788,0.42857142857142855,0.8404493920820332,1.0,5/22,13.60%,ANK3;KCNB1;CEMIP;PDZK1;SLC51B
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6274824474287637,-1.0818642790496569,0.484375,0.8408938713385803,1.0,3/12,6.13%,ZFP36;YBX3;ELAVL4
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5064186376290811,-1.0813406332722846,0.323943661971831,0.8419704419083687,1.0,1/29,0.54%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.6323890368414831,-1.0811634045772365,0.42028985507246375,0.8419201069045525,1.0,2/9,16.51%,RAMP3;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.6658288875464348,-1.08106665460197,0.45614035087719296,0.8416613350055683,1.0,1/7,0.54%,EFNA1
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6365328968543648,1.0810522358033061,0.40625,1.0,1.0,2/8,2.48%,BMP2;MYORG
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.63043953423644,-1.080854742781842,0.3870967741935484,0.8418007007806375,1.0,1/9,0.18%,ANXA1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.6936244026648024,1.0808473064325856,0.47619047619047616,1.0,1.0,4/5,29.28%,ALKBH3;JMJD6;ALKBH1;FTO
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.3481804534683824,1.0802590872304207,0.375,1.0,1.0,73/274,26.51%,U2AF1;PPARGC1A;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;ERCC2;WDR33;NOVA1;CWC27;SMNDC1;RAVER2;RBM41;LSM8;CSTF3;CPSF6;SNRPN;PAPOLA;SNRPB2;CPSF7;SPEN;LSM5;TFIP11;ERCC3;GTF2H5;SRSF8;RAVER1;GTF2H2;SYNCRIP;RBM17;LSM7;THOC3;HNRNPU;POLR2C;AQR;PPIE;THOC1;ZMAT2;PPWD1;SNRNP27;CLP1;RPRD1B;DHX15;PSPC1;PDCD7;RBMX;ERN1;CPSF2;GTF2H3;CRNKL1;RBM15;RNGTT;PPIH;USP49;PLRG1;RBM19;SART3;SUGP1;CMTR2;PRPF40B;MTREX;CCNH;HNRNPD;SCAF11;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;ZCCHC8;MAGOH
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.6963584564032201,-1.0802570523484198,0.4166666666666667,0.8428043106468147,1.0,2/6,11.39%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.6619736516665591,-1.0800603193806877,0.49056603773584906,0.8427157121268471,1.0,2/14,3.31%,TRIM22;TRIM5
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.5786656012925975,-1.0799333856360847,0.3548387096774194,0.8425705239047416,1.0,2/17,3.28%,ABCA5;ABCA8
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.37319723127971705,1.0798697449550725,0.2727272727272727,1.0,1.0,8/94,2.75%,G0S2;LEPR;GOLT1A;FGL1;PHLDA1;PLIN1;MTTP;CEBPA
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.5331810888412267,-1.0795172018654715,0.38028169014084506,0.8432693125759396,1.0,6/35,9.19%,CLIC1;SLC4A11;BEST1;SLC26A8;ANO9;CLIC4
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.6415555756933597,1.0794003128794627,0.4473684210526316,1.0,1.0,1/7,3.98%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6057147602712851,-1.0791892429095893,0.39285714285714285,0.8436965702112776,1.0,4/12,13.76%,RSPO3;SFRP4;GPC3;RNF213
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.648167891628595,1.0791402017271559,0.4318181818181818,1.0,1.0,2/7,5.26%,HSPA1A;GIT1
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.6923723466699593,-1.0790646485363964,0.4827586206896552,0.843582453072101,1.0,3/6,11.20%,IRF1;TNFRSF14;SYK
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5818258926450444,-1.0787706838481386,0.4090909090909091,0.8440403381831502,1.0,5/17,19.17%,MYO1F;MYO15A;MYO1E;MYO1H;MYO1C
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.6045715866207153,-1.078642492265889,0.43103448275862066,0.8438759044783856,1.0,3/13,14.82%,TENM4;RIMS2;MYRF
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3920101289890341,1.0781108568769067,0.3181818181818182,1.0,1.0,24/57,33.23%,MIOS;FBXO9;WDR24;PIK3CA;SLC38A9;DYRK3;PRKAA1;TBCK;MINAR1;TBC1D7;GOLPH3;LAMTOR3;RPTOR;NPRL3;ARAF;EPM2A;NPRL2;RHEB;WDR59;SIRT1;LARS1;ITFG2;MLST8;RICTOR
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6108971706617731,-1.077970606975695,0.40298507462686567,0.8452617460857421,1.0,2/14,10.92%,PLAAT4;LPCAT4
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.49317414971795615,-1.0779646507836351,0.3150684931506849,0.844726703109388,1.0,3/38,10.32%,LEF1;POLE3;TAF10
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.6812183558653172,-1.077957166845565,0.4444444444444444,0.8441735835788424,1.0,3/5,21.77%,THPO;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.7139108238653253,1.077616983153407,0.3191489361702128,1.0,1.0,1/5,7.93%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.7139108238653253,1.077616983153407,0.3191489361702128,1.0,1.0,1/5,7.93%,SNF8
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.7016612569502447,-1.0776099506894576,0.423728813559322,0.8447046730673694,1.0,2/7,6.95%,OGN;OMD
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.45765217182584983,-1.0775456994870352,0.38961038961038963,0.844352589780931,1.0,24/97,16.71%,APLNR;STMN2;L1CAM;RCAN2;RAMP3;MAOB;PLP1;THY1;APOD;GFAP;SLC18A2;ZNF536;IGSF21;SHC2;ADCY5;IGFBP5;RASL12;RGS7BP;TMEM132C;CRTAC1;CCDC3;CNTN2;PHYHIP;TCEAL5
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6193839173213334,-1.0774988108199597,0.45901639344262296,0.8439259305084104,1.0,3/10,8.52%,PVALEF;RCSD1;TNNT1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5916354550620038,1.077349517283995,0.3488372093023256,1.0,1.0,4/11,14.23%,ZNF502;VAPA;CHMP2B;VPS37B
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.49313481438469564,1.077310661986104,0.2972972972972973,1.0,1.0,2/24,5.81%,RAB33B;ARL5A
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.44524984885771257,-1.0771828735010904,0.3194444444444444,0.8442561084835501,1.0,9/63,11.00%,CDH22;PKP2;CDH6;TJP3;GJC1;FSCN1;CDH7;CDH19;CDH9
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.5508151636036615,1.0769519097348002,0.34210526315789475,1.0,1.0,10/18,27.02%,INTS7;EXOSC6;INTS8;INTS6L;EXOSC8;TOE1;INTS14;USB1;EXOSC5;INTS6
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.528298210793506,1.0768173032031036,0.3611111111111111,1.0,1.0,9/20,37.27%,AP3B1;BLOC1S4;PIKFYVE;AP1M1;RAB32;GPR143;BLOC1S2;HPS1;AP1G1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5772433986146306,1.0763771508206892,0.37142857142857144,1.0,1.0,4/12,20.77%,CPSF6;IWS1;NSUN2;NUP153
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),-0.676204700004321,-1.0763370632106393,0.4126984126984127,0.8462035222805475,1.0,1/5,8.06%,ANGPTL3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.4156471464234931,-1.0762446647571564,0.3333333333333333,0.84588258627086,1.0,26/146,15.22%,RIMBP2;TAGLN3;STMN2;CCK;NEFM;MFSD6;CASZ1;LRRTM1;ATRNL1;SYT4;GFRA2;MAP1B;ELAVL4;JPH3;GAP43;SLC7A14;ZNF536;CPLX2;CA10;STMN4;CRMP1;RGS7BP;VIP;CNTN2;KCNC1;GDAP1L1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6508594602641119,-1.0761747986798162,0.46296296296296297,0.8455745577025574,1.0,1/5,7.58%,PDHX
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.659533839830571,-1.075914350324029,0.4,0.8458902696102963,1.0,1/10,3.93%,ART3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.5070658444576563,-1.0757978160832742,0.45588235294117646,0.8456324829382117,1.0,2/32,3.28%,AGPAT4;ABCA8
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.440878087171513,-1.0755930290814917,0.3815789473684211,0.8456302627615917,1.0,13/103,13.76%,ERCC6L;WDR62;RPS27;PLK2;CENPH;CENPE;ZWILCH;NUF2;SPC24;CCNB1;KIF2C;CENPN;CENPU
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.6772257440713803,-1.0751870539092958,0.4489795918367347,0.8463620868921624,1.0,1/7,4.01%,MAFF
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5865422249727237,1.075084189591524,0.4117647058823529,1.0,1.0,3/9,14.84%,WDR91;PPP2R5A;PIK3R1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5717634674308824,1.074851125165618,0.4117647058823529,1.0,1.0,6/13,15.95%,SOX8;PEF1;KLHL12;CDH2;TAPT1;FBXL17
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.5124791918632636,-1.0745968244207091,0.3472222222222222,0.8476151150076614,1.0,13/37,24.73%,NLRC5;PARP14;ISG15;SLIT3;SIGIRR;CCDC3;USP18;PTPRC;SH2B3;SLIT2;RFFL;PPARG;STAT2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.4536918944956341,-1.0742541462595119,0.3972602739726027,0.8480340077453463,1.0,14/95,11.49%,RASGRP1;CDKN2A;RASGRP2;SHTN1;PLK2;RALGDS;PLD1;USP50;RIT2;PLD2;IGF1;SHC2;ARHGEF18;RAPGEF5
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.4343531177575167,1.0740686906149326,0.4444444444444444,1.0,1.0,3/31,4.15%,NGF;CEL;NLGN3
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.5813344126166089,1.0739441143035642,0.3488372093023256,1.0,1.0,4/12,14.18%,ABCD1;ELOVL2;SCP2;ACOX1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.6515544683369077,1.073842539364217,0.4146341463414634,1.0,1.0,1/6,1.86%,RPP40
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.351131680516446,1.0737285710546445,0.2727272727272727,1.0,1.0,97/231,34.61%,U2AF1;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;RAVER2;RBM41;LSM8;CSTF3;SNRPN;PAPOLA;SNRPB2;CPSF7;SPEN;LSM5;TFIP11;SRSF8;RAVER1;SYNCRIP;RBM17;LSM7;HNRNPU;POLR2C;AQR;PPIE;ZMAT2;PPWD1;SNRNP27;CLP1;DHX15;PSPC1;PDCD7;RBMX;CPSF2;CRNKL1;RBM15;PPIH;USP49;PLRG1;RBM19;SART3;SUGP1;PRPF40B;MTREX;HNRNPD;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;ZCCHC8;MAGOH;SNRNP35;SRSF2;POLR2K;POLR2D;PRCC;LSM6;PPIL3;MAGOHB;PABPC1;SNRNP40;CSTF2T;HNRNPH1;POLR2E;PTBP1;DHX16;RBM15B;CTNNBL1;HNRNPL;FRG1;SF3B3;EFTUD2;CCAR1;ELAVL1;BUD31;PCF11;RBM22;SFPQ;HNRNPH3;DDX5;METTL14;SART1;HNRNPR;DDX46;METTL3;SF1;TRA2A;CDC5L;BCAS2;RALY
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.6218955398690026,1.0736910945682459,0.4523809523809524,1.0,1.0,5/8,32.77%,METTL4;NSUN3;ALKBH1;TSFM;MTRES1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.5746836961521233,-1.0736680472344962,0.3380281690140845,0.8493587318024215,1.0,2/16,4.68%,HELB;POLQ
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.5701447496486732,-1.0735974668952966,0.359375,0.8489879848882986,1.0,5/17,22.46%,OVOL2;VEPH1;TGFB1;WWTR1;NODAL
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.5988332498964127,-1.0735312984536942,0.423728813559322,0.8486487339027208,1.0,4/12,19.00%,PROX1;MYLK3;FHOD3;PDGFRA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.48054761888772773,1.0733654828051045,0.36,1.0,1.0,7/33,14.70%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2;RRN3
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.5794421921777958,1.073272516482417,0.375,1.0,1.0,1/9,1.08%,CHAMP1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.4398801982277985,1.0732395563653787,0.4411764705882353,1.0,1.0,5/32,6.13%,BMP2;ADAMTS9;SGCD;SMAD5;TCAP
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.6320496229479955,-1.0729805886203247,0.3880597014925373,0.8499208207561069,1.0,4/11,11.93%,IFI35;DYSF;SYK;SBNO2
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5750673946500287,-1.072440180271662,0.4166666666666667,0.8510983323879716,1.0,5/18,15.64%,RPL3;RPL24;RPL10;MRPL20;RPL5
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.46624726582120585,1.0721751926216414,0.3333333333333333,1.0,1.0,13/47,21.09%,ANKRD50;SNF8;PTPN23;CMTM6;WASHC2C;VPS50;SNX31;VPS39;SNX27;EPS15;ACAP2;EIPR1;VPS29
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.6746082769181208,1.072172308847252,0.41025641025641024,1.0,1.0,3/6,25.66%,TAMM41;GPAM;PGS1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.423036141164323,-1.072016889558883,0.3448275862068966,0.8517669010826121,1.0,48/211,18.74%,EFNA1;SCN1B;POU4F1;L1CAM;ANK3;CCK;NEXN;SHTN1;S100A6;SEMA3B;DOK1;APP;SLITRK1;GFRA2;VLDLR;MAP1B;EFNB3;BAIAP2;DRAXIN;NEFH;DOK6;WNT5A;UNC5B;PRKCQ;SLIT3;SLITRK4;RAP1GAP;SLITRK5;SEMA3E;ROBO4;BDNF;PIK3CB;CNTN2;LAMA3;RELN;PIK3CD;LRTM1;IRS2;SH3KBP1;GPC1;NOTCH3;CDK5;SEMA4G;ANOS1;PTPRO;NIBAN2;VSTM2L;LAMA5
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5591796369871762,-1.0718701714115486,0.4461538461538462,0.851636932124205,1.0,7/18,28.23%,SEMA3B;SEMA3E;SEMA4G;SEMA4C;SEMA6D;SEMA3C;SEMA3D
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.4157872315334135,-1.0714207823146957,0.3448275862068966,0.8525514151598258,1.0,38/175,20.77%,IFI6;DHCR24;TGFBR2;TLR2;MX1;IRF1;HK2;APP;SEPTIN4;PLK3;PLSCR1;GADD45A;SCN2A;IER3;CSRNP1;BCL2L14;ELMO1;FADD;IFIT2;BOK;DLC1;TCHP;PRKCD;TSC2;CDK5;DAPK3;DDX41;TNFRSF10A;IFI27L2;BBC3;ZNF385A;TRPC5;CASP8;PAK5;RELT;PAK6;RTN4;IKBKG
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4033987528975047,1.0711614273876247,0.25806451612903225,1.0,1.0,12/82,11.34%,MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.4033987528975047,1.0711614273876247,0.25806451612903225,1.0,1.0,12/82,11.34%,MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4033987528975047,1.0711614273876247,0.25806451612903225,1.0,1.0,12/82,11.34%,MUC20;PSMD10;BCL10;TAB3;NRAS;PSMA1;PSMD11;CUL1;PSMB5;BTRC;PRKACB;PSMD14
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.4944754050886308,-1.0708569079630366,0.33783783783783783,0.8536993296049509,1.0,5/41,3.93%,CD24;EFNA1;EPS8L2;TJP3;OVOL2
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.6803180235936857,1.070770421642124,0.42857142857142855,1.0,1.0,3/7,27.65%,CSF1R;PARD6A;FERMT2
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.660516763555038,1.0706362795643278,0.48717948717948717,1.0,1.0,2/6,24.42%,XPO1;ABCE1
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.637064501351531,-1.0705045173186032,0.43283582089552236,0.8544014069935858,1.0,2/7,13.93%,FGF1;PTH1R
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6042688881123061,-1.0704161205829172,0.36065573770491804,0.8540788580348385,1.0,3/11,12.39%,PLAAT4;SFRP4;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4152289469792963,1.0704130614765417,0.34285714285714286,1.0,1.0,15/46,20.22%,ERCC8;SPRED1;EGFR;BRCC3;UBE2N;TRIM28;ERCC6;ATR;SPRED2;EYA1;CEBPG;EYA2;FXR2;CCAR2;FBH1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.6132856821844023,1.0703143706832663,0.41304347826086957,1.0,1.0,2/9,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5220179440470051,1.070273018062869,0.35294117647058826,1.0,1.0,1/17,0.30%,ACE2
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.5066334513667868,1.0700676135274967,0.4074074074074074,1.0,1.0,8/24,17.67%,ARFIP1;LLGL1;DISP1;SCFD1;P3H1;STXBP5;NDFIP1;GAPVD1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.523848465359966,-1.0698214949033655,0.38961038961038963,0.8554761337444121,1.0,5/31,7.61%,CLDN16;POF1B;LSR;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.6394243834726347,1.069502288547917,0.4666666666666667,1.0,1.0,2/8,11.56%,CEL;CYP46A1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.6469225164894203,-1.0692783882777368,0.4,0.8565574612092688,1.0,4/7,21.92%,CEACAM1;HLA-F;PTPRC;KLRD1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5378044500173654,1.0687767145279006,0.3076923076923077,1.0,1.0,7/13,37.37%,PCBP4;RBMX;SRSF9;PTBP1;SAP18;U2AF2;SFSWAP
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),-0.6785534266824487,-1.0682459009632665,0.4838709677419355,0.8591205880425111,1.0,2/6,10.08%,TLR3;IRF7
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.4831968703191483,1.0682432155207255,0.27586206896551724,1.0,1.0,3/25,3.54%,ARV1;PDK4;ADIPOR1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5587547342171597,-1.0680279188842432,0.39655172413793105,0.8591770868682508,1.0,7/16,27.16%,HLA-DRA;DDX60;HLA-DRB1;MYO18A;PTPRC;XBP1;RPS19
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.7221763117283877,-1.0676760932853426,0.38461538461538464,0.8597498030805562,1.0,1/5,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.5010044717952965,-1.067336298312649,0.3283582089552239,0.8602296253214665,1.0,8/45,12.78%,ANXA1;TLR2;KLF4;NOD1;TLR3;CHI3L1;SYK;FADD
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.5318256175540926,-1.0671203922138077,0.41025641025641024,0.8602852763131503,1.0,7/26,18.19%,CTSC;CAV3;ATP5IF1;DAB2IP;PSMC3;DDRGK1;NUPR1
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.42131239730092895,1.0670794307127738,0.2608695652173913,1.0,1.0,3/26,6.69%,OCLN;AKT2;AKT1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.390912828322757,1.0670041134384145,0.3333333333333333,1.0,1.0,64/162,31.50%,U2AF1;PPARGC1A;SF3A1;NUDT21;SNRPF;SF3B4;HNRNPC;RP9;NOVA1;TSEN2;FASTKD2;CSTF3;CPSF6;SNRPN;DROSHA;NUFIP1;LSM5;TFIP11;SYNCRIP;TENT4A;RNASEL;MTPAP;HNRNPU;THOC1;TENT4B;CLP1;DHX15;CCAR2;PDCD7;DKC1;RNGTT;CDK12;MBNL1;NOL9;USB1;RBM39;ADARB1;HNRNPD;SCAF11;SRSF9;SNRPB;SNRNP48;ZCCHC8;MAGOH;YJU2;SNRNP35;SCNM1;PRKACA;SRSF2;M1AP;TENT2;LSM1;KHSRP;SRPK2;LSM6;KIN;MAGOHB;SNRNP40;HNRNPH1;PTBP1;DHX16;HNRNPL;PIWIL2;TUT4
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.4730243261014833,-1.066993444736916,0.3246753246753247,0.8601077570259068,1.0,15/56,17.35%,B2M;ANK3;KCNJ13;KCNJ2;CHRM1;SYT4;ATP1A1;YWHAH;SYT1;PDZK1;NOS1;SYT5;SYT2;SYT13;SNX6
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.4484347679703986,1.066681107889548,0.3333333333333333,1.0,1.0,4/19,10.94%,CEL;NLGN3;NRXN1;GPHN
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.6088608355290234,-1.0663631793891872,0.38095238095238093,0.8614139465658512,1.0,5/13,22.35%,PLSCR1;SIGIRR;MYLK3;F3;APOL2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.6249569136683287,-1.0659938359161876,0.42424242424242425,0.8619771612386088,1.0,4/11,32.60%,LPCAT4;OSBPL10;MBOAT1;PLAAT3
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.6312442252347592,-1.0659386462962952,0.40298507462686567,0.8615478753293573,1.0,1/9,8.19%,DONSON
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),0.6551722452622825,1.0658705708116936,0.4375,1.0,1.0,4/6,29.88%,CSF1R;PTK2;IL33;MAPK1
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.4410398533803,-1.0657007147794635,0.33766233766233766,0.8617309470682246,1.0,12/96,7.16%,STMN2;NEFL;NEFM;SH3GL2;GJC1;PLP1;ZDHHC22;LRRTM1;SRRM4;MAP1B;GAP43;GRIA1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.5861803529906146,-1.06562068856913,0.4166666666666667,0.861455237396381,1.0,3/13,14.47%,C3;LDLR;MFSD2A
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6349387921742902,1.0655656090205226,0.325,1.0,1.0,4/6,30.88%,TST;CTH;GCLC;CDO1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.5914230819055539,1.0655346357998465,0.4418604651162791,1.0,1.0,2/11,3.55%,NR1D1;PGM2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.5914230819055539,1.0655346357998465,0.4418604651162791,1.0,1.0,2/11,3.55%,NR1D1;PGM2
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.6212907738146067,1.0654111188238062,0.4864864864864865,1.0,1.0,1/7,3.30%,SPRED1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.592119118290626,1.0651424991042948,0.4864864864864865,1.0,1.0,4/11,24.49%,RNF14;AR;DAXX;PLPP1
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.5670164268383452,1.0651355403404892,0.34285714285714286,1.0,1.0,3/9,14.67%,GRAMD1C;GRAMD1B;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.6586687037474626,-1.0650812651208048,0.47368421052631576,0.8625912613676706,1.0,2/7,14.82%,TENM4;MYRF
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.4784383534465223,1.064975367822706,0.36666666666666664,1.0,1.0,6/29,13.59%,UBTF;ERCC2;POLR1F;ERCC3;GTF2H5;GTF2H2
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.418725062112881,-1.0648640087629002,0.2876712328767123,0.8627427536020894,1.0,34/134,18.56%,RFTN1;FYB1;HLA-A;SKAP1;INPP5D;THY1;HLA-DRA;PSMB9;MOG;WAS;LAT2;NFKBID;EIF2B2;PSMB6;HHLA2;PRKCQ;SYK;BMX;PSMC3;FYB2;THEMIS;BTN3A1;BLNK;PIK3CB;PSMA8;PIK3CD;SH2B2;PSMA7;HLA-DRB1;PRKCB;PSME1;RIPK2;CARD11;CD4
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),0.6817707707947013,1.0646545392866973,0.32608695652173914,1.0,1.0,1/5,16.63%,ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),0.6817707707947013,1.0646545392866973,0.32608695652173914,1.0,1.0,1/5,16.63%,ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),0.6817707707947013,1.0646545392866973,0.32608695652173914,1.0,1.0,1/5,16.63%,ERLIN1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.4548510784057376,-1.0645103531355966,0.3088235294117647,0.8632235417049425,1.0,15/70,18.31%,TYMS;CDKN2A;PLK2;CCND1;PLK3;CRLF3;CCNE2;CDKN3;CDK2;MAX;CDC7;CDK5;CDKN2D;CDKN1A;SPDYA
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5717003522405464,1.064373962488262,0.42424242424242425,1.0,1.0,4/12,19.17%,ALG6;ALG3;ALG11;ALG13
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5278361936408035,1.0642819412576965,0.45,1.0,1.0,2/15,11.71%,FLT3;CSF1R
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.6992013889317651,1.064078128247852,0.4146341463414634,1.0,1.0,2/5,15.61%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.6992013889317651,1.064078128247852,0.4146341463414634,1.0,1.0,2/5,15.61%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4911050905428638,1.0640234456103552,0.4117647058823529,0.9998291489738037,1.0,6/21,17.34%,CRPPA;TMTC4;FKRP;POMT2;TMTC3;DPM1
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),0.7111237032218103,1.0638924696186811,0.4146341463414634,0.9976822503314644,1.0,4/5,28.90%,SMYD5;BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),0.7111237032218103,1.0638924696186811,0.4146341463414634,0.9976822503314644,1.0,4/5,28.90%,SMYD5;BEND3;SETD4;KMT5B
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.534720823144478,-1.0635079674642802,0.38461538461538464,0.8654964350516443,1.0,4/30,7.93%,KCNJ13;KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3981799265436979,1.063323569769328,0.3,0.9983530528675365,1.0,31/68,26.73%,PSMD10;CEBPA;HSPA1A;TRIB3;KEAP1;BAG2;VCP;RNF14;CSNK1E;CBFA2T3;PLK1;RCHY1;TRIB2;COP1;ZYG11B;MDM2;PYHIN1;SMAD7;RNF217;SUMO2;NUB1;DDA1;PTK2;HSPBP1;SIRT2;FBXW7;AXIN1;DNAJB2;HECTD1;PTEN;ANKIB1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.6059395053411489,-1.0631808904777296,0.423728813559322,0.8657675902614216,1.0,3/14,13.72%,MMP14;SYK;IL7
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.6628721502409923,-1.0628169929137679,0.43333333333333335,0.866288067507378,1.0,1/8,0.54%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.48488225092652903,1.0625747421584215,0.3,0.9996469658931666,1.0,3/22,11.49%,FAM47E;DNMT3B;KMT2A
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5978591022224281,1.0623863578130204,0.43333333333333335,0.9992422323827136,1.0,4/9,14.67%,PDE3B;PLIN5;AKT1;GPLD1
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.5886393242108625,-1.0622758041476699,0.423728813559322,0.8673981755480744,1.0,3/10,13.54%,POU2F3;PSMC3;TFAP4
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.5905067671690877,1.0619361762864334,0.3939393939393939,0.9996378150991488,1.0,3/10,8.36%,DAO;GLUD1;GLS
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.6148425439799302,1.0618637115068044,0.42105263157894735,0.9985845075061863,1.0,4/9,20.22%,DNASE1L2;DFFB;DNASE1L1;FBH1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.597059872605982,-1.0611773419517097,0.48333333333333334,0.8703739144243549,1.0,5/13,23.97%,B4GALNT1;ST8SIA3;B3GALT4;ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.4957035121442192,1.060841805043086,0.35294117647058826,1.0,1.0,1/12,0.60%,RGCC
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6713572597335002,-1.0608115650315788,0.4166666666666667,0.8702460066482999,1.0,1/8,2.14%,KMO
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6713572597335002,-1.0608115650315788,0.4166666666666667,0.8702460066482999,1.0,1/8,2.14%,KMO
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.536374470503798,1.0607428588072811,0.34146341463414637,0.9997119211917243,1.0,5/18,20.77%,TSPAN33;NDC1;NUP205;BAD;NUP153
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5680350278562645,1.0605261458853423,0.38235294117647056,0.9981942345324917,1.0,4/18,18.57%,TEX15;DNMT3B;BEND3;EHMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5680350278562645,1.0605261458853423,0.38235294117647056,0.9981942345324917,1.0,4/18,18.57%,TEX15;DNMT3B;BEND3;EHMT1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.6099247782946247,1.060276759117104,0.4878048780487805,0.9977273057516193,1.0,1/6,2.42%,HS3ST5
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.6800592509348655,1.0599506686768776,0.4807692307692308,0.9975705162331111,1.0,1/5,22.01%,GOLPH3
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.5801903288707174,-1.059804448488296,0.3939393939393939,0.8724188854931394,1.0,4/14,13.10%,HPN;ZIC1;MYO3A;PAX8
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.6131724907492448,-1.0594812695927045,0.37254901960784315,0.8728298393366246,1.0,1/8,12.39%,OGG1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.6409826883212062,-1.0593050733535014,0.4262295081967213,0.8727371246116696,1.0,1/8,2.72%,ALOX12
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),0.6665399582967533,1.0592292249253472,0.475,0.9984877392315596,1.0,3/6,29.39%,GLUL;MCRS1;POLR1A
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.5239848261221681,-1.0591858796552323,0.4626865671641791,0.8724809694554368,1.0,5/24,11.12%,THBS1;SP100;SVBP;GADD45A;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.4292419478896147,1.0590348134921646,0.29411764705882354,0.9978076390426485,1.0,4/32,10.09%,FAM47E;MSH2;ATR;PLK1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.6162601342211642,-1.0590252968739884,0.4696969696969697,0.8724007119380206,1.0,2/8,13.31%,CCDC39;BBOF1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.44508694825834844,-1.058998009088167,0.36764705882352944,0.8718970645710522,1.0,14/50,17.76%,RPE65;RDH13;PLB1;RBP2;AKR1C1;CYP1B1;GPC3;CYP3A4;ADH4;RDH12;DHRS13;GPC1;CYP3A5;LRP2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.631053777932589,1.058936165512117,0.5,0.9969283047434442,1.0,1/6,16.62%,NDFIP1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.5324126245277154,-1.0589068163207094,0.421875,0.8716298681049004,1.0,2/18,6.23%,GBP1;MMP14
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.4088461210867605,1.0587908903729493,0.3333333333333333,0.9961045299276308,1.0,11/61,11.15%,NGF;ASCL1;BRINP3;BMP2;MOSMO;BEND6;KCTD11;HEYL;EIF2AK4;NREP;ZC4H2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5608218262950473,-1.0587424831877759,0.43548387096774194,0.871634911678132,1.0,2/18,3.31%,TRIM22;TRIM5
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.5482855106797824,1.0585395130267476,0.39473684210526316,0.9957234872441066,1.0,3/10,20.90%,VDAC2;BAD;BCL2L11
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.5956341616679595,1.058343934283203,0.43902439024390244,0.9940179156208928,1.0,3/9,16.65%,VTA1;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.5956341616679595,1.058343934283203,0.43902439024390244,0.9940179156208928,1.0,3/9,16.65%,VTA1;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.5996276381007667,1.0582723045491549,0.46511627906976744,0.993068292102118,1.0,3/12,5.99%,AIFM2;SELENON;ABCD1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5218619116447878,-1.0581859077607114,0.4057971014492754,0.8727690707118669,1.0,6/31,18.13%,PIF1;RPA1;NOP10;ANKRD28;CDK2;TINF2
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6544227480805602,-1.0580268140584477,0.3770491803278688,0.8721686017658636,1.0,1/9,1.31%,TYMP
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6544227480805602,-1.0580268140584477,0.3770491803278688,0.8721686017658636,1.0,1/9,1.31%,TYMP
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.6317619866963144,-1.057769857241344,0.48148148148148145,0.872468569806179,1.0,1/7,1.92%,CIITA
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5147262307958399,1.0576482551009856,0.375,0.9933839226446827,1.0,2/19,10.14%,ARV1;GNB3
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.40611245310117644,-1.0575658230055731,0.4,0.8724971407850217,1.0,66/320,20.53%,RPL19;RPL3;RPS27A;WARS1;RPS27;RPS14;RPS4X;TESC;RPL27A;RPL35;SCX;RPL7A;RPL37A;ELAVL4;RPL27;RPL9;RPL21;RPL13A;POLR2I;RPS11;RPS16;RPL24;RPLP1;RPS13;RPL38;RPS3A;RPS8;RPL10A;RPL10;RPLP2;RPS23;RPS21;RPS7;RPS18;TSPAN32;PAX8;RPL8;DHX38;RPS6;GLE1;RPS15;RPS9;RPL12;THOC6;RPL5;RBM3;EEF1A2;RPL23;RPL4;DDX54;NXF5;RPL18A;RPL41;ANGPT2;RPL7;RPS12;RPS20;COPS5;RBMS1;MRPL23;RPL15;MRPL51;RPL11;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.5064907171798853,1.0574634321721743,0.38235294117647056,0.992862202106247,1.0,5/13,14.25%,BMP2;SOX9;SOX5;MDK;TAPT1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.4462769525375393,-1.0573307776408076,0.375,0.872597896083771,1.0,6/52,8.60%,L1CAM;NEXN;MYOT;FAT2;CEACAM1;IGSF21
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.40822315213196214,-1.0572979222164185,0.3829787234042553,0.8721151095346391,1.0,34/189,17.41%,PRAME;THBS1;HIC1;IL12A;NLRP12;SULF1;MMP14;PTK6;APOD;NOTUM;EGF;LRPAP1;IFT122;DAB2IP;HHIP;PRKCQ;SFRP4;TMBIM1;SIGIRR;IGFBP5;GPC3;MMRN2;EGFL7;BDNF;CBY1;PIK3CB;SFRP2;APLN;TNS2;PRKCD;TSC2;PRKCB;GPC1;NOTCH3
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.523646329727539,-1.0571025143381836,0.44,0.8721258224555866,1.0,10/28,20.75%,ACOT1;ACSM5;ACOT4;GLYAT;DBI;ACOT2;OXSM;ACOT8;ACOT6;HMGCS1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.6204062049782731,-1.05706781842581,0.40625,0.8716559823163977,1.0,1/7,8.00%,DBI
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5754571184262018,-1.057016271044898,0.45454545454545453,0.8712587856961795,1.0,1/18,0.54%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.472880151564659,1.0565219824629697,0.34285714285714286,0.9947690312291431,1.0,3/17,5.69%,BCL10;SLC39A10;FOXP1
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.4821008452279781,1.0564878910034312,0.34615384615384615,0.9937434632410042,1.0,5/17,21.11%,PDK4;CYP4F12;SLC12A9;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.6765615766144429,-1.0559770905257342,0.4444444444444444,0.8737955922526878,1.0,5/9,13.21%,HLA-A;CEACAM1;HLA-B;HLA-E;HLA-F
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6028083657377831,1.0559636292484318,0.45454545454545453,0.9941494735478518,1.0,6/7,38.53%,AGO3;AGO4;DHX36;DDX3X;DHX9;AGO2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.652917638898926,-1.0558884394721009,0.4,0.8734874504030472,1.0,3/6,14.15%,GABRB2;HRH1;GABRG2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.5624295199737563,-1.0556735255559813,0.4626865671641791,0.8735331875359779,1.0,5/21,20.15%,YBX3;BIRC3;FLOT1;CDC37;CASP8
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.4695822214234141,1.0555502636152736,0.2857142857142857,0.9944752333340671,1.0,2/25,0.94%,SLC26A7;SLC19A1
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.6564647390458009,-1.0553818948904465,0.43859649122807015,0.8738243453229485,1.0,3/7,18.51%,SLC25A45;SLC22A4;SLC25A29
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.5235608181373788,-1.0553793563176321,0.38095238095238093,0.8732834281908661,1.0,4/34,8.70%,ABO;B3GALT2;FUT2;ST3GAL6
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5581567402756948,-1.0550643931308006,0.41935483870967744,0.8736401464973764,1.0,4/11,14.84%,CYP1B1;CYP3A4;ADH4;RDH12
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.5111613566998999,1.0550205239846338,0.42105263157894735,0.9948530475659838,1.0,5/19,7.19%,ABCB10;ALAS1;HMBS;COX10;SUCLA2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.636461514380165,-1.055016852014957,0.4406779661016949,0.8732315124602213,1.0,1/8,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.6369597817496038,-1.0545841324822318,0.4603174603174603,0.8739461156757566,1.0,4/9,21.35%,VLDLR;DAB2IP;ALK;PACSIN1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.4816659335905039,-1.0545371586835175,0.3880597014925373,0.873603459420273,1.0,3/43,2.85%,S100A10;GBP1;PDPN
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.5946175013329251,-1.0544324437235875,0.36666666666666664,0.8732791372298694,1.0,1/11,2.93%,GMPR
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.5434261621914682,-1.0544284257403234,0.35526315789473684,0.8727227800169061,1.0,4/18,14.49%,KCNJ2;ATP1A1;ATP1B1;SLC12A7
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.5640152727276931,1.0542786008774134,0.4,0.9959157241901472,1.0,3/12,10.63%,GNL3L;CCT7;CCT3
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.6993356585527829,-1.054122176354954,0.4482758620689655,0.8731440032003864,1.0,1/5,6.29%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.7000746878175421,-1.0541038660487263,0.4406779661016949,0.8726539277166397,1.0,4/5,28.78%,TGFB1;CUEDC2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.48578676399748305,1.0540299505759907,0.3448275862068966,0.9956192243255932,1.0,3/18,6.69%,OCLN;AKT2;AKT1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.5113994293423456,-1.0539825360368433,0.4393939393939394,0.8724797703449454,1.0,8/27,15.12%,TLR2;APP;TLR3;WNT5A;SYK;IL18;IL7;CD74
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.4966648814068436,-1.0538778964450288,0.38461538461538464,0.8722344965241625,1.0,1/37,0.11%,LEF1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.48891099262840243,-1.0538676803511755,0.39705882352941174,0.8717221836791423,1.0,1/35,0.11%,LEF1
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),0.6465356376920859,1.053676019719091,0.47368421052631576,0.9957444269048151,1.0,1/5,2.42%,HS3ST5
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.4150926242736538,1.0530729171285764,0.3548387096774194,0.9966972602117204,1.0,12/48,14.55%,ADAMTS9;GAL3ST2;GANC;MAN1A2;GAL3ST4;PRKCSH;ENGASE;STT3B;GANAB;FBXO27;ST8SIA5;ADAMTS13
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.46943306559652825,1.0529837797412283,0.375,0.9957445634803651,1.0,4/18,6.09%,RAP2C;GREM1;PDGFD;PDGFC
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.4744170483404389,-1.052548767099025,0.36764705882352944,0.8747907721047404,1.0,9/52,13.19%,TLR2;RPS27A;PRDX4;TLR3;BIRC3;DAB2IP;MAP3K14;UBC;TNFRSF1A
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5714235465123543,1.0523853851677467,0.4634146341463415,0.9963018620045021,1.0,3/10,9.28%,BMP2;FOXJ1;SALL1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5921591245685923,1.052327112281087,0.4166666666666667,0.995364909121952,1.0,1/8,10.83%,PHETA1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5109234554273065,1.0521900728320779,0.42857142857142855,0.9947963827544994,1.0,3/14,14.77%,HSPA1A;SLC25A5;MUL1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.5828553617584251,-1.05213760252123,0.4782608695652174,0.8753929905569674,1.0,5/15,19.17%,MYO1F;MYO15A;MYO1E;MYO1H;MYO1C
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.49894361334666804,1.0518857045166603,0.3225806451612903,0.994764873819134,1.0,1/17,0.43%,NGF
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.46676329917754683,1.0516477964956545,0.4230769230769231,0.9945637720507728,1.0,14/43,23.42%,H2BC18;H2BC21;SOX9;ANP32B;RBBP4;H1-2;ASF1A;NOC2L;CDAN1;DAXX;KAT6B;H2BC5;SART3;BAHD1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.5051732568687003,1.051533837514473,0.4,0.9936852479806523,1.0,6/21,12.99%,EGFR;AKT1;MT1E;HSF1;MAPK8;AKR1C3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.5665091322807476,-1.0514615208886777,0.4411764705882353,0.8766763620491356,1.0,3/15,16.59%,OGFOD1;GLE1;CLN3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5257815731461599,-1.051460782517587,0.43478260869565216,0.876115109576633,1.0,1/24,2.00%,STMN2
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.5672799684446777,1.0514493253528872,0.3939393939393939,0.991661089294861,1.0,6/13,24.66%,COQ3;COQ2;COQ9;PDSS2;COQ6;UBIAD1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.5672799684446777,1.0514493253528872,0.3939393939393939,0.991661089294861,1.0,6/13,24.66%,COQ3;COQ2;COQ9;PDSS2;COQ6;UBIAD1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.3774893651197751,1.051250373521873,0.28125,0.9913864995287222,1.0,9/77,13.78%,WNT7A;PSMD10;PSMA1;PSMD11;PSMB5;AP2B1;PSMD14;DVL2;PSMD12
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),-0.7206587485592814,-1.050814835235431,0.5217391304347826,0.8774022990620793,1.0,3/5,24.22%,CCL2;COL4A3;PPARG
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.4540873657452954,1.050539257654778,0.375,0.9927476069235829,1.0,3/24,10.09%,INSC;LLGL1;PLK1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.6128938601299168,-1.0505238569118993,0.43283582089552236,0.8778711026282966,1.0,5/7,37.29%,ITGA3;FYN;IGF1R;PICK1;PRNP
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4871331784731561,1.0504617073751983,0.45161290322580644,0.9918891163368561,1.0,5/22,20.13%,PLD6;JAM2;DDX25;MKKS;FAM9B
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.5045321135728047,1.0502715257340094,0.375,0.9914080486812838,1.0,6/22,12.99%,EGFR;AKT1;MT1E;HSF1;MAPK8;AKR1C3
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6007518184241925,-1.0502082899826988,0.4576271186440678,0.8781086367749942,1.0,5/13,24.89%,SELP;DMTN;RYR2;PTPRC;GRM5
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.40422412069293895,1.0501749960232016,0.3181818181818182,0.990617694008335,1.0,9/50,14.03%,NR1D1;ADAMTS9;SOCS6;TRIM24;VCP;UBE2G1;STT3B;FBXO27;ATE1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.41519843967196113,-1.049943356820011,0.3793103448275862,0.8782985807861383,1.0,41/238,18.28%,THBS1;CCNB2;CDKN2A;DHCR24;DUSP1;POU4F1;PROX1;IL12A;IRF1;PIM3;BRCA1;PTK6;CCND1;GADD45A;TSPYL2;CRLF3;CCNB1;BIRC3;DAB2IP;BAP1;FOXM1;TFAP4;NR4A1;CDKN3;PES1;JUNB;NUDT6;SRA1;RPL23;PML;TSC2;CDK5;GPER1;GADD45B;GMNC;RASSF1;DAPK3;TGFB1;CDKN2D;NUPR1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6165359551681029,1.049821938418908,0.40625,0.9905137788305737,1.0,2/6,5.69%,BCL10;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5923567208181486,-1.0497750761216262,0.4142857142857143,0.8782342781703332,1.0,1/12,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.5360406496552049,-1.049629775747417,0.43333333333333335,0.8781051211953158,1.0,8/22,15.12%,TLR2;APP;TLR3;WNT5A;IL18;SIGIRR;IL7;CD74
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.44832722667800484,1.049457792218973,0.3076923076923077,0.9904230024774123,1.0,6/31,11.84%,NUDT21;SNRPF;WDR33;CSTF3;PAPOLA;CPSF7
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.45967045964097186,1.0494241211206914,0.3333333333333333,0.9893400113520985,1.0,5/27,23.39%,ZNF207;SLAIN2;TUBG1;TPX2;TUBGCP3
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.5433972758291973,-1.0494230267577715,0.45588235294117646,0.8781885124624097,1.0,7/24,15.82%,RSPH4A;CCDC39;SPAG17;CFAP74;SPAG1;DRC1;LRGUK
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.3474739013543396,1.0493676492882296,0.23529411764705882,0.9883624624052745,1.0,46/191,23.92%,TFB2M;ELOC;MTERF1;TRIM24;COPS2;EAF2;ERCC6;GTF2F2;ELOA;UBTF;BRF2;ERCC2;THAP1;HSF1;GTF2A2;RO60;TAF12;SOX5;ERCC3;SNAPC3;GTF2H5;TAF4;DDX21;GTF2H2;NFKBIB;NFKB1;TAF2;IWS1;POLR2C;TAF3;THRB;CCNT1;RBMX;GTF2H3;MED4;NELFA;RNGTT;CCNT2;TAF13;CTDP1;GTF3C3;PARP1;MLLT3;GTF2B;TRIP11;EPC1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.631070539523021,-1.0491567921284,0.453125,0.8785901699934207,1.0,2/9,10.15%,RAB11FIP5;CTSS
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.6339979514839637,1.0488531447073517,0.5263157894736842,0.9890845699626406,1.0,2/5,7.07%,CYP7B1;CXCL13
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.580823582835212,1.0486935677952147,0.4418604651162791,0.988404949499952,1.0,4/9,20.55%,FUT9;MDK;ZDHHC21;NFAT5
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.5218500336414162,-1.0486693259248918,0.4375,0.8793389461936304,1.0,4/25,5.98%,THBS1;ICAM1;CD160;CCL2
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.5670389189184479,1.0486039179878346,0.32432432432432434,0.9875985568969112,1.0,2/12,7.96%,CHRNA4;CHRNB4
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.6318415814289,1.048557037792764,0.475,0.9866145564155158,1.0,2/7,7.43%,PPARGC1A;VCP
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.6045239727547884,1.048407125482904,0.4791666666666667,0.9858247934989004,1.0,5/7,39.14%,TRIT1;ELAC2;HSD17B10;TRMT10A;TRMT10C
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.4893373933445953,1.048309721876691,0.35294117647058826,0.9849984437137546,1.0,2/18,8.22%,MTHFS;PTDSS1
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),0.6811569220398851,1.048188800711509,0.4,0.9842378130804373,1.0,2/5,6.69%,S1PR1;AKT1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.6858691169870734,-1.0477291053989732,0.47368421052631576,0.8816295006686724,1.0,2/6,5.98%,MSMP;CCL2
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.5377972480414286,1.0477208007076584,0.36585365853658536,0.9845506048107702,1.0,3/14,10.95%,PGM2;AGL;PYGM
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.33742959941833317,1.0476120048699609,0.4,0.9837284579797607,1.0,78/278,23.38%,NR1D1;PPARGC1A;INTS13;NR2E1;ELOC;RARB;ZC3H8;SNAPC5;MAML3;TRIM24;KAT2B;COPS2;ESRRG;NUDT21;SNRPF;EAF2;ERCC6;GTF2F2;ELOA;RORB;ERCC2;NRBF2;WDR33;AR;NR3C1;GTF2A2;CSTF3;NOTCH2;INTS7;PAPOLA;TAF12;ESRRA;CPSF7;SOX5;ERCC3;SNAPC1;SNAPC3;GTF2H5;TAF4;INTS8;DDX21;GTF2H2;ELP2;TAF8;NFKB1;TAF2;IWS1;POLR2C;POU2F1;NR2F1;NR1D2;ELP4;NR3C2;CLP1;TAF3;PCID2;HDAC10;INTS14;RPRD1B;THRB;CCNT1;MED23;RBMX;NR2F6;CPSF2;GTF2H3;MED4;NELFA;RNGTT;CCNT2;TAF13;CTDP1;CDK12;PARP1;MLLT3;ZBTB1;GTF2B;NR2C2
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),0.6118460884576413,1.0472166380885182,0.35714285714285715,0.9836210299612808,1.0,4/9,25.58%,DCLRE1B;TFIP11;DCLRE1C;DCLRE1A
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.4516814565000125,-1.0470829449891503,0.4117647058823529,0.882822617882716,1.0,12/89,12.85%,ST6GAL1;PLAAT4;ACOT1;ACSM5;ABCA12;ACOT4;GLYAT;DBI;NIT1;AEBP1;MTHFD2;ACOT2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.47452002391693854,-1.0469243758203117,0.44285714285714284,0.8826792765564547,1.0,2/45,1.91%,CP;B2M
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.39656502717779085,1.0466173754723906,0.2631578947368421,0.9842513565871138,1.0,11/71,12.98%,EPHA6;NCSTN;EFNA2;EFNB2;GIT1;YES1;AP2B1;ARHGEF28;EFNA5;EPHB4;WASL
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.46723049763816576,-1.0465632340144286,0.375,0.8831532096174486,1.0,15/64,20.40%,L1CAM;MYOT;SNCB;TJP3;APP;SLC8A3;CBLN2;SEMA3E;PPFIA1;SNCG;TGFB1;MAPT;MYO9A;AGRN;CXADR
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.4547403746669553,-1.0462034715885755,0.3972602739726027,0.8836089212173919,1.0,13/83,12.30%,SPATA12;TSKS;MAEL;BRCA1;MARCHF11;GSG1;TSACC;SPATA18;GAPDHS;CREB5;DNAH3;DEPDC4;BCL2L14
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5048811741132669,-1.0461415816069632,0.3918918918918919,0.8832305693018662,1.0,2/32,5.04%,TRAM1L1;APP
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.4320822821476258,-1.0461412505027738,0.3717948717948718,0.8826767200092147,1.0,20/143,15.68%,APLNR;POU4F1;PGR;OVOL2;SH3GL2;APP;KLF4;PARP14;LDLR;PARP9;IGF1;WDR54;LRPAP1;PINK1;PTRH2;CCDC3;SFRP2;MSR1;APLN;DDRGK1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6308455503797945,1.0458939901305266,0.4146341463414634,0.9856042661196768,1.0,3/6,16.37%,PEX13;PHYH;SLC25A17
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.43558662625958816,-1.0458776675714685,0.39285714285714285,0.8828973802696358,1.0,22/89,20.62%,TGFBR2;KIF14;ADCY7;TLR3;CHI3L1;IGF1;MINK1;WNT5A;FGF1;ADCY5;PINK1;IL18;STRADB;EMP2;SLC11A1;PRKCD;ADCY3;ADCY8;TNFRSF10A;GHR;PAK5;PAK6
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.6030429520589548,1.045833382416451,0.5,0.984657736676178,1.0,2/6,29.31%,PID1;APPL2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.6707515118002094,-1.045612788696914,0.4666666666666667,0.8831294781569398,1.0,1/7,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.46034398304512997,-1.045467321265518,0.4266666666666667,0.8828929011324139,1.0,12/44,19.41%,L1CAM;SHTN1;SYT4;SYT1;CPNE9;RIMS2;BDNF;PPIB;SYT2;MAPT;GHR;AGRN
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.49089526122456617,1.045410184092598,0.40540540540540543,0.9849426242863981,1.0,3/19,16.65%,ATF5;CHMP2B;VPS4B
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6200107869352526,1.0453866168382597,0.5405405405405406,0.9838976630266438,1.0,1/7,3.04%,NT5C1A
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.38459327659990294,-1.0453863315573706,0.3541666666666667,0.8825805593433983,1.0,86/545,18.45%,PRAME;LEF1;ANXA1;THBS1;HPN;APIP;IFI6;DHCR24;RPS27A;NAA38;PDPN;ARHGEF3;KIF14;PLK2;TP53I3;PRDX5;HTR2B;SCX;PLEKHG2;PIM3;GATA1;STEAP3;CYP1B1;CD44;NUAK2;SEPTIN4;ARHGEF17;PLK3;IFIT3;GADD45A;RPS6KA1;IGF1;STAT1;MLLT11;WNT5A;ARHGEF18;NDRG1;TFPT;BIRC3;DAB2IP;RPS3A;SFRP4;PINK1;BCL2L2;RPL10;BCL2L14;OBSCN;PIM1;UBC;FADD;PAX8;GRID2;IFIT2;TFAP4;CLEC5A;IL7;VIP;RPS6;BOK;CD74;SFRP2;THOC6;VAV1;APH1A;RASGRF2;DDRGK1;CCND2;SRA1;CLN3;BCL6;TEK;AHI1;MYO18A;CDK5;GPER1;RIPK2;AQP1;GADD45B;LRP2;HIPK3;DAPK3;NUPR1;NIBAN2;HSPA5;RARG;COPS5
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5755285279991801,-1.0452525790908596,0.45454545454545453,0.8824206437745483,1.0,3/15,5.98%,THBS1;CD160;CCL2
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.3636582168450633,1.045064464262074,0.3157894736842105,0.9837148924364009,1.0,27/90,18.77%,ABCD2;CEL;PEX11A;BCL10;ISOC1;ALDH1A1;PEX13;ABCD1;SLC25A19;MSH2;ABCD3;EHHADH;PRDX1;ECH1;ERCC3;SCP2;GNPAT;ACOX1;HSD17B11;PEX2;CAT;SLC25A17;VPS4B;CACNA1B;IDE;PEX6;CNBP
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.5238204194684277,-1.0449226356720942,0.4393939393939394,0.8827517990472116,1.0,3/25,6.33%,NOS1AP;HTR2B;CAV3
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.6169171349422058,1.0448062321951646,0.5,0.9836335762798037,1.0,2/6,3.86%,MYORG;SELENON
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.6367861182687811,-1.044291302815386,0.46551724137931033,0.8840753349028966,1.0,2/6,16.25%,GUCY2C;GUCY1A1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.4193713325195148,-1.04404757715328,0.39325842696629215,0.8841774132297278,1.0,25/215,12.44%,CXCL2;P2RY6;KCNQ1;POU4F1;NR4A3;P2RY12;TLR2;ZFP36;WNT8B;RAMP3;TESC;PRDX5;PDCD1LG2;CCL2;GLRA2;PTK6;WNT5A;PDK3;ROMO1;DAB2IP;SBNO2;TNIP2;IGFBP5;GNG2;DMTN
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.4278012517603908,1.043923319913607,0.2916666666666667,0.9850412567523008,1.0,1/38,0.01%,CPA1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.5064593249763352,1.0436719006165707,0.40540540540540543,0.9846057646329434,1.0,4/20,9.29%,CFAP53;ODAD3;FOXJ1;STIL
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4679161364282367,1.043393831511679,0.42424242424242425,0.9843474844222404,1.0,5/24,12.84%,DUSP19;MAP3K4;DVL2;SASH1;TAOK3
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.48395419330973977,-1.0433460384484468,0.4117647058823529,0.8858133448831381,1.0,10/43,11.85%,THBS1;TGFBR2;AKR1C1;BRCA1;CYP1B1;GADD45A;PDK3;ROMO1;PINK1;FOXM1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.5232609485162136,-1.0431803884169677,0.4594594594594595,0.8857859631044359,1.0,6/26,21.74%,APP;IGF1;MFSD2A;GHR;SPAAR;OLFM1
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),0.5240440864062903,1.0431759137469956,0.3448275862068966,0.9841023502594525,1.0,3/10,18.40%,H1-2;ASF1A;ATAD2B
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.43409986346396445,-1.0429150596454446,0.42105263157894735,0.8859391997738087,1.0,34/101,20.36%,CDH22;STMN2;GRIN2A;SLITRK1;SRRM4;GAP43;GRIA1;TCEAL6;RIT2;CPLX2;CA10;HPCA;SCN2A;SCN1A;STMN4;C11ORF87;SYNPR;GRIN2B;SCN3B;GAD2;DIRAS2;GABRG2;TMEM130;CNTN2;KCNC1;GABRA1;CNTNAP5;CELF4;SLC1A6;ST8SIA3;SLC17A7;PTPN5;KCNC2;PAK5
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6531643914763927,-1.0428491398738724,0.4827586206896552,0.885609048726414,1.0,1/7,5.22%,HTR2B
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.72180659174229,-1.0427242013323683,0.4915254237288136,0.885413125943347,1.0,1/5,4.00%,IFI35
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.4794828738372892,1.0426979425588165,0.41379310344827586,0.9843602125491996,1.0,6/25,12.67%,ABCD2;MACIR;IL17D;ABCD1;TICAM1;SIRPA
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.699447359575003,1.0426902356164027,0.4489795918367347,0.9833125627435505,1.0,3/5,24.01%,DRD2;CHD7;SELENOT
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4575072542528848,-1.0424289049439988,0.3875,0.8857000372318173,1.0,5/86,4.68%,APIP;BLM;B2M;KCNJ2;POLQ
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.6312559114902383,1.0419889520456533,0.5161290322580645,0.9841222103112433,1.0,3/8,26.17%,PLIN5;RHOC;PDPK1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.5593169504809509,-1.0419641365758698,0.42857142857142855,0.886573465226318,1.0,2/15,7.87%,OPALIN;TENM4
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.36043940842234434,1.041872446169915,0.3,0.9834527251811743,1.0,30/105,29.84%,WDR91;SNF8;PTPN23;WASHC2C;PHETA1;VTI1A;VPS50;PIK3C3;TBC1D5;RAB9A;RHOBTB3;SNX5;VAMP3;TBC1D23;RIC1;EPS15;KLHL20;PIKFYVE;VPS29;SNX2;BECN1;MON2;SORT1;RGP1;SNX1;VPS54;WASHC2A;AP2A1;VTI1B;VPS26B
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),-0.6504345420127366,-1.0418355006748166,0.4909090909090909,0.8857925668206282,1.0,2/8,11.70%,B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6504345420127366,-1.0418355006748166,0.4909090909090909,0.8857925668206282,1.0,2/8,11.70%,B3GALT2;B3GNT2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.4207305503380365,-1.041711629912902,0.37349397590361444,0.8855449451818846,1.0,15/114,14.45%,CD24;PRAME;CASZ1;KLF4;YWHAH;KLK6;SRF;LTBP4;RPS6KA1;ZFHX2;RUNX2;EMP2;NLGN1;FES;BDNF
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.48629421380780535,1.0415773410979738,0.4864864864864865,0.9834725506907298,1.0,7/21,15.16%,KMT5A;NCAPH2;CSNK2A1;CSNK2A2;PLK1;TENT4A;MCPH1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.5070071446531044,-1.0415347680723028,0.4266666666666667,0.8855526624317969,1.0,6/28,19.45%,DUSP1;DUSP16;TNS2;PTPRF;PTPRO;DUSP8
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5090719322684265,1.0414690844221204,0.45454545454545453,0.9829051879903151,1.0,2/16,5.75%,ALG6;ALG3
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.4917960839942809,1.0413645870271793,0.40476190476190477,0.9821019734033949,1.0,4/16,5.68%,SLC30A4;SLC39A10;SLC30A6;SLC39A8
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.5708647612218073,-1.0409720966264675,0.4583333333333333,0.8865335069214705,1.0,1/16,0.81%,BLM
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5811245317556767,1.040527392138239,0.4473684210526316,0.9836190221640595,1.0,3/10,16.00%,CSGALNACT1;GALT;UGP2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5252573197277723,-1.040517523210775,0.47560975609756095,0.8875189134477413,1.0,7/31,17.43%,CENPH;MIS18A;CABIN1;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.7078756794003999,-1.0403679863029043,0.5,0.8873633957514312,1.0,2/5,24.63%,ORMDL2;SPHK1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.6091719212133185,-1.0403348696144172,0.4126984126984127,0.8868843011953541,1.0,1/8,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.5524997853107716,-1.04028025343583,0.4430379746835443,0.8858990332559056,1.0,6/24,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.5524997853107716,-1.04028025343583,0.4430379746835443,0.8858990332559056,1.0,6/24,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.4225024459994607,-1.0402168995944179,0.41975308641975306,0.8855602472397986,1.0,17/105,19.21%,SP100;SPARC;WARS1;GPNMB;LZTS1;CEACAM1;LFNG;HECW2;EMP2;BCL6;CRB2;ETS1;CDK5;TGFB1;MAPT;PHLDB2;BMPER
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.33556051940627785,1.04004440243746,0.3333333333333333,0.9839000591317726,1.0,35/197,17.58%,TTC29;MACIR;FHDC1;CATIP;CEP19;SPAG16;BBS9;RAB23;SSX2IP;EXOC8;CEP20;EXOC6;INTU;DZIP1;CNGA4;TTC17;CEP290;RAB8B;PTPN23;FOXJ1;PARVA;PCM1;SCLT1;TEKT5;TTC8;NEK1;UNC119B;TCTN3;IQCB1;RAB8A;TMEM237;UBXN10;MKKS;SNAP29;EXOC5
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.62886838477096,1.0399080512744114,0.5,0.9831978933712497,1.0,2/6,14.48%,MAPK8;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5763612828624987,1.0397299169883,0.4782608695652174,0.9824848364738048,1.0,2/7,22.65%,OTUB2;TRIP12
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.5124678811308064,1.039510652188138,0.35294117647058826,0.9820711915986035,1.0,7/19,11.00%,ABCD2;ARV1;ACACB;ABCD1;MID1IP1;CPT2;ABCD3
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6014645461208392,-1.0393071900365676,0.42857142857142855,0.8877306233816963,1.0,5/12,27.02%,LAMA3;AHI1;LAMA5;CELSR1;ZDHHC7
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.46059872570731736,-1.039132217981132,0.45,0.8876908274202561,1.0,12/56,17.95%,TGFBR2;RPS27A;ADAMTSL2;ASPN;EID2;LDLRAD4;UBC;VEPH1;VASN;SNX6;LTBP1;TGFB1
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),-0.7064411984584237,-1.0391208821469056,0.5081967213114754,0.887161477522665,1.0,1/5,4.27%,GJC1
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.6171774198822737,1.039006191695888,0.4473684210526316,0.9814942763074904,1.0,1/5,2.23%,CARNMT1
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.6171774198822737,1.039006191695888,0.4473684210526316,0.9814942763074904,1.0,1/5,2.23%,CARNMT1
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.521303455024491,1.0389878133086532,0.4666666666666667,0.9804521751657251,1.0,6/15,19.47%,DAO;PSPH;SEPSECS;SRR;THNSL2;CTH
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.4878680976810652,1.0388320564689846,0.42105263157894735,0.9800178202090095,1.0,4/19,4.92%,LEPR;SDHAF4;PPARGC1A;COX10
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.6013230023186225,-1.0385583916974945,0.4262295081967213,0.8882100556886351,1.0,2/10,11.85%,NUAK1;FOXM1
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.5450688795979154,1.038236876955252,0.40425531914893614,0.9806089094866555,1.0,3/10,23.21%,DNM3;FGD4;EZR
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),-0.6891258651381913,-1.0380244318166079,0.5254237288135594,0.8892458247015115,1.0,1/5,4.77%,FSCN1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.4020239281594293,1.038000535528071,0.35294117647058826,0.980199985950824,1.0,15/61,17.28%,SLC26A7;SLC19A1;SLC25A24;CA2;SLC39A8;SLC4A7;SLC25A19;SLC25A41;SLC4A4;SLCO1C1;CYB5R4;CA3;CYB5R1;SLC25A17;CA12
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.5615093846912241,1.037904587330316,0.42857142857142855,0.9783759153980685,1.0,3/12,14.00%,MCU;TIRAP;MDK
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.5615093846912241,1.037904587330316,0.42857142857142855,0.9783759153980685,1.0,3/12,14.00%,MCU;TIRAP;MDK
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.561695366310712,1.0378240544636128,0.4,0.9776143158248553,1.0,6/12,26.34%,SALL1;HEYL;HEY1;HEY2;MDM4;HECTD1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.3379240635485226,1.037813289920531,0.29411764705882354,0.9765597156999093,1.0,49/179,22.77%,PDK4;MRPS30;ALAS1;NDUFB1;COX10;MRPL15;ATP6V1G1;ACADM;OAT;CS;SUCLA2;GLUD1;VDAC2;PHYH;TOMM22;LRPPRC;COX11;ATP5PB;OPA1;MPC1;ETFDH;ATP5MC2;ECH1;SLC25A5;NDUFA8;ATP5MC1;ACADSB;COX7A2L;UQCRC2;PRDX3;ATP5F1A;CPT1A;MTX2;BDH2;NQO2;NNT;NDUFS1;FH;NDUFV1;PDHA1;SLC25A3;DECR1;NDUFB4;MRPS11;ATP5F1C;DLAT;MTRF1;SLC25A20;SDHB
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.6809468582619095,-1.0375451255553676,0.4626865671641791,0.8899813430411493,1.0,4/6,30.99%,SLC12A7;RHD;RHCG;SLC12A4
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.46198441508582533,-1.0371438050989514,0.3561643835616438,0.8905952877419702,1.0,2/42,3.00%,CP;SLC39A14
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.657326610693774,-1.036947169169835,0.4716981132075472,0.8905653471666367,1.0,3/9,22.28%,ITM2A;ACOT8;ITM2C
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.5581243994063243,-1.0369394050063367,0.46551724137931033,0.8895076770239165,1.0,4/10,20.46%,CD44;CD74;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.5581243994063243,-1.0369394050063367,0.46551724137931033,0.8895076770239165,1.0,4/10,20.46%,CD44;CD74;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.5723433779701679,1.0367169725784129,0.4722222222222222,0.9787081858099357,1.0,2/9,18.19%,AGO3;CLP1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.5194682737786176,1.036624717388118,0.37142857142857144,0.9779241872081157,1.0,4/15,14.00%,MCU;TIRAP;XG;MDK
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.5326271976397201,-1.0364315898665193,0.4067796610169492,0.8905044054495485,1.0,4/17,10.88%,CYP1B1;C12ORF57;CACNA1C;IFT122
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.6250163822665592,1.0362128230484826,0.4318181818181818,0.9779740054635477,1.0,1/6,2.33%,ADAT2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.36457586166102995,1.035817712525187,0.25,0.9779625963277667,1.0,21/137,8.01%,G0S2;NGF;WNT7A;PTCD2;ETV5;TMEM100;GALNT3;BMP2;SPON1;TNFAIP3;SNAP91;DUSP6;SOX9;CA2;AKT2;ZNF639;MTMR10;USP12;STRN;ZNF277;WDR33
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5151945034190532,-1.035596499791451,0.4714285714285714,0.8923705504214812,1.0,8/28,19.00%,LMOD1;SYNPO2L;TNNT1;OBSCN;MYLK3;WDR1;FHOD3;PDGFRA
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.6266708521355107,1.0355379528951965,0.5,0.977829102094189,1.0,2/6,9.28%,BMP2;SALL1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.3990335513271667,-1.0351506226961986,0.4367816091954023,0.8931982674001828,1.0,36/175,18.74%,EFNA1;SCN1B;L1CAM;NEXN;SEMA3B;DOK1;GFRA2;VLDLR;EFNB3;GAP43;DRAXIN;DOK6;WNT5A;UNC5B;PRKCQ;SLIT3;RAP1GAP;SEMA3E;ROBO4;BDNF;PIK3CB;CNTN2;LAMA3;RELN;PIK3CD;LRTM1;IRS2;SH3KBP1;GPC1;NOTCH3;SEMA4G;ANOS1;PTPRO;NIBAN2;VSTM2L;LAMA5
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),0.6385016813536031,1.0347162284394538,0.38636363636363635,0.9793060128946757,1.0,3/7,18.23%,KDM5A;PRKD1;SPHK2
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4717120029205751,-1.034544643453581,0.40789473684210525,0.8944139811526151,1.0,2/48,1.31%,TLCD2;FABP3
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.6272567335000565,1.0341446483227128,0.45098039215686275,0.9800730421403185,1.0,4/7,30.97%,P3H4;JMJD6;VIPAS39;PLOD1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.5729974125934579,1.0339147971930367,0.46153846153846156,0.979828173062262,1.0,9/15,28.19%,INTS7;INTS8;MEPCE;MTREX;INTS4;ZCCHC8;INTS6;INTS9;INTS11
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.6333523680777401,-1.0336360645120994,0.5344827586206896,0.8964686431698279,1.0,3/7,15.12%,ICAM1;SLC11A1;CD74
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.3852119919542539,-1.0336271305199598,0.34782608695652173,0.8959266951005844,1.0,51/311,16.53%,PRAME;LEF1;THBS1;IL13RA1;NR4A3;TGFBR2;LAMB1;PROX1;RPS4X;S100A6;KIF14;COPS9;IL15;HTR2B;SCX;BST2;TIMP1;EGF;OSMR;IGF1;S1PR3;STAT1;THPO;WNT5A;TGFA;FGF1;ROMO1;FN1;NAMPT;SOX15;IL18;FOXM1;GLI1;PRKCH;PIM1;EMP2;FGF7;IL7;VIP;HYAL1;RPS6;RPS9;CD74;SFRP2;DDRGK1;CDK2;CCND2;CAPN1;CDC7;FGF22;RPL23
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.4479244990221845,-1.0332797055892746,0.425,0.8964760817174782,1.0,23/92,22.76%,COL4A1;COL4A2;LAMB1;SCARA3;CCND1;WNT5A;NUAK1;DAB2IP;FN1;AMOTL2;RHBDF1;COL12A1;PTPRF;LARP6;PTPN21;ABCG2;ANTXR1;WWTR1;CD276;SH3D19;LAPTM4B;MYO1B;SLIT2
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.6232508687056733,-1.0332730824261747,0.5084745762711864,0.895940504081705,1.0,3/7,20.03%,FN1;FERMT3;CX3CL1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.39069979907816826,1.033005886327874,0.4444444444444444,0.981213102993131,1.0,2/33,3.70%,DGKB;DGKE
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5426191148830005,1.0329279492719978,0.43243243243243246,0.9805059995346218,1.0,3/10,15.60%,CSGALNACT1;DSE;B3GAT2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.56159116906468,1.0328355240361455,0.41304347826086957,0.9797640052105384,1.0,4/8,14.26%,RABL3;PBX1;TOX;KAT7
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.565875455293391,1.0327869550225122,0.42105263157894735,0.9788417923502692,1.0,2/6,8.98%,LTV1;XPO1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.4882597117985277,-1.0326391332550133,0.453125,0.8970024982849151,1.0,5/46,10.09%,B4GALNT1;UGT8;FUT2;ST3GAL6;B3GNT5
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.5625338050260025,-1.032595034039805,0.4393939393939394,0.8966211491880252,1.0,1/15,1.09%,SIX3
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.6453475285324887,-1.0325758872581599,0.4642857142857143,0.8961149522248218,1.0,1/8,3.97%,RAB11A
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5781070250539602,1.0325112033385409,0.45454545454545453,0.9786116426425554,1.0,1/12,1.27%,AGMO
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4591355330053864,-1.0324916252846577,0.36764705882352944,0.8958484727184676,1.0,6/31,11.20%,THBS1;TGFBR2;AKR1C1;GADD45A;ROMO1;SYK
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),-0.6831118069597933,-1.0319430925559865,0.5666666666666667,0.8966689646866687,1.0,4/5,28.34%,VIL1;STK24;ALOX5;CADM4
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5923644844921742,-1.0318022157799478,0.4666666666666667,0.8966299018673322,1.0,4/12,7.93%,KCNJ2;PLN;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5007588218698816,-1.0317097861265068,0.38571428571428573,0.8962897277491939,1.0,4/22,6.56%,SFTPD;GPNMB;PDCD1LG2;CEACAM1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.6500939492572653,-1.0316088038177957,0.43333333333333335,0.8960124374278121,1.0,2/7,11.32%,IL12A;PRDM1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.34929738137172667,1.031426635177413,0.375,0.9806435916803549,1.0,108/254,34.61%,U2AF1;SF3A1;NUDT21;SNRPF;SF3B4;GTF2F2;HNRNPC;WDR33;NOVA1;CWC27;SMNDC1;RAVER2;RBM41;LSM8;CSTF3;SNRPN;PAPOLA;SNRPB2;CPSF7;SPEN;LSM5;TFIP11;SRSF8;RAVER1;SYNCRIP;RBM17;LSM7;HNRNPU;POLR2C;AQR;PPIE;ZMAT2;PPWD1;SNRNP27;CLP1;CLNS1A;WDR77;DHX15;PSPC1;GEMIN4;PDCD7;RBMX;CPSF2;CRNKL1;RBM15;PPIH;USP49;PLRG1;RBM19;SART3;SUGP1;PRPF40B;MTREX;HNRNPD;SCAF11;SRSF9;POLR2A;CSTF1;SNRPB;SNRNP48;ZCCHC8;MAGOH;SNRNP35;SCNM1;COIL;SRSF2;POLR2K;POLR2D;PRCC;DDX1;SRPK2;LSM6;PPIL3;MAGOHB;PABPC1;SNRNP40;CDK13;CSTF2T;HNRNPH1;POLR2E;PTBP1;DHX16;RBM15B;CTNNBL1;HNRNPL;STRAP;FRG1;SF3B3;EFTUD2;CCAR1;ELAVL1;BUD31;PCF11;RBM22;SFPQ;HNRNPH3;DDX5;METTL14;SART1;HNRNPR;DDX46;METTL3;SF1;TRA2A;TGS1;CDC5L;BCAS2;RALY
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.49872881598794605,-1.0312410914574466,0.4520547945205479,0.8964051704475641,1.0,10/29,13.52%,CDH22;CDH6;CDH23;CDH7;CDH19;CDH9;PCDHB5;SELP;CDH12;NLGN1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.6105875003434837,-1.0312395340260319,0.4406779661016949,0.8958615743783546,1.0,1/12,1.31%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.6427125926166156,-1.0311323132666135,0.49206349206349204,0.8956757489634644,1.0,1/7,7.29%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.539845733556461,1.031124931837374,0.5,0.9806294818166297,1.0,3/10,17.60%,HSPA1A;NCK1;VHL
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.4025130933948726,-1.0309197835168582,0.45555555555555555,0.8957450698143224,1.0,41/186,22.44%,ANO2;CFAP126;PPP1R14C;PDE4A;IMPDH1;TESC;SCN9A;CLGN;EFNB3;ARHGAP39;KIF9;PFN2;NYAP1;CARNS1;CIBAR2;HPCA;WDR54;SLC16A11;ZBBX;CCDC184;SEZ6L2;PTPRF;GPC1;FGF12;LARP6;SYBU;RARG;VSTM2L;CNTN4;DUSP8;PDE1C;PRR36;EPB41L4B;FLRT1;CCDC28B;STOM;MAPK8IP1;CERS5;CLSTN2;EPB41L1;SLC4A3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.5240013827581221,-1.0306363345168628,0.484375,0.8959501794176252,1.0,2/14,7.40%,OR51M1;OR51I2
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.569356215445978,-1.0305105515461037,0.5161290322580645,0.8957589826614802,1.0,5/19,18.95%,GMPPB;PMM1;UAP1;GFPT2;UAP1L1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.46207955600380796,-1.0301990765339513,0.4393939393939394,0.896020377984346,1.0,4/39,7.36%,MAOB;PLP1;BASP1;YWHAH
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),0.6469118630735079,1.0299804430663626,0.4528301886792453,0.983004968540603,1.0,3/5,29.88%,CSF1R;PTK2;MAPK1
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.49737718215208054,1.0299121935602427,0.45,0.9822168201330147,1.0,4/17,4.92%,ABCB10;ALAS1;HMBS;COX10
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.5156788121618897,-1.0291187660729455,0.4057971014492754,0.8985588188291823,1.0,4/37,7.93%,KCNQ1;NOS1AP;KCNJ2;ATP1B1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.45950125637602346,-1.028985140384909,0.44594594594594594,0.898315552202004,1.0,14/37,21.28%,S100A6;IGF1;WNT5A;DAB2IP;FN1;B4GALT7;CD74;EMD;AQP1;CDKN1A;NLRC3;PDGFRA;FTH1;SFRP1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.4090732728201008,1.0288347546311443,0.35714285714285715,0.9845494707187981,1.0,8/41,16.89%,NR1D1;REEP6;TTL;CSNK1E;STXBP4;EFNA5;PARD6G;PARD6B
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.6667521742683034,-1.0283926403407733,0.4909090909090909,0.8994497517911244,1.0,1/6,0.54%,EFNA1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.42152528886693175,-1.028288261318295,0.4375,0.8992062387290236,1.0,21/106,18.82%,LEF1;SEMA3B;APP;MAP1B;EFNB3;SCARA3;ARHGAP39;ARHGEF17;GFAP;NYAP1;KAZN;NUAK1;DAB2IP;AMOTL2;PHYHIP;SEZ6L2;PTPRF;GPC1;LARP6;PTPN21;ABCG2
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.6083336295948486,1.028280874393664,0.5128205128205128,0.9853613786705054,1.0,2/9,7.99%,TPRKB;SMC6
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.369214726689783,1.0282047689174072,0.34782608695652173,0.9844770984060626,1.0,9/78,6.49%,PIP5K1B;EPOR;FLT3;HCLS1;SOX9;EGFR;PDGFD;PDGFC;DIPK2A
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.6815801437733531,-1.0281414002979614,0.5076923076923077,0.8991039538420573,1.0,1/6,13.60%,SLC51B
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.5121669569090861,1.0273034688452198,0.375,0.985815583916681,1.0,7/14,31.50%,ERI1;MTPAP;TENT4B;TENT2;LSM1;XRN1;TUT4
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),0.62872114858492,1.0271936535312383,0.5833333333333334,0.9850526108015536,1.0,3/7,30.48%,SPHK2;SLC30A5;ATPSCKMT
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.40577593190719524,-1.027112242470525,0.3804347826086957,0.9016778635267603,1.0,22/124,19.17%,TOMM7;ANK3;ARIH2;KCNB1;CEMIP;AKAP5;YWHAH;PLK3;ZIC1;PPP3CC;PINK1;BAP1;PDZK1;SLC51B;OAZ2;NMT1;PRKCD;MICALL2;EMD;TGFB1;BBC3;MYO1C
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.4961567336355,1.0270895130989748,0.46875,0.9842433255753349,1.0,7/17,14.67%,EFNB2;ID1;GREM1;AKT1;ROBO1;EPHB4;GPLD1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5098901219173612,1.027067947552461,0.4,0.9822353596231902,1.0,1/11,1.85%,RAP2C
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5098901219173612,1.027067947552461,0.4,0.9822353596231902,1.0,1/11,1.85%,RAP2C
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),-0.6755138124599541,-1.0270231147398199,0.5333333333333333,0.9013546138651954,1.0,2/5,20.30%,GPER1;STX1B
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),0.5501600755603105,1.0269292061038269,0.4473684210526316,0.979566894046324,1.0,3/8,18.40%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),0.5501600755603105,1.0269292061038269,0.4473684210526316,0.979566894046324,1.0,3/8,18.40%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),0.5501600755603105,1.0269292061038269,0.4473684210526316,0.979566894046324,1.0,3/8,18.40%,H1-2;ASF1A;ATAD2B
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),0.5864845607827861,1.0267659852213051,0.5,0.9789708011298571,1.0,3/7,20.08%,MID1IP1;SPHK2;PIKFYVE
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.6500801821244493,1.0265636331352206,0.4883720930232558,0.9785900093824447,1.0,2/5,27.93%,DRD2;DRD4
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.6234132837678534,-1.0263494105834141,0.453125,0.9020926894694291,1.0,3/8,23.02%,IGF1;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.6234132837678534,-1.0263494105834141,0.453125,0.9020926894694291,1.0,3/8,23.02%,IGF1;AKAP6;SLC9A1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),0.6918111475709433,1.026301969413347,0.5319148936170213,0.9784594832459634,1.0,4/5,26.48%,NFKB1;RC3H1;RC3H2;RELA
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),-0.6484046010522633,-1.0262018683503407,0.48333333333333334,0.9020002028488199,1.0,2/5,14.51%,ZNF473;LSM11
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.591126635589263,-1.026148964445438,0.4915254237288136,0.9016269915306065,1.0,4/13,7.93%,KCNJ2;PLN;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.5261429258763551,1.0259170611876245,0.42857142857142855,0.978578439824863,1.0,4/13,17.25%,KBTBD7;ALS2;ARHGAP24;ARHGAP44
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5638764440232549,-1.0256811272777966,0.36363636363636365,0.9022758594017477,1.0,2/16,10.99%,CTSC;ATP5IF1
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.5722166737208154,1.0254319450392346,0.5,0.9789223898753628,1.0,2/10,6.81%,ZPR1;SOX12
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.5339573258667402,-1.025412579995924,0.5166666666666667,0.9024527065955785,1.0,6/18,21.26%,TNFRSF14;ROMO1;SELP;SLC11A1;AQP1;OPTN
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.45612618063548704,1.0253709072237231,0.4186046511627907,0.978164274469373,1.0,5/24,15.62%,MCU;MFF;RALA;MUL1;MIEF2
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4603937141754496,-1.025304126951945,0.4177215189873418,0.9021583908116947,1.0,2/53,2.75%,LEF1;WNT8B
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.4958177367429787,1.0249683670981755,0.4482758620689655,0.978330487587573,1.0,9/20,31.14%,FASTKD2;MRPS27;NSUN3;FASTKD3;RPUSD4;MALSU1;ALKBH1;TSFM;UQCC2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.40046782981579176,1.0248821400136354,0.28,0.9775745613125281,1.0,6/46,5.86%,SOX8;PPARGC1A;CEBPA;BBS9;AKT2;ATF5
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.5317809868022899,1.0248255916585676,0.42857142857142855,0.9766667303531541,1.0,1/12,0.55%,MSH4
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5249143351028696,1.0247615045433744,0.43902439024390244,0.9758787147215898,1.0,4/16,24.58%,NAF1;POT1;PARP1;ERCC4
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5332699517392222,-1.0245612211936919,0.4225352112676056,0.9036854514917145,1.0,5/16,17.39%,APP;EGF;TGFA;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5308824951401245,1.024546894402595,0.45714285714285713,0.9755517963322541,1.0,4/16,20.59%,SNF8;CHMP6;MDM2;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.43818197882919396,-1.0242237623110877,0.345679012345679,0.9040011187120274,1.0,12/83,14.21%,KLF2;RASGRP1;PLK2;APP;KLF4;WNT5A;DAB2IP;IL18;HECW2;GPC3;VIP;OAZ2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.5440636488338041,-1.024030378367904,0.5230769230769231,0.9040142005929666,1.0,5/14,18.19%,CPLX1;CPLX2;FLOT1;KCNMB4;MCTP1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.40341757398852635,1.0238471104850204,0.46875,0.9762494561877099,1.0,9/46,18.29%,MTHFS;SLC19A1;ME2;PHYH;MTHFD2L;DHFR;DHFR2;SLC46A1;FH
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5899465826148614,-1.0235711580231983,0.4807692307692308,0.9049668876702057,1.0,4/12,20.15%,GRIN2A;FADD;RIPK2;CASP8
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5231724630625965,1.0235180819874652,0.3902439024390244,0.9762285078725463,1.0,1/12,1.86%,RPP40
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.44741388251123015,-1.023321134688737,0.41025641025641024,0.9051750067248794,1.0,20/84,16.85%,ANXA1;SFTPD;GPNMB;IL15;NLRP12;HTR2B;LRRC19;MOG;IRF7;ISG15;HHLA2;HLA-B;IFIH1;FLOT1;SLC11A1;BTN3A1;SRGN;PIK3CD;HLA-DRB1;BCL6
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.690561510743511,-1.0231787552183906,0.543859649122807,0.904941562295884,1.0,1/6,5.11%,ATP23
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.5944172747288362,1.023065523606499,0.5,0.9754006572450975,1.0,3/6,31.03%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.5944172747288362,1.023065523606499,0.5,0.9754006572450975,1.0,3/6,31.03%,IWS1;NSUN2;SETD2
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.6366671701969457,1.0230471787758841,0.5625,0.9744547276956266,1.0,4/5,35.78%,NAA30;NAA25;NAA15;NAA16
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.47894192605803537,-1.022938071704846,0.48148148148148145,0.9050712855063449,1.0,4/46,9.85%,BLM;HELB;POLQ;POLR2I
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.5995108434772265,1.0224699907382857,0.5,0.9750328429419688,1.0,4/7,23.21%,PTPN23;RAB21;VPS11;EZR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5570529255909205,1.0224656909475718,0.5476190476190477,0.9740424501053807,1.0,1/8,7.70%,VDAC2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5860108263165674,-1.0222041102766726,0.43548387096774194,0.906595726575782,1.0,1/9,2.47%,IFIT1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.5946572812460251,1.0221117976093377,0.48717948717948717,0.9740238967552821,1.0,2/7,9.12%,TYR;DCT
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.40672177439470647,1.022069740774156,0.42857142857142855,0.9731883118162357,1.0,12/85,10.30%,U2AF1;PPARGC1A;RIDA;HSPA1A;NUDT16L1;SF3A1;NUDT21;SNRPF;SF3B4;HSF1;CSTF3;CPSF6
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.6291456690608167,-1.0220060965847049,0.5245901639344263,0.9066127742918705,1.0,1/7,2.46%,NOS1AP
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.4425515671240186,-1.0219310482758563,0.4266666666666667,0.9062118430749243,1.0,18/56,25.90%,AGPAT4;ACSM5;ACSL5;LIPI;LIPH;CYP21A2;OLAH;MVK;OXSM;SREBF1;PAM;SCD;ACSM3;LSS;XBP1;ALOX5;CBR4;ACSL1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.637027933284558,-1.0214607730772494,0.4909090909090909,0.907042237403982,1.0,1/6,6.47%,POLE3
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5819037903459212,1.0213754376723092,0.5454545454545454,0.974150150609681,1.0,1/9,3.16%,DERL2
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.6128307942016222,-1.021342319223104,0.41379310344827586,0.9067862481126318,1.0,5/9,19.02%,ANK3;NOS1AP;KCNG1;AKAP6;KCNE4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.5047835909772347,-1.0212442071384877,0.35064935064935066,0.9066084447440893,1.0,7/28,17.28%,EGF;WDR54;LRPAP1;SFRP4;FLOT1;CD63;AHI1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.4681653511086586,1.021187267891655,0.3548387096774194,0.9737704395915691,1.0,7/27,12.98%,MSRB1;CATIP;WASHC5;TTC17;SPIRE2;DIAPH3;WASL
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),-0.6769454997029485,-1.021045648299126,0.45,0.9065476021576443,1.0,4/6,27.22%,SYK;FES;ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5789356539068937,-1.0207514500568442,0.4918032786885246,0.9068702003182126,1.0,4/10,7.39%,DOCK8;APP;APOD;TNFRSF14
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.5371647449783603,-1.0206104680549382,0.4931506849315068,0.9066871138497317,1.0,8/25,20.15%,TRIM5;IRF1;BIRC3;CD55;HERC5;CD36;CX3CL1;CASP8
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.4551201889478991,1.0205477501905602,0.43333333333333335,0.974764626067492,1.0,9/33,20.40%,TBC1D12;SEC22B;RALB;RAB1B;SCFD1;PIP4K2B;PIP4K2C;PIKFYVE;RAB3GAP1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.5390619365773723,-1.0205141271699478,0.4696969696969697,0.9063877096818993,1.0,1/14,2.70%,ITPKC
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),-0.6696458011264721,-1.0199734719980786,0.58,0.9072200619250298,1.0,1/5,0.71%,FLRT3
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),0.6697558516615004,1.0199709509250936,0.5106382978723404,0.9754545384786161,1.0,3/5,15.94%,TNFAIP3;FOXJ1;RC3H1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),0.5883552940301816,1.0196279274530589,0.48,0.9754927221656974,1.0,3/5,11.77%,TPRKB;TP53RK;TRIT1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.4949833846675979,-1.018496475291028,0.43283582089552236,0.9106731361058833,1.0,8/20,19.00%,S100A6;IGF1;WNT5A;FN1;CD74;AQP1;CDKN1A;PDGFRA
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.46519580967880897,-1.0183964374039252,0.4857142857142857,0.910410660058178,1.0,3/42,6.82%,CP;SLC39A14;STEAP3
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.430575290082157,1.0183272220557047,0.37037037037037035,0.9777350241928031,1.0,2/32,5.74%,POLD3;RFC3
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.49892768547421545,-1.0182510399018223,0.45714285714285713,0.9103533342589871,1.0,4/35,6.29%,CD160;APP;THY1;BRCA1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.6498921405819411,-1.0180915277960143,0.4838709677419355,0.910296076990339,1.0,1/7,9.24%,IGF1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.4326669663530082,1.017908477264984,0.36363636363636365,0.9778751107957577,1.0,13/34,22.27%,TVP23B;ABCA1;MTTP;TMEM167A;RAB8B;MON1A;RAB8A;RCN3;TANGO6;PREB;MIA2;GOLPH3;SEL1L
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.40292791657929516,-1.0179035285469429,0.43529411764705883,0.910222299624943,1.0,15/185,12.25%,CCNB2;PIF1;ARHGAP4;ARHGEF3;FSCN1;PLEKHG2;ANLN;CENPE;LMNB1;CDC42EP1;RAPGEF5;RHOF;KIF2C;MYH9;MYO1E
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.5385199618326957,-1.017301809578536,0.3888888888888889,0.9113091124143405,1.0,9/18,25.29%,THY1;PTK6;SH3BP5;MVP;SNX6;ZFYVE28;PTPRC;SRCIN1;HYAL2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.40024960132987714,-1.0172849868426606,0.45569620253164556,0.9107874635059735,1.0,42/161,20.53%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7;RPL15;RPL11;EXOSC7;RPS25;RPL29;RPL36
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.5767583642263513,-1.0172801950383707,0.4426229508196721,0.9102609171094248,1.0,1/13,0.34%,RASGRP1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),0.659930559905401,1.0172577504618567,0.5238095238095238,0.9788253324269106,1.0,3/5,28.95%,RAB7B;SNX3;SNX12
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.5666780783535519,1.017183579478685,0.5,0.9779925105252418,1.0,4/9,30.02%,MUL1;RNF26;ITCH;TRAF3IP1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.5721875286364364,1.0167722153933711,0.5,0.978362987496414,1.0,4/8,23.28%,GTF2A2;TAF12;DR1;GTF2B
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4004639525599544,1.0166554092900126,0.4642857142857143,0.9776823724476632,1.0,15/43,25.88%,HSPA1A;HSF1;STT3B;DERL1;RHBDD1;TOR1B;ERP44;DAXX;ERN1;TM7SF3;DNAJB5;DNAJC4;HSPA13;DNAJB2;BAK1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.46645078242353794,-1.0166180400549536,0.4,0.9115222860848047,1.0,4/41,6.92%,AWAT1;ALOX12;CYP4Z1;CYP1B1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.4147481506391532,-1.016580648164577,0.4430379746835443,0.9111061899444627,1.0,19/124,14.45%,FLRT3;POU4F1;ANK3;CCK;SHTN1;CNTNAP1;S100A6;APP;SLITRK1;MAP1B;BAIAP2;NEFH;NYAP1;MINK1;DAB2IP;SLITRK4;NLGN1;SLITRK5;BDNF
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.5399385545236544,-1.0165156815480525,0.49206349206349204,0.9107401769361215,1.0,6/20,18.14%,STMN2;KIF14;STMN4;KIF2C;STMN1;MAPT
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.4004047092872693,-1.0164871426319797,0.39285714285714285,0.9102644698861739,1.0,12/170,7.77%,TLCD2;A4GALT;MYOF;ANK3;GOLGA8O;ATP8B4;SUN3;DYSF;CAV3;USP50;SYNGR2;SYP
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.642804831101549,1.016261848266723,0.4772727272727273,0.9778909857946717,1.0,3/5,23.79%,HEYL;HEY2;RBPJ
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6289726702594156,1.0158437445823456,0.5476190476190477,0.9781567710425049,1.0,2/7,6.69%,ZC3H8;AKT1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.5117249767975866,1.0157063847653995,0.4090909090909091,0.977605008171671,1.0,4/16,16.90%,MCU;TIRAP;MDK;MPP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.4781861819403849,-1.0157031058427228,0.5416666666666666,0.9119135643916783,1.0,6/32,12.43%,EFNA1;APP;THY1;PTK6;SH3BP5;MVP
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.5922393421807092,1.0156712777957495,0.5238095238095238,0.9767554751889735,1.0,3/9,8.69%,ARFIP1;WASHC5;ARFIP2
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.4954170676466117,-1.015496877952868,0.38235294117647056,0.9119602189869713,1.0,3/30,6.11%,FLRT3;SH3GL2;MAP1B
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5423079686515542,-1.0154702211861597,0.43283582089552236,0.9114791382396372,1.0,5/15,18.89%,IGF1;GLI1;PIM1;AKAP6;TBX20
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.47599272034803536,-1.0153443511454363,0.47368421052631576,0.9112568184892726,1.0,8/40,17.15%,BLM;ADCY7;BRCA1;GLRA2;ADCY5;GNG2;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.5118418225082069,1.0151569420391449,0.40540540540540543,0.9771708932552783,1.0,4/18,12.02%,FLT3;ARMC6;CSF1R;PRRC2C
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.42740194573361734,-1.0148854855154108,0.47058823529411764,0.9119186759065562,1.0,23/92,24.08%,DHCR24;B2M;CCND1;DBI;SRF;MAK;TPD52;HSD17B14;NDRG1;CENPN;GUCY1A1;PTPN21;UAP1;INSIG1;SELENOP;ARID5B;HMGCS1;STEAP4;PMEPA1;SCD;IDI1;CDK6;ADAMTS1
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.5821665525776563,-1.0148234416741475,0.49230769230769234,0.9115591868997527,1.0,1/7,1.67%,MX1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.4076887878714143,1.0147930858057197,0.4,0.9772642468069638,1.0,7/50,12.57%,SLC19A1;TFB2M;IMP4;RCL1;PLK1;NDUFAF4;PRMT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.40149433512038696,1.0147732399468294,0.3103448275862069,0.97629155432573,1.0,16/55,20.39%,CCT7;HCLS1;ZPR1;TESK1;TRIM28;AKT1;IPO5;SESN2;PLK1;CCT3;KAT7;PIK3R1;EIF2AK3;MCRS1;PYHIN1;DKC1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),-0.5793153656724059,-1.0145704646964124,0.4528301886792453,0.9117155860533827,1.0,1/10,2.70%,ITPKC
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.42316610205177563,1.0145639711109373,0.4,0.9759848788823087,1.0,4/39,4.15%,WNT7A;SLITRK2;LIG4;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.603418636663863,1.0145623196014222,0.4888888888888889,0.9750039895567989,1.0,2/6,5.69%,SLC39A10;FOXP1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.494147118180968,1.0142594837397947,0.42424242424242425,0.975099143800745,1.0,9/24,24.92%,KAT2B;KAT2A;KAT7;EP300;PHF20L1;KAT6B;RUVBL1;TRRAP;NAA50
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),0.5533615315700073,1.0142029282074532,0.40540540540540543,0.974235259132357,1.0,2/7,5.85%,RGS2;PLIN5
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.5532851205747235,-1.0141765975561987,0.4262295081967213,0.9122663883790302,1.0,1/13,1.24%,PGR
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.279850034217358,1.014068956706884,0.0,0.9737152082892095,1.0,401/1648,20.26%,MEOX2;POU6F2;ZNF300;WNT7A;RNF6;POU3F1;ASCL1;ZNF697;ZNF287;TFCP2L1;ETV5;ZNF615;ZNF202;ZNF415;LIMD1;FAM47E;NR1D1;CCNE1;SOX8;ZNF117;ZNF783;KCTD1;BMP2;MED21;POU3F4;PPARGC1A;ZFP3;ZNF441;ZNF195;SOX21;IRF2BP1;ANXA4;ZNF212;ZNF525;CEBPA;NR2E1;BCL10;ZNF358;DACH1;ZNF778;ZSCAN25;ZBTB43;ZNF107;EHF;ID1;ZNF658;MITF;ZNF426;MEN1;CARF;POFUT1;ELOC;ZSCAN20;ZC3H8;RUNX1;HSF5;MTERF3;ZNF24;ZNF624;KMT5A;ZXDA;POU3F2;LCORL;ZNF556;ZBTB37;ZFP2;RBM23;ZNF555;HCLS1;SCML2;TENM1;TRIB3;HES6;OTX1;SOX9;ZNF616;ZNF319;PHC1;USP13;ZNF706;ZBTB9;EGFR;POLR3F;SLC39A8;FOXP1;MTF1;THAP11;SMAD5;ATF5;SMARCAL1;ZNF707;ZNF384;ZNF613;ZNF304;APBB3;ZNF74;MSANTD1;ZNF577;ESRRG;GRHL1;ZNF502;ZNF484;ZNF684;TRIM28;ZNF639;AKT1;EED;ERCC6;SOX12;ZNF786;ELOA;ZBTB40;ZNF883;RORB;FBXO5;KLF16;ZNF320;BRF2;ZNF852;TSHZ1;ZNF680;ZNF268;ZBTB39;THAP1;ZNF211;GLI4;SNF8;ZNF782;ZFHX4;RNF14;ZBTB18;PBX1;ZNF561;KDM5A;ZBTB33;DPF1;AR;CBFA2T3;ELK4;YY1;ZNF696;PRMT6;NR3C1;ZSCAN23;PHF10;CEP290;ZNF595;NFYC;ZNF774;HSF1;JDP2;ARID3B;HMGB1;YAF2;ETV1;SLC2A4RG;BRPF1;FOXJ1;ZNF12;ZBTB6;SALL1;BTRC;HSF2;ZNF133;ZNF518A;ZNF587;HP1BP3;ZNF510;ZNF543;ZNF496;TRIM16;ZNF155;EBF4;ZGLP1;ZNF341;ZNF665;LCOR;PHF14;ERBB4;ZNF875;ZNF181;ZIC2;FOXJ2;PPM1A;ZNF703;TIAL1;ATF6;ZNF347;ANKRD2;ZSCAN22;ZNF677;HEYL;HLF;PTPRK;NIPBL;ZXDB;FOXJ3;ZNF397;ZNF676;ZNF121;ZNF761;ZNF669;ZXDC;ZNF408;ESRRA;BRWD1;ARX;ZBTB2;ZNF33A;VEZF1;ZNF736;ZNF280D;ZNF792;MXD3;KMT2A;EMX2;MAGED1;ZNF793;PATZ1;BRWD3;APBB2;SALL3;PLAGL1;TGFBRAP1;ZNF214;SPEN;TRPS1;SOX5;DVL2;HEXIM2;CNOT2;ZNF254;ZNF276;ZNF283;TOX;HTATSF1;DAP;ZNF138;BAZ1A;KAT2A;ZEB2;KLF12;ZNF14;E2F4;ZNF382;ZNF324B;ZNF354B;GTF2H2;GTF2H2C;ELP2;ZNF527;HMG20A;MYNN;ZNF230;ZNF324;ZNF764;PRDM5;RPS6KA3;GPBP1L1;DHFR;KAT7;ZNF530;ZNF18;PLAGL2;ZNF416;ZNF429;ZNF189;NFKB1;ZNF43;ZNF519;AEBP2;MAMSTR;ZNHIT3;PURG;KARS1;HDAC2;ZBTB20;LHX2;ZNF558;POU2F1;ZNF264;ZNF75A;ID2;TNFSF4;ZNF91;ZNF425;EP300;TADA1;SMARCA2;NRF1;ZNF471;ZNF25;ZNF34;PPIE;BACH1;ETS2;MGA;SNX5;HINFP;PBX2;NR2F1;ZNF492;CDK18;THOC1;ZHX2;NR1D2;PICALM;ELP4;ZNF470;ZNF521;NKRF;SCMH1;FOXN2;ZNF322;ZNF688;ZBTB34;CREG1;IRF2BPL;CD38;OLIG1;ZFP82;NCOA2;ZNF248;ZNF865;PHC3;ZNF589;LANCL2;CHD7;ELK1;ZNF611;NR3C2;ZNF879;VHL;ZNF41;BRD7;MYPOP;CEBPG;EFEMP1;ZNF236;ZNF582;HOMEZ;HEY1;PIAS4;CAMK4;ZHX3;SETD3;ZNF251;PURA;MED30;METTL4;EHMT1;CSRNP3;MAP2K2;ZNF526;PHF20L1;ZNF699;CNBP;PCID2;VSX1;ETV3;WDR77;NLK;ZNF805;HDAC10;HESX1;CHD4;PRDM2;ZNF771;ZNF737;GLI3;NFXL1;CCNT1;MED23;DAXX;ZNF460;ZBTB10;ZNF30;ZNF770;ZMYND11;ZNF334;PSPC1;HEY2;MDM2;CCAR2;PYHIN1;BATF2;ID4;HES5;ZNF534;SP3;BBX;ZNF354A;SMAD7;ZNF75D;NUP85;ZNF253;ELP3;SAP30L;ZNF354C;ING1;ZNF224
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.6268204663139059,1.013955609193019,0.45161290322580644,0.9729341824751164,1.0,2/5,16.57%,JAM2;EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.42530825829415825,-1.0137656376224873,0.48148148148148145,0.9127836759605132,1.0,21/90,19.04%,GGT5;PLK2;RAMP3;ADCY7;GIPR;RHBDF2;ADCY5;SYK;MYH9;GNG2;RXFP1;VIP;PTH1R;GLP1R;PTH2R;ADCY3;HLA-DRB1;ADCY8;NMI;NLRC3;ADM
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.5443640180414652,1.0134440806492138,0.5,0.9734521085880143,1.0,4/9,32.67%,PLXNA3;PLXNA2;PLXNB2;PLXNB3
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.39597182927488167,1.0133743394783887,0.4375,0.9727752292952054,1.0,4/48,5.94%,GDAP1;GRPEL2;SAMM50;MFF
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.5183980656851955,1.0132834003981932,0.37142857142857144,0.9720088378816892,1.0,6/13,25.19%,PPARGC1A;VCP;SPHK2;AK4;PARP1;PID1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5078926421891274,-1.013050637288579,0.4647887323943662,0.9141214385564931,1.0,5/28,11.12%,RASGRP1;DUSP1;GADD45A;MINK1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.40993507290600034,-1.012828529135896,0.40476190476190477,0.9142868949930569,1.0,27/119,17.89%,ANXA1;IL1R1;TLR2;IFI35;IL15;NLRP12;APP;KLF4;LRRC19;TLR3;WNT5A;BIRC3;IL18;SBNO2;TNFRSF1A;CXCL17;PRKCD;MVK;USP18;BCL6;CD200;TEK;SNX6;ETS1;GPER1;ABCC1;NMI
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5117966696575973,1.0127422625466218,0.4117647058823529,0.9724694045743936,1.0,3/21,6.17%,SLITRK2;ABHD17A;ABHD17B
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.690346555151341,-1.012725206477155,0.5306122448979592,0.9140256952088853,1.0,1/5,11.74%,PINK1
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5427966387676054,1.0126112842104802,0.4473684210526316,0.9719202146085285,1.0,1/10,3.52%,DUSP19
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.41876419614695803,-1.0125836774652797,0.3950617283950617,0.9138686239512942,1.0,27/120,22.27%,DHCR24;SLC39A14;BHMT;ZDHHC9;SCARA3;ARHGEF17;GYG2;GPT2;DAB2IP;SLC7A2;SFRP4;F10;AMOTL2;RHBDF1;BOK;ASS1;PTPRF;GPC1;PGAM1;PTPN21;EPB41L4B;KIAA1217;CD276;BCAT1;SH3D19;MYO1B;EPB41L1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.35005762700032217,1.0124411768292445,0.391304347826087,0.9714513855088566,1.0,26/91,20.89%,RANBP17;NXT2;NUP62CL;INTS13;PPP1R10;AKT1;IPO5;ARL2BP;IPO8;PLK1;NUP214;NXT1;RANBP6;MORC3;TAF8;NUP188;HNRNPU;TOR1B;TAF3;IPO11;MDM2;PIKFYVE;NUP85;NOL8;NUP153;NUP50
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4285787343497343,1.012276051602668,0.40540540540540543,0.9708137974271496,1.0,1/24,0.43%,NGF
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4044914090034413,-1.012191562308219,0.4625,0.9146455680698965,1.0,14/127,13.76%,ERCC6L;WDR62;RPS27;PLK2;RAB11A;CENPH;CENPE;ZWILCH;NUF2;SPC24;CCNB1;KIF2C;CENPN;CENPU
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4316892287382018,-1.0121675274306832,0.4696969696969697,0.9141499345297507,1.0,9/65,11.77%,CENPV;KIF14;SVIL;PLSCR1;EGF;IGF1;TGFA;CCNB1;SOX15
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.6188772885234595,1.0118058276857123,0.5384615384615384,0.971058992846557,1.0,2/5,28.12%,RBPJ;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.5532443062754316,1.0117997695624827,0.5384615384615384,0.9700956406711139,1.0,1/7,4.10%,SERPINB9
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.437998818291986,-1.011554146736869,0.4823529411764706,0.9153567073198405,1.0,13/81,14.28%,ANXA1;IL1R1;P2RY12;TRIM5;IRF1;LRRC19;PDE6B;WNT5A;BIRC3;CD55;SBNO2;HERC5;NMT1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.5569325415409612,-1.0109716041673766,0.4339622641509434,0.916578412742977,1.0,6/13,20.40%,CYP1B1;CRLF3;MGAT5;OCIAD2;GHR;HES1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.41340621295365126,1.010958947716975,0.4230769230769231,0.9710629242909088,1.0,6/27,8.12%,CSPG5;CHST11;NDNF;CSGALNACT1;CHST7;BCAN
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3374944506036479,1.010695205505065,0.5714285714285714,0.9710029105394747,1.0,63/312,19.44%,SPSB4;RNF6;ERCC8;FBXO45;KLHL8;SPSB2;PSMD10;KBTBD7;FEM1C;ELOC;TNFAIP3;PSMA1;WDR91;RNF150;PSMD11;KEAP1;FBXL14;ANAPC1;PSMB5;VCP;GID8;RNF146;RNF14;VPS37A;PTPN23;UBE2G1;BTRC;PLK1;FBXO8;RNF114;UBE2D1;RCHY1;PSMD14;FEM1B;KCTD17;PSMD12;FBXO10;ATE1;VPS37B;UBE4A;CDC26;UBE3B;FBXO21;RNF11;RC3H1;FBXL17;TRIM3;KCTD21;NDFIP1;VPS4B;SPOP;UBAP1L;COP1;CNOT4;RMND5A;UBQLN4;KCTD5;KLHL20;RNF166;UBE3D;KLHL42;UBL7;RC3H2
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3712751278690903,1.0105553183105258,0.3157894736842105,0.9705377711318572,1.0,12/54,19.44%,MITF;METTL18;NOVA1;PCBP4;CLK4;RBM12B;RC3H1;YTHDF2;METTL4;PCBP3;RRP1B;RC3H2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.4995343169547519,1.0104361502240802,0.4444444444444444,0.9699498486574964,1.0,4/13,17.49%,AKT2;AKT1;GPLD1;PPM1K
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.4256540608926085,1.0102605109643465,0.46875,0.9694754325744155,1.0,6/40,10.30%,HCLS1;ZPR1;ANP32B;TRIM28;IPO5;CPSF6
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),-0.6727429291709572,-1.0102547972932834,0.5192307692307693,0.918016605516948,1.0,1/5,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.4912066630181829,-1.010223682103587,0.4225352112676056,0.9175310450754549,1.0,6/24,19.25%,KCNQ1;IGFBP5;DMTN;AQP1;AKAP6;HCN1
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.6414995912285064,1.0101649609039707,0.5434782608695652,0.9688448234449649,1.0,2/5,2.81%,COQ3;GK
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.43707337963112886,-1.009978802970575,0.4935064935064935,0.9175902287084284,1.0,10/63,13.02%,AWAT1;ALOX12;ACOT1;CYP4Z1;ACOT4;CYP1B1;ACSL5;GLYATL2;ACOT2;CYP3A4
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),0.6167461262513037,1.0099018566872076,0.52,0.9686303166771939,1.0,3/5,34.60%,GPLD1;ATG7;ATG12
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5021715590256489,-1.0098970496681756,0.4691358024691358,0.9172632068551427,1.0,6/32,17.43%,CENPH;MIS18A;CENPN;CENPU;OIP5;CENPP
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.40859408097634536,-1.009894105067646,0.4268292682926829,0.9167408967844665,1.0,12/103,9.24%,THBS1;TLR2;CIITA;RPS4X;NLRP12;KLF4;ATAD5;NLRC5;CCL2;PLD1;EGF;IGF1
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.6389986277077097,-1.009763180862859,0.5,0.9165234002161501,1.0,1/7,2.16%,LAMB1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.4120468246126054,-1.0096301680641868,0.4375,0.9163604484267867,1.0,11/88,9.33%,FABP3;ABCA6;ABCA5;SLC51A;ABCA8;AKR1C1;ABCA12;CEACAM1;LDLR;SLCO3A1;ABCA10
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.5577827890484943,1.008906402845056,0.47368421052631576,0.9707797256025834,1.0,6/10,37.55%,HUS1;CLSPN;TICRR;STK33;CHEK2;RAD17
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.604500024098203,-1.0087228608118135,0.5185185185185185,0.917227595281141,1.0,5/8,35.92%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.604500024098203,-1.0087228608118135,0.5185185185185185,0.917227595281141,1.0,5/8,35.92%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.604500024098203,-1.0087228608118135,0.5185185185185185,0.917227595281141,1.0,5/8,35.92%,RAB27B;HSPB1;MAP1A;MAPK8IP3;KIF5B
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.5693485356467306,1.0086842949553267,0.47619047619047616,0.9705189766122074,1.0,4/7,19.38%,ALDH1A1;ADH5;ACSS1;ALDH2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5359889687801107,1.0083277592281297,0.45161290322580644,0.9707953503322305,1.0,5/11,5.99%,ABCD2;PPARGC1A;AKT2;PLIN5;ABCD1
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),0.6097055305700816,1.0081616664311692,0.5945945945945946,0.9704457504779851,1.0,1/6,5.97%,TPK1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4464279339292711,-1.008098088538238,0.4625,0.9184782562635926,1.0,4/51,8.19%,BLM;BRCA1;CCND1;DONSON
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.4798077096047064,1.007990102361805,0.5483870967741935,0.9699294741586236,1.0,6/17,24.23%,SRI;DRD2;GSTM2;GPR35;PKD2;UBQLN1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.45282546710187,-1.0079384081860776,0.4,0.9183417032054506,1.0,10/38,19.85%,IMPDH1;ADCY7;PAPSS2;ADCY5;ADCY3;GUCY2C;GUCY1A1;ADCY8;AK5;DCAKD
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.5323351871073181,-1.0077323007898824,0.4714285714285714,0.918378427436641,1.0,5/14,17.01%,GPR18;LPAR6;LPAR4;P2RY10;HTR2C
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.5407207399962306,-1.007694722199871,0.46774193548387094,0.917998787688978,1.0,5/11,24.64%,MMP14;SYK;SFRP1;INHA;XBP1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5251621871656904,1.0076492359169038,0.5,0.9698712171176674,1.0,3/14,16.16%,SEC24A;SEC31B;SEC23B
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.6243733881079213,-1.0073675195184983,0.5217391304347826,0.9182626208857047,1.0,2/6,16.15%,RAB11FIP5;PTPRN
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.5906854991654492,-1.0072031044516718,0.463768115942029,0.9181481141458837,1.0,1/10,1.31%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5068088695879912,-1.007155359663236,0.5072463768115942,0.9177476835472249,1.0,2/20,4.28%,PDPN;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.6060542948354124,-1.0070038674962853,0.4909090909090909,0.9175634862126172,1.0,1/6,6.29%,BRCA1
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.4694865916153307,-1.0069895879217332,0.46153846153846156,0.9170560420898896,1.0,6/39,12.60%,GRAMD2A;PLN;CAV3;EGF;PLPP4;NOS1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.6318038480108916,-1.006825154239698,0.5490196078431373,0.916436011788634,1.0,1/5,7.37%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.6318038480108916,-1.006825154239698,0.5490196078431373,0.916436011788634,1.0,1/5,7.37%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),0.7013794034261145,1.006700340503968,0.574468085106383,0.9716059103680109,1.0,4/5,28.45%,WASHC2C;CARMIL2;CARMIL1;MTPN
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.5909546579727191,1.0065585423932257,0.4727272727272727,0.9701750255270136,1.0,5/7,40.23%,HGF;SIRT2;APPL2;NRP1;LGMN
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.5909546579727191,1.0065585423932257,0.4727272727272727,0.9701750255270136,1.0,5/7,40.23%,HGF;SIRT2;APPL2;NRP1;LGMN
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.6171147175341389,-1.0060821380889773,0.49056603773584906,0.9178997809792817,1.0,2/7,22.95%,PTPRO;PTPRB
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5704233995905214,-1.0060273248741798,0.5151515151515151,0.9174955122233079,1.0,1/10,5.11%,ATP23
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.49741893425071687,-1.005925954105589,0.43333333333333335,0.9172314725965187,1.0,3/20,7.85%,THBS1;APP;EGF
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.49395352921414654,1.0058526010476356,0.46153846153846156,0.971171544784852,1.0,7/25,13.87%,TRIB3;DCUN1D2;UBE2N;DCUN1D1;BTRC;PLK1;DCUN1D5
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.43678709289104645,-1.0058428298855957,0.5061728395061729,0.9168710389710601,1.0,13/77,13.10%,THBS1;HPN;TGFBR2;RAMP3;KLF4;AKR1C1;EGF;GADD45A;CCNB1;ROMO1;SFRP4;CD63;PAX8
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.5047507002882133,1.0056795474121223,0.475,0.970690856869423,1.0,4/12,21.84%,GPHN;MOCS2;LIAS;NOXRED1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.5078840098328378,1.0055845492703988,0.4444444444444444,0.9699340696865028,1.0,5/12,17.11%,PPEF1;GUCA1B;NMT2;METAP1;CAMKMT
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.6555531839300819,1.005573610993407,0.4772727272727273,0.9680931117782364,1.0,2/8,5.74%,POLG2;RFC3
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.6555531839300819,1.005573610993407,0.4772727272727273,0.9680931117782364,1.0,2/8,5.74%,POLG2;RFC3
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5166836810187473,-1.005527787045882,0.5,0.9172090107875802,1.0,3/26,11.12%,SHTN1;IGSF10;DAB2IP
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.611997485701568,1.0054614096591845,0.4772727272727273,0.9675178371328972,1.0,1/5,3.84%,TNFAIP3
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.4987264963290004,-1.005148500399065,0.4864864864864865,0.9178256238227992,1.0,6/26,13.60%,ANK3;KCNB1;CEMIP;PDZK1;DMTN;SLC51B
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.42795562460092895,1.005111583705414,0.3793103448275862,0.9676280605978206,1.0,7/24,18.26%,DAO;BLMH;IDO1;ACADSB;DDO;THNSL2;PRODH
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5808413039859865,1.0050608554778664,0.5,0.9659198835145013,1.0,5/7,38.73%,GABPA;MAPK1;PRKN;ATF4;LRRK2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5808413039859865,1.0050608554778664,0.5,0.9659198835145013,1.0,5/7,38.73%,GABPA;MAPK1;PRKN;ATF4;LRRK2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.5315062345883759,-1.0047755203068927,0.5081967213114754,0.918280635009231,1.0,6/14,17.15%,ADCY7;ADCY5;ADCY3;GUCY2C;GUCY1A1;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5550941906374649,-1.0045922144172876,0.4666666666666667,0.9172762165591072,1.0,1/11,7.60%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5550941906374649,-1.0045922144172876,0.4666666666666667,0.9172762165591072,1.0,1/11,7.60%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5550941906374649,-1.0045922144172876,0.4666666666666667,0.9172762165591072,1.0,1/11,7.60%,ANAPC11
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.5171950446791456,-1.0045872380077987,0.5172413793103449,0.916756700116585,1.0,3/23,8.24%,TRPC3;CCL2;GRM6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.53671681376001,1.0044107076545428,0.47368421052631576,0.9665486331800894,1.0,3/9,30.43%,SLC5A6;PCCA;PDZD11
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5057450690215942,1.004284528766189,0.5,0.9659886256504665,1.0,6/17,17.34%,CRPPA;TMTC4;FKRP;POMT2;TMTC3;DPM1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.3592441067244433,1.0042563585298443,0.23809523809523808,0.9651440853781537,1.0,15/79,23.19%,PRDX6;RBM23;SF3B4;NOVA1;PCBP4;NSRP1;HNRNPU;RBFOX1;QKI;FXR2;RBMX;RBM15;MBNL1;RBM39;JMJD6
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.6635029152393955,1.004249240470146,0.475,0.9642133774848285,1.0,1/5,10.04%,ATIC
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.5874715342388765,-1.004148945127414,0.5230769230769231,0.9173821319868444,1.0,2/8,4.94%,PRDX4;PRDX5
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5801479686184827,-1.0033087805590732,0.4864864864864865,0.919166562003347,1.0,3/11,17.49%,IGF1;SLC51B;SOAT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.40230147732022836,1.0031649676692005,0.36363636363636365,0.9661131701259597,1.0,8/47,16.85%,PPARGC1A;PLD6;MCU;MFF;RALA;MUL1;MIEF2;BAD
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.3850878189842844,1.0031091459259096,0.3939393939393939,0.9653366690778933,1.0,10/56,11.34%,ERCC8;LIG4;SMARCAL1;BRCC3;UBE2N;ERCC6;DCLRE1B;HMGB1;CYREN;PSMD14
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.42845736592479333,1.0030697318405504,0.5,0.9644960039187166,1.0,3/29,4.15%,WNT7A;CEL;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5047903340751917,1.003011021058809,0.42857142857142855,0.9636897510257683,1.0,3/16,3.97%,RGCC;BMP2;RUNX1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.44980071591987536,-1.0029498126496939,0.5074626865671642,0.9196296440233105,1.0,3/52,8.23%,TRIM22;TRIM5;TRIM17
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.39914378255836613,-1.0029376642703847,0.47674418604651164,0.9191313214563924,1.0,22/170,12.48%,S100A10;CDKN2A;EPS8L2;PLK2;ATF3;APP;KLF4;RALGDS;STEAP3;PLK3;HEXIM1;BAIAP2;GADD45A;TSPYL2;IRAG2;BTG1;RHBDF2;TGFA;NDRG1;IER3;PVT1;PROCR
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",0.6441507698269977,1.0029071992605876,0.5277777777777778,0.9629287332168441,1.0,2/5,25.69%,SEC61A1;SEC61A2
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.49702566171393703,1.002742682790775,0.45161290322580644,0.9624528716611356,1.0,2/17,5.74%,POLD3;RFC3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.49061850651259065,-1.0026921744587352,0.5,0.9192684493329197,1.0,8/27,18.48%,KCNB1;SLC39A14;RAB11FIP5;PDK3;PTPRN;ADCY8;GPER1;PCK2
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5109206106576285,-1.0024613202435368,0.5147058823529411,0.9193094428806944,1.0,5/22,17.26%,RPS27A;RPA3;UBC;RPA1;POLD1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.5627931373768921,1.0023921789061605,0.4878048780487805,0.9623376537358774,1.0,4/10,18.05%,MCU;MAIP1;MICU2;MICU3
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.6110320150394184,-1.0020175893496657,0.46875,0.9199365736867698,1.0,2/9,16.44%,GINS2;CDC7
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),-0.5947363435045795,-1.0019939195382446,0.5,0.9194871543592559,1.0,2/9,4.21%,SULT1C3;CHST4
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.4819311247207262,-1.0019826699131786,0.5135135135135135,0.9189797008731331,1.0,7/37,19.49%,ATG9A;SPATA18;MAP1LC3A;PINK1;WDR45;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.6688818246979471,-1.0018375086105995,0.5740740740740741,0.918898411609309,1.0,1/6,4.39%,SIGLEC1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),0.5120572292026583,1.0018309782927854,0.42857142857142855,0.9627562927197081,1.0,4/14,17.93%,RBBP4;H1-2;NOC2L;CDAN1
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.4420695804268846,1.0016119652988362,0.3870967741935484,0.9624016422228179,1.0,6/26,18.30%,UBE2T;ANAPC13;ANAPC1;CDC26;RNF26;UBE2E3
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.5492154887215007,-1.001432788291178,0.5223880597014925,0.919338252935558,1.0,2/16,4.28%,ALOX12;DUOX1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.4308394794845868,1.0013621089472087,0.40540540540540543,0.9621346270693163,1.0,9/39,10.69%,CPAMD8;ADAMTS18;FREM2;ZDHHC16;SMG9;PBX1;CEP290;ATF6;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.5833217866161544,-1.0013429889543548,0.4852941176470588,0.9190283640449014,1.0,3/10,11.40%,PRKCQ;SYK;HLA-E
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.38529495606832875,1.001287916935339,0.4,0.9613251533120153,1.0,13/70,14.90%,TBC1D4;PDE3B;TRIB3;KAT2B;AKT2;AKT1;RAB8B;INSIG2;LPIN3;EPM2AIP1;GPLD1;PIK3R1;RAB8A
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5714830856405146,-1.0012861811565943,0.5483870967741935,0.9186497928629709,1.0,2/13,13.34%,ZFP36;DND1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.5708656494494458,1.0009696719836363,0.40625,0.9612224086192807,1.0,2/8,1.24%,LEPR;NR1D1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.49612355406131536,1.0007915890861092,0.44,0.9607296671870045,1.0,6/15,23.52%,NIPBL;GLI3;BMPR1B;PCSK5;MBNL1;MYH3
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.47963155706796606,-1.0006638424116512,0.5064935064935064,0.9196675442316701,1.0,3/52,3.82%,APIP;B2M;KCNJ2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.5552161466248634,-1.00050415626881,0.4807692307692308,0.9195648756331579,1.0,2/11,16.10%,APP;ATOX1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.5363347719092588,-1.0003404370399966,0.49206349206349204,0.9195630527744261,1.0,1/12,1.11%,APLNR
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6685641692805008,-1.0000539899985674,0.4915254237288136,0.9197784682964206,1.0,2/6,9.24%,ALOX12;IGF1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.2685959509922261,1.0,1.0,0.96219779771032,1.0,330/1616,17.74%,MEOX2;POU6F2;ZNF300;WNT7A;POU3F1;RGCC;ASCL1;ZNF697;ZNF287;TFCP2L1;ETV5;ZNF615;ZNF202;ZNF415;NR1D1;SOX8;ZNF783;KCTD1;BMP2;RITA1;MED21;POU3F4;PPARGC1A;ZFP3;ZNF441;PRDM6;SOX21;IRF2BP1;RTRAF;ANXA4;ZNF212;KDM1B;ZNF525;PSMD10;CEBPA;NR2E1;ZNF358;SERPINF2;DACH1;ZNF778;ZSCAN25;ZBTB43;ZNF107;EHF;ID1;ZNF658;MITF;ZNF426;MEN1;CARF;SMYD2;ELOC;RARB;ZSCAN20;RUNX1;HSF5;ZNF24;ZNF624;KMT5A;ZXDA;POU3F2;LCORL;BCLAF3;ZNF556;ZBTB37;ZFP2;MAML3;ZNF555;HCLS1;GREM1;TRIB3;HES6;OTX1;SOX9;ZNF616;LMO1;ZNF319;KAT2B;RNF2;ZBTB9;EGFR;FOXP1;MTF1;THAP11;SMAD5;ATF5;CDK8;SMARCAL1;ZNF707;ZNF384;ZNF613;PRDM4;ZNF304;ZNF74;ZNF577;ESRRG;GRHL1;ZNF484;ZNF684;TRIM28;ZNF639;EED;EAF2;SOX12;DNMT3B;ZNF786;FRK;ELOA;ZBTB40;ZNF883;RORB;KLF16;ZNF320;ZNF852;TSHZ1;ZNF268;NCOA3;ZBTB39;THAP1;ZNF211;SNF8;SIRT6;ZNF782;ZFHX4;RNF14;ZBTB18;PBX1;ZNF561;ZBTB33;DPF1;AR;ELK4;YY1;ZNF696;NR3C1;ZSCAN23;LMO7;PHF10;ZNF595;NFYC;ZNF774;HSF1;CAPRIN2;JDP2;ARID3B;HMGB1;ETV1;SLC2A4RG;FOXJ1;ZNF12;ZBTB6;SALL1;NRIP1;GABPB1;HSF2;ZNF133;ZNF518A;ZNF587;ZNF510;ZNF543;ZNF496;SLC30A9;ZNF155;EBF4;ZGLP1;ZNF665;LCOR;PHF14;ZNF875;ZNF181;PLK1;ZIC2;KCNIP3;FOXJ2;LPIN3;PPM1A;TIAL1;MIER3;ATF6;ZNF347;ANKRD2;ZSCAN22;ZNF677;HEYL;HLF;NUFIP1;NIPBL;ZXDB;FOXJ3;ZNF397;ZNF121;ZNF761;ZNF669;NCK1;ZXDC;ZNF408;ESRRA;BRWD1;SSBP3;ARX;ZBTB2;UBE2D1;TENM2;ZNF33A;VEZF1;ZNF792;MXD3;KMT2A;EMX2;ZNF793;PATZ1;BRWD3;SALL3;PLAGL1;ZNF214;CSF1R;SPEN;TRPS1;SOX5;DVL2;HEXIM2;ZNF451;CNOT2;ZNF254;ZNF276;ACVR2A;ZNF283;TOX;HTATSF1;WASL;SAP130;BAZ1A;KAT2A;ZEB2;GTF2H5;KLF12;ZNF14;E2F4;ZNF382;ZNF324B;ZNF354B;GTF2H2;GTF2H2C;ELP2;ZNF527;MYNN;ZNF230;MLLT10;ZNF324;ZNF764;PRDM5;RPS6KA3;RNASEL;KAT7;ZNF530;ZNF18;PLAGL2;ZNF416;ZNF429;PRKD1;ZNF507;ZNF189;NFKB1;PEX2;PIK3R1;ZNF43;AEBP2;MAMSTR;PURG;MCPH1;HDAC2;FIZ1;ZBTB20;HNRNPU;LHX2;ZNF558;POU2F1;ZNF264;ZNF75A;ID2;NCK2;WWOX;ZNF91;ZNF425;EP300;TADA1;SMARCA2;NRF1;ZNF471;ZNF25;CPEB3;ZNF34;BACH1;ETS2;MGA;HINFP;PBX2;NR2F1;DCAF1;ZHX2;NR1D2;ELP4;ZNF470;ZNF521;NKRF;ZNF322;ZNF688;ZBTB34;CREG1;NOC2L;IRF2BPL;OLIG1;ZFP82;NCOA2;ZNF248;ZNF865;ZNF589;AGO3;ELK1;AKIRIN2;ZNF611;NR3C2;BEND3;ZNF879;VHL;ZNF41;BRD7;CNOT1;MYPOP;CEBPG
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.45455770588843286,-0.9999071997246137,0.4473684210526316,0.9196070720493152,1.0,4/29,12.35%,LZTS1;YWHAH;IL1RAPL1;HECW2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5575624727770341,-0.999719827005033,0.5333333333333333,0.9195364271555277,1.0,1/11,3.94%,ATF3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.4331642083542969,0.999299302644891,0.46875,0.9632195961122858,1.0,2/19,7.35%,NCOA4;ZFYVE16
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.6097320136176487,0.9988409824844581,0.5686274509803921,0.9636342170009149,1.0,2/5,25.53%,PDCL3;DNAJB2
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.5556972470135905,0.9988234326177926,0.40476190476190477,0.962719953037916,1.0,6/10,30.11%,RBBP4;NOC2L;CDAN1;MTA2;M1AP;SUPT16H
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.5320964041269487,-0.9987726778023202,0.5,0.9214387954505894,1.0,5/14,20.40%,BEST1;ABCB1;ABCC1;ABCG2;CXADR
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.48501341680590354,0.9980208824006449,0.42424242424242425,0.9642022052843966,1.0,2/12,6.69%,FGL1;AKT1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.4215826882377067,-0.9979880403364226,0.4507042253521127,0.9231433961842515,1.0,15/83,17.67%,IL1R1;RPS27A;ST18;NOD1;PSMB9;PSMB6;PSMC3;TNIP2;UBC;PSMA8;IL1RAP;PSMA7;PSME1;RIPK2;RBX1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.5827435338041809,-0.9977606689447337,0.532258064516129,0.923213503584407,1.0,2/8,11.72%,CBLN2;DCTN1
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.5507050726041983,-0.9976449403196156,0.4868421052631579,0.9229878335728802,1.0,2/15,5.91%,P2RY12;TRPC3
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.5344860322789611,-0.9972930538493463,0.5217391304347826,0.9233376466624299,1.0,2/17,2.27%,B3GALT2;NDST4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.4320109394945423,0.9972670433492928,0.5172413793103449,0.9652936747937588,1.0,9/31,17.22%,KMT5A;NCAPH2;CSNK2A1;CSNK2A2;PLK1;H1-2;TENT4A;MCPH1;DFFB
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.45984560441284006,-0.9968020747475834,0.46835443037974683,0.9240298901970971,1.0,10/58,10.57%,CLIC1;ANO2;BEST1;GLRA2;SLC26A8;ANO9;CLIC4;GABRE;GABRB2;GABRD
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),-0.633561975089571,-0.9966348487400434,0.5614035087719298,0.9239991785493755,1.0,1/7,1.30%,ALDOB
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.42607477696522444,-0.9964868473697298,0.5128205128205128,0.9238209897413555,1.0,7/93,6.11%,COL4A1;CALD1;COL4A2;LAMB1;GJC1;THY1;MAP1B
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.5149348000458134,0.9961274722052655,0.375,0.9676643401413926,1.0,4/12,14.67%,INSIG2;GRAMD1C;GRAMD1B;GPLD1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.5045841498714172,0.9960306141112656,0.4857142857142857,0.9670186416379929,1.0,2/11,4.15%,CEL;NLGN3
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.6735282726024842,-0.995854435997248,0.48,0.9249645922516384,1.0,1/5,6.33%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3875170332345373,-0.9958230842768271,0.4936708860759494,0.9245176799095213,1.0,7/145,6.13%,RASGRP1;S100A10;DOCK8;RASGRP2;THY1;CCL2;TBC1D9
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.4289527956874625,0.9956250360098465,0.42424242424242425,0.9670297030840315,1.0,5/36,8.09%,SLC6A13;SLC47A1;SFXN2;SLC25A18;SLC3A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.4305416006052527,-0.9955884303169436,0.5,0.9246077250364184,1.0,16/61,20.77%,B2M;HLA-A;MFSD6;HLA-C;PSMB9;PSMB6;HLA-B;HLA-E;PSMC3;HLA-F;PSMA8;PSMA7;PSME1;CD36;PDIA3;IKBKG
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.575356304565583,0.9952321461306161,0.6,0.9672662086327922,1.0,2/7,12.99%,PTGIS;AKR1C3
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3665021860653567,0.9946600853692912,0.43333333333333335,0.9678562365340329,1.0,9/77,13.78%,WNT7A;PSMD10;PSMA1;PSMD11;PSMB5;AP2B1;PSMD14;DVL2;PSMD12
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.49968725161733973,0.9944768812258694,0.5384615384615384,0.9675342755879536,1.0,4/17,19.96%,NCSTN;NFKB1;RHBDD1;SPPL2A
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.5029254236560445,-0.9942718288530168,0.5205479452054794,0.9278514619341595,1.0,1/31,0.18%,ANXA1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.4130931410896434,-0.9941138091901743,0.5185185185185185,0.9277241258591894,1.0,25/105,22.28%,FLRT3;EFNB3;ARHGEF17;ATP1B1;GYG2;SHC2;DAB2IP;ADCY5;IGFBP5;SLC44A3;AMOTL2;SLC4A2;SLC4A10;SLC29A4;HTR2C;PTPRF;NOTCH3;AQP1;PTPN21;EPB41L4B;KIAA1217;PCDHB4;TOX3;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.6489436071258847,-0.9940888584105277,0.6071428571428571,0.9267247582873416,1.0,1/6,6.62%,PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.6489436071258847,-0.9940888584105277,0.6071428571428571,0.9267247582873416,1.0,1/6,6.62%,PARP14
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.5434992281568131,-0.9938488040477433,0.5,0.9267031652275716,1.0,3/14,9.24%,HTR2B;EGF;IGF1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),0.526878655732652,0.9931833602993388,0.4883720930232558,0.9700607501681259,1.0,4/11,18.96%,NUP214;UHMK1;AAAS;PTPN14
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.5371687163206719,0.9931459339185797,0.5384615384615384,0.9692559995847139,1.0,2/10,14.92%,NIPBL;POT1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.5907611937740992,-0.9930082415852242,0.4852941176470588,0.928484652460769,1.0,1/9,1.31%,TYMP
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.39178685505855504,-0.99278287039456,0.39759036144578314,0.9285459034643335,1.0,38/144,17.50%,TAGLN3;POU4F1;STMN2;NEFL;NEFM;SNCB;SH3GL2;ZDHHC22;SLITRK1;LRRTM1;SYT4;JPH3;NELL1;GAP43;TMEM163;CA10;NYAP1;PLPPR5;HPCA;TCEAL2;LHFPL5;CALY;STMN4;DCTN1;C11ORF87;CRMP1;NARF;SYT16;CNTN2;KCNC1;GDAP1L1;SNCG;CCDC184;TCEAL5;SLC29A4;SULT4A1;FGF12;RTN2
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.9268824909191411,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.9268824909191411,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.9268824909191411,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.6366262978459989,-0.9925850577190544,0.5283018867924528,0.9268824909191411,1.0,2/5,13.27%,RNASE10;TAC4
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.32210326869482825,0.9919707388186229,0.5,0.971434160280103,1.0,85/339,20.96%,POU6F2;RNF6;LIMD1;ZNF117;BMP2;PPARGC1A;ZNF195;SOX21;ZNF212;CEBPA;MITF;POFUT1;HCLS1;HES6;COPS2;USP13;SLC39A8;ATF5;APBB3;ZNF74;ESRRG;ZNF502;SOX12;RORB;ZNF680;ZNF268;THAP1;GLI4;RNF14;NR3C1;NFYC;YAF2;SLC2A4RG;HP1BP3;ZNF341;ZNF875;ZNF703;ZNF676;ESRRA;ZNF33A;ZNF736;ZNF280D;MAGED1;PATZ1;APBB2;TGFBRAP1;DVL2;ZNF138;HMG20A;GPBP1L1;KAT7;ZNF519;ZNHIT3;EP300;SMARCA2;PPIE;BACH1;HINFP;ZNF492;NR1D2;FOXN2;NCOA2;CHD7;VHL;EFEMP1;CNBP;VSX1;NLK;HDAC10;PRDM2;ZNF737;NFXL1;MED23;DAXX;ZNF460;PSPC1;CCAR2;SP3;ZNF253;SAP30L;ZNF2;UTP4;KAT6B;ZNF398;ZNF430
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.6448645057022783,-0.9918208647327168,0.484375,0.9284802392381074,1.0,1/6,11.74%,PINK1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.47167409648696823,-0.9918136719558327,0.4411764705882353,0.9279774447106136,1.0,2/41,5.22%,LEF1;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.41398280931111936,-0.9913152296076783,0.5063291139240507,0.928727490154111,1.0,16/84,15.30%,ARHGAP4;SULF1;THY1;PODN;SPOCK3;BST2;CYP1B1;WAS;CLIC4;IGFBP5;LDLRAD4;TMEFF2;SPINT2;CD74;SFRP2;DLC1
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.5851333455195553,-0.9912350044924811,0.47540983606557374,0.9283763539463785,1.0,1/6,1.67%,MX1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.5354351350231141,-0.991010681578281,0.5230769230769231,0.9285259583243496,1.0,3/16,12.99%,NLRC5;LDB2;EMP2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3128646671118757,0.9906761107282954,0.5714285714285714,0.9745050181290744,1.0,39/291,13.78%,SPSB4;ERCC8;FBXO45;FBXO48;SPSB2;PSMD10;KBTBD7;FEM1C;DERL2;PSMA1;PSMD11;FBXL14;DMAC2;ANAPC1;CUL1;PSMB5;TMUB2;FBXO5;VCP;RNF103-CHMP3;GID8;ECPAS;FBXL3;FBXO9;AUP1;UBE2G1;BTRC;PLK1;STT3B;UBE2D1;PSMD14;FEM1B;DERL1;FBXO38;CUL2;KCTD17;FBXO27;TMEM129;PSMD12
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.5529701282338125,-0.9905504145709225,0.49230769230769234,0.9292431748635527,1.0,4/9,18.25%,ARIH2;WNT5A;SFRP2;ETV6
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.5452997784061676,0.9904338892727044,0.5714285714285714,0.974157002634965,1.0,4/12,23.56%,WDR82;KMT2A;BEND3;TET3
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.39118152591696276,0.9900924739432182,0.3076923076923077,0.9742678470542306,1.0,11/45,13.41%,MSRB1;CATIP;WASHC5;VILL;TTC17;TWF1;SPIRE2;DIAPH3;MICAL2;WASL;MICAL1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),-0.6115187315947525,-0.9900134214004439,0.6229508196721312,0.9301886515427037,1.0,1/9,3.11%,AIPL1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),-0.6461162346467106,-0.9898803190830742,0.5689655172413793,0.9294399080990476,1.0,1/5,1.30%,ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),-0.6461162346467106,-0.9898803190830742,0.5689655172413793,0.9294399080990476,1.0,1/5,1.30%,ALDOB
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),0.49723876725576155,0.9898566316250511,0.4857142857142857,0.9740058728188651,1.0,2/10,8.98%,LTV1;XPO1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.5489140136468389,-0.9898450697821941,0.47058823529411764,0.9290115953707276,1.0,4/14,12.58%,IFIT1;COLEC12;IFIH1;FLOT1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.551055752356206,-0.9894342421124853,0.5185185185185185,0.9295187517866667,1.0,1/15,2.20%,ZFP36
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.47555371220529286,0.9893127034594948,0.5294117647058824,0.9746484556381932,1.0,8/22,16.11%,GDAP1;PEX11A;WASHC5;MFF;OPA1;DNM3;MUL1;MTFR1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.41155544032217656,-0.9892718002709183,0.5432098765432098,0.9294075547606117,1.0,18/83,18.23%,SEPTIN5;RAB11A;PLD1;HAP1;SEPTIN4;RIT2;CPLX1;SYT1;CPLX2;RIMS2;USP6;SYK;FES;RAB3C;ARFGAP1;TSC2;SEPTIN1;RAB15
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.6378247011001078,-0.9888542047214863,0.47368421052631576,0.92944481698696,1.0,1/5,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.6378247011001078,-0.9888542047214863,0.47368421052631576,0.92944481698696,1.0,1/5,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.523478114618968,0.9888076037555704,0.45454545454545453,0.9754811092953487,1.0,2/11,3.76%,PDE3A;OCLN
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.5695156835017561,0.988761624482722,0.5217391304347826,0.9746773080081494,1.0,3/9,14.24%,AIFM2;ABCD1;DHFR
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.44494063977737175,-0.9883987248046014,0.5540540540540541,0.9299972397087225,1.0,8/46,19.82%,MX1;RAMP3;CD9;SYK;TGFB1;ADM;CD36;DNM1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.5492087988971143,0.9883904091835105,0.5,0.9746280557623674,1.0,2/10,5.55%,RIOK2;RIOK1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.5040221559230315,-0.9883822434505279,0.5205479452054794,0.9294923554987532,1.0,4/28,7.61%,CLDN16;POF1B;CLDN20;CLDN18
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),0.562249508591177,0.9881544894897647,0.5227272727272727,0.9743987551781137,1.0,7/11,28.72%,EXOSC6;TENT4B;FBL;DKC1;EXOSC5;FBLL1;LARP7
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),0.6142664615817651,0.9880961380597918,0.5555555555555556,0.9736193771317166,1.0,2/6,18.86%,RAE1;PCID2
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.4420352996808429,-0.9880192737167047,0.4925373134328358,0.9298991791277333,1.0,4/40,11.18%,PIF1;KLF4;TCP1;PRKCQ
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.5563103839587541,0.9876194759047154,0.5102040816326531,0.9740260468600151,1.0,3/9,12.98%,CD200R1;AKT1;WASL
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.39294888646628795,0.9875934300606265,0.5185185185185185,0.9732061943592483,1.0,3/54,3.30%,FGF6;GALNT3;SPRED1
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),-0.6201185253284848,-0.9874650171326371,0.578125,0.9308384756795869,1.0,1/5,0.99%,IPCEF1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.43211861666131995,0.9874497010236435,0.42857142857142855,0.9726517917921977,1.0,7/26,21.02%,ABCB10;HSPA1A;HSF1;RHBDD1;DAXX;ERN1;TM7SF3
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.4994966750232426,-0.9872781019193417,0.48333333333333334,0.9307735167120625,1.0,1/18,0.95%,SP100
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.4329474573287587,-0.9869762786701148,0.4788732394366197,0.931054904894896,1.0,16/64,17.25%,THBS1;SPARC;PROX1;SULF1;HTR2B;FUT2;EGF;STAT1;WNT5A;ATP5IF1;VIP;EGFL7;NR4A1;PIK3CD;F3;TEK
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4834459206064099,0.9869013023619089,0.5,0.9732480802499738,1.0,3/13,5.99%,ABCD2;MACIR;ABCD1
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.6674454330340667,-0.9867097534061596,0.5714285714285714,0.9311087017059263,1.0,2/5,7.95%,PROX1;MYH11
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.5901146290707713,-0.9865803938419789,0.5737704918032787,0.9308733377910774,1.0,4/8,16.53%,SULF1;MYO1E;ITGA3;MCAM
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.6450561949888449,-0.9863222980696872,0.5882352941176471,0.931092284161424,1.0,1/6,5.09%,EMG1
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.48311325125488436,0.9863080651424284,0.42424242424242425,0.9739486405156222,1.0,10/18,29.15%,CWC27;PPIL2;PPIE;PPWD1;PPIL6;PPIC;PPIH;FKBP4;PPID;PPIL3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.4516489852688904,-0.9861244934000803,0.4931506849315068,0.9310325215013389,1.0,14/44,17.04%,RASGRP1;ARHGEF3;RASGEF1A;GPR18;SYNPO2L;IGF1;MAPRE2;LPAR6;LPAR4;P2RY10;PIK3CB;VAV1;ERBIN;IRS2
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.43013956083741794,-0.985665170029716,0.47368421052631576,0.9316686004712816,1.0,14/55,17.15%,RASGRP2;SYT4;NEUROD2;SYT1;CLIC4;WNT5A;HPCA;CPNE9;DMTN;NLGN1;SYT5;SYT2;SYT13;ADCY8
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5673150706503538,-0.9855517622280364,0.5423728813559322,0.930899965791051,1.0,3/9,19.49%,MAP1LC3A;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5673150706503538,-0.9855517622280364,0.5423728813559322,0.930899965791051,1.0,3/9,19.49%,MAP1LC3A;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.39608482886850843,-0.985394803398138,0.4714285714285714,0.93080957114432,1.0,28/119,18.56%,RFTN1;FYB1;HLA-A;SKAP1;INPP5D;THY1;HLA-DRA;PSMB9;MOG;WAS;NFKBID;EIF2B2;PSMB6;HHLA2;PRKCQ;PSMC3;FYB2;THEMIS;BTN3A1;PIK3CB;PSMA8;PIK3CD;PSMA7;HLA-DRB1;PSME1;RIPK2;CARD11;CD4
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),-0.6122608538575961,-0.9848135594511902,0.5849056603773585,0.9319483192327439,1.0,1/5,10.01%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5586880480466497,0.9843037989171409,0.5121951219512195,0.9773022477803548,1.0,3/8,21.18%,SRI;GSTM2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5586880480466497,0.9843037989171409,0.5121951219512195,0.9773022477803548,1.0,3/8,21.18%,SRI;GSTM2;PKD2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.5208441683123956,-0.9842841478318263,0.515625,0.9328288236948111,1.0,7/18,17.65%,CEACAM1;ACSL5;FBP1;IL4R;GUCY2C;CDH17;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.47481195958406963,-0.9842709079601004,0.5142857142857142,0.9323471177429742,1.0,7/27,18.14%,MET;PSRC1;CAV3;DCTN1;FES;ANKRD53;MAPT
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5229652782765329,0.984204238334705,0.5277777777777778,0.9767781478894256,1.0,4/12,20.81%,FBLN1;HNRNPU;AGO3;GJA1
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.5903593700918892,-0.9841658382623182,0.5769230769230769,0.9320969707258613,1.0,2/10,17.15%,ABCB1;ADCY8
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.5068645028548671,-0.9839514145742999,0.46774193548387094,0.9321600941130738,1.0,3/20,11.28%,EFNA1;ELN;SLIT3
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6535928499940118,0.9837591538602096,0.5128205128205128,0.9769584292410066,1.0,3/5,25.16%,PGAP1;PIGU;PIGT
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.5494605548459579,-0.9837124603704571,0.5217391304347826,0.9323205831942941,1.0,1/11,7.15%,C12ORF57
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.4629233926423814,0.9836057916740193,0.4444444444444444,0.9765929479790616,1.0,6/11,33.74%,SESN2;SESN3;KPTN;SESN1;ITFG2;SZT2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.554233692397308,0.9836033730562012,0.48717948717948717,0.9757041705066516,1.0,1/9,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.3880901628599445,-0.9834772184097003,0.5176470588235295,0.9324860198986241,1.0,31/172,18.86%,HPN;CDKN2A;RASGRP2;PSRC1;TMC8;TP53TG5;KIF14;MMP14;CEACAM1;BST2;LTBP4;FBP1;TSPYL2;RPS6KA1;BTG1;CRLF3;PRKCQ;SLIT3;BAP1;HYAL1;MFSD2A;SFRP2;TCHP;PML;BCL6;NUBP1;TGFB1;CDKN2D;CDKN1A;AKAP6;PLCE1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.5089672409904548,0.983467810225259,0.4444444444444444,0.9751625299082282,1.0,9/10,40.89%,MKKS;BBS2;PTEN;CTNNA2;SPEF2;PAFAH1B1;BBS4;FBXW11;VPS51
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.48559236260401667,-0.9831974480317985,0.5147058823529411,0.9327229887133919,1.0,8/31,12.58%,ANK3;SKAP1;PODXL;THY1;CD44;ADAM19;RNASE10;FLOT1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4893089209199141,-0.9831956978897594,0.5522388059701493,0.9322173414690792,1.0,10/35,23.86%,A4GALT;B3GNT5;PGAP2;PIGA;PIGH;PIGC;ST8SIA3;ST8SIA1;DPM3;PGAP4
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.47577641883737787,0.9826436126288729,0.5625,0.9763896456226336,1.0,3/17,6.16%,AGER;BMP2;MAP3K4
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),0.6131426439455518,0.9825648232412483,0.5526315789473685,0.9757438651497043,1.0,5/6,38.03%,NDUFV3;NDUFV1;NDUFB6;NDUFA12;COA6
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.4927501290708247,-0.982439928501083,0.5428571428571428,0.9339073828223706,1.0,5/29,15.80%,EFNA1;EGF;TGFA;BDNF;RELN
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.39365933383712,-0.9820770588567524,0.5301204819277109,0.9343017083670088,1.0,12/138,9.24%,KLF2;THBS1;FABP3;NOS1AP;RPS4X;KLF4;ATAD5;DUOXA1;PLD1;LDLR;EGF;IGF1
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.507971362310434,-0.9818683669621994,0.5882352941176471,0.9343633703509349,1.0,8/23,17.15%,ADCY7;GIPR;LGR5;ADCY5;RXFP1;GLP1R;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),-0.6429311931297794,-0.9816136888428523,0.46774193548387094,0.9345731073102856,1.0,4/7,27.22%,SYK;FES;ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5969719558754513,-0.9815716818231675,0.5,0.9342056842943604,1.0,1/8,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.5018143806244585,0.9815645745640638,0.4827586206896552,0.9765942843467443,1.0,2/12,18.23%,ASAH2B;SPHK2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.5018143806244585,0.9815645745640638,0.4827586206896552,0.9765942843467443,1.0,2/12,18.23%,ASAH2B;SPHK2
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.6175962019162486,0.9814591314202546,0.6,0.9759605124046177,1.0,1/5,4.35%,CSGALNACT1
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.3880844505672058,-0.9813547774175503,0.4823529411764706,0.9342162697530065,1.0,18/164,7.37%,ENPP2;IL1R1;DUSP1;APLNR;SPARC;C1R;A4GALT;KDELR3;ABCA8;RAMP3;MAOB;GPR34;SLA;HS3ST3A1;CCL2;PODN;LDB2;PAPSS2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.43625193887010805,-0.9812039651870446,0.4864864864864865,0.9340432458183526,1.0,7/59,7.81%,C3;MRAP2;SLC39A14;RAMP3;KLK6;SYP;PDE6B
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.6191522936909282,0.9810736059832067,0.575,0.9752061793666168,1.0,2/5,8.28%,NCOA4;AR
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.6191522936909282,0.9810736059832067,0.575,0.9752061793666168,1.0,2/5,8.28%,NCOA4;AR
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.7036482851263166,-0.9810227371378736,0.5882352941176471,0.9339825492674111,1.0,3/5,25.54%,F3;ANGPT2;NTRK3
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5989966289344006,0.9808766194813808,0.6122448979591837,0.9749079955842558,1.0,3/6,33.21%,ITCH;TANK;OTUD4
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.5526008626697603,-0.9805586706676904,0.4339622641509434,0.934624936146192,1.0,5/9,26.24%,SLCO3A1;SLCO2A1;ABCC1;ABCC6;ABCC4
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.5919577208162293,0.9805229766067254,0.6,0.9750153229992436,1.0,3/6,27.00%,VCP;SART3;TANK
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.44949364347595716,-0.9804357703794933,0.5,0.9344010577288274,1.0,3/44,0.95%,RECQL4;BLM;SP100
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.5216704132880253,0.9803344774246986,0.4864864864864865,0.9745829908629071,1.0,2/12,5.13%,PDK4;SOX9
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.6084381524193128,-0.9802201251902533,0.5714285714285714,0.9343657081846102,1.0,1/7,4.70%,ARG2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6506405270168817,0.9800517971704893,0.6046511627906976,0.974483121639512,1.0,2/5,6.18%,INTS13;LHFPL2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.5053709864434174,0.9798814354905442,0.5263157894736842,0.9740624159622971,1.0,5/12,21.18%,NUDT21;CPSF6;CPSF7;FARSB;PKD2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.6518551020436104,-0.9798748318417048,0.5454545454545454,0.9348186463914273,1.0,1/5,6.20%,ABCB1
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.47808107222722107,-0.9798566836413911,0.5064935064935064,0.9343256243681433,1.0,6/29,15.41%,ANK3;CLDN16;LETM2;FAM20A;SLC12A7;CIB2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.4286884959316468,-0.9797072349000434,0.4625,0.9341582855039753,1.0,4/67,8.75%,ANXA1;BLM;BRCA1;GADD45A
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.45934216940103695,0.9794823519798719,0.4444444444444444,0.9743046199574713,1.0,11/18,36.07%,RIDA;YTHDF2;ROCK2;FTO;MEX3D;CELF1;METTL14;METTL3;ROCK1;YTHDF3;GIGYF2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.47063229897079295,-0.97913586333651,0.5151515151515151,0.9351995886728387,1.0,2/32,5.91%,CP;TRPC3
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.38739769649468714,0.9789883361047437,0.4090909090909091,0.9747737895082575,1.0,6/48,7.15%,GNL3L;HSPA1A;TNFAIP3;BAG2;AKT1;FBXO5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4739797823688118,0.9789633858609951,0.4634146341463415,0.9739408759648822,1.0,7/15,35.95%,AKT1;UBQLN1;NFE2L2;MAPK7;SIRT1;SFPQ;NME5
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.4716303354226008,-0.9789452437574274,0.4533333333333333,0.9351892721024521,1.0,6/33,12.43%,EPN1;SH3GL2;EGF;TGFA;DAB2IP;MVP
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.5738804091924548,-0.9786750441885215,0.4925373134328358,0.9353869185120938,1.0,1/8,2.05%,ABCA5
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.5653760487313509,-0.9782467720712114,0.5645161290322581,0.9359391934496823,1.0,3/8,18.28%,IL12A;HYAL1;CDKN1A
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.5414579116527284,-0.9782035535897486,0.5147058823529411,0.9355181073771653,1.0,4/12,16.52%,CYP4Z1;GLYATL2;OLAH;OXSM
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.5774916160633219,-0.9780964357018608,0.5740740740740741,0.9352595193944057,1.0,1/7,5.75%,SLC4A11
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.46581835107725683,0.9774806952713856,0.48484848484848486,0.9770715355826404,1.0,4/22,7.32%,PDK4;ADIPOR1;TRIB3;MID1IP1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.5064463416475118,-0.9774188574165071,0.5616438356164384,0.9364587532811631,1.0,5/25,18.28%,KIF14;GLI1;DDRGK1;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.5651170562247745,0.9773080563238611,0.5833333333333334,0.9766400821712776,1.0,2/10,9.81%,INSC;MAL
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5924813874810196,0.9772015423742186,0.475,0.976157913684905,1.0,3/8,13.87%,DCUN1D2;DCUN1D1;DCUN1D5
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.36259811258933417,-0.9768232921224812,0.5204081632653061,0.9374290604929603,1.0,104/523,19.12%,PRAME;LEF1;THBS1;CDKN2A;IL13RA1;SIX3;NR4A3;FABP3;TGFBR2;WARS1;PROX1;PDPN;RPS4X;IRF1;BTG3;KIF14;TESC;STAT4;GPNMB;IFI35;ST18;CHRM1;COPS9;IL15;APP;KLF4;HTR2B;SCX;PODN;CYP1B1;TIMP1;IFIT3;EGF;ELN;BTG1;SHCBP1;P3H2;OSMR;IGF1;S1PR3;STAT1;THPO;SST;TGFA;IGFBP7;FGF1;ROMO1;NUAK1;DAB2IP;FN1;SFRP4;NAMPT;BAP1;FOXM1;EID2;GLI1;SQLE;EMP2;FGF7;TFAP4;FES;CLMN;IL7;VIP;RPS6;CDKN3;BOK;RPS9;SFRP2;DLC1;TNS2;DDRGK1;JUNB;CDK2;CCND2;NUDT6;CAPN1;CDC7;FGF22;RPL23;STAT6;PML;CDCA7;BCL6;CD200;TSC2;IRS2;ETS1;GPER1;NMI;TGFB1;CDKN2D;NUPR1;GSDME;NIBAN2;CDKN1A;SPDYA;RARG;TRAPPC14;ADAMTS8;IER5;PDGFRA;CAPNS1;ALK
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.4178796088530023,-0.9767292287444095,0.5142857142857142,0.9371445756687715,1.0,10/72,13.14%,GRIN2D;GRIN2A;SLC24A2;TRPC3;SLC24A1;SLC8A3;CACNA1C;SLC24A5;GRIN2B;MCUB
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.6398659318326985,0.9766039045182757,0.5510204081632653,0.9768908235566722,1.0,2/5,32.71%,GALC;GBA2
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3597676168307462,0.9765509602041776,0.5714285714285714,0.9762242490744868,1.0,7/42,13.65%,BMP2;S1PR1;GREM1;GPM6B;ACVR2A;SGMS2;ANKH
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.6398859769834814,-0.9763689680736868,0.5490196078431373,0.9374768201024355,1.0,2/5,21.38%,OSMR;ADAM8
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.5897483074714895,-0.9757537458189904,0.559322033898305,0.9385005322525959,1.0,3/5,25.29%,HYAL1;CDKN1A;HYAL2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.445888807789584,0.9757160076579957,0.4666666666666667,0.9775309695686423,1.0,3/19,10.68%,SOX8;SOX9;LIN7C
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.4642390401575428,0.9755134884422231,0.5,0.9770702609672394,1.0,3/12,19.53%,UBE2N;POT1;DAXX
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.5290708169898046,0.9751864803135458,0.4666666666666667,0.9770512530628631,1.0,1/12,0.43%,NGF
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.4592929769783589,0.9750996726108541,0.5365853658536586,0.976407421239819,1.0,3/14,7.96%,SOX8;SOX9;SIRT6
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.5351974936657651,0.9745992640116691,0.4166666666666667,0.9767574807108386,1.0,4/10,21.32%,PSPH;SRR;SERINC5;PHGDH
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.654096758489743,-0.9744456572878952,0.609375,0.9411432478490539,1.0,2/5,13.52%,LRRC4;NLGN1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.43047615112498966,0.9743619330970512,0.37037037037037035,0.9764627255059602,1.0,6/29,10.14%,PDK4;ADIPOR1;AKT2;AKT1;RUBCNL;GNB3
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.44566791798770794,0.9742232530864782,0.6060606060606061,0.9759846116632525,1.0,2/19,1.92%,AGMO;ARV1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.629485388937072,-0.973656408135099,0.5185185185185185,0.9425320838625908,1.0,1/5,17.54%,CDK5
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.45413526034546436,0.9734147105592248,0.5909090909090909,0.9769363113089163,1.0,3/19,3.21%,ACE2;ANXA4;EHF
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.503189082629048,0.9733933131541798,0.5294117647058824,0.9761017110763518,1.0,2/11,12.63%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.32802933177452087,0.97275308033042,0.42857142857142855,0.9770108476508685,1.0,16/186,9.33%,SPSB4;ERCC8;NR1D1;FBXO45;SPSB2;PSMD10;KBTBD7;FEM1C;SOCS6;PSMA1;PSMD11;PSMB5;VCP;GID8;UBE2G1;BTRC
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.6206943282202905,-0.9725395459881818,0.6101694915254238,0.9446453980023064,1.0,1/7,0.81%,BLM
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.5320461591284278,-0.9723868014394751,0.4868421052631579,0.9445040409684679,1.0,1/8,1.32%,GPR183
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.5891042881913539,0.9721870374288543,0.5789473684210527,0.9776740513239972,1.0,1/7,3.58%,NMB
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.37287775348636915,-0.9721358293792215,0.5851063829787234,0.9445793908391317,1.0,35/373,11.52%,CD24;ARHGAP4;BLM;POU4F1;GBP1;TAGAP;VRK2;ARHGEF3;NLRP12;DEPDC1B;ARHGAP9;PLEKHG2;ARHGAP15;TRIP10;BRCA1;CEACAM1;ARHGAP39;ARHGEF17;AKAP5;PLK3;RIT2;ARHGDIG;MINK1;RPA3;WNT5A;TAF10;WDR54;ARHGEF18;FGF1;NUAK1;BIRC3;DAB2IP;IER3;PRDM1;RHOF
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.47590564450422135,-0.972095768463289,0.47761194029850745,0.9441966211991668,1.0,2/22,5.22%,KLF2;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5017043450138574,0.9718958785151264,0.5,0.9775122719268573,1.0,2/14,11.53%,HSPA1A;OPA1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.4697223047497682,-0.9718803153093526,0.4861111111111111,0.9442619949551745,1.0,8/33,12.60%,KCNQ1;ANK3;NOS1AP;KCNJ2;CTSS;PDZK1;GNG2;NOS1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.42211950296529194,-0.9717466233518325,0.5,0.9441161253986224,1.0,21/67,24.22%,ATF3;SEMA3B;PLSCR1;LDLR;CD9;PDK3;SQLE;ADH4;MVK;FASN;FDPS;PLAUR;HMGCS1;HSD17B7;ACAT2;NFIL3;FADS2;SCD;IDI1;LSS;PPARG
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),0.6140861595120333,0.9714792994697549,0.58,0.9777978769299251,1.0,2/5,30.05%,BDP1;POLR3H
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.4137636382903109,0.9711069945098622,0.5333333333333333,0.9780525157877372,1.0,4/34,4.81%,C1ORF162;NR1D1;EPX;HCLS1
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),0.4801274636702318,0.971046789243857,0.5151515151515151,0.9773126721624746,1.0,1/16,1.18%,GRPEL2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6064415755056868,-0.9710436432985945,0.5409836065573771,0.9454478177722989,1.0,1/10,9.71%,HR
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.5746664581373324,0.9708758190584291,0.5,0.976999779054403,1.0,2/7,25.53%,SLC36A4;SLC1A4
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.4110471343480545,-0.970769708785034,0.5316455696202531,0.9456329451550602,1.0,26/103,18.82%,AMN;SLC6A15;SLC25A45;PDPN;RAMP3;SLC18A2;SLC38A4;SLC7A14;SLC3A1;SLC7A2;MYH9;SLC43A2;ARRDC2;SLC11A1;SLC38A1;SLC22A4;ARRDC3;SLC35F3;SLC29A4;AQP1;LRP2;ABCC1;SLC15A4;SLC7A7;SLC25A29;ABCG2
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.4803447175338215,-0.9706358077677805,0.5538461538461539,0.9455016286434993,1.0,3/38,0.95%,RECQL4;BLM;SP100
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.589504974301515,-0.9706046761958028,0.6031746031746031,0.9451196039249631,1.0,5/8,22.09%,YWHAH;HSD17B14;CYP3A4;SPP1;HSD11B1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.34439725315090686,0.9703571547008175,0.4782608695652174,0.9775278260356407,1.0,16/100,12.58%,NGF;EPHA6;CASS4;GUCA1B;FLT3;EGFR;YES1;FRK;CNKSR1;EFS;SHC4;ERBB4;CSF1R;PTPRG;EPHB4;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.661046122372544,-0.9703229113512924,0.5409836065573771,0.9452795367812941,1.0,1/5,18.14%,MAPT
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.38011827694436445,-0.970161298518138,0.6049382716049383,0.9451586480601523,1.0,37/179,17.91%,RPL19;RPL3;RPS27;RPS14;RPL27A;RPL35;EMG1;RPL7A;RPL37A;RPL27;RPL9;RPL21;NOB1;RPL13A;RPS16;RPL24;RPLP1;RPL38;RPL10A;RPL10;RPLP2;RPS7;RPL8;RPS6;MRTO4;RPS15;RPL26L1;RPS9;RPL12;PES1;RPL5;RPL23;RPL4;DDX54;RPL18A;RPL41;RPL7
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.47293394133928357,-0.9700781122790137,0.515625,0.9448976419058407,1.0,5/29,9.28%,B2M;THY1;EFNB3;YWHAH;MAG
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.42330602346262486,-0.9699198610795797,0.5194805194805194,0.9447871028024998,1.0,13/77,21.26%,TRIM22;TRIM5;PLK2;PLK3;PINK1;PLEKHF1;PIK3CB;TSC2;KAT5;TRIM65;SUPT5H;IKBKG;OPTN
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.5908963955662208,-0.969182686118417,0.5094339622641509,0.9462527704613366,1.0,3/9,11.40%,SFTPD;HLA-A;HLA-E
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.5615923123729433,-0.9691021369831823,0.5254237288135594,0.9460266014731766,1.0,1/12,2.14%,KMO
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.49933807763387444,-0.9690385405059664,0.5806451612903226,0.9456707274715355,1.0,1/16,0.94%,DUSP1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.4678615571070889,0.9689191942314601,0.5128205128205128,0.9805232627625063,1.0,6/23,12.89%,GAL3ST2;GK;ALG6;GAL3ST4;RRM2B;ALG11
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.5298667831135999,-0.9686082471514073,0.5588235294117647,0.9463043170838051,1.0,6/13,28.73%,IGF1;IGFBP5;SLIT2;CCN4;LRP1;SERPINE1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.6017473188065903,-0.968543260619607,0.5967741935483871,0.9459336992180319,1.0,1/6,6.13%,ELAVL4
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.5983666234689359,-0.9685156483597491,0.5,0.9454686716009226,1.0,1/6,7.78%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.4592957085707565,-0.968394593821048,0.44871794871794873,0.9452734580312913,1.0,4/34,9.53%,ALDOB;PLSCR1;ATP1B1;PFN2
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.45842563413923504,-0.9682829391732838,0.5223880597014925,0.9450784547078303,1.0,3/38,5.04%,B2M;RPS27A;APP
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5864399019879091,-0.9680470493142017,0.5692307692307692,0.9452124672344797,1.0,1/8,7.01%,APOD
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3641918422227956,0.968042005244636,0.5454545454545454,0.9821893467639488,1.0,6/53,6.09%,EPOR;FLT3;HCLS1;SOX9;PDGFD;PDGFC
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5452919544177723,0.9677774203692218,0.6176470588235294,0.982014611135039,1.0,2/13,14.11%,HUS1;RAD9B
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.5917091265625681,-0.9675679778777362,0.5178571428571429,0.9458890714739925,1.0,4/7,23.77%,NIT1;CYP3A4;CYP3A5;CYP2D6
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.43058511727375476,0.9670400040403495,0.5428571428571428,0.9828995508874633,1.0,4/21,16.16%,LLPH;CAPRIN2;CAPRIN1;CPEB3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.38480129793235707,0.9666878575248894,0.5263157894736842,0.982865619375754,1.0,4/38,6.66%,DGKB;PLD6;DGKE;ABHD5
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.5823223984277368,-0.9666625926045584,0.6617647058823529,0.9477145315422817,1.0,1/8,5.61%,RAB11FIP5
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.5258015517118194,-0.9665246672270273,0.5538461538461539,0.9475783221821508,1.0,3/14,16.77%,NLRC5;ISG15;USP18
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.43606575552360116,0.9665202593064414,0.46153846153846156,0.9824893223976756,1.0,6/26,15.29%,BMP2;TWSG1;GDF11;ACVR2A;GDF9;GDF10
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.3603023575713406,-0.9665198545352276,0.5604395604395604,0.947079361091288,1.0,47/332,16.53%,LEF1;THBS1;HPN;POU4F1;TLR2;ANK3;NOS1AP;WARS1;RPS4X;RAMP3;TESC;OVOL2;IL15;APP;KLF4;HTR2B;SCX;ELAVL4;PLD1;BRCA1;TLR3;PLSCR1;EGF;IGF1;ADAM19;WNT5A;RIMS2;FGF1;HHLA2;FN1;SFRP4;FLOT1;RPS7;C1QTNF1;FGF7;SLC11A1;BTN3A1;PIK3CB;CD74;SAMD4A;RPL5;RBM3;DDRGK1;PIK3CD;F3;FGF22;RPL23
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.38508026917736615,0.9665152967009084,0.5263157894736842,0.981660881309585,1.0,4/37,6.66%,DGKB;PLD6;DGKE;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5955725520914478,-0.9664974836012074,0.5333333333333333,0.9466504951797874,1.0,2/10,6.33%,MLIP;CAV3
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3245389940103363,0.9664972704216916,0.3333333333333333,0.9808741180783346,1.0,33/206,14.00%,LIMD1;AMER2;BMP2;PSMD10;BICC1;GSKIP;CCDC88C;PSMA1;GREM1;PSMD11;SOX9;EGFR;GPC5;PSMB5;VCP;GID8;RNF146;CSNK1E;STK4;CAPRIN2;BTRC;PPM1A;ZNF703;KLHL12;INVS;PSMD14;DVL2;ZEB2;CSNK1G3;PSMD12;KANK1;TMEM170B;MDK
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.42553812922859396,-0.9662746287778197,0.5606060606060606,0.9465796322123148,1.0,13/55,18.31%,CDKN2A;PLK2;CCND1;PLK3;CRLF3;CCNE2;CDKN3;CDK2;MAX;CDC7;CDKN2D;CDKN1A;SPDYA
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),-0.5500828319225995,-0.9662503982351813,0.5084745762711864,0.9461514941617802,1.0,3/11,6.92%,RDH13;AKR1C1;CYP1B1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.5469100242899112,0.965927759620149,0.45714285714285713,0.9816255784186241,1.0,3/9,15.09%,PGM2;GALT;GALK2
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.5183282000542816,0.9655300799046629,0.4444444444444444,0.9818538511101897,1.0,3/14,8.47%,PDE12;GIT1;CBFA2T3
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.49196520480636685,-0.9649562191273948,0.527027027027027,0.9487795135296688,1.0,1/30,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.43863461824196853,-0.9649245426156156,0.5070422535211268,0.9483605716043509,1.0,12/43,22.46%,GRIN2A;NOD1;USP50;NLRP2;SYK;GRIN2B;FADD;GPER1;RIPK2;CASP8;ARL6IP5;NODAL
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.5786352519928795,-0.9647140041232486,0.5740740740740741,0.9483781392120424,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.5492989519339619,0.9646591301794532,0.525,0.9831245266216336,1.0,1/8,1.02%,TMEM100
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.5531408168158601,-0.9646150689111509,0.5333333333333333,0.9481084379625426,1.0,3/10,8.24%,RPE65;PDE6B;GRM6
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3902835157565418,-0.9646040591808785,0.5057471264367817,0.9476509274903586,1.0,26/120,24.11%,EFNA1;TGFBR2;KIF14;CENPE;MINK1;DAB2IP;STRADB;EMP2;SLC11A1;MTCP1;PRKCD;RELN;CDKN1A;SPDYA;CD4;DOK7;PAK5;PAK6;PTPRC;CALM3;STK3;NEDD9;MMD2;SRCIN1;MAP2K3;CAMK1
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5184513432061857,0.9643445671879546,0.5675675675675675,0.9831106424433145,1.0,5/15,17.90%,STN1;DCLRE1B;TFIP11;POT1;DCLRE1C
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.6323381225989987,0.9643155931806616,0.5636363636363636,0.9822860266203803,1.0,1/5,0.64%,CD200R1
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.6145017826924608,0.9642968558087953,0.5652173913043478,0.9814628600343931,1.0,5/6,36.70%,TAOK2;SEMA3A;PTN;NRP1;CHRNA7
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.415782162200278,-0.9637141204675336,0.48717948717948717,0.9493261894235825,1.0,15/92,19.14%,RHOBTB2;NEXN;FSCN1;RND2;BST2;BAIAP2;CLIC4;RHOF;DMTN;DLC1;PRKCD;RHOD;CLN3;MAPT;PHLDB2
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.582412898688468,-0.963181494305397,0.5166666666666667,0.95011456913032,1.0,1/11,2.19%,KDELR3
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.48624283803326707,0.9631803441204894,0.5348837209302325,0.9838385015911113,1.0,6/14,22.73%,ACACB;PMVK;ACSS1;MLYCD;NUDT7;TDO2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.5073021341303197,-0.9631767684895238,0.5373134328358209,0.9496171842941564,1.0,2/25,3.77%,ICAM1;TJP3
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.5088276833996846,0.9628914648638236,0.46153846153846156,0.9837142269034803,1.0,2/13,6.48%,DAO;MOXD1
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3689193080981886,-0.9624979929849428,0.5795454545454546,0.9509083834067089,1.0,39/254,16.53%,KLF2;LEF1;HPN;POU4F1;TLR2;ANK3;NOS1AP;WARS1;RAMP3;TESC;OVOL2;APP;KLF4;SCX;BRCA1;TLR3;PLSCR1;EGF;IGF1;ADAM19;WNT5A;RIMS2;FGF1;FN1;SFRP4;RPS7;C1QTNF1;CD63;FGF7;SLC11A1;PIK3CB;CD74;RPL5;DDRGK1;PIK3CD;F3;FGF22;ANXA2;RPL23
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.5189043776253363,0.9622168804069702,0.525,0.9848768475873345,1.0,2/11,10.59%,CEP19;PCM1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3084879211457996,0.9621769121013203,0.5,0.9840941576188118,1.0,93/375,20.96%,POU6F2;RNF6;LIMD1;ZNF117;BMP2;PPARGC1A;ZNF195;SOX21;ZNF212;CEBPA;MITF;POFUT1;HCLS1;HES6;USP13;METTL18;SLC39A8;ATF5;APBB3;ZNF74;ESRRG;RABL3;ZNF502;SOX12;RORB;FBXO5;ZNF680;ZNF268;THAP1;GLI4;RNF14;NR3C1;NFYC;YAF2;SLC2A4RG;HP1BP3;ZNF341;ZNF875;ZNF703;EIF4E;ZNF676;ESRRA;ZNF33A;ZNF736;ZNF280D;MAGED1;PATZ1;APBB2;TGFBRAP1;DVL2;ORC5;ZNF138;HMG20A;GPBP1L1;KAT7;ZNF519;ZNHIT3;DDX25;EP300;SMARCA2;PPIE;BACH1;METAP1;HINFP;ZNF492;NR1D2;FOXN2;NCOA2;CHD7;VHL;EFEMP1;CCDC88A;CNBP;VSX1;NLK;HDAC10;PRDM2;ZNF737;NFXL1;MED23;DAXX;ZNF460;PSPC1;CCAR2;ANKRD17;SP3;ZNF253;SAP30L;ZNF2;UTP4;KAT6B;ZNF398;ZNF430
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.5182560770250167,-0.9619589823215771,0.5714285714285714,0.9518082028645655,1.0,3/13,13.56%,SLC39A14;TRPC3;SLC11A1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.47151341513071277,-0.9616119464699239,0.5454545454545454,0.9522333887154337,1.0,10/34,21.35%,LZTS1;VLDLR;DAB2IP;HECW2;MFSD2A;BCL11A;ALK;CAMK1D;NSMF;PACSIN1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4201947579338903,-0.9614806946089288,0.52,0.9519923718950655,1.0,11/64,19.21%,THBS1;SKOR1;SULF1;VWC2;DAB2IP;MMRN2;APLN;GPC1;LRP2;NIBAN2;BMPER
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),0.65052210686205,0.9614124632800959,0.5769230769230769,0.9852942387398348,1.0,3/5,31.86%,ACADSB;SDSL;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4239810236275703,-0.9612975836225885,0.5945945945945946,0.9518846907733566,1.0,6/60,11.85%,PRAME;GRIN3A;THY1;NEUROD2;PINK1;FOXM1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.5476709865528138,-0.9610795918934215,0.5666666666666667,0.9518362390227056,1.0,1/8,2.09%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.6022132325759575,-0.9607569624605843,0.6065573770491803,0.952122644249371,1.0,1/5,6.13%,ELAVL4
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.5068338114169555,-0.9607145640994358,0.5,0.9517444110642007,1.0,2/26,4.38%,NPY;CCDC39
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.38731822606352617,0.960688224775272,0.5555555555555556,0.9864126371110535,1.0,18/69,17.70%,POLD3;ERCC8;COPS2;RFC3;COPS8;ERCC6;ERCC2;COPS7A;ERCC3;GTF2H5;GTF2H2;POLK;POLR2C;EP300;AQR;PPIE;HMGN1;COPS7B
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.5989919139457403,0.9606734706730479,0.5833333333333334,0.9856505353576095,1.0,2/5,12.63%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.5077634181534604,-0.9606626369002381,0.5535714285714286,0.9513911717121122,1.0,5/15,20.40%,CYP1B1;CRLF3;OCIAD2;GHR;HES1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.5003963158220958,0.9605864806263704,0.5517241379310345,0.9850387245270572,1.0,4/13,21.53%,FASTKD2;MRPS27;FASTKD3;RPUSD4
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.5183643027085986,-0.9605501470705667,0.5409836065573771,0.9511710332029052,1.0,5/14,18.86%,SRF;CHRM3;KCNB2;DAPK3;PLCE1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.43478583937080684,-0.9604491030913985,0.5405405405405406,0.9508921705169701,1.0,9/43,14.82%,BCAS1;CNTNAP1;PLP1;KLK6;SLC8A3;EIF2B2;SCN2A;PLLP;MYRF
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.5645131570978172,0.960287350944739,0.5526315789473685,0.9851423694536705,1.0,3/6,16.49%,GLUD1;GLS;GLUL
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.46835554421924896,-0.9598921865423418,0.559322033898305,0.9518559726885034,1.0,2/35,2.70%,AGPAT4;ITPKC
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6562275078120569,-0.9598530721416219,0.6037735849056604,0.9514690677464355,1.0,1/5,4.06%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4789559011768184,0.9598346157943315,0.5789473684210527,0.9857415051095832,1.0,3/18,10.63%,NAF1;CCT7;CCT3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.56192315215897,0.9594748370570195,0.5121951219512195,0.9858245483857881,1.0,1/5,10.13%,NRXN1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.47583390762585714,-0.9594716310229525,0.5483870967741935,0.9519361028608117,1.0,6/33,13.92%,ZFP36;YBX3;ELAVL4;DND1;SLC11A1;VIP
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.5913702792340243,-0.9592765495998856,0.5254237288135594,0.9519761042842229,1.0,2/6,5.72%,PDPN;PLN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.46338936882824433,-0.959223657793581,0.5945945945945946,0.9515946503578927,1.0,2/31,3.17%,THBS1;IL12A
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.43833348633107855,0.959217977309675,0.4857142857142857,0.9855511845729005,1.0,4/25,7.72%,HCLS1;ZPR1;TRIM28;IPO5
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.4505651767768323,-0.9588983672179137,0.5714285714285714,0.9513909792425738,1.0,1/47,0.52%,CCNB2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.4505651767768323,-0.9588983672179137,0.5714285714285714,0.9513909792425738,1.0,1/47,0.52%,CCNB2
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),0.5809629742480233,0.9584089540493389,0.5,0.9868998600737204,1.0,2/5,11.25%,TSPAN12;ADAMTS12
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5219604622259267,0.9582856415436567,0.4473684210526316,0.9863889413175474,1.0,2/13,10.96%,PPP1R15B;NCK1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.5949906072367847,0.9582745922568886,0.627906976744186,0.9855729252815106,1.0,2/7,8.94%,AGER;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5583459307519338,-0.9580385768986253,0.5306122448979592,0.9529429300511648,1.0,1/9,2.05%,ABCA5
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.5912722621195929,-0.9579785088928977,0.578125,0.9525813306055161,1.0,4/7,12.58%,SKAP1;THY1;CD44;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.5720113335217722,-0.9579313279767847,0.5423728813559322,0.9521859024905989,1.0,2/9,12.39%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.5590866764599155,-0.9575509667924521,0.5818181818181818,0.9526798954927471,1.0,4/10,20.40%,IFT122;RYR2;TBX20;HES1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.3934802871745328,0.9575417135421581,0.42857142857142855,0.9867011144288383,1.0,4/42,4.15%,WNT7A;SLITRK2;SLIT1;NLGN3
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3607893370809789,0.9575157467519521,0.6153846153846154,0.9859552145396007,1.0,19/58,27.72%,ZNF207;SGO2;NSL1;PLK1;EPS8;CEP192;TUBG1;AAAS;TOGARAM1;TPX2;ESPL1;CTDP1;KIF3B;PIBF1;MAP9;KIFC2;INO80;CLASP2;SMC3
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.5864533643311355,0.9573957628944623,0.6086956521739131,0.9854370360149302,1.0,5/6,38.54%,UBQLN1;NFE2L2;UBQLN2;BCAP31;SGTA
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.4489929917537431,0.9572331498071599,0.5945945945945946,0.9851066431453531,1.0,2/23,0.94%,SLC26A7;SLC19A1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.44043630055283783,0.9571325345157529,0.5476190476190477,0.9844131916461504,1.0,6/19,18.05%,MCU;MAIP1;LETM1;MICU2;PDZD8;MICU3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.3669198769171003,-0.9570333840983494,0.5531914893617021,0.9535590501343078,1.0,57/270,18.75%,HPN;OGN;CDKN2A;FABP3;B2M;WARS1;PROX1;PDPN;IL12A;IRF1;BTG3;TESC;GPNMB;IFI35;ST18;APP;KLF4;PODN;NELL1;CYP1B1;APOD;IFIT3;BTG1;P3H2;WNT5A;SST;IGFBP7;DAB2IP;SFRP4;BAP1;IGFBP5;TFAP4;CLMN;VIP;B4GALT7;CDKN3;SFRP2;DLC1;TNS2;NUDT6;PML;EMD;CD200;TSC2;ETS1;GPER1;NMI;TGFB1;CDKN2D;TINF2;NUPR1;GSDME;NIBAN2;CDKN1A;RARG;ADAMTS8;NLRC3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.5267446881708167,-0.9567175187553606,0.5901639344262295,0.9538224626135001,1.0,1/13,1.14%,NR4A3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4640663162066514,-0.9566817064223317,0.5675675675675675,0.9534320908557748,1.0,8/27,20.42%,CD160;HTR2B;IGF1;NYAP1;PIK3CB;PIK3CD;HTR2A;NYAP2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.5458246029089401,0.9565735705206478,0.5454545454545454,0.9849188960415942,1.0,1/9,12.81%,SLC25A5
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.5353846379254533,0.95624589723409,0.5660377358490566,0.9850803479700093,1.0,1/8,1.24%,NR1D1
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.397483818183449,-0.955830402121811,0.5375,0.9549869947995541,1.0,15/86,16.24%,HPN;L1CAM;SHTN1;SYT4;MMP14;RPS6KA1;SYT1;IGF1;CPNE9;RIMS2;HYAL1;BDNF;MFSD2A;SFRP2;SYT2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.4258463825363249,-0.9557717304285448,0.5384615384615384,0.9546012928296326,1.0,9/65,16.32%,STMN2;CAV3;LDLR;PFDN6;PFN2;KANK3;PRKCD;STMN1;PFDN1
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.598181112599103,-0.9557190919768737,0.5454545454545454,0.9542208658673056,1.0,5/7,18.20%,F8;F10;SERPING1;F3;A2M
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3575147541135703,-0.9556518573292796,0.6224489795918368,0.9538846388647084,1.0,71/418,18.40%,PRAME;CDKN2A;BLM;DUSP1;SP100;FABP3;TLR2;WARS1;PSRC1;PROX1;PDPN;TP53TG5;IRF1;BTG3;TESC;GPNMB;IFI35;ST18;PODXL;APP;KLF4;HTR2B;DYSF;PODN;BST2;CYP1B1;IFIT3;PLSCR1;ARHGDIG;FBP1;TSPYL2;BTG1;P3H2;CRLF3;CD9;SST;IGFBP7;LRPAP1;DAB2IP;SLIT3;SFRP4;BAP1;FOXM1;MYH9;NOS1;TFAP4;CLMN;NR4A1;HYAL1;APOBEC3H;CDKN3;SFRP2;DLC1;TNS2;TCHP;NUDT6;PML;BCL6;CD200;TSC2;ETS1;GPER1;GMNC;NMI;TGFB1;CDKN2D;NUPR1;GSDME;NIBAN2;CDKN1A;RARG
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.540720467160014,-0.954869145007272,0.5694444444444444,0.9551976956969906,1.0,2/16,1.31%,NR4A3;FABP3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.4016260046843455,0.954734349092409,0.5517241379310345,0.9886429625056085,1.0,4/31,10.22%,RGCC;BMP2;AKT1;ZNF703
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.35705885038163754,0.954716678742247,0.5,0.9878607089153217,1.0,9/61,7.64%,ACE2;TMEM229A;KCNE1;EHF;ARHGEF16;TRIM29;MYO5B;CAPN13;PLEKHA6
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.4287558740024317,-0.9545848109165009,0.5616438356164384,0.955371771268684,1.0,7/28,17.54%,GBP1;MMP14;PDZK1;GPC3;CLN3;GPC1;CDK5
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.4936753346695869,0.954457157392433,0.6382978723404256,0.9877158623313946,1.0,1/11,6.91%,RAB27A
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.524617539368826,0.9544470971508013,0.6052631578947368,0.9869064178206006,1.0,1/6,5.13%,SOX9
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.363496125690822,-0.9544433584159744,0.6170212765957447,0.9551812394579721,1.0,50/273,18.56%,ENPP2;RASGRP1;EFNA1;C3;APLNR;CSPG4;RAMP3;GPNMB;IL15;CEMIP;ITGA5;APP;GATA1;BMP8A;CD44;CCND1;TNFRSF14;CENPE;EGF;CHI3L1;SLCO3A1;IGF1;PFN2;THPO;FAM20A;FGF1;PINK1;FLOT1;NOS1;FGF7;NEK10;MTCP1;BDNF;CD74;SFRP2;DDRGK1;RELN;SH2D3A;CCND2;HLA-DRB1;FGF22;SH2D3C;TEK;GPER1;RIPK2;LIMK2;TGFB1;CDKN1A;SPDYA;CD4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.42316597947566725,0.9544428055350487,0.6333333333333333,0.986069056614696,1.0,6/24,17.67%,CNOT9;FOXP1;HEYL;CNOT2;VPS11;CNOT1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.35813543127098413,0.9542299022802129,0.4827586206896552,0.9858870777325572,1.0,10/75,10.14%,NR1D1;ADIPOR1;ELOVL6;ACACB;PMVK;MID1IP1;RUBCNL;NFYC;CHD9;GNB3
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.5378235308123702,-0.9537722537027615,0.5507246376811594,0.9563409994793817,1.0,1/13,0.94%,DUSP1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.41177383693414693,0.9536317048851991,0.5172413793103449,0.9867001172547253,1.0,11/37,16.60%,WASHC5;PI4K2A;EXOC8;RAB27A;RAB22A;PHETA1;CHMP2B;ALS2;RNF26;VPS11;DNAJC13
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.5420056966467917,0.9536083070400306,0.5789473684210527,0.9859235454853226,1.0,2/9,10.59%,CEP19;PCM1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.530047300582844,0.9536044279215038,0.5952380952380952,0.9850801549417081,1.0,1/7,4.10%,SERPINB9
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.578064353968454,-0.9535623504067395,0.6166666666666667,0.9562520911248135,1.0,4/10,20.15%,IL15;HLA-DRB1;CD4;CASP8
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.5962709459233755,0.9533352806779294,0.5102040816326531,0.9850552757384327,1.0,3/5,16.45%,NIPBL;ID2;RBPMS2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5548383278161431,0.9533019009468191,0.627906976744186,0.9842723794121409,1.0,1/6,4.10%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5153242769875745,0.9532582094838802,0.5714285714285714,0.9835782128717948,1.0,1/7,10.84%,EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.6178089641606211,0.9531829666186391,0.5263157894736842,0.9820867948310369,1.0,1/5,10.30%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.6178089641606211,0.9531829666186391,0.5263157894736842,0.9820867948310369,1.0,1/5,10.30%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.5787025367483041,0.9524643693594439,0.5714285714285714,0.9829943893286449,1.0,1/6,5.33%,EIF3E
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.491195914834371,0.952257810134303,0.5128205128205128,0.982574637600046,1.0,3/14,11.53%,PSMD10;AKT1;OPA1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5204379367763965,-0.9522161809511493,0.5671641791044776,0.9588315212610871,1.0,4/16,15.93%,NOS1AP;CAV3;NOS1;CACNB1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4074681395380026,-0.9522074599375401,0.5641025641025641,0.9583680427711561,1.0,19/87,21.59%,P2RY6;KCNQ1;P2RY12;BRCA1;GLRA2;GABRB2;IGFBP5;DMTN;HRH1;GABRG2;CIB2;AQP1;AKAP6;HCN1;GLRA1;NSMF;SFRP1;SPAAR;P2RX7
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4790464573486416,-0.9518507536480812,0.5344827586206896,0.9586513759689993,1.0,5/19,19.24%,ABCA5;IL18;PRKCH;MSR1;CD36
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.5366633562815893,-0.9517680171876817,0.5070422535211268,0.9583095702889678,1.0,6/10,37.29%,ITGA3;FYN;IGF1R;SUPV3L1;PICK1;PRNP
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.41752030119078826,-0.9517401359583153,0.5903614457831325,0.9578858216475854,1.0,8/59,7.68%,RPE65;SIX3;CDH23;CLRN1;BEST1;SLC24A1;ARR3;CRYBA1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.42556468865091923,0.9517320361518475,0.6071428571428571,0.9831515236254494,1.0,2/20,2.78%,G0S2;BCL10
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5897948754229587,-0.9516795451497477,0.6122448979591837,0.9575350961529621,1.0,3/8,9.05%,APOLD1;CEACAM1;BTG1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5303303881431947,-0.9516791757360733,0.6031746031746031,0.9570348165833943,1.0,1/15,1.14%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4669564467152904,-0.9516289035696389,0.5507246376811594,0.9566704009057736,1.0,8/23,19.87%,EFNA1;PRKCG;RPS7;RPL5;RPL23;PML;GABARAPL2;RPL11
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.6191264293750671,-0.951610223201135,0.6031746031746031,0.9562580546312724,1.0,1/5,8.05%,CTU2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5746435477113316,0.9515539450504179,0.5681818181818182,0.9827806559663491,1.0,2/7,12.67%,YY1;SIRPA
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.30838189259399806,0.9515238857514682,0.6666666666666666,0.9820146539600947,1.0,27/134,18.23%,LCMT2;GAL3ST2;ALAS1;ESD;ELOVL6;ELOVL4;ELOVL2;CSNK2A1;CHPT1;CSNK2A2;PLA2G4C;GAL3ST4;LPIN3;ASL;HACD2;GPHN;VAPA;SGMS2;PRKD1;VAPB;GSTM2;SLC25A15;PCTP;MOCS2;CEPT1;DMD;SPHK2
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.579991864243917,-0.9515196551376136,0.5932203389830508,0.9554780865593956,1.0,1/9,6.10%,VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.579991864243917,-0.9515196551376136,0.5932203389830508,0.9554780865593956,1.0,1/9,6.10%,VLDLR
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.43523073333274387,-0.95139074830167,0.527027027027027,0.9553323012830975,1.0,7/47,17.86%,SP100;PDPN;EGF;CD9;FES;ETS1;DAPK3
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.3605079438477262,0.9512414440285284,0.52,0.9818768484328473,1.0,15/60,18.38%,PPP1R15B;EIF3E;MIF4GD;MTIF2;EIF2AK4;NCK1;UHMK1;EIF4EBP2;EIF3H;C8ORF88;PAIP1;NCK2;EIF2AK3;CDC123;YTHDF2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.3133643275855943,0.9508406131134289,0.5454545454545454,0.9819801867960309,1.0,52/293,16.55%,TBC1D4;ATP6V0D2;TVP23B;ABCA1;MTTP;TMED5;ARFIP1;ATP6V1A;TXNIP;RAB23;SCFD2;TBC1D12;ARL5A;RABL3;BLZF1;ATP6V1G1;CALCRL;STX7;TMEM167A;DNAJC27;CEP290;ARFIP2;RAB8B;C17ORF75;CMTM6;RAB22A;RAB1B;NDC1;AP3B1;MON1A;RAB28;COPB2;SNX31;SCFD1;CHMP2B;SEC23IP;NAPB;TBC1D5;UNC119B;SEC31B;TMED3;RAB26;RAB21;RAB8A;LRP1B;SNX27;TBC1D8B;ARCN1;RCN3;SCAMP4;TANGO6;HERC2
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4268645659047045,-0.9507015207100789,0.5512820512820513,0.9564160315653952,1.0,10/62,15.79%,S100A10;MET;SYNPO2L;WAS;PFN2;ARHGEF18;TMEFF2;PPFIA1;DLC1;STMN1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),-0.5838532636881217,-0.9505982486642011,0.55,0.9560675317834422,1.0,3/8,17.76%,GC;CYP3A4;LRP2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.5094360123476629,-0.9504332112504248,0.5454545454545454,0.9559890916203462,1.0,2/20,2.46%,C3;NOS1AP
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4916660639250835,-0.9503992532571699,0.5694444444444444,0.9555545330763273,1.0,3/20,3.19%,AMN;PDPN;GC
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.4444851135718661,-0.9500842237517494,0.5694444444444444,0.9557602907424447,1.0,7/41,19.53%,ABCA8;ARG2;FA2H;CYP4F22;ASS1;RHD;PAM
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5406538323860985,0.9500401661791804,0.5952380952380952,0.9829884075109917,1.0,3/7,24.52%,NFIB;RYK;SMO
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3502747322338589,0.9495892853151663,0.5806451612903226,0.9833792354366848,1.0,15/63,16.36%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;VAPA;SCFD1;CNIH1;SEC24A;SEC23IP;SEC31B;VAPB;SEC23B;CNIH3
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),-0.6281325428756109,-0.9491724517885142,0.6491228070175439,0.9573795371467625,1.0,1/5,4.77%,FSCN1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.4648700313402459,-0.9490834988178937,0.5538461538461539,0.9570843079950299,1.0,6/27,14.26%,PTP4A3;CYP1B1;STAT1;MYH9;EMP2;NR4A1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.42041128640451186,0.9490541582160045,0.625,0.9840865993178064,1.0,5/20,8.12%,CSPG5;CHST11;CSGALNACT1;CHST7;BCAN
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5601881964888002,-0.9489867971979484,0.5454545454545454,0.9567749746927056,1.0,3/9,23.00%,BRCA1;SET;TAF7
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.6228821247467355,-0.9488996989135355,0.546875,0.9564707633053722,1.0,1/5,5.61%,ABCA12
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.5028138637898792,-0.94867263499313,0.5245901639344263,0.9564355856197777,1.0,5/11,30.45%,KAT5;FAM161A;CAMK1;PARK7;TERF2IP
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5887740993487602,0.9485734148334961,0.5952380952380952,0.9844662369813897,1.0,2/5,8.94%,AGER;HMGB1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.5096174253531147,-0.9483140160707677,0.6166666666666667,0.9568224971980082,1.0,5/15,12.44%,TLR2;APP;GATA1;THPO;DMTN
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.4984447981254439,0.9481941690080791,0.5294117647058824,0.9845669563897972,1.0,1/14,5.18%,ASAH2B
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.589921106689181,-0.9476354570651155,0.5806451612903226,0.9579807729616334,1.0,3/8,15.80%,NEUROD2;DAB2IP;RELN
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.39046966627407675,-0.9473560985592622,0.5945945945945946,0.9581269297337609,1.0,12/95,10.74%,TAGLN3;SIX3;SNCB;ZDHHC22;MAP1B;RND2;EFNB3;GAP43;ZNF536;NEFH;HPCA;LGR5
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.4808830168970829,-0.9472621914332937,0.5409836065573771,0.957875480551483,1.0,6/25,8.69%,CD5;TAGAP;GPR171;SLA;ARHGAP9;WAS
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.43920190513770574,0.947219293350805,0.4857142857142857,0.9862878292508953,1.0,4/24,7.72%,HCLS1;ZPR1;TRIM28;IPO5
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5410955902286969,0.9471697393613121,0.5526315789473685,0.985591735607742,1.0,3/9,20.77%,NDC1;NUP205;NUP153
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.36550853315522625,0.946904902895381,0.5666666666666667,0.9853753920355521,1.0,8/46,12.53%,WNT7A;ASCL1;LIG4;HES6;HEYL;PCM1;SPEN;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.5439703618039955,-0.9468332062296787,0.5806451612903226,0.9582991364641177,1.0,3/7,24.63%,SRF;GPER1;SPHK1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.40623674075159066,-0.9466252632286746,0.65,0.958263122960929,1.0,11/66,15.76%,CDKN2A;DUSP1;CAV3;HEXIM1;SLC8A3;GADD45A;DAB2IP;PAQR3;TFAP4;PIK3CB;PRKCD
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.44445220644030753,-0.9466223730559414,0.5342465753424658,0.9577824959121338,1.0,8/38,14.63%,RPS27;RPS14;EMG1;NOB1;RPS16;RPS7;RPS6;RPS15
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5121744051896004,-0.9465206851327865,0.6027397260273972,0.9574935140228696,1.0,7/18,19.45%,HIC1;HEXIM1;RPS7;RPS15;RPL23;RPS20;EIF5A
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6210039229851918,-0.9464798320632254,0.582089552238806,0.9571093052263927,1.0,1/6,11.44%,DDX60
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.6028773259767851,0.9464086556577317,0.6326530612244898,0.9858479869666835,1.0,2/5,19.35%,AKT1;GLI3
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.6141796920742336,-0.946296976735746,0.5686274509803921,0.9570214679195804,1.0,2/7,6.33%,MLIP;CAV3
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.5749304815023661,-0.9460063052911273,0.5737704918032787,0.9571675164705042,1.0,3/9,15.80%,NEUROD2;DAB2IP;RELN
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.4517104333664156,-0.9459943899734985,0.5352112676056338,0.9566886919676825,1.0,1/31,2.00%,STMN2
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.5206139964206069,-0.9459499781141423,0.5441176470588235,0.9562627911978588,1.0,1/19,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.5219555827708218,-0.9458881817957424,0.5238095238095238,0.9559230802069855,1.0,1/13,5.64%,YBX3
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.4370213147655705,-0.9458776866201672,0.5507246376811594,0.955459919318498,1.0,7/32,4.84%,MYO1F;GPR183;CD5;TAGAP;GPR171;SLA;ARHGAP9
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.4025593336426193,0.9457890395580508,0.5897435897435898,0.9867497862576117,1.0,5/31,7.72%,RAB23;HCLS1;ZPR1;TRIM28;IPO5
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.5871157489594412,0.9457634061329077,0.5833333333333334,0.9859792609987131,1.0,1/6,16.90%,MPP1
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.4370165601510363,-0.9454688372157588,0.5641025641025641,0.9558491076978212,1.0,1/50,0.52%,CCNB2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.39988590784741723,0.9454466052445716,0.59375,0.9859254893199919,1.0,4/19,6.69%,RGCC;PSMD10;EGFR;AKT1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5979642205790465,-0.945411921514194,0.5573770491803278,0.9554578101581281,1.0,1/7,5.72%,PLN
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.5164074954930362,0.9452751489765283,0.6363636363636364,0.9855763311606693,1.0,2/11,3.13%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.6074985093688761,-0.9452091156721333,0.6349206349206349,0.9553997070611309,1.0,1/6,3.86%,BHMT
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.391823745126254,0.9447280030896287,0.5,0.9860277335063076,1.0,11/35,16.49%,ZDHHC16;ZDHHC14;KAT2B;ZDHHC18;ZDHHC13;KAT2A;ZDHHC20;ZDHHC5;ZDHHC21;EP300;GLUL
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.4614573681180717,-0.9446480078422163,0.5671641791044776,0.9562539973018034,1.0,6/32,19.14%,STMN2;STMN4;MAPRE2;STMN1;MAPT;PHLDB2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.5259862050060498,-0.9445604788676817,0.5384615384615384,0.9560150719216518,1.0,1/12,2.46%,NEFL
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.5717764097419116,0.944504453936119,0.6222222222222222,0.9858979316762437,1.0,5/9,39.32%,RIOX2;RIOX1;KDM4B;KDM8;KDM7A
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.3483258368589931,0.944142807651085,0.56,0.9859870218272332,1.0,9/64,14.07%,CDKL1;TBC1D12;TBC1D19;ODAD3;STIL;TRAPPC12;RAB1B;ALMS1;TBC1D5
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.33279376039333897,0.9439006082333985,0.5,0.985724475200971,1.0,18/107,12.91%,WNT7A;ASCL1;RUNX1;FUT9;POU3F2;TENM1;FZD8;ERCC6;RORB;ERCC2;PBX1;ADNP2;TDP2;TENM2;EMX2;CASP3;TENM3;ERCC3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.4303795991785224,-0.9438240248395765,0.5692307692307692,0.9572099446292494,1.0,8/52,17.04%,TLCD2;SLC4A11;SLC4A9;ANGPTL3;SLC4A2;SLC4A10;PNPLA3;IRS2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.5925168168745797,-0.9437953455635174,0.6451612903225806,0.9568047191009728,1.0,1/7,2.20%,ZFP36
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.444011079904668,-0.9437728529963928,0.6197183098591549,0.9563572307558802,1.0,10/41,18.51%,SLC6A15;SLC17A5;SLC16A3;SLC16A11;SLC16A4;SLC16A14;SLC38A1;CLN3;SLC15A4;SLC25A29
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3894364119945975,0.9435332959456825,0.6129032258064516,0.9859369542130252,1.0,6/26,17.67%,CNOT9;RUNX1;CNOT2;VPS11;UFM1;CNOT1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.4586542771939049,-0.9435147189054544,0.5,0.9563888975116447,1.0,2/26,12.77%,RPS27A;UBC
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.3673729062763058,0.9434783950516784,0.5,0.9852765654345228,1.0,8/56,8.98%,PAK1IP1;NAF1;ZNF658;LTO1;RIOK2;RIOK1;LTV1;XPO1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.34815494985398926,0.9434573293477755,0.5294117647058824,0.9845035650175988,1.0,10/42,20.19%,PDE12;RIDA;HSPA1A;NUDT16L1;NBDY;LSM5;RC3H1;AGO3;YTHDF2;ERN1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.38356331490399465,-0.9433649651249735,0.6477272727272727,0.9562310459698523,1.0,16/129,12.06%,CXCL2;POU4F1;ZFP36;WNT8B;RAMP3;TESC;ATP1A1;PDCD1LG2;CCL2;PTK6;WNT5A;PDK3;DAB2IP;ADCY5;SBNO2;TNIP2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.40809944061056463,-0.9432045296560522,0.5857142857142857,0.956134907325531,1.0,16/59,21.81%,B2M;HLA-A;HLA-C;PSMB9;PSMB6;HLA-B;HLA-E;PSMC3;HLA-F;PSMA8;PSMA7;PSME1;CD36;PDIA3;IKBKG;PSMA3
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.518058136574678,-0.9431672139898744,0.6,0.9557359995633293,1.0,5/12,18.56%,IRF7;FES;CD74;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.6102065914113228,0.9430275351468872,0.5833333333333334,0.9846502530001644,1.0,1/5,5.33%,EIF3E
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.5419692232924262,-0.9428955643201308,0.5230769230769231,0.9558530569696458,1.0,3/8,16.85%,HLA-DRA;HLA-DRB1;BCL6
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.424610261537531,-0.9426376582906278,0.5972222222222222,0.9560314519125607,1.0,14/48,18.28%,CCNB2;BLM;CCNI2;CCND1;GADD45A;CCNB1;CCNE2;HERC5;CDKN3;CCND2;CDC37;CDKN2D;CCNF;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.5715138629670012,0.942243982533794,0.5405405405405406,0.9858562387994501,1.0,1/7,0.25%,LEPR
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3956941091672031,-0.9421878383483859,0.6707317073170732,0.9566349198033677,1.0,8/95,8.06%,GGT5;ALOX12;ACOT1;ACSM5;ACOT4;ACSL5;FA2H;ANGPTL3
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3653105829942756,0.9421128021415951,0.5909090909090909,0.9853020867426148,1.0,16/83,13.78%,FBXO48;PSMD10;PSMA1;PSMD11;FBXL14;DMAC2;CUL1;PSMB5;FBXL3;FBXO9;BTRC;PSMD14;FBXO38;CUL2;FBXO27;PSMD12
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3398179858751962,0.9419880615257117,0.65,0.9848149658847059,1.0,14/75,12.84%,WNT7A;AGER;BMP2;SERPINF2;DUSP19;MID1;MAP3K4;HMGB1;TIRAP;MAP4K2;TAOK2;SASH1;SH3RF1;TAOK3
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.4819657017341032,-0.9419418935635072,0.576271186440678,0.9568457923206528,1.0,3/17,5.16%,PKP2;ITGA5;CTNNA3
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5035765918817239,-0.9419090401051818,0.5373134328358209,0.9564428189125141,1.0,4/17,25.25%,SUN3;EMD;SUN1;VPS4A
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.3910518023349325,-0.9418019548691481,0.6309523809523809,0.956111023755795,1.0,28/109,17.63%,GGT5;PLK2;RAMP3;NLRP12;ADCY7;KLF4;GIPR;IGF1;RHBDF2;ADCY5;SYK;MYH9;GNG2;TNFRSF1A;CXCL17;RXFP1;VIP;PTH1R;GLP1R;PTH2R;PRKCD;ADCY3;HLA-DRB1;MVK;CD200;ADCY8;TEK;GPER1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5854270689240693,0.941755034748696,0.6,0.984602316019357,1.0,2/5,12.24%,AKT1;TICAM1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4481336290721589,-0.9413137528484432,0.5901639344262295,0.9567179368539841,1.0,4/34,6.99%,ANXA1;WDR62;GCM2;HAP1
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6005372408139844,-0.9412231871067555,0.6,0.9563816264665488,1.0,4/7,18.13%,WARS1;XRCC1;HPF1;TINF2
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5585509749530833,0.9410287009844253,0.5294117647058824,0.9855497661470232,1.0,4/6,41.39%,TENT4B;TUT4;LIN28B;DIS3L2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.399618698977215,-0.9410287000479429,0.5697674418604651,0.9563754023924085,1.0,17/86,20.15%,ANK3;KCNB1;RAMP3;CEMIP;AKAP5;YWHAH;PPP3CC;PDZK1;PRKCH;SLC51B;NMT1;ITGA3;GPER1;BBC3;MYO1C;STAC2;CASP8
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.5601207291771998,-0.9409418247007596,0.5789473684210527,0.9560678577568672,1.0,4/8,24.99%,IL18;CD74;RSAD2;RARA
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.4317248437137738,-0.9408428740082406,0.5882352941176471,0.9558076842165215,1.0,2/30,4.36%,IFI6;HK2
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.5329512669222136,0.9406135732198442,0.5121951219512195,0.9857137015607633,1.0,4/8,24.15%,SOX9;HEY1;HEY2;ROCK2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.534420219904951,0.9405365425591024,0.52,0.9851054797106047,1.0,3/5,27.02%,KAT7;WRNIP1;TICRR
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5084966976808835,-0.940233100185457,0.5692307692307692,0.9569023680798657,1.0,8/20,22.15%,HTR2B;ITPR3;HTR2C;RYR2;HTR2A;ITPR1;PTPRC;ERO1A
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.4708048928391162,-0.9401804647809962,0.578125,0.9565151063873188,1.0,3/26,7.83%,ART3;PARP14;PARP9
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3995159807466065,-0.9401527373943037,0.6052631578947368,0.9560859497982765,1.0,20/88,13.60%,SLC28A2;ALDOB;NR1I3;L1CAM;SLC51A;SPON2;RBP2;ART3;ASPN;GFRA2;CEACAM1;ACSL5;VIL1;CA1;TMC4;CDH19;CD55;PDZK1;CYP3A4;SLC51B
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.3793096204037511,-0.940010759033665,0.5777777777777777,0.9559014357049553,1.0,49/179,24.82%,DHCR24;WARS1;LDHA;SLA;HK2;CTSC;VLDLR;GLRX;LDLR;PDK1;MLLT11;CD9;PGK1;M6PR;ARPC5L;NAMPT;IGFBP5;MTHFD2;SQLE;RPA1;NMT1;GPI;SDF2L1;PFKL;RIT1;CCNF;NUPR1;CDKN1A;HSPA5;COPS5;INSIG1;PPA1;BHLHE40;HMGCS1;BCAT1;PSMA3;ERO1A;NFIL3;FADS2;HSPD1;EIF2S2;SCD;IDI1;ATP6V1D;DDIT4;MAP2K3;PNP;XBP1;SQSTM1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.631155977826215,-0.939860179372576,0.6792452830188679,0.9556983331157902,1.0,2/7,7.01%,GAP43;APOD
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5075038218764647,0.9394321241743018,0.6216216216216216,0.9868872513570679,1.0,4/12,22.01%,NCSTN;APEH;IDE;MME
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.5720063682173941,-0.9389343839290598,0.5964912280701754,0.9573251324776335,1.0,1/8,16.59%,CLN3
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.3961434206449665,0.9387147558219626,0.6,0.9880552299527395,1.0,5/31,14.85%,REEP6;GAS1;NUP214;SCFD1;AAAS
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),-0.6224917209684029,-0.938416745799202,0.5396825396825397,0.9581109254550599,1.0,2/5,4.67%,CHST4;TPST1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4195481487588129,-0.9384016412133825,0.6493506493506493,0.9576539266639369,1.0,17/72,21.28%,KCNB1;NNAT;ABCA12;BMP8A;ITPR3;GIPR;CELA2A;CACNA1C;ADCY5;GLP1R;IRS2;MYRIP;GPER1;DOC2B;KCNC2;ITPR1;SFRP1
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.601332740686822,-0.9383883524635407,0.631578947368421,0.9571880216109652,1.0,2/5,9.10%,HPN;MYO3A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.47841441287872255,0.9383224692364923,0.46511627906976744,0.9880757079410777,1.0,1/16,0.25%,LEPR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.46722169326797536,-0.9382843232371784,0.5166666666666667,0.9570035100531762,1.0,4/23,7.93%,KCNQ1;PLN;CAV3;ATP1B1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.6081986931111342,-0.9382500825894423,0.6363636363636364,0.9561392520748268,1.0,4/5,24.22%,STAT1;SOAT1;TGFB1;PPARG
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.6081986931111342,-0.9382500825894423,0.6363636363636364,0.9561392520748268,1.0,4/5,24.22%,STAT1;SOAT1;TGFB1;PPARG
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.44930348079638205,-0.9382209581314181,0.5538461538461539,0.9557077778265446,1.0,4/22,14.82%,TLR2;APP;EIF2B2;MYRF
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.5266959350515854,0.9381080797850768,0.5555555555555556,0.987927272500785,1.0,4/10,25.53%,HSPA1A;SACS;SNCAIP;DNAJB2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.41769737492647874,0.9378385629996706,0.5277777777777778,0.9877603326494522,1.0,3/20,8.97%,SNX18;GULP1;SPIRE2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.46244289409278216,0.9377519517180625,0.5135135135135135,0.9871721634131998,1.0,5/19,25.89%,PPP1R1B;STYXL1;PPP4R4;PPP1R8;MASTL
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3297946846811291,0.9376982837447332,0.6086956521739131,0.9865475253337775,1.0,26/143,15.33%,BRINP3;INTS13;PSMD10;PSMA1;ANGEL2;PSMD11;TTL;ANAPC1;CUL1;PSMB5;FBXO5;ZNF268;ERCC2;GAS1;THAP1;HSF1;BTRC;PLK1;EIF4E;UBE2D1;PSMD14;ERCC3;PSMD12;BRINP2;CDC26;HNRNPU
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.4885564164824624,0.9376788343099912,0.6086956521739131,0.9857836432790323,1.0,2/17,10.45%,QRICH2;PARVA
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5154673349530337,-0.9371307863195487,0.5714285714285714,0.9577765707109464,1.0,2/15,11.44%,BIRC3;DDX60
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.4390762756522661,-0.9370895969218568,0.5454545454545454,0.9574147591328601,1.0,4/20,10.55%,RAB11A;ATAD5;CCND1;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.47178103744745525,0.9365591759648221,0.5365853658536586,0.9877680600494041,1.0,4/11,20.40%,RALB;PIP4K2B;PIP4K2C;RAB3GAP1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),0.6018697325836749,0.9363951840026485,0.6818181818181818,0.9874432231445011,1.0,1/6,7.37%,SLC4A7
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.5202084016160429,0.9361914794735495,0.5217391304347826,0.9871375755016416,1.0,4/13,11.32%,TMEM100;SOX9;FOXJ1;VEZF1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.527835999729283,-0.9357489222785305,0.5507246376811594,0.9599333880365339,1.0,5/14,22.86%,ATAD5;GLI1;DDRGK1;ZNF16;PAF1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5025569467478584,0.935063176619287,0.5813953488372093,0.9893117430412547,1.0,5/10,32.26%,WHAMM;ABI2;WASF3;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.3637976510668613,0.9349611132018704,0.5454545454545454,0.987991674462395,1.0,9/57,16.01%,CD247;MYO10;YES1;WIPF2;NCK1;WASL;PIK3CA;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3637976510668613,0.9349611132018704,0.5454545454545454,0.987991674462395,1.0,9/57,16.01%,CD247;MYO10;YES1;WIPF2;NCK1;WASL;PIK3CA;PIK3R1;ABI1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5606660463136484,0.9348327477599452,0.5641025641025641,0.9875285135182637,1.0,2/6,22.65%,OTUB2;TRIP12
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5062325380043741,0.9345187137385865,0.6857142857142857,0.9874748817915419,1.0,3/15,10.63%,NAF1;CCT7;CCT3
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.29873939130451743,0.9343391530420293,1.0,0.98703146337632,1.0,30/309,8.00%,FGF6;NGF;EPHA6;VEGFD;ATP6V0D2;GALNT3;NCSTN;EFNA2;VEGFC;CASS4;EFNB2;FLT3;MUC20;PDK4;SPRED1;ATP6V1A;GIT1;EGFR;AKT2;PDGFD;PDGFC;ATP6V1G1;YES1;AKT1;GTF2F2;FRK;AP3S1;CNKSR1;EFS;SHC4
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),-0.6000456673633506,-0.9342978096278378,0.5932203389830508,0.9626780883270963,1.0,1/5,9.64%,SQOR
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.4078644398718191,-0.9341290304186631,0.5584415584415584,0.9625801547794867,1.0,6/69,6.29%,RECQL4;BLM;MEIOB;ZSWIM7;POLQ;BRCA1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.319699675177349,0.9340225021215685,0.45,0.9870246999285748,1.0,14/111,9.92%,SPSB4;POU6F2;ASCL1;CSPG5;EFNA2;POU3F2;SNAP91;EGFR;TSHZ1;BTBD17;PBX1;RHBDL3;CNTFR;ERBB4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.33073998444904545,0.9331778219131971,0.6666666666666666,0.9881671299105335,1.0,30/147,15.53%,NR1D1;PPARGC1A;TFB2M;NR2E1;TFB1M;RARB;MAML3;KAT2B;ESRRG;GTF2F2;UBTF;RORB;BRF2;ERCC2;NRBF2;AR;NR3C1;GTF2A2;NOTCH2;TAF12;ESRRA;POLR1F;ERCC3;GTF2H5;TAF4;GTF2H2;RRN3;TAF8;TAF2;POLR2C
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.4439503132554938,-0.9327005781231659,0.5652173913043478,0.9654559220449299,1.0,4/35,2.77%,EFNA1;MET;PKP2;PROX1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.3990327924070356,0.9325680549031297,0.45454545454545453,0.9889095182192125,1.0,8/28,18.80%,RAB27A;SNF8;VPS37A;VTA1;CHMP2B;VPS37B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.42392395609256306,-0.9324729720228823,0.589041095890411,0.9655104186708513,1.0,2/39,3.31%,ARIH2;TRIM5
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.5554597344709417,0.9321910503441324,0.6511627906976745,0.9890770424799177,1.0,2/5,14.00%,PPP1R10;MDK
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.31005552660690905,0.9319977771763451,0.5454545454545454,0.9887265737485345,1.0,31/231,13.90%,OTUD3;KDM1B;PSMD10;CDC25A;TNFAIP3;PSMA1;PSMD11;KEAP1;KAT2B;COPS2;USP13;COPS8;BRCC3;USP38;USP40;USP12;PSMB5;INO80D;VCP;AR;YY1;USP27X;OTUB2;UBE2D1;PSMD14;COPS7A;NFRKB;ADRB2;KAT2A;PSMD12;DESI2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6044913633781676,0.931839361420146,0.575,0.9883304864073735,1.0,3/5,36.41%,MARK2;TTBK2;PPP2CB
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.4159817336914936,-0.9317024199693443,0.5443037974683544,0.9668080470546571,1.0,9/42,20.30%,STMN2;YWHAH;MAG;PAQR3;GRIN2B;CRMP1;PTPRO;DPYSL3;STX1B
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.4147984885027277,-0.931198922187529,0.6103896103896104,0.9674388788658331,1.0,3/63,2.20%,RFTN1;TGFBR2;ZFP36
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.5266340110530533,0.9311318324932037,0.5945945945945946,0.989098023888067,1.0,3/9,14.24%,AKT1;QDPR;DHFR
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.6387730846535422,-0.931053441358459,0.6666666666666666,0.966797153909839,1.0,1/5,5.70%,STPG4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.6387730846535422,-0.931053441358459,0.6666666666666666,0.966797153909839,1.0,1/5,5.70%,STPG4
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),0.5952691419583289,0.930809013099626,0.6285714285714286,0.9891265142777527,1.0,2/5,10.55%,TNFAIP3;TIRAP
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3885786622241406,0.9306654645728711,0.5555555555555556,0.9886757748263437,1.0,8/49,14.37%,TMEM100;BMP2;SOX9;SMAD5;ZFYVE16;ADAMTS12;ACVR2A;GDF9
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4127289800148181,0.930556278913325,0.6097560975609756,0.9880784428764187,1.0,5/19,20.90%,HSPA1A;NCK1;OPA1;EIF2AK3;BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.5402001220650008,0.9301563881524129,0.5555555555555556,0.9883100921946102,1.0,2/6,14.66%,HS3ST5;SERPINE2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3630486200064814,0.9298562269606497,0.5142857142857142,0.9881552721733903,1.0,6/50,6.89%,PSMD10;PSMA1;PSMD11;ATF5;CUL1;PSMB5
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.46726329736154737,-0.9298146793894951,0.6231884057971014,0.9690394737558875,1.0,3/18,12.58%,APLNR;PRKCH;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.38331725332129724,0.929661765308651,0.6153846153846154,0.987835366282187,1.0,3/46,4.38%,SLC6A13;EFNB2;EIF2S1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6114092987596546,0.9292362721720033,0.5714285714285714,0.9880941849289795,1.0,1/5,6.72%,LMO3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4170156446672558,-0.9291715365889488,0.581081081081081,0.9700116090155809,1.0,14/48,22.37%,IRF1;IFI35;PLSCR1;PARP9;BIRC3;HLA-E;USP18;CDC37;NMI;SLC15A4;NLRC3;CASP8;ADAM8;ERAP1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6138464230191418,-0.9286476148884357,0.6721311475409836,0.9707228105448837,1.0,2/7,6.59%,RFTN1;TLR3
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.5831956935266137,0.928308198552877,0.574468085106383,0.9887388557727282,1.0,1/5,5.70%,FLAD1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.5831956935266137,0.928308198552877,0.574468085106383,0.9887388557727282,1.0,1/5,5.70%,FLAD1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.45940062289431,-0.9280626981601326,0.6338028169014085,0.9715817724415414,1.0,1/27,0.18%,ANXA1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4013837612217075,-0.9279756139388516,0.65,0.9712851442015464,1.0,4/84,6.27%,THBS1;RPS4X;YBX3;PLD1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3821868562246382,0.9272991583818013,0.6571428571428571,0.9903879988135025,1.0,5/26,8.12%,CSPG5;CHST11;CSGALNACT1;CHST7;BCAN
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.5257970278209224,-0.9271578576402267,0.6065573770491803,0.9726713708399692,1.0,2/13,11.12%,SHTN1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4850457156087801,0.9268941293033544,0.5277777777777778,0.9905890428744674,1.0,3/9,14.67%,AKT2;AKT1;GPLD1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.43835905163307576,-0.9268014759047883,0.6268656716417911,0.9730508867144727,1.0,2/33,0.81%,RECQL4;BLM
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3736924061355236,0.9267748586416116,0.5833333333333334,0.9901041848802071,1.0,7/35,15.29%,BMP2;GREM1;TWSG1;GDF11;ACVR2A;GDF9;GDF10
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.6053144627300763,-0.926620319514188,0.6774193548387096,0.9729716025909593,1.0,1/7,2.20%,ZFP36
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.45192325323553567,-0.9265828879058756,0.5692307692307692,0.9725406551026508,1.0,14/29,27.22%,SEPTIN5;SYT4;SYT1;RIMS2;SYT5;SYT2;SYT13;RAB15;SYT12;RIMS1;SYT17;RIMS3;RAB3A;UNC13D
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.4849179931403572,0.9264121331614903,0.4857142857142857,0.9901772619625417,1.0,3/11,20.11%,ACVR2A;MAGI2;SMAD7
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.5580806192068826,0.9263602507733897,0.6428571428571429,0.9895292367380877,1.0,1/7,0.44%,WNT7A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4975728137077652,0.9260531389489431,0.5517241379310345,0.989438513949449,1.0,2/11,4.92%,AFG1L;COX10
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.4214754334363038,0.9259309942536021,0.5294117647058824,0.9889196827839597,1.0,7/28,10.28%,CPAMD8;ADAMTS18;FREM2;ZDHHC16;SMG9;PBX1;ATF6
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.3449413143425726,0.925065835216755,0.6153846153846154,0.9903591471743214,1.0,12/64,17.11%,NGF;SOX8;LIG4;CAPRIN2;DCT;SPEN;ROBO1;TIAM2;DRD2;CAPRIN1;FAIM;MAP6
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),0.5338493162803788,0.9248351194564788,0.6060606060606061,0.9893861302196494,1.0,4/8,31.14%,LYRM7;UQCC1;UQCRFS1;UQCC2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),0.5338493162803788,0.9248351194564788,0.6060606060606061,0.9893861302196494,1.0,4/8,31.14%,LYRM7;UQCC1;UQCRFS1;UQCC2
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.39161103341644904,0.924656558109673,0.5405405405405406,0.9891323952103478,1.0,5/27,11.80%,ACE2;EHF;CAPN13;SLC26A3;KRT8
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.29067721359988036,0.9243694153196499,0.875,0.9891150265539211,1.0,22/194,10.19%,FGF6;LEPR;EPHA6;VEGFD;DSCAM;AGER;BMP2;VEGFC;FLT3;BCL10;SOX9;TESK1;EGFR;AKT2;P2RY1;AKT1;RALB;AR;STK4;ERBB4;CDK2AP1;SLC4A4
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.5760234677197914,-0.9242949231742774,0.6271186440677966,0.9775871800403451,1.0,2/7,12.25%,PODXL;MYO1E
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4424102349984155,-0.924290367869764,0.52,0.9771173690323287,1.0,9/35,17.39%,EPN1;SH3GL2;EGF;TGFA;DAB2IP;MVP;SH3KBP1;SNX6;ZFYVE28
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.34127360589045874,0.9242043074906341,0.5862068965517241,0.988744025094772,1.0,10/73,9.30%,SPSB4;MEX3A;CSPG5;EFNA2;POU3F2;SNAP91;KLHL23;BTBD17;RHBDL3;CNTFR
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.36770658321332217,0.9241068211084281,0.47058823529411764,0.9882830044266264,1.0,4/45,7.35%,TMEM100;BMP2;SMAD5;ZFYVE16
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3683577607871044,0.9240429657028861,0.6296296296296297,0.9876325877119886,1.0,11/31,33.74%,SESN2;SESN3;DYRK3;KPTN;SESN1;SIK3;LARS1;ITFG2;KLHL22;PIP4P1;SZT2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.45778321127232613,-0.9239949034833165,0.6081081081081081,0.9773597013037356,1.0,7/29,15.96%,ANXA1;CCND1;GLI1;HYAL1;LSM11;DDRGK1;CCND2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.3126379687693709,0.923767585772169,0.5555555555555556,0.9875531403524869,1.0,41/114,30.67%,FASTKD1;GTF2F2;HNRNPC;TP53RK;NOVA1;FASTKD2;LSM8;DROSHA;PAPOLA;NUFIP1;TFIP11;SYNCRIP;RNASEL;HNRNPU;POLR2C;THOC1;AGO3;CLP1;PCBP3;RBMX;DKC1;PPP1R8;RNGTT;NOL9;RBM39;ADARB1;MTREX;PAPOLG;HNRNPD;POLR2A;ALKBH1;M1AP;POLR2K;TENT2;LSM1;POLR2D;FTO;SNRNP40;HNRNPH1;POLR2E;PTBP1
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.5210133441511982,0.9237520265628,0.5833333333333334,0.9867958637031403,1.0,4/7,40.95%,MAGI2;LEMD3;ACVR1;SKI
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.4138628463628436,-0.9237237034280099,0.5606060606060606,0.9774447472620338,1.0,11/37,20.15%,IRF1;TLR3;GADD45A;PIEZO2;MAP3K14;FADD;TNFRSF1A;LTBR;AQP1;TNFRSF10A;CASP8
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.5422853584719652,-0.9236606604689026,0.5901639344262295,0.9761451155981766,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.5422853584719652,-0.9236606604689026,0.5901639344262295,0.9761451155981766,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.5422853584719652,-0.9236606604689026,0.5901639344262295,0.9761451155981766,1.0,1/9,0.81%,BLM
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4532811236991252,-0.9235181281620592,0.5945945945945946,0.9760738653886192,1.0,7/35,17.28%,CLDN16;POF1B;CLDN20;CLDN18;WDR1;MICALL2;VCL
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.530630308632954,-0.9234458283555333,0.6166666666666667,0.9757354534774904,1.0,1/9,0.55%,TYMS
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.5481055141097393,-0.9229846737914403,0.5873015873015873,0.9763092013436735,1.0,2/9,14.82%,VIL1;WDR1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.4716695183602576,-0.9229006342158647,0.5070422535211268,0.9760860808921739,1.0,4/21,13.39%,RPS27A;RPA3;UBC;RPA1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3582869198742024,-0.9228209152935548,0.7126436781609196,0.975761969267687,1.0,17/163,16.23%,THBS1;TYMS;RPS4X;APP;PLD1;RPL13A;RPS6KA1;PATL2;EIF2B2;OGFOD1;RPL10;IGFBP5;GLE1;SAMD4A;RPL5;RBM3;RBM4B
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5702502650753122,0.9227410193482158,0.6470588235294118,0.9886230075733554,1.0,1/6,7.43%,VCP
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.38461263363592857,-0.9223643985437985,0.6626506024096386,0.9763440455052596,1.0,22/84,19.26%,P2RY12;ADGRE5;RAMP3;ADCY7;AKAP5;GIPR;S1PR3;LGR5;ADCY5;GPR12;RXFP1;CNR1;VIP;PTH1R;HTR1E;GLP1R;PTH2R;ADCY3;ADCY8;GPER1;ADM;ADGRG2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),0.49159147029096495,0.9223003969993525,0.6052631578947368,0.9888588412409587,1.0,3/16,8.21%,C1D;MPHOSPH6;RPF1
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.4607359736607569,0.9219574947978326,0.5135135135135135,0.9889049248775692,1.0,3/15,18.80%,CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.4259536887187182,0.9219311829136463,0.5483870967741935,0.9881489762742027,1.0,2/20,6.31%,PHC1;UBE2N
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.334986564163765,-0.92163205199352,0.8085106382978723,0.977624138844718,1.0,59/735,12.14%,PRAME;KLF2;LEF1;EFNA1;CDKN2A;FOSB;SKOR1;SP100;SIX3;POU4F1;NR4A3;SUV39H1;NR1I3;MAEL;HIC1;CIITA;ZFP36;RPS27A;PROX1;MLIP;CIC;RPS14;IRF1;ATF3;MSX2;PRDX5;KLF4;ZNF750;BRCA1;GFI1B;GATA1;LDB2;NKX6-2;BASP1;CCND1;PLK3;ZFP69;HEXIM1;PARP9;ZFPM1;ZNF536;GADD45A;FBP1;STAT1;MAFK;WNT5A;IRF7;DAB2IP;PRDM1;ZNF20;AEBP1;ZBTB32;SOX15;BAP1;FOXM1;SBNO2;RPL10;RUNX2;EID2
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.4971072197753045,-0.9215112034336712,0.6,0.9774237774362924,1.0,7/16,23.55%,UNC13C;GRIK1;GRID2;GRIK2;SLC17A7;CDH8;GRIK4
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.44038375444023126,0.921493288626375,0.5714285714285714,0.9884476507811167,1.0,3/11,27.92%,MYCBP2;PTEN;ARHGAP35
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.5894279841709033,-0.9214780363055952,0.5714285714285714,0.9770032246682038,1.0,2/5,18.88%,ST6GALNAC2;ST8SIA3
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.5122067128207838,-0.9208738331911788,0.6307692307692307,0.9778221687716847,1.0,2/15,14.52%,ATG9A;WDR45
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.3441712339495702,0.9206965371431632,0.68,0.9895825305485615,1.0,11/57,11.53%,POU6F2;REEP6;RDH10;EYS;CRYGS;OAT;CRYBB2;TYR;ZIC2;ATF6;OPA1
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.6120595094638229,0.9205103600137975,0.6444444444444445,0.9893132670470868,1.0,3/5,33.08%,CSF1R;LRP5;LRP6
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.5296820263608182,-0.9200594035907168,0.59375,0.9791540352178577,1.0,2/11,6.56%,BRCA1;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4081635024908519,-0.9199928970169291,0.6268656716417911,0.9788203584898792,1.0,9/50,16.44%,ANXA1;RAB11A;CCND1;ANAPC11;CCNB1;HYAL1;LSM11;CCND2;CDC7
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.4585226046151539,0.9199551147220802,0.6153846153846154,0.9901133259347789,1.0,6/19,29.18%,SLAIN2;TUBG1;TPX2;TUBGCP3;CLASP2;TUBGCP5
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.39011663465106516,-0.9199435992091876,0.5925925925925926,0.9784411884443152,1.0,8/84,9.94%,RECQL4;BLM;MEIOB;ZSWIM7;POLQ;BRCA1;GINS2;RPA3
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.5235119185042394,-0.919537152377512,0.6212121212121212,0.9787494088810711,1.0,1/12,3.31%,TRIM5
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),0.4823183105920259,0.919383050496314,0.53125,0.9907146674703461,1.0,2/11,12.63%,NT5C1A;NUDT15
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.4069409458821479,0.9193313048666282,0.5945945945945946,0.9901581668053139,1.0,7/20,28.98%,CYP7B1;CYP46A1;SCP2;ABCB11;OSBPL3;OSBPL6;OSBPL1A
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.5751595485324896,-0.9191923244001334,0.6065573770491803,0.9789932347392696,1.0,1/7,2.27%,NDST4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5174721498848104,-0.9190832476190868,0.5925925925925926,0.9787289308683637,1.0,1/9,4.15%,ST18
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.38075566690817475,0.9189427085168329,0.5151515151515151,0.9904448870992245,1.0,13/39,18.61%,WASHC5;PI4K2A;EXOC8;ZFYVE16;RAB22A;PHETA1;WASL;CHMP2B;ALS2;RNF26;VPS11;DNAJC13;EPS15
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.4428314172345824,-0.9186542579176203,0.5833333333333334,0.9793338176359624,1.0,9/33,24.91%,B4GALNT1;FA2H;CYP4F22;ST8SIA3;B3GALT4;ST6GALNAC3;CERS5;ST8SIA4;CERS4
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4595439694347189,0.9186480514862405,0.6153846153846154,0.9903550856117482,1.0,2/17,6.13%,BMP2;TCAP
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.32138408552017117,0.9186169041914221,0.6363636363636364,0.9896480807516245,1.0,25/103,24.23%,ATP6V0D2;ATP6V1A;EXOC8;ATP6V1G1;AKT1;PRKAB1;SESN2;MAPK8;CASP3;PIK3CA;QSOX1;SESN3;SNX5;SLC38A9;RUFY4;GPSM1;ERN1;PRKAA1;SMG1;LAMTOR3;ATP6V0A2;EXOC7;USP36;RPTOR;UBQLN1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.503060569214242,-0.918564302056367,0.5932203389830508,0.9790193250165968,1.0,6/16,16.59%,TMCC2;KLK6;ADAM19;ACHE;APH1A;CLN3
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.5438582823995702,-0.9184111208600322,0.609375,0.9789153075789387,1.0,5/9,15.76%,ALOX12;CEACAM1;CD9;C1QTNF1;PRKCD
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.4078978772224577,-0.9181872173887462,0.5897435897435898,0.9789483891051739,1.0,8/55,9.54%,PLEKHG2;LMOD1;BAIAP2;BAIAP2L1;VIL1;CDC42EP1;PFN2;CDC42EP3
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.42129027240742256,0.9181854161283721,0.5581395348837209,0.9896663262120068,1.0,12/19,31.90%,BRCC3;KAT2A;USP3;USP49;USP22;ENY2;TRRAP;USP36;USP15;USP7;UIMC1;EPOP
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.4980445244548921,0.9181848706131326,0.5365853658536586,0.988889508059564,1.0,1/9,1.24%,NR1D1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.31433650353145426,0.9181828315154518,0.6428571428571429,0.9881139084453998,1.0,23/112,21.51%,NUP42;AIFM2;HSPA1A;NUP37;ABCD1;BAG2;NUP54;HSF1;ATR;NDC1;NUP214;RAE1;AAAS;NUP188;EP300;NUP205;CCAR2;DYRK3;NUP210;NUP85;NUP153;NUP50;SMG1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.4323240351725185,0.9181314908805637,0.6857142857142857,0.987455471188188,1.0,2/24,8.16%,KDM1B;KDM5A
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.3956996122925261,0.9176691046111831,0.53125,0.9878675041169807,1.0,1/21,0.60%,RGCC
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.45481292936931533,-0.917597351668528,0.6911764705882353,0.9797528034647837,1.0,5/30,13.10%,PROX1;SULF1;ITGA8;STAT1;PAX8
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.49465486468627096,-0.9175406421135404,0.6,0.9793931039108049,1.0,1/11,0.55%,TYMS
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.5945754280393729,-0.9175356313053253,0.5961538461538461,0.9789152040495177,1.0,2/5,23.70%,ARL13A;ZDHHC3
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.39960581371818643,-0.9175022534721099,0.5714285714285714,0.9785243682572516,1.0,7/51,14.25%,ANXA1;THSD7B;MINK1;MYH9;DMTN;FGF7;PDLIM4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.5721054281013803,-0.91737132588186,0.6842105263157895,0.9783434613057757,1.0,4/7,29.81%,DND1;TGFB1;PPARG;NCOR1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.295644582019922,0.9172791918088028,1.0,0.9880918868598306,1.0,30/207,12.89%,FGF6;LEPR;VEGFD;AGER;BMP2;VEGFC;MEN1;OCLN;PPP1R15B;CCDC88C;FBLN1;SOX9;TESK1;EGFR;AKT2;P2RY1;AKT1;RALB;ANKRD54;STK4;TWF1;ERBB4;SESN2;CDK2AP1;CSF1R;EFNA5;DVL2;ACVR2A;SIRPA;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.45280901722561423,0.9172709733746993,0.5,0.9873549287401335,1.0,1/11,2.91%,ADRA1A
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.5096126943470157,-0.9171636588967,0.625,0.9782811120704075,1.0,6/18,18.54%,SYNPO2L;TNNT1;OBSCN;MYLK3;WDR1;FHOD3
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.5943419482765083,0.9171187854979537,0.6,0.9869658751680681,1.0,1/5,5.93%,PEX13
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.48843052980320323,-0.9170585442501177,0.6949152542372882,0.9780140368522799,1.0,2/17,1.91%,SIX3;B2M
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),-0.5964985748576029,-0.9167729642806478,0.6458333333333334,0.97762161058191,1.0,2/5,23.13%,TCP1;WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),-0.5964985748576029,-0.9167729642806478,0.6458333333333334,0.97762161058191,1.0,2/5,23.13%,TCP1;WRAP53
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3902814283138543,0.9167664681606907,0.6153846153846154,0.9870482896624029,1.0,11/30,25.88%,HSPA1A;HSF1;RHBDD1;DNAJB14;DAXX;ERN1;TM7SF3;DNAJC18;HSPA13;DNAJB12;BAK1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.5300944243452155,-0.9161559312658261,0.576271186440678,0.9784867399372275,1.0,3/8,3.84%,CD5;SKAP1;GPR171
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.394383064845947,-0.9160177262946938,0.625,0.9782745907735553,1.0,13/61,15.75%,FLRT3;POU4F1;SLITRK1;LRRC4;WNT5A;GABRB2;PCDHB5;ACHE;GRID2;NLGN1;GABRG2;BDNF;GABRA1
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.42715541741861807,-0.9158805276709139,0.6027397260273972,0.9781398240776568,1.0,3/34,9.28%,L1CAM;SHTN1;MAG
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.5498472964123524,-0.9158689797631463,0.6,0.9776966433227081,1.0,4/8,25.60%,SYK;HLA-F;GAB2;STX4
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.5597033793124223,0.9158127490011432,0.717391304347826,0.9883822654639155,1.0,1/6,1.24%,NR1D1
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.5835605062470457,0.9157548158570364,0.7045454545454546,0.9877538223942387,1.0,2/6,16.94%,GPHN;MOCS2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.3794044408156413,-0.9155643222250149,0.6296296296296297,0.977988602603116,1.0,21/118,11.90%,C1QL1;TAGLN3;STMN2;CSPG4;SNCB;PLP1;NNAT;LRRTM1;GAP43;NKX6-2;GFAP;TCEAL6;ZNF536;IGSF21;CA10;NYAP1;HAPLN2;HPCA;ADCY5;STMN4;C11ORF87
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.5370775222448345,0.9155247632967958,0.6486486486486487,0.9875429382765889,1.0,1/6,2.88%,SERPINF2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.45408042814661365,-0.915197970587228,0.576271186440678,0.9782576109305117,1.0,2/21,4.80%,FSCN1;CLRN1
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.32556156642154294,0.9151277829638282,0.7307692307692307,0.9877309252489123,1.0,16/95,15.34%,PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;MAPK10;PSMB5;BTRC;MAPK8;PSMD14;PIK3CA;PSMD12;NFKB1;PIK3R1;MAP2K4
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4375041209238192,-0.9151125497044847,0.625,0.9779509467298205,1.0,10/31,24.22%,KLF4;SRF;FOS;APLN;ETS1;TGFB1;SPI1;GNL3;STAT3;PPARG
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.4373994660616254,-0.9150344858172939,0.6338028169014085,0.9776581682849486,1.0,2/40,0.33%,CCBE1;THBS1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.5174321212615031,-0.9149988774324668,0.6153846153846154,0.9772887282280605,1.0,3/12,11.60%,ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.5323007888425217,-0.9149893529644763,0.6176470588235294,0.9768382148286269,1.0,1/11,1.53%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.31845079852543196,0.9146902471267708,0.5263157894736842,0.9878301236494142,1.0,19/129,14.00%,LIMD1;AMER2;BMP2;PSMD10;BICC1;CCDC88C;PSMA1;GREM1;PSMD11;SOX9;PSMB5;STK4;KLHL12;INVS;PSMD14;DVL2;PSMD12;TMEM170B;MDK
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.4617429904809959,0.9144441912449964,0.55,0.9877169420130836,1.0,6/16,23.92%,EP400;ING3;SPHK2;RUVBL1;TRRAP;EPC1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3277898434957006,0.9143773341382279,0.6296296296296297,0.9870826192274574,1.0,13/112,8.78%,NR1D1;PSMD10;ADIPOR1;PSMA1;PSMD11;ELOVL6;ACACB;PMVK;PSMB5;RUBCNL;PRKAB1;NFYC;CHD9
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.48399258334447814,-0.9141434664429183,0.576271186440678,0.9783370923311826,1.0,4/11,23.00%,BRCA1;SET;SPI1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6240475061101306,-0.9138390558157058,0.6981132075471698,0.978650339582058,1.0,1/5,8.26%,VIL1
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.5816925715155745,-0.9136763663114394,0.6551724137931034,0.9779935692228844,1.0,1/6,2.99%,SFTPD
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.5816925715155745,-0.9136763663114394,0.6551724137931034,0.9779935692228844,1.0,1/6,2.99%,SFTPD
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.3664229797577823,-0.9136095303001303,0.7045454545454546,0.9776927430235637,1.0,13/136,9.57%,TRIM22;APLNR;TRIM61;PROX1;TRIM5;APP;YBX3;NELL1;LDLR;ATP1B1;TRIM17;IGF1;NFKBID
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.28150070187870724,0.9131179994451473,1.0,0.9892127654071904,1.0,46/337,14.48%,DGKB;LMTK3;LIMD1;CDKL1;CCNE1;BMP2;GK;PDK4;PASK;DGKE;PIK3R4;COPS2;ACVR1C;COPS8;CDK8;MAPK10;AKT1;FRK;PRKAB1;TP53RK;CSNK2A1;POMK;CSNK1E;STK4;PRKACB;MAPK6;PLK1;EIF2AK4;MAPK8;STK38L;MAP4K5;MAP4K2;PRKG1;TAOK2;FGGY;ACVR2A;TRIB2;TAOK3;WNK3;STK17B;SGK2;PIK3CA;MORC3;RNASEL;NEK1;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.5209231563083556,-0.9131091611670862,0.6129032258064516,0.978303413667793,1.0,1/12,6.29%,BRCA1
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.5342683995904356,0.9129510520535936,0.6666666666666666,0.9887547101262255,1.0,3/6,30.39%,LRPPRC;MAP1S;RHOT1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.4956440696017591,0.9127253315718605,0.53125,0.9884119639690443,1.0,3/12,18.80%,CHMP2B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.45967502924598447,0.9123114902992682,0.6046511627906976,0.9886687280071846,1.0,6/13,23.50%,NOTCH2;HEYL;ROBO1;HEY1;HEY2;JAG1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.385111002116177,-0.9120795544425443,0.6753246753246753,0.9800000889704213,1.0,5/86,7.39%,SIX3;IHO1;PLK2;RAB11A;PLK3
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.5491108502936874,-0.912064439441169,0.717391304347826,0.9795500102089884,1.0,2/8,18.59%,LRRC19;OCIAD2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.39994087410974233,-0.9119240387058456,0.6111111111111112,0.9793255856725752,1.0,2/44,2.09%,AMN;ANK3
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.3504374254400887,0.9118605308444878,0.7419354838709677,0.9889250948851732,1.0,14/44,23.21%,NGF;PLCB4;PIK3C2G;CSF1R;PIK3C3;PIK3CA;ADAP2;PIK3R1;PIK3C2A;PLCB1;PI4KB;RPS6KB1;PLCH1;EZR
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.41186432874587803,-0.9115071481426246,0.6197183098591549,0.9797902058006773,1.0,10/49,15.64%,RPL3;RPL7A;RPL24;RPL10A;RPL10;MRTO4;RPL26L1;PES1;MRPL20;RPL5
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5550369749868281,-0.9113248891473429,0.6379310344827587,0.979741380529163,1.0,1/7,10.92%,LPCAT4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5165870331702482,-0.9112837110789962,0.5666666666666667,0.9793687641472006,1.0,3/12,15.12%,NR4A3;WNT5A;CD74
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.49647276397126494,-0.911012429651683,0.625,0.9794730404779803,1.0,2/14,11.21%,LMOD1;ARPC5L
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.4930173946499643,0.9107813213488938,0.6486486486486487,0.9906234306879654,1.0,2/11,9.40%,AKT1;QDPR
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5376128751433932,0.9105761486061664,0.6857142857142857,0.9903593932416281,1.0,2/10,12.58%,ACVR1C;ACVR2A
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.6010272059685076,-0.910494292633581,0.671875,0.9800040877163495,1.0,1/6,9.32%,ATG9A
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.3702139879507457,0.9104644160162417,0.5357142857142857,0.9899113551804108,1.0,9/41,16.33%,WNT7A;WDR91;METTL18;AKT1;EIF4E;SSH1;NFKB1;DDX25;METAP1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.474571946907164,0.9101836617074871,0.5,0.9898588635020019,1.0,9/13,43.83%,DESI2;SENP6;ATG7;UBA3;NAE1;UBA1;DESI1;UBA6;SAE1
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.38491571937654445,-0.9100851210712112,0.6052631578947368,0.980435812987019,1.0,12/69,11.73%,CLDN16;KCNJ2;LETM2;HTR2B;SLC24A2;ATP1A1;SLC24A1;GCM2;ATP1B1;SLC8A3;TMPRSS3;SLC24A5
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.475060895198783,-0.9100168318692222,0.6612903225806451,0.9801129620141479,1.0,3/21,3.84%,CD5;TAGAP;GPR171
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.5480893993386444,-0.90993422256166,0.5901639344262295,0.9798083714600538,1.0,3/8,24.22%,ADAM19;NODAL;PPARG
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.3751902011598008,0.9098623988791451,0.6666666666666666,0.9897450780583885,1.0,1/28,0.54%,RNF6
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.3732367375716143,-0.9097744553363984,0.6376811594202898,0.979710371465073,1.0,10/40,17.76%,RPE65;PLB1;RBP2;AKR1C1;GPC3;ADH4;RDH12;ALDH3A2;GPC1;LRP2
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.4245071047880614,0.9097070526230665,0.6176470588235294,0.9893511139825582,1.0,3/15,10.13%,CEL;NLGN3;NRXN1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.31900251209994857,0.9095517144807407,0.6666666666666666,0.9889314930523634,1.0,36/107,27.23%,MTERF3;PIK3R4;VCP;RUBCNL;PRKAB1;SNF8;CSNK2A1;VPS37A;CSNK2A2;VTA1;TOMM22;PGAM5;PIK3C3;CHMP2B;VPS39;TBC1D5;VPS37B;PIP4K2B;VPS4B;SNAP29;CHMP6;HDAC10;PRKAA1;BECN1;VIPAS39;EI24;TMEM74;UBQLN1;DYNLL2;MFN2;LIX1L;VPS16;VPS25;VAMP7;ATG3;VPS41
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.49135718299520775,-0.9095031687990913,0.6551724137931034,0.9798903820758337,1.0,4/19,15.28%,ANK3;SYT1;RIMS2;GRIK2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.4030291016326664,0.9094320874869651,0.5833333333333334,0.9886087406726837,1.0,6/27,8.58%,ADRA1A;SLC35G1;MCU;MAIP1;JPH1;CACNB3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.43694712759420856,-0.9091340529354648,0.5921052631578947,0.9803345585738896,1.0,7/51,12.16%,CTSC;DENND3;VLDLR;SPATA18;CTSS;DAB2IP;CTSZ
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.5588679187469253,-0.909118118296427,0.6774193548387096,0.9799229740738394,1.0,3/8,13.87%,WNT5A;SYK;NOXA1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.3610935832974794,-0.9089752453469727,0.6235294117647059,0.9797221600222413,1.0,33/142,19.53%,IFITM3;MAFF;HK2;SCN9A;ABCB1;GATA1;CD44;SYNGR2;PLSCR1;EMP1;IL4R;ADAM19;NDRG1;SELP;PTRH2;CTSZ;MYO1E;PRKCH;PIM1;PTH1R;DRC1;IL3RA;PRAF2;CCND2;GABARAPL1;LRIG1;SPP1;GADD45B;ITIH5;PLEC;MYO1C;BHLHE40;KLF6
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.6122843231917,-0.908827788260308,0.6491228070175439,0.9795752262287762,1.0,1/5,6.59%,TLR3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.6003304283425767,-0.9087792105982913,0.603448275862069,0.9791869634742981,1.0,1/5,10.73%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.4905674945406401,-0.9087522495181077,0.5686274509803921,0.9787722585240315,1.0,3/14,7.30%,CIITA;CEACAM1;SLC18A2
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.412951822430496,-0.9087143281821782,0.5945945945945946,0.9783847580732279,1.0,7/52,13.02%,DHCR24;GC;AKR1C1;CYP1B1;HSD17B14;CYP21A2;CYP3A4
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),0.5595094515734909,0.9085858826458076,0.6744186046511628,0.9898685815704396,1.0,1/7,5.97%,TPK1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3277046927440119,0.9084391306563973,0.8,0.9895019346025268,1.0,29/99,25.57%,PHC1;UBE2N;PRMT6;MIER3;KAT2A;PRDM5;HDAC2;EP300;EYA1;EYA2;EHMT1;PHF20L1;HDAC10;USP3;KAT6B;MIER2;USP22;ENY2;RUVBL1;TRRAP;MTA2;USP36;UBE2A;SIRT2;PRMT1;NAA50;RPS6KA4;PADI4;BAZ1B
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.439737467994593,-0.9073388002921204,0.6216216216216216,0.9809803934224561,1.0,8/35,21.86%,RHOBTB2;RND2;RHOF;NLGN1;RHOD;FHOD3;RHOBTB1;FHOD1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.3418713127645603,0.9073352466290362,0.625,0.9913700807381656,1.0,13/72,16.49%,DAO;CARNMT1;ALDH7A1;GLUD1;BLMH;IDO1;GLS;QDPR;PIPOX;DBT;ACADSB;DDO;GLUL
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.5426622816344044,0.9072450281221086,0.6097560975609756,0.9907848257022249,1.0,2/5,16.19%,MGLL;ABHD6
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.48797264484468966,0.9071350850095881,0.6388888888888888,0.9903050361068456,1.0,2/14,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.5607835445051229,0.9071268277806275,0.6041666666666666,0.9895734651831413,1.0,1/6,10.68%,LIN7C
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.43624417208237726,-0.907084666745647,0.6086956521739131,0.9810518971048646,1.0,6/25,16.72%,SLC51A;AKR1C1;CEACAM1;SLC51B;SLCO1A2;ATP8B1
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.40934456271846026,-0.9067386323884747,0.618421052631579,0.9813062291236816,1.0,16/59,22.27%,LMOD1;SYNPO2L;TNNT1;ZYX;MYH9;OBSCN;MYLK3;ALKBH4;WDR1;MYO18A;FHOD3;EPB41L4B;EPB41L4A;SORBS1;MYOZ2;EPB41L1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.3409090768860056,-0.9065748384191339,0.7078651685393258,0.9812169916110087,1.0,41/238,17.95%,RASGRP1;MET;ZFP36;RPS27A;NEFL;ZDHHC9;RASGEF1A;HTR2B;GFRA2;CCL2;RALGDS;PSMB9;EGF;RIT2;IGF1;MINK1;PTPN7;TGFA;SHC2;FGF1;PSMB6;DAB2IP;PRKCQ;IL18;PSMC3;TNIP2;PAQR3;UBC;GRIN2B;FGF7;IL3RA;PIK3CB;PSMA8;RASGRF2;PSMA7;FGF22;IRS2;TEK;PSME1;RBX1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5526833688464958,-0.9065337060444018,0.6041666666666666,0.9808247903338543,1.0,2/8,9.37%,RSPO3;PLEKHA4
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6041009462885689,-0.9064642470721984,0.7068965517241379,0.9805265103743174,1.0,2/5,11.40%,HLA-A;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.5697148207144951,-0.906455087379287,0.6323529411764706,0.9800726859547008,1.0,2/8,12.43%,NLRP12;MVP
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.5639433643873963,-0.9064012284125487,0.6333333333333333,0.9797083016114286,1.0,2/8,13.52%,LRRC4;NLGN1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3762836467124848,-0.9063479353731322,0.5432098765432098,0.9793620596567568,1.0,10/76,16.36%,SH3GL2;HLA-DRA;CENPE;AP1S1;CTSS;DCTN1;KIF2C;CD74;MARCHF1;HLA-DRB1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6243952929780896,0.9059449086818879,0.6923076923076923,0.9917664730746398,1.0,2/6,9.80%,MYOM1;PRKACB
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.3929546509099095,-0.9057075742280783,0.6764705882352942,0.9803143561503476,1.0,1/66,0.11%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.2920791751512219,0.9055204320261909,0.7142857142857143,0.9917912925488074,1.0,14/164,7.50%,FGF6;LEPR;VEGFD;AGER;BMP2;VEGFC;SOX9;TESK1;EGFR;AKT2;P2RY1;UBE2N;AKT1;RALB
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),-0.5589403716012149,-0.9053162997725969,0.6206896551724138,0.980745816495961,1.0,1/6,3.86%,BHMT
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.42517534258072576,-0.9051465683333133,0.6142857142857143,0.9805861241583189,1.0,5/37,10.55%,DUSP1;EGF;IGF1;TGFA;CCNB1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.40272952084299135,-0.9050963654699031,0.6621621621621622,0.9802445649522178,1.0,8/71,8.20%,FMO6P;P2RY14;CLDN16;CYP4Z1;ZNF750;DCDC1;EGF;SPAG17
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.4215609268380023,0.9050855343746276,0.5806451612903226,0.992120136308482,1.0,6/25,16.65%,TNFAIP3;ZDHHC11;APOBEC3F;EIF2AK4;MUL1;IFNLR1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.46626312582005186,-0.9049904515690252,0.6142857142857143,0.9800009556978736,1.0,5/23,17.91%,PLEKHG2;WAS;PFN2;WDR1;COTL1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.4406915733568093,-0.9044682796272698,0.5915492957746479,0.9808087362765432,1.0,7/23,10.15%,MYO1F;ICAM1;TAGAP;IGSF6;CLEC12A;IL4R;CTSS
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.4460366766305272,-0.9044677444859034,0.6388888888888888,0.9803390002917364,1.0,6/33,19.49%,ATG9A;MAP1LC3A;PINK1;WDR45;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.34641923300782707,0.9043686593957018,0.6521739130434783,0.9932297561758915,1.0,20/64,20.89%,NUP42;NUP37;GIT1;NUP54;CBFA2T3;SLC4A4;NDC1;NUP214;RAE1;AAAS;NUP188;ZBTB20;EP300;NUP205;JMJD8;NUP210;NUP85;PRKAA1;NUP153;NUP50
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.43756872213312664,-0.9042263669572321,0.6712328767123288,0.9804191596031014,1.0,11/37,17.17%,ST6GAL1;GCNT1;CHST4;GALNT15;B3GNT5;GALNT10;B3GNT2;GALNT12;ST6GALNAC2;MUC6;GALNT8
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.6442268122910779,-0.9040844453878439,0.711864406779661,0.9802645109001082,1.0,1/5,9.42%,FRMPD4
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.40153974516702623,-0.9038168244457337,0.6338028169014085,0.9803977504586007,1.0,11/45,20.15%,RASGRP1;GPR183;TPD52;LAT2;AKAP17A;BLNK;PIK3CD;PRKCB;RAG1;KLF6;CASP8
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.43886455128791296,-0.9037977664958055,0.6065573770491803,0.9799689310126265,1.0,6/30,22.47%,ABCA5;ANGPTL3;SQLE;SOAT1;APOL2;IDH2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.3265906546276806,0.903786068397624,0.7142857142857143,0.9939560176521632,1.0,14/85,12.84%,WNT7A;AGER;SERPINF2;MEN1;DUSP19;EGFR;HMGB1;TIRAP;MAP4K2;TAOK2;MARVELD3;SH3RF1;SIRPA;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5375632261917751,-0.9034824473256914,0.6153846153846154,0.9801994804524964,1.0,5/14,17.54%,BAIAP2;BAIAP2L1;FES;TEK;CDK5
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.5092875889109691,0.903455514266166,0.5714285714285714,0.9938490793071375,1.0,2/7,8.94%,AKT1;HMGB1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5356862008493278,-0.9033629290742741,0.5932203389830508,0.979987766449833,1.0,2/9,16.45%,APOD;F3
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.5432590936142725,-0.9032757217641487,0.6451612903225806,0.9797364896588759,1.0,3/13,16.07%,CHST4;CHST6;MGAT3
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.5864235425027242,0.9032057205642235,0.631578947368421,0.9936903374606196,1.0,1/5,10.97%,MAPK8
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.5752017009768817,0.9029955090636596,0.72,0.9933068211252856,1.0,2/5,26.18%,CXCL12;RAPGEF2
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.520956731919098,0.902775189854782,0.5957446808510638,0.992975774934573,1.0,1/6,7.46%,ALCAM
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.513903081582335,-0.9022686864790741,0.6086956521739131,0.9814065059238095,1.0,1/13,1.31%,TYMP
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.5062607492664345,0.9021229230716177,0.5384615384615384,0.9938118091079615,1.0,1/11,3.55%,PGM2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.3974230320129681,-0.9020918055112093,0.6296296296296297,0.9814152246304588,1.0,9/62,18.73%,ANK3;SEPTIN5;ANLN;SEPTIN4;ALKBH4;STMN1;SEPTIN9;SEPTIN1;SEPTIN14
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.5746393424924642,0.9018068039219228,0.64,0.9938608115316926,1.0,2/5,13.02%,MOGAT1;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.4421964792593914,-0.9016858442937441,0.6323529411764706,0.9817813073923576,1.0,4/27,11.74%,BRCA1;WDR54;LRPAP1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.5776406323067937,-0.9016622006062964,0.6610169491525424,0.9813885380955834,1.0,1/8,0.94%,DUSP1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.2970288720269794,0.9013624423248504,0.9411764705882353,0.9939615089310134,1.0,26/163,14.81%,RGCC;HMMR;PSMD10;PSMA1;RIOK2;PSMD11;ANAPC1;CUL1;PSMB5;FBXO5;ERCC2;HAUS1;CSNK1E;CEP290;CEP152;BTRC;PLK1;PCM1;UBE2D1;PSMD14;ERCC3;ALMS1;PSMD12;CDC26;CEP192;TUBG1
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.49959221299957307,-0.9011777583548398,0.6,0.9819041502041191,1.0,1/15,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5158968729711529,0.9010892549329164,0.6,0.9938637551996834,1.0,4/12,19.36%,LIMD1;EDC3;RC3H1;PATL1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.38734407846562896,0.9010684289270986,0.6538461538461539,0.9931458586792953,1.0,5/32,9.61%,DNA2;PRIMPOL;RFWD3;SMARCAL1;ATR
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.5562756884835055,-0.9008609841585885,0.6379310344827587,0.9821284949794445,1.0,3/7,16.53%,SULF1;MYO1E;MCAM
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.44203704889163337,0.9006175163085283,0.5384615384615384,0.9934965187381973,1.0,7/14,37.37%,PCBP4;RBMX;SRSF9;PTBP1;SAP18;U2AF2;SFSWAP
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.4961813240886971,-0.9005448234089855,0.5882352941176471,0.9824186804269472,1.0,3/15,16.07%,CHST4;CHST6;MGAT3
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.43682387987055044,0.9005227566368558,0.5789473684210527,0.9929778339541383,1.0,7/18,31.04%,EIF3M;DENR;EIF2D;EIF2S3;EIF5;EIF2B3;EIF4A2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.42098829887439065,-0.9001152313091345,0.6417910447761194,0.9828758474617173,1.0,8/45,13.20%,OVOL2;MSX2;ABCA12;CCND1;BAIAP2L1;AMOTL2;EMP2;RHBDF1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.4364219056595301,0.8999241846578727,0.5348837209302325,0.993560173207931,1.0,3/17,8.31%,CHRNA4;KCNA2;SYT3
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.5571425056859354,-0.89985830342773,0.6037735849056604,0.9828706405367232,1.0,3/6,24.39%,UBXN1;AQP11;SVIP
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.42871073302299717,-0.8998519149042864,0.647887323943662,0.982430102613897,1.0,4/32,7.79%,ABCA5;ABCA8;AKR1C1;LDLR
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5923854025339713,-0.899745132316812,0.6333333333333333,0.9817260076165834,1.0,4/6,33.97%,DPAGT1;DHDDS;MVD;DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5923854025339713,-0.899745132316812,0.6333333333333333,0.9817260076165834,1.0,4/6,33.97%,DPAGT1;DHDDS;MVD;DOLK
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.47366629236274743,0.8995378906868069,0.6153846153846154,0.9936434632321912,1.0,5/15,20.90%,USP13;NCK1;PIK3R1;ERN1;BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.38734347771159783,-0.8994391134760898,0.6625,0.9818926079505844,1.0,18/78,24.63%,TYMS;HAP1;RPL13A;PATL2;IGF1;IGFBP5;SAMD4A;RTN1;ORMDL2;RTN2;DAPK3;SHMT1;RTN4;EIF4A3;EIF2AK2;ENC1;EIF4ENIF1;SPHK1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3829754005025744,-0.8991402712895695,0.6463414634146342,0.9820634392873494,1.0,14/86,17.95%,SKOR1;TGFBR2;RPS27A;ADAMTSL2;ASPN;VWC2;EID2;LDLRAD4;UBC;VEPH1;VASN;SNX6;LRP2;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.4258832755240125,0.8991302995507557,0.6428571428571429,0.9937437929591925,1.0,7/16,16.11%,GDAP1;MFF;SLC25A46;OPA1;DNM3;MUL1;MTFR1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3765638687763667,0.8991231337531899,0.6428571428571429,0.9930120803992258,1.0,9/32,17.26%,VCP;GLRB;TRPV1;DERL1;DRD2;DHFR;KAT7;RCN3;RHBDD1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.4447817829169476,-0.8991154480786824,0.6619718309859155,0.9816725838912244,1.0,4/25,13.10%,ARG2;CYP1B1;NOS1;GCHFR
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3009926592845521,0.8990885558554058,0.7857142857142857,0.9923585974639553,1.0,26/153,14.58%,BET1;GOLT1A;PEF1;TMED5;TMEM115;PGAP1;SEC22B;TRAPPC11;TRAPPC12;KLHL12;RAB1B;COG6;ATL2;ANK2;ERGIC3;TRAPPC8;COPB2;VTI1A;VAPA;CAPZA1;SCFD1;CNIH1;SEC24A;DCTN5;VAPB;TMED3
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.4864107623053623,-0.899020079892274,0.6612903225806451,0.981396104494027,1.0,5/25,15.79%,STMN2;PFN2;KANK3;PRKCD;STMN1
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.5783359724149506,-0.8989782266094272,0.6296296296296297,0.9810015524407466,1.0,2/6,17.95%,EID2;TGFB1
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),-0.5916777073278291,-0.898894999263404,0.6346153846153846,0.9807519364146954,1.0,1/5,3.76%,MAOB
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.4264788655496031,-0.898822184670776,0.6119402985074627,0.9804806634844639,1.0,13/38,27.52%,TMC8;KIF14;RPL13A;LDLRAD4;HSPA5;NLRC3;PMEPA1;SVIP;HDAC6;NOP53;ANKRD27;ULK1;SMAD6
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.35445887539595294,0.8981247379482908,0.6071428571428571,0.9939668066148396,1.0,7/41,9.38%,POLD3;PRIMPOL;RFC3;UBE2N;VCP;WDR33;MSH2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.42098635839030907,-0.8980333418884675,0.6376811594202898,0.9816976712233244,1.0,4/26,12.78%,ICAM1;BRCA1;TMBIM1;FADD
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.447025073006446,-0.8979953177069979,0.676923076923077,0.9813212203909679,1.0,1/23,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.5942729050513705,-0.8979455626869629,0.6610169491525424,0.9809188907625216,1.0,1/5,18.14%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.43362966807685344,-0.8975397059189226,0.6301369863013698,0.9812380475676928,1.0,10/28,25.61%,RAMP3;SYT1;RIMS2;GRIK2;ANXA2;CLSTN2;RIMS1;ECE1;WLS;RIMS3
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.4436772369355629,-0.8972297725174008,0.5970149253731343,0.9813603305356703,1.0,5/23,8.14%,RIMBP2;ALDOB;GC;SLC18A2;PLPPR1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4247651301309723,-0.8970431077681992,0.6153846153846154,0.9813253142376768,1.0,4/32,9.67%,ZFP36;GATA1;ZFPM1;STAT1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.32283912483917043,0.8969346919226849,0.8,0.9957266207391451,1.0,15/97,12.57%,GNL3L;PSMD10;BCL10;HSPA1A;TNFAIP3;BAG2;UBE2N;AKT1;COMMD1;DCUN1D1;UBE2D1;RCHY1;SASH1;DERL1;PRMT3
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.4971404825996023,-0.8962570838040076,0.6417910447761194,0.9824206486594095,1.0,3/14,12.57%,PLK2;BRCA1;CEP76
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),0.4428837279493938,0.8962511188739116,0.5666666666666667,0.9966458490658977,1.0,4/17,15.55%,NCSTN;VCP;MAPK12;RCN3
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.4652641114654036,-0.8960505514084397,0.625,0.9823808035814792,1.0,6/19,16.72%,SLC51A;AKR1C1;CEACAM1;SLC51B;SLCO1A2;ATP8B1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.3403906259178456,-0.8960214278898576,0.8172043010752689,0.9819747518659308,1.0,74/391,19.00%,THBS1;TRIM22;MET;P2RY12;TLR2;NOS1AP;PTP4A3;TRIM5;PLK2;RAMP3;IFI35;NLRP12;APP;HTR2B;NOD1;LRRC19;TLR3;BST2;SEPTIN4;HEXIM1;EGF;RIT2;CHI3L1;NEUROD2;IGF1;THPO;WNT5A;TGFA;FGF1;UNC5B;BIRC3;DAB2IP;FN1;SELP;DDX60;PINK1;IL18;SHISA5;TNIP2;MAP3K14;F10;FADD;FGF7;TNFRSF1A;NLGN1;APOL3;RPS15;PIK3CB;BOK;CD74;LTBR;VAV1;RELN;PIK3CD;HLA-DRB1;F3;FGF22;RPL23;IRS2;PRKCB;TEK;ALPK1;GPER1;RIPK2;LRP2;NMI;TGFB1;CARD11;NUPR1;GSDME;RPS20;CD4;BBC3;PDGFRA
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.4429647720721219,-0.8960134640069176,0.6142857142857143,0.9815167865333656,1.0,2/23,5.04%,TRAM1L1;APP
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.5526212236501821,-0.8957732269671723,0.6271186440677966,0.9816255252221586,1.0,3/8,11.93%,CHI3L1;ST3GAL6;SBNO2
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.42418232229461883,-0.8956204204316359,0.6323529411764706,0.9814511582972462,1.0,7/34,17.95%,CEMIP;APP;EGF;CHI3L1;DMTN;RIPK2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.37168347733850665,-0.895331252910245,0.625,0.9815641774450687,1.0,19/84,17.25%,HPN;NR4A3;LAMB1;PROX1;HTR2B;EGF;IGF1;WNT5A;TGFA;FGF1;FGF7;VIP;EGFL7;NR4A1;HYAL1;PIK3CD;PTPRN;F3;TEK
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.5218232485708756,-0.895219156141405,0.6818181818181818,0.9813552047859666,1.0,6/12,19.00%,ALOX12;CEACAM1;CD9;C1QTNF1;PRKCD;PDGFRA
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5660803062515039,0.8950028508287865,0.6052631578947368,0.9989307377635447,1.0,4/6,38.35%,DCP1A;DDX1;DDX3X;DHX9
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.5661033187592985,-0.8947501961209634,0.6964285714285714,0.9818681569450706,1.0,3/6,34.46%,RAB3A;CAST;PCLO
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.4857429348656853,-0.8945643710937216,0.640625,0.9818156837431236,1.0,3/20,12.44%,SP100;APOD;DMTN
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5491874329747689,-0.8943208606936685,0.5964912280701754,0.9818327586943297,1.0,4/7,29.43%,WNT5A;WNT3;WNT9B;CTNNB1
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.49153440077509225,0.8943113539672053,0.5510204081632653,1.0,1.0,2/10,6.30%,LIG4;RABL3
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.5469462684670447,-0.8939328750945669,0.6296296296296297,0.9821841242334498,1.0,4/10,18.14%,NEFL;HAP1;SYBU;MAPT
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.395321756772137,0.8938241392008505,0.64,1.0,1.0,2/26,4.15%,WNT7A;NLGN3
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.5215249667125599,0.8936765570055719,0.6190476190476191,0.9998657013695319,1.0,2/8,12.23%,POMK;FGGY
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.3986503310865087,-0.8935933504400806,0.75,0.9824049720529195,1.0,16/78,20.29%,SCN1B;STMN2;VLDLR;PTK6;RIT2;PLPPR5;WNT5A;DAB2IP;FES;BDNF;RELN;LRRC7;ALK;DPYSL3;CX3CL1;CAMK1D
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.37634542156786965,-0.8935035537117811,0.7215189873417721,0.9821398044687351,1.0,20/73,18.31%,CCNB2;CDKN2A;BLM;PSRC1;PROX1;CCNI2;CCND1;HEXIM1;GADD45A;CCNB1;CCNE2;TFAP4;HERC5;CDKN3;CCND2;CDC37;CDKN2D;CCNF;CDKN1A;SPDYA
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.5813662859066431,-0.8934887382351797,0.6153846153846154,0.9817188057169842,1.0,2/5,23.00%,SPI1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3538176270929807,-0.8931513380728895,0.6976744186046512,0.981961228771729,1.0,30/257,15.68%,TYMS;APLNR;POU4F1;PGR;ZFP36;CENPV;GPNMB;OVOL2;SH3GL2;NLRP12;APP;KLF4;PARP14;PARP9;RPL13A;PATL2;IGF1;RPS13;PINK1;PTRH2;IGFBP5;SLC11A1;CCDC3;SRGN;SFRP2;MSR1;NUDT16;SAMD4A;APLN;DDRGK1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.505823058373943,-0.8929471715821622,0.6515151515151515,0.9819651932169786,1.0,3/10,17.28%,S1PR3;TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.5550498080566824,0.8928031044642729,0.725,1.0,1.0,2/5,38.73%,PTEN;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.37743802818230243,-0.8926116772166605,0.6842105263157895,0.9823328285943744,1.0,18/99,18.28%,CDKN2A;PSRC1;TP53TG5;BST2;FBP1;TSPYL2;BTG1;CRLF3;MT1H;SLIT3;HYAL1;SFRP2;TCHP;PML;BCL6;TGFB1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.4727218418052448,-0.8924851683712817,0.6078431372549019,0.9817132140813665,1.0,1/12,1.22%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.4727218418052448,-0.8924851683712817,0.6078431372549019,0.9817132140813665,1.0,1/12,1.22%,GBP1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.5247130806986953,0.8921930088783679,0.5961538461538461,1.0,1.0,2/6,24.00%,STIM2;STIM1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.36060807104180165,-0.8920611959928811,0.6551724137931034,0.9822144772137539,1.0,12/141,11.74%,ENPP2;SCX;VLDLR;BASP1;VIL1;NEUROD2;SRF;RPS6KA1;NLRP5;WNT5A;DAB2IP;PINK1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.5167822669202536,-0.8917215365010184,0.578125,0.9825424173087095,1.0,2/9,13.10%,ZIC1;PAX8
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5398684695054423,-0.891649911495829,0.6197183098591549,0.9822351056312087,1.0,1/10,1.31%,TYMP
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.4974971980285853,0.8911039882513274,0.6097560975609756,1.0,1.0,1/8,2.65%,MTTP
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.4317576808095057,0.8910976704264355,0.5625,1.0,1.0,1/14,2.52%,FHDC1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.4317576808095057,0.8910976704264355,0.5625,1.0,1.0,1/14,2.52%,FHDC1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.5067919225059283,-0.8907222600096997,0.696969696969697,0.9837197783776648,1.0,2/15,3.62%,POU4F1;RAMP3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4031648047061161,-0.8906951006405143,0.6376811594202898,0.9833258977268908,1.0,3/40,5.06%,L1CAM;SHTN1;SLITRK1
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),-0.5825491958626812,-0.8905417800559517,0.7,0.9832084366628663,1.0,1/5,21.31%,ST6GALNAC3
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.47875752677257677,-0.8897132011045176,0.6779661016949152,0.984431902851734,1.0,3/17,3.84%,CD5;TAGAP;GPR171
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3357336709886353,0.8891911022665874,0.7307692307692307,1.0,1.0,5/59,6.93%,SPSB4;MEX3A;PLEKHG4B;PHC1;DNMT3B
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.3728751842515271,-0.8891862279644182,0.6746987951807228,0.9850164528459742,1.0,17/107,12.84%,COL4A1;COL4A2;SEMA3B;PLP1;LRRTM1;THY1;GFRA2;LMOD1;MAP1B;EFNB3;SCARA3;EDIL3;NUAK1;DAB2IP;IGFBP5;TUSC3;AMOTL2
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.29672700849319755,0.8891631357663773,0.6666666666666666,1.0,1.0,36/129,21.12%,G0S2;CEL;REEP6;PRDX6;ALDH1A1;KMT5A;OSTC;CA2;ACADM;NCAPH2;SUCLA2;CPT2;EHHADH;ETFDH;PTPRG;ECH1;ACOX1;HSD17B11;SLC22A5;MGLL;ACADS;METAP1;GLUL;CPT1A;BLVRA;FH;MAOA;ACSS1;BCKDHB;EPHX1;PDHA1;CRYZ;BMPR1B;DECR1;HIBCH;MLYCD
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.40445741579291594,0.8889651738463447,0.6111111111111112,1.0,1.0,9/22,17.28%,SLC26A7;CA2;SLC39A8;SLC4A7;SLC4A4;CYB5R4;CA3;CYB5R1;CA12
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4045269703240833,0.8888637899967389,0.6896551724137931,1.0,1.0,4/16,6.69%,RGCC;PSMD10;EGFR;AKT1
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.5580945361041071,0.8888307136431817,0.6842105263157895,1.0,1.0,1/5,2.48%,MYORG
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.2881705037247755,0.8887447567071955,0.7692307692307693,1.0,1.0,28/223,13.90%,OTUD3;KDM1B;PSMD10;CDC25A;TNFAIP3;PSMA1;PSMD11;KEAP1;KAT2B;USP13;BRCC3;USP38;USP40;USP12;PSMB5;INO80D;VCP;AR;YY1;USP27X;OTUB2;UBE2D1;PSMD14;NFRKB;ADRB2;KAT2A;PSMD12;DESI2
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.46540525024653034,-0.8886385577773016,0.6212121212121212,0.985742599685929,1.0,8/21,31.04%,CAV3;VAV1;RARG;RDX;DEPTOR;VAV2;MSN;PLEK
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.49920038942513756,0.8885819124383113,0.627906976744186,1.0,1.0,2/8,17.77%,GREM1;ECM1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.4699259746892624,-0.8884644674929134,0.6984126984126984,0.9856457595845959,1.0,1/23,0.55%,PIF1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.39239046135139644,-0.8881390211245518,0.6578947368421053,0.9858631499907222,1.0,7/56,15.13%,HPN;RFTN1;MMP14;RPS6KA1;HYAL1;MFSD2A;SFRP2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.5396382444693397,-0.888056831808937,0.5862068965517241,0.9855641830359962,1.0,1/7,1.32%,GPR183
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.36021086954019943,-0.8877648160187103,0.6666666666666666,0.9856438318999977,1.0,19/112,17.44%,RECQL4;BLM;RPS27A;HELB;POLE3;PSMB9;GINS2;POLE4;RPA3;PSMB6;PSMC3;UBC;RPA1;PSMA8;CDK2;PSMA7;CDC7;POLD1;PSME1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.4728537695531033,-0.8875589315097504,0.6716417910447762,0.9855858931903414,1.0,5/19,20.15%,BIRC3;FLOT1;CDC37;NUPR1;CASP8
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.4458511374834318,-0.8873662729386562,0.6119402985074627,0.9854335115092078,1.0,9/22,20.03%,IFI35;APP;DYSF;SYK;SBNO2;SLC11A1;NMI;MAPT;CX3CL1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.39101882619138134,0.8872408133654439,0.6875,1.0,1.0,3/23,5.74%,POLD3;LIG4;RFC3
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.5355697346209014,0.8872235078502089,0.5319148936170213,1.0,1.0,1/6,10.69%,NIPBL
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.2928471468885894,0.887104750393853,0.6875,1.0,1.0,22/146,11.34%,RAD54B;SEM1;DNA2;LIG4;KPNA2;RFWD3;SMARCAD1;SMARCAL1;BRCC3;UBE2N;VCP;SMC6;YY1;DCLRE1B;RAD52;HMGB1;XRCC2;HUS1;TDP2;MAPK8;CYREN;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.48758389849338823,-0.8870570373224612,0.6428571428571429,0.9856118563803454,1.0,7/18,18.44%,PROX1;MMP14;IGF1;MYLK3;TGFB1;NIBAN2;AKAP6
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.45225305556900186,0.8868796261578198,0.6590909090909091,1.0,1.0,1/13,13.72%,SMG7
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.48494627707551413,0.886764449955817,0.6,1.0,1.0,2/7,7.99%,RCC2;SMC6
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.47579903225375936,0.8865997948692586,0.5116279069767442,1.0,1.0,2/8,5.13%,IL17D;SOX9
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.4261367519858965,-0.8864883017580159,0.6323529411764706,0.9861934203275402,1.0,2/32,2.70%,SOCS3;ITPKC
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5051205259153874,0.8864690236078908,0.6578947368421053,1.0,1.0,1/9,3.79%,RARB
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.466830739676468,0.8863000189238397,0.5555555555555556,1.0,1.0,3/14,10.14%,PDK4;ADIPOR1;GNB3
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.472502157376458,0.8861348745327268,0.6041666666666666,1.0,1.0,1/7,7.52%,GMPS
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3291293169179416,-0.8860112021669255,0.797752808988764,0.986667211908961,1.0,34/385,13.10%,KLF2;LEF1;BLM;SP100;CIITA;PSRC1;SKAP1;IRF1;TESC;CASZ1;KLF4;SCX;DNAJC2;BRCA1;TEAD2;GATA1;YWHAH;ZIC1;PARP9;EGF;RPS6KA1;CRLF3;IGF1;STAT1;MLLT11;WNT5A;IRF7;CREB5;FOXM1;RUNX2;GLI1;NOS1;FGF7;PAX8
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.4460454577400927,0.885957805112186,0.5625,1.0,1.0,4/11,29.88%,DNAJC13;MAP2K2;USP7;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.48966937246761244,-0.8858706219844873,0.7313432835820896,0.9864631635219597,1.0,1/18,0.55%,PIF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.44332781988939907,-0.8858211538704509,0.5970149253731343,0.9860964602497064,1.0,6/21,20.46%,CD44;CD74;SFRP2;CDKN2D;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.41166251047326685,0.8857798885031039,0.4838709677419355,1.0,1.0,3/15,8.94%,AGER;JAM2;HMGB1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4932035007039685,-0.8857759470052843,0.6949152542372882,0.9857300963603984,1.0,2/15,6.03%,TYMS;HROB
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.39662507698347704,-0.8857533554691042,0.6486486486486487,0.9853084131909359,1.0,8/38,19.43%,SEPTIN4;PINK1;BCL2L2;BOK;NUPR1;GSDME;BBC3;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.5473134762035043,0.8856175076537873,0.6904761904761905,1.0,1.0,2/6,26.48%,NFKB1;RELA
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),-0.5786944976816009,-0.885561101492651,0.64,0.9852294735287168,1.0,1/5,3.77%,TJP3
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.4321946438766599,0.8855219944718609,0.6060606060606061,1.0,1.0,9/19,32.38%,DBT;ACADSB;BCKDHB;HIBCH;HIBADH;ECHS1;IVD;HSD17B10;ALDH6A1
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.4321946438766599,0.8855219944718609,0.6060606060606061,1.0,1.0,9/19,32.38%,DBT;ACADSB;BCKDHB;HIBCH;HIBADH;ECHS1;IVD;HSD17B10;ALDH6A1
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.4845450056066656,-0.8849623971059292,0.6567164179104478,0.9859718757772701,1.0,5/13,23.21%,RAB11FIP5;HYAL1;GPR68;SLC9A1;HVCN1
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.5594227628207424,-0.8848209066190948,0.6491228070175439,0.9852836893942294,1.0,2/5,8.24%,RPE65;GRM6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.5594227628207424,-0.8848209066190948,0.6491228070175439,0.9852836893942294,1.0,2/5,8.24%,RPE65;GRM6
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.4640928996751823,-0.8846283110657154,0.6142857142857143,0.9851963638120518,1.0,1/23,1.83%,PLAAT4
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.5477613332927175,0.8845566410875708,0.7142857142857143,1.0,1.0,3/7,24.58%,WAPL;ESPL1;ERCC4
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),-0.5099892385079282,-0.8845146302421917,0.6666666666666666,0.9849810322733374,1.0,2/11,17.46%,ACOT4;ACOT8
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.35594564931143946,-0.8840138069680828,0.7439024390243902,0.9855767398806208,1.0,29/113,23.61%,TRIM22;TLR2;RPS27A;TRIM5;APP;NOD1;SLCO3A1;WNT5A;PRKCQ;IL18;PRKCH;FLOT1;UBC;IL1RAP;DDRGK1;PRKCB;RIPK2;CARD11;ALK;CD36;CX3CL1;TRIM62;IKBKG;ADAM8;EIF2AK2;STAT3;NFKB2;CARD14;TRIML2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.38208660848608317,-0.8836979899700961,0.6835443037974683,0.9857112119814608,1.0,15/70,17.04%,RASGRP1;EPS8L2;KIF14;RASGEF1A;DENND3;FBP1;IGF1;ARHGEF18;DAB2IP;FOXM1;DLC1;VAV1;ARFGAP1;ERBIN;IRS2
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.4298859518076904,-0.883630328983543,0.6712328767123288,0.985368031332434,1.0,1/24,0.81%,BLM
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3343518359443042,0.8834856993762633,0.7142857142857143,1.0,1.0,7/53,9.03%,PPP1R10;PHC1;RNF2;EED;FBXO5;YAF2;RBBP4
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4557055770884848,0.8833889423656547,0.6111111111111112,1.0,1.0,5/14,24.07%,TNFAIP3;RNF26;IFNLR1;ELMOD2;ITCH
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.5736383353225141,-0.8832338534267077,0.6833333333333333,0.9857752237077716,1.0,3/5,22.80%,SLC18A2;SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),-0.5068037421870826,-0.8830259693084425,0.62,0.9857219908559953,1.0,1/11,3.02%,PTP4A3
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.4663975753923477,-0.883025369094512,0.6229508196721312,0.9852685768767608,1.0,3/19,13.20%,IL12A;RHBDF2;RHBDF1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4035317939363175,0.882903198640857,0.6410256410256411,1.0,1.0,7/21,18.23%,PNLDC1;CNOT9;CNOT2;CNOT8;CNOT6L;CNOT1;CNOT4
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.4114935796054146,0.8824314918851431,0.5882352941176471,1.0,1.0,14/29,21.24%,ZDHHC16;ZDHHC14;ZDHHC11;ZDHHC18;ZDHHC13;ZDHHC20;ZDHHC5;ZDHHC21;GLUL;GOLGA7;ZDHHC11B;PORCN;CLIP3;ZDHHC6
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.38888583490530443,0.8823767281808002,0.7777777777777778,1.0,1.0,6/28,20.01%,GRPEL2;PEX2;TIMM23;PEX6;CHCHD4;PEX12
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.4343186510077397,-0.8822017859138604,0.7101449275362319,0.9864072525546087,1.0,5/26,17.67%,RPS27A;RPA3;UBC;RPA1;RBX1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.5687536264662937,-0.8821360723008884,0.6538461538461539,0.9861113329823963,1.0,2/6,23.13%,WNT5A;ROBO2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.3808395081637544,-0.8820400606535498,0.6578947368421053,0.9858156852701493,1.0,4/76,5.22%,DHCR24;SNCB;RAMP3;HTR2B
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.536109193559644,0.8819245906131572,0.625,1.0,1.0,1/6,2.91%,AFG1L
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.45665133052690166,-0.88153964534981,0.6666666666666666,0.9863405488969791,1.0,6/16,20.36%,IFI35;NLRP12;HDAC7;NMI;NLRC3;SPI1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.3569566502614731,-0.8813376656996209,0.7529411764705882,0.9862319792211779,1.0,18/118,16.95%,RASGRP2;TMC8;KIF14;ANGPTL7;CEACAM1;GFAP;RIT2;LTBP4;WNT5A;DAB2IP;PRKCQ;PINK1;BAP1;SLITRK4;ALKBH4;ARFGAP1;TSC2;NUBP1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.5395017395498762,0.8808462742580835,0.5862068965517241,1.0,1.0,2/5,18.51%,VPS4B;CEP120
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4319750731863692,0.8805107034761231,0.6666666666666666,1.0,1.0,2/19,6.39%,RPP40;ERI1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.46684795050039,-0.8803548377398053,0.6507936507936508,0.9878346666531679,1.0,9/16,27.71%,DAB2IP;B4GALT7;EMD;NLRC3;FTH1;SFRP1;TRIM32;TP53;GSTP1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.5685912864497127,0.8801802064846048,0.6666666666666666,1.0,1.0,2/5,31.30%,HDAC2;SIRT1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.39040450890663925,-0.8801113443013759,0.691358024691358,0.9879759134679529,1.0,13/72,19.00%,RHOBTB2;FSCN1;RND2;BST2;BAIAP2;RHOF;DMTN;SEMA3E;DLC1;PRKCD;RHOD;DAPK3;PDGFRA
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),0.511554387185523,0.880072550291308,0.7045454545454546,1.0,1.0,2/7,8.63%,NCOA3;SMYD5
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.5187841431965186,-0.8799974190206841,0.639344262295082,0.9877267524186535,1.0,3/8,14.15%,GABRB2;HRH1;GABRG2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.5236857920982042,0.8799757084965164,0.7,1.0,1.0,1/7,12.08%,SASH1
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.5764503419130447,-0.8798693314754362,0.6981132075471698,0.9870426308715157,1.0,2/5,13.56%,SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.5764503419130447,-0.8798693314754362,0.6981132075471698,0.9870426308715157,1.0,2/5,13.56%,SLC39A14;SLC11A1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.43069130804032973,-0.8798423579376452,0.6338028169014085,0.9866247857699647,1.0,3/22,18.14%,MAP1B;AEBP1;MAPT
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5002083512187512,-0.8797941750777594,0.6140350877192983,0.9862708388718314,1.0,1/10,3.86%,BHMT
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4918709510389341,0.8797749966590015,0.627906976744186,1.0,1.0,3/10,24.38%,GREM1;MAP2K2;RNF13
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.2979206102886199,0.8797416437290112,0.8125,1.0,1.0,29/134,19.67%,FASTKD1;PSMD10;PDE12;RIDA;HSPA1A;PSMA1;EXOSC1;PSMD11;AKT1;PSMB5;PCBP4;XPO1;EXOSC6;DIS3;PSMD14;NUP214;ZC3H14;PSMD12;PAIP1;HNRNPU;RC3H1;CSDC2;EXOSC8;YTHDF2;FXR2;PCID2;FASTKD3;RC3H2;PUM2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.5132972662722435,-0.879587903651852,0.6610169491525424,0.986221952627398,1.0,3/10,13.35%,SPOCK3;WAS;SPINT2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.49987518919809903,-0.8791295747574573,0.6615384615384615,0.9867315401755629,1.0,2/12,13.78%,BRCA1;PCGF3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.47038886864748297,0.879091762840438,0.631578947368421,1.0,1.0,1/13,2.36%,ABCA1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4532845498210336,-0.878868377196063,0.6521739130434783,0.9868051172708381,1.0,5/23,15.96%,ANXA1;CCND1;HYAL1;LSM11;CCND2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.4286443249323732,0.8786560948861387,0.6842105263157895,1.0,1.0,11/24,29.35%,NUDT16L1;EXOSC6;DIS3;TENT4B;EXOSC8;POP1;EXOSC5;MTREX;ZCCHC8;DIS3L;XRN1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.41651565888886877,-0.8786040599547795,0.7049180327868853,0.986963160373313,1.0,5/25,17.79%,P2RY12;DMTN;RHOD;VCL;PTPRO
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5846406969151923,0.8786002832652273,0.7209302325581395,1.0,1.0,3/5,32.28%,SETD3;SETD2;SETD5
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),-0.5069449730937914,-0.8782637913976968,0.6727272727272727,0.9872055538289378,1.0,2/10,5.68%,ICAM1;THY1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5165960511833952,0.8781517489993574,0.6666666666666666,1.0,1.0,8/11,32.84%,HNRNPU;YTHDF2;HES5;ZFP36L2;JAG1;ESRRB;REST;N4BP2L2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.4328660780448994,-0.8781071680969871,0.6285714285714286,0.9871056790308048,1.0,3/25,11.12%,ZFP36;VIL1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.568394263015458,-0.8779586926754454,0.6764705882352942,0.9869805700496391,1.0,5/8,27.22%,SYK;FES;GAB2;ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.5112297489238624,-0.8778761691551595,0.6,0.9866404084511408,1.0,2/7,17.30%,HTR2B;RYR2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),-0.4848147359930989,-0.8769993757138566,0.6065573770491803,0.9879198971279826,1.0,5/13,24.64%,SLC9A2;SLC9A5;SLC9A7;SLC9A1;SLC9A9
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.3796237461281813,-0.8765913627905735,0.620253164556962,0.9882245296903629,1.0,11/64,10.78%,KCNB1;AIPL1;MYO15A;SLC24A2;SRRM4;SLC7A14;XKR4;PDE6B;GRM6;UNC13C;CDH7
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.32508846290883053,0.8765525956995891,0.64,1.0,1.0,10/56,13.91%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.32508846290883053,0.8765525956995891,0.64,1.0,1.0,10/56,13.91%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.32508846290883053,0.8765525956995891,0.64,1.0,1.0,10/56,13.91%,BET1;PEF1;SEC22B;PPP6R1;KLHL12;RAB1B;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.42073178489584373,0.8762272717721041,0.7142857142857143,1.0,1.0,4/25,5.13%,WNT7A;BMP2;RUNX1;SOX9
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.352028904298056,-0.8761478317603092,0.7435897435897436,0.9887563973696113,1.0,8/86,8.48%,DHCR24;ABCA6;ABCA5;GC;ABCA8;PRDX5;ACSL5;DIO1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.440340462620853,0.87580963653427,0.6097560975609756,1.0,1.0,6/12,36.22%,PLXNA3;SEMA3A;PLXNA2;PLXNB2;PLXNB3;NRP1
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.5313579867107524,0.8757554638672521,0.6666666666666666,1.0,1.0,2/5,16.77%,ATP2C1;ACSL3
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3579511039722795,-0.8755062305797453,0.7558139534883721,0.9897046974551057,1.0,20/157,15.95%,FYB1;ICAM1;NEXN;ITGA2;CDH6;FSCN1;THY1;THBS3;YWHAH;CLDN18;BAIAP2;ZYX;SYK;RHOF;MYH9;ITGA9;ITGA3;PIK3CB;LAMA3;ITGB4
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.3951619310472189,0.8754161166931671,0.625,1.0,1.0,10/28,26.63%,ERCC6;ATR;INTS7;HUS1;ATRIP;HINFP;CLSPN;RAD1;USP28;CLOCK
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.35816532710196197,-0.8749780209617747,0.6883116883116883,0.9903406423214041,1.0,17/112,14.38%,KCNT2;STMN2;RCAN2;THY1;LMOD1;MAP1B;EFNB3;GAP43;LDB2;EDIL3;SHC2;ADCY5;IGFBP5;CRMP1;RASL12;RGS7BP;CCDC3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.4844496988708318,-0.8749563590281312,0.625,0.9899409768594283,1.0,4/15,19.63%,TYMP;CRMP1;DPYSL2;DPYSL3
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.4195780429392775,-0.8749076382527292,0.6818181818181818,0.9895753188553833,1.0,8/29,20.40%,CCND1;LFNG;ST3GAL6;WNT5A;APH1A;NOTCH3;RBX1;HES1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.5338965756667459,0.8748138602589276,0.627906976744186,1.0,1.0,1/6,3.58%,HSPA1A
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.44091982971338955,0.8747438488171771,0.5714285714285714,1.0,1.0,3/17,8.13%,MYORG;SELENON;ZBTB18
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.3801613035774083,-0.8746809302311238,0.7222222222222222,0.98956309758968,1.0,3/55,3.30%,THBS1;SP100;TMC8
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.48641240862851126,-0.8745334951370278,0.6333333333333333,0.9894080289956081,1.0,2/15,3.79%,SIX3;POF1B
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.4871764533336807,0.8737334236194128,0.6388888888888888,1.0,1.0,2/7,16.77%,ATP2C1;ACSL3
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.5082907789418994,0.873718957535717,0.6666666666666666,1.0,1.0,2/7,17.02%,CACNB3;CACNA2D1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5262948490908619,0.8734167887156341,0.6666666666666666,1.0,1.0,2/5,38.73%,PRKN;LRRK2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.5278190571357677,0.8733805336341381,0.7,1.0,1.0,2/5,21.44%,PIK3C2A;EDNRB
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.5690901305846843,0.873323201357609,0.7111111111111111,1.0,1.0,2/5,36.93%,AXIN1;GSK3B
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.49673798058864704,0.873311867956142,0.6,1.0,1.0,4/9,18.13%,ZC3H8;FOXJ1;TOX;CAMK4
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.41064457794788595,-0.8732501430067818,0.7313432835820896,0.9914412031336455,1.0,12/48,16.14%,EPS8L2;OVOL2;LSR;MMP14;BAIAP2L1;RARRES1;RUNX2;SLC44A3;BTN3A1;LAMA3;ITGB4;RHOD
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.44063042387710105,-0.873040999248937,0.6290322580645161,0.9914239543822372,1.0,5/24,17.91%,RPL35;RPL7A;RPL10A;PES1;RPL7
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.5007902030931968,-0.8726925660423933,0.6721311475409836,0.9915997374669142,1.0,1/10,6.29%,BRCA1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.4792509532451106,-0.872485640033503,0.6166666666666667,0.9915530737923908,1.0,4/11,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.517031038627036,-0.8721620661515957,0.7017543859649122,0.9916699483251884,1.0,2/12,6.84%,IFITM3;BST2
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.5547512559169003,0.8721253160865218,0.6829268292682927,1.0,1.0,1/5,0.30%,ACE2
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.5442606769927714,-0.8721034691916687,0.7288135593220338,0.991342544627186,1.0,1/7,8.12%,DRAXIN
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.3418722897812605,-0.871739308872112,0.8023255813953488,0.9915934377645226,1.0,23/189,12.16%,GGT5;PRSS48;HPN;PCSK2;MMEL1;PHEX;MMP19;CTSC;MMP14;SVBP;TMPRSS11D;PRSS57;ADAM19;CELA2A;FOLH1;CTSS;MMP25;CELA2B;AEBP1;MMP24;TMPRSS3;CAPN8;CTSZ
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34854146767202193,0.8717385205618186,0.6666666666666666,1.0,1.0,5/38,9.05%,QRICH2;COMMD1;CSNK2A1;XPO1;CSNK2A2
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.4556039604857052,-0.8716330398560682,0.7361111111111112,0.9914003333220098,1.0,5/21,13.13%,GRIN2D;GRIN2A;INSYN2A;GRIN2B;GRID2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.49043336702061846,0.8714444311414529,0.6097560975609756,1.0,1.0,4/7,41.39%,AGO3;AGO4;AGO2;DICER1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.5311497250957898,-0.8713676524950608,0.6949152542372882,0.9909853688690542,1.0,2/9,22.57%,PPP3CC;NFATC2
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.5311497250957898,-0.8713676524950608,0.6949152542372882,0.9909853688690542,1.0,2/9,22.57%,PPP3CC;NFATC2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),0.5055980701926279,0.8711107955342645,0.6904761904761905,1.0,1.0,2/8,5.99%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.4719371048185006,0.8710760344722569,0.7142857142857143,1.0,1.0,5/13,20.09%,ABCA1;RELCH;STARD4;NPC2;SERAC1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.325666016940197,0.870934131495808,0.96,1.0,1.0,11/49,21.51%,RALB;SESN2;ADRB2;SLC25A5;PIP4K2B;SESN3;RUFY4;PIP4K2C;GPSM1;RAB3GAP1;FYCO1
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.3286859505041067,-0.870816381503687,0.7789473684210526,0.9915829799826916,1.0,43/354,11.84%,ZIC4;FLRT3;TAGLN3;MET;POU4F1;L1CAM;WDR62;NRSN1;WNT8B;PROX1;SH3GL2;CHRM1;SLITRK1;GFRA2;UGT8;SRRM4;VLDLR;NINJ2;EFNB3;NELL1;LDB2;HAP1;NRGN;ZIC1;KLK6;MOG;MOBP;NEUROD2;GRIK1;RAPGEFL1;HAPLN2;EIF2B2;SH3GL3;B3GNT5;CHRM3;SCN2A;PCDHA1;PCDHB5;FN1;RAPGEF5;ACHE;DCTN1;NUMBL
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),0.480218218216968,0.8705554189279329,0.6818181818181818,1.0,1.0,1/8,1.56%,AGER
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.3161105932442278,-0.8703001165389035,0.875,0.9920588617953516,1.0,44/531,11.97%,KLF2;EFNA1;FOSB;SKOR1;SP100;POU4F1;NR4A3;SUV39H1;NR1I3;HIC1;CIITA;ZFP36;RPS27A;PROX1;MLIP;RPS14;ATF3;MSX2;KLF4;ZNF750;GFI1B;GATA1;LDB2;CCND1;PLK3;ZFP69;HEXIM1;PARP9;ZFPM1;ZNF536;SRF;GADD45A;FBP1;STAT1;MAFK;IRF7;DAB2IP;PRDM1;ZNF20;AEBP1;ZBTB32;SOX15;FOXM1;RPL10
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.5875991761049577,0.8701671955240403,0.6285714285714286,1.0,1.0,1/5,18.86%,PCID2
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.5875991761049577,0.8701671955240403,0.6285714285714286,1.0,1.0,1/5,18.86%,PCID2
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.4536522380492503,0.870026361598769,0.5813953488372093,1.0,1.0,2/12,11.05%,GLUD1;IREB2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.36460603048581575,-0.8698236914184885,0.6455696202531646,0.9925176058347193,1.0,9/74,16.36%,SH3GL2;HLA-DRA;CENPE;AP1S1;CTSS;DCTN1;KIF2C;CD74;HLA-DRB1
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.4004470365799754,-0.86972875152003,0.6891891891891891,0.9922452786290695,1.0,14/41,19.24%,SLC51A;SLC16A3;AKR1C1;CEACAM1;SLCO3A1;SLC16A11;SLC16A4;SLCO2A1;SLC16A14;SLC51B;SLCO1A2;ATP8B1;ABCG2;CD36
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.44012539882178614,-0.8696522813467622,0.6470588235294118,0.9919731969844713,1.0,4/24,11.18%,GPNMB;THY1;CCL2;PRKCQ
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.35846760124753047,0.8695372223816906,0.7407407407407407,1.0,1.0,8/51,13.78%,PSMD10;PDK4;PSMA1;PSMD11;PSMB5;PSMD14;SIRT5;PSMD12
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),0.4087612058811317,0.8694080994652169,0.625,1.0,1.0,3/18,5.58%,CEL;CYP4F3;CYP4F12
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.43402025067395167,-0.8693243692822992,0.7058823529411765,0.9921727312590013,1.0,8/32,16.45%,TLR2;NOD1;TLR3;CHI3L1;SYK;FADD;CD74;F3
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.5562088076190993,0.8693047382101807,0.75,1.0,1.0,4/6,39.14%,ELAC2;HSD17B10;PTCD1;TRMT10C
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.479944396351869,-0.8691646679308799,0.6811594202898551,0.9920927263907815,1.0,2/17,7.95%,LAMB1;MYH11
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.5255200174035733,-0.8690636511814089,0.6268656716417911,0.9918710929331016,1.0,1/8,13.60%,SLC51B
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),0.571146643984431,0.8685100643341197,0.6410256410256411,1.0,1.0,2/5,22.44%,CCDC88A;LZTFL1
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.510888508456556,-0.8678845021936074,0.6567164179104478,0.993774211892532,1.0,2/11,18.70%,SLC51B;INSIG1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.4256930354844393,-0.8676982765660992,0.704225352112676,0.993701922411162,1.0,4/34,6.72%,APLNR;CEMIP;THY1;JPH3
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.5462514618824007,-0.8674825367027644,0.7368421052631579,0.9937087767712584,1.0,4/9,23.40%,RAB11A;STX1B;GRIP2;STX3
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.4337681218651712,-0.8673275306238252,0.6811594202898551,0.9935700189061211,1.0,1/29,0.37%,S100A10
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.4703018256181777,0.8673248386892017,0.5833333333333334,1.0,1.0,2/13,7.30%,PUS7L;PUS10
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),0.5348107674338555,0.8671196444066326,0.7045454545454546,1.0,1.0,2/6,13.32%,PGM2;GALT
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.45601886179944945,0.867058796916963,0.5681818181818182,1.0,1.0,1/11,5.50%,USP13
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.41512839025753345,-0.8667517220885803,0.6349206349206349,0.994258888278092,1.0,4/29,12.44%,FSCN1;CLRN1;WAS;DMTN
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.47684705588633447,-0.8665668793288579,0.6842105263157895,0.9941324773194284,1.0,6/12,31.47%,UAP1;GFPT2;UAP1L1;GNPNAT1;GNPDA1;AMDHD2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.3546161879390448,-0.8664722594149167,0.6933333333333334,0.993839996972077,1.0,22/101,21.99%,ARHGAP4;RHOBTB2;CNTNAP1;THY1;CCL2;RND2;PLD2;RHOF;DMTN;DPYSL2;ANK1;RHOD;SH3KBP1;SYNE3;PLCE1;PAK5;PAK6;RHOBTB1;PACSIN1;ARHGAP10;SH3D19;NEDD9
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5176107354360103,0.8660939751452492,0.6976744186046512,1.0,1.0,2/8,7.43%,PPARGC1A;VCP
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.3818305203022961,0.8660649684613598,0.5882352941176471,1.0,1.0,8/28,24.64%,HSPA1A;UGGT1;DNAJB14;CHCHD4;DNAJC18;DNAJB5;HSPA13;DNAJB12
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.5509013109689257,-0.8659580034657355,0.6842105263157895,0.994411542261445,1.0,1/6,6.29%,BRCA1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.45531452893469476,0.8658517574644696,0.6,1.0,1.0,3/14,3.97%,RGCC;SERPINF2;RUNX1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.39122319361461927,0.8656679198770129,0.6896551724137931,1.0,1.0,7/19,26.76%,MSH2;AEN;EP300;DYRK2;CDIP1;USP28;PHLDA3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.4018438883954313,-0.8654092431169744,0.6712328767123288,0.9950240834092883,1.0,2/37,4.67%,PIF1;HELB
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.30672389694228763,0.8651748615700386,0.8695652173913043,1.0,1.0,16/87,15.85%,WNT7A;PDE3A;ID1;SOX9;TWSG1;LPXN;SMAD5;NR3C1;PTPRK;TGFBRAP1;SOX5;GDF9;GDF10;CRKL;WWOX;CGN
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.5238956970804488,-0.8647136380727689,0.6875,0.996021931042566,1.0,1/11,6.59%,TLR3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.3699562945582967,-0.8645356804503164,0.676056338028169,0.9959903972696011,1.0,12/76,17.67%,KLF2;RPS27A;ATF3;PSMB9;PSMB6;PSMC3;UBC;ELOB;PSMA8;PSMA7;PSME1;RBX1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.4840418651578233,-0.8643493881350259,0.6615384615384615,0.9958303884035384,1.0,5/13,31.21%,EIF2B2;INHA;EIF2B4;EIF2B5;COL9A3
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.3597436513692887,-0.864003717727123,0.7236842105263158,0.9961055811914626,1.0,17/114,10.37%,TAGLN3;STMN2;IFIT1;S100A6;PLP1;ZDHHC22;SLITRK1;RND2;TLR3;EFNB3;GAP43;GFAP;ZIC1;ZNF536;NYAP1;PLPPR5;ISG15
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3687044683713403,-0.8640002787684745,0.75,0.9956598963676633,1.0,20/73,18.82%,SLC6A15;SLC25A45;PDPN;SLC51A;AKR1C1;CEACAM1;SLC26A8;SLC38A4;SLC7A14;SLC3A1;SLC7A2;SLC43A2;SLC51B;SLC38A1;MFSD2A;SLCO1A2;ATP8B1;SLC7A7;SLC25A29;ABCG2
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5812180614260043,-0.863896573202415,0.6470588235294118,0.9945278960103315,1.0,1/5,15.88%,MAN1A1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5812180614260043,-0.863896573202415,0.6470588235294118,0.9945278960103315,1.0,1/5,15.88%,MAN1A1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5812180614260043,-0.863896573202415,0.6470588235294118,0.9945278960103315,1.0,1/5,15.88%,MAN1A1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.43692886891627214,-0.8638941664526096,0.6885245901639344,0.9940919803671808,1.0,6/23,23.98%,DND1;SLC11A1;VIP;AXIN2;MEIOC;EIF4ENIF1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.48791834222010894,-0.8638739070630175,0.7,0.9936771155091977,1.0,3/16,7.96%,PKP2;PROX1;ZFPM1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3630737158374847,-0.8636804287765051,0.7631578947368421,0.9936261023484599,1.0,9/84,12.98%,SUV39H1;RPS27A;CENPV;CENPH;POLE3;NUF2;SOX15;UBC;FAM50A
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.4430060148458503,-0.8636082868516493,0.5909090909090909,0.9933109024591131,1.0,6/21,16.24%,CYP1B1;IGF1;CYP3A4;ADH4;RDH12;ALDH3A2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.40605820545789234,-0.8635382865811605,0.6428571428571429,0.993012490773855,1.0,3/28,14.98%,POU4F1;NDRG1;BOK
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.5507061557821296,-0.8632650007034877,0.7321428571428571,0.9922589734594648,1.0,3/8,22.39%,EGF;MGAT3;RDX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.5507061557821296,-0.8632650007034877,0.7321428571428571,0.9922589734594648,1.0,3/8,22.39%,EGF;MGAT3;RDX
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.5507061557821296,-0.8632650007034877,0.7321428571428571,0.9922589734594648,1.0,3/8,22.39%,EGF;MGAT3;RDX
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.4918463247854011,-0.8632544484300864,0.6575342465753424,0.9918462167727827,1.0,2/11,10.16%,TYMP;SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4769997679103556,0.863252702954241,0.7837837837837838,1.0,1.0,5/13,20.81%,CCNE1;KAT7;HNRNPU;PDCD2;GJA1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.5469681127347104,0.8632227451290289,0.7368421052631579,1.0,1.0,1/6,2.36%,ABCA1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.4421932477980921,0.863166549143693,0.631578947368421,1.0,1.0,4/13,31.00%,SNAPC3;SPIN1;RPAP2;NIFK
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.3292527380431046,0.862971539978158,0.7368421052631579,1.0,1.0,9/84,7.02%,ACE2;TFCP2L1;PPARGC1A;MUC20;EHF;LARP1B;MYO5B;ESRRG;FRK
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.345921384734617,0.8628553487926601,0.8076923076923077,1.0,1.0,11/40,26.84%,GRPEL2;AKT2;PEX2;TIMM23;PEX6;CHCHD4;PEX12;SEC61A1;PEX16;SEC61A2;PEX5
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),0.42066740439538586,0.8627949350111888,0.7058823529411765,1.0,1.0,3/17,5.99%,ABCD2;PLIN5;ABCD1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.47958335614438374,-0.8627201437027603,0.7076923076923077,0.9923644069881861,1.0,1/16,2.79%,SHTN1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.37281314519578135,-0.8624082086030846,0.7532467532467533,0.9925158321125533,1.0,11/78,12.43%,WARS1;CAMK2N2;THY1;CAV3;CEACAM1;PTK6;SLC8A3;GADD45A;DAB2IP;SH3BP5;MVP
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.4452815231555146,0.8623320386212475,0.7317073170731707,1.0,1.0,2/14,1.13%,WNT7A;SLIT1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.39108344672984563,0.8618122954878817,0.6176470588235294,1.0,1.0,9/27,16.77%,ABCD2;ACACB;ABCD1;MID1IP1;CPT2;ABCD3;SPX;CPT1A;ACSL3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3550075227095037,0.861789952057297,0.6296296296296297,1.0,1.0,4/49,2.65%,ATP11C;PRELID2;ABCA1;MTTP
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33061407524499653,0.8617064030173782,0.6666666666666666,1.0,1.0,13/58,14.20%,POLD3;DNA2;PDE12;RFC3;ERCC2;DCP1B;DNASE1L2;EDC3;ERCC3;EXD2;GTF2H5;GTF2H2;POLK
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.5566933290617857,-0.8613126467576278,0.6444444444444445,0.9940411816396023,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.43749818124289663,-0.8609972131272954,0.6451612903225806,0.9942821939945572,1.0,7/21,15.93%,PLN;CAV3;JPH3;HPCA;NOS1;JPH4;CACNB1
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.5472989504888783,-0.8609051421841624,0.6415094339622641,0.9940297568448708,1.0,2/5,19.04%,ARR3;ADM
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.4397070050562929,0.8607964333423893,0.6,1.0,1.0,10/15,38.20%,UHMK1;CDC123;YTHDF2;RPS6KB1;POLR2D;MTOR;YTHDF3;RPS6KB2;DDX3X;KHDRBS1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3826420631554053,-0.8607797862183169,0.6708860759493671,0.9938597132079482,1.0,1/51,0.33%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5448968900700674,-0.8604862100909593,0.6545454545454545,0.9939978190828324,1.0,2/6,11.79%,HLA-E;IL18
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4105562077082663,0.8604689508463452,0.6285714285714286,1.0,1.0,1/14,6.78%,NOL11
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.48799002044820466,0.8604570650707712,0.6060606060606061,1.0,1.0,5/8,29.99%,GTF2H5;GTF2H3;CDK12;CCNH;CDK13
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.4804793497981419,0.8604210055448053,0.6585365853658537,1.0,1.0,1/8,0.44%,WNT7A
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.3549078669259978,0.8602713615047757,0.6333333333333333,1.0,1.0,4/38,2.79%,SOX8;BMP2;ZNF358;LIG4
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.44328629312126083,-0.8598733203113893,0.6142857142857143,0.9946242769144769,1.0,2/15,11.74%,SVBP;PINK1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.6040607880992235,-0.8598051642548894,0.7377049180327869,0.9943516206771087,1.0,4/5,36.37%,ULK1;ULK2;FGF13;DCC
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.4732254517535671,-0.859668344209052,0.6984126984126984,0.9941366227071065,1.0,3/15,22.33%,FOLH1;ASS1;NIT2
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.5910637855493,0.8595458250328628,0.6744186046511628,1.0,1.0,1/5,6.42%,CSAD
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5814446557851878,0.8592925144210781,0.6956521739130435,1.0,1.0,2/5,24.70%,FYCO1;KIF3B
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.4228641921032417,-0.858853474194799,0.6617647058823529,0.995176223478593,1.0,5/23,17.44%,EFNA1;USP50;GRIN2B;APH1A;PSME1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.3464556246245515,0.8587557838002395,0.7142857142857143,1.0,1.0,12/47,17.54%,GNL3L;NAF1;CCT7;STN1;MAP3K4;HNRNPC;ATR;CCT3;POT1;HNRNPU;PKIB;TENT4B
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.3385745318185569,0.858683202789453,0.6666666666666666,1.0,1.0,8/42,9.72%,AGER;CARD18;TNFAIP3;GIT1;FOXP1;STMP1;TMEM106A;TRIM16
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.4522669403683037,-0.8585979818760682,0.6181818181818182,0.995194611682347,1.0,1/14,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.342952088075404,0.8584873560878489,0.76,1.0,1.0,6/43,11.69%,HS3ST5;SDC4;SDC3;GPC5;EXT2;HSPG2
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.48962342911496654,-0.8581890468441918,0.6268656716417911,0.9955324517854044,1.0,2/9,7.93%,ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.46411931508843435,0.8581451913660026,0.6410256410256411,1.0,1.0,3/11,14.00%,SIRT6;HMGB1;MDK
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.44112772521722404,-0.8580511434857064,0.7058823529411765,0.9953705330600917,1.0,8/23,20.77%,RPS27A;NOD1;IFIH1;UBC;ALPK1;RIPK2;CASP8;IKBKG
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3703923326236376,-0.8579579242605908,0.7297297297297297,0.9950859937655995,1.0,3/62,6.69%,THBS1;SULF1;BMP8A
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.47308614458656834,-0.8578599484024853,0.6491228070175439,0.9947894349934647,1.0,2/8,15.12%,EGF;CD74
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5396083591006258,-0.8572123311291575,0.6818181818181818,0.9955602391773739,1.0,1/8,21.74%,OLFM1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.4815748533773977,-0.8571389977828113,0.6515151515151515,0.995267819591831,1.0,3/12,15.90%,CCND1;PLK3;CDK2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.5214983863564083,0.8571170938531917,0.6829268292682927,1.0,1.0,2/7,9.15%,AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3419114866305677,0.8563389772500205,0.76,1.0,1.0,8/59,8.86%,NGF;CNOT9;HCLS1;TENM1;EGFR;AKT1;STK4;CAPRIN2
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.3345711358726579,-0.8562954513628815,0.7752808988764045,0.9964298828290621,1.0,3/178,0.81%,ENPP2;COL4A1;C3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.402960215825727,0.8562837833949108,0.6764705882352942,1.0,1.0,4/14,13.82%,NR1D1;TNFAIP3;TIRAP;RAB7B
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.5192201750768978,-0.8562326553702897,0.6458333333333334,0.9961169221178157,1.0,3/7,34.74%,IFT88;PLS1;PDZD7
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.3560934229894194,0.8561490715048913,0.8,1.0,1.0,8/32,19.78%,TESK1;AKT1;SESN2;PLK1;KAT7;GLUL;EIF2AK3;PYHIN1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.5507099932098085,-0.8559071992807873,0.6949152542372882,0.9962450176478347,1.0,1/6,8.66%,SRF
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.41676373848131765,-0.8556706541255346,0.6617647058823529,0.9961812637686608,1.0,6/26,17.99%,IFI35;PLSCR1;SCIMP;DDX60;NMI;SLC15A4
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.44273193166521696,-0.8555786292675405,0.7323943661971831,0.9959055255114561,1.0,9/19,19.43%,F8;F10;C1QTNF1;SERPING1;PLAT;F3;A2M;PDGFRA;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.48866943415758995,-0.8550227868587094,0.7192982456140351,0.996608247842538,1.0,5/15,28.63%,PARP9;WRAP53;SHLD1;DTX3L;KDM4D
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.3697468967637296,-0.8548378570340285,0.7534246575342466,0.9965851594063311,1.0,5/63,12.22%,GOLGA8O;RAB11A;GOLGA8B;MAPRE2;HAUS7
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),-0.5212570941194574,-0.8548327061302402,0.65625,0.9961507868705157,1.0,1/7,2.86%,SMTNL1
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.4225501506400565,0.8546735655619226,0.6388888888888888,1.0,1.0,6/13,29.35%,EXOSC6;DIS3;EXOSC8;EXOSC5;DIS3L;XRN1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.4428181581250982,-0.8546576175244825,0.6911764705882353,0.9960342977181232,1.0,1/21,3.86%,BHMT
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.3728760429809438,0.8546142241934723,0.7692307692307693,1.0,1.0,5/35,5.13%,WNT7A;BMP2;SNORC;RUNX1;SOX9
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.4062252336943183,-0.8544991722285682,0.7564102564102564,0.9958772235649951,1.0,4/41,9.53%,S100A10;SYNPO2L;VIL1;PFN2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.552975472079509,-0.8544529930417863,0.7377049180327869,0.9955535423568999,1.0,1/5,11.00%,NUAK1
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.49007755628833477,0.8541244241518667,0.6428571428571429,1.0,1.0,2/7,9.28%,BMP2;SALL1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.3593696061665098,0.8536584839781426,0.6875,1.0,1.0,4/22,6.69%,RITA1;BEND6;EGFR;AKT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3952544489108669,-0.8535714648883052,0.6323529411764706,0.9967789741207398,1.0,5/29,10.01%,NLRP12;APP;USP50;NLRP2;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.5243742755375969,-0.8535604024415094,0.6818181818181818,0.9963454699115112,1.0,5/9,28.78%,HLA-F;TGFB1;CUEDC2;TGFB2;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.4553338189577875,-0.8534039290796253,0.5714285714285714,0.9961519805126342,1.0,4/16,11.20%,TLR2;TLR3;SCIMP;SYK
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.4525262512734718,-0.8532317296985283,0.6923076923076923,0.99600737865971,1.0,6/13,25.60%,HLA-E;GPI;PTPRC;XBP1;CD22;STX4
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.4007112661034786,-0.8529692689346812,0.71875,0.9960171090525657,1.0,6/29,17.62%,SEMA3B;HTR2B;FN1;RADIL;SEMA3E;SEMA4G
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4245329591376945,-0.8528397668604676,0.7164179104477612,0.9958199616534947,1.0,6/26,20.15%,YWHAH;PPP3CC;NMT1;BOK;BBC3;CASP8
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.39910866926192745,-0.8527792453830143,0.6944444444444444,0.9954891890127988,1.0,6/44,7.03%,OGN;CSPG4;CEMIP;BGN;OMD;CD44
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.5133455033025945,-0.8524538924270216,0.6491228070175439,0.9957422959942442,1.0,1/7,16.59%,CLN3
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.46224824018688304,0.8521941161851422,0.6285714285714286,1.0,1.0,4/10,23.65%,MOXD1;SMOX;SRM;SAT1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.42521732332227724,-0.8518700043155065,0.7384615384615385,0.9963476127456462,1.0,3/23,9.88%,SLC39A14;TMC8;MT1H
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.48493753814140317,-0.8518514091872091,0.6470588235294118,0.9959482076086099,1.0,5/11,15.76%,ALOX12;CEACAM1;CD9;C1QTNF1;PRKCD
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.46087648069204384,0.8516824080393187,0.627906976744186,1.0,1.0,4/7,13.27%,AGER;TWSG1;SH3RF1;TARM1
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.36863023697715686,-0.8516576328087652,0.7857142857142857,0.9959903174823038,1.0,22/80,22.76%,COL4A1;CALD1;COL4A2;PDPN;P3H2;WNT5A;AMOTL2;PDLIM4;PLAT;NOTCH3;PCDH18;PTPN21;GFPT2;DPYSL3;NXN;ANTXR1;WWTR1;CD276;SFRP1;FBLIM1;CNN3;SLIT2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.3985933966908469,-0.8515151351333423,0.7538461538461538,0.995850337510215,1.0,5/33,17.76%,TGFBR2;KLF4;NOS1;EMD;LRP2
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.4615100626973498,0.8515003658523745,0.6875,1.0,1.0,4/13,22.51%,IWS1;DDX25;PCID2;ENY2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.42629625259070225,-0.8513331559380768,0.6451612903225806,0.9957306991228501,1.0,1/18,1.11%,APLNR
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.33947662075497115,0.8511380511414836,0.7391304347826086,1.0,1.0,13/56,20.24%,GNL3L;TESK1;AKT1;TRAPPC12;SESN2;PLK1;TMEM35A;CENPQ;KAT7;EIF2AK3;CCDC88A;PYHIN1;PRKAA1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.3979184115502495,-0.8506568821542211,0.6666666666666666,0.9964923407858375,1.0,8/33,17.54%,MX1;SNCB;SYT1;NLGN1;SYT5;SNCG;SYT2;CDK5
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.3424808065577855,-0.8505314802782562,0.7951807228915663,0.9962472765246471,1.0,15/126,14.31%,ANXA1;TGFBR2;STMN2;ZFP36;OVOL2;KLF4;CCL2;CD44;VIL1;WNT5A;DAB2IP;RUNX2;NOS1;NR4A1;HYAL1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.2879219693118016,0.8503298046984976,0.8888888888888888,1.0,1.0,23/222,10.22%,G0S2;LEPR;RGCC;KSR2;SOX8;BMP2;PPARGC1A;ABCA1;ADRA1A;ADIPOR1;SOX9;ELOVL6;PDGFC;ESRRG;FBXO5;NCOA3;PRKAB1;SIRT6;HSF1;FOXJ1;TRIM16;CPT2;ZNF703
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.4985689935015542,-0.8502425300390493,0.65,0.9963012797396189,1.0,2/10,14.52%,ATG9A;WDR45
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.3014943798173277,0.8501903551937767,0.8947368421052632,1.0,1.0,16/96,12.57%,BMP2;GNL3L;CARD18;MEN1;TRIB3;STYX;BAG2;AKT1;RALB;CSNK1E;STK4;CAPRIN2;PLK1;MAPK8;DERL1;TFIP11
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.5391333020663227,-0.8501371547619413,0.7321428571428571,0.9961009173668042,1.0,1/6,7.87%,TENM4
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.5471384063355107,0.8500248221420335,0.7209302325581395,1.0,1.0,1/5,5.93%,PEX13
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.525803512419866,-0.8498160212677647,0.6909090909090909,0.9963405492154416,1.0,1/10,3.28%,ABCA8
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.3802571416997084,-0.8494740535297396,0.7317073170731707,0.9965436726836093,1.0,5/70,8.11%,RECQL4;KREMEN2;PRDX4;TEAD2;BAIAP2L1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.28441821991190824,0.8493526446768308,0.9,1.0,1.0,21/132,15.59%,HMMR;PSMD10;CDC25A;PSMA1;RCC2;PSMD11;CUL1;PSMB5;FBXO5;HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;PSMD14;ALMS1;PSMD12;CEP192;TUBG1;RAD51B
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),-0.5379990805325413,-0.8492589203580705,0.7368421052631579,0.9965410113489345,1.0,2/7,15.09%,ARG2;ASS1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.45628688995378164,0.8491671193746877,0.717948717948718,1.0,1.0,5/12,24.83%,S1PR1;HEY1;RBPJ;TGFBR1;BMP7
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.47688125313024476,-0.8491399263174294,0.6610169491525424,0.9959194088653273,1.0,6/11,31.47%,UAP1;GFPT2;UAP1L1;GNPNAT1;GNPDA1;AMDHD2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.47688125313024476,-0.8491399263174294,0.6610169491525424,0.9959194088653273,1.0,6/11,31.47%,UAP1;GFPT2;UAP1L1;GNPNAT1;GNPDA1;AMDHD2
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.5346802876309696,-0.8486231317297152,0.6615384615384615,0.9965491463001108,1.0,4/6,23.12%,XRCC1;PRKCD;RNF112;SP1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4798420518359261,0.8484240438737084,0.65,1.0,1.0,1/12,1.39%,NCSTN
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3322940427573615,-0.8481066239959845,0.7738095238095238,0.9970374780969402,1.0,28/209,16.14%,TLCD2;RSPH4A;PKP2;CALD1;ANK3;STAG3;FSCN1;TEAD2;BAIAP2;BAIAP2L1;SPAG17;NEFH;VIL1;SYCE2;SYCE1;WAS;CFAP74;WNT5A;DMTN;TEX11;NLGN1;TFAP4;ELOB;CD74;ADD2;IL1RAP;LRGUK;RHOD
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.4037601914206228,-0.8480919530763517,0.6891891891891891,0.9966122174680393,1.0,7/18,22.75%,MLLT11;PINK1;GPER1;BBC3;PLAUR;FAM162A;HRK
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3208148131018585,0.8476524497886943,0.76,1.0,1.0,15/47,20.79%,RGCC;CNOT9;PCBP4;PLAGL1;CNOT2;CRADD;E2F4;EP300;CNOT8;CNOT6L;CNOT1;CNOT4;MDM2;TRIAP1;CASP2
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.4580211386350902,0.8474781980786239,0.6590909090909091,1.0,1.0,2/11,12.49%,PIK3R4;PIK3C3
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.5202158641656405,-0.8473951672582031,0.6607142857142857,0.9973735268839357,1.0,2/6,20.40%,FADD;HES1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),-0.5190797654462362,-0.84733898773517,0.7017543859649122,0.9970409329241278,1.0,3/7,27.42%,PSMC3;PSMC4;TP53
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.4579983384946757,0.8473247586430083,0.6190476190476191,1.0,1.0,2/13,3.97%,LEPR;RUNX1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2745895879948304,0.8473125264003349,1.0,1.0,1.0,41/239,15.61%,CHRNA4;POLD3;DNA2;UBE2T;LIG4;KPNA2;TOP3B;PRIMPOL;MEN1;SMARCAD1;LTO1;RFC3;STN1;SMARCAL1;UBE2N;TRIM28;VCP;CSNK1E;DCLRE1B;RAD52;HMGB1;DNASE1L2;TOP1MT;MSH2;ATR;XRCC2;HUS1;ORC5;NUDT15;ERCC3;THAP9;EXD2;DDX21;RAD9B;POLK;ATRIP;MSH3;POT1;ALKBH3;RAD51B;ASF1A
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.34004299563704943,-0.8472964779361531,0.8192771084337349,0.9966724699185033,1.0,26/141,17.53%,SOCS3;STMN2;RCAN2;GRIN2A;PLP1;GRIA3;OPALIN;GAP43;GFAP;TCEAL6;IGSF21;CA10;TCEAL2;FGF1;SYNM;ADCY5;C11ORF87;BAALC;SYNPR;RGS7BP;TMEM132C;CNTN2;PHYHIP;TCEAL5;ADCY8;ETS1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.43419270063728904,-0.8463728659757288,0.7333333333333333,0.9979307197339812,1.0,1/21,1.95%,GRIN3A
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.5400646922143004,0.8463012352228997,0.7441860465116279,1.0,1.0,3/6,24.42%,APEH;VPS4B;ABCE1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),0.39034595451377047,0.8462000322624388,0.7631578947368421,1.0,1.0,6/24,9.38%,SOX8;SOX9;LHFPL2;NCOA4;AR;MSH2
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.4954331429124951,-0.846178797050376,0.7090909090909091,0.9974226819662485,1.0,3/8,16.90%,WDR1;ANK1;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.4954331429124951,-0.846178797050376,0.7090909090909091,0.9974226819662485,1.0,3/8,16.90%,WDR1;ANK1;CRB2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5146843688016893,-0.8461710096249854,0.6984126984126984,0.9970185970513953,1.0,3/9,15.47%,GCNT1;SELP;ADD2
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.4075240675980294,-0.8459390714132852,0.5789473684210527,0.9971320010490808,1.0,7/18,25.05%,APP;SCN2A;CDK5;TRPC5;FAM162A;SIAH1;FAS
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.5908421086253222,-0.8455947863298138,0.7142857142857143,0.9973494912870042,1.0,1/5,0.67%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.5125559955556045,0.8453646699480667,0.7,1.0,1.0,2/7,14.00%,PPP1R10;MDK
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.39754162755753353,-0.8453643271784975,0.7236842105263158,0.9973665253348071,1.0,8/48,14.21%,PLK2;ANGPTL3;WNT5A;DAB2IP;HECW2;GPC3;VIP;OAZ2
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.33553360646435565,-0.8453407128562901,0.8313253012048193,0.996987185579676,1.0,27/138,20.77%,TRIM22;TRIM5;PLK2;HTR2B;NOD1;BST2;BIRC3;PINK1;SHISA5;TNIP2;MAP3K14;FADD;TNFRSF1A;APOL3;CD74;LTBR;HLA-DRB1;PRKCB;ALPK1;RIPK2;CARD11;CD4;LGALS1;CX3CL1;CASP8;TRIM62;IKBKG
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),-0.5583728224581311,-0.8452738774406284,0.7090909090909091,0.9967202269198542,1.0,2/6,24.13%,PTPRF;PTPRD
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2911639196604786,0.8451004910508153,0.9411764705882353,1.0,1.0,25/108,21.24%,GDAP1;SRPRB;ZDHHC14;ZDHHC11;TRAK2;MFF;VPS37A;ZDHHC18;AP1S3;TOMM22;TAOK2;ZDHHC20;VPS37B;ZDHHC21;TIMM23;GOLGA7;ZDHHC11B;PEX6;ZFAND6;RAB3IP;ICMT;PEX12;PIKFYVE;KATNB1;ZDHHC6
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4788729886515523,0.8450046354412944,0.7674418604651163,1.0,1.0,1/11,0.08%,MEOX2
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5219161842099898,0.8449654751882947,0.7142857142857143,1.0,1.0,2/5,9.89%,ACADM;ABHD1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.4549631923299062,-0.8448157669189422,0.676923076923077,0.9971255269812763,1.0,1/18,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.40838267758418867,0.8448087515449401,0.6875,1.0,1.0,4/16,16.77%,ELOVL6;ELOVL2;HACD2;ACSL3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.447345575173264,0.8446669743270102,0.65625,1.0,1.0,4/13,24.99%,LPIN3;CEPT1;ETNPPL;CHKA
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.29172513664575045,0.84434134794905,0.9333333333333333,1.0,1.0,21/147,14.00%,LIMD1;CXXC4;AMER2;BMP2;PSMD10;BICC1;CCDC88C;PSMA1;GREM1;PSMD11;SOX9;PSMB5;STK4;KLHL12;INVS;PSMD14;TAX1BP3;DVL2;PSMD12;TMEM170B;MDK
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.2785605397788007,0.8441905162630226,0.9333333333333333,1.0,1.0,26/153,15.51%,DGKB;PIP5K1B;PLD6;DGKE;PI4K2A;PIK3R4;ABHD5;CPNE3;CSNK2A1;PTDSS1;CHPT1;CSNK2A2;PLA2G4C;SACM1L;LPIN3;PIK3C2G;PLEKHA3;PIK3C3;RAB4A;PIK3CA;GNPAT;FIG4;PIK3R1;PIP4K2B;DGKH;CPNE1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3973371438849268,-0.8439053181322144,0.7397260273972602,0.9985260881177923,1.0,3/40,8.69%,HELB;POLQ;WAS
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.40048043223055224,0.8431410832808525,0.5609756097560976,1.0,1.0,7/19,21.00%,TFB2M;TFB1M;ZCCHC4;METTL15;NSUN3;FBL;MRM3
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5138531791628906,0.8422734532455473,0.7073170731707317,1.0,1.0,2/6,14.52%,MSH2;MSH3
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),0.44882380196820776,0.8422575015588237,0.5681818181818182,1.0,1.0,2/9,4.42%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.4182591053673379,-0.8420906620557218,0.7123287671232876,1.0,1.0,1/22,2.93%,GMPR
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.4838676674954857,-0.8420107730906731,0.6551724137931034,1.0,1.0,4/9,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.3451822759132539,-0.8419706398177675,0.8414634146341463,1.0,1.0,14/110,16.99%,SOCS3;MTMR7;ITPKC;INPP5D;VAC14;SBF1;PLEKHA4;BMX;PITPNM2;PIK3CB;PGAP2;PIK3CD;PIGA;PIGH
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.3766182784073511,0.8419222630471328,0.7,1.0,1.0,1/22,0.97%,DSCAM
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),0.52061524900383,0.8418037921819433,0.6428571428571429,1.0,1.0,2/5,11.43%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.41139723889258595,-0.841659571104425,0.7530864197530864,1.0,1.0,3/33,6.56%,PROX1;BRCA1;CEACAM1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.3548161905183522,-0.8415739625335319,0.7948717948717948,1.0,1.0,17/84,17.02%,KCNQ1;RIMBP2;APLNR;ANK3;MAOB;SHC2;LGR5;ADCY5;IGFBP5;SLC44A3;ITGA9;RASL12;TMEM132C;ZNF704;RAI2;SYT13;LRIG1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.43241850426215545,0.8414973313974928,0.6216216216216216,1.0,1.0,3/14,9.15%,PLIN5;AUP1;PLA2G4C
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.4637308686468315,-0.8413988875297992,0.6290322580645161,1.0,1.0,5/16,17.95%,CCL2;PLK3;IGF1;TSC2;TGFB1
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.4411306823159534,0.841232545207809,0.75,1.0,1.0,4/12,35.04%,SNX2;SNX1;SURF4;TRAPPC10
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.5349058620223879,0.841126892241524,0.6666666666666666,1.0,1.0,1/6,1.36%,DCHS1
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.27602237990767214,0.8410473680421141,1.0,1.0,1.0,71/445,16.55%,SPSB4;RNF6;ERCC8;RNF25;FBXO45;KLHL8;SPSB2;IRF2BP1;UBE2T;PSMD10;BCL10;RFWD3;ELOC;PSMA1;MSL2;MKRN3;PSMD11;TRIM24;KEAP1;PHC1;FBXL14;PEX13;CUL1;UBE2N;PSMB5;COMMD1;VCP;BLMH;RNF103-CHMP3;RNF146;RNF14;FBXO30;FBXL3;LMO7;FBXO9;UBE2G1;FBXO15;BTRC;PLK1;KLHL12;DTX4;RNF114;UBE2D1;RCHY1;PSMD14;RNF141;SASH1;DERL1;SH3RF1;CUL2;TSPAN17;FBXO27;TMEM129;PSMD12;FBXO10;UBE4A;MUL1;PEX2;PPIL2;RNF26;UBE3B;FBXO21;RNF11;CBLL1;RC3H1;FBXL17;MARCHF7;TRIM3;VPS11;KLHL24;HERC2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.49686749681924086,-0.8410454789131518,0.7017543859649122,1.0,1.0,4/10,25.60%,STX19;STX1B;STX3;STX4
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.4215410601604705,-0.8408898309117507,0.6323529411764706,1.0,1.0,3/17,12.44%,GADD45A;PAQR3;DMTN
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.4164107092637888,-0.8407271703006675,0.7230769230769231,1.0,1.0,5/31,18.14%,NEFL;HAP1;DCTN1;SYBU;MAPT
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3018175607925628,0.8406347387710462,0.8461538461538461,1.0,1.0,27/70,30.04%,U2AF1;NUDT21;WDR33;CSTF3;CPSF6;PAPOLA;CPSF7;MTPAP;THOC3;THOC1;TENT4B;CLP1;RPRD1B;CPSF2;SSU72;PAPOLG;SRSF9;CSTF1;MAGOH;RPRD2;SRSF2;TENT2;POLR2D;SCAF8;MAGOHB;PABPC1;CSTF2T
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.37735406176823616,0.8406171914145011,0.6285714285714286,1.0,1.0,4/21,4.32%,PSMD10;SPRED1;SMYD2;KMT5A
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.44715800926729954,-0.8405725270205341,0.7321428571428571,1.0,1.0,5/20,15.79%,TYMS;SPON2;CCNB1;P2RY10;STMN1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.3919390772907744,-0.8404873687148916,0.7532467532467533,1.0,1.0,8/46,13.56%,MYOF;DYSF;SRF;IGF1;WNT5A;FGF1;MYH9;SLC11A1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.4566940382490482,0.8402576142569536,0.6923076923076923,1.0,1.0,2/11,2.51%,GABRA4;GABRG1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.40818252810228445,-0.8397627645315632,0.7121212121212122,1.0,1.0,6/27,14.44%,RPS14;HELB;RPS16;RPS8;RPS21;TSR2
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.531011957225269,-0.8395158409316268,0.7307692307692307,1.0,1.0,1/5,10.12%,SCIMP
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.3876056292023996,-0.8394249438656721,0.6557377049180327,1.0,1.0,5/28,17.79%,P2RY12;DMTN;RHOD;VCL;PTPRO
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.3762192225120129,-0.8393249590449164,0.7733333333333333,1.0,1.0,7/61,11.12%,CDKN2A;NLRP12;KLF4;NLRC5;CYP1B1;NLRP2;DAB2IP
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.2567905170680532,0.8392527737037581,1.0,1.0,1.0,64/351,20.88%,LIMD1;MACIR;FHDC1;CEP19;SPAG16;BBS9;EIF2S1;RAB23;SSX2IP;EXOC8;CEP20;GORASP2;EXOC6;HAUS1;STX7;SNF8;INTU;DZIP1;CNGA4;CEP290;AUP1;VPS37A;RAB8B;PTPN23;PLA2G4C;FOXJ1;VTA1;PARVA;RAB1B;PCM1;EDC3;PRRC2C;PIK3C3;G3BP1;CHMP2B;SCLT1;TEKT5;E2F4;TTC8;VPS37B;NEK1;UNC119B;TCTN3;IQCB1;RAB8A;RC3H1;TMEM237;VPS4B;UBXN10;MKKS;SNAP29;EXOC5;YTHDF2;CHMP6;RUFY4;GOLGA8N;PATL1;RAB3IP;SEPTIN6;UBAP2L;WDR11;BBS2;TMEM138;CEP83
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.4439520329346711,-0.8391011369498401,0.7397260273972602,1.0,1.0,5/22,10.38%,DOK1;PTK6;HAP1;EGF;TGFA
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.37895165564569105,0.8387435522686197,0.6551724137931034,1.0,1.0,6/22,21.58%,PDE12;CSTF3;POP1;TOE1;ERN1;ZC3H12C
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.48224763395757664,-0.838717352598956,0.6666666666666666,1.0,1.0,1/8,3.00%,SLC39A14
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.3756567721196797,-0.8386788194070576,0.75,1.0,1.0,3/64,5.04%,TRAM1L1;SHTN1;APP
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.34616739195469537,0.8386218544314508,0.6774193548387096,1.0,1.0,6/41,9.72%,ASCL1;BRINP3;SOX9;RORB;ADNP2;TRIM16
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.29967198701301134,0.8385828751659907,0.75,1.0,1.0,27/109,15.08%,PCDH19;TSPAN11;ADGRA1;SNAP91;SPRY1;PDGFD;ADGRB3;MAPK10;TMEM47;EFS;GRIA2;NOVA1;FAT3;MEGF10;ATP1A2;PCDH17;CNTFR;GPM6B;ANK2;EMX2;TMEM35A;SLC6A1;SHC3;FAIM2;NDRG4;SLC35F1;PURG
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.5871320534086494,-0.8383067703847913,0.7586206896551724,1.0,1.0,3/5,31.23%,MAPT;HDAC6;BAG3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.31923220172775224,0.8381481740971357,0.7916666666666666,1.0,1.0,4/66,3.46%,FGF6;GALNT3;SPRED1;NDNF
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.34921710923531885,-0.8380136450493458,0.7468354430379747,1.0,1.0,19/75,20.35%,POU4F1;KCNB1;KIF14;CCL2;PRKCG;MAG;UNC5B;PINK1;GRID2;BDNF;NRBP2;CLN3;SNX6;CDK5;NUPR1;VSTM2L;FOXB1;SET;NSMF
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),-0.44044076603130233,-0.8375660500412588,0.7678571428571429,1.0,1.0,2/16,9.91%,PTP4A3;TCP1
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.48215089388770377,-0.8373706181167803,0.7619047619047619,1.0,1.0,3/9,8.11%,GAS2L3;BAIAP2;BAIAP2L1
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.42732003039934563,-0.8373367806404352,0.6956521739130435,1.0,1.0,5/19,20.15%,YWHAH;PPP3CC;NMT1;BBC3;CASP8
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.42732003039934563,-0.8373367806404352,0.6956521739130435,1.0,1.0,5/19,20.15%,YWHAH;PPP3CC;NMT1;BBC3;CASP8
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.5075178636942641,-0.8370894934070878,0.7166666666666667,1.0,1.0,1/10,3.62%,RAMP3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.41477779974218476,-0.8370469872232885,0.7236842105263158,1.0,1.0,5/41,16.68%,HIC1;BRCA1;BCL2L2;BOK;PML
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.5376997317874624,0.836955658845165,0.6818181818181818,1.0,1.0,3/5,23.79%,HEY1;HEY2;RBPJ
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.5376997317874624,0.836955658845165,0.6818181818181818,1.0,1.0,3/5,23.79%,HEY1;HEY2;RBPJ
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.5149546933232035,-0.8366366820773662,0.6545454545454545,0.9999424757105957,1.0,1/6,11.45%,MAPRE2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.5149546933232035,-0.8366366820773662,0.6545454545454545,0.9999424757105957,1.0,1/6,11.45%,MAPRE2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.47951401560786955,-0.8365580300351035,0.7045454545454546,0.9996540930385454,1.0,3/6,8.52%,COL5A1;ITGA5;PLET1
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.44729510941908024,0.8363182068383364,0.5789473684210527,1.0,1.0,4/11,19.81%,TTL;AGBL1;GPLD1;ICMT
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.40031410085038666,-0.8360278939503131,0.7466666666666667,1.0,1.0,7/37,17.84%,DUSP1;CAV3;DAB2IP;PAQR3;PIK3CB;PRKCD;HIPK3
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.5511163362524022,-0.8359909534593387,0.75,0.999445110588951,1.0,1/5,12.81%,CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.5511163362524022,-0.8359909534593387,0.75,0.999445110588951,1.0,1/5,12.81%,CD63
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.3903183246124954,-0.83570429411092,0.6712328767123288,0.9996265578871112,1.0,8/35,18.04%,PODXL;CEACAM1;MINK1;RNASE10;SPINT2;PTPRR;TGFB1;FERMT3
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.3993699959599523,-0.8356628650341025,0.6805555555555556,0.9992916367753886,1.0,4/29,5.98%,CDH23;SCN9A;CLRN1;CCL2
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3734184549414146,-0.8353525109477659,0.7558139534883721,0.9994414838587548,1.0,5/62,7.50%,CTAGE14P;ART3;CTNNA3;GCM2;SYNPO2L
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.4819098391220762,0.8352890182247313,0.6444444444444445,1.0,1.0,1/6,7.52%,GMPS
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.4333831165352803,0.8351922734485856,0.696969696969697,1.0,1.0,5/16,21.18%,NUDT21;CPSF6;CPSF7;FARSB;PKD2
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.4937540655173851,-0.8351014874424174,0.7868852459016393,0.9994967103780567,1.0,6/15,30.69%,SNRNP200;SNRPC;WBP4;DDX23;NCBP2;PSIP1
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),-0.5632428713308294,-0.8350824525250232,0.7192982456140351,0.9991150452122822,1.0,2/5,17.95%,EGF;TGFB1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.43249929870262493,-0.8348611590613011,0.7101449275362319,0.9991310248682732,1.0,4/16,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4763811103301565,0.8346924377342044,0.6170212765957447,1.0,1.0,2/10,10.09%,BTRC;PLK1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.4916096555791408,-0.8340482363035399,0.6949152542372882,1.0,1.0,1/12,1.31%,FABP3
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4306791442968999,0.834037250935021,0.7209302325581395,1.0,1.0,2/13,12.98%,SNAP91;WASL
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.46510962644069487,0.8339103422998719,0.6818181818181818,1.0,1.0,2/8,7.22%,SIGMAR1;DISP1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.46510962644069487,0.8339103422998719,0.6818181818181818,1.0,1.0,2/8,7.22%,SIGMAR1;DISP1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.3346055955017138,0.8338334155515843,0.6666666666666666,1.0,1.0,4/30,12.58%,BMP2;FBXO5;GPM6B;ACVR2A
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.42836398142792304,-0.8338153912501549,0.6268656716417911,1.0,1.0,2/24,6.56%,C3;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),0.5137692854387168,0.8338012510504171,0.7045454545454546,1.0,1.0,3/6,14.00%,NOTCH2;STXBP4;MDK
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5508373763245454,-0.8337649203222343,0.7586206896551724,1.0,1.0,3/5,16.72%,ABCB1;PDZK1;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3423036972328776,0.8336131506341744,0.7878787878787878,1.0,1.0,14/34,27.65%,PHC1;RNF2;EED;YAF2;RBBP4;MGA;PHC3;EHMT1;PCGF2;EPC1;FOXO4;E2F6;TFDP2;EZH2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.34663355903429083,-0.833573959970276,0.7285714285714285,0.9999841729754568,1.0,15/80,18.28%,CDKN2A;GPNMB;KLF4;CCL2;GFI1B;PSMB9;PSMB6;PSMC3;PSMA8;PSMA7;WEE1;PSME1;RBX1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.48693106674425657,-0.8334162219979139,0.6727272727272727,0.9998309526304086,1.0,4/9,32.22%,SREBF1;SEC14L2;SREBF2;RAN
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.40447088498692507,-0.8329795417735248,0.7313432835820896,1.0,1.0,4/28,10.01%,WNT8B;TESC;PTK6;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.3111430635210593,0.832876294693114,0.7272727272727273,1.0,1.0,10/56,12.84%,WNT7A;AGER;SERPINF2;DUSP19;HMGB1;TIRAP;MAP4K2;TAOK2;SH3RF1;TAOK3
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.5263722974976295,-0.8325929555698158,0.6545454545454545,1.0,1.0,2/5,22.98%,HES1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.46443597415072735,-0.8321016951860674,0.7352941176470589,1.0,1.0,4/13,17.15%,APP;AKAP5;RELN;ADCY8
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.40779180700762574,0.8320535518266121,0.7631578947368421,1.0,1.0,4/19,12.09%,MCU;MAIP1;LETM1;MICU2
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.40929142797195434,0.8318348620592443,0.631578947368421,1.0,1.0,5/17,13.02%,AGMO;GK;MOGAT1;LPIN3;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.35924768327083606,-0.8317457296695506,0.7297297297297297,1.0,1.0,13/58,18.19%,CDKN2A;DUSP1;BTG3;HEXIM1;TSPYL2;BTG1;TFAP4;NR4A1;NUDT6;GPER1;GMNC;TGFB1;NUPR1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.35496142117295526,0.8315350456407805,0.85,1.0,1.0,4/28,10.03%,CHST11;CSGALNACT1;GAL3ST4;EXT2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.4587118534665704,0.8314789743554276,0.6976744186046512,1.0,1.0,2/8,17.71%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.4587118534665704,0.8314789743554276,0.6976744186046512,1.0,1.0,2/8,17.71%,ERI1;EXOSC8
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.3434643731233445,-0.8314236996864026,0.7631578947368421,1.0,1.0,3/71,5.04%,CP;SLC39A14;APP
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.3461733175460675,-0.8314101949111428,0.8378378378378378,1.0,1.0,27/105,20.39%,FLRT3;RIMBP2;STMN2;RCAN2;PROX1;MAOB;SYT4;ATP1B1;PLPPR1;SST;SHC2;IGFBP5;GPC5-AS1;APOBEC2;RGS7BP;SEMA3E;PCP4;SYT13;FGF12;SYBU;PPP1R9A;ST8SIA3;CNTN4;ABCC9;PLPPR4;PAK5;PCDHB4
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.4419571750267075,0.831403914778779,0.6410256410256411,1.0,1.0,4/8,17.67%,CNOT9;CNOT2;VPS11;CNOT1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.367087930427628,-0.8310729586787562,0.8133333333333334,1.0,1.0,5/53,7.17%,MET;TIMP2;HTR2B;NELL1;TIMP1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5651650264852669,-0.830970910391647,0.8113207547169812,1.0,1.0,1/5,2.09%,ANK3
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),-0.5651650264852669,-0.830970910391647,0.8113207547169812,1.0,1.0,1/5,2.09%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.344313732350927,-0.8307690324801662,0.7857142857142857,1.0,1.0,22/105,17.95%,THBS1;MET;P2RY12;RAMP3;EGF;CHI3L1;THPO;TGFA;FGF1;PINK1;IL18;F10;FGF7;PIK3CB;VAV1;PIK3CD;F3;FGF22;IRS2;TEK;LRP2;TGFB1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.44882725371799403,-0.8305873270138074,0.6825396825396826,1.0,1.0,3/15,19.36%,WNT5A;MFSD2A;MYO9A
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),0.5051459124698421,0.8305555968916937,0.7450980392156863,1.0,1.0,1/5,5.84%,FAM3A
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3402039845023831,-0.8304493820853928,0.7647058823529411,0.9999864630074397,1.0,12/108,12.54%,CDKN2A;SP100;PROX1;NLRP12;KLF4;NLRC5;CYP1B1;NLRP2;DAB2IP;SFRP4;SIGIRR;PIM1
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),0.5110556260733613,0.8300739932855083,0.6666666666666666,1.0,1.0,2/6,13.32%,PGM2;GALT
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.33419351581106727,0.8300440383152702,0.7777777777777778,1.0,1.0,9/40,24.54%,SIRT6;MIER3;SIRT5;PRDM5;HDAC2;HDAC10;MIER2;MTA2;SIRT2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.3620347489212047,-0.8299825079561229,0.775,1.0,1.0,10/57,18.28%,B2M;IFIT1;TMC8;ZFPM1;LRPAP1;CTSZ;IFIT2;PRKCD;PTPRF;CDKN1A
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.41684207334823403,-0.8298954769467499,0.6290322580645161,1.0,1.0,4/23,13.19%,EFNA1;ELN;SLIT3;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.3698023481543029,-0.8295862903129314,0.8648648648648649,1.0,1.0,18/86,21.38%,KCNB1;IL12A;ITPR3;GIPR;IGF1;RHBDF2;CELA2A;CACNA1C;ACHE;RHBDF1;GLP1R;MYO18A;TGFB1;KCNC2;TMED10;RSAD2;ITPR1;ADAM8
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.3193032241720642,0.8295224298192275,0.8387096774193549,1.0,1.0,6/61,6.72%,NR1D1;BMP2;TRIB3;ANKRD26;AKT1;LMO3
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.43302542495437113,-0.8290160560589246,0.7910447761194029,1.0,1.0,6/23,19.95%,ANK3;UNC13C;DCTN1;CACNB1;AGRN;DOK7
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.3597749509218367,-0.8290107955056254,0.7215189873417721,1.0,1.0,18/78,17.49%,OGN;CSPG4;CEMIP;HS3ST3A1;BGN;OMD;ST3GAL6;B3GNT2;CHST15;GPC3;HYAL1;B4GALT7;CHSY3;CHST6;HS3ST3B1;HS6ST1;GPC1;PXYLP1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3623475041144036,0.8285673636724472,0.7419354838709677,1.0,1.0,10/35,30.02%,ATF5;EFNA5;MARK2;MAP6;KLHL42;PRKAA1;MEMO1;CLASP2;BICD2;TRAF3IP1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.36152952604707367,0.8282049554590982,0.6923076923076923,1.0,1.0,6/23,19.35%,MOSMO;VCP;BTRC;KCTD21;HERC4;GLI3
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.47208901420109206,-0.8277882046137004,0.6885245901639344,1.0,1.0,1/11,8.20%,SPAG17
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.5733760741594802,-0.827726184598025,0.7962962962962963,1.0,1.0,2/5,12.60%,ARG2;NOS1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.31758022555817755,0.8276454314435501,0.8387096774193549,1.0,1.0,5/55,6.89%,PSMD10;PSMA1;PSMD11;CUL1;PSMB5
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3642595990332085,0.8275471431047707,0.6764705882352942,1.0,1.0,6/28,17.74%,FLT3;RABL3;MSH2;SLC25A5;DCAF1;CEBPG
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.48732712610312756,-0.8273361321436958,0.7666666666666667,1.0,1.0,3/12,21.46%,FSCN1;MYO9A;PATJ
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.46829739965348904,-0.8268890737274202,0.7115384615384616,1.0,1.0,3/11,20.05%,PARP9;NAMPT;NNMT
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.438668161232165,-0.826670128525787,0.7272727272727273,1.0,1.0,4/14,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.4741753297299275,0.826448393912252,0.7142857142857143,1.0,1.0,1/7,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.5488001450112414,-0.826429021443006,0.7090909090909091,1.0,1.0,5/6,18.19%,NR4A3;SGPP2;NR4A1;PTPRN;NUPR1
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.47463615862587294,-0.8264152901327677,0.6885245901639344,1.0,1.0,2/12,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.36685534882889453,0.8262186125009195,0.7105263157894737,1.0,1.0,4/23,12.58%,ABCB10;HSPA1A;ANKRD54;ACVR2A
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.4193346032897328,-0.8261084189596055,0.782608695652174,1.0,1.0,2/17,6.29%,BLM;BRCA1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3436297098814225,-0.8260682691670292,0.7875,1.0,1.0,14/64,19.94%,SP100;PLK2;PLK3;GADD45A;ARID3A;CCNB1;NDRG1;FOXM1;TFAP4;PML;RPS6KA6;CDKN1A;KAT5;ZNF385A
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5167472344695287,0.8258860877106141,0.75,1.0,1.0,1/7,1.56%,AGER
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.46451015310931354,-0.8256409836655778,0.7142857142857143,1.0,1.0,5/11,19.12%,CEACAM1;APOD;CCDC3;GPER1;ALK
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3396170019793082,0.8256302969936264,0.7931034482758621,1.0,1.0,22/47,26.55%,CDC25A;EIF2S1;YY1;ATR;PTPRK;EIF2AK4;POLK;SMPD1;EP300;NOC2L;RHBDD1;GNGT1;TRIAP1;USP47;N4BP1;PARP1;ZBTB1;ERCC4;BAK1;SDE2;INO80;USP28
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.356127099737575,-0.8251791928651631,0.7764705882352941,1.0,1.0,12/72,18.23%,DUSP1;GBP1;PSCA;CAV3;DAB2IP;FOXM1;PAQR3;PIK3CB;PRKCD;PTPRR;GPER1;RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.3463832029868494,-0.8247709745643388,0.8028169014084507,1.0,1.0,6/59,13.35%,DUSP1;PODXL;CYP1B1;ARHGDIG;DMTN;SPINT2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.5074957510897886,0.8246525141393429,0.717948717948718,1.0,1.0,1/7,0.89%,CFAP53
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5142003843916136,0.8246366894071878,0.7441860465116279,1.0,1.0,3/5,28.21%,PMPCA;IMMP2L;MIPEP
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.39846498556625287,-0.8243427895285144,0.7777777777777778,1.0,1.0,2/32,6.99%,NEFL;HAP1
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.4606021170333898,0.8240689567623697,0.725,1.0,1.0,3/7,26.86%,KMT2A;KMT2C;SETD4
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.4832246750208773,-0.8240529261080364,0.696969696969697,1.0,1.0,3/8,18.59%,APLN;OXTR;FOXB1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.3826117031101435,0.8239841269822277,0.6842105263157895,1.0,1.0,4/20,22.66%,INSC;PLK1;GJA1;UBXN2B
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.4072506279720787,-0.8239583752959689,0.7540983606557377,1.0,1.0,8/28,19.00%,BAIAP2;BAIAP2L1;FES;SEMA3E;TEK;CDK5;DAPK3;PDGFRA
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),0.5065394388007773,0.8236489206263777,0.6923076923076923,1.0,1.0,1/5,6.32%,AOX1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3172355388734645,-0.8233071580125224,0.8888888888888888,1.0,1.0,33/178,20.77%,TRIM22;TRIM5;PLK2;NLRP12;HTR2B;NOD1;BST2;STAT1;WNT5A;BIRC3;DAB2IP;PINK1;SHISA5;TNIP2;CARD19;MAP3K14;FADD;TNFRSF1A;APOL3;CD74;LTBR;HLA-DRB1;PRKCB;ALPK1;RIPK2;CARD11;CD4;NLRC3;LGALS1;CX3CL1;CASP8;TRIM62;IKBKG
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.38715264121322895,-0.8230479541224579,0.7671232876712328,1.0,1.0,1/42,0.33%,THBS1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.36511631238005265,-0.8229568232927748,0.7916666666666666,1.0,1.0,14/67,18.14%,DHCR24;KIF14;SNCB;GPNMB;WNT5A;CTSZ;GRIN2B;GRID2;HLA-F;FOS;SNCG;CD200;CDK5;MAPT
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.34494407332278054,-0.8223283575208659,0.7808219178082192,1.0,1.0,8/105,12.71%,KDELR3;IFIT1;RPS14;ATF3;CCL2;TSPYL2;DCTN1;MTHFD2
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.5626105089843663,-0.822303024870782,0.74,1.0,1.0,3/5,18.51%,PDZK1;SLC22A4;SLC25A29
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.44467186880819254,0.8222975679082891,0.7142857142857143,1.0,1.0,4/11,21.74%,CCT7;CCT3;DKC1;MEPCE
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.44467186880819254,0.8222975679082891,0.7142857142857143,1.0,1.0,4/11,21.74%,CCT7;CCT3;DKC1;MEPCE
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.43249226233252763,0.8221380107322045,0.6923076923076923,1.0,1.0,4/14,15.62%,BMP2;MDK;SERPINE2;ID2
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),0.473479299647681,0.8219777349564944,0.6341463414634146,1.0,1.0,2/6,18.44%,RFT1;NPC2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.36779324448321876,0.8219107792347822,0.5882352941176471,1.0,1.0,1/21,0.33%,SLC2A5
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.36304289295783104,-0.8213561829577721,0.8311688311688312,1.0,1.0,10/49,19.00%,PRDX5;APOD;PLK3;ROMO1;FOS;TXNRD2;HYAL1;PTPRN;MAPT;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3711092376255939,-0.8213370844120509,0.7714285714285715,1.0,1.0,7/38,12.36%,TLR2;APP;TLR3;WNT5A;SCIMP;SYK;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.5066773255733693,0.8211906195868744,0.6808510638297872,1.0,1.0,2/6,36.93%,PARD6A;GSK3B
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.32896861216694057,-0.8205400274946749,0.925,1.0,1.0,26/169,18.92%,CCNB2;CDKN2A;SUV39H1;NAA38;PRDX4;BRCA1;PMS2;CENPE;DONSON;LMNB1;WDR90;POLE4;RPA3;SPC24;KIF2C;MTHFD2;RPA1;CDKN3;UBE2S;STMN1;WEE1;POLD1;CDKN1A;CDCA3;JPT1;SHMT1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),-0.5239674634381691,-0.820533874175734,0.7586206896551724,1.0,1.0,2/6,27.42%,CDKN1A;TP53
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.5559615562485652,0.8201567921322008,0.8529411764705882,1.0,1.0,2/5,33.02%,MTRES1;NEMF
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.34080937068613876,0.8199048883450558,0.7666666666666667,1.0,1.0,4/39,7.43%,POLD3;PRIMPOL;RFC3;VCP
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),0.4879474505691987,0.8198229454126491,0.7435897435897436,1.0,1.0,2/5,29.38%,NOL8;WRN
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.29890657344776284,-0.8197692419576723,0.97,1.0,1.0,115/835,17.95%,ANXA1;CP;THBS1;SOCS3;C3;DUSP1;SERPINA10;B3GALT2;CHGB;TGFBR2;MTMR7;LAMB1;VRK2;PLK2;PHEX;ART3;RAB11A;ASB16;CHST4;MAP3K6;APP;FLG;CCL2;PIM3;FUT2;PARP14;PTK6;SBF1;NUAK2;TIMP1;PP2D1;GLRX;PSMB9;SERPIND1;NOTUM;PARP9;F13A1;FBXL18;PDK1;PRKCG;ST3GAL6;MAK;FAM20C;FBXW12;SPSB1;FAM20A;MINK1;B3GNT5;CHRM3;FBXO32;PPP3CC;PTPN7;ISG15;PDK3;IGFBP7;OGFOD1;PSMB6;USP6;NUAK1;SYK;FN1;FBXW10;BMX;B3GNT2;GAD1;PINK1;SHISA5;BAP1;LIPE;PSMC3;PRSS23;IGFBP5;PRKCH;PIM1;DUSP16;STRADB;GPC3;ASB14;HERC5;F5;NEK10;MYLK3;WDR45;ELOB;ST6GALNAC2;B4GALT7;AATK;UBE2S;COQ8B;PSMA8;GLYCTK;PLAT;PRKCD;PIK3CD;CDK2;ITIH2;PSMA7;NRBP2;PTPRR;ALG1L2;PIGH;FBXL2;PRKCB;PTPRF;PSME1;SPP1;CDK5;RBX1;LTBP1;LIMK2;PTPRO;FBXL13;HIPK3;DAPK3;TGFB1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.41817897598804016,-0.8197344479604062,0.8235294117647058,1.0,1.0,4/25,14.68%,SULF1;NOTUM;SFRP4;PPIB
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.49926514213023937,0.8190162365329393,0.6829268292682927,1.0,1.0,5/8,15.21%,LEPR;GNB3;EIF2AK4;UCN;SGIP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.44005158351037615,-0.8188477519854744,0.6666666666666666,1.0,1.0,5/14,24.09%,CD44;CD74;ZNF385A;TAF9B;PTTG1IP
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4434902279324635,0.818720668696981,0.7931034482758621,1.0,1.0,2/9,18.84%,HOMER2;DYRK2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.4434902279324635,0.818720668696981,0.7931034482758621,1.0,1.0,2/9,18.84%,HOMER2;DYRK2
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),0.45586725187842264,0.818582651627378,0.7142857142857143,1.0,1.0,2/10,5.99%,PDE3B;ABCD1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.4330394752545937,-0.8182416815170593,0.7903225806451613,1.0,1.0,1/24,0.55%,TYMS
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.352603707151231,-0.8181965629059798,0.8028169014084507,1.0,1.0,17/75,20.50%,MET;VAC14;NLRC5;LDB2;TSPYL2;EMP2;CD74;HLA-DRB1;IRS2;TEK;MAPT;CD4;PLCE1;PDGFRA;ALK;ZNF16;CDKN1C
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.29921118133238084,0.8180659241441747,0.9047619047619048,1.0,1.0,16/56,20.79%,RGCC;CNOT9;RFWD3;PCBP4;PLAGL1;CNOT2;CRADD;E2F4;EP300;CNOT8;CNOT6L;CNOT1;CNOT4;MDM2;TRIAP1;CASP2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.40039524152439576,-0.8179642226069493,0.7910447761194029,1.0,1.0,13/42,18.05%,SERPINA10;ALDOB;BHMT;ANGPTL3;DIO1;SLC3A1;SLC16A11;PDZK1;CYP3A4;ADH4;ITIH2;CYP3A5;PAH
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.4195703861463465,-0.8179536604957928,0.7230769230769231,1.0,1.0,8/22,19.50%,SLC32A1;SLC18A2;CPLX1;PLD2;CPLX2;NLGN1;CDK5;SLC17A7
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.4766709715801828,-0.8176984489261,0.6984126984126984,1.0,1.0,3/13,18.53%,BRCA1;RAI2;CELF4
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.35410243677276365,-0.817646065500608,0.8333333333333334,1.0,1.0,5/65,10.43%,A4GALT;ABCA8;FA2H;SGPP2;CYP4F22
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.4366470648244122,0.817598652129618,0.6578947368421053,1.0,1.0,1/11,1.02%,TMEM100
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.47222940621891535,-0.8172474899378588,0.7272727272727273,1.0,1.0,2/11,19.59%,ARPC5L;ARPC3
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.42337334019491063,0.8170682034138463,0.7142857142857143,1.0,1.0,5/8,23.80%,ADO;TST;PON1;CTH;TXN2
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.40480625814898463,0.8170643019236934,0.7222222222222222,1.0,1.0,4/16,9.69%,SLC30A4;SLC30A6;SLC39A8;SLC30A9
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.3498214685647949,0.8168139457864956,0.8787878787878788,1.0,1.0,3/22,8.54%,ZNF658;SLC30A4;MT1E
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4012827921319624,-0.8161516536049572,0.8181818181818182,1.0,1.0,1/32,1.13%,POU4F1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.3522349212478645,-0.8161038425605751,0.7808219178082192,1.0,1.0,4/60,4.84%,RFTN1;RAB11A;ZDHHC9;ZDHHC22
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2769631653016923,0.8155555128496591,1.0,1.0,1.0,65/263,23.14%,TBC1D4;ABHD17A;TMED5;ARFIP1;ID1;OCLN;RAB23;COX18;SCFD2;TBC1D12;EGFR;ARL5A;RABL3;SEPTIN11;STX7;DNAJC27;ARFIP2;FOXJ1;C17ORF75;RAB22A;RAB1B;PTPRK;NIPBL;AP3B1;ANK2;TRAPPC8;RAB28;COPB2;SNX31;SCFD1;SEC23IP;NAPB;TBC1D5;SEC31B;TMED3;RAB21;SNX27;TBC1D8B;ARCN1;HERC2;RIC1;DMD;EVI5L;TBC1D22B;HEY2;SEPTIN6;TMED2;PRRT1;ITSN1;WDR11;BBS2;TBCK;GJA1;RAB18;VPS29;RAB31;AMOT;PIGU;RUNDC1;RABL2A;ERP29;LAMTOR3;TLK1;TM9SF3;SNX17
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),0.4173331043029916,0.815300995591922,0.8048780487804879,1.0,1.0,3/12,10.09%,RIOK2;ANAPC1;PLK1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3844124952420865,0.81513792982445,0.717948717948718,1.0,1.0,11/24,31.30%,KAT2B;NAA11;EP300;GTF2B;NAA50;CLOCK;NAT10;NAA15;NAA35;DSCC1;SIRT1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.42471279357650527,0.8149963653260923,0.6170212765957447,1.0,1.0,4/13,15.88%,TNFAIP3;FOXJ1;SAMSN1;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.40835515549287765,-0.8149218249699367,0.6756756756756757,1.0,1.0,1/25,2.47%,IFIT1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.42282363919680876,0.8148384610178317,0.7045454545454546,1.0,1.0,1/10,2.57%,NAF1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.5579835377008882,-0.8146485115104186,0.7222222222222222,1.0,1.0,2/6,16.93%,LFNG;DOCK10
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),-0.5133793347051988,-0.8141681568793969,0.7868852459016393,1.0,1.0,1/6,10.14%,CHRM3
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.3605757320581543,0.8140701443004245,0.7297297297297297,1.0,1.0,3/22,15.58%,BMP2;PPP2R5A;SMPD1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.4121234609855872,-0.8139724235354902,0.7213114754098361,1.0,1.0,1/13,2.72%,ALOX12
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.3896615550501363,-0.8139139847103242,0.726027397260274,1.0,1.0,4/35,15.09%,KMO;FOLH1;GPT2;ASS1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3000582517840391,0.8137988837342631,0.85,1.0,1.0,12/62,22.01%,LVRN;CARNMT1;GSTT2;APEH;LTA4H;ADAMTS13;GSTM2;DMD;IDE;PCSK5;LNPEP;MME
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.43073062998316436,0.8136256514674316,0.6111111111111112,1.0,1.0,1/9,0.64%,CD200R1
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.5161002038951966,0.8133715130842504,0.7560975609756098,1.0,1.0,2/5,32.46%,EZR;DLG1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.27826284474454904,0.8133109108861855,1.0,1.0,1.0,16/97,17.33%,TMX1;PPP1R15B;EIF2S1;TRIB3;GORASP2;TMEM33;VCP;ATF6;NCK1;DERL1;PIK3R1;RCN3;EIF2AK3;RHBDD1;UFM1;TMTC3
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.4278858697448329,0.813074489421376,0.7837837837837838,1.0,1.0,9/13,28.65%,ADAT2;DPH3;MTO1;ELP4;ELP3;URM1;ALKBH1;ALKBH8;CTU1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2982746413481867,-0.8127774713161953,0.9473684210526315,1.0,1.0,65/669,13.19%,KLF2;LEF1;MET;POU4F1;NR4A3;PGR;NR1I3;TLR2;PLAG1;CIITA;FOSL2;RPS27A;LMO2;BARX2;PROX1;MLIP;SKAP1;IRF1;ATF3;MAFF;ST18;CASZ1;APP;KLF4;SCX;ZNF750;BEX1;NLRC5;BRCA1;GATA1;TLR3;LDB2;POU2F3;PLSCR1;ZFPM1;SRF;WAS;RPS6KA1;CRLF3;IGF1;MACC1;STAT1;HELZ2;WNT5A;IRF7;FGF1;DAB2IP;CSRNP1;ADIRF;NAMPT;LAGE3;SOX15;IL18;FOXM1;SBNO2;RUNX2;PSMC3;TNIP2;GLI1;NOS1;UBC;FADD;PPARGC1B;PAX8;TNFRSF1A
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.4772062556106913,-0.8127332279794458,0.7368421052631579,1.0,1.0,1/11,1.90%,HIC1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.2932698899899116,0.8126384539687973,1.0,1.0,1.0,32/119,19.48%,NR1D1;PPARGC1A;NR2E1;RARB;MAML3;KAT2B;ESRRG;GTF2F2;RORB;ERCC2;NRBF2;AR;NR3C1;GTF2A2;NOTCH2;TAF12;ESRRA;ERCC3;GTF2H5;TAF4;GTF2H2;TAF8;TAF2;POLR2C;NR2F1;NR1D2;NR3C2;DR1;TAF3;HDAC10;THRB;MED23
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.2571353955029854,0.8125957672005519,1.0,1.0,1.0,34/231,13.91%,CD247;BET1;PPARGC1A;PEF1;MCU;TSPAN33;MITF;SAMM50;MEN1;OCLN;SOX9;PYGO2;LPXN;CUL1;TCAP;SEC22B;LLGL1;PYGO1;PPP6R1;HSF1;WDCP;MDN1;TRADD;KLHL12;RAB1B;PDE4DIP;KMT2A;OPA1;CAPZA1;WASL;SCFD1;CNIH1;SEC24A;SEC23IP
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.4086882043582688,-0.8122491010789094,0.7758620689655172,1.0,1.0,3/25,8.20%,P2RY12;KIF17;NEFH
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.4017487127379879,-0.8122321609368807,0.696969696969697,1.0,1.0,7/23,17.54%,SNCB;SYT1;NLGN1;SYT5;SNCG;SYT2;CDK5
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.5221718300211458,-0.8120867120391418,0.76,1.0,1.0,3/7,17.69%,CD55;SUSD4;CR1L
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.3239864456489549,-0.811921883009111,0.8390804597701149,1.0,1.0,22/107,20.03%,ARHGAP4;SULF1;THY1;PODN;BST2;CYP1B1;TIMP1;CLIC4;PFN2;DAB2IP;IGFBP5;LDLRAD4;TMEFF2;CD74;SFRP2;DLC1;PTPRR;VCL;MCTP1;PHLDB2;DPYSL3;CX3CL1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.2906547910424492,0.8118450555380263,0.90625,1.0,1.0,13/76,15.12%,TBC1D4;ARHGEF16;TBC1D12;CXCL13;FOXJ1;ARHGEF26;GARNL3;TAX1BP3;TIAM2;SYDE2;MTSS2;TBC1D5;TBC1D8B
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.3308637390682023,0.811701192723539,0.8064516129032258,1.0,1.0,6/42,10.43%,GDAP1;GRPEL2;MFF;AKT1;RALA;TOMM22
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.295954252923178,-0.8115673416809801,0.967391304347826,1.0,1.0,16/362,7.62%,PRAME;LEF1;CDKN2A;SIX3;SUV39H1;MAEL;CIITA;PROX1;CIC;IRF1;MSX2;KLF4;BRCA1;NKX6-2;BASP1;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3797244074917765,-0.8115200832809198,0.7142857142857143,1.0,1.0,3/31,11.85%,DUSP1;PINK1;FOXM1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.43170219141106125,0.8107510968363615,0.6904761904761905,1.0,1.0,3/7,24.64%,DNAJB14;DNAJC18;DNAJB12
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.39453565220589465,-0.8104917991311329,0.7352941176470589,1.0,1.0,8/35,17.27%,GPR183;MMP14;SYK;TNIP2;IL7;CD74;IRS2;SH3KBP1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.3075158845586397,0.8104783362264661,0.8695652173913043,1.0,1.0,10/29,27.12%,SESN2;SESN3;PRKAA1;MINAR1;TBC1D7;KPTN;NPRL3;EPM2A;NPRL2;SESN1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.3308074201646213,0.8104151361922595,0.8181818181818182,1.0,1.0,1/39,0.30%,ACE2
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.3466207314324624,0.8103789739649211,0.6857142857142857,1.0,1.0,7/27,18.80%,SNF8;VPS37A;VTA1;CHMP2B;VPS37B;VPS4B;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4252025469369451,0.8102580375893091,0.6666666666666666,1.0,1.0,6/13,37.11%,TNFSF4;NECTIN2;KMT5B;RIF1;TP53BP1;PAXIP1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.439129132036621,-0.8101659088681376,0.6949152542372882,1.0,1.0,3/11,24.42%,MFSD2A;MYO9A;ERMN
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.346913448002402,0.8098347528151414,0.7435897435897436,1.0,1.0,2/21,2.79%,PDE3A;LIG4
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.41309738828785725,-0.8085044839794014,0.8032786885245902,1.0,1.0,5/17,12.77%,NLRP12;USP50;PSMB9;BIRC3;GRIN2B
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),-0.5394430322323742,-0.8082145790327776,0.8363636363636363,1.0,1.0,1/5,6.35%,ACOT4
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.5372637000544838,-0.8078519935835047,0.8,1.0,1.0,3/5,33.48%,PARP10;PPIA;GPS2
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.4768585700937681,-0.8076059379362653,0.6739130434782609,1.0,1.0,2/10,13.75%,TTLL7;TTLL6
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.37301254320404276,-0.8071637940662914,0.7972972972972973,1.0,1.0,2/42,6.37%,ANK3;ANLN
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.2985904075443289,0.8070793161893549,0.9642857142857143,1.0,1.0,6/70,8.62%,CD200R1;PPARGC1A;PDE12;HSPA1A;AKT1;ADNP2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.2941067262787645,-0.8066645770596022,0.9263157894736842,1.0,1.0,29/429,12.29%,PRAME;LEF1;TYMS;CDKN2A;SIX3;SUV39H1;MAEL;CIITA;PROX1;CIC;IRF1;MSX2;KLF4;BRCA1;NKX6-2;BASP1;HEXIM1;DBI;RPL13A;TSPYL2;PATL2;WNT5A;DAB2IP;BAP1;FOXM1;SBNO2;RUNX2;EID2;IGFBP5
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.4609899010995324,-0.8066031188564968,0.7727272727272727,1.0,1.0,1/14,2.46%,NOS1AP
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.34017655874302255,-0.8065954820332082,0.8607594936708861,1.0,1.0,10/96,7.50%,FABP3;NEXN;ART3;COX7A1;CTNNA3;PLN;LMOD1;VLDLR;CAV3;SYNPO2L
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.49495930665112176,-0.806542028474707,0.7619047619047619,1.0,1.0,1/8,5.52%,AKR1C1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.40354831098973104,-0.8064765623148081,0.7714285714285715,1.0,1.0,1/30,0.81%,BLM
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.32723434296414433,-0.8064510152188527,0.813953488372093,1.0,1.0,10/120,15.64%,RPL3;RPS27;RPS14;SNRPD2;RPL24;RPL38;RPL10;RPS15;MRPL20;RPL5
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.40394563584180376,0.8064442907943298,0.7142857142857143,1.0,1.0,3/15,5.89%,DNA2;EGFR;STN1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.39970292833402854,-0.8064156916979531,0.7352941176470589,1.0,1.0,6/21,17.72%,RAB11A;ADCY7;ADCY5;ADCY3;ADCY8;AQP1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.2694921972270108,0.8064059825887261,0.9615384615384616,1.0,1.0,25/111,19.67%,PSMD10;HSPA1A;PSMA1;EXOSC1;PSMD11;AKT1;PSMB5;PCBP4;XPO1;EXOSC6;DIS3;PSMD14;NUP214;ZC3H14;PSMD12;RC3H1;CNOT8;CSDC2;CNOT1;EXOSC8;YTHDF2;FXR2;PCID2;RC3H2;PUM2
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.34999616436321845,0.8062135341798526,0.6818181818181818,1.0,1.0,4/33,8.47%,PDE3B;GIT1;EGFR;CBFA2T3
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.44169565173658426,-0.8062010677199135,0.796875,1.0,1.0,1/12,8.06%,ANGPTL3
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.5487791354775575,-0.8060000029878621,0.8095238095238095,1.0,1.0,3/5,23.55%,CLN3;AQP1;AQP11
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.523932122176974,-0.8059956702649999,0.8333333333333334,1.0,1.0,1/5,10.53%,PDK3
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.4551453068541071,-0.8059761866787062,0.71875,1.0,1.0,2/13,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.38886488081585746,0.8059544020896844,0.6875,1.0,1.0,6/15,26.99%,CASK;SERPINE2;AJAP1;SLC12A2;PTEN;CLASP2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.2859458025475551,0.8058306250230564,0.896551724137931,1.0,1.0,11/60,14.78%,ATP13A5;CALCB;SLC24A3;SELENON;ATP2C1;STIM2;ATP13A4;ANK2;RGN;VAPB;SLC24A4
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.3394401014429534,-0.8056674802847695,0.8641975308641975,1.0,1.0,18/95,18.28%,CCNB2;BLM;CCNI2;THY1;CCND1;SLC8A3;GADD45A;CCNB1;DAB2IP;CCNE2;HERC5;MTCP1;CDKN3;CCND2;CDC37;CDKN2D;CCNF;CDKN1A
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.3051657361984218,0.8056612295382338,0.8148148148148148,1.0,1.0,7/46,11.56%,ARV1;ABCA1;CYP7B1;PMVK;CYP4V2;INSIG2;CYP46A1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.3501083228207098,-0.8055827183047508,0.8028169014084507,1.0,1.0,8/43,17.28%,CDH22;CDH6;CDH7;CDH19;CDH9;CDH12;CDH17;VCL
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),0.4679988231418084,0.8050067197615315,0.6666666666666666,1.0,1.0,3/7,12.70%,CYP4F3;CYP4F12;HSD17B6
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.43450882179606576,-0.8049733139719465,0.6964285714285714,1.0,1.0,1/13,3.97%,RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.43450882179606576,-0.8049733139719465,0.6964285714285714,1.0,1.0,1/13,3.97%,RAB11A
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),0.5021171679164018,0.8049197393095535,0.7291666666666666,1.0,1.0,1/5,20.22%,FBH1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.38040258430870577,0.8047810781802597,0.8666666666666667,1.0,1.0,1/21,1.98%,PPARGC1A
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4080775619650279,0.8045794573441484,0.7027027027027027,1.0,1.0,5/18,14.54%,GANC;MAN1A2;PRKCSH;GANAB;ST8SIA5
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.46465168935516327,0.8044183555531363,0.7551020408163265,1.0,1.0,2/9,3.82%,ABCB10;ALAS1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.4428221982255539,-0.8041460581424601,0.7222222222222222,1.0,1.0,1/12,10.88%,IFT122
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.25139070000669717,0.8036707198046139,1.0,1.0,1.0,41/241,18.25%,MACIR;RAP2C;FHDC1;CEP19;S1PR1;SPAG16;BBS9;RAB23;SSX2IP;EXOC8;CEP20;EXOC6;INTU;DZIP1;CNGA4;CEP290;ARFIP2;RAB8B;PTPN23;FOXJ1;PARVA;PCM1;DNM3;SCLT1;TEKT5;TTC8;NEK1;UNC119B;TCTN3;IQCB1;RAB8A;TMEM237;UBXN10;WHAMM;MKKS;TNIK;ARHGEF6;SNAP29;EXOC5;FGD4;CCDC88A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.34784504407446426,-0.8034020711469202,0.7972972972972973,1.0,1.0,8/62,17.58%,ARHGAP9;ARHGAP15;ATP5IF1;DAB2IP;NOS1;RAP1GAP;VAV1;CFAP73
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.43628745599347873,-0.802803835763444,0.8,1.0,1.0,1/17,1.70%,KREMEN2
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4029230026504176,-0.8027437089186887,0.7714285714285715,1.0,1.0,6/23,24.71%,THY1;NLGN1;LRRC7;AGRN;ITGAL;DNAJA3
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.33271726439546784,-0.8019851571703525,0.8641975308641975,1.0,1.0,19/98,17.76%,AMN;ABCA6;ABCA5;ABCA8;RAMP3;ABCA12;SLC18A2;ABCA10;MYH9;ARRDC2;SLCO2A1;SLC22A4;MFSD2A;ARRDC3;SLC35F3;SLCO1A2;SLC29A4;SLC50A1;LRP2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.33875034684806693,-0.8018868594548655,0.8375,1.0,1.0,22/100,17.12%,PHEX;SULF1;MMP14;CD44;PAPSS2;NOTUM;COL11A2;CHI3L1;IGF1;COL10A1;WNT5A;HAPLN2;ALPL;HHIP;PTH1R;HYAL1;PPIB;ADAMTS4;TLL1;DDRGK1;COL9A2;DEAF1
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.426274847054938,-0.801656425167237,0.7213114754098361,1.0,1.0,3/18,14.77%,HK2;RBKS;GPI
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.5199229152536238,0.8013939991025179,0.8,1.0,1.0,1/5,18.82%,DMC1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.3892241890632758,-0.801027101862701,0.7922077922077922,1.0,1.0,3/35,9.53%,S100A10;SYNPO2L;PFN2
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.48721443422975724,0.8010088612569941,0.7446808510638298,1.0,1.0,5/8,47.08%,GBA2;ABHD10;GUSB;FUCA2;GLA
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.41578725574725384,-0.800989276535897,0.7432432432432432,1.0,1.0,11/25,24.05%,DHCR24;SQLE;MVK;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;IDI1;LSS
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.47091965140172,0.8008660879281396,0.7647058823529411,1.0,1.0,1/11,1.26%,NIPAL1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4350284414580894,-0.8008340512822353,0.7397260273972602,1.0,1.0,5/17,17.28%,EGF;SFRP4;CD63;APLN;AHI1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4211956051160337,0.8005613095532924,0.7894736842105263,1.0,1.0,6/18,17.89%,SRI;ATP1A2;CASQ1;ANK2;GSTM2;DMD
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3393672528330709,0.8005283789212273,0.7352941176470589,1.0,1.0,5/36,7.43%,BCO2;AKT2;ABCD1;AKT1;VCP
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.3902101125485458,-0.8003529921901079,0.7710843373493976,1.0,1.0,4/28,10.43%,ST6GAL1;ACOT4;GLYAT;CYP4F22
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.43866411041463804,0.7999117932579927,0.7073170731707317,1.0,1.0,2/10,10.63%,CCT7;CCT3
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.5252382382795582,0.7999010416727587,0.8717948717948718,1.0,1.0,1/5,17.40%,AGO3
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.4347583963919295,-0.7998599930324625,0.6885245901639344,1.0,1.0,1/12,3.97%,RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.4347583963919295,-0.7998599930324625,0.6885245901639344,1.0,1.0,1/12,3.97%,RAB11A
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.3968583096260516,-0.7997356790014746,0.7307692307692307,1.0,1.0,8/31,15.68%,SULF1;SCX;CD44;COL11A2;CHI3L1;NAMPT;HYAL1;DDRGK1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.42073239909935073,0.7996535505176414,0.6774193548387096,1.0,1.0,4/9,21.11%,SLC12A9;CA12;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.42073239909935073,0.7996535505176414,0.6774193548387096,1.0,1.0,4/9,21.11%,SLC12A9;CA12;SLC12A8;SLC12A2
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.47111351335557416,-0.7995421988775319,0.7704918032786885,1.0,1.0,1/8,16.59%,CLN3
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.4607288902579056,-0.7992021345921323,0.7543859649122807,1.0,1.0,2/10,3.45%,SIX3;KIF14
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.44949483704547577,-0.7991438916206366,0.7272727272727273,1.0,1.0,3/13,20.57%,HEXIM1;NELFE;SUPT5H
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.4769301829103415,-0.7989493555235655,0.7068965517241379,1.0,1.0,1/8,10.01%,WNT5A
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.5063522906437792,0.7988577808025519,0.7954545454545454,1.0,1.0,1/7,16.16%,CPEB3
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.3587615267309364,-0.7985517201714828,0.7605633802816901,1.0,1.0,9/58,17.65%,ZFP36;RPS27A;NOD1;MINK1;TNIP2;UBC;SH2D3A;SH2D3C;RIPK2
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.42584126866721544,0.7983194067401359,0.7777777777777778,1.0,1.0,1/11,1.56%,AGER
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3151598496851255,0.7981817669284873,1.0,1.0,1.0,13/65,17.60%,LIMD1;PSMD10;ELOC;PSMA1;PSMD11;PSMB5;PSMD14;EGLN3;CUL2;PSMD12;EP300;BACH1;VHL
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.42071112089450324,0.7981355116315384,0.7567567567567568,1.0,1.0,3/9,28.27%,POGLUT1;SMO;NF1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.38778855919125266,-0.7976329983688424,0.8857142857142857,1.0,1.0,3/34,4.36%,KCNB1;SLC39A14;HK2
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5331085441786402,-0.797554661800665,0.7083333333333334,1.0,1.0,1/5,11.67%,SFRP4
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.35341078666700665,0.7972964714282433,0.7142857142857143,1.0,1.0,1/21,0.48%,DAO
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.440455465857059,0.7967208953309214,0.7435897435897436,1.0,1.0,1/9,1.08%,CHAMP1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.4942262018729169,-0.7966932004229774,0.711864406779661,1.0,1.0,3/6,18.37%,COX7A1;COX7A2;HIGD1B
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.46328435158700454,0.7966173806299547,0.7837837837837838,1.0,1.0,2/11,4.69%,RUNX1;IL17D
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.44478403528261545,-0.7964409665534704,0.7090909090909091,1.0,1.0,3/11,11.20%,LDLR;CD9;SYK
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.41357729489856243,0.7963160358903639,0.75,1.0,1.0,1/11,2.78%,BCL10
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.41269163840561496,-0.7961542799965615,0.7534246575342466,1.0,1.0,11/26,24.05%,DHCR24;SQLE;MVK;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;IDI1;LSS
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.4083963183833751,0.796094442122722,0.6842105263157895,1.0,1.0,2/13,10.83%,FOXJ2;FOXJ3
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.5015423172889436,0.7960639260392413,0.7916666666666666,1.0,1.0,1/5,10.69%,NIPBL
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4049137095459636,0.7960541359895388,0.6944444444444444,1.0,1.0,4/13,31.30%,ADRB2;PKIB;RAPGEF2;SIRT1
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.40682677639628423,-0.7958756328981356,0.8253968253968254,1.0,1.0,1/18,0.33%,THBS1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.46468876643550605,-0.7956671927383165,0.847457627118644,1.0,1.0,3/10,25.69%,ROMO1;TIMM10;TIMM22
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.4574581462642431,-0.7955759425114762,0.7313432835820896,1.0,1.0,2/11,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.2979423215976213,0.7955413899592272,0.8,1.0,1.0,20/113,15.78%,PSMD10;GSKIP;PSMA1;PSMD11;EGFR;GPC5;PSMB5;VCP;GID8;RNF146;CSNK1E;CAPRIN2;PPM1A;PSMD14;ZEB2;CSNK1G3;PSMD12;KANK1;NFKB1;LGR4
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.31633841636135634,-0.7953532822111533,0.8620689655172413,1.0,1.0,34/165,19.45%,ALDOB;PLAAT4;ITPKC;PLB1;INPP5D;HK2;HTR2B;ANGPTL3;PLPPR1;PRKCG;FBP1;PLPPR5;PGK1;ALPL;LPCAT4;NUDT4;DUSP16;PLCH2;GPI;PIK3CB;HDHD2;PFKFB4;PIK3CD;PFKL;PFKFB3;PXYLP1;CDK5;LIMK2;TGFB1;PLCE1;GFPT2;ALK;PPA1;DUSP8
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.31654201919038094,-0.795272652831857,0.925531914893617,1.0,1.0,22/147,15.13%,HPN;EFNA1;KREMEN2;GPNMB;OVOL2;IL15;NLRP12;ZNF750;RAB11FIP5;TIMP1;TNNT1;SRF;PFN2;RAB11FIP1;LRPAP1;DAB2IP;PROCR;LDLRAD4;SLC11A1;ARRDC3;SRGN;SFRP2
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.43518401913250887,0.7952482928052599,0.625,1.0,1.0,4/7,17.32%,PIK3C2G;PIK3C3;PIK3CA;PIK3C2A
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.2723075115537792,0.7938133697870635,0.9523809523809523,1.0,1.0,17/119,12.54%,EPHA6;FLT3;NAF1;POLG2;GREM1;TRIB3;DCUN1D2;EGFR;RFC3;MAP3K4;UBE2N;DCUN1D1;ERBB4;PLK1;CSF1R;EPM2AIP1;EPHB4
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.3160635196378507,0.7934022446336647,0.90625,1.0,1.0,7/49,13.97%,LEPR;TAB3;AKT1;EIF4E;DAP;PIK3CA;QSOX1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.29848296406335734,-0.7933953740232643,0.9222222222222223,1.0,1.0,28/277,13.06%,CP;SOCS3;C3;SERPINA10;CHGB;LAMB1;RAB11A;ASB16;APP;TIMP1;PSMB9;SERPIND1;NOTUM;FBXL18;FAM20C;FBXW12;SPSB1;FBXO32;IGFBP7;PSMB6;FN1;FBXW10;SHISA5;PSMC3;PRSS23;IGFBP5;GPC3;ASB14
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),0.49285557396542634,0.7931264846371708,0.7906976744186046,1.0,1.0,3/6,23.65%,SMOX;SRM;SAT1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.4221776608517882,-0.7924294033807924,0.7741935483870968,1.0,1.0,2/14,11.77%,IGF1;SOX15
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.38828676591618566,-0.7919101049537517,0.7922077922077922,1.0,1.0,2/35,2.68%,RSPH4A;PSRC1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.4681667617193147,-0.7918994290823879,0.7878787878787878,1.0,1.0,1/9,3.52%,PLK2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.36499570507009826,0.7918798735797975,0.7837837837837838,1.0,1.0,6/28,14.92%,NUDT16L1;ERCC6;HSF1;CYREN;TFIP11;POT1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.37993883817012747,0.7915552236468364,0.75,1.0,1.0,1/25,0.54%,RNF6
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.29913675390123823,0.7910524984446436,0.96,1.0,1.0,4/53,4.92%,UQCRHL;AFG1L;NDUFB1;COX10
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.34580473285711877,-0.791031310342501,0.8375,1.0,1.0,9/59,13.02%,HPN;ALDOB;GC;BHMT;GLYAT;FBP1;ALPL;PDZK1;CYP3A4
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.3247383064055305,0.790977588021185,0.84,1.0,1.0,6/46,9.61%,FANCF;UBE2T;RFWD3;VCP;DCLRE1B;ATR
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.29989416726955714,0.7907990294377639,1.0,1.0,1.0,4/52,4.92%,UQCRHL;AFG1L;NDUFB1;COX10
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.4996080667370698,0.7904161744128324,0.7058823529411765,1.0,1.0,4/6,38.65%,USP7;UHRF2;ZNF445;HELLS
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.3642794585700028,-0.7903535941715141,0.8133333333333334,1.0,1.0,4/41,11.85%,RASGRP1;SCIMP;DAB2IP;FOXM1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.3764168378525109,-0.7903520677845035,0.8311688311688312,1.0,1.0,5/43,9.36%,TEKT2;RSPH4A;CCDC39;SPAG17;ODAD1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.28789726193092163,0.7899887537881409,0.8888888888888888,1.0,1.0,9/85,8.17%,SLC26A7;CHRNA4;SLC24A3;SLC15A2;SLC25A18;TRPM3;VDAC2;CHRNB4;GLRB
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),-0.5352237784671043,-0.7899165690489087,0.7413793103448276,1.0,1.0,3/5,20.77%,RAB11A;LIMK2;IKBKG
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.35703799949048975,0.7898645052157239,0.7037037037037037,1.0,1.0,4/30,9.00%,PDE3A;ADCY1;SOX9;PDE7B
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.42825022366597854,0.7898036282116143,0.71875,1.0,1.0,2/11,12.35%,ZNF502;VAPA
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.43611500413773424,-0.7897892761243974,0.7894736842105263,1.0,1.0,5/12,30.45%,KAT5;FAM161A;CAMK1;DIP2B;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.4234487772939593,-0.7896959800714488,0.7213114754098361,1.0,1.0,3/16,9.24%,B2M;CAV3;IGF1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.4236414735603136,0.7890599042775021,0.7380952380952381,1.0,1.0,2/11,10.63%,CCT7;CCT3
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.41137570992402306,-0.7890420063967535,0.7638888888888888,1.0,1.0,11/28,24.05%,DHCR24;SQLE;MVK;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;IDI1;LSS
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5004303884638581,-0.7890191333310067,0.7894736842105263,1.0,1.0,1/9,6.29%,BRCA1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.3621759867097536,-0.7889645692576234,0.76,1.0,1.0,7/38,17.65%,RPS27A;NOD1;MINK1;UBC;SH2D3A;SH2D3C;RIPK2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.39580961330209136,-0.7886564477631277,0.7285714285714285,1.0,1.0,9/27,22.78%,THY1;FN1;DLC1;LAMA3;ITGB4;RHOD;PLEC;SORBS1;DST
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.33042148634002094,0.7884310229883691,0.8421052631578947,1.0,1.0,2/24,11.53%,HSPA1A;OPA1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.5282788536590759,-0.788320349415012,0.7777777777777778,1.0,1.0,2/5,25.06%,BDNF;FYN
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.45757451102654834,-0.7882791351851155,0.7358490566037735,1.0,1.0,1/11,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5083129451228834,-0.7880901237038265,0.7169811320754716,1.0,1.0,3/7,29.81%,TGFB1;STAT3;NCOR1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),0.4984092745463485,0.7875740210451795,0.7692307692307693,1.0,1.0,2/6,20.11%,GSTM2;CRYZ
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4566386278049206,-0.787475863753424,0.7894736842105263,1.0,1.0,1/10,2.20%,ZFP36
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.4779832571834054,0.7872489044491009,0.7254901960784313,1.0,1.0,2/5,15.88%,HMGB1;TNFSF4
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),-0.4813781874258254,-0.7871494822388345,0.7183098591549296,1.0,1.0,2/7,7.35%,TIMP1;CCND1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.30748633828772204,-0.7871212045173355,0.9058823529411765,1.0,1.0,25/188,18.31%,CCNB2;CDKN2A;PLK2;CCNI2;ABCB1;CCND1;PLK3;CRLF3;CCNB1;DCTN1;FOXM1;CCNE2;HAUS7;CEP76;CDKN3;UBE2S;CDK2;CCND2;MAX;CDC7;WEE1;CDKN2D;CCNF;CDKN1A;SPDYA
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),0.48840561327383514,0.786842876549448,0.7333333333333333,1.0,1.0,2/5,4.42%,ASCL1;POU3F2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3557227769974284,-0.7867660997119696,0.8533333333333334,1.0,1.0,12/52,21.38%,TLR2;NNAT;IGF1;ACHE;IRS2;MYO18A;MYRIP;GPER1;TGFB1;DOC2B;TMED10;ADAM8
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.4648588910355348,-0.7862599674322612,0.7571428571428571,1.0,1.0,4/11,16.59%,SYN3;HAP1;NLGN1;CLN3
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.4259358910342657,0.7862114702547044,0.627906976744186,1.0,1.0,4/11,25.83%,APOBEC3F;TASOR;RESF1;SETDB1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.39480717488019934,0.7855563784422838,0.7297297297297297,1.0,1.0,3/12,12.02%,GUCA1B;ERBB4;SLC22A2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),0.507256758353403,0.7855137466971704,0.7857142857142857,1.0,1.0,2/5,14.00%,XG;MDK
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),0.507256758353403,0.7855137466971704,0.7857142857142857,1.0,1.0,2/5,14.00%,XG;MDK
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.5390053125948927,-0.7854748061553724,0.803921568627451,1.0,1.0,2/6,20.15%,CAPN1;CASP8
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.31836085733657044,0.7852188075520278,0.8518518518518519,1.0,1.0,12/40,25.51%,ADAMTS9;UBE2G1;DNASE1L2;STT3B;FBXO27;DFFB;DNASE1L1;IDE;PPP1R8;RAB12;MTREX;HNRNPD
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.39045567667086906,-0.7851804105526283,0.7647058823529411,1.0,1.0,3/30,7.85%,RAB11FIP5;CAV3;EGF
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.33580366350539553,-0.7851136642359868,0.8441558441558441,1.0,1.0,15/84,16.87%,TLR2;HIC1;DEPDC1B;SULF1;APP;RSPO3;NOTUM;SFRP4;RSPO4;GPC3;ITGA3;CBY1;SFRP2;EMD;TSC2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.49037938819044796,-0.7847396756692502,0.711864406779661,1.0,1.0,4/6,35.19%,SPI1;KLF7;PLAAT3;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.32666880983855506,-0.7847170905160784,0.7972972972972973,1.0,1.0,10/92,13.39%,WARS1;SKAP1;FSCN1;USP50;RPA3;ISG15;DAB2IP;SYK;PSMC3;RPA1
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),-0.4859254746003502,-0.7842870813108046,0.7741935483870968,1.0,1.0,4/6,22.80%,ABCB1;ABCC1;ABCG2;SLC22A1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.3827852195457161,-0.7840684814533537,0.8082191780821918,1.0,1.0,3/33,11.48%,BLM;GADD45A;ADIRF
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.4411585773715976,0.7839155927059989,0.717391304347826,1.0,1.0,3/7,22.31%,SPX;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),0.48504505833105294,0.7838112952081123,0.7631578947368421,1.0,1.0,1/5,8.98%,PTPN23
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.43270304142449384,0.7833140166904214,0.6944444444444444,1.0,1.0,2/8,13.68%,AKT1;PIK3CA
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.2774460989198658,0.7832495175441633,1.0,1.0,1.0,11/83,10.13%,TBC1D4;PDE3B;ADCY1;TRIB3;KAT2B;AKT2;AKT1;RAB8B;PRKACB;INSIG2;LPIN3
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.3770048446194125,-0.7828819857227242,0.78125,1.0,1.0,5/31,10.76%,TYMP;KIF14;NKX6-2;TENM4;HES7
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.39103553976426497,-0.7828573622204339,0.7971014492753623,1.0,1.0,6/30,19.66%,NDUFA2;NDUFB9;NDUFB11;NDUFB10;NDUFA6;NDUFA3
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.3396940141446813,0.7828428941311418,0.7941176470588235,1.0,1.0,3/27,14.17%,NCOA4;ZFYVE16;MFSD1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.36005511442761456,-0.7828327137074048,0.8767123287671232,1.0,1.0,5/42,12.15%,BLM;ATAD5;EGF;TSPYL2;GLI1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),0.5100305677048006,0.782751679921676,0.7857142857142857,1.0,1.0,1/6,2.91%,ADRA1A
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.41280183441547363,-0.7825085615958667,0.855072463768116,1.0,1.0,2/26,7.79%,FABP3;LDLR
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.49703300521388283,-0.7824045870346795,0.78125,1.0,1.0,1/8,11.67%,SFRP4
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.36016639799589545,-0.7823263311137486,0.7833333333333333,1.0,1.0,5/31,15.27%,FABP3;CAV3;LIPI;LIPH;PNPLA3
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.4302589691551931,-0.7821508870904085,0.75,1.0,1.0,6/17,21.46%,FSCN1;CLIC4;ERBIN;CRB2;LRRC7;PATJ
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.25473663077381303,0.7818431859855507,1.0,1.0,1.0,26/226,13.46%,NGF;NCSTN;BMP2;PHLDA1;AIFM2;BCL10;ARHGEF16;DUSP6;ACVR1C;ARHGEF12;C3ORF38;IP6K2;ZNF268;STK4;HMGB1;USP27X;TRADD;ATF6;ARHGEF26;MAPK8;CASP3;TIAM2;CRADD;ERCC3;STK17B;PNMA3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.3239386094947263,-0.781821258550572,0.8518518518518519,1.0,1.0,4/89,6.27%,THBS1;RPS4X;KLF4;PLD1
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.5430468280655028,-0.7817304097484966,0.8360655737704918,1.0,1.0,3/5,26.83%,RHD;AQP1;RHCG
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.40271362441020375,-0.7815370505534757,0.8166666666666667,1.0,1.0,2/18,7.62%,CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.4097968375930753,0.7814917426573641,0.71875,1.0,1.0,2/13,7.30%,MTHFS;GLUD1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3724228700235588,-0.7814718786628285,0.8260869565217391,1.0,1.0,7/31,19.45%,SEPTIN4;RPS7;BOK;NUPR1;GSDME;BBC3;EIF5A
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.317072491560748,-0.7812002693206308,0.8666666666666667,1.0,1.0,21/98,18.00%,CDH23;HTR2B;SLC24A2;PLN;TRPC3;CAV3;SLC24A1;GCM2;ATP1B1;SLC8A3;HCRTR2;SLC24A5;MCUB;PTH1R;CLN3;PML;HTR2C;ADCY8;RYR2;GPER1;HTR2A
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.38969238704393083,-0.7809509615733284,0.8,1.0,1.0,9/37,16.65%,CD5;TAGAP;GPR171;IL4R;P2RY10;CCR10;THEMIS;LTBR;STAT6
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.5545958926611625,-0.7809048191117588,0.8507462686567164,1.0,1.0,2/5,30.69%,SNRPC;PSIP1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.3720039818166729,-0.7808664391268425,0.775,1.0,1.0,13/42,20.30%,ANO2;GLRA2;ANO9;GABRE;GABRB2;GABRD;GABRG2;SLC12A7;GABRA1;GLRA1;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.5183544866635521,-0.7807884167520458,0.7758620689655172,1.0,1.0,1/6,13.72%,IL7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.4573123563160906,0.7807449056070467,0.7435897435897436,1.0,1.0,3/7,24.69%,EXOSC6;EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.4573123563160906,0.7807449056070467,0.7435897435897436,1.0,1.0,3/7,24.69%,EXOSC6;EXOSC8;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.36439952769056455,-0.7807394652779129,0.8181818181818182,1.0,1.0,5/32,10.01%,NLRP12;APP;USP50;NLRP2;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.3847041131992364,-0.7806932661681192,0.7910447761194029,1.0,1.0,5/21,19.00%,P2RY12;EEF1A2;TEK;TGFB1;PDGFRA
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.2714698079712271,0.7803803369732933,1.0,1.0,1.0,31/182,15.62%,NGF;RGCC;ASCL1;TMEM100;BRINP3;BMP2;SERPINF2;BEND6;SOX9;NUDT21;AKT1;LMO3;FBXO5;ZNF268;RANBP3L;KCTD11;AR;ZNF703;HEYL;ZC4H2;SOX5;MAPK12;ACVR2A;CDH2;MDK;RPS6KA3;PRKD1;BRINP2;NFKB1;CPNE1;ID2
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.39002118088743376,0.7800689658404718,0.7105263157894737,1.0,1.0,4/18,10.09%,BAG2;FBXO5;BTRC;PLK1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.40184168375419627,-0.7798945888661605,0.7391304347826086,1.0,1.0,6/20,25.60%,HLA-E;GPI;PTPRC;XBP1;SHLD1;STX4
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.427022160740764,0.7794499535459886,0.6904761904761905,1.0,1.0,4/10,25.83%,APOBEC3F;TASOR;RESF1;SETDB1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.38358814772981575,0.7793426155429095,0.7931034482758621,1.0,1.0,2/16,8.15%,LLGL1;FMNL3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.4018688121315923,-0.7791182240533017,0.8387096774193549,1.0,1.0,6/18,18.82%,ABCA8;ABCB1;SLC22A4;SLC29A4;ABCC1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.5113575249521134,0.7791043502257368,0.8043478260869565,1.0,1.0,2/5,10.55%,HMGB1;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.3980659948032307,0.7790866429502725,0.7567567567567568,1.0,1.0,1/13,5.96%,ANP32B
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.40257959339695376,-0.7788789226474084,0.7761194029850746,1.0,1.0,10/25,24.64%,SLC4A9;SLC9A2;SLC4A2;SLC4A10;SLC9A5;CLN3;SLC9A7;SLC4A3;SLC9A1;SLC9A9
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.4740485835668813,-0.7788544842970037,0.75,1.0,1.0,1/10,8.20%,SPAG17
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.35299733812573864,-0.7786537537368495,0.8,1.0,1.0,12/39,16.60%,TJP3;PLEKHG6;KLF4;FBP1;TGFA;IL18;HRH1;TNFAIP2;ST6GALNAC2;RDH12;LTBR;CEBPD
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.45240607839553454,-0.7785252315345883,0.7931034482758621,1.0,1.0,4/11,7.77%,C3;MRAP2;SLC39A14;KLK6
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),0.4933378133708922,0.778169824594812,0.8292682926829268,1.0,1.0,2/7,10.47%,APOBEC3F;EXOSC6
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.3988915663288075,-0.7777333001231378,0.7536231884057971,1.0,1.0,2/16,10.82%,AKAP5;CACNA1C
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.32834758461077834,0.777682239709025,0.7878787878787878,1.0,1.0,7/23,19.21%,SLC47A1;SLC25A18;SLC3A2;SLC22A2;SLC25A22;SLC36A4;SLC25A38
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.450313975986194,-0.7775309282706752,0.7727272727272727,1.0,1.0,5/12,19.04%,KCNQ1;SCN3B;APLN;RYR2;ADM
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.30969162677089257,-0.7773369713059313,0.8875,1.0,1.0,22/93,18.19%,APP;LRRC4;SYN3;GRM6;SLC8A3;CPLX1;SYT1;GRIK1;CPLX2;RIMS2;DLGAP3;GRID2;NLGN1;NPTX2;BDNF;GRM7;GRIK2;RELN;KCNMB4;CLN3;CDK5;MCTP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.481129933323048,-0.7773223019251416,0.74,1.0,1.0,1/5,11.74%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3957172358260067,-0.7772291870707467,0.8125,1.0,1.0,1/19,1.53%,P2RY12
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.3361913646712067,-0.7770631592783737,0.8604651162790697,1.0,1.0,12/76,18.92%,TYMS;NELL1;RPL13A;PATL2;DAB2IP;IGFBP5;SAMD4A;PLAT;CLN3;CDK5;DAPK3;SHMT1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.43873990425566917,-0.7767410550935225,0.7666666666666667,1.0,1.0,5/11,21.76%,CYP1B1;PDK1;PRKCD;STK24;ARL6IP5
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.392667889412237,0.7764446550892111,0.8666666666666667,1.0,1.0,6/15,24.88%,STIL;PCM1;C2CD3;CEP192;CEP83;PIBF1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.3373149542949863,-0.7764312153372911,0.8947368421052632,1.0,1.0,18/100,18.28%,CDKN2A;PSRC1;TP53TG5;BST2;FBP1;TSPYL2;BTG1;CRLF3;MAG;SLIT3;HYAL1;SFRP2;TCHP;PML;BCL6;TGFB1;CDKN2D;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.4766105400999565,0.7763390297048606,0.6585365853658537,1.0,1.0,1/5,6.63%,LETM1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.35731248723725473,0.7762424350124632,0.8157894736842105,1.0,1.0,5/24,22.66%,INSC;PLK1;GJA1;ESPL1;UBXN2B
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.30402096746496066,0.7760682325465871,0.8709677419354839,1.0,1.0,8/52,16.01%,VEGFD;VEGFC;NCK1;PIK3CA;PRKD1;PIK3R1;NCK2;ABI1
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.31473492207419496,-0.776049690540494,0.8953488372093024,1.0,1.0,20/132,19.38%,DUSP1;MET;TGFBR2;GCNT1;VLDLR;MAP1B;LDLR;ICA1;IGFBP5;BDNF;DLC1;PIK3CD;F3;ANXA2;MTA1;LTBP1;ABCC1;PTPN21;INSIG1;BHLHE40
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.42449977636313435,0.7760165287509604,0.6875,1.0,1.0,3/10,26.62%,SERTAD2;ARID1B;SERTAD1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.4509531885691943,-0.7759634491170491,0.7884615384615384,1.0,1.0,1/13,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.5415330287745151,-0.7757537691251679,0.7586206896551724,1.0,1.0,1/5,10.14%,CHRM3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.4177946161620557,-0.7753395873292068,0.7936507936507936,1.0,1.0,6/14,21.14%,PVALEF;TNNT1;KCNB2;DAPK3;PLCE1;MYL5
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.4270074816345497,-0.7751057284559808,0.8225806451612904,1.0,1.0,4/14,19.24%,ABCA8;LDLR;MSR1;CD36
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.319258914338321,0.7749574978389722,0.8,1.0,1.0,9/41,18.02%,FLT3;TTL;EGFR;ERBB4;CSF1R;ABI1;ABI2;EFEMP1;ABL2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.34533248745613504,-0.7747504804401946,0.8571428571428571,1.0,1.0,7/69,13.97%,TGFBR2;RPS27A;ZYX;ARHGEF18;EID2;UBC;FOS
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3444114224071406,0.7742580149471735,0.7575757575757576,1.0,1.0,3/22,8.35%,ATP11C;ABCA1;RFT1
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.4639062825446533,-0.7739444079187612,0.7413793103448276,1.0,1.0,3/6,22.76%,SLIT3;SH2B3;SLIT2
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.5106162204234177,-0.7739328246746943,0.7959183673469388,1.0,1.0,2/5,13.10%,FGF1;PAX8
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.507740615050492,-0.7739040368379502,0.9074074074074074,1.0,1.0,1/9,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.44303661291963115,-0.7732945001237811,0.8035714285714286,1.0,1.0,1/10,11.32%,PRDM1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.4239590533889752,0.7732504116251138,0.6842105263157895,1.0,1.0,2/10,12.79%,DCT;DRD2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4078445841283934,-0.77319208999392,0.7903225806451613,1.0,1.0,2/19,12.02%,SRF;PSMC3
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.468243445291159,-0.773146975811896,0.7936507936507936,1.0,1.0,2/9,15.90%,PRKCD;CDK2
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.39210455220722484,-0.7728901197511261,0.7903225806451613,1.0,1.0,6/24,20.77%,RPS27A;NOD1;UBC;RIPK2;CASP8;IKBKG
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.4091764381791211,-0.7728402475222338,0.711864406779661,1.0,1.0,4/17,20.77%,RAB11A;CDK5;LIMK2;IKBKG
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),0.45280088210111524,0.7721725425358348,0.7727272727272727,1.0,1.0,1/7,7.15%,FBXO5
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.2799557202897384,0.7718108324328989,0.8571428571428571,1.0,1.0,13/69,23.19%,HSPA1A;RBM23;ZPR1;CLK4;RBM12B;PIK3R1;QKI;METTL4;RRP1B;ERN1;MBNL1;RBM39;JMJD6
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.4061850243950407,0.7717908310740088,0.7428571428571429,1.0,1.0,1/13,0.62%,SLITRK2
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.3955150557144639,0.7717274535813569,0.7906976744186046,1.0,1.0,2/14,8.28%,NCOA4;AR
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3568786706678539,-0.7716910708882833,0.7837837837837838,1.0,1.0,9/38,17.54%,CCL2;GRM6;SYT1;GRIK1;NLGN1;GRM7;RELN;CLN3;CDK5
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.3798705916788628,-0.7712612219871587,0.803030303030303,1.0,1.0,8/28,18.19%,APP;IGF1;GAPDHS;PINK1;PRXL2C;PFKFB4;PFKFB3;NUPR1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.45011806824294387,-0.7710149304646233,0.75,1.0,1.0,1/7,7.81%,PDE6B
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.4180552154723571,0.770425333216507,0.775,1.0,1.0,2/8,8.47%,GIT1;CBFA2T3
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.4180552154723571,0.770425333216507,0.775,1.0,1.0,2/8,8.47%,GIT1;CBFA2T3
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.36693904437997243,-0.7703578354424828,0.8208955223880597,1.0,1.0,4/40,12.67%,ITPKC;INPP5D;NUDT4;PLCH2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.470143143466012,0.7702056565813912,0.7708333333333334,1.0,1.0,5/6,34.31%,VCP;WAPL;VCPIP1;SETD2;RB1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.3424457704210393,-0.7701659476392454,0.7926829268292683,1.0,1.0,1/61,0.17%,ST6GAL1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.31515472642489595,-0.7701434509697461,0.9078947368421053,1.0,1.0,12/108,16.21%,LEF1;PSMB9;PDE6B;WNT5A;PSMB6;SFRP4;PSMC3;GNG2;PRICKLE1;SFRP2;PSMA8;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.4162378331501485,-0.7699602946692418,0.8032786885245902,1.0,1.0,3/13,18.89%,GLI1;PIM1;TBX20
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.4560394662712809,-0.7698909098013161,0.7962962962962963,1.0,1.0,4/7,18.14%,KCNB1;GRID2;ADCY8;MAPT
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.357243642409799,-0.7696989521533819,0.8235294117647058,1.0,1.0,1/35,1.24%,PGR
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.43795663976507265,0.7695534926620591,0.675,1.0,1.0,4/6,35.38%,ZBTB1;MED1;ATF4;TFCP2
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.3503204591063592,0.7695202294796238,0.7307692307692307,1.0,1.0,13/30,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;RNGTT;CMTR2;CCNH;POLR2A;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.3503204591063592,0.7695202294796238,0.7307692307692307,1.0,1.0,13/30,28.78%,GTF2F2;ERCC2;ERCC3;GTF2H5;GTF2H2;POLR2C;GTF2H3;RNGTT;CMTR2;CCNH;POLR2A;POLR2K;POLR2D
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.4965230257339571,-0.7689936036451925,0.7543859649122807,1.0,1.0,3/7,24.33%,GCKR;ABCG2;PNP
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.27956315797896325,-0.7687384174628635,1.0,1.0,1.0,78/886,13.19%,KLF2;LEF1;BLM;SP100;MET;POU4F1;NR4A3;PGR;NR1I3;TLR2;PLAG1;CIITA;FOSL2;RPS27A;LMO2;PSRC1;BARX2;PROX1;MLIP;SKAP1;IRF1;TESC;ATF3;MAFF;ST18;CASZ1;APP;KLF4;SCX;DNAJC2;ZNF750;BEX1;NLRC5;BRCA1;TEAD2;GATA1;TLR3;LDB2;YWHAH;POU2F3;ZIC1;PLSCR1;PARP9;EGF;ZFPM1;SRF;WAS;RPS6KA1;CRLF3;IGF1;MACC1;STAT1;MLLT11;HELZ2;WNT5A;IRF7;CREB5;FGF1;DAB2IP;CSRNP1;ADIRF;NAMPT;LAGE3;SOX15;IL18;FOXM1;SBNO2;RUNX2;PSMC3;TNIP2;GLI1;NOS1;UBC;FADD;PPARGC1B;FGF7;PAX8;TNFRSF1A
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.49767496841618597,0.7686867425465393,0.7941176470588235,1.0,1.0,3/7,35.69%,DKC1;TRUB1;RPUSD2
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.5133381907941553,-0.7684325069861128,0.7959183673469388,1.0,1.0,3/6,20.15%,FADD;TNFRSF1A;CASP8
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.3655922843026724,-0.76837878740258,0.8,1.0,1.0,7/28,20.19%,APP;RPL10;RBM3;PRKCD;RBM4B;PGAM1;TMED10
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.4089823475592274,-0.7679612633870608,0.8529411764705882,1.0,1.0,2/15,7.22%,SVIL;BASP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.4434252739126106,-0.7678636715332385,0.7777777777777778,1.0,1.0,1/8,10.89%,ENTPD3
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.38623756271806936,-0.7676598981250538,0.7966101694915254,1.0,1.0,1/18,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.44369382820085923,-0.767507164097033,0.734375,1.0,1.0,2/9,16.79%,OAZ2;SLC29A4
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.41401237033247845,0.767404967501278,0.6857142857142857,1.0,1.0,9/13,34.72%,SLC25A18;SLC25A22;SLC25A14;SLC25A12;SLC13A5;LRRC8D;SLC1A2;SLC25A11;SLC25A13
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.44825568400069754,-0.7671210509381012,0.7758620689655172,1.0,1.0,4/12,32.22%,SREBF1;SEC14L2;SREBF2;RAN
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.47006687484466037,0.7667282319019854,0.7380952380952381,1.0,1.0,2/6,11.93%,BTRC;CRH
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.2874767853091964,0.7666877831445966,1.0,1.0,1.0,31/128,15.99%,DAO;SLITRK2;AMER2;ADGRA1;GABRG1;KCNA2;NTSR2;EGFR;ADGRB3;P2RY1;MAPK10;CHL1;TRPM3;GRIA2;BTBD17;ATP1A2;NRXN1;SLC4A4;CADM2;GPM6B;KCNJ10;SLCO1C1;ZEB2;SLC6A1;FAIM2;PMP2;ELAVL3;GRM3;GDF10;KIF1B;GPR37L1
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.40576458686678607,-0.7666857980893634,0.7741935483870968,1.0,1.0,3/14,17.91%,RPL35;PES1;RPL7
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3302642106105611,0.7666845577159505,0.9444444444444444,1.0,1.0,3/29,6.16%,NAF1;GREM1;MAP3K4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.4434665424082688,-0.7666785691571422,0.7586206896551724,1.0,1.0,2/8,12.99%,PDPN;EMP2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.36144659813816804,0.766571484989199,0.8,1.0,1.0,4/12,9.05%,ZNF207;SMC6;CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.26381524920194216,0.7663557420512986,1.0,1.0,1.0,30/135,18.99%,SAMM50;STXBP6;HSPA1A;BBS10;PSMD11;RAB5IF;MID1IP1;TTC12;HSF1;DNAJC28;CASQ1;NDC1;NCK1;PDE4DIP;POMP;TMEM35A;ADRB2;SGIP1;COX7A2L;NCK2;NUP205;PSMG2;VAMP3;PICALM;PIK3C2A;MKKS;DMD;DNAJB14;EPS15;CHCHD4
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.42029182692168643,0.7661183504570032,0.7073170731707317,1.0,1.0,1/11,1.09%,PDE3A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.29346578827011505,0.7659886748041189,0.8857142857142857,1.0,1.0,2/30,3.84%,NR1D1;TNFAIP3
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.43096464136107837,-0.7650624392738016,0.8208955223880597,1.0,1.0,1/13,3.94%,ATF3
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.45506366031274326,0.7644793997802277,0.7708333333333334,1.0,1.0,1/6,7.07%,CXCL13
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.38912869011366436,-0.7643967910529708,0.803030303030303,1.0,1.0,6/22,20.77%,RPS27A;NOD1;UBC;RIPK2;CASP8;IKBKG
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.35369880208687315,-0.7642180262000733,0.8701298701298701,1.0,1.0,10/48,19.40%,IL15;PTK6;SYK;BMX;FES;AATK;RELN;TEK;PDGFRA;GHR
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.41868978595202383,-0.764187173484637,0.8676470588235294,1.0,1.0,2/12,13.10%,BASP1;PAX8
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.447632795011075,-0.7641453069575957,0.7884615384615384,1.0,1.0,2/13,11.47%,ANGPTL7;AEBP1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.33223264351553217,0.7641247474880066,0.78125,1.0,1.0,4/23,6.87%,SMYD2;KMT5A;METTL18;VCPKMT
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),0.45205522305538615,0.763704242147473,0.7894736842105263,1.0,1.0,2/6,27.19%,EP300;GCK
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.246647747428304,0.7635976994868983,1.0,1.0,1.0,38/273,14.90%,MACIR;FHDC1;CEP19;SPAG16;BBS10;BBS9;RAB23;SSX2IP;EXOC8;CEP20;EXOC6;HAUS1;INTU;DZIP1;CSNK1E;CNGA4;CEP290;RAB8B;PTPN23;CEP152;FOXJ1;PLK1;PARVA;PCM1;CEP97;ALMS1;C2CD3;SCLT1;TEKT5;E2F4;TTC8;NEK1;UNC119B;TCTN3;IQCB1;CEP192;TUBG1;RAB8A
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.30439012371827573,0.7630726381632102,0.9444444444444444,1.0,1.0,11/44,20.54%,MOSMO;VCP;GAS1;INTU;BTRC;TUBD1;FBXL17;KCTD21;HERC4;GLI3;WDR11
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.4061532872139321,0.7627385748884538,0.8333333333333334,1.0,1.0,1/9,1.24%,NR1D1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.2555837195895392,0.7625227601722923,0.9523809523809523,1.0,1.0,14/88,14.81%,HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;CEP97;ALMS1;C2CD3;SCLT1;TCTN3;IQCB1;CEP192;TUBG1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.4343031667435801,0.7625094485399987,0.8,1.0,1.0,6/10,20.59%,COMMD1;GPM6B;TAX1BP3;LEPROTL1;PICALM;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.49082520480039776,-0.762228460287548,0.8769230769230769,1.0,1.0,2/8,7.41%,ANK3;GLRX
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.2619655524036792,0.7618313628672081,1.0,1.0,1.0,29/138,18.38%,WNT7A;ASCL1;NDNF;RUNX1;FUT9;POU3F2;HES6;EML1;PEX13;FZD8;TAFA1;ERCC6;ADNP2;HEYL;GPM6A;EMX2;CASP3;SH3RF1;PRUNE1;TUBB2B;LHX2;MARK2;LRP12;ACSL3;OLIG1;CEP85L;HEY1;DTNB;YTHDF2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3242156208653822,0.7612756292647735,0.7666666666666667,1.0,1.0,4/37,7.64%,RGCC;BRINP3;ANGEL2;GAS1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.3151793999750112,0.7612416339532885,0.8823529411764706,1.0,1.0,2/34,4.38%,EFNB2;EIF2S1
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.3663048307644938,-0.7611704999276458,0.8461538461538461,1.0,1.0,4/41,12.67%,ITPKC;INPP5D;NUDT4;PLCH2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.2735517014387008,0.7609198771596496,0.9565217391304348,1.0,1.0,11/79,15.48%,NR1D1;MACIR;TNFAIP3;PTGIS;SIRPA;CASK;DRD2;ENPP3;MUL1;RNF26;AJAP1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.3574397071137855,0.7608875020987274,0.775,1.0,1.0,4/14,12.99%,AR;NR3C1;ATP1A2;AKR1C3
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.398517447889819,-0.76079157022574,0.8333333333333334,1.0,1.0,4/23,15.88%,RPS27A;MAN1C1;UBC;MAN1A1
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),0.46812037603029333,0.760651948669748,0.8,1.0,1.0,2/7,5.81%,ABCB10;SLC25A37
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.3527755327316574,0.7605474464586114,0.7878787878787878,1.0,1.0,4/21,9.17%,ATP6V1A;DMAC2L;UCP3;ATP1A2
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),0.47220418819731474,0.7603243718301942,0.7727272727272727,1.0,1.0,1/6,2.36%,ABCA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3287925653528755,0.7601404740848398,0.9032258064516129,1.0,1.0,7/33,14.20%,POLD3;RFC3;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.4118910928254656,-0.760068532365077,0.7794117647058824,1.0,1.0,1/18,2.23%,RPS27A
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.41710123120426706,0.7600625269808928,0.7837837837837838,1.0,1.0,7/11,33.28%,ATL2;VAPB;STX18;VCPIP1;STEEP1;MOSPD3;BNIP1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.46749706233031385,-0.7596244701139212,0.7575757575757576,1.0,1.0,2/8,11.12%,PIK3IP1;DAB2IP
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.32315867789990194,-0.7596025207147369,0.9315068493150684,1.0,1.0,10/67,17.11%,PHEX;ST3GAL6;CHRM3;USP6;BAP1;B4GALT7;UBE2S;PLAT;PIGH;FBXL2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.37659428643902565,0.7594464492363899,0.7692307692307693,1.0,1.0,2/14,14.92%,ATR;POT1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.44123218815346066,-0.7585974927068925,0.8870967741935484,1.0,1.0,3/9,15.37%,APOBEC2;APOBEC3H;NUDT16
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4196520640116998,0.7578068066911529,0.75,1.0,1.0,4/8,15.88%,RUNX1;HMGB1;SH3RF1;TNFSF4
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),0.3535541800648015,0.757494874544964,0.7222222222222222,1.0,1.0,6/24,12.99%,SOX8;SOX9;NCOA4;AR;MSH2;AKR1C3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.45631920181394303,-0.7571119102277257,0.8448275862068966,1.0,1.0,6/10,33.48%,CCDC3;RFFL;GSTP1;TRAIP;GAS6;GPS2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.3031010452842073,-0.7568400472271378,0.9418604651162791,1.0,1.0,19/146,18.23%,TGFBR2;VRK2;PLK2;PRKCG;RPS6KA1;SBK1;PDK3;PRKCQ;PINK1;PRKCH;STK32B;PRKCD;CDK2;CDC7;HIPK4;PRKCB;CDK5;HIPK3;RPS6KA6
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.43148852963875695,-0.7568029830907219,0.7636363636363637,1.0,1.0,2/12,18.55%,HEXIM1;NELFE
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.3447130744340261,0.7564814906823077,0.7714285714285715,1.0,1.0,6/28,19.67%,LIMD1;PRKRA;CNOT8;AGO3;CNOT1;PUM2
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.3985021926120099,-0.7563441309702634,0.8450704225352113,1.0,1.0,2/20,10.92%,PLSCR1;LPCAT4
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.3790272021779627,-0.755604725738596,0.7384615384615385,1.0,1.0,8/20,26.88%,TRIM5;PML;TRIM62;CHMP2A;TRIM25;VPS4A;TRIM32;DDB1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.24886747972086115,0.7554461345686007,1.0,1.0,1.0,28/246,13.46%,NGF;NCSTN;BMP2;PHLDA1;AIFM2;BCL10;ARHGEF16;DUSP6;ACVR1C;ARHGEF12;PTGIS;C3ORF38;IP6K2;ZNF268;STK4;HMGB1;USP27X;TRADD;ATF6;ARHGEF26;MAPK8;TP53BP2;CASP3;TIAM2;CRADD;ERCC3;STK17B;PNMA3
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.3550959443425612,-0.7552504628803514,0.8266666666666667,1.0,1.0,4/38,13.10%,PROX1;SULF1;ITGA8;PAX8
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.26706749087030124,0.7549698737944348,1.0,1.0,1.0,16/95,15.34%,PSMD10;BCL10;TAB3;PSMA1;PSMD11;CUL1;MAPK10;PSMB5;BTRC;MAPK8;PSMD14;PIK3CA;PSMD12;NFKB1;PIK3R1;MAP2K4
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.3679042016733218,0.7548888587152203,0.8518518518518519,1.0,1.0,5/17,16.63%,BMP2;TRIB3;PRMT3;AKR1C3;ERLIN1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.30743471220974367,-0.754729447537878,0.9310344827586207,1.0,1.0,22/145,20.30%,SCN1B;STMN2;PTK6;RIT2;IL1RAPL1;MAG;PLPPR5;WNT5A;DAB2IP;PAQR3;CRMP1;FES;BDNF;MFSD2A;RELN;CDK5;PTPRO;LRRC7;DPYSL3;CX3CL1;CAMK1D;STX1B
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.45334749040780503,-0.7539509794128751,0.7413793103448276,1.0,1.0,1/9,2.46%,NOS1AP
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.4123949073207088,0.7539485670542024,0.6857142857142857,1.0,1.0,2/6,17.09%,FOXP1;NOC2L
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.4600421587785379,0.7539466646168894,0.7435897435897436,1.0,1.0,2/6,18.18%,SLC25A18;SLC25A22
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3633489773982993,-0.7537925914647982,0.8513513513513513,1.0,1.0,1/42,0.37%,S100A10
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.3371537944472323,-0.7530680569681523,0.8615384615384616,1.0,1.0,10/63,13.56%,GRIN3A;CDH23;RAMP3;TRPC3;SLC24A1;NIPAL2;SLC8A3;CACNA1C;TUSC3;SLC11A1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.2876076496853454,0.7530589369899141,1.0,1.0,1.0,8/77,8.86%,NGF;CNOT9;HCLS1;TENM1;EGFR;AKT1;STK4;CAPRIN2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.4682743386959491,0.7530166361761829,0.7045454545454546,1.0,1.0,1/6,12.79%,DRD2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.40845056629761156,-0.7523809020106964,0.8676470588235294,1.0,1.0,2/15,5.96%,CSPG4;BGN
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.4889594381478134,0.7523497280692558,0.7708333333333334,1.0,1.0,3/7,32.44%,SNAP29;VAMP8;STX17
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.4363875921098694,-0.7523234243372053,0.7457627118644068,1.0,1.0,2/11,7.96%,PROX1;ZFPM1
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.48312779633549663,-0.7517835924536252,0.8333333333333334,1.0,1.0,4/6,30.14%,TAC4;GRK2;TAC1;TACR1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.31297006573539193,-0.7514982154796802,0.9358974358974359,1.0,1.0,17/79,18.59%,POU4F1;KIF14;GPNMB;CCL2;PRKCG;MAG;UNC5B;PINK1;HLA-F;BDNF;NRBP2;CLN3;CD200;SNX6;CDK5;VSTM2L;FOXB1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.41253442296936293,-0.7512699268695798,0.8142857142857143,1.0,1.0,3/15,11.60%,ATP1A1;ATP1B1;TMPRSS3
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.2851542232018958,0.7512269323604838,0.9230769230769231,1.0,1.0,16/55,21.80%,ZDHHC16;ZDHHC14;PIGP;ZDHHC18;ZDHHC13;PIK3C3;ZDHHC20;ZDHHC5;ZDHHC21;GPLD1;GLUL;DPM1;PORCN;ZDHHC6;PIGF;PIGU
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.41575002957786916,-0.7510580811246103,0.8095238095238095,1.0,1.0,4/14,17.95%,CEMIP;CD44;HYAL1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),-0.5097172619595548,-0.7508754493764387,0.8076923076923077,1.0,1.0,3/5,41.84%,SIX4;AKIRIN1;MSTN
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.4425465657775255,-0.750578487083989,0.8421052631578947,1.0,1.0,2/10,14.82%,VIL1;WDR1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.2670147952243207,0.7504651655476466,1.0,1.0,1.0,20/53,28.62%,ELOVL6;ELOVL4;ELOVL2;HACD2;VAPA;SGMS2;PRKD1;VAPB;SPHK2;PLPP3;PPM1L;CERS3;SGMS1;ST3GAL2;PLPP1;DEGS1;ACER3;ELOVL7;CERS6;SGPP1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.39255759229110043,-0.7499114413597885,0.8524590163934426,1.0,1.0,2/14,16.10%,APP;ATOX1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3826097420639712,-0.7497809792403212,0.8032786885245902,1.0,1.0,4/20,21.03%,RPS27A;UBC;RBX1;CETN2
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.4410881144858518,0.7493664388758913,0.8,1.0,1.0,3/8,13.07%,SRI;ATP1A2;SPX
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.36273558859622995,-0.7493590851817653,0.875,1.0,1.0,1/28,0.18%,ANXA1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.4165205295005221,0.7492527116131598,0.8148148148148148,1.0,1.0,2/9,11.23%,CASQ1;ANK2
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.43294520646506446,0.7491069515335742,0.75,1.0,1.0,4/8,32.26%,ABI2;WASF3;NCKAP1;BRK1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.3264655381295518,-0.7490493429734428,0.9342105263157895,1.0,1.0,14/78,18.96%,ST6GAL1;GCNT1;CHST4;GALNT15;B3GNT5;GALNT10;B3GNT2;GALNT12;ST6GALNAC2;SDF2L1;MUC6;GALNT8;GALNTL6;MUCL1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.37741850243870667,-0.7488840630265773,0.8412698412698413,1.0,1.0,2/20,7.62%,CDKN2A;HEXIM1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.39533141392923,0.748650738175222,0.775,1.0,1.0,2/10,10.49%,RAP2C;RAB1B
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.3446930264141477,-0.7485619129479699,0.8387096774193549,1.0,1.0,2/23,4.46%,TJP3;LSR
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3169413935071798,-0.7484596179773187,0.9452054794520548,1.0,1.0,26/119,24.39%,TRIM22;TRIM5;PLK2;APP;IGF1;GAPDHS;PLEKHF1;PRXL2C;PIK3CB;PFKFB4;PRKCD;IRS2;PFKFB3;KAT5;TRIM65;OPTN;ADAM8;P2RX7;SH3D19;RDX;PFKFB2;MTLN;DXO;TRIML2;PTTG1IP;SVIP
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3766180435264682,-0.7483940496351917,0.8695652173913043,1.0,1.0,1/27,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.3724652052841735,-0.7483397543704234,0.8958333333333334,1.0,1.0,3/17,10.55%,RAB11A;CCND1;CCNB1
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.29656581806664734,0.7482401577053742,1.0,1.0,1.0,21/64,24.73%,PSMD10;BCL10;DCUN1D2;COMMD1;DCUN1D1;UBE2D1;RCHY1;DERL1;DCUN1D5;MUL1;NDFIP1;PIAS4;MALT1;SMAD7;TBC1D7;SENP2;DCUN1D4;UBQLN1;HSPBP1;FBXW7;AXIN1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2776090045723063,-0.7480395836650443,1.0,1.0,1.0,68/776,13.09%,LEF1;HPN;TRIM22;SKOR1;APLNR;POU4F1;PGR;TLR2;PLAG1;SPIN2A;HIC1;TRIM61;ANK3;NOS1AP;ZNF114;WARS1;PROX1;SFTPD;PTP4A3;TRIM5;MYT1;ELAVL2;RAMP3;TESC;OVOL2;SH3GL2;CASZ1;APP;KLF4;SCX;YBX3;SRRM4;BRCA1;LRRC19;TEAD2;TLR3;PARP14;NELL1;NKX6-2;PLSCR1;PARP9;EGF;ATP1B1;MOG;ZNF536;TRIM17;BTG1;IGF1;NFKBID;ADAM19;WNT5A;RIMS2;FGF1;HHLA2;PRKCQ;FN1;PRDM1;SFRP4;PINK1;SOX15;PTRH2;SBNO2;OGG1;RPS7;C1QTNF1;FAM50A;PPARGC1B;FGF7
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.28662077927669455,0.7479442747583578,0.9473684210526315,1.0,1.0,7/69,11.45%,RGCC;GNL3L;SDC4;VCP;SNF8;TIRAP;SMPD3
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.41328059338181855,0.7478258036984239,0.7894736842105263,1.0,1.0,1/11,5.94%,MFF
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.3907431175762587,-0.7477737762663565,0.8,1.0,1.0,6/24,19.62%,ANK3;NOS1;CD63;VIP;KCNAB3;KCNIP4
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3326107380821361,-0.7476787893078999,0.918918918918919,1.0,1.0,12/74,18.28%,CDKN2A;WARS1;SH3GL2;FBP1;DAB2IP;PAQR3;IRS2;TGFB1;CDKN2D;MAPT;NUPR1;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),-0.4757588785243562,-0.7474260938658724,0.7627118644067796,1.0,1.0,1/5,7.39%,TNFRSF14
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),-0.48570624626426184,-0.747321757420788,0.7222222222222222,1.0,1.0,1/5,3.00%,SLC39A14
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.3092777143665069,-0.7472356845530536,0.8666666666666667,1.0,1.0,10/88,12.84%,TRAM1L1;C1QL1;B4GALNT1;MAP1B;EFNB3;SCARA3;PFN2;DAB2IP;TUSC3;AMOTL2
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.4230092624999312,0.7470174514055047,0.8292682926829268,1.0,1.0,2/5,23.28%,WDR70;RNF20
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.2873750087506689,0.7467550824134964,1.0,1.0,1.0,8/58,15.38%,NR1D1;MACIR;TNFAIP3;PTGIS;SIRPA;ENPP3;MUL1;RNF26
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.3530621165759792,-0.7466540641842699,0.8769230769230769,1.0,1.0,6/41,14.47%,TGFBR2;TEAD2;ZFPM1;IFT122;RPL10;MFSD2A
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.3158450494497029,0.7462271639907391,0.9032258064516129,1.0,1.0,9/26,29.35%,ERI1;SNRPF;MTPAP;TENT4B;CPSF2;SNRPB;TENT2;LSM1;XRN1
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),-0.49382125960868306,-0.7458116053037751,0.7966101694915254,1.0,1.0,2/5,16.90%,THY1;CRB2
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),-0.49382125960868306,-0.7458116053037751,0.7966101694915254,1.0,1.0,2/5,16.90%,THY1;CRB2
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.41296696361804974,0.745391442171749,0.8461538461538461,1.0,1.0,3/9,30.10%,LTA4H;MGST2;CYP2C8
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4410094453988528,-0.7452989707228677,0.6964285714285714,1.0,1.0,1/7,5.89%,DUOXA1
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.4347688363277904,-0.7452662318705984,0.8431372549019608,1.0,1.0,2/13,10.72%,P3H2;OGFOD1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.4546911203862894,-0.7451048448387763,0.8363636363636363,1.0,1.0,1/9,1.11%,APLNR
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.2968443763331948,0.7447260629883113,0.8823529411764706,1.0,1.0,5/36,9.03%,PHC1;RNF2;EED;YAF2;RBBP4
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.3089796044464612,0.7447189578538193,0.8571428571428571,1.0,1.0,6/32,12.89%,RAP2C;TESK1;PDGFD;PDGFC;TAOK2;PPP2R5A
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.3400709964072231,-0.7444416515415024,0.803030303030303,1.0,1.0,3/26,18.12%,PLK2;CEP76;CCNF
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.45648430959729813,0.744202150246899,0.7272727272727273,1.0,1.0,1/6,24.10%,ADARB1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.42806512668224556,0.7441335526910308,0.8048780487804879,1.0,1.0,1/8,3.90%,BCO2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.29070734294393025,0.7440444220726561,0.9375,1.0,1.0,14/60,16.85%,NGF;ANP32B;VCP;TRADD;SLC22A2;ROBO1;EGLN3;CRADD;DAP;CFLAR;MUL1;BCL2L13;EIF2AK3;BAD
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.29632520085640146,0.7438801262106103,0.95,1.0,1.0,12/39,19.83%,CEBPA;RUNX1;HCLS1;TIRAP;CASP3;SLC25A5;PRDX3;FLVCR1;SNRK;SLC25A38;PRKX;DYRK3
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.32988061334277463,-0.7433259179523695,0.8641975308641975,1.0,1.0,8/67,14.21%,PLK2;PLK3;WNT5A;DAB2IP;HECW2;GPC3;VIP;OAZ2
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.42393510397986756,-0.7432335301746248,0.8676470588235294,1.0,1.0,1/12,2.77%,PROX1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.4428403650935152,-0.7429787385544946,0.8524590163934426,1.0,1.0,3/10,14.82%,VIL1;DSTN;WDR1
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.34168917488272166,-0.7429342300977219,0.90625,1.0,1.0,7/47,16.15%,ANXA1;STEAP3;SVBP;RIMS2;VIP;RAB3C;PTPRN
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.3017444981132948,0.7428318086203084,0.8666666666666667,1.0,1.0,10/65,11.34%,PSMD10;PSMA1;PSMD11;COPS8;CUL1;AKT1;PSMB5;BTRC;TIRAP;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.37533269425595484,-0.7427326806923991,0.8387096774193549,1.0,1.0,5/30,13.58%,TESC;GATA1;STAT1;THPO;FES
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.3559620534871749,-0.7426444782810961,0.8493150684931506,1.0,1.0,7/33,18.39%,SLC25A21;ABCB1;SLC38A4;SLC38A11;SLC38A1;ABCC1;SLC7A7
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.34374957382493526,-0.7421374152471707,0.8955223880597015,1.0,1.0,6/34,14.44%,RPS14;HELB;NOB1;RPS16;RPS8;TSR2
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.42756304717919,-0.741847577826352,0.7846153846153846,1.0,1.0,2/12,8.03%,TLR3;CHI3L1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.4196436431744673,-0.7415860020622213,0.75,1.0,1.0,4/9,22.35%,USP50;NLRC3;CD36;EIF2AK2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.26056032588922934,0.7413769783229556,1.0,1.0,1.0,15/63,19.94%,NR1D1;SOCS6;TNFAIP3;VCP;ADAMTS12;RSPRY1;ATE1;CTSV;FBXL17;VPS4B;RHBDD1;IDE;ZYG11B;MDM2;MALT1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.3478087965675676,-0.7408761888679813,0.9102564102564102,1.0,1.0,2/41,2.09%,GBP1;PSCA
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),0.4960718564041802,0.7408274317317093,0.8292682926829268,1.0,1.0,1/5,13.44%,ENPP3
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.46726197846179,-0.7406977869201559,0.82,1.0,1.0,3/6,26.54%,EDF1;PECAM1;KDM6B
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.3992778910674462,0.740511177728712,0.8235294117647058,1.0,1.0,6/14,23.50%,NOTCH2;HEYL;ROBO1;HEY1;HEY2;JAG1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.4640740520057567,0.7404126369022402,0.7551020408163265,1.0,1.0,2/5,13.55%,CEP152;E2F4
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.4507489879552302,0.7404109234924386,0.8627450980392157,1.0,1.0,4/6,29.09%,CUL1;CAND1;FBXL7;CAND2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.27819431004973294,-0.7396692038696782,0.9894736842105263,1.0,1.0,53/337,19.43%,C3;TLR2;B2M;TIMP2;ADGRE5;IMPDH1;ATP8B4;PRDX4;ARHGAP9;CTSC;TMC6;HLA-C;PLD1;CEACAM1;BST2;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;MMP25;PYGL;HLA-B;SYK;CD55;RHOF;TMBIM1;PSMC3;CTSZ;MVP;CD63;SLC11A1;CLEC5A;GPI;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;PGAM1;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2;CD36;FLG2;PLAUR
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.3969414974017078,-0.7389552645643194,0.796875,1.0,1.0,4/15,17.95%,CEMIP;CD44;HYAL1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.26341761064189795,0.7389322887648231,1.0,1.0,1.0,10/65,17.84%,HSPA1A;AR;HSF1;WASHC2C;TFIP11;WASL;PRKD1;EP300;CARMIL2;PON1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.4963813775654017,-0.7388764648345428,0.8461538461538461,1.0,1.0,5/7,29.59%,MVK;IDI1;DHDDS;HMGCR;MVD
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.4518858157430112,-0.7385899808728194,0.7903225806451613,1.0,1.0,2/8,18.13%,OGG1;TINF2
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.41044270571828056,-0.7384531644807104,0.8245614035087719,1.0,1.0,1/13,2.77%,PROX1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.3573662510127658,0.7384052653823863,0.7560975609756098,1.0,1.0,2/18,5.13%,SOX8;SOX9
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.48743369385711555,-0.738183774829984,0.8076923076923077,1.0,1.0,1/5,13.64%,SLC38A1
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.388427149553337,0.7371534237674144,0.7894736842105263,1.0,1.0,2/13,2.56%,PLD6;TEX15
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.30003224055835026,0.7371425080769126,0.9310344827586207,1.0,1.0,8/34,22.90%,QRICH2;CSNK2A1;CSNK2A2;EIF3H;FHIT;CCAR2;N4BP1;PDCL3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3643268720239129,-0.7370710348379842,0.8484848484848485,1.0,1.0,5/23,21.03%,RPS27A;UBC;RBX1;COPS5;CETN2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.34388687007013563,0.7366852657441763,0.9629629629629629,1.0,1.0,4/25,11.56%,AGER;ADCY1;EIF2AK4;CYP46A1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.3280275520057758,0.7363696552352155,0.8918918918918919,1.0,1.0,7/27,16.85%,MCU;GLUD1;CRH;DRD2;UCN;SLC30A8;BAD
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.43585855113491384,0.7362521208312977,0.8571428571428571,1.0,1.0,2/7,9.17%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.44708194084091335,-0.7357611412158438,0.796875,1.0,1.0,2/10,6.56%,SH3GL2;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.43213353084602124,-0.735747549418791,0.8125,1.0,1.0,2/13,6.56%,BRCA1;CEACAM1
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.49928831661070483,-0.7355354967337193,0.8095238095238095,1.0,1.0,2/6,25.06%,BDNF;FYN
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),0.3465721714090701,0.7354414925853957,0.78125,1.0,1.0,3/19,10.84%,ZDHHC11;APOBEC3F;EIF2AK4
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.4268335110048847,-0.7354225853851052,0.7941176470588235,1.0,1.0,1/10,16.59%,CLN3
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.37413162787833676,-0.7350518172786624,0.875,1.0,1.0,3/20,6.99%,DOK1;PTK6;HAP1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.2578309241886196,0.7348779667417007,0.9166666666666666,1.0,1.0,12/128,6.69%,RTRAF;SPRED1;MEN1;DUSP19;GSKIP;OCLN;PPP1R15B;FBLN1;GREM1;TRIB3;TESK1;AKT1
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.4299874602709064,-0.7346997433578519,0.82,1.0,1.0,4/8,24.14%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.4299874602709064,-0.7346997433578519,0.82,1.0,1.0,4/8,24.14%,BLVRB;ABCC1;ABCG2;HMOX1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.32847362631737614,0.733976377951045,0.8787878787878788,1.0,1.0,4/20,16.77%,ELOVL6;ELOVL2;HACD2;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.2916386643553463,-0.7334309149750922,0.9176470588235294,1.0,1.0,12/158,12.09%,THBS1;DUSP1;APLNR;IFI35;NLRP12;CAV3;STAT1;PIK3IP1;DAB2IP;PINK1;BCL2L2;CARD19
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.363132749454236,-0.7334051912134316,0.8360655737704918,1.0,1.0,1/24,2.23%,RPS27A
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.4650024332823587,-0.7330464564477749,0.7678571428571429,1.0,1.0,3/5,22.76%,SLIT3;SH2B3;SLIT2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.28537128538439477,-0.732893499141595,0.9767441860465116,1.0,1.0,20/150,16.66%,IL1R1;TPST1;ARG2;PAPSS2;ANGPTL3;FBP1;BLVRB;IGF1;GAD1;PINK1;F10;RAP1GAP;TNFRSF1A;SPINT2;NMT1;MAN1A1;GSS;PMM1;GCKR;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.32609629444112004,-0.7328109651650813,0.8734177215189873,1.0,1.0,8/53,18.19%,RIT2;LRPAP1;CALY;FLOT1;GPC3;ARFGAP1;TSC2;MCTP1
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.4484619131281941,0.7327592395467034,0.7567567567567568,1.0,1.0,1/5,10.13%,NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.4484619131281941,0.7327592395467034,0.7567567567567568,1.0,1.0,1/5,10.13%,NRXN1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.26655714070317194,0.7324398084965742,1.0,1.0,1.0,9/106,6.89%,RGCC;LIMD1;PSMD10;NDNF;ELOC;PSMA1;PSMD11;PTGIS;PSMB5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.40774896235076485,-0.7323264189659586,0.8135593220338984,1.0,1.0,4/12,22.98%,ISG15;SYK;HSPD1;STAT3
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.41106146377542085,-0.7321322334462866,0.8431372549019608,1.0,1.0,2/11,7.96%,PROX1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.4794045436231473,0.731653491149919,0.8181818181818182,1.0,1.0,2/5,12.67%,AKT1;SIRPA
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.26989218927144965,0.7315689266532771,1.0,1.0,1.0,15/106,13.78%,H2BC18;PSMD10;PSMA1;H2BC21;PSMD11;SOX9;ANP32B;PSMB5;ERCC2;PSMD14;ORC5;ERCC3;GTF2H5;GTF2H2;PSMD12
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3057815330499221,0.7314425691603443,0.84,1.0,1.0,6/46,8.86%,BMP2;MEN1;TRIB3;RALB;STK4;CAPRIN2
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.4516804489757017,-0.7311085074524053,0.8245614035087719,1.0,1.0,1/6,11.20%,SYK
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.41290116562296897,0.7309629698907067,0.8974358974358975,1.0,1.0,4/11,20.97%,TESK1;CEP97;EVI5L;TBC1D7
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.2925534435243095,0.7308783608878888,0.9666666666666667,1.0,1.0,23/58,26.55%,CDC25A;EIF2S1;YY1;ATR;PTPRK;EIF2AK4;POLK;SMPD1;EP300;NOC2L;RHBDD1;TRIAP1;USP47;MME;N4BP1;PARP1;ZBTB1;ERCC4;CUL4B;BAK1;SDE2;INO80;USP28
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.456457455576598,0.7307762938371227,0.7857142857142857,1.0,1.0,3/6,21.21%,CACNA1S;GSTM2;RYR1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.456457455576598,0.7307762938371227,0.7857142857142857,1.0,1.0,3/6,21.21%,CACNA1S;GSTM2;RYR1
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.3345132593585456,0.7307434800517173,0.8461538461538461,1.0,1.0,7/25,20.27%,ABHD17A;ABHD17B;ABHD17C;ARHGAP44;ABI2;PDLIM5;LZTS3
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.27478459610180717,-0.7305170677889958,0.9789473684210527,1.0,1.0,52/335,19.43%,C3;TLR2;B2M;TIMP2;ADGRE5;IMPDH1;ATP8B4;PRDX4;ARHGAP9;CTSC;TMC6;HLA-C;PLD1;CEACAM1;BST2;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;MMP25;PYGL;HLA-B;CD55;RHOF;TMBIM1;PSMC3;CTSZ;MVP;CD63;SLC11A1;CLEC5A;GPI;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;PGAM1;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2;CD36;FLG2;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.4317382637596515,-0.7304023135888464,0.859375,1.0,1.0,2/9,21.16%,CDC7;STOML2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.3280044337669262,-0.73039915920422,0.8405797101449275,1.0,1.0,12/57,17.25%,APLNR;PROX1;HTR2B;EGF;WNT5A;VIP;EGFL7;NR4A1;APLN;PIK3CD;F3;TEK
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.35757235445743596,-0.7301214950334995,0.8378378378378378,1.0,1.0,12/31,20.30%,GRIN2D;GRIN2A;GABRE;INSYN2A;GRIN2B;GRID2;GABRG2;GABRA1;GLRA1;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.35538512953930235,0.7300168367588852,0.8378378378378378,1.0,1.0,2/16,6.09%,PDK4;ZNF304
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.2739978455943631,-0.7300157148482302,0.968421052631579,1.0,1.0,52/338,19.43%,C3;TLR2;B2M;TIMP2;ADGRE5;IMPDH1;ATP8B4;PRDX4;ARHGAP9;CTSC;TMC6;HLA-C;PLD1;CEACAM1;BST2;CD44;CLEC12A;CHI3L1;IRAG2;CTSS;MMP25;PYGL;HLA-B;CD55;RHOF;TMBIM1;PSMC3;CTSZ;MVP;CD63;SLC11A1;CLEC5A;GPI;PRKCD;CAPN1;FRMPD3;ANXA2;PFKL;VCL;PGAM1;ENPP4;COTL1;SLC15A4;CTSA;HRNR;HEBP2;LRRC7;PGRMC1;PTGES2;CD36;FLG2;PLAUR
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.3936918700650638,-0.7299195668399115,0.90625,1.0,1.0,5/16,20.40%,MYH11;MYLK3;FHOD3;PDGFRA;CXADR
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3859495790534826,-0.7296898621322815,0.8333333333333334,1.0,1.0,1/11,6.29%,BRCA1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3125403285481049,-0.72919109606795,0.9473684210526315,1.0,1.0,12/69,17.44%,RPS27A;PSMB9;ANAPC11;CCNB1;PSMB6;PSMC3;UBC;UBE2S;PSMA8;CDK2;PSMA7;PSME1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3395990523402953,-0.7290135461678658,0.8933333333333333,1.0,1.0,7/29,13.52%,ICAM1;TENM4;IGSF21;IL1RAPL1;SELP;GRID2;NLGN1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.4184477892485505,0.7285715750307596,0.8108108108108109,1.0,1.0,1/8,7.32%,MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.44725085171706014,-0.7285393464494869,0.8070175438596491,1.0,1.0,3/9,24.11%,FLOT1;EHD1;CAMK1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.33368205176598337,0.7282818018862298,0.8809523809523809,1.0,1.0,2/22,3.13%,CHRNA4;KCNA2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.3678711311272424,0.7282715833172521,0.8421052631578947,1.0,1.0,4/15,24.54%,SPRED1;SPRED2;SMAD7;SIRT2
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.3806254928185605,-0.7274228984625136,0.8545454545454545,1.0,1.0,5/18,22.79%,PARP9;NAMPT;NNMT;NMNAT3;QPRT
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.3863235943439912,-0.7271944897769419,0.828125,1.0,1.0,1/19,2.77%,PROX1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.3602792473187188,0.727186012181176,0.8529411764705882,1.0,1.0,4/17,25.72%,RNF2;UBE2A;RNF168;CUL4B
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.41925223623047786,-0.7271841221375641,0.847457627118644,1.0,1.0,4/13,18.45%,DAB2IP;DDRGK1;HSPA5;COPS5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.38579829603475363,0.727161052134007,0.8372093023255814,1.0,1.0,1/11,2.88%,SERPINF2
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3015636436003127,0.7271361354159844,0.8235294117647058,1.0,1.0,17/62,24.38%,ERCC8;UBE2T;RNF146;RNF141;SH3RF1;RNF11;MARCHF7;KLHL24;TRIM52;CNOT4;UBE3D;MDM2;RNF208;UBE2A;ITCH;MARCHF5;RNF13
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.34533730843622357,0.7268554309608821,0.8387096774193549,1.0,1.0,1/16,0.89%,CFAP53
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.4611787930848322,-0.7267688550613337,0.7894736842105263,1.0,1.0,4/6,39.85%,RTN4RL1;INPP5F;CERS2;PTPRS
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.42254970915675716,0.7258144918772456,0.7619047619047619,1.0,1.0,1/8,5.99%,ABCD1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.33845159867180147,0.7257905637006473,0.8275862068965517,1.0,1.0,3/15,15.95%,GIT1;CBFA2T3;EP300
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2970529380110838,0.7257156110375931,1.0,1.0,1.0,5/48,6.69%,GNL3L;HSPA1A;TNFAIP3;BAG2;AKT1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3522191112121639,-0.725307201230201,0.9012345679012346,1.0,1.0,3/37,9.14%,LDLR;PRKCG;PFDN6
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),0.4708063398767689,0.7247539581385245,0.8627450980392157,1.0,1.0,2/6,5.81%,ABCB10;SLC25A37
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.44568069182885317,0.72461684584759,0.8125,1.0,1.0,2/7,18.68%,EGFR;MAP2K2
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.4706294594016801,-0.7243902189979181,0.8301886792452831,1.0,1.0,1/6,4.75%,SULF1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.29619371285395407,0.724179144519759,0.9655172413793104,1.0,1.0,10/38,18.69%,MYO10;TENM1;ARAP1;RALA;GPM6A;TENM2;WASL;PIK3R1;ARHGAP44;FXR2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.35876575142841743,0.7240550943128687,0.9090909090909091,1.0,1.0,2/17,6.13%,MYBPC1;TCAP
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.35876575142841743,0.7240550943128687,0.9090909090909091,1.0,1.0,2/17,6.13%,MYBPC1;TCAP
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.3025432265935166,-0.7240364966607712,0.9634146341463414,1.0,1.0,7/77,11.88%,PSRC1;KIF14;RAB11A;CENPE;NCAPD3;CCNB1;KIF2C
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.3682616851411895,-0.7234079504558938,0.8484848484848485,1.0,1.0,8/32,18.75%,NLRC5;ISG15;SUSD4;SERPING1;USP18;NMI;A2M;NLRC3
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.43511925417897335,-0.723301563103338,0.8059701492537313,1.0,1.0,1/8,6.08%,DYSF
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.4660520023728398,0.7229454133690674,0.8666666666666667,1.0,1.0,2/6,3.54%,PPARGC1A;ADIPOR1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.39664711134191083,-0.722318944868438,0.803030303030303,1.0,1.0,1/15,2.20%,ZFP36
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.3329409362500635,0.7221043772484498,0.9259259259259259,1.0,1.0,4/30,9.29%,CFAP53;ODAD3;FOXJ1;STIL
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.44134781836923676,0.7217589499671624,0.8604651162790697,1.0,1.0,1/5,12.58%,ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.3060108121996609,-0.7215075423903312,0.9647058823529412,1.0,1.0,9/107,11.12%,SCN1B;STMN2;SLITRK1;PTK6;RIT2;IL1RAPL1;PLPPR5;WNT5A;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.319727639194052,-0.7207806718154975,0.8947368421052632,1.0,1.0,6/57,10.55%,PSRC1;PROX1;APP;PTK6;CCND1;CCNB1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.37963765260678706,0.7206500389119239,0.7931034482758621,1.0,1.0,8/17,24.87%,TRAK2;MUL1;MARK2;MSTO1;MARK1;ZBED3;NECTIN2;MFN2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),0.3256011483004344,0.7206075897805246,0.8378378378378378,1.0,1.0,6/27,9.38%,SOX8;SOX9;NCOA4;AR;SALL1;MSH2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.28881827303988317,0.7205150813447309,0.9310344827586207,1.0,1.0,3/27,12.58%,BMP2;GPM6B;ACVR2A
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.466136989913975,-0.7200984469907764,0.7924528301886793,1.0,1.0,3/5,37.29%,DPM3;DPY19L1;DPY19L2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.466136989913975,-0.7200984469907764,0.7924528301886793,1.0,1.0,3/5,37.29%,DPM3;DPY19L1;DPY19L2
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.4141120151165142,-0.7197354765374456,0.8301886792452831,1.0,1.0,1/9,12.53%,SEC11C
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.4420555873620776,-0.7196716856741426,0.7777777777777778,1.0,1.0,1/6,16.44%,CDC7
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37257560243735327,0.719509185962384,0.8918918918918919,1.0,1.0,10/17,36.93%,PPP1R1B;STYXL1;PPP4R4;ROCK2;MASTL;CRY2;PTPA;ROCK1;IKBKB;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.4064190949845712,-0.7194066320577657,0.8833333333333333,1.0,1.0,2/13,12.23%,CAV3;SLC43A2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.35037352332722527,0.7193558820890068,0.8913043478260869,1.0,1.0,4/16,21.45%,MITF;MED30;MED4;SUB1
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.46114701486255405,0.7193293382887038,0.7954545454545454,1.0,1.0,2/5,12.50%,HMGB1;FBXO38
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.3761368775306607,-0.719321082027859,0.8518518518518519,1.0,1.0,4/18,12.60%,CAV3;C12ORF57;SLC8A3;NOS1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.46342213775483865,0.7183465124360341,0.8918918918918919,1.0,1.0,1/6,0.44%,WNT7A
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.3529371866414801,-0.718182658347212,0.9027777777777778,1.0,1.0,4/30,18.14%,PLEKHG2;PFN2;COTL1;MAPT
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.4078632599662215,-0.7175132816450805,0.8888888888888888,1.0,1.0,3/15,11.93%,GPR183;SNX10;SBNO2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.3883577026303887,-0.717438671866567,0.8484848484848485,1.0,1.0,4/12,23.13%,USP50;PML;ETS1;WRAP53
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.32422256202748617,-0.7173019162799504,0.927536231884058,1.0,1.0,5/56,6.56%,WARS1;CAMK2N2;THY1;CAV3;CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.33399543446800384,0.7169401493252355,0.7894736842105263,1.0,1.0,6/19,21.18%,SRI;ATP1A2;DRD2;GSTM2;GPR35;PKD2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.4003338671368492,0.7169306217069289,0.8536585365853658,1.0,1.0,2/8,12.04%,ZNF703;ROBO1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.3193165258885288,-0.7165593193756608,0.9027777777777778,1.0,1.0,6/46,19.49%,WNT8B;MAP1LC3A;RPL23;CLN3;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3205588715106315,-0.7165096204594389,0.8955223880597015,1.0,1.0,15/57,20.22%,POU4F1;KIF14;CCL2;PRKCG;MAG;UNC5B;PINK1;BDNF;NRBP2;CLN3;SNX6;VSTM2L;FOXB1;CX3CL1;SET
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.325559570965027,-0.716165845871227,0.9066666666666666,1.0,1.0,15/53,24.05%,DHCR24;ABCA5;ANGPTL3;SQLE;MVK;SOAT1;FDPS;INSIG1;MSMO1;HMGCS1;HSD17B7;ACAT2;APOL2;IDI1;LSS
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.3933278686477165,-0.7161481725563204,0.8387096774193549,1.0,1.0,1/13,6.47%,POLE3
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.4432641789556054,-0.7160842834040156,0.8703703703703703,1.0,1.0,4/7,33.09%,CD4;HYAL2;PPIA;GAS6
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.4432641789556054,-0.7160842834040156,0.8703703703703703,1.0,1.0,4/7,33.09%,CD4;HYAL2;PPIA;GAS6
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3797609224700599,0.71573743392576,0.868421052631579,1.0,1.0,4/11,17.84%,KMT2A;WNK3;SGK2;PON1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.44364079875739276,0.7149585535293626,0.851063829787234,1.0,1.0,1/6,31.34%,GPATCH3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4224856412784495,0.7146814241698008,0.8333333333333334,1.0,1.0,1/7,3.40%,PDE3B
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.4424636950778225,0.7146717146488564,0.7948717948717948,1.0,1.0,1/8,5.44%,RNF2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.31044167575507225,0.7143346183884812,0.9117647058823529,1.0,1.0,7/24,14.84%,TENM1;ARAP1;RALA;GPM6A;TENM2;WASL;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.37861501036857753,-0.7141209552700915,0.8493150684931506,1.0,1.0,4/19,17.95%,LTBP4;EID2;ITGA3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.40750610894860645,-0.7137728872107457,0.8548387096774194,1.0,1.0,3/14,9.24%,NLRP12;CEACAM1;IGF1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3793187519830175,-0.7137675223172866,0.8513513513513513,1.0,1.0,3/21,11.37%,CAV3;ATP1B1;KCNG1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.41149103579383317,0.7134233223116837,0.7560975609756098,1.0,1.0,1/6,11.49%,KMT2A
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.3346568722443181,-0.7132449543087176,0.9090909090909091,1.0,1.0,3/36,13.10%,SCX;POLR2I;PAX8
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.41517258090101006,-0.7130999948145004,0.9076923076923077,1.0,1.0,3/12,23.02%,WAS;FHOD1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.4222842876972379,-0.712644859255811,0.8571428571428571,1.0,1.0,1/7,8.69%,WAS
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.3732547739601359,-0.712394395508926,0.8421052631578947,1.0,1.0,7/16,28.78%,APLN;OXTR;FOXB1;WNT3;GLI2;NRG1;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3541848728780703,0.7121350108327721,0.8837209302325582,1.0,1.0,2/22,5.64%,LIMD1;EGFR
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.4067559316909479,-0.7121071280478222,0.8064516129032258,1.0,1.0,1/13,1.45%,TGFBR2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.31230530527307643,-0.7120494760966769,0.8783783783783784,1.0,1.0,18/58,19.26%,ADGRE5;RAMP3;ADCY7;S1PR3;LGR5;ADCY5;GNG2;GPR12;RXFP1;CNR1;VIP;PTH1R;GLP1R;ADCY3;ADCY8;GPER1;ADM;ADGRG2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.27853042347933904,-0.7119409013230872,1.0,1.0,1.0,42/184,23.72%,TRIM22;TLR2;RPS27A;TRIM5;APP;NOD1;BEX1;SLCO3A1;NEUROD2;SRF;WNT5A;PRKCQ;IL18;PRKCH;FLOT1;UBC;PPARGC1B;IL1RAP;DDRGK1;RELN;CD200;ADCY8;PRKCB;RIPK2;CARD11;COPS5;ALK;CD36;ARID5B;CX3CL1;CAMK1D;TRIM62;IKBKG;ADAM8;STK3;EIF2AK2;NODAL;STAT3;NFKB2;CARD14;TRIML2;IKBKE
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.44891205193734207,-0.7116630768805151,0.8813559322033898,1.0,1.0,3/7,25.01%,ATP1B1;ATP1B3;WNK4
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.28975274300822534,-0.7115178790230386,0.9655172413793104,1.0,1.0,24/140,17.95%,THBS1;MET;P2RY12;RAMP3;EGF;CHI3L1;THPO;TGFA;FGF1;PINK1;IL18;F10;FGF7;PIK3CB;VAV1;PIK3CD;F3;FGF22;TSC2;IRS2;TEK;GPER1;LRP2;TGFB1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.43083908816237204,-0.7114735469578921,0.8181818181818182,1.0,1.0,3/8,24.09%,RPS7;EIF5A;PTTG1IP
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.34491871677604913,-0.7112051672606771,0.8947368421052632,1.0,1.0,4/22,18.19%,ICAM1;TNIP2;TEK;NUPR1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3492839352446036,-0.7111169208080641,0.8493150684931506,1.0,1.0,2/35,8.19%,BLM;DONSON
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4214058258223212,-0.7110014223461647,0.847457627118644,1.0,1.0,1/11,13.60%,SLC51B
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.30518408253108553,-0.7105454042364502,0.9358974358974359,1.0,1.0,11/86,15.80%,WARS1;NEUROD2;FRMPD4;DAB2IP;SYK;CALY;DCTN1;FLOT1;GPC3;HYAL1;RELN
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.4298483738685877,0.7105325202701519,0.8292682926829268,1.0,1.0,2/7,14.75%,CA2;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.3614734647662322,-0.7101337741354286,0.8923076923076924,1.0,1.0,1/25,0.55%,PIF1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3512087795451368,0.7097331377673853,0.8181818181818182,1.0,1.0,3/19,7.61%,SRI;SELENON;JPH1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.34197878211233923,0.7097287904310053,0.8611111111111112,1.0,1.0,3/18,14.23%,KPNA2;CHMP2B;VPS37B
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.30841685735318874,0.709374253077414,0.8787878787878788,1.0,1.0,4/27,12.50%,TENM1;CEP290;PCM1;UHMK1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.33366364667689036,-0.7084960540618139,0.890625,1.0,1.0,3/40,7.35%,RASGRP1;CD44;LFNG
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.3346188807010352,-0.7084621515756467,0.9,1.0,1.0,1/30,1.88%,MAEL
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.38477080154853777,-0.7083987994189559,0.8688524590163934,1.0,1.0,2/13,20.22%,RPL23;SET
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.3660835587172383,0.707735192441269,0.8181818181818182,1.0,1.0,2/9,15.53%,CAPRIN2;CAPRIN1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.27505246515839465,0.7076013102161535,1.0,1.0,1.0,28/121,17.32%,FEZF2;ASCL1;AMER2;ADGRA1;FUT9;POU3F2;SNAP91;ADGRB3;GRIA2;NOVA1;FAT3;STIM2;UNC79;NRXN1;CADM2;GPM6B;ANK2;SOX5;ROBO1;ELAVL3;NDRG4;SLC35F1;GRM3;PURG;KIF1B;RBFOX1;CACNA1B;ABI2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3154359345265952,-0.7073696617231147,0.9583333333333334,1.0,1.0,6/58,12.44%,PODXL;FSCN1;PLD1;GAP43;WAS;DMTN
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),-0.43788628671147367,-0.7071106575849975,0.8596491228070176,1.0,1.0,2/6,22.62%,FLOT1;EHD1
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.4034479815339336,0.7070771673417211,0.8378378378378378,1.0,1.0,2/8,23.68%,TASOR;FZD5
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.3868654825046744,0.7070358620662871,0.868421052631579,1.0,1.0,6/13,34.31%,NIPBL;NAA50;POGZ;PDS5B;DSCC1;RB1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.4395156597922927,0.7065968585832758,0.8163265306122449,1.0,1.0,1/6,16.41%,PDZD8
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.32219070845039816,0.706284014132157,0.88,1.0,1.0,2/21,8.89%,PIK3R4;AP2B1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.26180447161760484,0.7058791161213378,0.9655172413793104,1.0,1.0,19/85,18.31%,NGF;BCL10;ACVR1C;ANP32B;VCP;HMGB1;TRADD;SLC22A2;ROBO1;EGLN3;CRADD;DAP;CFLAR;MUL1;BCL2L13;EIF2AK3;BAD;PRR7;PDCD2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.34930207183955064,0.7058178103760372,0.8387096774193549,1.0,1.0,7/24,21.01%,BMP2;HES6;HEYL;HEY1;HEY2;HES5;PCSK5
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.37711921154499795,0.7057718257678394,0.8787878787878788,1.0,1.0,3/9,33.08%,MBNL1;MYH3;LRP6
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.43121699711634526,-0.7057703024511477,0.84375,1.0,1.0,4/10,36.78%,STK24;RTN4RL1;INPP5F;CERS2
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.3684681625923677,0.7057632725268435,0.8571428571428571,1.0,1.0,3/11,12.31%,AKT2;AKT1;EPM2AIP1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.3416741962279514,0.7054434274203196,0.8285714285714286,1.0,1.0,2/18,3.66%,TNFSF13B;CD320
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),0.4083932120534182,0.7053243378745752,0.8205128205128205,1.0,1.0,3/6,23.65%,HDAC10;SRM;SAT1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.3422531967602444,-0.7052488945740912,0.8787878787878788,1.0,1.0,5/35,12.44%,RPS14;GATA1;ZFPM1;ATP5IF1;DMTN
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.30200113353354124,0.7051111346109724,0.9285714285714286,1.0,1.0,8/32,18.23%,ADCY1;NCOA4;AR;NR3C1;AKR1C3;TNFSF4;ADAM15;SPHK2
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.3761634000667784,0.705110533215176,0.851063829787234,1.0,1.0,1/8,6.83%,PTGIS
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.34177297232345444,-0.7046423775657875,0.9253731343283582,1.0,1.0,3/36,11.85%,PARP9;WAS;FOXM1
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.46860646589101335,-0.7045930606763386,0.8163265306122449,1.0,1.0,1/6,6.79%,SCARA3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.41105046816356267,0.7039831054206239,0.8181818181818182,1.0,1.0,3/7,26.53%,RBPJ;CCM2;STARD13
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4394563737726278,-0.7037731746198299,0.84375,1.0,1.0,1/7,16.44%,CDC7
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.2895583758903511,0.7037279747494116,0.95,1.0,1.0,6/42,13.22%,CYP7B1;PMVK;INSIG2;CYP46A1;AKR1C3;SCP2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),-0.4476809237415489,-0.7037043933239091,0.9122807017543859,1.0,1.0,5/7,29.91%,AKAP6;CALM3;GSTO1;TRDN;JPH2
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.4712391346618193,-0.7029647290539245,0.8076923076923077,1.0,1.0,3/5,33.52%,TRIM25;CLPB;OAS3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.42649002481893633,-0.702307735698961,0.8070175438596491,1.0,1.0,3/8,25.01%,ATP1B1;ATP1B3;WNK4
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.34265664754927094,-0.7016051115614976,0.9090909090909091,1.0,1.0,6/27,17.88%,ATP8B4;ABCB1;PLSCR1;MFSD2A;ATP8B1;ABCC1
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.43638556928475725,0.7009471482783618,0.8958333333333334,1.0,1.0,2/5,12.02%,SLC47A1;SLC22A2
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.23724224166981223,0.7008670955144147,1.0,1.0,1.0,34/185,20.16%,U2AF1;KPNA2;CCT7;PSMA1;EIF2S1;SF3A1;CUL1;TRIM28;AP3S1;HNRNPC;XPO1;SNRPB2;CCT3;EIF4E;PSMD14;ERH;G3BP1;DDX21;SYNCRIP;LSM7;KARS1;HDAC2;HNRNPU;PRDX3;MRPL9;FAM120A;CNBP;CLNS1A;DHX15;NOP56;EIF1AX;FBL;MCM6;SLC25A3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.30549661437540954,0.7008330232612132,0.9310344827586207,1.0,1.0,7/35,14.20%,POLD3;RFC3;ERCC2;ERCC3;GTF2H5;GTF2H2;POLK
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.3255208475157939,-0.7008176063238545,0.9166666666666666,1.0,1.0,9/38,17.49%,B3GALT2;HS3ST3A1;B3GNT2;GPC3;B4GALT7;HS3ST3B1;HS6ST1;GPC1;PXYLP1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3289046938822641,-0.7007979897602935,0.9264705882352942,1.0,1.0,13/40,23.30%,DOK1;GFI1B;GATA1;BLVRB;PRSS57;FES;EMP3;RASSF1;FERMT3;IKBKG;CCS;DPM3;MFSD2B
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3648843235163558,-0.7007650159036,0.8529411764705882,1.0,1.0,7/23,17.04%,RASGRP1;RASGEF1A;IGF1;VAV1;RELN;ERBIN;IRS2
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.42387422526477436,-0.7006293106496141,0.875,1.0,1.0,5/9,28.43%,PRKCB;CD36;ZDHHC3;PPARG;LRP1
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.4113107137107204,-0.7002449480066234,0.8666666666666667,1.0,1.0,2/10,11.66%,HES7;BMX
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.2629100115925668,0.7000818665872472,1.0,1.0,1.0,25/81,26.13%,STXBP6;EXOC8;LLGL1;COMMD1;EXOC6;AP1B1;AP1S3;SCFD1;FTL;GOLGA7;EXOC5;EPS15;KLHL20;BLOC1S4;MYO5A;ARL3;ACBD3;SCAMP2;MON2;AP1M1;EXOC6B;ARRB1;SORT1;RABIF;SCAMP1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.41178601147201543,-0.69988234112345,0.8225806451612904,1.0,1.0,1/8,17.19%,PRKCB
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.36519713110386565,0.6998413009016696,0.7368421052631579,1.0,1.0,2/12,6.09%,PDK4;ZNF304
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.3050108706288698,-0.6992904707714437,0.9726027397260274,1.0,1.0,8/54,17.44%,RPS27A;PSMB9;PSMB6;PSMC3;UBC;PSMA8;PSMA7;PSME1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.4511046517821471,-0.6987788385008346,0.8909090909090909,1.0,1.0,3/5,27.81%,MAPT;BEX4;TPPP
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.4474038780856714,-0.6985041553891905,0.76,1.0,1.0,1/5,4.06%,SH3GL2
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.334296927007702,0.6983680764903872,0.9,1.0,1.0,1/20,2.00%,RAB33B
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.4204099769646585,-0.698146662298927,0.875,1.0,1.0,2/7,7.79%,AKR1C1;LDLR
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.3846237030598179,0.6980790187810587,0.8717948717948718,1.0,1.0,2/14,5.71%,DSCAM;BSG
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.4435554444684501,0.697346757895775,0.918918918918919,1.0,1.0,3/5,38.73%,MIA3;BCAP31;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.43241906134218944,-0.6970477815766738,0.8360655737704918,1.0,1.0,1/7,11.44%,DDX60
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.44718982876774327,-0.6967806529113231,0.85,1.0,1.0,3/5,32.65%,PPARG;CTBP2;PER2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.2730989313764682,0.6967220995459186,0.96875,1.0,1.0,8/58,11.49%,PSMD10;RUNX1;PSMA1;PSMD11;LMO1;PSMB5;PSMD14;KMT2A
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.4391178283487891,-0.6965631689862487,0.8656716417910447,1.0,1.0,4/6,30.81%,TGFB1;TGFB2;TGFB3;MSN
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.31862596085631434,0.6964351785523798,0.8205128205128205,1.0,1.0,6/26,17.50%,CSNK2A1;CHPT1;CSNK2A2;LPIN3;PCTP;CEPT1
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.3682405617312693,0.6964201404578518,0.8529411764705882,1.0,1.0,3/11,16.66%,ACADM;CPT2;CPT1A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.41972745361608077,0.6962546673787418,0.75,1.0,1.0,3/5,40.04%,EPB41L2;EPB41;NUMA1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.3544549311334218,-0.6962460173671503,0.9014084507042254,1.0,1.0,5/31,15.10%,RPS27A;ANLN;ANAPC11;UBC;UBE2S
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.4184152187980964,0.6962096134612099,0.8974358974358975,1.0,1.0,3/7,26.69%,QDPR;ASRGL1;KYNU
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.31062263513901356,0.6958558084886828,0.9428571428571428,1.0,1.0,6/23,24.64%,HSPA1A;DNAJB14;DNAJC18;DNAJB5;HSPA13;DNAJB12
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.28396402705332935,-0.6948564681984528,1.0,1.0,1.0,19/165,18.12%,CCNB2;SUV39H1;POLQ;CCND1;CENPE;EGF;GINS2;LMNB1;KIF2C;SQLE;SLC38A1;CDKN3;UBE2S;STMN1;CDC7;PML;CBX1;TGFB1;CCNF
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.3596713471861599,-0.6948073987725324,0.9310344827586207,1.0,1.0,6/18,23.37%,PSMB9;PSMB6;PSMA8;PSMA7;PSMA3;ENC1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.4508899912459877,-0.6947628247605172,0.8867924528301887,1.0,1.0,5/5,54.93%,MTMR1;MTMR3;MTMR4;MTMR2;MTMR9
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.4265468348959602,-0.6943410595234534,0.8545454545454545,1.0,1.0,4/8,21.77%,THPO;ANXA2;ZNF385A;SH2B3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.30194796490625275,0.6942692616617963,0.9375,1.0,1.0,3/25,6.23%,SDC4;SDC3;GPC5
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.40326027414215676,0.6941349708639458,0.825,1.0,1.0,1/7,9.07%,MEGF10
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.30822272785308147,-0.6941134070204108,0.9722222222222222,1.0,1.0,13/54,30.11%,RPS27A;UBC;DDRGK1;LGALS8;DYNC1LI2;HDAC6;SQSTM1;ULK1;ULK2;PARK7;RETREG1;ATG14;CFTR
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.3735558630771143,-0.6939635569354637,0.9324324324324325,1.0,1.0,1/19,2.16%,LAMB1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.36692990706073636,-0.6935205908831019,0.847457627118644,1.0,1.0,3/20,18.89%,SULF1;CRB2;TBX20
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.31419495210485693,0.6931864979636067,0.8372093023255814,1.0,1.0,2/21,5.13%,SOX8;SOX9
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.35081111992776615,-0.6920436662031694,0.9375,1.0,1.0,6/26,19.00%,P2RY12;PIK3IP1;DAB2IP;TEK;TGFB1;PDGFRA
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.3081310388692841,-0.6920157254815709,0.9102564102564102,1.0,1.0,10/58,15.76%,NR4A3;BAIAP2;WAS;PLD2;PLPP4;SYK;ELMO1;PIK3CB;VAV1;PRKCD
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.41135921183839175,-0.6919264733855176,0.8709677419354839,1.0,1.0,4/9,24.96%,SLC29A4;ANTXR1;SLC22A1;RAB40B
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.447930292416601,-0.691830098155249,0.8846153846153846,1.0,1.0,1/7,14.79%,PNKD
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.28090909369446004,0.691704832560044,0.96,1.0,1.0,10/31,25.55%,VCP;MRRF;MTIF2;DENR;GFM2;UFM1;DYRK3;EIF2D;ZFAND1;ATG2B
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.259750065585979,0.6916546415072617,1.0,1.0,1.0,11/75,14.81%,HMMR;ATF5;HAUS1;CSNK1E;CEP290;CEP152;PLK1;PCM1;ALMS1;CEP192;TUBG1
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.452563561035324,0.6910213113125009,0.8979591836734694,1.0,1.0,3/6,47.08%,GBA2;FUCA2;GLA
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.452563561035324,0.6910213113125009,0.8979591836734694,1.0,1.0,3/6,47.08%,GBA2;FUCA2;GLA
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.46040697007692044,-0.6907348345596396,0.8461538461538461,1.0,1.0,3/5,32.63%,P2RX7;SHANK3;ANO6
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3597720274271883,0.6899558392967987,0.9117647058823529,1.0,1.0,3/14,10.13%,NLGN3;CACNG2;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),0.39463142354693437,0.689798583788754,0.926829268292683,1.0,1.0,1/9,7.15%,FBXO5
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.47296974043336787,-0.6896659148883316,0.8461538461538461,1.0,1.0,2/5,30.38%,PAF1;CTR9
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.47296974043336787,-0.6896659148883316,0.8461538461538461,1.0,1.0,2/5,30.38%,PAF1;CTR9
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.37103627782748977,-0.689644592683489,0.873015873015873,1.0,1.0,3/21,18.26%,BHMT;EEF1AKMT2;EEF2KMT
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.3661413912110598,0.6893403978174543,0.9259259259259259,1.0,1.0,3/12,12.31%,AKT2;AKT1;EPM2AIP1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.30904575616943186,-0.6892166508345818,0.9342105263157895,1.0,1.0,17/64,22.58%,B3GALT2;GCNT1;FUT2;ST3GAL6;IGF1;B3GNT5;B3GNT2;ST6GALNAC2;B4GALT7;ALG1L2;ST8SIA3;B3GALT4;CHST10;CHST9;CHST12;B3GALNT1;ST8SIA1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.3685363749612536,-0.6888605585946301,0.859375,1.0,1.0,4/15,17.15%,ADCY7;ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.2978576959904148,-0.6888114749836205,0.9629629629629629,1.0,1.0,9/57,12.36%,TLR2;NLRP12;APP;TLR3;WNT5A;SCIMP;HLA-B;SYK;IFIH1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.3239658913036949,-0.6887615316859662,0.8307692307692308,1.0,1.0,8/27,20.48%,IFT122;PRICKLE1;DLC1;TSC2;DEAF1;LRP2;TGFB1;SEMA4C
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.3239658913036949,-0.6887615316859662,0.8307692307692308,1.0,1.0,8/27,20.48%,IFT122;PRICKLE1;DLC1;TSC2;DEAF1;LRP2;TGFB1;SEMA4C
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.4088133537949093,0.6880257969366059,0.8780487804878049,1.0,1.0,1/6,3.46%,NDNF
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.3340185102483034,0.6880022536480982,0.8918918918918919,1.0,1.0,8/19,26.62%,PPARGC1A;KAT7;BRD7;SPHK2;TADA2B;RPS6KA4;ARRB1;SMAD4
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.36760024965351246,-0.6877533946576744,0.9122807017543859,1.0,1.0,3/13,18.65%,DCTN1;CLMN;SYNE3
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.32275194860182477,0.6875384440096822,0.96875,1.0,1.0,4/17,23.21%,CYTH3;FERMT1;GOLPH3;EZR
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.36200705589656107,-0.6874903303811292,0.8533333333333334,1.0,1.0,2/19,4.06%,STMN2;SH3GL2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.41209582144615525,-0.6874414109108885,0.84375,1.0,1.0,3/10,15.47%,GCNT1;SELP;ADD2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.42244284906597923,0.6866783677813032,0.7954545454545454,1.0,1.0,1/7,2.88%,SERPINF2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.3480210321387846,0.6862800704524024,0.9,1.0,1.0,5/12,23.01%,XPR1;SLC37A1;SLC20A1;SLC25A3;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.3480210321387846,0.6862800704524024,0.9,1.0,1.0,5/12,23.01%,XPR1;SLC37A1;SLC20A1;SLC25A3;SLC25A14
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.35185580590165877,-0.6861946957400504,0.9041095890410958,1.0,1.0,11/27,26.38%,CCDC39;ODAD1;SPAG1;DRC1;CFAP73;DNAH17;DNAAF1;ODAD4;CFAP100;CCDC40;DNAI2
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.3700167122225682,-0.6859479487620024,0.9122807017543859,1.0,1.0,2/15,18.13%,OGG1;TINF2
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.43327045615844584,-0.6858720415587621,0.7868852459016393,1.0,1.0,1/6,6.29%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.36594265812795496,-0.6857186960117821,0.88,1.0,1.0,2/22,9.24%,ARG2;IGF1
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.37085756140703335,-0.6851160531889581,0.9180327868852459,1.0,1.0,1/12,6.29%,BRCA1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.29658948531607543,-0.6851040555194193,1.0,1.0,1.0,15/63,21.77%,TGFBR2;ARIH2;ZFPM1;WNT5A;RUNX2;SFRP2;TEK;TGFB1;ETV6;GLRX5;RRAS;SFRP1;PTPRC;KIRREL3;SH2B3
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3188633046790167,-0.6846598825677565,0.9117647058823529,1.0,1.0,1/41,2.20%,ZFP36
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.3369145453356869,-0.684487985136664,0.8985507246376812,1.0,1.0,1/20,2.72%,ALOX12
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.27965565277644866,-0.6842941259751125,0.9696969696969697,1.0,1.0,13/89,17.44%,ST18;TNFRSF14;PSMB9;STAT1;PSMB6;BIRC3;PSMC3;MAP3K14;TNFRSF1A;PSMA8;LTBR;PSMA7;PSME1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.40228875530225067,-0.6837774135610767,0.8909090909090909,1.0,1.0,1/8,10.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),-0.4540505420236873,-0.6836905461936483,0.8153846153846154,1.0,1.0,1/6,8.69%,WAS
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.4259079890520405,-0.68343765502437,0.8421052631578947,1.0,1.0,2/6,7.79%,AKR1C1;LDLR
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.39997135954678664,0.6834197689390038,0.7948717948717948,1.0,1.0,2/5,20.99%,HMGB1;APLF
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.3495053829947351,-0.6831251697170112,0.9552238805970149,1.0,1.0,6/25,19.21%,LZTS1;PINK1;NRBP2;TSC2;NUPR1;PHF23
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.30215549749902937,-0.6830195218383412,0.9428571428571428,1.0,1.0,6/42,18.14%,RAB11FIP5;EGF;GPC3;BDNF;GPC1;MAPT
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.2862734389412967,0.6830144936256177,0.9696969696969697,1.0,1.0,7/25,19.77%,PSMD10;FBXO5;MARCHF7;THOC1;TPT1;MDM2;CCAR2
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.2985103443757717,-0.6826032242297893,0.92,1.0,1.0,4/64,11.78%,THBS1;IGF1;PINK1;BCL2L2
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.43577809214367835,0.6823925946986585,0.8297872340425532,1.0,1.0,2/5,22.54%,QDPR;ASRGL1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3034185641461166,-0.682248384126985,0.9473684210526315,1.0,1.0,6/53,17.84%,TGFBR2;SBK1;PRKCD;HIPK4;CDK5;HIPK3
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.31723934415406874,-0.6818954824940672,0.9324324324324325,1.0,1.0,5/38,13.10%,SLC39A14;ATP5IF1;DAB2IP;NOS1;GCHFR
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.38728594733274146,-0.6818598141244807,0.9285714285714286,1.0,1.0,1/14,3.46%,IMPDH1
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.2832642952297532,-0.6818438794459097,1.0,1.0,1.0,10/95,15.85%,MTMR7;INPP5D;VAC14;MTMR11;SBF1;PLEKHA4;BMX;PITPNM2;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.29217301605684753,0.6815212435007082,0.9444444444444444,1.0,1.0,2/25,7.58%,ERCC6;ERCC2
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.3259235457903288,0.6814475664191735,0.8275862068965517,1.0,1.0,4/22,11.25%,CHST11;CSGALNACT1;GAL3ST4;ADAMTS12
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.45826137045898424,-0.6813479255092695,0.8,1.0,1.0,2/6,26.55%,NFATC2;ENG
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.44221999147156743,-0.6810170177260662,0.7962962962962963,1.0,1.0,1/6,11.81%,BAP1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.37045060566237875,-0.6809045369736827,0.8695652173913043,1.0,1.0,3/14,16.42%,TNFRSF1A;PRKCD;ORMDL2
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.3815173030868194,0.6808066427653259,0.8636363636363636,1.0,1.0,2/8,27.08%,SNX5;CARMIL1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.44550514695700005,-0.6806988705274367,0.819672131147541,1.0,1.0,1/7,8.87%,RPS6KA1
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.42260865895816957,-0.6802968282660071,0.8363636363636363,1.0,1.0,4/6,28.12%,SFRP1;TP53;MEOX1;LMBR1L
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.3267107011114404,0.6802630586423819,0.8648648648648649,1.0,1.0,3/13,17.02%,SRI;ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3601229277602249,-0.6799470166522228,0.8783783783783784,1.0,1.0,2/23,9.24%,ARG2;IGF1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.2915323191215679,-0.6798790167710077,0.972972972972973,1.0,1.0,6/73,9.24%,MET;B2M;APP;PARP9;EGF;IGF1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.3157758696690041,0.6796651959505526,0.8857142857142857,1.0,1.0,4/21,9.69%,SLC39A10;SLC39A8;MT1E;SLC30A9
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.4360275839118359,-0.6792046400577737,0.896551724137931,1.0,1.0,3/6,27.13%,AHI1;DNAAF1;CITED2
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.3126928291600496,0.6788405886846504,0.9210526315789473,1.0,1.0,5/27,13.65%,BBS10;CEP290;PCM1;C2CD3;TTC8
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.333161805374977,0.6787671403336567,0.9375,1.0,1.0,2/12,12.99%,PTGIS;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.29884586309234545,0.6787458436695244,0.967741935483871,1.0,1.0,6/43,13.78%,PSMD10;PSMA1;PSMD11;PSMB5;PSMD14;PSMD12
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.385662948726214,0.6784379705565222,0.8055555555555556,1.0,1.0,1/9,3.02%,RIDA
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.3988163545766231,0.6782434776424096,0.9024390243902439,1.0,1.0,1/7,4.81%,HCLS1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3281854061779686,-0.6780362004209384,0.9565217391304348,1.0,1.0,1/28,1.55%,SUV39H1
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.4196049535321274,0.6779274148608161,0.8695652173913043,1.0,1.0,2/5,12.35%,EIF2AK4;VAPA
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.37239630129179396,0.677795018527203,0.8536585365853658,1.0,1.0,2/10,9.38%,BTN3A3;MSH2
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.4294642960309847,0.6776441855745089,0.868421052631579,1.0,1.0,1/6,13.26%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.4294642960309847,0.6776441855745089,0.868421052631579,1.0,1.0,1/6,13.26%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),0.4142669757830375,0.6772424109553203,0.8333333333333334,1.0,1.0,4/5,24.54%,RCC2;HNRNPU;BECN1;SIRT2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.3896113139853211,-0.6768390595279472,0.8656716417910447,1.0,1.0,2/10,16.59%,DCTN1;CLN3
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.44657847986758453,0.676811001957806,0.8260869565217391,1.0,1.0,2/6,24.69%,EXOSC6;EXOSC5
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3835278670921052,0.6766621983473273,0.8478260869565217,1.0,1.0,1/10,5.64%,EGFR
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.3956770727927921,-0.6764898199066853,0.9166666666666666,1.0,1.0,2/7,17.28%,TNFRSF1A;VCL
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.2975819474084927,0.6763790549111595,0.96875,1.0,1.0,6/20,24.98%,GPHN;SCP2;MOCS2;LIAS;NOXRED1;DHRS11
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.290817136802186,-0.6762774147111758,0.9873417721518988,1.0,1.0,8/90,11.74%,WARS1;TMC8;GFAP;KIF9;DAB2IP;SYK;SELP;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.38869446652247674,-0.6759141789052581,0.8524590163934426,1.0,1.0,1/9,7.29%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.38869446652247674,-0.6759141789052581,0.8524590163934426,1.0,1.0,1/9,7.29%,AKAP5
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.38897324461375143,0.6758044748992771,0.9,1.0,1.0,2/9,20.11%,ZNF703;SMAD7
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.42406242608203193,0.675373331589773,0.8636363636363636,1.0,1.0,2/5,9.05%,CSNK2A1;CSNK2A2
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),0.4469000473017495,0.6752546804142487,0.8372093023255814,1.0,1.0,2/5,11.25%,FOXP1;ADAMTS12
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.28866371778145344,-0.67492888537809,0.9875,1.0,1.0,19/94,20.76%,FLRT3;C1QL1;EFNB3;ATP1B1;SHC2;DAB2IP;SLC7A2;SLC44A3;ASS1;CKMT1B;SEZ6L2;PTPRF;PRR36;EPB41L4B;KIAA1217;NKAIN1;HES1;CXADR;CD276
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3677974736073254,-0.674913565949907,0.8153846153846154,1.0,1.0,3/14,16.36%,CD55;IL18;HLA-DRB1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.31806805780813185,0.6748356659537592,0.9142857142857143,1.0,1.0,1/14,1.20%,RGS10
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.44889636770760455,-0.6746085873714793,0.8823529411764706,1.0,1.0,2/5,17.95%,FLOT1;TGFB1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.2867064692446385,-0.6744329118248024,0.9726027397260274,1.0,1.0,15/73,18.35%,SLC39A14;HTR2B;SLC24A2;SLC24A1;GCM2;ATP1B1;SLC8A3;MT1H;SLC24A5;SLC11A1;PTH1R;HTR2C;RYR2;HTR2A;SLC39A7
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.33817948268695963,-0.6741858629841714,0.9180327868852459,1.0,1.0,2/14,10.89%,CMPK2;ENTPD3
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),-0.47549850835483337,-0.6741644908829907,0.890625,1.0,1.0,1/5,10.43%,PLEKHM1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.32622827754516937,0.6731758005791093,0.9428571428571428,1.0,1.0,4/16,14.76%,SLC47A1;SLC25A19;SLC22A2;SLC22A5
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.34416204321154176,-0.672617583738115,0.921875,1.0,1.0,5/21,17.15%,ABCA12;PIM3;ADCY5;HLA-DRB1;ADCY8
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.3587735962367601,0.6725284367309597,0.9069767441860465,1.0,1.0,1/8,7.52%,GMPS
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.4022957386698546,-0.6720595471880372,0.8703703703703703,1.0,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.4022957386698546,-0.6720595471880372,0.8703703703703703,1.0,1.0,1/7,10.01%,WNT5A
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.33881758162713504,-0.6719811136987532,0.9857142857142858,1.0,1.0,10/30,24.64%,SLC4A9;SLC9A2;SLC4A2;SLC4A10;SLC9A5;CLN3;SLC9A7;SLC4A3;SLC9A1;SLC9A9
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.4483492748980885,-0.6719588406517355,0.8181818181818182,1.0,1.0,1/5,16.53%,RPL23
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.26282904126914175,-0.6719573165917462,1.0,1.0,1.0,18/163,15.92%,C3;AGPAT4;LMO2;GYPE;GATA1;TMCC2;UROD;CA1;P4HA2;BLVRB;KLF3;NUDT4;DMTN;RAP1GAP;NARF;SLC22A4;ADD2;ANK1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.30596951256783184,-0.671722245256861,0.9726027397260274,1.0,1.0,9/57,19.21%,SKOR1;SULF1;VWC2;SFRP4;ITGA3;CRB2;LRP2;TBX20;BMPER
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.44246005560681756,-0.6716158101081237,0.8225806451612904,1.0,1.0,2/5,21.28%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.3729119402418693,0.6715308089967276,0.8478260869565217,1.0,1.0,2/7,11.18%,PTGIS;TP53BP2
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),-0.41824931016705796,-0.6711443805440291,0.8909090909090909,1.0,1.0,3/5,32.40%,CDK6;EIF2B5;MT3
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.25889189180398015,0.6711335115140747,0.9523809523809523,1.0,1.0,6/55,10.59%,TENM1;APBB3;MYOM1;ATP2C1;CEP290;PCM1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.34070609476960934,-0.6710631262186627,0.9428571428571428,1.0,1.0,5/22,17.19%,PRKCQ;TNS2;PRKCD;TSC2;PRKCB
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.39930024356385274,-0.6710556978644265,0.8688524590163934,1.0,1.0,2/10,18.05%,CARNS1;PAH
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.35490795032023836,-0.6709089616261382,0.9264705882352942,1.0,1.0,3/23,9.24%,POU4F1;EGF;IGF1
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),0.4023465101903713,0.6706247361166554,0.8780487804878049,1.0,1.0,4/7,40.35%,ELAC2;TRMT10A;TRMT10C;PNPT1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.2487524957005679,0.6706037622636227,1.0,1.0,1.0,10/74,11.49%,PSMD10;RUNX1;PSMA1;PSMD11;LMO1;NUDT21;PSMB5;SMYD5;PSMD14;KMT2A
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.32415877348299277,-0.6703736295215716,0.9130434782608695,1.0,1.0,1/22,1.70%,KREMEN2
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.386261718769911,-0.670178491171861,0.8305084745762712,1.0,1.0,1/11,7.29%,AKAP5
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.30192354696510176,-0.6700044156871998,0.961038961038961,1.0,1.0,6/52,11.74%,SUV39H1;SLC8A3;SCN2A;NDRG1;PGK1;PINK1
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.39599517849363786,0.6698319908815609,0.7659574468085106,1.0,1.0,1/6,5.79%,SFXN2
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.4223066972912346,-0.6698221431861452,0.8363636363636363,1.0,1.0,2/7,10.53%,AKR1C1;PDK3
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.2587995871836155,0.6697179914495567,0.967741935483871,1.0,1.0,8/62,11.49%,PSMD10;RUNX1;PSMA1;PSMD11;LMO1;PSMB5;PSMD14;KMT2A
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.32107089351633367,-0.6696661381070061,0.9365079365079365,1.0,1.0,8/30,20.48%,IFT122;PRICKLE1;DLC1;TSC2;DEAF1;LRP2;TGFB1;SEMA4C
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.3503754058384744,0.6695770096534474,0.9523809523809523,1.0,1.0,1/10,3.46%,NDNF
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.308031898111935,-0.6690946311673596,0.9876543209876543,1.0,1.0,1/45,0.81%,BLM
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.2905270769936089,-0.6688672368439025,0.987012987012987,1.0,1.0,7/90,8.85%,WARS1;CAMK2N2;THY1;CAV3;CEACAM1;CENPE;TSPYL2
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.41560221801139074,-0.6688061211707862,0.8636363636363636,1.0,1.0,3/7,24.93%,MUC6;CXADR;MUC4
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.3307840694395965,-0.6684533208752315,0.8928571428571429,1.0,1.0,2/18,13.75%,TTLL7;TTLL6
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.31570511524592815,0.6684234467318834,0.896551724137931,1.0,1.0,2/25,3.66%,TNFSF13B;CD320
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.38776131268359143,-0.6677292354615652,0.9193548387096774,1.0,1.0,1/12,7.89%,SGPP2
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3278890048190875,-0.6676281715964951,0.9113924050632911,1.0,1.0,4/27,15.76%,CAV3;PFN2;KANK3;PRKCD
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.41706774258299834,-0.6676171027452301,0.8936170212765957,1.0,1.0,1/6,6.33%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.39386021276698435,-0.6674834330062651,0.859375,1.0,1.0,2/8,15.50%,NOS1;APLN
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.34040952212408826,-0.6674463573133553,0.9264705882352942,1.0,1.0,2/21,4.84%,ZDHHC9;ZDHHC22
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.34040952212408826,-0.6674463573133553,0.9264705882352942,1.0,1.0,2/21,4.84%,ZDHHC9;ZDHHC22
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.31585569964479604,-0.6672753558691357,0.9736842105263158,1.0,1.0,8/32,25.78%,PRKCG;DDRGK1;UBXN1;GABARAPL2;RPL11;GIPC1;AQP11;NOP53
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.37476606293449,-0.6672561705618362,0.8431372549019608,1.0,1.0,1/14,1.94%,ICAM1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.4261548585661925,-0.667247536569716,0.8596491228070176,1.0,1.0,2/8,18.89%,ZFPM1;TBX20
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.35499089799618677,-0.6665708577967642,0.9193548387096774,1.0,1.0,2/14,9.88%,GLRA2;MT1H
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.4209557710299061,-0.6665567873695905,0.8,1.0,1.0,1/6,6.92%,CYP1B1
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.25124233124968537,-0.666280655726929,1.0,1.0,1.0,54/408,18.23%,TGFBR2;TLR2;VRK2;PLK2;PRDX4;MAP3K6;APP;CCL2;PIM3;TLR3;PTK6;NUAK2;PDK1;PRKCG;MAK;FAM20C;RPS6KA1;MYO3A;SBK1;FAM20A;MINK1;PDK3;NUAK1;DAB2IP;PRKCQ;SYK;BMX;PINK1;LIPE;PRKCH;PIM1;STRADB;FES;NEK10;MYLK3;STK32B;AATK;COQ8B;GLYCTK;PRKCD;RELN;PIK3CD;CDK2;CDC7;NRBP2;HIPK4;PRKCB;TEK;CDK5;LIMK2;HIPK3;DAPK3;TGFB1;RPS6KA6
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.3815800303924739,-0.6659896213100939,0.9019607843137255,1.0,1.0,1/12,6.29%,BRCA1
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.28948006392118797,0.6659267363668534,1.0,1.0,1.0,12/35,22.55%,BMP2;SOX9;TCAP;HEYL;NIPBL;EPHB4;FLRT2;CHD7;HEY1;HEY2;MDM4;PTK2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4370405749207646,-0.6658302264253156,0.8813559322033898,1.0,1.0,2/6,21.28%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.43914845144160497,-0.6657123716066954,0.8548387096774194,1.0,1.0,2/6,16.52%,OLAH;OXSM
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.3165794215781881,0.6653210696099973,0.9393939393939394,1.0,1.0,1/20,2.08%,ADAMTS9
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.28027737527941377,0.6651758721615493,1.0,1.0,1.0,11/34,27.72%,ZNF207;CEP192;AAAS;TOGARAM1;TPX2;KIF3B;PIBF1;MAP9;KIFC2;CLASP2;SMC3
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.3353111154110645,-0.6650362926163991,0.9166666666666666,1.0,1.0,3/29,10.01%,KREMEN2;NOTUM;WNT5A
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.4285868994216208,-0.6647831626943105,0.8333333333333334,1.0,1.0,1/5,19.40%,GHR
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.2868325819429879,-0.6643656735526798,0.9759036144578314,1.0,1.0,10/81,15.85%,PLK2;GFAP;PRKCG;WNT5A;DAB2IP;HECW2;GPC3;VIP;OAZ2;EEF1A2
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.36358418962744976,-0.6636567131531721,0.8983050847457628,1.0,1.0,1/12,5.41%,SLC25A21
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.36358418962744976,-0.6636567131531721,0.8983050847457628,1.0,1.0,1/12,5.41%,SLC25A21
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.4282436449871649,-0.6632268849823846,0.875,1.0,1.0,2/6,17.63%,CD200;GPER1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.31908168575202417,-0.6628675536769513,0.9264705882352942,1.0,1.0,5/45,11.12%,SHTN1;CNTNAP1;NYAP1;MINK1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.39126764523833707,-0.6625771766338022,0.9411764705882353,1.0,1.0,4/10,22.29%,LDLR;MFSD2A;SREBF1;SCARB1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.30704777413830153,0.6623481482626478,0.926829268292683,1.0,1.0,1/15,1.20%,RGS10
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.34366165905128876,-0.6616544879156758,0.9142857142857143,1.0,1.0,1/18,2.27%,NDST4
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3306216319908384,-0.6614633260845061,0.9436619718309859,1.0,1.0,5/23,17.19%,PRKCQ;TNS2;PRKCD;TSC2;PRKCB
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.33773231853298885,0.6613500511189762,0.9354838709677419,1.0,1.0,4/16,20.01%,RCC2;RRP1B;GPSM1;TMED2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.3938633782715928,-0.6612040409251675,0.8947368421052632,1.0,1.0,3/11,22.98%,IL7;IRS2;STAT3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.3938633782715928,-0.6612040409251675,0.8947368421052632,1.0,1.0,3/11,22.98%,IL7;IRS2;STAT3
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.4084009695384816,0.6610106655362754,0.8421052631578947,1.0,1.0,2/6,25.15%,RBPMS2;FOXO4
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.369895582415779,-0.6609143197991016,0.8833333333333333,1.0,1.0,3/12,17.95%,CCL2;IL18;TGFB1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.2817891850934766,-0.660496927913009,0.9743589743589743,1.0,1.0,10/98,13.97%,TGFBR2;RPS27A;SCX;BMP8A;ZYX;ARHGEF18;RUNX2;EID2;UBC;FOS
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.3059290196717871,0.6601745774830382,0.9230769230769231,1.0,1.0,4/25,17.53%,KCNE1;KCNIP3;WNK3;DPP6
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.3139781266883767,0.6596610314738471,0.896551724137931,1.0,1.0,2/30,5.16%,NCSTN;NAPSA
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3655994339918474,0.659574075644663,0.9142857142857143,1.0,1.0,5/11,20.90%,TMEM33;ATF6;PIK3R1;ERN1;BCL2L11
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.26206424952039664,0.6592375730772784,0.9655172413793104,1.0,1.0,8/35,22.40%,BMP2;FBXO5;ACVR2A;PRKD1;ZHX3;BMPR1B;HGF;WNT7B
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.3873004640756177,-0.6589104936249319,0.864406779661017,1.0,1.0,4/8,28.43%,PRKCB;CD36;PPARG;LRP1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.2472385102697272,0.658812622365146,1.0,1.0,1.0,21/57,30.40%,KPNA2;PDE12;GTF2F2;VAPB;POLR2C;PPIE;CCNT1;NELFA;PPIH;CTDP1;ADARB1;PKN2;POLR2A;NR5A2;POLR2K;PPID;POLR2D;SRPK2;CNOT7;PABPC1;POLR2E
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.4045124043049808,-0.6586713917481486,0.9137931034482759,1.0,1.0,2/7,22.28%,MMP24;CTNND1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.4178991141400922,-0.6585525917458914,0.8813559322033898,1.0,1.0,1/8,6.90%,GAP43
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.312840480583006,-0.6580461147758071,0.9871794871794872,1.0,1.0,14/56,20.30%,ANO2;GLRA2;ANO9;GABRE;GABRB2;GABRD;SLC20A2;GABRG2;SLC12A7;GABRA1;GLRA1;GABRA6;GABRG3;GABRA3
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),0.38133890554502486,0.6577279614182011,0.9117647058823529,1.0,1.0,3/5,22.80%,GPLD1;ACSL3;ABCB11
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.2927197950741469,0.657496143916612,0.9166666666666666,1.0,1.0,3/24,15.38%,TNFAIP3;MUL1;RNF26
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.31043507820519445,-0.6573542189958319,0.9565217391304348,1.0,1.0,1/39,2.59%,WARS1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.30455424816610954,-0.6571327281045772,0.948051948051948,1.0,1.0,9/49,19.49%,PRKCG;DAB2IP;PINK1;PSMC3;RHBDF1;DDRGK1;PSME1;NUPR1;GABARAPL2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.2952389998677064,-0.6568791579219028,0.9710144927536232,1.0,1.0,8/46,17.44%,BHMT;PSMB9;PSMB6;PSMC3;OAZ2;PSMA8;PSMA7;PSME1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.2837632370915306,0.6565750167510901,1.0,1.0,1.0,5/35,20.01%,UBE2T;KLHL12;MARCHF7;UBE3D;PEX12
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.3171107272924518,-0.6565556789362341,0.9066666666666666,1.0,1.0,4/35,13.59%,NLRC5;ISG15;IFIH1;HERC5
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.4044804871801482,-0.6557778587274593,0.9333333333333333,1.0,1.0,3/7,31.44%,BCAT1;BCAT2;HMGCLL1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.33654591953657775,0.6557134773598711,0.9166666666666666,1.0,1.0,2/10,11.18%,PTGIS;TP53BP2
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.4002522167906716,-0.6556276722051851,0.8923076923076924,1.0,1.0,2/8,10.53%,PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.4002522167906716,-0.6556276722051851,0.8923076923076924,1.0,1.0,2/8,10.53%,PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.4214058384739842,-0.655602297875064,0.8709677419354839,1.0,1.0,2/7,21.28%,BTG1;SFRP1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.3657899851639138,-0.6555653518903468,0.9333333333333333,1.0,1.0,3/13,22.98%,STAT6;GHR;STAT3
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.2730913003658354,-0.6553783333616253,0.9864864864864865,1.0,1.0,13/80,18.28%,SIX3;PSMB9;ANAPC11;CCNB1;PSMB6;PSMC3;TFAP4;NEK10;UBE2S;PSMA8;PSMA7;PSME1;CDKN1A
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2684395006050263,-0.6553231911661616,0.9879518072289156,1.0,1.0,8/122,12.57%,CCNB2;ABCB1;PLK3;CCNB1;DCTN1;FOXM1;HAUS7;CEP76
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.42017332743900004,0.6551687176574275,0.8837209302325582,1.0,1.0,3/5,30.50%,ATP8A1;TMEM30A;ATP11B
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.416715535697081,0.655141060016283,0.8421052631578947,1.0,1.0,1/5,4.04%,FUT9
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.26708688041425677,-0.6550863235268266,0.9880952380952381,1.0,1.0,8/121,12.57%,CCNB2;ABCB1;PLK3;CCNB1;DCTN1;FOXM1;HAUS7;CEP76
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.3182466778076363,-0.6550439346330824,0.9552238805970149,1.0,1.0,8/39,18.05%,RPS27A;HROB;RPA3;ISG15;UBC;RPA1;POLD1;CDKN2D
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.4580623083487628,-0.6550392517295069,0.9454545454545454,1.0,1.0,2/5,24.63%,ORMDL2;SPHK1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.2664491078785529,0.6549737867806515,0.9545454545454546,1.0,1.0,12/70,16.38%,RAB33B;SPATA4;TMEM33;MFF;PRMT6;PDE4DIP;ZEB2;MUL1;MIEF2;MARK2;EP300;VPS11
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.39758154175320715,0.6547510082428735,0.8863636363636364,1.0,1.0,1/5,10.45%,PARVA
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),-0.38140668528109667,-0.6544714754274963,0.8421052631578947,1.0,1.0,1/7,5.75%,SLC4A11
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.4382258535161949,-0.6538486931485475,0.8833333333333333,1.0,1.0,5/5,56.20%,CLU;HSP90AA1;NAB2;HSP90AB1;EGR1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.3048225245364476,0.6535479105175602,0.9696969696969697,1.0,1.0,2/17,9.92%,RUNX1;ERBB4
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3321869373188949,-0.6534676144233328,0.9285714285714286,1.0,1.0,2/20,5.61%,PDPN;ABCA12
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.35915560536544555,-0.653292200850131,0.9032258064516129,1.0,1.0,4/16,17.99%,VLDLR;MFSD2A;CLN3;SLC15A4
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.3748748270655651,0.6531808666128183,0.9347826086956522,1.0,1.0,2/9,18.04%,MUL1;PIAS4
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.2803937167246673,-0.6523497445447217,1.0,1.0,1.0,8/54,21.31%,KCNB1;MAP1LC3A;MFSD2A;WDR45;SREBF1;SFRP1;KLF10;STK24
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.2966961948048256,-0.652332142543635,0.9466666666666667,1.0,1.0,2/36,10.88%,KIF17;IFT122
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.4075375183059939,-0.6520986741377869,0.7936507936507936,1.0,1.0,2/6,21.28%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3635102901735445,-0.652045425375414,0.9,1.0,1.0,6/16,23.48%,ATP1B1;CACNA1C;RYR2;CALM3;SLC9A1;GSTO1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.3415353351786369,-0.651978039584336,0.9272727272727272,1.0,1.0,1/16,6.29%,BRCA1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.3647662594572496,0.6519408179697036,0.8780487804878049,1.0,1.0,3/8,24.83%,SALL1;PKD2;BMP7
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),0.4097251278735411,0.6518880830978305,0.8936170212765957,1.0,1.0,1/5,6.69%,AKT1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.29452770497239766,-0.6518798703436574,0.9444444444444444,1.0,1.0,2/39,8.98%,SUN3;IRAG2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.32544439522393515,0.6513970695042506,0.9767441860465116,1.0,1.0,1/18,1.98%,PPARGC1A
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.30703444546587094,-0.6512242281840254,0.9701492537313433,1.0,1.0,1/35,2.59%,WARS1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.34913636835994905,0.6511009994290912,0.9142857142857143,1.0,1.0,1/11,2.91%,ADRA1A
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.3993478233958149,0.6510262124458474,0.8717948717948718,1.0,1.0,1/6,16.38%,VPS11
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.39232904219190956,0.6509291644573155,0.8913043478260869,1.0,1.0,3/6,18.99%,TMX3;PRDX3;CHCHD4
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.2938867052129155,0.650905811213985,1.0,1.0,1.0,6/34,14.25%,SOX8;PEF1;ERBB4;KLHL12;CDH2;TAPT1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.39783955786502,0.6508997360495987,0.8958333333333334,1.0,1.0,2/5,18.58%,SLC3A2;SLC36A4
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.39240323457638704,0.6505772726695034,0.9111111111111111,1.0,1.0,3/7,26.98%,QDPR;ASRGL1;FAH
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.24740644715791396,-0.6504487923566429,1.0,1.0,1.0,20/285,13.76%,PRAME;TRIM22;RPS27A;ARIH2;TRIM5;BRCA1;PSMB9;ANAPC11;FBXL18;HERC6;FBXW12;SPSB1;FBXO32;PSMB6;FBXW10;PSMC3;HECW2;UBC;HERC5;RNF213
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.30390341871989424,0.650360120268596,0.8666666666666667,1.0,1.0,12/24,29.87%,WDR33;CSTF3;PAPOLA;MTPAP;TENT4B;CLP1;CPSF2;SSU72;PAPOLG;TENT2;SCAF8;PABPC1
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.30390341871989424,0.650360120268596,0.8666666666666667,1.0,1.0,12/24,29.87%,WDR33;CSTF3;PAPOLA;MTPAP;TENT4B;CLP1;CPSF2;SSU72;PAPOLG;TENT2;SCAF8;PABPC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.37707043778923555,-0.6501311099379788,0.8709677419354839,1.0,1.0,3/10,24.87%,SELP;ETS1;ALOX5
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.3131408125005623,0.6496555754380853,0.9230769230769231,1.0,1.0,3/15,17.98%,KANSL2;KAT7;MCRS1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.3131408125005623,0.6496555754380853,0.9230769230769231,1.0,1.0,3/15,17.98%,KANSL2;KAT7;MCRS1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3295022329456083,-0.6496108431379568,0.9324324324324325,1.0,1.0,4/20,17.31%,SULF1;HS3ST3B1;HS6ST1;GPC1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.2939765779530943,0.6491396042541718,0.9090909090909091,1.0,1.0,3/26,10.74%,ELOVL6;ELOVL2;HACD2
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.357059947370633,-0.6489973282368243,0.9354838709677419,1.0,1.0,4/17,26.51%,FGF1;SREBF1;SEC14L2;SREBF2
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.38062491961725164,-0.6489291864599986,0.9180327868852459,1.0,1.0,3/10,17.36%,NOS1;CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.2619277558237554,-0.64856811760142,1.0,1.0,1.0,20/133,17.95%,TLR2;DEPDC1B;SULF1;RSPO3;PSMB9;EGF;LRRK1;PLEKHA4;LGR5;PSMB6;SFRP4;PSMC3;RSPO4;GPC3;SFRP2;PSMA8;PSMA7;PSME1;DAPK3;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.27979951179616913,-0.6481094433786464,0.975609756097561,1.0,1.0,9/72,18.14%,WARS1;SH3GL2;DBI;DAB2IP;PAQR3;XRCC1;TGFB1;TINF2;MAPT
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),0.39545824414307806,0.6476471925577076,0.8958333333333334,1.0,1.0,1/6,4.85%,GREM1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.28401413974635215,0.6474105954508942,0.9354838709677419,1.0,1.0,10/30,25.30%,COMMD1;GPM6B;TAX1BP3;LEPROTL1;PICALM;NEDD4L;LZTFL1;UBXN2B;ROCK2;LATS1
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.3786829443790809,0.6472281509243096,0.8571428571428571,1.0,1.0,4/7,41.07%,CTH;CDO1;MTR;CBS
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.30180434554722524,0.646998276839814,0.918918918918919,1.0,1.0,9/22,24.89%,AKT1;EIF4EBP2;CCDC88A;EIF4EBP1;SMG1;RPS6KB1;MEAK7;RPTOR;NPRL3
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.37836730097121707,-0.6469310879887906,0.9285714285714286,1.0,1.0,1/12,7.17%,TIMP1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.32399819341829045,-0.6461446369574784,0.9393939393939394,1.0,1.0,5/27,17.37%,PTK6;EGF;PTPRR;ERBIN;CDC37
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.27269881749253316,-0.6459139588833719,0.9743589743589743,1.0,1.0,23/86,25.54%,MET;VAC14;CENPE;CD74;RELN;EEF1A2;HLA-DRB1;TEK;MAPT;CDKN1A;SPDYA;CD4;PDGFRA;ALK;ZNF16;PTPRC;EPHA10;MMD2;MAP2K3;TYRO3;NBN;MRE11;NTRK3
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.37417427340551024,0.645804708145395,0.9523809523809523,1.0,1.0,4/8,31.30%,HDAC10;SIRT2;HDAC9;SIRT1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.36358634247588917,0.6453253025425634,0.8222222222222222,1.0,1.0,1/5,12.81%,SLC25A5
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.37482833278840155,0.6451270182101848,0.94,1.0,1.0,6/8,38.54%,UBQLN1;USP14;NFE2L2;UBQLN2;BCAP31;SGTA
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.32987682477062596,0.6451221892870806,1.0,1.0,1.0,4/17,14.81%,STIL;PCM1;C2CD3;CEP192
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.3130763085218861,0.6451180804430401,0.9696969696969697,1.0,1.0,6/18,25.98%,ALDH7A1;PIPOX;DDO;SDSL;GOT2;OGDH
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.2831388213118071,0.6447767216097192,0.9642857142857143,1.0,1.0,1/24,5.44%,RNF2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3284915114466783,-0.6446642407901738,0.974025974025974,1.0,1.0,6/25,21.23%,LTBP4;SFRP4;EID2;ITGA3;TGFB1;PCSK6
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.38362627916029945,-0.6442502747051267,0.875,1.0,1.0,5/9,26.76%,DLGAP3;NPTX2;DLGAP2;BEGAIN;NPTX1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.3935509006670849,-0.6439290275000459,0.9,1.0,1.0,4/10,30.11%,HLA-DRB1;ADCY8;STX4;CFTR
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.45975406274141983,-0.6438583076620896,0.9807692307692307,1.0,1.0,2/6,21.63%,SYK;GAB2
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.3699866593140883,0.6432874582401085,0.8780487804878049,1.0,1.0,3/8,25.32%,KAT7;IWS1;ARRB1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.29377696953466265,0.643152992476849,0.9166666666666666,1.0,1.0,5/21,24.15%,GPM6B;EFNA5;SLK;PTK2;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.4337301363977577,-0.6430817601165112,0.96,1.0,1.0,2/6,21.59%,PDZK1;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.4075517656740649,-0.6427411079198958,0.8571428571428571,1.0,1.0,3/6,17.04%,PRKCQ;BCL6;IRS2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),0.3717830321116955,0.6420251639497869,0.9069767441860465,1.0,1.0,2/8,13.82%,HMGB1;RAB7B
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.364794483979989,0.6414742518475794,0.8717948717948718,1.0,1.0,3/8,28.59%,NIPBL;CHD8;KIT
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.2567471525947228,-0.6412301885055092,1.0,1.0,1.0,12/128,10.81%,DUSP1;MTMR7;SBF1;PP2D1;SGPP2;PLPPR1;FBP1;PLPPR5;PLPP4;PPP3CC;PTPN7;ALPL
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.35284596551363445,-0.6408044405855978,0.8793103448275862,1.0,1.0,1/14,6.59%,TLR3
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3195411486329935,-0.6406814353183685,1.0,1.0,1.0,2/19,11.12%,FBP1;DAB2IP
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.30407611182531913,-0.640614432549437,0.9743589743589743,1.0,1.0,3/29,10.88%,FSIP2;SNX10;IFT122
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.41346244474707783,-0.6400783322323025,0.896551724137931,1.0,1.0,5/6,24.01%,GAD1;GAD2;PAH;BCAT1;BCAT2
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.2605702226442575,0.6397091731146466,0.9,1.0,1.0,8/34,22.56%,PIK3R4;SESN2;PIK3C3;SESN3;EIF2AK3;PRKAA1;KPTN;BECN1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.36921908375423984,-0.6396792345060631,0.8955223880597015,1.0,1.0,1/10,6.29%,BRCA1
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.3896017923546024,0.6393716943720531,0.8,1.0,1.0,2/6,18.79%,PHYH;PDSS2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.3391497781893072,0.6393546178273707,0.85,1.0,1.0,1/11,11.91%,TMEM35A
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.26845748880325176,0.6392531965426148,0.9333333333333333,1.0,1.0,12/26,30.64%,EAF2;HNRNPU;ZMYND11;NELFA;WDR43;CDK12;RNF168;RECQL5;LARP7;CDK13;SUPT16H;LDB1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.2671045253894311,0.6390039666942483,0.9655172413793104,1.0,1.0,5/42,10.07%,SPRED1;CCDC88C;KAT2B;RABL3;SESN2
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),0.38743266124929665,0.6389282982648082,0.85,1.0,1.0,1/6,5.23%,CA2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.34733356480861227,0.6386177875547216,0.9166666666666666,1.0,1.0,5/14,15.88%,RUNX1;SOX12;KAT2A;MDK;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.32106129884948487,-0.638468711424046,0.935064935064935,1.0,1.0,2/30,6.29%,APLNR;BRCA1
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.2569658956166111,-0.6384089727821599,1.0,1.0,1.0,15/120,19.86%,DUSP1;MTMR7;SBF1;PP2D1;PPP3CC;PTPN7;DUSP16;TNS2;PTPRR;PTPRF;PTPRO;PTPN21;DUSP8;PPP2R3A;PTPN5
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.3822083549903537,-0.6380390630347094,0.9107142857142857,1.0,1.0,3/8,18.05%,ACHE;NOS1;PAH
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.41793235474181695,0.6379817233019414,0.8367346938775511,1.0,1.0,1/5,13.67%,CDH2
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),-0.43323400601878165,-0.6379341205373283,0.921875,1.0,1.0,1/5,6.37%,ANLN
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.39801814762869914,-0.6368819439309388,0.9152542372881356,1.0,1.0,1/8,3.20%,SKAP1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.31875883383785986,0.6367377068960489,0.8461538461538461,1.0,1.0,1/11,6.31%,UBE2N
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.3236597053046376,-0.6365168955823841,0.9605263157894737,1.0,1.0,5/23,15.80%,MINK1;SHISA9;SHISA8;NLGN1;RELN
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.374233024456415,-0.6360194322419545,0.8596491228070176,1.0,1.0,2/9,21.79%,GSS;CHAC2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.35512694159741204,0.6357689365736187,0.8918918918918919,1.0,1.0,2/7,18.13%,FOXP1;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3783706507989756,0.6356690483204587,0.9166666666666666,1.0,1.0,2/6,18.13%,TICAM1;CAMK4
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.3052072132843322,0.635644800500482,0.8857142857142857,1.0,1.0,1/17,5.44%,RNF2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.3467703939628692,0.6353058404036844,0.9736842105263158,1.0,1.0,3/9,28.14%,ABL2;PDP2;PDP1
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.3388648581845209,-0.6348639078564629,0.9,1.0,1.0,2/13,17.54%,NLGN1;CDK5
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.40988786799752835,-0.6343489802290404,0.9354838709677419,1.0,1.0,4/7,29.80%,PIK3CD;MYO1C;PRKD2;HSPB1
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.3668510881362782,0.633831950027674,0.8444444444444444,1.0,1.0,1/6,10.17%,SLC26A3
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.31082741615080633,0.6335263751631139,0.9166666666666666,1.0,1.0,4/15,18.13%,EIF2AK4;KAT2A;CPEB3;CAMK4
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),-0.4390009776711855,-0.6332965566331128,0.9310344827586207,1.0,1.0,2/5,28.09%,ULK1;ULK2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.30499833803018,-0.63297776311418,0.9516129032258065,1.0,1.0,1/26,4.39%,SIGLEC1
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.36976562065473084,0.6328046696175591,0.9473684210526315,1.0,1.0,4/9,21.65%,RORB;CEP290;RP1;ARL3
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.2456214946980413,0.632540307963187,1.0,1.0,1.0,13/50,21.88%,NDUFB1;DMAC2;NDUFAF3;NDUFAF4;NDUFAF2;NDUFV3;NDUFA8;TIMMDC1;NDUFS1;NDUFV1;NDUFAF7;NDUFB4;NDUFAF5
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.2456214946980413,0.632540307963187,1.0,1.0,1.0,13/50,21.88%,NDUFB1;DMAC2;NDUFAF3;NDUFAF4;NDUFAF2;NDUFV3;NDUFA8;TIMMDC1;NDUFS1;NDUFV1;NDUFAF7;NDUFB4;NDUFAF5
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3346285267986566,0.6321703804955882,0.9761904761904762,1.0,1.0,3/14,12.84%,MID1;TAOK2;TAOK3
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),-0.3942501872320426,-0.632104801711609,0.8846153846153846,1.0,1.0,3/5,19.74%,GAD1;GAD2;ALDH5A1
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.3708001923080919,-0.6318123309253395,0.8653846153846154,1.0,1.0,1/7,9.07%,PATL2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.29320799629136624,-0.6317836047573933,0.9571428571428572,1.0,1.0,1/42,0.88%,SKOR1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.39507064348015186,-0.6317219279137146,0.8928571428571429,1.0,1.0,2/7,21.54%,RARG;FBN2
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.29600398440526204,-0.6312586692753338,0.9875,1.0,1.0,3/42,10.43%,ABCA12;FA2H;CYP4F22
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.328234595541166,0.6305156090830919,0.9393939393939394,1.0,1.0,1/18,1.39%,NCSTN
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),0.34302657866366976,0.6295327188218902,0.9375,1.0,1.0,3/14,7.43%,PDE12;ABCD1;VCP
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.2705316517541324,-0.6294172241717684,0.974025974025974,1.0,1.0,10/56,18.86%,PTK6;EGF;VIL1;TGFA;MVP;PTPRR;ERBIN;CDC37;TGFB1;PLCE1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.29838644757046207,-0.6291625701996362,0.9859154929577465,1.0,1.0,3/23,17.28%,EMP2;FGF7;VCL
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.4315665097865044,-0.6288607958175223,0.8775510204081632,1.0,1.0,1/5,20.40%,HES1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.24755801678539294,-0.6283840207719446,1.0,1.0,1.0,20/156,18.23%,TGFBR2;VRK2;PLK2;PRKCG;RPS6KA1;SBK1;PDK3;PRKCQ;PINK1;PRKCH;STK32B;PRKCD;CDK2;CDC7;HPF1;HIPK4;PRKCB;CDK5;HIPK3;RPS6KA6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.37179863031113836,0.6280714745951528,0.88,1.0,1.0,2/6,16.76%,THOC3;THOC1
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.37179863031113836,0.6280714745951528,0.88,1.0,1.0,2/6,16.76%,THOC3;THOC1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.2946728577380281,-0.6280463633044673,1.0,1.0,1.0,9/37,19.17%,APP;HLA-DRA;C12ORF57;TUSC3;MFSD2A;MGAT3;SHROOM4;CTNS;PTCHD1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.3547192846208171,-0.6279601253666983,0.8214285714285714,1.0,1.0,1/12,6.59%,TLR3
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.25592745010453183,0.6277883342922965,1.0,1.0,1.0,9/37,17.94%,SOX9;EGFR;AKT1;PIK3CA;SHC3;PIK3R1;NCK2;PIK3C2A;EFEMP1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.3386467645224663,-0.6277623449451488,0.9130434782608695,1.0,1.0,1/12,5.52%,AKR1C1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.39784067697694775,-0.6276052069775082,0.803921568627451,1.0,1.0,5/5,60.23%,ARF6;PIP5K1A;INPP5K;RAC1;AIF1L
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.24509154617042134,0.627268518883865,0.9565217391304348,1.0,1.0,12/59,19.83%,GALNT3;AKT1;CSNK2A1;CSNK2A2;MAPK8;WNK3;PRKD1;MARK2;GALNT1;DYRK2;NLK;DYRK3
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.41616265528305646,-0.6268830706738924,0.864406779661017,1.0,1.0,2/6,12.35%,CENPE;HECW2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.36954034997138724,-0.6267001051628217,0.9354838709677419,1.0,1.0,1/9,12.04%,MYH9
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.37810060342297835,-0.6263957649983615,0.8596491228070176,1.0,1.0,2/8,17.36%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.37810060342297835,-0.6263957649983615,0.8596491228070176,1.0,1.0,2/8,17.36%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.37810060342297835,-0.6263957649983615,0.8596491228070176,1.0,1.0,2/8,17.36%,CYP3A4;CYP3A5
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.3595754259337968,-0.6260007987617757,0.9344262295081968,1.0,1.0,2/11,16.90%,THY1;CRB2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.31849065985773545,0.6256837394655368,1.0,1.0,1.0,3/13,21.51%,ADRB2;UBQLN4;FYCO1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.36255012630382005,-0.6255805304848429,0.9076923076923077,1.0,1.0,2/13,25.23%,SLC15A4;SHLD1
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.40816530618738145,-0.6255570301216373,0.8909090909090909,1.0,1.0,1/5,7.17%,TIMP1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.35597042636321946,-0.6252498049271603,0.9259259259259259,1.0,1.0,2/10,17.81%,TSPYL2;GMNC
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.3720701759134526,0.6244577248361362,0.925,1.0,1.0,2/8,7.15%,BAG2;FBXO5
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.3535986124204204,0.6243736688575711,0.9459459459459459,1.0,1.0,1/7,4.85%,GREM1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.31995159946878127,0.6241439836374821,0.8863636363636364,1.0,1.0,2/10,12.02%,GUCA1B;SLC22A2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.30906063634124525,0.623981625216939,0.9393939393939394,1.0,1.0,3/18,14.38%,SGCD;ZBTB18;CFLAR
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.2491167825354549,-0.6237891100456303,1.0,1.0,1.0,6/202,5.22%,DEPP1;TRIM22;MET;TRIM5;PLK2;HTR2B
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.386360101254247,-0.6232958799823531,0.9310344827586207,1.0,1.0,2/5,32.27%,XBP1;CDKN2B
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.32991557452175024,0.6229307610509076,0.967741935483871,1.0,1.0,3/9,31.30%,SNX5;IRS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.33619577560251107,-0.6226869367759701,0.9365079365079365,1.0,1.0,6/18,30.17%,CDK5;NUPR1;TGFB2;DDIT3;CTNNB1;MCL1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.3717892150682224,-0.622629132944612,0.875,1.0,1.0,1/11,4.38%,CCDC39
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.40931072512854916,-0.6225570971629006,0.9137931034482759,1.0,1.0,2/6,32.40%,HDAC6;MT3
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.2824817137672506,0.6222585256913312,0.9642857142857143,1.0,1.0,2/25,8.91%,SF3B4;SMNDC1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.34251919856298596,0.622092086427496,0.9,1.0,1.0,3/9,22.31%,SPX;ACSL3;RPS6KB1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.3125834843115,-0.6218584703392795,0.9705882352941176,1.0,1.0,7/29,19.71%,NNAT;HLA-DRB1;IRS2;ADCY8;MYRIP;GPER1;DOC2B
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.3274502964514532,0.6214847988917488,0.9024390243902439,1.0,1.0,5/10,29.35%,EXOSC6;EXOSC8;PCID2;EXOSC5;XRN1
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.3696041228825217,0.6207590408982342,0.9047619047619048,1.0,1.0,2/8,15.51%,CPNE3;CPNE1
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.38428894023840393,-0.6207304976022925,0.9152542372881356,1.0,1.0,3/8,22.78%,ARR3;ADM;GRK2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.33915331085404976,-0.6205839936248241,0.9074074074074074,1.0,1.0,1/11,7.83%,PARP9
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.25393589299051866,-0.6202831839846769,1.0,1.0,1.0,20/135,20.67%,POU4F1;TP53I3;STEAP3;SEPTIN4;STAT1;NDRG1;BIRC3;PINK1;BCL2L14;PAX8;SRA1;BCL6;CDK5;DAPK3;RARG;TNFRSF10A;ALK;LGALS1;ZNF420;RTN4
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.3486200879328478,-0.6193320345266751,0.9180327868852459,1.0,1.0,1/8,17.28%,VCL
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.3673708343893015,-0.6193038088195166,0.9193548387096774,1.0,1.0,2/12,25.23%,TGFB1;SHLD1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.3291616106895253,-0.6192923628002578,0.9594594594594594,1.0,1.0,7/19,30.67%,IGF1;AKAP6;MYOZ2;SLC9A1;FHL2;EFHB;HOMER3
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.40201737952845973,-0.6192429220756231,0.9310344827586207,1.0,1.0,1/7,7.01%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.40201737952845973,-0.6192429220756231,0.9310344827586207,1.0,1.0,1/7,7.01%,APOD
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.3816972102252831,-0.619131677620316,0.8571428571428571,1.0,1.0,6/6,61.85%,PRPS1;PRPS2;G6PD;PRPSAP1;TKT;PRPSAP2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.3267851561804622,0.6184127178095843,0.8846153846153846,1.0,1.0,3/11,15.94%,HAVCR2;ENPP3;RC3H1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.36982416452033506,-0.6175846135856898,0.9672131147540983,1.0,1.0,3/9,20.15%,FADD;TGFB1;CASP8
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.34942822997272843,-0.6174468103726979,0.9375,1.0,1.0,3/12,11.74%,HK2;ISG15;PINK1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.31323845485858315,-0.6169052670553883,0.9180327868852459,1.0,1.0,4/24,15.00%,SLC4A11;SLC4A9;SLC4A2;SLC4A10
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.3161978426250305,-0.6168305420370397,0.9852941176470589,1.0,1.0,3/16,20.18%,AKR1C1;CD74;PNPLA8
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.41045730367120137,-0.6164487571547839,0.9361702127659575,1.0,1.0,1/6,3.35%,IRF1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.2765601748775372,0.6160553113329706,0.9545454545454546,1.0,1.0,6/29,20.44%,NAF1;PAIP1;HNRNPU;ZCCHC17;DKC1;NSUN2
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.31211385261179414,0.6156657526965659,0.8888888888888888,1.0,1.0,2/19,16.82%,PRKD1;PICALM
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.3728877876778804,0.6156067995532449,0.8333333333333334,1.0,1.0,1/5,9.38%,MSH2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.38598798168752324,-0.6156000895515525,0.8928571428571429,1.0,1.0,3/5,30.47%,MACROH2A2;NOP53;FLNA
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.3816596634045553,-0.6155852422837133,0.9491525423728814,1.0,1.0,2/7,24.50%,PHF23;HDAC6
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.2534069292839549,0.6153333342072904,1.0,1.0,1.0,14/46,26.87%,ERCC6;ATR;SESN2;INTS7;HUS1;ATRIP;HINFP;TRIAP1;MDM4;CLSPN;RAD1;USP28;CLOCK;BID
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),0.3666046884564385,0.614960085584121,0.9230769230769231,1.0,1.0,1/8,6.33%,ZNF502
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.2641621977403243,0.6148519960480633,1.0,1.0,1.0,4/31,11.53%,PSMD10;MFF;AKT1;OPA1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.273551211411593,0.6146301220930016,0.9666666666666667,1.0,1.0,6/24,21.80%,PGAP1;PIGP;GPLD1;DPM1;PIGF;PIGU
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.37386781065847396,0.6144898193067669,0.8604651162790697,1.0,1.0,1/6,13.10%,SLCO1C1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.37386781065847396,0.6144898193067669,0.8604651162790697,1.0,1.0,1/6,13.10%,SLCO1C1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.38237116673513993,-0.6141909275546814,0.8771929824561403,1.0,1.0,3/6,34.00%,HDAC5;NRG1;RBM24
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.35097740221744045,-0.6140557451252174,0.9242424242424242,1.0,1.0,2/9,15.76%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.35097740221744045,-0.6140557451252174,0.9242424242424242,1.0,1.0,2/9,15.76%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.4052738192499129,0.6138673164773428,0.9607843137254902,1.0,1.0,2/5,13.07%,SRI;SPX
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.3092986735262394,-0.6138346503521938,0.9866666666666667,1.0,1.0,4/23,15.80%,CCL2;EGF;TGFA;RELN
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.35766363496543085,-0.6135218383431397,0.9830508474576272,1.0,1.0,2/11,21.35%,MICALL1;PACSIN1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.32843407046084505,0.6128522677539856,0.9736842105263158,1.0,1.0,3/11,16.49%,ATP1A2;SLC22A2;GLUL
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.30908741514119287,-0.6122725526283872,0.9365079365079365,1.0,1.0,3/27,12.77%,RPS27A;TNIP2;UBC
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.3543579734183079,-0.6121970971114531,0.8709677419354839,1.0,1.0,1/13,4.26%,MSX2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2900657920574144,0.6116678235458806,0.9142857142857143,1.0,1.0,8/18,25.72%,ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H3;PARP1;ERCC4;CUL4B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2900657920574144,0.6116678235458806,0.9142857142857143,1.0,1.0,8/18,25.72%,ERCC2;ERCC3;GTF2H5;GTF2H2;GTF2H3;PARP1;ERCC4;CUL4B
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.2857995214737446,0.6100181485908087,1.0,1.0,1.0,5/19,17.31%,RCC2;PTPRK;TAOK2;THSD1;WHAMM
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.2662212011523061,0.6100016725976882,0.9722222222222222,1.0,1.0,5/29,17.66%,PPARGC1A;KMT2A;IWS1;NOC2L;BRD7
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.36366721324193696,-0.6099504651594665,0.9577464788732394,1.0,1.0,3/14,17.95%,RPS13;NUDT16;TGFB1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.3503364215566386,-0.60988888186068,0.9444444444444444,1.0,1.0,4/10,32.48%,ADA;MTHFD1;PRPS1;PRPS2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3253540367136938,-0.6093773724315066,0.9402985074626866,1.0,1.0,7/17,32.14%,BCL2L2;BOK;FAS;ITGAV;BCL2L1;MCL1;MOAP1
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.3319309083433237,-0.6093023847718682,0.8870967741935484,1.0,1.0,2/12,15.37%,ENTPD3;NUDT16
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.3228467221782621,-0.6092217863773516,0.9649122807017544,1.0,1.0,1/13,12.39%,OGG1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.3820343141384527,-0.6092039692527468,0.8983050847457628,1.0,1.0,3/7,22.35%,NELL1;SFRP1;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.28422488089604536,-0.6092033212248501,0.9615384615384616,1.0,1.0,3/33,14.21%,ABCA12;PLK3;OAZ2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.3020198606635682,-0.6089742253224875,0.9705882352941176,1.0,1.0,3/23,14.68%,P3H2;OGFOD1;PPIB
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.27532175151751864,-0.6089044448915137,1.0,1.0,1.0,4/50,9.28%,SLITRK1;THY1;EFNB3;MAG
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.2491364590739804,-0.6085074005239656,1.0,1.0,1.0,23/103,22.28%,ATP1A1;ARHGEF17;ATP1B1;UNC5B;DAB2IP;SLC43A2;SLC44A3;RAP1GAP;RHBDF1;GPRC5C;ASS1;PTPRF;GPC1;PTPN21;LAMA5;PARM1;AGRN;EPB41L4B;KIAA1217;ARHGEF37;TSPAN15;EPB41L1;CTNND1
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.3389731948851614,-0.6084136873509322,0.9,1.0,1.0,3/9,17.15%,ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.3389731948851614,-0.6084136873509322,0.9,1.0,1.0,3/9,17.15%,ADCY5;ADCY3;ADCY8
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.40325836870773324,-0.6084118540485192,0.9772727272727273,1.0,1.0,1/5,9.68%,THPO
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.2997796816012051,0.6077330770627828,0.9714285714285714,1.0,1.0,4/22,10.82%,TTL;PPP1R10;HSF1;EIF4E
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.31042405683906593,0.6076418564534198,1.0,1.0,1.0,1/10,2.70%,PSMD10
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.3096201443926194,-0.6075974580397382,0.9818181818181818,1.0,1.0,2/22,16.59%,HAP1;CLN3
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.22929144608257654,0.6075437469917117,1.0,1.0,1.0,26/134,20.19%,FLT3;PASK;RIOK2;EGFR;AKT1;STK4;ATR;ERBB4;EIF2AK4;CSF1R;TAOK2;UHMK1;EPHB4;TAOK3;WNK3;STK17B;PRKD1;MARK2;EIF2AK3;TNIK;SLK;CAMK4;MAP2K2;PRKX;PIKFYVE;ERN1
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.22897983692391907,0.6074891906320914,1.0,1.0,1.0,10/74,15.49%,KIF15;TMEM115;SEC22B;RAB1B;DNAJC28;ERGIC3;COPB2;SCFD1;TMED3;ARCN1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.27438835857258864,-0.6074777221395369,0.9857142857142858,1.0,1.0,5/40,16.23%,APP;PARP9;RPL10;RBM3;RBM4B
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.4141957579570277,-0.6070225338529457,0.8846153846153846,1.0,1.0,3/5,28.68%,SLIT3;SLIT2;MYO9B
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.3768538772062998,-0.6067669530159572,0.9464285714285714,1.0,1.0,2/6,25.36%,CFAP73;CFAP100
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.38537410995681104,-0.6067113179365458,0.9230769230769231,1.0,1.0,6/6,61.48%,ACVR1B;VEGFA;C1QBP;SMURF2;SYDE1;AGO2
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.3376565763475186,0.6066468308116663,0.9210526315789473,1.0,1.0,3/8,15.40%,RUBCNL;VPS39;PIP4K2B
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.3392730768170121,0.6065785643678997,0.925,1.0,1.0,2/8,16.63%,INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.3392730768170121,0.6065785643678997,0.925,1.0,1.0,2/8,16.63%,INSIG2;ERLIN1
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.35837854818111414,-0.6063705402885597,0.9354838709677419,1.0,1.0,2/9,13.02%,NOS1;CYP3A4
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.3608692036468331,-0.6059770185159086,1.0,1.0,1.0,1/9,5.98%,CCL2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.2614323849591364,-0.60596375180189,1.0,1.0,1.0,6/79,13.59%,IRF1;NLRC5;IRF7;ISG15;IFIH1;HERC5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.2756233644658894,-0.6050728895024557,0.9868421052631579,1.0,1.0,11/47,25.92%,RAMP3;AKAP5;PRKCH;ITGA3;GPER1;STAC2;SORBS1;STX3;SQSTM1;STX4;CNPY4
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),0.30935654326586515,0.6050336601870799,0.9583333333333334,1.0,1.0,3/12,23.65%,PARP11;PARP1;PARP6
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.369597178607131,-0.6048571949445747,0.9,1.0,1.0,2/7,20.20%,GARS1;DARS2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.3172993684525916,0.6048319134155731,0.96875,1.0,1.0,2/13,17.47%,MAP3K4;PKIB
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.3506945104980379,0.6045543359998867,0.9302325581395349,1.0,1.0,1/8,16.57%,EIF2AK3
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.40219860675817376,-0.6042404816251088,0.9137931034482759,1.0,1.0,1/5,8.00%,DBI
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.24812556457968085,-0.6042115706838066,1.0,1.0,1.0,4/81,12.29%,TYMS;RPL13A;PATL2;IGFBP5
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.327919270033464,0.603287483092814,0.9361702127659575,1.0,1.0,7/8,37.82%,FERMT1;PTEN;CLASP2;FERMT2;MTOR;CLASP1;RREB1
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.40051336825814127,-0.6031961780721675,0.9464285714285714,1.0,1.0,1/6,10.12%,SCIMP
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.39868098517567413,-0.6028341569515339,0.8928571428571429,1.0,1.0,6/6,60.15%,HADHA;PLA2G4A;PLA2G5;HADHB;PLA2G6;LCLAT1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.2718277748731918,-0.60269169534902,0.9733333333333334,1.0,1.0,6/47,18.34%,KDELR3;TSPYL2;DCTN1;TLN1;ARFGAP1;HSPA5
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.2805874206144845,-0.6019675073861427,0.9876543209876543,1.0,1.0,1/60,0.62%,DEPP1
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.31137542396781964,-0.6019450803373849,0.9558823529411765,1.0,1.0,1/19,4.08%,MEIOB
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.3477856581528779,0.600665690821133,0.9534883720930233,1.0,1.0,3/9,10.55%,FOXP1;HMGB1;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.40200497338140073,0.6005837028171487,0.9318181818181818,1.0,1.0,3/5,35.81%,PTPN2;NR1H2;NR1H3
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.2563868165281902,-0.6005820050256996,1.0,1.0,1.0,15/72,23.55%,BLM;POLQ;RNF213;BOK;KCNC1;HLA-DRB1;ADCY8;CARD11;KCNC2;STOML2;RNF112;EHD1;SLC9A1;CHMP2A;AQP11
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.3480867711611143,-0.6004573669052107,0.8983050847457628,1.0,1.0,5/11,32.44%,TGFB1;NODAL;TGFB3;BMP6;RBPMS
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.32311599530832774,-0.5997468912229871,0.9436619718309859,1.0,1.0,4/15,24.99%,PDCD1LG2;HLA-DRB1;INHA;RARA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.368052633488,-0.5996657791584429,0.9545454545454546,1.0,1.0,2/10,15.08%,BMX;AATK
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.3120131664248819,0.5992366908799863,0.96,1.0,1.0,5/8,32.95%,SMG1;RPTOR;NPRL3;MTOR;MLST8
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.24667120642161355,-0.5991221365781326,1.0,1.0,1.0,23/112,22.71%,B3GALT2;FUT2;ST3GAL6;B3GNT5;GALNT10;B3GNT2;MAN1C1;TUSC3;ST6GALNAC2;B4GALT7;MGAT3;MGAT5;PMM1;ALG1L2;ST8SIA3;GFPT2;TMEM258;B3GALT4;DPAGT1;POMGNT2;B3GALNT1;ST8SIA1;DPM3
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3378486184502843,-0.599113781464207,0.9393939393939394,1.0,1.0,4/14,24.22%,APLN;GPER1;CDKN1A;PPARG
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.3774849914583293,-0.5984893389263923,0.9310344827586207,1.0,1.0,2/6,19.24%,USP50;CD36
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.32437804790350305,0.5983129933382916,0.9534883720930233,1.0,1.0,4/8,31.39%,DRD2;GPR35;DRD4;CBARP
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.3303941890694684,0.5978909580049216,0.9285714285714286,1.0,1.0,4/7,35.81%,DISP3;NR1H2;PRKN;NR1H3
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.4016825517380594,0.597438850478191,0.9487179487179487,1.0,1.0,2/5,31.68%,HMGCL;IVD
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.2334453371387115,-0.5946573750984966,1.0,1.0,1.0,22/152,20.67%,EFNA1;TESC;ZSWIM7;ATP1B1;IGF1;PFN2;TCP1;PINK1;TNIP2;FLOT1;RPS7;PPIB;RPL5;PRKCD;RPL23;CDC37;CDKN1A;RPL11;UBE2B;TAF9B;ATP1B3;RTN4
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.26468965145484935,-0.5944854928737566,0.9864864864864865,1.0,1.0,6/56,13.02%,ALOX12;ACSM5;LIPI;LIPH;OLAH;CYP3A4
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.403445678540281,-0.5939200334334043,0.9242424242424242,1.0,1.0,2/5,13.52%,HAP1;NLGN1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.26614847791653135,-0.5936162775298313,0.9733333333333334,1.0,1.0,15/59,21.63%,CD160;HTR2B;IGF1;NYAP1;PITPNM2;PLCH2;PIK3CB;PIK3CD;IRS2;HTR2A;PLCE1;PDGFRA;NYAP2;PTAFR;GAB2
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.38159970362495826,-0.593198062193958,0.9107142857142857,1.0,1.0,2/5,21.62%,EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.2400660037146794,0.5931351975672945,0.9655172413793104,1.0,1.0,8/31,23.77%,IPO5;GLRB;SESN2;CPEB3;SLC38A9;LAMTOR3;MEAK7;RPTOR
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.38080268591233757,-0.5929203798427618,0.8947368421052632,1.0,1.0,1/6,11.18%,PRKCQ
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.35289288140996167,-0.5928174705839654,0.9649122807017544,1.0,1.0,3/9,19.87%,COPS9;RPL5;RPL11
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.36208082298140926,0.5921326481013224,0.95,1.0,1.0,1/5,10.47%,EIF5A2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.3752107157029816,-0.5916003970483299,0.9183673469387755,1.0,1.0,3/5,21.16%,SLC15A4;RTN4;RSAD2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.3237966929621868,0.5914388163345407,0.9777777777777777,1.0,1.0,1/8,7.42%,COMMD1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.3023148473617367,-0.5912249892716076,0.9692307692307692,1.0,1.0,11/28,28.23%,SEMA3B;SLIT3;SEMA3E;LRTM1;SEMA4G;SEMA4C;SLIT2;SEMA6D;LGR6;SEMA3C;SEMA3D
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.31622325478234964,-0.5905142299302402,0.9552238805970149,1.0,1.0,3/16,21.37%,GLI1;SFRP1;TXNDC15
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.3459671752485547,0.5898355616075334,0.8717948717948718,1.0,1.0,1/7,19.75%,MCM6
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.23414799939525,-0.5892815406105638,1.0,1.0,1.0,14/302,10.08%,RECQL4;BLM;SUV39H1;HIC1;HELB;POLQ;HROB;BRCA1;POLE3;CCND1;PLK3;GADD45A;SPATA18;IRF7
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3176904811276211,-0.5882078961137457,0.9552238805970149,1.0,1.0,6/18,21.54%,RYR2;RARG;TBX20;PDGFRA;HES1;FBN2
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.3714432414993054,-0.5878547271001113,0.9629629629629629,1.0,1.0,1/7,17.94%,ARL13A
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.29337342429855984,0.5876762076747908,1.0,1.0,1.0,4/14,31.09%,PANK2;NUDT7;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),0.33146159580960666,0.5873814234485925,0.8837209302325582,1.0,1.0,2/8,28.12%,GPR37L1;NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.33238387392259894,-0.5870116748634135,0.9508196721311475,1.0,1.0,3/12,19.21%,PINK1;NUPR1;PHF23
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.36339267884192195,0.5862637496001871,0.9523809523809523,1.0,1.0,2/5,16.85%,DUSP12;BAD
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),0.30725096357643944,0.5861017460511528,1.0,1.0,1.0,2/13,8.83%,MT1E;HSF1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3368047317591689,0.5853417234021168,0.9622641509433962,1.0,1.0,1/8,4.99%,RCC2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),0.3359813361923216,0.5852624899513468,0.9333333333333333,1.0,1.0,4/10,29.56%,DENR;EIF2D;EIF2S3;EIF5
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.29289633307298824,-0.5851994055749273,0.9692307692307692,1.0,1.0,2/29,4.68%,HELB;POLQ
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),-0.3223014010019024,-0.584910428994849,0.9375,1.0,1.0,1/8,7.10%,CMPK2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.36509478732130934,0.5845512933641074,0.8421052631578947,1.0,1.0,1/6,5.88%,TMEM33
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.37811685513647647,-0.5845408771593348,0.9642857142857143,1.0,1.0,4/6,29.91%,NLGN1;LHFPL4;SHISA7;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.2737730085033813,-0.5843390528446879,0.9875,1.0,1.0,3/31,10.37%,NELL1;WNT5A;ISG15
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.3326525294939093,-0.5834863048991745,0.9344262295081968,1.0,1.0,1/10,8.06%,ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.3329815847226184,-0.5829558952985318,0.9827586206896551,1.0,1.0,1/12,9.05%,BTG1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3177226277372263,-0.5828633675767919,0.9846153846153847,1.0,1.0,15/15,68.26%,GPR137C;GPR137;TELO2;SEH1L;RRAGB;CLEC16A;LAMTOR5;RRAGD;PIH1D1;RRAGA;GPR137B;PIP4P1;KLHL22;LARS1;SIK3
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.38415665646646124,-0.5823515653707456,0.9516129032258065,1.0,1.0,2/5,20.54%,XRCC1;REC8
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3280079653224185,-0.5817866938034155,0.971830985915493,1.0,1.0,3/16,15.47%,SVIL;VIL1;ADD2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3280079653224185,-0.5817866938034155,0.971830985915493,1.0,1.0,3/16,15.47%,SVIL;VIL1;ADD2
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.2637425726430449,0.5813777522627652,1.0,1.0,1.0,7/18,28.62%,ASAH2B;SPHK2;PLPP3;NAAA;PLPP1;ACER3;SGPP1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.2920580888658716,-0.5806539281766673,0.9848484848484849,1.0,1.0,5/24,19.38%,PDE6B;RBM4B;PML;MTA1;BHLHE40
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2418155834009367,0.5804062512772,1.0,1.0,1.0,8/44,19.99%,HSPA1A;TNFAIP3;TRADD;CFLAR;SPATA2;CPNE1;SPPL2A;CLIP3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.2986790129510968,-0.5803167037665935,0.9523809523809523,1.0,1.0,4/17,18.34%,HK2;PINK1;PML;HSPA5
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.4115689070954953,-0.5801706449536135,1.0,1.0,1.0,1/5,15.68%,DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.4115689070954953,-0.5801706449536135,1.0,1.0,1.0,1/5,15.68%,DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.4115689070954953,-0.5801706449536135,1.0,1.0,1.0,1/5,15.68%,DDRGK1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.32867285750764164,0.5800742281716632,0.9230769230769231,1.0,1.0,2/7,14.45%,AGBL1;AGBL2
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.3645960327907247,-0.5799809653398853,0.9387755102040817,1.0,1.0,4/6,32.40%,STAT3;CDK6;EIF2B5;MT3
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.33312095191636937,0.5782338677655943,0.95,1.0,1.0,2/8,25.55%,SLC2A10;SORT1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.2632997231709929,-0.5781347364318928,1.0,1.0,1.0,2/48,6.11%,CCK;MAP1B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3165305698550536,0.5780747220404928,0.9411764705882353,1.0,1.0,2/14,7.15%,BAG2;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.26254916168860737,-0.5779992940920705,0.9861111111111112,1.0,1.0,10/41,25.48%,ZFP36;ADIRF;PIM1;SFRP2;ZNF385A;SFRP1;PPARG;VSTM2A;XBP1;AAMDC
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.28794849534035455,0.5777997518310978,0.9722222222222222,1.0,1.0,5/16,24.94%,MT1E;HSF1;DAXX;LOXL2;MT1A
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.3913735673711522,-0.5776350393517775,0.9152542372881356,1.0,1.0,1/5,14.31%,HYAL1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.2648028607989033,-0.5774175262469224,1.0,1.0,1.0,6/32,23.10%,PSRC1;DCTN1;ANKRD53;FSD1;DRG1;CHMP2A
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.2847562654734416,0.5772510219689881,0.9714285714285714,1.0,1.0,5/19,20.02%,EIF2S1;PRRC2C;G3BP1;YTHDF2;UBAP2L
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.32477725089306386,-0.5750130045251136,0.9838709677419355,1.0,1.0,4/15,24.22%,ANGPTL3;EEF1A2;SORBS1;PPARG
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.2717172782050827,0.5748840615401399,0.9032258064516129,1.0,1.0,5/18,29.88%,MAP3K4;PKIB;HNRNPD;USP7;MAPK1
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.3707248745185012,-0.5745511244299379,0.9591836734693877,1.0,1.0,6/6,62.95%,CELSR1;BRSK1;BRSK2;FUZ;NPHP1;VANGL2
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.36142382871943346,0.573947992395623,0.9090909090909091,1.0,1.0,3/5,28.33%,LRRC17;SBDS;LRP5
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.33062114290270994,0.5735704988156689,0.8947368421052632,1.0,1.0,2/9,28.12%,GPR37L1;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3256769892831486,-0.5732350059309463,0.9710144927536232,1.0,1.0,2/10,21.70%,ECHDC3;SORBS1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.28040923989024624,-0.5729816313447995,0.9827586206896551,1.0,1.0,2/28,10.32%,HELB;TAF10
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.38508229251780085,-0.5727850463189904,0.9672131147540983,1.0,1.0,6/6,61.51%,MTHFD1;MTHFR;GOT1;MTRR;PLOD2;MTR
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.30378404223566446,-0.5723403879471852,0.9661016949152542,1.0,1.0,3/12,24.87%,NUPR1;AQP11;ALOX5
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.30738183848918715,0.5719412847652876,0.9117647058823529,1.0,1.0,4/10,30.99%,NDFIP1;SNX3;SNX12;TERF1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.3226119429114236,-0.5712853685781304,0.9552238805970149,1.0,1.0,1/8,7.10%,CMPK2
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),0.3464203427249659,0.5706938740698664,0.8780487804878049,1.0,1.0,4/6,34.33%,SLC25A14;SLC13A5;SLC13A3;SLC25A11
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.3135152034949473,-0.5696108179996132,0.9848484848484849,1.0,1.0,2/17,13.10%,SGPP2;GCHFR
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.2802781479448181,0.569195860936066,0.9523809523809523,1.0,1.0,1/13,7.15%,FBXO5
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.29077875197168945,-0.5690294238902444,0.9545454545454546,1.0,1.0,4/21,16.36%,PDCD1LG2;ISG15;SYK;HLA-DRB1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),-0.36379025291911504,-0.5688631323149068,0.9642857142857143,1.0,1.0,2/5,18.92%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),-0.36379025291911504,-0.5688631323149068,0.9642857142857143,1.0,1.0,2/5,18.92%,TMLHE;SHMT1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.27577484770901634,0.5688175098460966,1.0,1.0,1.0,4/21,18.13%,RUNX1;KAT2A;MDK;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.31416368264571926,-0.5687469976935028,0.9682539682539683,1.0,1.0,3/19,19.16%,HAP1;SEPTIN9;CEP135
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.38003065286077997,-0.568202065790004,1.0,1.0,1.0,2/5,16.59%,CEACAM1;PTPRR
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.377631744260217,-0.5680474057167245,0.9583333333333334,1.0,1.0,1/6,9.57%,NFKBID
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.34099147996538315,0.56731146508328,0.9411764705882353,1.0,1.0,1/7,4.94%,KLKB1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.31452019182518026,0.5670230698172076,0.9024390243902439,1.0,1.0,5/9,26.72%,SOCS4;CHMP6;CBLB;VPS25;CBL
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.2965910863247561,0.5670006129812629,1.0,1.0,1.0,3/13,14.67%,PLIN5;ABHD5;GPLD1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.2526009618185905,-0.5660307551104353,0.9871794871794872,1.0,1.0,12/47,25.92%,RAMP3;AKAP5;PRKCH;ITGA3;CLN3;GPER1;STAC2;SORBS1;STX3;SQSTM1;STX4;CNPY4
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.25729237011536715,-0.5659789054247881,1.0,1.0,1.0,8/50,20.53%,ATG9A;MAP1LC3A;WDR45;GABARAPL1;GABARAPL2;ATG16L2;TMEM41B;RAB19
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.26838632655914163,0.5652268815953299,0.972972972972973,1.0,1.0,1/14,2.70%,PSMD10
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.30053538177630806,-0.5648876931697814,0.9696969696969697,1.0,1.0,4/10,31.65%,CNTN4;RTN4;EPHB2;SEMA5A
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.27196246118260536,-0.5647897590731217,1.0,1.0,1.0,7/41,16.65%,CYP1B1;PDK3;PINK1;FOXM1;FLOT1;CNDP1;FASN
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.3031119380432803,-0.5647210835728589,0.967741935483871,1.0,1.0,5/17,27.99%,FASN;FAR2;SCD;CBR4;DGAT1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.25344780793390276,0.5643980343279983,0.972972972972973,1.0,1.0,5/23,26.47%,AKT1;CCDC88A;MARK1;EFHC2;PTEN
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.35436291403705245,0.564385888182648,0.9772727272727273,1.0,1.0,1/5,14.75%,NFKB1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.3044986407974393,0.5623337655975643,0.9285714285714286,1.0,1.0,3/10,19.32%,PYGM;UGP2;PPP1R3C
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.2811159702736854,-0.5623059493019354,0.9692307692307692,1.0,1.0,5/25,19.38%,PDE6B;RBM4B;PML;MTA1;BHLHE40
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),0.370626925294107,0.5621143732517218,0.9130434782608695,1.0,1.0,2/5,25.19%,FBL;FBLL1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.234990009507375,-0.5617808572891018,1.0,1.0,1.0,21/139,20.46%,BLM;POU4F1;BRCA1;PLK3;HEXIM1;RPA3;TAF10;NUAK1;PRDM1;RPA1;RPS15;RPL5;CDK2;RPL23;PML;CDK5;RPS20;KAT5;RPL11;ZNF385A;TAF9B
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.29504038432564894,-0.5609697348344088,0.9692307692307692,1.0,1.0,7/21,22.76%,PFN2;RAP1GAP;TCHP;PRKCD;LIMK2;ODF2L;SLIT2
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.27300127155975296,-0.5608515618797489,0.9861111111111112,1.0,1.0,5/32,17.19%,PRKCQ;TNS2;PRKCD;TSC2;PRKCB
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.32191459054167354,-0.5607761305469473,0.9833333333333333,1.0,1.0,1/12,6.99%,HAP1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.3133137582537931,-0.5607594196655322,0.9836065573770492,1.0,1.0,5/16,24.22%,CCL2;APLN;COL4A3;SP1;PPARG
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.29391707793672156,0.5607201122897599,1.0,1.0,1.0,2/11,12.35%,EIF2AK4;VAPA
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.2613581128578295,0.5604822335594346,1.0,1.0,1.0,4/27,15.62%,MEGF10;MAPK12;CDH2;ID2
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.338743082271571,-0.5599289933442475,0.9672131147540983,1.0,1.0,1/10,7.95%,MYH11
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.3282503669799095,-0.5592096226468832,0.9696969696969697,1.0,1.0,2/16,11.12%,NELL1;DAB2IP
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.33128680394562493,-0.5587292293249819,0.9516129032258065,1.0,1.0,3/10,21.13%,CYP3A4;SPP1;HSD17B7
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.30986738099180566,0.5586375531847754,0.9705882352941176,1.0,1.0,4/12,24.16%,THAP1;PRKX;ERN1;LOXL2
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.35913150061285243,-0.5586238695842104,0.9482758620689655,1.0,1.0,7/7,64.11%,TRERF1;WBP2;YAP1;NEDD4;SRC;UBE3A;UBR5
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.29698248573148855,-0.5584404810941687,0.9666666666666667,1.0,1.0,1/12,5.98%,CCL2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.321476469345482,0.5581627014955275,0.95,1.0,1.0,4/9,32.28%,PRKAA1;KLF15;SIRT1;SETD5
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.2688047588506254,-0.5579710757695421,1.0,1.0,1.0,5/29,19.14%,NLRP5;CRB2;RPS6KA6;NIBAN2;PHLDB2
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.3545569220851629,-0.5575865323072253,0.9824561403508771,1.0,1.0,1/6,10.00%,WEE2
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.2995937923232744,0.5571710615569869,0.95,1.0,1.0,5/10,32.98%,ALKBH3;ASCC3;ALKBH1;FTO;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.2995937923232744,0.5571710615569869,0.95,1.0,1.0,5/10,32.98%,ALKBH3;ASCC3;ALKBH1;FTO;ASCC2
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.32399561741472116,-0.5569285804446551,0.9365079365079365,1.0,1.0,5/15,26.38%,ODAD1;DNAH17;DNAAF1;ODAD4;DNAI2
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.3376628293508521,0.5567414543085125,0.9459459459459459,1.0,1.0,3/7,37.12%,ISYNA1;PPIP5K2;IPPK
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.318600293103376,-0.5549498390191907,0.9666666666666667,1.0,1.0,3/15,18.16%,PIGA;PIGH;PIGC
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.3328488092326741,-0.5543664790828371,0.9672131147540983,1.0,1.0,2/11,17.89%,SCIMP;NMI
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),0.28863859314738444,0.5542277938775679,1.0,1.0,1.0,1/9,12.30%,H1-2
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.27684835897981225,-0.5540848211775289,0.9848484848484849,1.0,1.0,6/28,19.36%,WDR1;ANK1;ERBIN;CRB2;LRRC7;MYO9A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.27744048733634735,-0.5538463003423152,1.0,1.0,1.0,7/32,19.21%,BRCA1;CAV3;PINK1;TCHP;LIMK2;NUPR1;PHF23
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.2704621846651234,0.5536739167915246,1.0,1.0,1.0,5/22,19.39%,AK1;ENPP3;FHIT;AK4;DCK
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.3634486149533385,-0.55350192605931,0.8936170212765957,1.0,1.0,1/5,22.47%,IDH2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.3259550884230724,0.5532193685943474,0.975609756097561,1.0,1.0,4/10,27.08%,SPIRE2;CARMIL2;PLS3;CARMIL1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.22201129129135036,0.5530335987419128,1.0,1.0,1.0,4/37,14.92%,SIRT6;SPIRE2;OTUB2;POT1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.29906032116368664,0.5529821974773268,0.9705882352941176,1.0,1.0,3/9,33.38%,CEBPG;VAMP7;ARL8B
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3281314343858165,0.5527764941601221,0.9459459459459459,1.0,1.0,2/10,15.61%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.265486099471001,0.5526411835418525,1.0,1.0,1.0,1/16,3.99%,ADCY1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.3486048675004686,-0.5525242983937235,0.9516129032258065,1.0,1.0,2/6,22.80%,SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.3023044911259833,0.5515415672309313,0.9767441860465116,1.0,1.0,1/9,10.28%,ATF6
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),-0.3063800083264283,-0.551446876923162,0.9692307692307692,1.0,1.0,1/8,7.10%,CMPK2
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.35157694306682835,0.5509473938773303,0.9361702127659575,1.0,1.0,2/5,29.47%,RBPJ;REST
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.33486481707225824,-0.550878799595466,0.9571428571428572,1.0,1.0,1/8,11.74%,PINK1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.3233697675305206,0.5508733398587079,0.95,1.0,1.0,1/7,10.68%,LIN7C
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.34321737100163435,-0.5507937054769204,0.9402985074626866,1.0,1.0,8/8,65.70%,C5AR1;CLU;HSP90AA1;NAB2;HSP90AB1;EGR1;SORL1;RB1
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.2911969773320217,0.5504497427818561,0.9777777777777777,1.0,1.0,1/10,8.83%,HSF1
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.3374225687345059,0.5495154987323098,0.9791666666666666,1.0,1.0,1/5,27.65%,FERMT2
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.3158705039119939,-0.5491964563480225,0.9692307692307692,1.0,1.0,1/11,10.04%,GPT2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.31185692055065733,-0.5484451515672851,0.9701492537313433,1.0,1.0,4/8,36.03%,AKAP8;CDK9;AKAP8L;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.2739793031551698,0.547621453478404,0.95,1.0,1.0,2/11,24.15%,PICALM;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),-0.3393796735592452,-0.5471725410872422,0.9019607843137255,1.0,1.0,1/6,7.39%,TNFRSF14
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.3378751086944739,-0.5470549929240922,0.9607843137254902,1.0,1.0,1/8,11.74%,PINK1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.301844932274638,-0.54640094543767,0.9333333333333333,1.0,1.0,12/12,69.84%,PARP2;PARK7;MT3;HDAC1;HLCS;SIRT7;HELLS;UFL1;SETD5;SIRT1;CHD1;MBD2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.30844466881712895,-0.5459478959780943,0.9701492537313433,1.0,1.0,2/13,14.58%,GRM6;GRM7
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.2672350188680652,-0.5452620125512523,1.0,1.0,1.0,1/35,2.20%,ZFP36
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.29165045797549316,0.5452537723496602,1.0,1.0,1.0,2/10,18.83%,PIK3C3;PORCN
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.23564657141947537,0.5448916472089458,1.0,1.0,1.0,3/30,15.78%,TRAK2;LRPPRC;TMEM201
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.3343255705363918,-0.5439948034041704,0.9818181818181818,1.0,1.0,7/7,66.59%,STK25;RIPOR1;ARHGAP21;PDCD10;COPG1;YWHAZ;CDC42
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.3127277635758423,-0.5435420391808298,0.9682539682539683,1.0,1.0,3/13,16.23%,COX7A1;PINK1;COX7A2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.34788978274455584,-0.5433771683740509,0.9649122807017544,1.0,1.0,2/6,25.10%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.34788978274455584,-0.5433771683740509,0.9649122807017544,1.0,1.0,2/6,25.10%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.34788978274455584,-0.5433771683740509,0.9649122807017544,1.0,1.0,2/6,25.10%,TMED10;ARFGAP3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.25632126488805385,-0.5433241106333679,1.0,1.0,1.0,3/34,11.74%,GFAP;DAB2IP;PINK1
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),-0.3501740359614599,-0.5427319292049118,0.9833333333333333,1.0,1.0,1/6,15.09%,ASS1
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.3067808151326016,0.5412789302198933,0.9782608695652174,1.0,1.0,1/10,10.14%,GNB3
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.364596708299288,-0.5412787776612268,0.9661016949152542,1.0,1.0,6/6,63.56%,PHF19;SUPT6H;PHF1;MACROH2A1;MTF2;OGT
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.3485528475314902,-0.541121335926306,0.9375,1.0,1.0,3/6,24.92%,SOX15;TGFB1;MRTFB
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),0.30266038700922715,0.5405369852180623,1.0,1.0,1.0,3/8,33.74%,ABL2;ECSIT;SZT2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.27821753888760337,-0.5403946163057485,0.9857142857142858,1.0,1.0,2/29,12.15%,CC2D2A;GLI1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.2967858310377384,-0.5398354325425851,1.0,1.0,1.0,7/13,28.87%,CMPK2;AK5;NMNAT3;PNP;AK7;NMNAT2;ME1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.34218377862713417,0.5397522112099874,0.926829268292683,1.0,1.0,1/8,10.01%,ENGASE
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.3231557811649284,-0.5391028234851839,0.9672131147540983,1.0,1.0,2/8,16.59%,ADCY3;CLN3
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.22093152429841223,0.5386134994682188,1.0,1.0,1.0,8/36,27.56%,SNRPF;AAR2;CLNS1A;WDR77;GEMIN4;SART3;SNRPB;COIL
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.25344689345394017,0.5385253578981887,0.9714285714285714,1.0,1.0,2/13,23.30%,AAR2;SART3
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.27643624076039347,0.5384062181194128,1.0,1.0,1.0,6/20,24.86%,NT5C1A;PRTFDC1;MLYCD;PDE9A;NUDT7;NT5E
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.2971083264251487,-0.5383227088859361,0.9848484848484849,1.0,1.0,1/16,7.01%,APOD
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.30213987202005116,-0.5376906985641291,0.95,1.0,1.0,1/12,8.69%,WAS
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.37443828421359787,-0.537261764695028,0.9818181818181818,1.0,1.0,5/5,62.57%,KDM6B;KDM6A;PHF8;KDM7A;UTY
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),-0.3555586399423333,-0.5365813067850027,0.9682539682539683,1.0,1.0,1/5,15.09%,ASS1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2613145344554326,0.5348456950110925,0.9743589743589743,1.0,1.0,1/11,10.41%,PAPOLA
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.2776308214773968,0.5341285429033846,0.9743589743589743,1.0,1.0,7/13,28.65%,DPH3;MTO1;ELP4;ELP3;URM1;ALKBH8;CTU1
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.3233713709112556,0.5336669518496434,0.95,1.0,1.0,2/6,29.87%,TLK1;MAP1S
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3042494018706734,-0.5334495267034942,0.9464285714285714,1.0,1.0,1/10,8.66%,SRF
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.3134669694132465,0.5334248699545163,1.0,1.0,1.0,3/5,33.88%,RNF20;KDM1A;RNF40
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.2310264109253718,-0.5334245240418076,1.0,1.0,1.0,10/51,24.26%,RAB11A;PLK3;DCTN1;LIMK2;MAPT;FSD1;HOOK2;DST;CLIP2;TRDN
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),-0.33940723680075957,-0.5322883215311832,0.94,1.0,1.0,3/6,23.58%,DCX;STAT3;NKD1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.2989170589159419,-0.5322300886851777,1.0,1.0,1.0,3/16,17.95%,ASPN;SRGN;TGFB1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.3376588426990622,-0.5321216097760113,0.9552238805970149,1.0,1.0,4/8,32.55%,DDRGK1;DDIT3;TMSB4X;ZNF593
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.3310009229090114,-0.5313017931612131,0.9811320754716981,1.0,1.0,3/7,29.54%,AK5;DHODH;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.3064837850890526,0.5312931133392315,0.9210526315789473,1.0,1.0,2/8,31.30%,PKIB;SIRT1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),-0.34671724540414356,-0.5312647719946212,0.9830508474576272,1.0,1.0,5/5,65.34%,TMEM107;NPHP4;TCTN1;TCTN2;SPATA7
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.25827891220661914,0.5309259622669715,1.0,1.0,1.0,2/22,13.67%,MAPK12;CDH2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.31149092318223043,-0.5304593706569151,0.9696969696969697,1.0,1.0,2/9,20.90%,B4GALT7;CHST9
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.29591394252691683,0.5295896149597287,0.9230769230769231,1.0,1.0,6/9,34.74%,DRD2;SNCAIP;DRD4;RNF180;PNMT;PRKN
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.31851367612940074,-0.5294735155151302,0.9836065573770492,1.0,1.0,3/10,25.76%,SLC50A1;SLC5A10;SLC5A9
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.3300369656121286,-0.529327649079226,0.9636363636363636,1.0,1.0,1/6,15.91%,JADE2
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.22823971987353536,0.5288123623247973,1.0,1.0,1.0,10/29,27.68%,DNASE1L2;NUDT15;DFFB;DNASE1L1;NUDT9;ENTPD1;PPP1R8;MTREX;HNRNPD;ENTPD4
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.2909929367812737,0.5281753015857763,0.9583333333333334,1.0,1.0,9/9,70.92%,RYK;LRP6;NR4A2;MANF;CDNF;LMX1B;VEGFA;CTNNB1;WNT9B
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.34245394400170537,-0.5281735059402268,0.9310344827586207,1.0,1.0,2/5,22.80%,SLC29A4;SLC22A1
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.28947341207866817,-0.5281070911108838,1.0,1.0,1.0,4/19,19.24%,NOS1AP;HPCA;CACNB1;STAC2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.28806770797018977,-0.528058427805205,0.9701492537313433,1.0,1.0,2/18,15.80%,IL1RAPL1;RELN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.2824650692806844,0.5280541233855472,0.9375,1.0,1.0,4/13,17.89%,ATP1A2;ANK2;GSTM2;DMD
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.20017122842685467,0.5268347045788234,1.0,1.0,1.0,15/47,32.16%,NOVA1;NSRP1;HNRNPU;RBFOX1;FXR2;RBMX;RBM15;MBNL1;MAGOH;REST;PTBP1;RBM15B;HNRNPL;SAP18;CELF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.23715736663122294,-0.525933115978492,1.0,1.0,1.0,7/54,19.43%,YBX3;PINK1;BCL2L2;SFRP2;CREB3;CDKN2D;PLAUR
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.32003625541525754,0.5258000994993292,0.9428571428571428,1.0,1.0,2/6,16.12%,SASH1;MARCHF7
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.27579197154049767,0.5257141745261298,0.9523809523809523,1.0,1.0,2/9,19.53%,POT1;DAXX
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.27579197154049767,0.5257141745261298,0.9523809523809523,1.0,1.0,2/9,19.53%,POT1;DAXX
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.327446816632817,-0.5253454356476814,0.9661016949152542,1.0,1.0,1/5,11.32%,PRDM1
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.31004321308627775,-0.5252002020041757,0.9824561403508771,1.0,1.0,2/8,18.19%,PINK1;NUPR1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.3270343835338779,-0.5247099717757409,0.9107142857142857,1.0,1.0,2/7,15.09%,NOS1;ASS1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.27817242356186433,-0.524089753876933,0.9857142857142858,1.0,1.0,1/17,6.51%,GSTM5
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.27817242356186433,-0.524089753876933,0.9857142857142858,1.0,1.0,1/17,6.51%,GSTM5
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.25270118694673427,0.5238394193220303,1.0,1.0,1.0,2/21,10.49%,TBC1D12;RAB1B
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.26372563601660615,0.5229495419871493,1.0,1.0,1.0,1/17,6.69%,AKT1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.3396452847358806,0.521728561087944,0.9761904761904762,1.0,1.0,3/8,16.45%,NIPBL;ID2;RBPMS2
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.3290141093221921,-0.5215963856129329,0.9846153846153847,1.0,1.0,2/8,17.58%,CXCL17;CREB3
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),-0.3414566689530283,-0.5205569290028785,0.94,1.0,1.0,1/5,19.21%,PHF23
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.3299734070638985,0.5201463192826269,0.9361702127659575,1.0,1.0,3/5,40.35%,HSD17B10;TRMT10C;PNPT1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.2921851180365588,-0.5200071091599047,1.0,1.0,1.0,3/9,24.64%,HSPA5;COPS5;XBP1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.34692124304502625,0.5190397333788631,0.9387755102040817,1.0,1.0,1/5,19.21%,SLC25A38
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.27994658109607273,-0.5186097687924445,0.9583333333333334,1.0,1.0,5/19,25.25%,DCTN1;EMD;GPER1;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.25499580482858514,0.5185028776848127,1.0,1.0,1.0,4/15,18.61%,SGIP1;PICALM;PIK3C2A;EPS15
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2703835233213727,-0.518292276531896,1.0,1.0,1.0,4/23,22.15%,DAB2IP;BBC3;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.23573487666713705,0.51822519320871,1.0,1.0,1.0,1/26,5.78%,SF3A1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.32850650789617986,0.5172619552301958,0.95,1.0,1.0,3/6,21.74%,METTL4;DKC1;MEPCE
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.29213578432412834,-0.5156632201919162,1.0,1.0,1.0,4/11,33.65%,MYO9A;ZDHHC7;MSN;CAMSAP3
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.29374478468723336,-0.5149096571971216,1.0,1.0,1.0,3/9,21.62%,RPS21;EXOSC7;EXOSC10
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.3554483209865486,-0.5139326951227327,1.0,1.0,1.0,2/5,17.99%,BIRC3;SLC15A4
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.2822458270106221,0.5137083935562182,0.9302325581395349,1.0,1.0,6/6,71.79%,SMO;PTPRJ;CDHR2;YAP1;FAP;PAK1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.2803607747516616,-0.5121746399929368,0.9827586206896551,1.0,1.0,2/12,20.67%,CNTN4;RTN4
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.3272692772117038,-0.5118788983931489,0.9508196721311475,1.0,1.0,1/5,17.19%,PRKCB
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.23851841324021403,-0.5109131215577281,0.9876543209876543,1.0,1.0,9/36,22.34%,LTBP4;FADD;PLAT;CLN3;AURKAIP1;CDK5;PLAUR;CASP8;GSAP
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.31352518825520986,-0.5105171734929809,0.9642857142857143,1.0,1.0,9/9,68.67%,TSPAN6;RIOK3;C1QBP;DHX58;TKFC;SEC14L1;NPLOC4;UFD1;GPATCH3
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.24715295216959646,0.5104926156966066,0.9696969696969697,1.0,1.0,17/17,75.31%,GTF3C3;SPIN1;NIFK;GTF3C4;TCOF1;TAF1B;SIRT7;MARS1;GTF3C2;GTF3C5;GTF3C1;BRF1;GTF3A;POLR1E;CAVIN1;POLR1G;GTF3C6
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.27489088838653425,0.5089275416193576,0.9761904761904762,1.0,1.0,4/9,29.35%,EXOSC6;EXOSC8;EXOSC5;XRN1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.293862341325848,0.508807250754405,1.0,1.0,1.0,1/7,19.75%,HEY2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.24628476000383923,-0.5084548270337897,1.0,1.0,1.0,6/38,22.02%,ALOX12;SQLE;ACOT8;INSIG1;MSMO1;SLC27A5
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.2578834265817489,-0.5081046434443985,1.0,1.0,1.0,1/24,5.52%,AKR1C1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.297454560909844,0.5078601832573596,0.9512195121951219,1.0,1.0,2/6,21.21%,ANK2;RYR1
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.32263910128651674,-0.5057814728792072,0.9807692307692307,1.0,1.0,3/7,19.24%,BIRC3;SLC15A4;CD36
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.3007276443117911,0.5035864554844874,0.9607843137254902,1.0,1.0,2/6,31.08%,GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.25410657360918953,0.5020855183385653,0.975,1.0,1.0,1/15,7.15%,FBXO5
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.31558430759386,0.5019339520915155,0.9736842105263158,1.0,1.0,1/5,24.07%,ITCH
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.3423683810903474,-0.5012351260623226,0.9811320754716981,1.0,1.0,1/5,14.68%,PPIB
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.2152446125583935,0.4975635521089057,1.0,1.0,1.0,5/27,22.84%,STYX;EIF3H;FHIT;CCAR2;N4BP1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.29497133153659116,-0.4974224599229649,1.0,1.0,1.0,3/10,21.79%,FADD;CASP8;INHA
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.2516494424008874,0.4967885883152124,1.0,1.0,1.0,13/13,74.85%,PARP1;ERCC4;TERF1;TERF2;PINX1;TNKS2;TNKS;ERCC1;SMG6;ATM;TERF2IP;SLX4;NBN
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.2925738948798476,0.4967864584591689,0.9814814814814815,1.0,1.0,3/7,24.14%,HEY2;JAG1;ZFPM2
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.3128508262150203,0.4929762467673656,0.9523809523809523,1.0,1.0,4/6,32.53%,SIRT2;EZH2;DPY30;RIF1
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),-0.32301646245015486,-0.492855127797524,0.9830508474576272,1.0,1.0,2/6,29.18%,CHMP2A;FCHO2
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.26370513446602256,0.49244465177568647,0.9545454545454546,1.0,1.0,4/10,22.72%,DCP1B;EDC3;PATL1;DCP1A
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2947342408688155,-0.4913637216707318,0.984375,1.0,1.0,2/10,21.97%,ADAM8;SH3D19
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),0.3158487168691752,0.4898417632121511,0.9814814814814815,1.0,1.0,2/5,24.83%,DHFR;BMP7
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.22291619171903698,-0.4895076524018585,1.0,1.0,1.0,8/52,20.53%,ATG9A;MAP1LC3A;WDR45;GABARAPL1;GABARAPL2;ATG16L2;TMEM41B;RAB19
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.295130192418361,-0.48800721896913657,0.9830508474576272,1.0,1.0,2/8,18.89%,ZFPM1;TBX20
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.2960290793881467,-0.48793570396672575,1.0,1.0,1.0,1/8,12.35%,HECW2
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.23690768903753,-0.48789308477828497,1.0,1.0,1.0,1/36,3.86%,BHMT
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.22297823552411633,-0.48755866404923515,1.0,1.0,1.0,11/47,25.81%,ACSM5;LIPI;LIPH;OXSM;ACOT8;SLC27A5;ACMSD;ACSM3;XBP1;ALOX5;CBR4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.28495615822947307,-0.48753994662426287,1.0,1.0,1.0,4/14,19.49%,DDRGK1;RYR2;HSPA5;GABARAPL2
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.26400914122941455,-0.4872733508301304,1.0,1.0,1.0,2/17,12.08%,HSD17B14;CYP21A2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.32974383325066525,0.48665461633140855,0.9722222222222222,1.0,1.0,1/5,13.93%,NAPB
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.307522818901288,-0.48642784761368657,0.9821428571428571,1.0,1.0,2/6,26.55%,HES1;ENG
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.26350188521203094,-0.4859297066435867,0.9838709677419355,1.0,1.0,1/12,9.00%,NLRP5
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.2627987698369137,0.4859240486703838,1.0,1.0,1.0,1/10,6.55%,SLC25A18
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.28418840833479253,0.48511908176452223,0.975609756097561,1.0,1.0,7/7,71.59%,ADI1;SMS;MTR;MTRR;MTHFR;MSRA;MTHFD1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.3062102767082282,0.48509813426350956,0.9545454545454546,1.0,1.0,3/5,29.28%,ALKBH3;ALKBH1;FTO
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.21619327586494266,0.4850727442265829,1.0,1.0,1.0,8/23,27.41%,SLC25A18;SLC3A2;SLC25A22;SLC36A4;SLC7A9;SFXN1;SLC1A4;SLC25A12
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.2863972252143044,-0.48482755739093303,0.9833333333333333,1.0,1.0,2/10,22.63%,SH2B2;FPR3
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.32247090652377364,-0.4847258651365941,0.9622641509433962,1.0,1.0,2/5,20.04%,CD4;DCAF15
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.288466028484707,-0.4841385010791586,0.95,1.0,1.0,8/8,71.17%,NEU4;GBA3;NAGA;GLA;GM2A;HEXB;NEU1;NEU3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.21976686584205282,0.48400296470035015,1.0,1.0,1.0,8/29,26.91%,VCP;RUBCNL;SNAP29;VIPAS39;UBQLN1;LIX1L;VPS16;VAMP7
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.28567840545657086,0.4829659409780471,0.9767441860465116,1.0,1.0,4/6,39.95%,NAGK;GNPDA2;NPL;RENBP
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.25377458980660383,-0.48185868485602207,0.9833333333333333,1.0,1.0,1/15,12.57%,CORO7
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.2692788281421911,0.4793398124139295,1.0,1.0,1.0,4/12,17.89%,TCAP;CDH2;PIK3CA;DMD
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.27831699720764136,-0.47905991237496526,1.0,1.0,1.0,3/11,19.40%,IGF1;TSC2;GHR
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.25909192381122687,-0.4777402935735315,1.0,1.0,1.0,5/12,28.60%,ALKBH4;HPF1;PARG;CDK9;SETD1A
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.29424245934469817,-0.4772599724775722,0.9807692307692307,1.0,1.0,2/7,22.62%,FLOT1;EHD1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.2903508644401066,-0.4764933667914063,0.9850746268656716,1.0,1.0,1/10,13.52%,NLGN1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.29257241726417665,-0.476161175586473,0.9818181818181818,1.0,1.0,2/5,24.18%,AK5;DHODH
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.2934320240314095,0.4761505020069792,0.9777777777777777,1.0,1.0,4/6,34.19%,GAMT;CKB;SLC6A8;CKMT2
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.3015334841217813,0.4753578178588839,0.9736842105263158,1.0,1.0,4/6,28.62%,NFKB1;ROCK2;RELA;SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.2391280386130923,0.47533416028554576,1.0,1.0,1.0,4/11,34.36%,CDK12;CDK13;SUPT16H;CDC73
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.2582645454060079,0.47486607212039617,1.0,1.0,1.0,3/8,23.28%,ZC3H14;CCNT1;RNF20
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.2535500377871849,0.4745152440752212,1.0,1.0,1.0,5/13,25.54%,AK1;ENPP3;AK4;AK3;CMPK1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.2332399383100202,-0.4733587791001469,1.0,1.0,1.0,7/29,26.17%,DAB2IP;BCL2L14;BDNF;CX3CL1;FAS;RPS3;DEPTOR
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.2409902471825,-0.4721230715366312,1.0,1.0,1.0,5/25,20.65%,ZFPM1;WNT5A;GPER1;TGFB1;WWTR1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.284850284730889,-0.4710198104396783,0.9642857142857143,1.0,1.0,1/7,17.31%,GPC1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.27705147659624135,0.4696899228006727,0.9782608695652174,1.0,1.0,6/6,72.30%,CARMIL1;MAPKAPK2;SNX33;MAPKAPK3;DOCK2;RAB34
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.2882480961561304,0.4678784649985369,0.9782608695652174,1.0,1.0,1/7,11.38%,ABCC2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.24015710534595452,0.4678279915576814,1.0,1.0,1.0,1/15,10.35%,RRM2B
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),0.2043944896864967,0.4670921338483236,1.0,1.0,1.0,9/25,30.40%,GTF2F2;POLR2C;CCNT1;NELFA;CTDP1;POLR2A;POLR2K;POLR2D;POLR2E
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.22460159411977143,-0.4646879049771433,1.0,1.0,1.0,8/33,25.06%,GLRA2;GLRA1;NSMF;SPAAR;LAMTOR2;NEURL1;XBP1;FYN
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.2578047530964238,-0.4642066597797297,1.0,1.0,1.0,2/14,20.18%,LPCAT4;PNPLA8
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.2703335062867846,0.4616278664160819,0.9743589743589743,1.0,1.0,1/7,15.48%,ACADS
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.2956967684449561,-0.46117761136682106,0.95,1.0,1.0,2/6,21.28%,GNG2;SFRP1
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),0.28938201402910557,0.46046986734433704,0.9772727272727273,1.0,1.0,3/5,34.33%,SLC25A14;SLC13A5;SLC25A11
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.2504783341773308,0.4590221771593835,0.9772727272727273,1.0,1.0,1/10,10.57%,WASHC2C
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.288466028484707,-0.45823950284693554,1.0,1.0,1.0,8/8,71.17%,NEU4;MAN2C1;MAN2B2;GBA3;MANBA;MAN2B1;NEU1;NEU3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.2967531017394176,-0.45627490464375287,0.9821428571428571,1.0,1.0,2/7,26.55%,GPER1;ENG
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.2079642096193063,0.4562680542394166,1.0,1.0,1.0,6/19,29.80%,ABL2;PDPK1;GNA13;KIT;ARF4;ESR1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.2902830463962651,0.4562376144799151,1.0,1.0,1.0,5/5,70.98%,DDAH1;TMBIM6;HYOU1;ENO1;NOL3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.24835652270394976,-0.45577691400740783,1.0,1.0,1.0,6/14,31.83%,SFRP2;CDKN2D;RPS3;TRIM32;BCL2L1;DDIAS
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.2922843469125713,0.45537276037649416,1.0,1.0,1.0,6/6,70.78%,FBXW7;PRKN;NONO;HIF1A;MCL1;PARK7
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.27272230671478526,-0.455041663744403,0.9545454545454546,1.0,1.0,2/9,23.20%,KLRD1;TUBB4B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.2870316330103888,0.4534251916901577,1.0,1.0,1.0,6/6,71.31%,SMAD4;BMPR1A;CDH3;HIF1A;SMAD3;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.25508147084799715,0.4523568693314211,0.975,1.0,1.0,2/11,14.66%,PRKG1;NDRG4
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.2884155237817333,-0.4502476611742063,0.9649122807017544,1.0,1.0,5/5,71.17%,NEU4;GM2A;HEXB;NEU1;NEU3
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.24301505125006162,-0.4502049111767754,1.0,1.0,1.0,1/18,10.69%,RPS13
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.3006946190540828,-0.4494998455158752,1.0,1.0,1.0,1/5,19.14%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.3006946190540828,-0.4494998455158752,1.0,1.0,1.0,1/5,19.14%,PHLDB2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.272339928792389,0.4476531303138386,1.0,1.0,1.0,7/7,72.78%,ATG2B;ATG7;RB1CC1;ATG2A;ATG13;ULK2;ULK1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.272339928792389,0.4476531303138386,1.0,1.0,1.0,7/7,72.78%,ATG2B;ATG7;RB1CC1;ATG2A;ATG13;ULK2;ULK1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.24437174400225944,0.4450974823035075,1.0,1.0,1.0,4/11,29.96%,EPS8;CTDP1;CLASP2;SPAST
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.20457144214830245,0.4449053332596063,1.0,1.0,1.0,5/27,21.80%,PGAP1;PIGP;DPM1;PIGF;PIGU
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),0.28473176854464455,0.444207872720913,0.9555555555555556,1.0,1.0,3/5,34.33%,SLC25A14;SLC13A3;SLC25A11
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.2692330767056028,-0.4434116778010798,1.0,1.0,1.0,4/10,28.66%,CLN3;RAB20;RAB34;RAB39A
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.2690662707747167,-0.4432113396553812,0.9850746268656716,1.0,1.0,3/8,33.65%,MYO9A;MSN;CAMSAP3
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.24982484820177486,-0.44287778873482875,1.0,1.0,1.0,12/12,75.04%,SET;HMGA1;ARID1A;SMARCD3;SMARCA4;SMARCB1;SMARCD2;SMARCD1;GRWD1;SUPT16H;ARID2;SMARCC1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.24982484820177486,-0.44287778873482875,1.0,1.0,1.0,12/12,75.04%,SET;HMGA1;ARID1A;SMARCD3;SMARCA4;SMARCB1;SMARCD2;SMARCD1;GRWD1;SUPT16H;ARID2;SMARCC1
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.28129559381383135,0.4427069339784623,1.0,1.0,1.0,5/5,71.88%,RPS6KA4;FMR1;MAPK3;RPS6KA5;CDK9
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.28611152798830924,0.44203935710344866,0.9722222222222222,1.0,1.0,2/5,33.48%,PTPN2;HIP1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.26610198598240703,-0.4395502241857474,0.9830508474576272,1.0,1.0,3/9,23.00%,TMEFF2;TGFB1;TAF7
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.2515466324267538,0.43688530158901806,1.0,1.0,1.0,6/6,74.85%,ERCC4;TERF2;ERCC1;SMG6;ATM;NBN
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.21666848493462587,-0.4365441400141668,1.0,1.0,1.0,5/18,29.23%,PINK1;SREBF1;HDAC6;SREBF2;PARK7
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.25162886461420575,-0.4361741154437478,1.0,1.0,1.0,3/10,30.38%,PAF1;DTX3L;CTR9
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.2143914099100086,0.4358029475456033,1.0,1.0,1.0,8/14,38.35%,RBM17;SRSF9;SCNM1;CDK13;SFPQ;DDX5;RSRC1;DHX9
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.2490051325115245,-0.4347038926010684,1.0,1.0,1.0,4/11,28.66%,CLN3;RAB20;RAB34;RAB39A
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.2573591325806144,-0.43459510409322416,1.0,1.0,1.0,2/10,21.79%,GSS;CHAC2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.24933966438501598,0.43317832303064363,0.9722222222222222,1.0,1.0,2/10,25.66%,TAMM41;PGS1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.2507630019891825,0.43255690338243924,0.98,1.0,1.0,2/7,31.08%,GTF3C3;GTF3C4
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.25021671120805855,-0.43253660801926996,1.0,1.0,1.0,1/11,12.54%,PIM1
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.2802614684253531,-0.4319950993575887,1.0,1.0,1.0,6/6,71.99%,GMFB;PICK1;DNAI3;CORO1B;CTNNA2;GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.2802614684253531,-0.4319950993575887,1.0,1.0,1.0,6/6,71.99%,GMFB;PICK1;DNAI3;CORO1B;CTNNA2;GMFG
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.26551100215957496,0.4306772856366019,1.0,1.0,1.0,7/7,73.46%,RBPJ;TGFBR1;BMPR1A;NOTCH1;TGFB2;NRG1;ENG
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.2275911216707626,0.4298096652831935,1.0,1.0,1.0,3/11,31.09%,PANK2;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2275911216707626,0.4298096652831935,1.0,1.0,1.0,3/11,31.09%,PANK2;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2275911216707626,0.4298096652831935,1.0,1.0,1.0,3/11,31.09%,PANK2;SLC25A16;PPCS
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.27425787886420677,-0.4293817645267087,0.9818181818181818,1.0,1.0,1/6,18.14%,MAPT
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.22619812036658693,0.42936680634709967,1.0,1.0,1.0,9/9,77.39%,EIPR1;RAB11B;SORL1;ACTN2;ATP9A;EHD2;INPP5F;ARHGAP1;EHD1
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.2618526559075333,-0.42818252470936713,0.9836065573770492,1.0,1.0,3/7,27.18%,NMNAT3;QPRT;NMNAT2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.24801540975951436,-0.427460809371582,1.0,1.0,1.0,8/8,75.22%,HES1;TGFB2;SIX4;PTCH1;BMPR2;BMPR1A;BMP7;TGFBR1
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.2539248809255256,-0.42613670681675286,1.0,1.0,1.0,4/12,29.75%,DDRGK1;ULK1;ULK2;RETREG1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),0.2223977270478909,0.42475066158363456,0.9736842105263158,1.0,1.0,4/10,23.65%,HDAC10;SMOX;SRM;SAT1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.23660334242887782,-0.42464815367313974,1.0,1.0,1.0,3/20,22.12%,POLR2I;TINF2;POLR2J
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.23660334242887782,-0.42464815367313974,1.0,1.0,1.0,3/20,22.12%,POLR2I;TINF2;POLR2J
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),0.21843279551827416,0.4244044662168353,1.0,1.0,1.0,6/13,30.67%,NUDT15;ENPP3;ENTPD1;ENTPD4;ENTPD6;DCTPP1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.24819052066308664,0.4239437632012436,1.0,1.0,1.0,8/8,75.19%,BECN1;PRKN;AMBRA1;PHB2;MAP1LC3B;ATG13;ATG14;SQSTM1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.19049352450885837,-0.4230816578692974,1.0,1.0,1.0,9/42,29.03%,SNRPD2;CELF4;SNRNP200;PRPF6;SRSF5;DDX23;SMN1;TXNL4A;NOL3
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.1910756468027178,0.42304169739323133,1.0,1.0,1.0,2/24,15.99%,AKT1;GPR37L1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.2470231146392716,0.4228866304699917,1.0,1.0,1.0,8/8,75.31%,GTF3C3;GTF3C4;GTF3C2;GTF3C5;GTF3C1;BRF1;POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2143534448873066,0.4223222735917878,1.0,1.0,1.0,4/18,29.42%,KCTD17;RAP1GDS1;BAK1;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.2753988399759886,0.42078048931219575,1.0,1.0,1.0,2/6,22.55%,PIK3R1;PTK2
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.2684293468744528,-0.4180025623108531,1.0,1.0,1.0,7/7,73.17%,SQSTM1;MAP1LC3B;ATM;PJVK;NBR1;USP30;PEX5
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),0.2281244527464831,0.41781752712212017,1.0,1.0,1.0,9/9,77.20%,EP300;GCK;PGP;CRY1;CLK2;BCKDK;NCOR1;MST1;ACMSD
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.2407834624496239,0.4141764738524655,1.0,1.0,1.0,3/9,31.23%,BDH2;HMGCL;BDH1
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.2611904642102988,-0.4136050369288062,1.0,1.0,1.0,1/5,21.37%,PTPRC
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.19831762068719685,0.4134165849453233,1.0,1.0,1.0,7/17,34.37%,EPS8;ABI2;TIAM1;NCKAP1;BRK1;HACE1;FARP2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.2584184417858185,-0.4124967075196904,1.0,1.0,1.0,5/5,74.17%,SMC5;MACROH2A1;SLF1;SLF2;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.2584184417858185,-0.4124967075196904,1.0,1.0,1.0,5/5,74.17%,SMC5;MACROH2A1;SLF1;SLF2;NSMCE2
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.2584184417858185,-0.4124967075196904,1.0,1.0,1.0,5/5,74.17%,SMC5;MACROH2A1;SLF1;SLF2;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.2538965574787988,0.4116729142183982,1.0,1.0,1.0,2/6,26.93%,RNF34;FZD3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.19163950095498616,-0.4103157476113438,1.0,1.0,1.0,8/34,28.71%,DLC1;PRKCD;TGFB1;NSMF;CALM3;PPP1R16B;PPP1R7;HSP90B1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.2490797343334814,0.409805170016919,1.0,1.0,1.0,3/8,31.23%,BDH2;HMGCL;BDH1
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.25532535745550045,0.40962595236940136,0.9807692307692307,1.0,1.0,5/5,74.47%,TMEM108;ZDHHC17;DOK5;AGT;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.24935540449150664,0.40895690141815666,1.0,0.9993396941534312,1.0,2/6,28.27%,HES5;NF1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.24935540449150664,0.40895690141815666,1.0,0.9993396941534312,1.0,2/6,28.27%,HES5;NF1
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.2705639425137778,-0.4080318358104588,1.0,1.0,1.0,3/5,33.48%,SQSTM1;ATG14;GPS2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.2407467184617899,-0.40704735420167804,0.9827586206896551,1.0,1.0,1/10,12.02%,PSMC3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.2786092568395656,-0.4059247073185749,0.9814814814814815,1.0,1.0,2/5,29.54%,DHODH;CTPS1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.2413897900127157,0.3991345343928528,1.0,0.9996612861821775,1.0,1/6,15.38%,RNF26
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.2658885322439452,0.3980651921172971,1.0,0.9992776299273143,1.0,5/5,73.42%,RPS6KA4;VRK1;HMGA2;RPS6KA5;MST1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),-0.2711918488530951,-0.39651704819467476,1.0,1.0,1.0,1/5,24.22%,PPARG
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.26356276761294617,-0.39554194416448546,1.0,1.0,1.0,3/7,27.22%,FES;ADGRE2;UNC13D
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.2327486664295091,-0.39312507584770706,1.0,1.0,1.0,2/7,23.98%,STAT3;EIF4ENIF1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.2327486664295091,-0.39312507584770706,1.0,1.0,1.0,2/7,23.98%,STAT3;EIF4ENIF1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.21621034991804888,-0.3925568332488219,1.0,1.0,1.0,4/12,29.04%,CAMK1D;SLIT2;MST1;ADAM17
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.2598577455840472,-0.3912583797922046,1.0,1.0,1.0,2/5,24.01%,BCAT1;BCAT2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.23476535138921317,0.3906865666887611,1.0,0.9991825854976695,1.0,8/8,76.53%,RGN;GSTO2;CYB5A;SLC23A2;SLC2A1;SLC2A3;CYB5R3;GSTO1
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.25294059314215644,-0.38308881269570827,1.0,1.0,1.0,1/5,17.35%,SNX6
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.21547903420539205,-0.38171193338828224,1.0,1.0,1.0,1/13,12.54%,PIM1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.22672438809894963,-0.3802828634386242,1.0,1.0,1.0,4/9,31.86%,CTNS;GIPC1;MFSD12;ASIP
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.22400607157452276,-0.3800205011500998,1.0,1.0,1.0,11/11,77.62%,HSPA5;SEC62;SEC61B;SEC61G;SGTB;CHMP4B;SGTA;SEC63;GET3;SEC61A2;SEC61A1
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.2372697329608118,-0.3775734679718991,1.0,1.0,1.0,2/6,27.09%,RPUSD1;RPUSD3
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.1852113196376351,-0.37657707930360684,1.0,1.0,1.0,3/21,23.24%,OGG1;TINF2;PARP2
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.2280401859701892,0.37518055308331005,1.0,0.9993490694894998,1.0,2/7,20.24%,EP300;PRKAA1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.2364793219757621,-0.37335379660159207,0.9827586206896551,1.0,1.0,1/7,18.34%,HSPA5
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.2173954765438452,-0.36100482150553675,1.0,1.0,1.0,3/8,29.43%,AXIN2;DDX11;CTNNB1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.20058394160583942,-0.3609490079540634,1.0,1.0,1.0,15/15,79.96%,EMC1;EMC3;EMC9;CAMLG;EMC6;EMC4;EMC10;BAG6;EMC7;SGTA;GET3;EMC2;EMC8;UBL4A;MMGT1
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.20995858565151984,-0.3599218580581364,1.0,1.0,1.0,5/10,33.67%,EMC1;EMC3;EMC9;EMC6;EMC4
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.2151395986941737,-0.35486699017810475,1.0,1.0,1.0,5/9,30.38%,NELFE;SUPT5H;BARD1;CDK9;CTR9
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.22663865055740384,-0.3448958394109391,1.0,1.0,1.0,7/7,77.35%,KIF11;RANBP1;CHEK1;NSFL1C;CEP85;MAP9;UBXN2B
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.1923234213163153,-0.34447449130877333,1.0,1.0,1.0,3/15,25.81%,FASN;SCD;CBR4
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.2032918928383821,-0.3233404547349197,1.0,0.9999741361473206,1.0,7/7,79.68%,PAH;MTHFD1;SDS;CPS1;ALDH18A1;CAD;SDSL
